broad_name	name	smiles	unii	clinical_phase	moa	target
(1E)-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime	(1E)-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime	CCCCCCCCCCCC([N+][O-])c1cc(C)ccc1O		Preclinical		
1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol	1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol	CC(C)NCC(O)COc1cc(C)ccc1Cl		Preclinical		
1-(piperidin-1-yl)prop-2-en-1-one	1-(piperidin-1-yl)prop-2-en-1-one	C=CC(=O)N1CCCCC1		Preclinical		
1-acetyl-4-methylpiperazine	1-acetyl-4-methylpiperazine	CN1CCN(CC1)C(C)=O		Preclinical	acetylcholine receptor agonist	
1-azakenpaullone	1-azakenpaullone	Brc1ccc2[nH]c-3c(CC(=O)Nc4cccnc-34)c2c1		Preclinical	glycogen synthase kinase inhibitor	CCNB1|CDK1|CDK5|GSK3B
1-deoxymannojirimycin	1-deoxymannojirimycin|MIGALASTAT|DUVOGLUSTAT	OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O	C4XNY919FW|FZ56898FLE	Preclinical	alpha mannosidase inhibitor	MAN2A1
1-EBIO	1-EBIO|1-ETHYL-2-BENZIMIDAZOLINONE	CCn1c2ccccc2[nH]c1=O	M82W79SS4W	Preclinical	potassium channel activator	KCNN1|KCNN2|KCNN3|KCNN4
1-ethyl-2-pyrrolidone	1-ethyl-2-pyrrolidone|ETHYL PYRROLIDONE	CCN1CCCC1=O	H0229SX1CW	Preclinical	transdermal absorption-enhancing compound	
1-hexadecanal	1-hexadecanal|HEXADECANAL	CCCCCCCCCCCCCCCC=O	WQD27655QE	Preclinical	sphingosine 1 phosphate receptor substrate	DBI|RHO
1-hexadecanol	1-hexadecanol|CETYL ALCOHOL	CCCCCCCCCCCCCCCCO	936JST6JCN	Launched		
1-naphthyl-PP1	1-naphthyl-PP1	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc12		Preclinical	src inhibitor	SRC
1-octacosanol	1-octacosanol|1-OCTACOSANOL	CCCCCCCCCCCCCCCCCCCCCCCCCCCCO	81I2215OVK	Phase 2		
1-octanol	1-octanol|CAPRYLIC ALCOHOL	CCCCCCCCO	NV1779205D	Phase 2		GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1
1-phenylbiguanide	1-phenylbiguanide|PHENYL BIGUANIDE	NC(=N)NC(=N)Nc1ccccc1	W8PKA3T2I3	Preclinical	serotonin receptor agonist	HTR3A|HTR3B
10-deacetylbaccatin	10-deacetylbaccatin|10-DEACETYLBACCATIN III	CC(=O)O[C@@]12CO[C@@H]1C[C@@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](O)C(C)=C([C@@H](O)C1=O)C2(C)C	4K6EWW2Z45	Preclinical	antitumor agent	
10-DEBC	10-DEBC	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc12		Preclinical	AKT inhibitor	PIM1
10-hydroxycamptothecin	10-hydroxycamptothecin|10-HYDROXYCAMPTOTHECIN	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)cc4cc3Cn1c2=O	9Z01632KRV	Preclinical	topoisomerase inhibitor	TOP1
10058-F4	10058-F4	CCc1ccc(cc1)\C=C1\SC(=S)NC1=O		Preclinical	c-Myc inhibitor	
12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate|PHORBOL 12-MYRISTATE 13-ACETATE DIESTER	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@]2(O)[C@@H]3C=C(C)C(=O)[C@@]3(O)CC(CO)=C[C@H]2[C@@H]2C(C)(C)[C@]12OC(C)=O	NI40JAQ945	Phase 2	PKC activator	KCNT2|TRPV4
1400W	1400W	CC(=N)NCc1cccc(CN)c1		Preclinical	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
17-alpha-methyltestosterone	17-alpha-methyltestosterone|METHYLTESTOSTERONE	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	V9EFU16ZIF	Launched	aromatase inhibitor	AR
17-hydroxyprogesterone-caproate	17-hydroxyprogesterone-caproate|HYDROXYPROGESTERONE CAPROATE	CCCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O	276F2O42F5	Launched	progesterone receptor agonist	AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR
17-PA	17-PA	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CC=C2c1ccccc1		Preclinical	glucocorticoid receptor agonist	
2'-c-methylguanosine	2'-c-methylguanosine	C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(O)nc(N)nc12		Preclinical	HCV inhibitor	
2'-MeCCPA	2'-MeCCPA	C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC3CCCC3)nc(Cl)nc12		Preclinical	adenosine receptor agonist	ADORA1
2-(3-mercaptopropyl)pentanedioic acid	2-(3-mercaptopropyl)pentanedioic acid	OC(=O)CCC(CCCS)C(O)=O		Phase 1	glutamate carboxypeptidase inhibitor	FOLH1
2-[1-(4-piperonyl)piperazinyl]benzothiazole	2-[1-(4-piperonyl)piperazinyl]benzothiazole	C(N1CCN(CC1)c1nc2ccccc2s1)c1ccc2OCOc2c1		Preclinical	serotonin receptor agonist	HTR4
2-aminobenzenesulfonamide	2-aminobenzenesulfonamide	Nc1ccccc1S(N)(=O)=O		Preclinical	carbonic anhydrase inhibitor	CA12|CA14|CA2|CA6|CA9
2-APB	2-APB|2-AMINOETHOXYDIPHENYLBORATE	NCCOB(c1ccccc1)c1ccccc1	E4ES684O93	Preclinical	1,4,5-trisphosphate inhibitor	TRPC1|TRPC3|TRPC4|TRPC5|TRPC6|TRPC7|TRPM2|TRPM3|TRPM6|TRPV1|TRPV6
2-BFI	2-BFI	C1CN=C(N1)c1cc2ccccc2o1		Preclinical	imidazoline receptor ligand	ADRA2A|ADRA2B|ADRA2C|MAOA|MAOB
2-chloro-N6-cyclopentyladenosine	2-chloro-N6-cyclopentyladenosine	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NC3CCCC3)nc(Cl)nc12		Preclinical	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
2-Chloropyrazine	2-Chloropyrazine	Clc1cnccn1		Preclinical		
2-CMDO	2-CMDO|2-CHLORO-11-(4-METHYLPIPERAZINO)DIBENZ(B,F)OXEPIN	CN1CCN(CC1)C1=Cc2ccccc2Oc2ccc(Cl)cc12	3Y353LOH79	Preclinical	dopamine receptor antagonist	DRD2|DRD4
2-cyanopyrimidine	2-cyanopyrimidine	N#Cc1ncccn1		Preclinical	cathepsin inhibitor	
2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose	2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose|STREPTOZOCIN	CN([N+][O-])C(=O)NC(C=O)C(O)C(O)C(O)CO	5W494URQ81	Preclinical		
2-deoxyglucose	2-deoxyglucose|2-DEOXYGLUCOSE	OC[C@H]1O[C@H](O)C[C@@H](O)[C@@H]1O	9G2MP84A8W	Phase 2	glycolysis inhibitor	SLC2A1|SLC2A2|SLC2A3|SLC2A4
2-ethoxybenzoic-acid	2-ethoxybenzoic-acid	CCOc1ccccc1C(O)=O		Phase 1	analgesic agent	
2-fluoro-2-deoxy-D-galactose	2-fluoro-2-deoxy-D-galactose	OCC1OC(O)C(F)C(O)C1O		Phase 1		LCT
2-hydroxyethyl-salicylate	2-hydroxyethyl-salicylate|GLYCOL SALICYLATE	OCCOC(=O)c1ccccc1O	3I1VBB7AXH	Launched		
2-hydroxyflutamide	2-hydroxyflutamide|HYDROXYFLUTAMIDE	CC(C)(O)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O	31D90UKP5Y	Phase 1/Phase 2	androgen receptor antagonist	AR
2-hydroxysaclofen	2-hydroxysaclofen|2-HYDROXYSACLOFEN	NCC(O)(CS(O)(=O)=O)c1ccc(Cl)cc1	X5IFR0UF10	Preclinical	GABA receptor antagonist	GABBR1|GABBR2
2-iminobiotin	2-iminobiotin|2-IMINOBIOTIN	OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=N)N[C@H]12	HXH71NRQ5C	Phase 2	nitric oxide synthase inhibitor	NOS1|NOS2
2-iodohippuric-acid	2-iodohippuric-acid|IODOHIPPURIC ACID	OC(=O)CNC(=O)c1ccccc1I	3Y68K91A3M	Preclinical		
2-iodomelatonin	2-iodomelatonin	COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1		Preclinical	melatonin receptor agonist	MTNR1A|MTNR1B|NQO2
2-methoxyestradiol	2-methoxyestradiol|2-METHOXYESTRADIOL	COc1cc2[C@@H]3CC[C@]4(C)[C@H](O)CC[C@H]4[C@@H]3CCc2cc1O	6I2QW73SR5	Phase 2	hypoxia inducible factor inhibitor	COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB
2-methyl-5-hydroxytryptamine	2-methyl-5-hydroxytryptamine	Cc1[nH]c2ccc(O)cc2c1CCN		Preclinical	serotonin receptor agonist	HTR1B|HTR1D|HTR1E|HTR1F|HTR3A|HTR3B|HTR6
2-methyl-5-nitrophenol	2-methyl-5-nitrophenol	Cc1ccc(cc1O)[N+]([O-])=O		Preclinical		
2-methylimidazole	2-methylimidazole|2-METHYLIMIDAZOLE	Cc1ncc[nH]1	T0049Z45LZ	Preclinical	cholesterol inhibitor	
2-octyldodecan-1-ol	2-octyldodecan-1-ol|OCTYLDODECANOL	CCCCCCCCCCC(CO)CCCCCCCC	461N1O614Y	Preclinical		
2-Oleoylglycerol	2-Oleoylglycerol|GLYCERYL 2-OLEATE	CCCCCCCC\C=C/CCCCCCCC(=O)OC(CO)CO	9A2389K694	Phase 1	glucose dependent insulinotropic receptor ligand	GPR119
2-oxoglutaric-acid	2-oxoglutaric-acid|OXOGLURIC ACID	OC(=O)CCC(=O)C(O)=O	8ID597Z82X	Preclinical		OXGR1
2-oxopropanoate	2-oxopropanoate|PYRUVIC ACID	CC(=O)C(O)=O	8558G7RUTR	Preclinical	pyruvate dehydrogenase kinase inhibitor	ABAT|AGXT2|PC|PDHB|PKLR|PKM|SLC16A1|SLC16A2|SLC16A3|SLC16A4|SLC16A5|SLC16A6|SLC16A7|SLC16A8
2-phenylmelatonin	2-phenylmelatonin	COc1ccc2[nH]c(c(CCNC(C)=O)c2c1)-c1ccccc1		Preclinical	melatonin receptor agonist	MTNR1A|MTNR1B
2-PMDQ	2-PMDQ	O=C1Nc2ccccc2C2=NC(CN3CCN(CC3)c3ccccc3)CN12		Preclinical	adrenergic receptor antagonist	ADRA1A
2-pyridylethylamine	2-pyridylethylamine|2-PYRIDINEETHANAMINE	NCCc1ccccn1	ATW1AH7OJ5	Preclinical	histamine receptor agonist	HRH1
2-TEDC	2-TEDC	Oc1ccc(\C=C(/C#N)C(=O)OCCc2cccs2)cc1O		Preclinical	lipoxygenase inhibitor	ALOX12
2-thiouracil	2-thiouracil|THIOURACIL	Oc1ccnc(S)n1	59X161SCYL	Preclinical		
20-hydroxyecdysone	20-hydroxyecdysone|20-HYDROXYECDYSONE	CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@@H]3CC[C@]12C	779A7KPL0Y	Preclinical	ecdysone receptor modulator	
3'-fluorobenzylspiperone	3'-fluorobenzylspiperone	Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CN(Cc1cccc(F)c1)C2=O)c1ccccc1		Preclinical	dopamine receptor ligand	DRD2
3-(4-methylbenzylidene)camphor	3-(4-methylbenzylidene)camphor|ENZACAMENE, (+)-|ENZACAMENE	Cc1ccc(cc1)\C=C1\C2CCC(C)(C1=O)C2(C)C	7576E1028E|8I3XWY40L9	Launched	endocrine disruptor	
3-alpha-bis-(4-fluorophenyl)-methoxytropane	3-alpha-bis-(4-fluorophenyl)-methoxytropane	CN1C2CCC1CC(C2)OC(c1ccc(F)cc1)c1ccc(F)cc1		Preclinical	dopamine uptake inhibitor	CHRM1|SLC6A2|SLC6A3|SLC6A4
3-alpha-Hydroxy-5-beta-androstan-17-one	3-alpha-Hydroxy-5-beta-androstan-17-one|EPIANDROSTERONE|ETIOCHOLANOLONE|EPIETIOCHOLANOLONE|ANDROSTERONE	C[C@]12CCC3[C@@H](CC[C@@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O	8TR252Z538|97CGB1M48I|C1751JYC6P|C24W7J5D5R	Preclinical		
3-amino-benzamide	3-amino-benzamide|3-AMINOBENZAMIDE	NC(=O)c1cccc(N)c1	8J365YF1YH	Phase 2	PARP inhibitor	PARP1
3-anilinopropan-1-ol	3-anilinopropan-1-ol	OCCCNc1ccccc1		Preclinical		
3-AQC	3-AQC	C=CCN1CCN(CC1)c1nc2ccccc2nc1C#N		Preclinical	serotonin receptor agonist	HTR3A
3-bromo-7-nitroindazole	3-bromo-7-nitroindazole	[O-][N+](=O)c1cccc2c(Br)n[nH]c12		Preclinical	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
3-bromocamphor	3-bromocamphor|3-BROMOCAMPHOR, (+)-|3-BROMOCAMPHOR, (+/-)-	CC1(C)C2CCC1(C)C(=O)C2Br	E6SHQ2AT1P|NAY429URSN	Launched		
3-bromopyruvate	3-bromopyruvate|BROMOPYRUVATE	OC(=O)C(=O)CBr	63JMV04GRK	Preclinical	hexokinase inhibitor	HK2
3-carboxy-4-hydroxyphenylglycine-(R)	3-carboxy-4-hydroxyphenylglycine-(R)	N[C@@H](C(O)=O)c1ccc(O)c(c1)C(O)=O		Preclinical	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C
3-carboxy-4-hydroxyphenylglycine-(S)	3-carboxy-4-hydroxyphenylglycine-(S)	N[C@H](C(O)=O)c1ccc(O)c(c1)C(O)=O		Preclinical	glutamate receptor antagonist	GRM1|GRM5
3-CPMT	3-CPMT|CLOBENZTROPINE	CN1C2CCC1CC(C2)OC(c1ccccc1)c1ccc(Cl)cc1	M8CDT278F8	Preclinical	dopamine reuptake inhibitor	
3-deazaadenosine	3-deazaadenosine|3-DEAZAADENOSINE	Nc1nccc2n(cnc12)[C@@H]1O[C@H](CO)C(O)C1O	037V4520IY	Phase 2	adenosylhomocysteinase inhibitor	AHCY
3-deazaneplanocin-A	3-deazaneplanocin-A|3-DEAZANEPLANOCIN	Nc1nccc2n(cnc12)[C@@H]1C=C(CO)[C@@H](O)[C@@H]1O	544SH4020S	Preclinical	histone lysine methyltransferase inhibitor	EZH2
3-deazauridine	3-deazauridine|3-DEAZAURIDINE	OCC1OC(C(O)C1O)N1C=CC(=O)CC1=O	263CU738ZY	Preclinical	cytidine deaminase inhibitor	
3-hydroxy-3-phenylpentanamide	3-hydroxy-3-phenylpentanamide	CCC(O)(CC(N)=O)c1ccccc1		Phase 1	GABA receptor modulator	
3-indolebutyric-acid	3-indolebutyric-acid|INDOLEBUTYRIC ACID	OC(=O)CCCc1c[nH]c2ccccc12	061SKE27JP	Preclinical		B2M|HLA-A|TRAC|TRBC1
3-MATIDA	3-MATIDA	Cc1cc(sc1C(N)C(O)=O)C(O)=O		Preclinical		GRM1
3-methyl-GABA	3-methyl-GABA	CC(CN)CC(O)=O		Preclinical	GABA aminotransferase activator	ABAT
3-methyladenine	3-methyladenine	Cn1cnc(=N)c2nc[nH]c12		Preclinical	PI3K inhibitor	PI3
3-MPPI	3-MPPI	COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c4ccccc4[nH]c3c2=O)CC1		Preclinical	adrenergic receptor ligand	ADRA1A
3PO	3PO|TRIPHOSPHORIC ACID	O=C(\C=C\c1cccnc1)c1ccncc1	NU43IAG5BC	Preclinical	phosphofructokinase inhibitor	PFKFB3
4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine	4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine	Fc1ccc(cc1)C(=O)C1CCN(CCCCc2ccccc2)CC1		Preclinical	serotonin receptor antagonist	HTR2A
4-aminohippuric-acid	4-aminohippuric-acid|AMINOHIPPURIC ACID	Nc1ccc(cc1)C(=O)NCC(O)=O	Y79XT83BJ9	Preclinical		SLC22A6
4-carboxy-3-hydroxyphenylglycine-(RS)	4-carboxy-3-hydroxyphenylglycine-(RS)|4-CARBOXY-3-HYDROXYPHENYLGLYCINE, (R)-|4-CARBOXY-3-HYDROXYPHENYLGLYCINE, (S)-	NC(C(O)=O)c1ccc(C(O)=O)c(O)c1	97Z873Y20X|DFS3SIU1ME	Preclinical	glutamate receptor agonist|glutamate receptor antagonist	GRM1
4-carboxy-3-hydroxyphenylglycine-(S)	4-carboxy-3-hydroxyphenylglycine-(S)|4-CARBOXY-3-HYDROXYPHENYLGLYCINE, (S)-	N[C@H](C(O)=O)c1ccc(C(O)=O)c(O)c1	DFS3SIU1ME	Preclinical	glutamate receptor agonist|glutamate receptor antagonist	GRM1|GRM2
4-chlorophenylguanidine	4-chlorophenylguanidine	NC(=N)Nc1ccc(Cl)cc1		Preclinical	urokinase inhibitor	PLAUR
4-DAMP	4-DAMP	C[N+]1(C)CCC(CC1)OC(=O)C(c1ccccc1)c1ccccc1		Preclinical	cholinergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
4-galactosyllactose	4-galactosyllactose|.ALPHA.-CELLULOSE	OC[C@H]1O[C@@H](O[C@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O	I355QGZ19A	Preclinical		AMY2B
4-HQN	4-HQN|4-HYDROXYQUINAZOLINE	Oc1ncnc2ccccc12	84JOT4EY5X	Preclinical	PARP inhibitor	PARP1
4-hydroxy-phenazone	4-hydroxy-phenazone	Cc1c(O)c(=O)n(-c2ccccc2)n1C		Preclinical		
4-IBP	4-IBP	Ic1ccc(cc1)C(=O)NC1CCN(Cc2ccccc2)CC1		Preclinical	sigma receptor agonist	SIGMAR1
4-iodo-6-phenylpyrimidine	4-iodo-6-phenylpyrimidine	Ic1cc(ncn1)-c1ccccc1		Preclinical	macrophage migration inhibiting factor inhibitor	MIF
4-iodo-L-phenylalanine	4-iodo-L-phenylalanine|4-IODOPHENYLALANINE	N[C@H](Cc1ccc(I)cc1)C(O)=O	J882Z73MPL			DPP4
4-methylgenistein	4-methylgenistein|BIOCHANIN A	COc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O	U13J6U390T	Preclinical	protein tyrosine kinase inhibitor	CYP19A1|ESRRA|ESRRB|ESRRG|FASN
4-methylhistamine	4-methylhistamine|4-METHYLHISTAMINE	Cc1nc[nH]c1CCN	54ST71P9EE	Preclinical	histamine receptor agonist	HRH4
4-mu-8C	4-mu-8C	Cc1cc(=O)oc2c(C=O)c(O)ccc12		Preclinical	IRE1 inhibitor	ERN1
4-P-PDOT	4-P-PDOT	CCC(=O)NC1CC(c2ccccc2)c2ccccc2C1		Preclinical	melatonin receptor antagonist	MTNR1A|MTNR1B
4-phenolsulfonic-acid	4-phenolsulfonic-acid|PHENOLSULFONIC ACID	Oc1ccc(cc1)S(O)(=O)=O	L74LRO149A	Preclinical		
4-PPBP	4-PPBP	C(CCc1ccccc1)CN1CCC(CC1)c1ccccc1		Preclinical	sigma receptor ligand	SIGMAR1
4-propylbenzoic-acid	4-propylbenzoic-acid|4-N-PROPYLBENZOIC ACID	CCCc1ccc(cc1)C(O)=O	3P1V85E45O	Preclinical		
4-pyrimidinecarbonitrile	4-pyrimidinecarbonitrile	N#Cc1ccncn1		Preclinical		
4-tert-butylphenol	4-tert-butylphenol|4-TERT-BUTYLPHENOL	CC(C)(C)c1ccc(O)cc1	O81VMW36CV	Preclinical		
4E1RCat	4E1RCat	OC(=O)c1ccc(cc1)N1C(=O)C(=C/c2ccc(o2)-c2ccc(cc2)[N+]([O-])=O)\C=C1c1ccccc1		Preclinical	protein synthesis inhibitor	EIF4E|EIF4G1
4EGI-1	4EGI-1	OC(=O)C(\Cc1ccccc1[N+]([O-])=O)=N\Nc1nc(cs1)-c1ccc(Cl)c(Cl)c1		Preclinical	protein synthesis inhibitor	EIF4E
4SC-202	4SC-202	Cn1cc(cn1)-c1ccc(cc1)S(=O)(=O)n1ccc(\C=C\C(=O)Nc2ccccc2N)c1	264ARM7UXX	Phase 1	HDAC inhibitor	HDAC1
5'-Chloro-5'-deoxy-ENBA-(+/-)	5'-Chloro-5'-deoxy-ENBA-(+/-)	O[C@@H]1[C@@H](CCl)O[C@H]([C@@H]1O)n1cnc2c(NC3CC4CCC3C4)ncnc12		Preclinical	adenosine receptor agonist	ADORA1
5-aminolevulinic-acid	5-aminolevulinic-acid|AMINOLEVULINIC ACID	NCC(=O)CCC(O)=O	88755TAZ87	Launched	oxidizing agent	ALAD
5-BDBD	5-BDBD	Brc1cccc(c1)C1=NCC(=O)Nc2c1oc1ccccc21		Preclinical	purinergic receptor antagonist	P2RX4
5-carboxamidotryptamine	5-carboxamidotryptamine|5-CARBOXAMIDOTRYPTAMINE	NCCc1c[nH]c2ccc(cc12)C(N)=O	91H76044O0	Preclinical	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
5-fluoro-3-pyridyl-methanol	5-fluoro-3-pyridyl-methanol	OCc1cncc(F)c1		Preclinical		
5-fluorouracil	5-fluorouracil|FLUOROURACIL	Fc1c[nH]c(=O)[nH]c1=O	U3P01618RT	Launched	thymidylate synthase inhibitor	DPYD|TYMS
5-FP	5-FP|5-FLUOROPYRIMIDIN-2-ONE	Oc1ncc(F)cn1	1VXI7T1BI5	Phase 1	thymidylate synthase inhibitor	TYMS
5-HMF	5-HMF|5-(HYDROXYMETHYL)-2-FURALDEHYDE	OCc1ccc(C=O)o1	70ETD81LF0	Phase 2		
5-hydroxyectoine	5-hydroxyectoine|HYDROXYECTOIN	O[C@H]1CNC(=C)N[C@@H]1C(O)=O	CIJ7YN252E	Preclinical		
5-hydroxymethyl-tolterodine	5-hydroxymethyl-tolterodine|DESFESOTERODINE	CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1O)C(C)C	YU871O78GR	Phase 1	acetylcholine receptor antagonist	CHRM3
5-hydroxytryptophan	5-hydroxytryptophan|OXITRIPTAN	NC(Cc1c[nH]c2ccc(O)cc12)C(O)=O	C1LJO185Q9	Launched	neurotransmitter	SLC36A1|SLC36A2
5-iodo-A-85380	5-iodo-A-85380|3-((2S)-2-AZETIDINYLMETHOXY)-5-IODO-PYRIDINE	Ic1cncc(OC[C@@H]2CCN2)c1	POX639L40H	Phase 2	acetylcholine receptor agonist	
5-methylfurmethiodide	5-methylfurmethiodide	Cc1ccc(C[N+](C)(C)C)o1		Preclinical	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
5-methylhydantoin-(D)	5-methylhydantoin-(D)	C[C@H]1NC(=O)NC1=O		Preclinical		
5-methylhydantoin-(L)	5-methylhydantoin-(L)	C[C@@H]1NC(=O)NC1=O		Preclinical		
6-aminochrysene	6-aminochrysene|6-CHRYSENAMINE	Nc1cc2c3ccccc3ccc2c2ccccc12	I56L81BL2L	Phase 2	transferase inhibitor	
6-aminopenicillanic-acid	6-aminopenicillanic-acid|6-AMINOPENICILLANIC ACID	CC1(C)S[C@@H]2[C@H](N)C(=O)N2[C@H]1C(O)=O	QR0C4R7XVN	Preclinical		
6-benzylaminopurine	6-benzylaminopurine|N6-BENZYLADENINE	N(Cc1ccccc1)c1ncnc2nc[nH]c12	KXG6A989PS	Preclinical	purinergic receptor activator	
6-chloromelatonin	6-chloromelatonin	COc1cc2c(CCNC(C)=O)c[nH]c2cc1Cl		Preclinical	melatonin receptor agonist	MTNR1A|MTNR1B
6-iodo-nordihydrocapsaicin	6-iodo-nordihydrocapsaicin	CCCCCCCCC(=O)NCc1cc(OC)c(O)cc1I		Preclinical	TRPV antagonist	TRPV1
7-aminocephalosporanic-acid	7-aminocephalosporanic-acid|7-AMINOCEPHALOSPORANIC ACID	CC(=O)OCC1=C(N2[C@H](SC1)[C@@H](N)C2=O)C(O)=O	9XI67897RG	Preclinical	beta lactamase inhibitor	
7-chlorokynurenic-acid	7-chlorokynurenic-acid|7-CHLOROKYNURENIC ACID	OC(=O)c1cc(O)c2ccc(Cl)cc2n1	S7936QON2K	Preclinical	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C
7-hydroxy-DPAT	7-hydroxy-DPAT|7-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN	CCCN(CCC)C1CCc2ccc(O)cc2C1	RR7D75YDF4	Preclinical	dopamine receptor agonist	DRD2|DRD3
7-hydroxy-PIPAT	7-hydroxy-PIPAT	CCCN(C\C=C\I)C1CCc2ccc(O)cc2C1		Preclinical	dopamine receptor ligand	DRD3
7-hydroxystaurosporine	7-hydroxystaurosporine|7-HYDROXYSTAUROSPORINE	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4[C@H](O)NC(=O)c4c4c5ccccc5n2c4c13	7BU5H4V94A	Phase 2	CDK inhibitor|CHK inhibitor|PKC inhibitor	CHEK1|MARK3|PDPK1
7-keto-DHEA	7-keto-DHEA|7-KETO-DEHYDROEPIANDROSTERONE	CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3C(=O)C=C2C1	2334LJD2E9	Launched	steroid	
7-methoxytacrine	7-methoxytacrine	COc1ccc2nc3CCCCc3c(N)c2c1		Phase 2	acetylcholinesterase inhibitor	ACHE
7-methylxanthine	7-methylxanthine|7-METHYLXANTHINE	Cn1cnc2nc(O)nc(O)c12	E9M81NJM6G	Phase 2	adenosine receptor antagonist	
7-nitroindazole	7-nitroindazole|7-NITROINDAZOLE	[O-][N+](=O)c1cccc2cn[nH]c12	UX0N37CMVH	Preclinical	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
8-bromo-cAMP	8-bromo-cAMP	Nc1ncnc2n([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)c(Br)nc12		Preclinical	PKA activator	
8-bromo-cGMP	8-bromo-cGMP	Nc1nc(O)c2nc(Br)n([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)c2n1		Preclinical	PKA activator	PRKG1
8-hydroxy-DPAT	8-hydroxy-DPAT|8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, (+/-)-	CCCN(CCC)C1CCc2cccc(O)c2C1	IWS1724PX6	Preclinical	serotonin receptor agonist	CDK1|CHEK1|CHEK2|GSK3B|HTR5A|HTR7|LCK|MAPK14|MARK1|PDPK1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG
8-hydroxy-PIPAT	8-hydroxy-PIPAT	CCCN(C\C=C\I)C1CCc2cccc(O)c2C1		Preclinical	dopamine receptor ligand	DRD2|DRD3
8-M-PDOT	8-M-PDOT	CCC(=O)NC1CCc2cccc(OC)c2C1		Preclinical	melatonin receptor agonist	MTNR1A|MTNR1B
80841-78-7	80841-78-7	Cc1oc(=O)oc1CCl		Preclinical		
9-aminoacridine	9-aminoacridine|AMINACRINE	Nc1c2ccccc2nc2ccccc12	78OY3Z0P7Z	Preclinical		
9-aminocamptothecin	9-aminocamptothecin|9-AMINOCAMPTOTHECIN	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cccc(N)c4cc3Cn1c2=O	5MB77ICE2Q	Phase 2	topoisomerase inhibitor	TOP1
9-anthracenecarboxylic-acid	9-anthracenecarboxylic-acid|9-AMINOCAMPTOTHECIN	OC(=O)c1c2ccccc2cc2ccccc12	5MB77ICE2Q	Preclinical		ANO1|CLCN1
A-317491	A-317491	OC(=O)c1cc(C(O)=O)c(cc1C(O)=O)C(=O)N(Cc1cccc(Oc2ccccc2)c1)[C@H]1CCCc2ccccc12	H327N08IPV	Preclinical	purinergic receptor antagonist	P2RX3
A-33903	A-33903	CC(=O)NC1C(=O)Nc2ccccc2C(=N1)c1ccccc1		Phase 2		
A-366	A-366	COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1		Preclinical	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
A-674563	A-674563	Cc1n[nH]c2ccc(cc12)-c1cncc(OC[C@@H](N)Cc2ccccc2)c1		Preclinical	AKT inhibitor	AKT1|PKIA|PRKACA
A-7	A-7	NCCCCCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12		Preclinical	calmodulin antagonist	
A-769662	A-769662	Oc1ccccc1-c1ccc(cc1)-c1csc2[nH]c(=O)c(C#N)c(O)c12	P68477CD2C	Preclinical	AMPK activator	
A-803467	A-803467	COc1cc(NC(=O)c2ccc(o2)-c2ccc(Cl)cc2)cc(OC)c1	339LBH1395	Preclinical	sodium channel blocker	SCN10A
A0001	A0001|ALPHA-TOCOPHERYLQUINONE	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O	ZO763K43XR	Phase 2		
A205804	A205804|A-205804	Cc1ccc(Sc2cncc3sc(cc23)C(N)=O)cc1	TP7TB1SSZD	Preclinical	ICAM1 expression inhibitor	ICAM1|SELE
A61603	A61603|HELIUM|HYDROGEN CATION|HYDROGEN|HELIUM HE-3	CS(=O)(=O)Nc1c(O)ccc2C(CCCc12)C1=NCCN1	206GF3GB41|5046UKT60S|7YNJ3PO35Z|I83W8ELB18	Preclinical	adrenergic receptor agonist	ADRA1A
A66	A66	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(n1)C(C)(C)C		Preclinical	PI3K inhibitor	PIK3CA
A740003	A740003|A-740003	COc1ccc(CC(=O)NC(N\C(Nc2cccc3ncccc23)=N\C#N)C(C)(C)C)cc1OC	532OV6WA05	Preclinical	purinergic receptor antagonist	P2RX7
A77636	A77636|HELIUM|HYDROGEN CATION|HYDROGEN|HELIUM HE-3	NC[C@@H]1O[C@@H](Cc2c(O)c(O)ccc12)[C@@]12CC3CC(CC(C3)C1)C2	206GF3GB41|5046UKT60S|7YNJ3PO35Z|I83W8ELB18	Preclinical	dopamine receptor agonist	CALY
A922500	A922500|A-922500	OC(=O)[C@H]1CCC[C@H]1C(=O)c1ccc(cc1)-c1ccc(NC(=O)Nc2ccccc2)cc1	44698M475X	Preclinical	diacylglycerol O acyltransferase inhibitor	DGAT1
abacavir	abacavir|ABACAVIR	Nc1nc(NC2CC2)c2ncn(C3C[C@H](CO)C=C3)c2n1	WR2TIP26VS	Launched	nucleoside reverse transcriptase inhibitor	
abafungin	abafungin|ABAFUNGIN	Cc1ccc(Oc2ccccc2-c2csc(N=C3NCCCN3)n2)c(C)c1	11DI31LWXF	Phase 3	sterol methyltransferase inhibitor	
abamectin	abamectin|ABAMECTIN B1A	CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C	K54ZMM929K	Launched	benzodiazepine receptor agonist	GABBR1|GABBR2
abametapir	abametapir|ABAMETAPIR	Cc1ccc(nc1)-c1ccc(C)cn1	6UO390AMFB	Phase 3	metalloproteinase inhibitor	MMP9
ABC-294640	ABC-294640	Clc1ccc(cc1)C12CC3CC(CC(C3)(C1)C(=O)NCc1ccncc1)C2	DRG21OQ517	Phase 1/Phase 2	sphingosine kinase inhibitor	SPHK2
abiraterone	abiraterone|ABIRATERONE	C[C@]12CC[C@@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2c1cccnc1	G819A456D0	Launched	androgen biosynthesis inhibitor	CYP11B1|CYP17A1
abiraterone-acetate	abiraterone-acetate|ABIRATERONE ACETATE	CC(=O)O[C@H]1CC[C@]2(C)[C@@H]3CC[C@@]4(C)[C@@H](CC=C4c4cccnc4)[C@H]3CC=C2C1	EM5OCB9YJ6	Launched	androgen biosynthesis inhibitor	CYP17A1
ABT-202	ABT-202	NC1CCN(C1)c1cccnc1	RJ89CX560B	Phase 1	acetylcholine receptor agonist	
ABT-239	ABT-239	C[C@@H]1CCCN1CCc1cc2cc(ccc2o1)-c1ccc(cc1)C#N	86H6B395PI	Phase 1	histamine receptor antagonist	HRH1|HRH2|HRH3
ABT-491	ABT-491	CN(C)C(=O)n1cc(C(=O)c2ccc(Cn3c(C)nc4cnccc34)c(F)c2)c2c(cccc12)C#C	N7IG7Z867J	Phase 1	platelet activating factor receptor antagonist	PTAFR
ABT-639	ABT-639	Fc1ccccc1NS(=O)(=O)c1cc(C(=O)N2CCN3CCC[C@@H]3C2)c(Cl)cc1F		Phase 2	calcium channel blocker	CACNA1G|CACNA1H|CACNA1I
ABT-702	ABT-702	Nc1ncnc2nc(cc(-c3cccc(Br)c3)c12)-c1ccc(nc1)N1CCOCC1	2P206WS5B3	Preclinical	adenosine kinase inhibitor	ADK
ABT-724	ABT-724	C(N1CCN(CC1)c1ccccn1)c1nc2ccccc2[nH]1	4WV2575JWT	Phase 2	dopamine receptor agonist	DRD4
ABT-737	ABT-737	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1	Z5NFR173NV	Phase 1/Phase 2	BCL inhibitor	BCL2|BCL2L1|BCL2L2
ABT-751	ABT-751	COc1ccc(cc1)S(=O)(=O)Nc1cccnc1Nc1ccc(O)cc1	WDT5V5OB9F	Phase 2	tubulin polymerization inhibitor	TUBB
AC-264613	AC-264613	C\C(=N/NC(=O)[C@H]1[C@@H](CNC1=O)c1ccccc1)c1cccc(Br)c1	1ST2P4BE17	Preclinical	PAR agonist	F2RL1
AC-55541	AC-55541	C\C(=N/NC(=O)C(NC(=O)c1ccccc1)c1n[nH]c(=O)c2ccccc12)c1cccc(Br)c1		Preclinical	PARP inhibitor	PARP2
AC-55649	AC-55649	CCCCCCCCc1ccc(cc1)-c1ccc(cc1)C(O)=O		Preclinical	retinoid receptor agonist	RARA|RARB
AC-7954-(+/-)	AC-7954-(+/-)	CN(C)CCC1(Cc2ccccc2C(=O)O1)c1ccc(Cl)cc1		Preclinical	urotensin receptor agonist	UTS2R
AC1NDSS5	AC1NDSS5	CCCCCCCCCCCCCCCCCC[S+](CCC)c1ccccc1C(=O)OCC		Phase 1		
acadesine	acadesine|ACADESINE	NC(=O)c1ncn([C@@H]2O[C@@H](CO)[C@@H](O)[C@H]2O)c1N	53IEF47846	Phase 3	AMPK activator	
acalabrutinib	acalabrutinib|ACALABRUTINIB	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(cc2)C(=O)Nc2ccccn2)c2c(N)nccn12	I42748ELQW	Phase 3	Bruton's tyrosine kinase (BTK) inhibitor	BTK
acalisib	acalisib|ACALISIB	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1	OVW60IDW1D	Phase 1	PI3K inhibitor	PIK3CB|PIK3CD
acamprosate	acamprosate|ACAMPROSATE	CC(=O)NCCCS(O)(=O)=O	N4K14YGM3J	Launched	glutamate receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM5
acarbose	acarbose|ACARBOSE	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O	T58MSI464G	Launched	glucosidase inhibitor	AMY2A|GAA|MGAM|SI
ACDPP	ACDPP	CN(C)c1nc(N)c(nc1Cl)C(=O)Nc1cccnc1		Preclinical	glutamate receptor antagonist	GRM5
acebutolol	acebutolol|ACEBUTOLOL	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(C)=O	67P356D8GH	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
acecainide	acecainide|ACECAINIDE	CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1	910Q707V6F	Phase 3	polarization inhibitor	SCN5A
aceclidine	aceclidine|ACECLIDINE	CC(=O)OC1CN2CCC1CC2	0578K3ELIO	Launched	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
aceclofenac	aceclofenac|ACECLOFENAC	OC(=O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	RPK779R03H	Launched	prostanoid receptor antagonist	PTGS2
acedapsone	acedapsone|ACEDAPSONE	CC(=O)Nc1ccc(cc1)S(=O)(=O)c1ccc(NC(C)=O)cc1	0GZ72U84TN	Launched		
acedoben	acedoben|ACEDOBEN	CC(=O)Nc1ccc(cc1)C(O)=O	04Z20NMK31	Phase 2		
acefylline	acefylline|ACEFYLLINE	Cn1c2ncn(CC(O)=O)c2c(=O)n(C)c1=O	M494UE2YEP	Launched	adenosine receptor agonist	ADORA1
aceglutamide	aceglutamide|ACEGLUTAMIDE	CC(=O)N[C@@H](CCC(N)=O)C(O)=O	01J18G9G97	Launched		
acemetacin	acemetacin|ACEMETACIN	COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(O)=O)c2c1	5V141XK28X	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
aceneuramic-acid	aceneuramic-acid|ACENEURAMIC ACID	CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O	GZP2782OP0	Phase 3		AZGP1|CES1|MBL2|REG1A|SELE|SELP|SIGLEC1
acenocoumarol	acenocoumarol|ACENOCOUMAROL	CC(=O)CC(c1ccc(cc1)[N+]([O-])=O)c1c(O)c2ccccc2oc1=O	I6WP63U32H	Launched	vitamin K antagonist	VKORC1
acepromazine	acepromazine|ACEPROMAZINE	CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(C)=O	54EJ303F0R	Launched	dopamine receptor antagonist	ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A
acesulfame-potassium	acesulfame-potassium|ACESULFAME POTASSIUM	CC1=CC(=O)NS(=O)(=O)O1	23OV73Q5G9	Phase 3		
acetanilide	acetanilide|ACETANILIDE	CC(=O)Nc1ccccc1	SP86R356CC	Preclinical	hydrogen peroxide decomposition inhibitor	
acetarsol	acetarsol|ACETARSOL	CC(=O)Nc1cc(ccc1O)[As](O)(O)=O	806529YU1N	Launched		
acetazolamide	acetazolamide|ACETAZOLAMIDE	CC(=O)Nc1nnc(s1)S(N)(=O)=O	O3FX965V0I	Launched	carbonic anhydrase inhibitor	AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7
acetohexamide	acetohexamide|ACETOHEXAMIDE	CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1	QGC8W08I6I	Launched	ATP channel blocker	ABCC8|KCNJ1|KCNJ10|KCNJ11
acetohydroxamic-acid	acetohydroxamic-acid|ACETOHYDROXAMIC ACID	CC(=O)NO	4RZ82L2GY5	Launched	urease inhibitor	MMP12
acetophenazine	acetophenazine|ACETOPHENAZINE	CC(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(CCO)CC3)c2c1	8620H6K4QH	Launched	dopamine receptor antagonist	DRD1|DRD2
acetriazoic-acid	acetriazoic-acid|ACETRIZOIC ACID	CC(=O)Nc1c(I)cc(I)c(C(O)=O)c1I	24256BQV7M	Preclinical		
acetyl-11-keto-beta-boswellic-acid	acetyl-11-keto-beta-boswellic-acid|3.BETA.-ACETYL-11-KETO-.BETA.-BOSWELLIC ACID|3-ACETYL-11-KETO-.BETA.-BOSWELLIC ACID	C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)(C5CC[C@@]34C)C(O)=O)[C@@H]2[C@H]1C	8Y662G4PPI|BS16QT99Q1	Phase 2	lipoxygenase inhibitor	HSD11B1|HSD11B2
acetyl-farnesyl-cysteine	acetyl-farnesyl-cysteine|ACETYL FARNESYLCYSTEINE	CC(=O)N[C@@H](CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O	KK6984C8O3	Launched	methyltransferase inhibitor	PPARG
acetyl-l-leucine	acetyl-l-leucine|ACETYLLEUCINE, L-	CC(C)C[C@H](NC(C)=O)C(O)=O	E915HL7K2O	Launched		
acetylcholine	acetylcholine|ACETYLCHOLINE	CC(=O)OCC[N+](C)(C)C	N9YNS0M02X	Launched	acetylcholine receptor agonist	ACHE|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2
acetylcysteine	acetylcysteine|ACETYLCYSTEINE	CC(=O)N[C@@H](CS)C(O)=O	WYQ7N0BPYC	Launched	mucolytic agent	ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11
acetylsalicylsalicylic-acid	acetylsalicylsalicylic-acid|ACETYLSALICYLSALICYLIC ACID	CC(=O)Oc1ccccc1C(=O)Oc1ccccc1C(O)=O	VBE72MCP5L	Preclinical	cyclooxygenase inhibitor	
acexamic-acid	acexamic-acid|ACEXAMIC ACID	CC(=O)NCCCCCC(O)=O	7IC4BO7D3R	Launched	5 alpha reductase inhibitor	GAST
acifran	acifran|ACIFRAN, (-)-|ACIFRAN|ACIFRAN, (+)-	CC1(OC(=CC1=O)C(O)=O)c1ccccc1	61IZ92GN57|B1X701S0MV|FP3LLW01BL	Phase 3	cholesterol inhibitor	HCAR2|HCAR3
acipimox	acipimox|ACIPIMOX	Cc1cnc(c[n+]1[O-])C(O)=O	K9AY9IR2SD	Launched	cholesterol inhibitor	HCAR2
acitazanolast	acitazanolast|ACITAZANOLAST	OC(=O)C(=O)Nc1cccc(c1)-c1nnn[nH]1	99Y8VJ356G	Launched	mediator release inhibitor	
acitretin	acitretin|ACITRETIN	COc1cc(C)c(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)c(C)c1C	LCH760E9T7	Launched	retinoid receptor agonist	RARA|RARB|RARG|RBP1|RXRA|RXRB|RXRG|STAT3
acivicin	acivicin|ACIVICIN	N[C@H]([C@@H]1CC(Cl)=NO1)C(O)=O	O0X60K76I6	Phase 2	gamma glutamyltransferase Inhibitors	CTPS1
aclarubicin	aclarubicin|ACLARUBICIN	CCC1(O)CC(OC2CC(C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)N(C)C)c2c(cc3C(=O)c4cccc(O)c4C(=O)c3c2O)C1C(=O)OC	74KXF8I502	Launched	topoisomerase inhibitor	TOP1|TOP2A
aclidinium	aclidinium|ACLIDINIUM	OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1	K17VY42F6C	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
ACPC	ACPC|1-AMINOCYCLOPROPANECARBOXYLIC ACID	NC1(CC1)C(O)=O	3K9EJ633GL	Phase 1	glutamate receptor antagonist	
acriflavine	acriflavine	Nc1ccc2cc3ccc(N)cc3nc2c1.C[n+]1c2cc(N)ccc2cc2ccc(N)cc12		Launched	hypoxia inducible factor inhibitor	HIF1A
acriflavinium	acriflavinium	C[n+]1c2cc(N)ccc2cc2ccc(N)cc12		Launched	hypoxia inducible factor inhibitor	HIF1A
acrisorcin	acrisorcin|ACRISORCIN	CCCCCCc1ccc(O)cc1O.Nc1c2ccccc2nc2ccccc12	2U918O4BEV	Launched	other antifungal	
acrivastine	acrivastine|ACRIVASTINE	Cc1ccc(cc1)C(=C/CN1CCCC1)\c1cccc(\C=C\C(O)=O)n1	A20F9XAI7W	Launched	histamine receptor antagonist	HRH1
acrylate	acrylate|SODIUM ACRYLATE	[Na].OC(=O)C=C	7C98FKB43H	Phase 3	mucus protecting agent	
ACT-132577	ACT-132577	NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1	MZI81HV01P	Launched	endothelin receptor antagonist	EDNRA|EDNRB
ACT-462206	ACT-462206	COc1ccc(cc1)S(=O)(=O)N1CCC[C@H]1C(=O)Nc1cc(C)cc(C)c1		Phase 1	orexin receptor antagonist	HCRTR1|HCRTR2
actarit	actarit|ACTARIT	CC(=O)Nc1ccc(CC(O)=O)cc1	HW5B6351RZ	Launched	interleukin receptor agonist	
ACTB-1003	ACTB-1003	COCc1c(CN2CCOCC2)n2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(ccc2F)C(F)(F)F)c(F)c1	44750KD9OE	Phase 1	FGFR inhibitor|VEGFR inhibitor	KDR|TEK
actinomycin-d	actinomycin-d|DACTINOMYCIN	CC(C)C1NC(=O)C(NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)c4nc23)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C1=O	1CC1JFE158	Launched	RNA polymerase inhibitor	
actinoquinol	actinoquinol|ACTINOQUINOL	CCOc1ccc(c2cccnc12)S(O)(=O)=O	470VQE23O3	Preclinical		
ACY-1215	ACY-1215|RICOLINOSTAT	ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1	WKT909C62B	Phase 1/Phase 2	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC6|HDAC8
acyclovir	acyclovir|ACYCLOVIR	Nc1nc2n(COCCO)cnc2c(=O)[nH]1	X4HES1O11F	Launched	DNA polymerase inhibitor	PNP
AD-5467	AD-5467	CC(C)C1Oc2c(cccc2N(CC(O)=O)C1=S)C(C)C		Phase 2	aldose reductase inhibitor	AKR1B1
adapalene	adapalene|ADAPALENE	COc1ccc(cc1C12CC3CC(CC(C3)C1)C2)-c1ccc2cc(ccc2c1)C(O)=O	1L4806J2QF	Launched	retinoid receptor agonist	RARA|RARB|RARG|RXRA|RXRB|RXRG
adaprev	adaprev|.BETA.-D-MANNOSE 6-PHOSPHATE	OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O	05ZIE5U7RX	Phase 3	TGF beta receptor inhibitor	IGF2R|M6PR
adaptavir	adaptavir|DAPTA	C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O	J208V4ZMP2	Phase 2	CC chemokine receptor antagonist	CCR5
adarotene	adarotene|ADAROTENE	OC(=O)\C=C\c1ccc(cc1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2	W6SU73VG8H	Phase 1	retinoid receptor agonist	RARB|RARG
adatanserin	adatanserin|ADATANSERIN	O=C(NCCN1CCN(CC1)c1ncccn1)C12CC3CC(CC(C3)C1)C2	W5U6WQM26H	Phase 2	serotonin receptor agonist|serotonin receptor antagonist	HTR1A|HTR2A
ADD-233089	ADD-233089|IMEPITOIN	Clc1ccc(cc1)N1CC(=NC1=O)N1CCOCC1	19V39682LI	Phase 1	benzodiazepine receptor agonist	
adefovir	adefovir|ADEFOVIR	Nc1ncnc2n(CCOCP(O)(O)=O)cnc12	6GQP90I798	Launched	DNA polymerase inhibitor	
adefovir-dipivoxil	adefovir-dipivoxil|ADEFOVIR DIPIVOXIL	CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc12)OCOC(=O)C(C)(C)C	U6Q8Z01514	Launched	DNA polymerase inhibitor	
adelmidrol	adelmidrol|ADELMIDROL	OCCNC(=O)CCCCCCCC(=O)NCCO	1BUC3685QU	Phase 2/Phase 3	anti-inflammatory agent	
ademetionine	ademetionine|ADEMETIONINE	C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12	7LP2MPO46S	Launched	methyltransferase stimulant|phosphodiesterase inhibitor	AMD1|CBS|COMT|GNMT|MAT1A|MAT2A
adenine	adenine|ADENINE	Nc1ncnc2[nH]cnc12	JAC85A2161	Preclinical	protein synthesis stimulant	ACACB|ACP1|APRT|MTAP|PECR|SRPK2
adenosine	adenosine|ADENOSINE	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	K72T3FS567	Launched	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4
adenosine-phosphate	adenosine-phosphate|ADENOSINE PHOSPHATE	Nc1ncnc2n(cnc12)C1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O	415SHH325A	Launched	adenosine receptor agonist	ACSL1|ACSS1|ACSS2|ADCY1|ADK|CREB1|FBP1|HINT1|PDE4B|PDE4D|PIM1|PRKAA1|PRKAB1|PRKAB2|PYGL|TRPM4
adenosine-triphosphate	adenosine-triphosphate|ADENOSINE TRIPHOSPHATE	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O	8L70Q75FXE	Phase 2	adenosine receptor agonist	ABCA1|ABCB1|ABCB11|ABCC2|ABCC8|ABCC9|ABCG1|ABL1|ABL2|ACSL1|ACSS1|ACSS2|ACVR1|ACVR1B|ACVRL1|ADCY1|ADRBK1|ADRBK2|AFG3L2|AKT1|ALK|AMHR2|APAF1|ARAF|ASNA1|ASNS|ASS1|CDK15|GPR17|ITPR1|NAE1|NT5C2|P2RY1|P2RY11|P2RY13|P2RY2|P2RY4|PRKAA1|RYR1|RYR2|RYR3|SLC25A4|TNK2|TRPM4|TRPM7
adiphenine	adiphenine|ADIPHENINE	CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1	YKG6OR043Q	Launched	acetylcholine receptor antagonist	CHRNA1
adipic-acid	adipic-acid|ADIPIC ACID	OC(=O)CCCCC(O)=O	76A0JE0FKJ	Preclinical	solute carrier family member inhibitor	SLC22A6
adiporon	adiporon	O=C(COc1ccc(cc1)C(=O)c1ccccc1)NC1CCN(Cc2ccccc2)CC1		Preclinical	adiponectin receptor agonist	ADIPOR1|ADIPOR2
ADL5859	ADL5859|ADL-5859	CCN(CC)C(=O)c1ccc(cc1)C1=CC2(CCNCC2)Oc2cccc(O)c12	FA554TW3UP	Phase 2	opioid receptor agonist	OPRD1
adoprazine	adoprazine|ADOPRAZINE	Fc1ccc(cc1)-c1cncc(CN2CCN(CC2)c2cccc3OCCOc23)c1	7SNB18Q89D	Phase 2	dopamine receptor antagonist|serotonin receptor agonist	DRD2|HTR1A
adrafinil	adrafinil|ADRAFINIL	ONC(=O)CS(=O)C(c1ccccc1)c1ccccc1	BI81Z4542G	Launched	adrenergic receptor agonist	
adrenalone	adrenalone|ADRENALONE	CNCC(=O)c1ccc(O)c(O)c1	EGU41QL329	Launched	adrenergic receptor agonist	ADRA1A
adrenosterone	adrenosterone|ADRENOSTERONE	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O	AE4E9102GY	Preclinical	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1|HSD11B2
ADX-47273	ADX-47273	Fc1ccc(cc1)C(=O)N1CCC[C@@H](C1)c1nc(no1)-c1ccc(F)cc1	4C4P7L0W63	Preclinical	glutamate receptor modulator	GRM5
AEE788	AEE788|AEE-788	CCN1CCN(Cc2ccc(cc2)-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)CC1	F9JLR95I3I	Phase 1/Phase 2	EGFR inhibitor|VEGFR inhibitor	EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR
AEG3482	AEG3482|AEG-3482	NS(=O)(=O)c1nn2cc(nc2s1)-c1ccccc1	7EZF1A283N	Preclinical	HSP inducer	
AF38469	AF38469	Cc1cccc(NC(=O)c2ccc(cc2C(O)=O)C(F)(F)F)n1		Preclinical	sortilin inhibitor	SORT1
afalanine	afalanine|AFALANINE	CC(=O)N[C@@H](Cc1ccccc1)C(O)=O	FFW2NGO18S	Phase 3	dopamine receptor agonist	DRD2
afatinib	afatinib|AFATINIB	CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1	41UD74L59M	Launched	EGFR inhibitor	EGFR|ERBB2|ERBB4
afimoxifene	afimoxifene|HYDROXYTAMOXIFEN	CC\C(c1ccccc1)=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1	95K54647BZ	Phase 2	estrogen receptor antagonist	ESR1|ESR2|ESRRG|PLD1|PRKCD|PRKCE|PRKCQ|PRKCZ
afloqualone	afloqualone|AFLOQUALONE	Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O	CO4U2C8ORZ	Launched	acetylcholine receptor antagonist	
AFN-1252	AFN-1252	CN(Cc1oc2ccccc2c1C)C(=O)\C=C\C1=CNC2=NC(=O)CCC2=C1	T3O718IKKM	Phase 2	FABI inhibitor	
afobazole	afobazole|FABOMOTIZOLE	CCOc1ccc2[nH]c(SCCN3CCOCC3)nc2c1	0F8K1X115C	Launched	anxiolytic	
AG-1024	AG-1024	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		Preclinical	insulin growth factor receptor inhibitor	IGF1R
AG-14361	AG-14361	CN(C)Cc1ccc(cc1)-c1nc2cccc3C(=O)NCCn1c23	48N0U0K50I	Preclinical	PARP inhibitor	PARP1
AG-490	AG-490	Oc1ccc(cc1O)\C=C(/C#N)C(=O)NCc1ccccc1		Preclinical	EGFR inhibitor|JAK inhibitor	EGFR|JAK2|JAK3
AG-555	AG-555	Oc1ccc(\C=C(/C#N)C(=O)NCCCc2ccccc2)cc1O		Preclinical	tyrosine kinase inhibitor	CDK2
AG-556	AG-556	Oc1ccc(\C=C(/C#N)C(=O)NCCCCc2ccccc2)cc1O		Preclinical	tyrosine kinase inhibitor	
AGI-5198	AGI-5198	Cc1nccn1CC(=O)N(C(C(=O)NC1CCCCC1)c1ccccc1C)c1cccc(F)c1		Preclinical	isocitrate dehydrogenase inhibitor	IDH1
AGI-6780	AGI-6780	FC(F)(F)c1cccc(NC(=O)Nc2cc(ccc2-c2ccsc2)S(=O)(=O)NC2CC2)c1		Preclinical	isocitrate dehydrogenase inhibitor	IDH2
AGM-1470	AGM-1470|TNP-470	CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)NC(=O)CCl	X47GR46481	Phase 2	cell cycle inhibitor	METAP2
agmatine	agmatine|AGMATINE	NCCCCNC(N)=N	70J407ZL5Q	Phase 3	nitric oxide synthase inhibitor	ADRA2C|ASIC3|CACNA1B|CHRNA1|GRIN1|KCNJ1|NISCH
AGN-192403	AGN-192403	CC(C)C1C2CCC(C2)C1N		Preclinical	imidazoline receptor ligand	NISCH
AGN-194310	AGN-194310	CCc1ccc(cc1)C1=CC(C)(C)Sc2ccc(cc12)C#Cc1ccc(cc1)C(O)=O		Phase 3	retinoid receptor antagonist	RXRA|RXRB|RXRG
AGN-195183	AGN-195183|IRX-5183	CC1(C)CCC(C)(C)c2c(Cl)c(O)c(cc12)C(=O)Nc1cc(F)c(C(O)=O)c(F)c1	RC87L028HU	Phase 1/Phase 2	retinoid receptor agonist	RARA
agomelatine	agomelatine|AGOMELATINE	COc1ccc2cccc(CCNC(C)=O)c2c1	137R1N49AD	Launched	melatonin receptor agonist|serotonin receptor antagonist	HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B
AGP-103	AGP-103|BEHENIC ACID	CCCCCCCCCCCCCCCCCCCCCC(O)=O	H390488X0A	Launched	membrane permeability inhibitor	
AH11110	AH11110	OC(COc1ccccc1-c1ccccc1)CC(=N)N1CCCCC1		Preclinical	adrenergic receptor ligand	ADRA1B
AH6809	AH6809	CC(C)Oc1ccc2c(c1)oc1ccc(cc1c2=O)C(O)=O		Preclinical	prostanoid receptor antagonist	PTGDR|PTGER1|PTGER2|PTGER3
AI-10-49	AI-10-49	FC(F)(F)Oc1ccc2nc([nH]c2c1)-c1ccc(OCCOCCOc2ccc(nc2)-c2nc3ccc(OC(F)(F)F)cc3[nH]2)cn1		Preclinical	core binding factor inhibitor	CBFB
AJ76-(+)	AJ76-(+)	CCCN[C@@H]1CCc2c(OC)cccc2[C@@H]1C		Preclinical	dopamine receptor antagonist	DRD2|DRD3|DRD4
ajmaline	ajmaline|AJMALINE	CC[C@H]1C2CC3[C@@H]4N(C)c5ccccc5[C@]44C[C@@H](C2C4O)N3[C@@H]1O	1PON08459R	Launched	sodium channel blocker	SCN5A
AKBA	AKBA|3-ACETYL-11-KETO-.BETA.-BOSWELLIC ACID	C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)([C@@H]5CC[C@@]34C)C(O)=O)[C@@H]2[C@H]1C	BS16QT99Q1	Phase 3	lipoxygenase inhibitor	ALOX5
aklomide	aklomide|AKLOMIDE	NC(=O)c1ccc(cc1Cl)[N+]([O-])=O	B0E341RA20	Launched		
alacepril	alacepril|ALACEPRIL	C[C@H](CSC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O	X39TL7JDPF	Launched	angiotensin converting enzyme inhibitor	ACE
alafosfalin	alafosfalin|ALAFOSFALIN	C[C@H](N)C(=O)N[C@@H](C)P(O)(O)=O	0M8OM373BS	Phase 1	bacterial cell wall synthesis inhibitor	
alagebrium	alagebrium|ALAGEBRIUM	Cc1sc[n+](CC(=O)c2ccccc2)c1C	DGH49JXB1F	Phase 2/Phase 3	glycosylation inhibitor	
alanine	alanine|ALANINE	CC(N)C(O)=O	OF5P57N2ZX	Launched		AARS|AARS2|ABAT|AGXT|AGXT2|GPRC6A|GPT|GPT2|KYNU|NFS1|PHYKPL|SLC1A4|SLC36A1|SLC7A8
alaproclate	alaproclate|ALAPROCLATE	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1	C4R42570ZO	Phase 2	serotonin receptor antagonist	SLC6A4
alarelin	alarelin	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1		Launched	gonadotropin releasing factor hormone receptor antagonist	GNRH1
albendazole	albendazole|ALBENDAZOLE	CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1	F4216019LN	Launched	tubulin polymerization inhibitor	TUBA1A|TUBB|TUBB4B
albendazole-oxide	albendazole-oxide|ALBENDAZOLE OXIDE	CCCS(=O)c1ccc2nc(NC(=O)OC)[nH]c2c1	J39B52TV34	Launched	anthelmintic agent	
albuterol	albuterol|ALBUTEROL	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1	QF8SVZ843E	Launched	adrenergic receptor agonist	ADRB1|ADRB2
alcaftadine	alcaftadine|ALCAFTADINE	CN1CCC(CC1)=C1c2ncc(C=O)n2CCc2ccccc12	7Z8O94ECSX	Launched	histamine receptor antagonist	HRH1
alclofenac	alclofenac|ALCLOFENAC	OC(=O)Cc1ccc(OCC=C)c(Cl)c1	M9CP5H21N8	Launched	cyclooxygenase inhibitor	PTGS1
alclometasone-dipropionate	alclometasone-dipropionate|ALCLOMETASONE DIPROPIONATE	CCC(=O)OCC(=O)C1(OC(=O)CC)[C@H](C)C[C@H]2C3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	S56PQL4N1V	Launched	glucocorticoid receptor agonist	CYP3A4|NR3C1|SERPINA6
alcuronium	alcuronium|ALCURONIUM	OC\C=C1/C[N@+]2(CC=C)CC[C@@]34[C@@H]2C[C@@H]1\C1=C\N2C5[C@]6(CC[N@@+]7(CC=C)C\C(=C/CO)[C@H](C[C@@H]67)\C5=C\N(C31)c1ccccc41)c1ccccc21	S8U3J5W06N	Launched	muscle relaxant	CHRM1|CHRM2|CHRM3|CHRM4|CHRNA7
aldoxorubicin	aldoxorubicin|ALDOXORUBICIN	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(\CO)=N\NC(=O)CCCCCN1C(=O)C=CC1=O	C28MV4IM0B	Phase 3	topoisomerase inhibitor	TOP2A
alectinib	alectinib|ALECTINIB	CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1	LIJ4CT1Z3Y	Launched	ALK tyrosine kinase receptor inhibitor	ALK|MET
alendronate	alendronate|ALENDRONIC ACID	NCCCC(O)(P(O)(O)=O)P(O)(O)=O	X1J18R4W8P	Launched	bone resorption inhibitor	ATP6V1A|FDPS|PTPN4|PTPRE|PTPRS
alexidine	alexidine|ALEXIDINE	CCCCC(CC)C\N=C(/N)N\C(N)=N\CCCCCC\N=C(/N)N\C(N)=N\CC(CC)CCCC	GVN71CAL3G	Preclinical	phosphatidylglycerophosphatase inhibitor	PTPMT1
alfacalcidol	alfacalcidol|ALFACALCIDOL	CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C\C=C1\C[C@@H](O)C[C@H](O)C1=C	URQ2517572	Launched	vitamin D receptor agonist	CYP27B1|VDR
alfadolone-acetate	alfadolone-acetate|ALFADOLONE ACETATE	CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	00TN4GS00S	Phase 2	benzodiazepine receptor agonist	
alfaxalone	alfaxalone|ALFAXALONE	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	BD07M97B2A	Launched	chloride channel agonist|benzodiazepine receptor agonist	GABBR1
alfuzosin	alfuzosin|ALFUZOSIN	COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1	90347YTW5F	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|KCNH2
algestone-acetophenide	algestone-acetophenide|ALGESTONE ACETOPHENIDE	CC(=O)[C@@]12OC(C)(O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]21C)c1ccccc1	OL7KC2O3OT	Launched		
alibendol	alibendol|ALIBENDOL	COc1cc(CC=C)cc(C(=O)NCCO)c1O	A8CO1VZK2Z	Launched	antispasmodic	
alimemazine	alimemazine|TRIMEPRAZINE	CC(CN(C)C)CN1c2ccccc2Sc2ccccc12	76H78MJJ52	Launched	histamine receptor agonist	HRH1
alisertib	alisertib|ALISERTIB	COc1cc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2OC)ccc1C(O)=O	T66ES73M18	Phase 3	Aurora kinase inhibitor	AURKA
aliskiren-hemifumarate	aliskiren-hemifumarate|ALISKIREN HEMIFUMARATE	COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC	C8A0P8G029	Launched	renin inhibitor	REN
alizapride	alizapride|ALIZAPRIDE	COc1cc2[nH]nnc2cc1C(=O)NCC1CCCN1CC=C	P55703ZRZY	Launched	dopamine receptor antagonist	DRD2
alizarin	alizarin|ALIZARIN	Oc1ccc2C(=O)c3ccccc3C(=O)c2c1O	60MEW57T9G	Preclinical		
allantoin	allantoin|ALLANTOIN	NC(=O)NC1NC(=O)NC1=O	344S277G0Z	Launched	cosmetic	
allicin	allicin|ALLICIN	C=CCSS(=O)CC=C	3C39BY17Y6	Phase 2	cytokine production inhibitor	TRPA1|TRPV1
allopurinol	allopurinol|ALLOPURINOL	O=c1[nH]cnc2[nH]ncc12	63CZ7GJN5I	Launched	xanthine oxidase inhibitor	XDH
allopurinol-riboside	allopurinol-riboside|ALLOPURINOL RIBOSIDE	OC[C@H]1O[C@H](C(O)[C@H]1O)n1[nH]cc2c1ncnc2=O	WZS8452SEC	Phase 2	anti-leishmanial agent	
allylestrenol	allylestrenol|ALLYLESTRENOL	C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)CC=C	I47VB5DZ8O	Launched	steroidal progestin	ESR1|PGR|SLC6A9
allylisothiocyanate	allylisothiocyanate|BRASSICA JUNCEA VOLATILE OIL|BRASSICA NIGRA VOLATILE OIL|ALLYL ISOTHIOCYANATE	C=CCN=C=S	3Q8WYZ89W7|3ZT10W4376|BN34FX42G3	Preclinical	TRPV agonist	TRPA1
allylthiourea	allylthiourea|ALLYLTHIOUREA	NC(S)=NCC=C	706IDJ14B7	Preclinical	nitrification inhibitor	
almitrine	almitrine|ALMITRINE	Fc1ccc(cc1)C(N1CCN(CC1)c1nc(NCC=C)nc(NCC=C)n1)c1ccc(F)cc1	9A1222NBG4	Launched	neurotransmitter agonist	ATP1A1
almorexant	almorexant|ALMOREXANT	CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(cc1)C(F)(F)F)c1ccccc1	9KCW39P2EI	Phase 3	orexin receptor antagonist	HCRTR1|HCRTR2
almotriptan	almotriptan|ALMOTRIPTAN	CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12	1O4XL5SN61	Launched	serotonin receptor agonist	HTR1B|HTR1D
aloe-emodin	aloe-emodin|ALOE EMODIN	OCc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1	C8IYT9CR7C	Preclinical	anticancer agent	CASP8
alogliptin	alogliptin|ALOGLIPTIN	Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O	JHC049LO86	Launched	dipeptidyl peptidase inhibitor	DPP4
aloin	aloin|ALOIN A|ALOIN B	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1c2cccc(O)c2C(=O)c2c(O)cc(CO)cc12	648RW354S9|69VIB0J2WK	Preclinical	angiogenesis inhibitor	
aloperine	aloperine	C1CCN2C[C@H]3C[C@H](C=C4CCCN[C@@H]34)[C@H]2C1		Preclinical		
alosetron	alosetron|ALOSETRON	Cc1[nH]cnc1CN1CCc2c(C1=O)c1ccccc1n2C	13Z9HTH115	Withdrawn	serotonin receptor antagonist	HTR3A
aloxistatin	aloxistatin|ALOXISTATIN	CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)NCCC(C)C	L5W337AOUR	Phase 3	protease inhibitor	CTSG
alpelisib	alpelisib|ALPELISIB	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F	08W5N2C97Q	Phase 3	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
alpha-Asarone	alpha-Asarone|.ALPHA.-ASARONE	COc1cc(OC)c(\C=C\C)cc1OC	DQY9PNE5FK	Preclinical	cytochrome P450 inhibitor|HMGCR inhibitor	HMGCR
alpha-D-glucopyranose	alpha-D-glucopyranose|.ALPHA.-D-GLUCOPYRANOSE	OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O	5J5I9EB41E	Preclinical		
alpha-linolenic-acid	alpha-linolenic-acid|LINOLENIC ACID	CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O	0RBV727H71	Phase 3	omega 3 fatty acid stimulant	ELOVL4|FADS1|FADS2|FFAR1|FFAR4|PTGS2|SLC8A1|TRPV1
alpha-methylhistamine-dihydrobromide-(R)-(-)	alpha-methylhistamine-dihydrobromide-(R)-(-)	C[C@@H](N)Cc1c[nH]cn1		Preclinical	histamine receptor agonist	HRH3
alpha-methylhistamine-dihydrobromide-(S)-(+)	alpha-methylhistamine-dihydrobromide-(S)-(+)	C[C@H](N)Cc1c[nH]cn1		Preclinical	histamine receptor agonist	HRH3
alpha-methylserotonin	alpha-methylserotonin	CC(N)Cc1c[nH]c2ccc(O)cc12		Preclinical	serotonin receptor agonist	HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR4
alpha-tochopherol	alpha-tochopherol|.ALPHA.-TOCOPHEROL, DL-	CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(O)c(C)c(C)c2O1	7QWA1RIO01	Launched	antioxidant	
alpha-tochopheryl-acetate	alpha-tochopheryl-acetate|.ALPHA.-TOCOPHEROL ACETATE, DL-	CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(C)=O)c(C)c(C)c2O1	WR1WPI7EW8	Launched	antioxidant	
alpidem	alpidem|ALPIDEM	CCCN(CCC)C(=O)Cc1c(nc2ccc(Cl)cn12)-c1ccc(Cl)cc1	I93SC245QZ	Withdrawn	benzodiazepine receptor agonist	GABRA1
alprenolol	alprenolol|ALPRENOLOL	CC(C)NCC(O)COc1ccccc1CC=C	877K5MQ27W	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|HTR1A
alprostadil	alprostadil|ALPROSTADIL	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	F5TD010360	Launched	prostanoid receptor agonist	CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR
alrestatin	alrestatin|ALRESTATIN	OC(=O)CN1C(=O)c2cccc3cccc(C1=O)c23	515DHK15LG	Preclinical	aldose reductase inhibitor	AKR1B1
ALS-8176	ALS-8176|4'-CHLOROMETHYL-2'-DEOXY-2'-FLUOROCYTIDINE	Nc1ccn([C@@H]2O[C@@](CO)(CCl)[C@@H](O)[C@H]2F)c(=O)n1	7795987MKM	Phase 1	RNA polymerase inhibitor	
altanserin	altanserin|ALTANSERIN	Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1	5015H744JQ	Phase 2	serotonin receptor antagonist	HTR2A
althiazide	althiazide|ALTIZIDE, (-)-|ALTHIAZIDE|ALTIZIDE, (+)-	NS(=O)(=O)c1cc2c(NC(CSCC=C)NS2(=O)=O)cc1Cl	D9KLS88BLV|GI8CB72B0D|JI3ZO158IN	Launched	diuretic	
altinicline	altinicline|ALTINICLINE	CN1CCC[C@H]1c1cncc(c1)C#C	RJ9V9V09VM	Phase 2	nicotinic receptor agonist	CHRNA4|CHRNB2
altiratinib	altiratinib|ALTIRATINIB	Fc1ccc(NC(=O)C2(CC2)C(=O)Nc2cc(F)c(Oc3ccnc(NC(=O)C4CC4)c3)cc2F)cc1	T678746713	Phase 1	VEGFR inhibitor|MET inhibitor	KDR|MET|TEK
altrenogest	altrenogest|ALTRENOGEST	C[C@]12C=CC3=C4CCC(=O)C=C4CCC3C1CC[C@@]2(O)CC=C	2U0X0JA2NB	Launched	progestogen hormone	PGR
altretamine	altretamine|ALTRETAMINE	CN(C)c1nc(nc(n1)N(C)C)N(C)C	Q8BIH59O7H	Launched	DNA synthesis inhibitor	
alverine	alverine|ALVERINE	CCN(CCCc1ccccc1)CCCc1ccccc1	46TIR1560O	Launched	muscle relaxant	HTR1A
alvespimycin	alvespimycin|ALVESPIMYCIN	CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(C)=C/C=C\[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O	001L2FE0M3	Phase 2	HSP inhibitor	HSP90AA1
alvimopan	alvimopan|ALVIMOPAN	C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(O)=O)CC[C@@]1(C)c1cccc(O)c1	677C126AET	Launched	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
alvocidib	alvocidib|ALVOCIDIB	CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl	45AD6X575G	Phase 2	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM
ALX-5407	ALX-5407	CN(CC[C@@H](Oc1ccc(cc1)-c1ccccc1)c1ccc(F)cc1)CC(O)=O		Phase 1	Glycine transporter 1 inhibitor	SLC6A9
AM-1241	AM-1241	CN1CCCCC1Cn1cc(C(=O)c2cc(ccc2I)[N+]([O-])=O)c2ccccc12	DLM851L3RD	Preclinical	cannabinoid receptor agonist	CNR1|CNR2
AM-24	AM-24|2,4,6-TRIIODOPHENOL	Oc1c(I)cc(I)cc1I	9RB2R81A7U	Phase 2	lipoxygenase inhibitor	ALOX5
AM-251	AM-251	Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1	3I4FA44MAI	Preclinical	cannabinoid receptor antagonist	CNR1|GPR18|GPR55
AM-281	AM-281	Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCOCC1		Preclinical	cannabinoid receptor antagonist	CNR1|CNR2|GPR55
AM-404	AM-404	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)Nc1ccc(O)cc1	XVJ94H0U21	Preclinical	cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist	CNR1|CNR2|FAAH|TRPV1
AM-580	AM-580|4-((5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)CARBOXAMIDO)BENZOIC ACID	CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O	VZ5S5G9ZFZ	Preclinical	retinoid receptor agonist	RARA
AM-630	AM-630|6-IODOPRAVADOLINE	COc1ccc(cc1)C(=O)c1c(C)n(CCN2CCOCC2)c2cc(I)ccc12	U1LNJ6NBKA	Preclinical	cannabinoid receptor antagonist	CNR1|CNR2
AM-92016	AM-92016|1-(4-METHANESULFONAMIDOPHENOXY)-3-(N-METHYL-3,4-DICHLOROPHENYLETHYLAMINO)-2-PROPANOL	CN(CCc1ccc(Cl)c(Cl)c1)CC(O)COc1ccc(NS(C)(=O)=O)cc1	RV6721I4H5	Preclinical	potassium channel blocker	GRIN1
AM679	AM679|1-PENTYL-3-(2-IODOBENZOYL)INDOLE	COc1cnc(nc1)-c1ccc(Cn2c(CC(C)(C)C(O)=O)c(SC(C)(C)C)c3cc(OC[C@@H]4Cc5ccccc5N4C(C)=O)ccc23)cc1	61TFT4BO1C	Preclinical	cannabinoid receptor agonist|lipoxygenase inhibitor	ALOX5AP|CNR1|CNR2
amantadine	amantadine|AMANTADINE	NC12CC3CC(CC(C3)C1)C2	BF4C9Z1J53	Launched	glutamate receptor antagonist	DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A
ambazone	ambazone|AMBAZONE	NC(=N)N=Nc1ccc(NNC(S)=N)cc1	BYK4592A3Q	Phase 1	DNA damage inducer	
ambenonium	ambenonium|AMBENONIUM	CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl	L16PUN799N	Launched	cholinesterase inhibitor	ACHE
ambrisentan	ambrisentan|AMBRISENTAN	COC([C@H](Oc1nc(C)cc(C)n1)C(O)=O)(c1ccccc1)c1ccccc1	HW6NV07QEC	Launched	endothelin receptor antagonist	EDNRA|EDNRB
ambroxol	ambroxol|AMBROXOL	Nc1c(Br)cc(Br)cc1CNC1CCC(O)CC1	200168S0CL	Launched	sodium channel blocker	CYP3A4
amcinonide	amcinonide|AMCINONIDE	CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1CC1C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C	423W026MA9	Launched	glucocorticoid receptor agonist	ANXA1|NR3C1
AMD11070	AMD11070|AMD-070	NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc12	0G9LGB5O2W	Phase 1/Phase 2	CC chemokine receptor antagonist	CXCR4
amdinocillin	amdinocillin|AMDINOCILLIN	CC1(C)S[C@@H]2[C@H](\N=C\N3CCCCCC3)C(=O)N2[C@H]1C(O)=O	V10579P3QZ	Launched	bacterial cell wall synthesis inhibitor	
ameltolide	ameltolide|AMELTOLIDE	Cc1cccc(C)c1NC(=O)c1ccc(N)cc1	F83240ZOVE	Preclinical	anticonvulsant	
amezinium	amezinium|AMEZINIUM	COc1cc(N)cn[n+]1-c1ccccc1	T4VA39MO9X	Launched	adrenergic receptor agonist	ADRB2
amfenac	amfenac|AMFENAC	Nc1c(CC(O)=O)cccc1C(=O)c1ccccc1	28O5C1J38A	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
amfepramone	amfepramone|DIETHYLPROPION, (+)-|DIETHYLPROPION, (-)-|DIETHYLPROPION	CCN(CC)C(C)C(=O)c1ccccc1	I535TOV6LY|P1A5AE6Q2R|Q94YYU22B8	Launched	adrenergic receptor agonist	SLC6A2|SLC6A3
amflutizole	amflutizole|AMFLUTIZOLE	Nc1c(snc1-c1cccc(c1)C(F)(F)F)C(O)=O	83N680M457	Phase 2	xanthine oxidase inhibitor	XDH
AMG-208	AMG-208	COc1ccc2c(OCc3nnc4ccc(nn34)-c3ccccc3)ccnc2c1	Y2SR66P7VM	Phase 1	tyrosine kinase inhibitor	MET
AMG-232	AMG-232	CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1		Phase 1/Phase 2	MDM inhibitor	MDM2
AMG-319	AMG-319	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cc2nc1-c1ccccn1	19DG7G1U5Q	Phase 2	PI3K inhibitor	PIK3CD
AMG-337	AMG-337	COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(cn34)-c3cnn(C)c3)c(=O)c2c1		Phase 2	MET inhibitor	MET
AMG-487	AMG-487	CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)[C@@H](C)N(Cc1cccnc1)C(=O)Cc1ccc(OC(F)(F)F)cc1	355CGR2CBL	Phase 2	CC chemokine receptor antagonist	CXCR3
AMG-517	AMG-517	CC(=O)Nc1nc2c(Oc3cc(ncn3)-c3ccc(cc3)C(F)(F)F)cccc2s1	172V4FBZ75	Phase 1	TRPV antagonist	TRPV1
AMG-548	AMG-548	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O	PGR0H531I4	Phase 1	MAP kinase inhibitor	MAPK11|MAPK12|MAPK13|MAPK14
AMG-837	AMG-837	CC#C[C@@H](CC(O)=O)c1ccc(OCc2cccc(c2)-c2ccc(cc2)C(F)(F)F)cc1	NE6U6R66U4	Phase 1	free fatty acid receptor agonist	FFAR1
AMG-925	AMG-925	C[C@H]1CC[C@@H](CC1)n1c2cnccc2c2cnc(Nc3ccc4CN(CCc4n3)C(=O)CO)nc12	RB6Y814V4I	Phase 1	CDK inhibitor|FLT3 inhibitor	CDK4|CDK6|FLT3
AMG-9810	AMG-9810	CC(C)(C)c1ccc(cc1)\C=C\C(=O)Nc1ccc2OCCOc2c1	182HIJ2D7F	Preclinical	TRPV antagonist	TRPV1
AMG319	AMG319|AMG-319	CC(Nc1ncnc2nc[nH]c12)c1cc2ccc(F)cc2nc1-c1ccccn1	19DG7G1U5Q	Phase 2	PI3K inhibitor	PIK3CD
AMG458	AMG458|AMG-458	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1	4535RW5Y3A	Preclinical	MET inhibitor	MET
AMG900	AMG900|AMG-900	Cc1csc(c1)-c1nnc(Nc2ccc(Oc3ncccc3-c3ccnc(N)n3)cc2)c2ccccc12	9R2G075611	Phase 1	Aurora kinase inhibitor	AURKA|AURKB|AURKC
AMI-1	AMI-1	Oc1cc(cc2cc(NC(=O)Nc3ccc4c(O)cc(cc4c3)S(O)(=O)=O)ccc12)S(O)(=O)=O		Preclinical	protein arginine N-methyltransferase inhibitor	PRMT1
amibegron	amibegron|AMIBEGRON	CCOC(=O)COc1ccc2CC[C@@H](Cc2c1)NC[C@H](O)c1cccc(Cl)c1	PDQ3ME68U3	Phase 3	adrenergic receptor agonist	ADRB3
amidopyrine	amidopyrine|AMINOPHENAZONE	CN(C)c1c(C)n(C)n(-c2ccccc2)c1=O	01704YP3MO	Launched	analgesic agent	
amifampridine	amifampridine|AMIFAMPRIDINE	Nc1ccncc1N	RU4S6E2G0J	Launched	potassium channel blocker	
amiflamine	amiflamine|AMIFLAMINE	CC(N)Cc1ccc(cc1C)N(C)C	NE25WV9C8S	Phase 1	monoamine oxidase inhibitor	MAOA|SLC6A2
amifostine	amifostine|AMIFOSTINE	NCCCNCCSP(O)(O)=O	M487QF2F4V	Launched	reducing agent	ALPPL2|ENPP1
amikacin	amikacin|AMIKACIN	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O	84319SGC3C	Launched	bacterial 30S ribosomal subunit inhibitor	
amiloride	amiloride|AMILORIDE	NC(=N)NC(=O)c1nc(Cl)c(N)nc1N	7DZO8EB0Z3	Launched	sodium channel blocker	AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2
amineptine	amineptine|AMINEPTINE	OC(=O)CCCCCCNC1c2ccccc2CCc2ccccc12	27T1I13L6G	Withdrawn	dopamine receptor agonist	SLC6A2|SLC6A4
aminocaproic-acid	aminocaproic-acid|AMINOCAPROIC ACID	NCCCCCC(O)=O	U6F3787206	Launched	plasminogen activator inhibitor	LPA|PLAT|PLG
aminoglutethimide	aminoglutethimide|AMINOGLUTETHIMIDE	CCC1(CCC(=O)NC1=O)c1ccc(N)cc1	0O54ZQ14I9	Launched	glucocorticoid receptor antagonist	CYP11A1|CYP19A1
aminoguanidine	aminoguanidine|PIMAGEDINE	NNC(N)=N	SCQ4EZQ113	Phase 3	nitric oxide synthase inhibitor	NOS2
aminohydroxybutyric-acid	aminohydroxybutyric-acid|.GAMMA.-AMINO-.BETA.-HYDROXYBUTYRIC ACID	NCC(O)CC(O)=O	1ZHM019FLD	Launched		
aminolevulinic-acid-benzyl-ester	aminolevulinic-acid-benzyl-ester	NCC(=O)CCC(=O)OCc1ccccc1		Phase 1		
aminomethyltransferase	aminomethyltransferase	CC1CCN=C(N)S1		Preclinical	nitric oxide synthase inhibitor	NOS2
aminopentamide	aminopentamide|AMINOPENTAMIDE	CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C	IP1B47L61M	Launched	acetylcholine receptor antagonist	CHRM1
aminophylline	aminophylline|AMINOPHYLLINE	Cn1c2nc[nH]c2c(=O)n(C)c1=O	27Y3KJK423	Launched	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D
aminopterin	aminopterin|AMINOPTERIN	Nc1nc(N)c2nc(CNc3ccc(cc3)C(=O)NC(CCC(O)=O)C(O)=O)cnc2n1	JYB41CTM2Q	Phase 3	dihydrofolate reductase inhibitor	DHFR|SLC46A1
aminopurvalanol-a	aminopurvalanol-a	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		Preclinical	CDK inhibitor|tyrosine kinase inhibitor	CDK1|CDK2|CDK5|CDK6
aminosalicylate	aminosalicylate|AMINOSALICYLIC ACID	Nc1ccc(C(O)=O)c(O)c1	5B2658E0N2	Launched	cyclooxygenase inhibitor	ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2
aminothiadiazole	aminothiadiazole|2-AMINO-1,3,4-THIADIAZOLE	Nc1nncs1	6L41AOK74P	Phase 2	inosine monophosphate dehydrogenase inhibitor	ADORA3|IMPDH1
aminothiazole	aminothiazole|AMINOTHIAZOLE	Nc1nccs1	5K8WKN668K	Preclinical	cyclin D inhibitor	NOS2
amiodarone	amiodarone|AMIODARONE	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1	N3RQ532IUT	Launched	potassium channel blocker	ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2
amiprilose	amiprilose|AMIPRILOSE	CN(C)CCCO[C@H]1[C@H](O[C@@H]2OC(C)(C)O[C@H]12)[C@H](O)CO	S0FG5X68QT	Phase 3	CD antagonist	
amisulpride	amisulpride|AMISULPRIDE	CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC	8110R61I4U	Launched	dopamine receptor antagonist	DRD2|DRD3|HTR2A|HTR7
amitifadine	amitifadine|DOV-216303 FREE BASE|AMITIFADINE	Clc1ccc(cc1Cl)C12CC1CNC2	5W2YA6F455|GE0J375F8F	Phase 3	serotonin transporter (SERT) inhibitor	SLC6A2|SLC6A3|SLC6A4
amitraz	amitraz|AMITRAZ	CN(\C=N\c1ccc(C)cc1C)\C=N\c1ccc(C)cc1C	33IAH5017S	Launched	adrenergic receptor agonist	ADRA1A|ADRA2A
amitriptyline	amitriptyline|AMITRIPTYLINE	CN(C)CCC=C1c2ccccc2CCc2ccccc12	1806D8D52K	Launched	norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninnorepinephrine reuptake inhibitor (SNRI)	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4
amlexanox	amlexanox|AMLEXANOX	CC(C)c1ccc2oc3nc(N)c(cc3c(=O)c2c1)C(O)=O	BRL1C2459K	Launched	histamine receptor modulator	FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13
amlodipine	amlodipine|AMLODIPINE	CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC	1J444QC288	Launched	calcium channel blocker	CA1|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNA2D3|CACNB1|CACNB2|SMPD1
ammonium-glycyrrhizinate	ammonium-glycyrrhizinate|AMMONIUM GLYCYRRHIZATE	C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@]4(C)CC[C@H](O[C@H]5O[C@@H]([C@@H](O)[C@H](O)[C@@H]5O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C(O)=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O	3VRD35U26C	Launched	thrombin inhibitor	HSD11B1|HSD11B2|SLCO1B1|SLCO1B3
ammonium-lactate	ammonium-lactate|AMMONIUM LACTATE	N.CC(O)C(O)=O	67M901L9NQ	Launched		HCAR1
ammonium-perfluorocaprylate	ammonium-perfluorocaprylate|AMMONIUM PERFLUOROOCTANOATE	OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	E904OF18PS	Phase 1	Pim kinase inhibitor	PIM1
AMN-082	AMN-082	C(CNC(c1ccccc1)c1ccccc1)NC(c1ccccc1)c1ccccc1		Preclinical	glutamate receptor modulator	GRM7
amodiaquine	amodiaquine|AMODIAQUINE	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O	220236ED28	Launched	histamine receptor agonist	HNMT
amonafide	amonafide|AMONAFIDE	CN(C)CCN1C(=O)c2cccc3cc(N)cc(C1=O)c23	1Q8D39N37L	Phase 3	topoisomerase inhibitor	TOP2A|TOP2B
amorolfine	amorolfine|AMOROLFINE	CCC(C)(C)c1ccc(CC(C)CN2C[C@H](C)O[C@H](C)C2)cc1	AB0BHP2FH0	Launched	membrane integrity inhibitor	
amoxapine	amoxapine|AMOXAPINE	Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1	R63VQ857OT	Launched	norepinephrine reputake inhibitor	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4
amoxicillin	amoxicillin|AMOXICILLIN	CC1(C)S[C@@H]2[C@H](NC(=O)[C@@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O	804826J2HU	Launched	penicillin binding protein inhibitor	CYP2C19|SLC15A1|SLC15A2|SLC22A6
AMPA-(RS)	AMPA-(RS)|AMPA	Cc1onc(O)c1CC(N)C(O)=O	J090588E6X	Preclinical	glutamate receptor agonist	GRIN1
AMPA-(S)	AMPA-(S)|AMPA, L-	Cc1onc(O)c1C[C@H](N)C(O)=O	9280SC28GD	Preclinical	glutamate receptor agonist	GRIN1
ampalex	ampalex|CX516	O=C(N1CCCCC1)c1ccc2nccnc2c1	Z5QU38B4V9	Phase 2	glutamate receptor agonist	GRIA1|GRIA2|GRIA3|GRIA4
amperozide	amperozide|AMPEROZIDE	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	0M2W3TAG39	Launched	dopamine receptor antagonist	FAAH|HTR2A
amphotericin-b	amphotericin-b|AMPHOTERICIN B	CC1OC(O[C@@H]2CC3O[C@@](O)(C[C@H](O)C3C(O)=O)CC(O)CC(O)C(O)CCC(O)CC(O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)C(O)[C@H](N)C1O	7XU7A7DROE	Launched	membrane permeability enhancer	
ampicillin	ampicillin|AMPICILLIN	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O	7C782967RD	Launched	bacterial cell wall synthesis inhibitor	
ampiroxicam	ampiroxicam|AMPIROXICAM	CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1	0PV32JZB1J	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
amprenavir	amprenavir|AMPRENAVIR	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1	5S0W860XNR	Launched	HIV protease inhibitor	
amprolium	amprolium|AMPROLIUM	CCCc1ncc(C[n+]2ccccc2C)c(N)n1	95CO6N199Q	Launched	thiamine uptake blocker	
ampyrone	ampyrone|AMPYRONE	Cc1c(N)c(=O)n(-c2ccccc2)n1C	0M0B7474RA	Preclinical	cyclooxygenase inhibitor	
amrinone	amrinone|INAMRINONE	Nc1cc(c[nH]c1=O)-c1ccncc1	JUT23379TN	Launched	phosphodiesterase inhibitor	PDE3A|PDE3B|PDE4B|TNF
amrubicin	amrubicin|AMRUBICIN	CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)c2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c2C1	93N13LB4Z2	Launched	topoisomerase inhibitor	TOP2A|TOP2B
amsacrine	amsacrine|AMSACRINE	COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12	00DPD30SOY	Launched	topoisomerase inhibitor	KCNH2|TOP2A
amthamine	amthamine	Cc1nc(N)sc1CCN		Preclinical	histamine receptor agonist	HRH2
amtolmetin-guacil	amtolmetin-guacil|AMTOLMETIN GUACIL	COc1ccccc1OC(=O)CNC(=O)Cc1ccc(C(=O)c2ccc(C)cc2)n1C	323A00CRO9	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
amuvatinib	amuvatinib|AMUVATINIB	S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12	SO9S6QZB4R	Phase 2	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor	KIT|MET
amygdalin	amygdalin|AMYGDALIN	OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H](C#N)c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	214UUQ9N0H	Phase 2	caspase activator	CASP3
amyl-nitrite	amyl-nitrite|PENTYL NITRITE	CCCCCO[N+][O-]	H2HUX79FYK	Preclinical	atrial natriuretic peptide receptor agonist	NPR1
amyleine	amyleine|AMYLOCAINE	CCC(C)(CN(C)C)OC(=O)c1ccccc1	QRW683O56T	Preclinical	local anesthetic	
amylene-hydrate	amylene-hydrate|AMYLENE HYDRATE	CCC(C)(C)O	69C393R11Z	Preclinical	local anesthetic	
AMZ30	AMZ30	[O-][N+](=O)c1cccc(c1)S(=O)(=O)n1cccc1\C=C(/C#N)S(=O)(=O)c1ccc(F)cc1		Preclinical	protein phosphatase inhibitor	
AN2718	AN2718|AN-2718	OB1OCc2cc(Cl)ccc12	810U6C2DGG	Phase 1	leucyl-tRNA synthetase inhibitor	
anabasine	anabasine|ANABASINE	C1CCC(NC1)c1cccnc1	LMS11II2LO	Preclinical	acetylcholine receptor agonist	
anacetrapib	anacetrapib|ANACETRAPIB	COc1cc(F)c(cc1-c1ccc(cc1CN1[C@H](C)[C@H](OC1=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C	P7T269PR6S	Phase 3	cholesteryl ester transfer protein inhibitor	CETP
anagliptin	anagliptin|ANAGLIPTIN	Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N	K726J96838	Launched	dipeptidyl peptidase inhibitor	DPP4
anagrelide	anagrelide|ANAGRELIDE	Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl	K9X45X0051	Launched	phosphodiesterase inhibitor	PDE3A
anamorelin	anamorelin|ANAMORELIN	CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C1)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(C)N	DD5RBA1NKF	Phase 3	growth hormone secretagogue receptor agonist	GHSR
anandamide	anandamide|ANANDAMIDE	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO	UR5G69TJKH	Phase 2	cannabinoid receptor agonist	CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1
anastrozole	anastrozole|ANASTROZOLE	CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N	2Z07MYW1AZ	Launched	aromatase inhibitor	CYP19A1
andarine	andarine|ANDARINE	CC(=O)Nc1ccc(OC[C@](C)(O)C(=O)Nc2ccc(c(c2)C(F)(F)F)[N+]([O-])=O)cc1	7UT2HAH49H	Phase 1	androgen receptor modulator	AR
andrographolide	andrographolide|ANDROGRAPHOLIDE	C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@@H](C\C=C3/C(O)COC3=O)C(=C)CC[C@H]12	410105JHGR	Phase 2	tumor necrosis factor production inhibitor	NFKB1
androstenone	androstenone|5.ALPHA.-ANDROST-16-EN-3-ONE	CC12CCC3C(CCC4CC(=O)CCC34C)C1CC=C2	BWD3D5941J	Preclinical	steroid	
androsterone	androsterone|ANDROSTERONE	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CCC2=O	C24W7J5D5R	Preclinical	androgen receptor agonist	
anecortave-acetate	anecortave-acetate|ANECORTAVE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@]12C	Y0PC411K4T	Launched	angiogenesis inhibitor	
anethole	anethole|ANETHOLE	COc1ccc(cc1)\C=C\C	Q3JEK5DO4K	Launched	glutathione transferase stimulant	
anethole-trithione	anethole-trithione|ANETHOLTRITHION	COc1ccc(cc1)-c1cc(=S)ss1	QUY32964DJ	Launched	glutathione transferase stimulant	
anguidine	anguidine	CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@@]11CO1		Phase 2	protein synthesis inhibitor	SLC5A1
anidulafungin	anidulafungin|ANIDULAFUNGIN	CCCCCOc1ccc(cc1)-c1ccc(cc1)-c1ccc(cc1)C(=O)NC1CC(O)C(O)NC(=O)C2C(O)C(C)CN2C(=O)C(NC(=O)C(NC(=O)C2CC(O)CN2C(=O)C(NC1=O)C(C)O)C(O)C(O)c1ccc(O)cc1)C(C)O	9HLM53094I	Launched	fungal 1,3-beta-D-glucan synthase inhibitor	
aniracetam	aniracetam|ANIRACETAM	COc1ccc(cc1)C(=O)N1CCCC1=O	5L16LKN964	Launched	glutamate receptor agonist	DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A
anisindione	anisindione|ANISINDIONE	COc1ccc(cc1)C1C(=O)c2ccccc2C1=O	S747T1ERAJ	Launched	vitamin K antagonist	GGCX
anisodamine	anisodamine|ANISODAMINE	CN1C2C[C@H](O)[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c1ccccc1	01343Q8EL8	Phase 3	lipid peroxidase inhibitor	ADRA1A
anisomycin	anisomycin|ANISOMYCIN	COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1	6C74YM2NGI	Preclinical	DNA synthesis inhibitor	NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1
anisotropine	anisotropine|ANISOTROPINE	CCCC(CCC)C(=O)OC1C[C@@H]2CC[C@H](C1)[N+]2(C)C	MJJ5G1G8OM	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
anlotinib	anlotinib|ANLOTINIB	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1	GKF8S4C432	Phase 2/Phase 3	VEGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor	KDR|PDGFRB
anpirtoline	anpirtoline|ANPIRTOLINE	Clc1cccc(SC2CCNCC2)n1	32K9S228IK	Phase 1	serotonin receptor agonist	HTR1B
ansamitocin-p-3	ansamitocin-p-3|ANSAMITOMICIN P-3	CO[C@@H]1C=C\C=C(C)/Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]2(C)O[C@H]2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2	7SUK7876BG	Preclinical	apoptosis stimulant	
antagonist-g	antagonist-g	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O		Phase 1	neuropeptide receptor antagonist	MAPK8
antazoline	antazoline|ANTAZOLINE	C(N(Cc1ccccc1)c1ccccc1)C1=NCCN1	DHA8014SS1	Launched	antihistamine	HRH1
anthralin	anthralin|ANTHRALIN	Oc1cccc2Cc3cccc(O)c3C(=O)c12	U8CJK0JH5M	Launched	DNA synthesis inhibitor	
anthranilic-acid	anthranilic-acid|ANTHRANILIC ACID	OC(=O)c1ccccc1NC(=O)C12CC3CC(CC(C3)C1)C2	0YS975XI6W	Preclinical		
anthraquinone	anthraquinone|ANTHRAQUINONE	O=C1c2ccccc2C(=O)c2ccccc12	030MS0JBDO	Preclinical	CDC inhibitor	CDC25B
antimony-potassium	antimony-potassium|ANTIMONY TARTRATE ION	OC(=O)C1O[Sb]2OC(C(O[Sb]3OC1C(=O)O3)C(O)=O)C(=O)O2	CQN5KB2U1M	Phase 2		
antimonyl	antimonyl	O=C1O[SbH]23OC1C1O[SbH]4(OC(C(O2)C(=O)O3)C(=O)O4)OC1=O		Phase 1		
antimycin-a	antimycin-a|ANTIMYCIN A1B	CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)C(NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O	75G3NMU1TS	Preclinical	ATP synthase inhibitor	CYCS
antioxine	antioxine|CARVACROL	CC(C)c1ccc(C)c(O)c1	9B1J4V995Q	Launched		
AP1903	AP1903|RIMIDUCID	CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)NCCNC(=O)COc2cccc(c2)[C@@H](CCc2ccc(OC)c(OC)c2)OC(=O)[C@@H]2CCCCN2C(=O)[C@@H](CC)c2cc(OC)c(OC)c(OC)c2)c1)c1cc(OC)c(OC)c(OC)c1	H564L1W5J2	Phase 1/Phase 2		
AP26113	AP26113|BRIGATINIB	COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N(C)C	HYW8DB273J	Phase 2	ALK tyrosine kinase receptor inhibitor	ALK|EGFR
apabetalone	apabetalone|APABETALONE	COc1cc(OC)c2c(c1)[nH]c(nc2=O)-c1cc(C)c(OCCO)c(C)c1	8R4A7GDZ1D	Phase 3	apolipoprotein expression enhancer	BRD3
apafant	apafant|APAFANT	Cc1nnc2CN=C(c3cc(CCC(=O)N4CCOCC4)sc3-n12)c1ccccc1Cl	J613NI05SV	Phase 3	platelet activating factor receptor antagonist	PTAFR
apatinib	apatinib|APATINIB	O=C(Nc1ccc(cc1)C1(CCCC1)C#N)c1cccnc1NCc1ccncc1	TK02X14ASJ	Phase 3	RET tyrosine kinase inhibitor	CSK|KDR|KIT|RET
APC-100	APC-100|CHROMANOL	Cc1c(C)c2OC(C)(C)CCc2c(C)c1O	7G73627R36	Phase 1/Phase 2	anti-inflammatory agent|androgen receptor antagonist	AR
APD597	APD597|ADP-597	COc1c(Nc2ccc(nc2C)S(C)(=O)=O)ncnc1OC1CCN(CC1)C(=O)OC(C)C	345354O7AT	Phase 1	glucose dependent insulinotropic receptor agonist	GPR119
APD668	APD668|IPSAPIRONE	CC(C)OC(=O)N1CCC(CC1)Oc1ncnc2n(ncc12)-c1ccc(cc1F)S(C)(=O)=O	6J9B11MN0K	Phase 1	glucose dependent insulinotropic receptor agonist	GPR119
aphidicolin	aphidicolin|APHIDICOLIN|APHIDICOLIN, (+/-)-	C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]1C[C@@H]3C[C@]21CC[C@]3(O)CO	192TJ6PP19|6B3F8QW8TU	Phase 1	RNA synthesis inhibitor	
API-001	API-001|E-52862	Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1	ZW18DSD1H4	Phase 2	sigma receptor antagonist	SIGMAR1
apigenin	apigenin|APIGENIN	Oc1ccc(cc1)-c1cc(=O)c2c(O)cc(O)cc2o1	7V515PI7F6	Preclinical	casein kinase inhibitor|cell proliferation inhibitor	AKR1B1|AR|CDK6|CFTR|CYP19A1|CYP1B1|HSD17B1
apixaban	apixaban|APIXABAN	COc1ccc(cc1)-n1nc(C(N)=O)c2CCN(C(=O)c12)c1ccc(cc1)N1CCCCC1=O	3Z9Y7UWC1J	Launched	coagulation factor inhibitor	F10
apocynin	apocynin|APOCYNIN	COc1cc(ccc1O)C(C)=O	B6J7B9UDTR	Phase 1	NADPH oxidase inhibitor	NOX4
apoptosis-activator-II	apoptosis-activator-II	Clc1ccc(CN2C(=O)C(=O)c3ccccc23)cc1Cl		Preclinical	carboxylesterase inhibitor	BCHE|CES1
APR-246	APR-246	COCC1(CO)N2CCC(CC2)C1=O	Z41TGB4080	Phase 1/Phase 2	p53 activator	TP53
apraclonidine	apraclonidine|APRACLONIDINE	Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1	843CEN85DI	Launched	adrenergic receptor agonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C
apramycin	apramycin|APRAMYCIN	CN[C@H]1[C@@H](O)[C@H]2O[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@H]1O[C@H](CO)[C@@H](N)[C@H](O)[C@H]1O	388K3TR36Z	Launched	bacterial 30S ribosomal subunit inhibitor	
apratastat	apratastat|APRATASTAT	CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)c1ccc(OCC#CCO)cc1	C6BZ5263BJ	Phase 2	matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor	ADAM17|MMP1|MMP13|MMP9
apremilast	apremilast|APREMILAST	CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O	UP7QBP99PN	Launched	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D
aprepitant	aprepitant|APREPITANT	C[C@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F	1NF15YR6UY	Launched	tachykinin antagonist	TACR1
apricitabine	apricitabine|APRICITABINE	Nc1ccn([C@H]2CO[C@@H](CO)S2)c(=O)n1	K1YX059ML1	Phase 3	nucleoside reverse transcriptase inhibitor	
aprindine	aprindine|APRINDINE	CCN(CC)CCCN(C1Cc2ccccc2C1)c1ccccc1	5Y48085P9Q	Launched	voltage-gated sodium channel blocker	CALM1|SCN5A
aptiganel	aptiganel|APTIGANEL	CCc1cccc(c1)N(C)C(=N)Nc1cccc2ccccc12	46475LV84I	Phase 3	glutamate receptor antagonist	GRIN1
APTO-253	APTO-253	Cc1[nH]c2ccc(F)cc2c1-c1nc2c([nH]1)c1cccnc1c1ncccc21		Phase 1	krppel-like factor expression enhancer	KLF4
APY0201	APY0201	Cc1cccc(\C=N\Nc2cc(N3CCOCC3)n3nc(cc3n2)-c2ccncc2)c1		Preclinical	phosphoinositide dependent kinase inhibitor	IL12A|IL12B|PIKFYVE
AQ-RA741	AQ-RA741	CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1		Preclinical	acetylcholine receptor antagonist	CHRM2
AR-12	AR-12	NCC(=O)Nc1ccc(cc1)-n1nc(cc1-c1ccc2c(ccc3ccccc23)c1)C(F)(F)F	EX3O2Q61UV	Phase 1	phosphoinositide dependent kinase inhibitor	PDPK1
AR-42	AR-42	CC(C)[C@H](C(=O)Nc1ccc(cc1)C(=O)NO)c1ccccc1	E0GG29V0AQ	Phase 1	HDAC inhibitor	HDAC1
AR-A014418	AR-A014418|AR-AO-14418	COc1ccc(CNC(=O)Nc2ncc(s2)[N+]([O-])=O)cc1	87KSH90Q6D	Preclinical	glycogen synthase kinase inhibitor	GSK3B
AR-C155858	AR-C155858	CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(C(=O)N3C[C@H](O)CO3)c2c(=O)n(C)c1=O		Preclinical	monocarboxylate transporter inhibitor	SLC16A1|SLC16A7
arachidonic-acid	arachidonic-acid|ARACHIDONIC ACID	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O	27YG812J1I	Phase 1	cytochrome P450 inhibitor	CLCN2|KCNJ4|KCNK10|KCNK18|KCNK2|PRKCZ|PTGS1|TRPC6|TRPM2
arbidol	arbidol|UMIFENOVIR	CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12	93M09WW4RU	Launched	cytochrome P450 inhibitor	CYP3A4
arbutin	arbutin|ARBUTIN	OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O	C5INA23HXF	Phase 2/Phase 3	melanin inhibitor	TYR
ARC-239	ARC-239|AR-C-239	COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1	M7H349ZZ5T	Preclinical	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C
arctigenin	arctigenin|ARCTIGENIN, (+/-)-|ARCTIGENIN	COc1cc(C[C@@H]2[C@@H](Cc3ccc(OC)c(OC)c3)COC2=O)ccc1O	2FD8L150E7|U76MR9VS6M	Preclinical	MEK inhibitor	CHUK|MAP2K1
arcyriaflavin-a	arcyriaflavin-a	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		Preclinical	CDK inhibitor	CCND1|CDK4
ardeparin	ardeparin|NADROPARIN|HEPARIN (PORCINE; 7000 MW)|REVIPARIN|SEVUPARIN|PARNAPARIN|HEPARIN, BOVINE|BEMIPARIN|CERTOPARIN|ARDEPARIN	CC(=O)NC1C(O)OC(COS(O)(=O)=O)C(OC2OC(C(OC3OC(CO)C(OC4OC(C(O)C(O)C4OS(O)(=O)=O)C(O)=O)C(OS(O)(=O)=O)C3NS(O)(=O)=O)C(O)C2OS(O)(=O)=O)C(O)=O)C1O	1K5KDI46KZ|26GW6E5M72|5R0L1D739E|7C17NQF03M|M316WT19D8|P776JQ4R2F|PUE0TO3XDR|V72OT3K19I|VL0L558GCB	Withdrawn	thrombin inhibitor	SERPINC1|SERPIND1
arecaidine-but-2-ynyl-ester	arecaidine-but-2-ynyl-ester	CC#CCOC(=O)C1=CCCN(C)C1		Preclinical	acetylcholine receptor agonist	CHRM2
arecaidine-propargyl-ester	arecaidine-propargyl-ester	CN1CCC=C(C1)C(=O)OCC#C		Preclinical	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
arecoline	arecoline|ARECOLINE	COC(=O)C1=CCCN(C)C1	4ALN5933BH	Phase 1	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
argatroban	argatroban|ARGATROBAN	C[C@@H]1CCN([C@@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)c1cccc2CC(C)CNc12	IY90U61Z3S	Launched	thrombin inhibitor	F2
arglabin	arglabin	CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13		Launched	farnesyltransferase inhibitor	FNTA|NFKB1
aripiprazole	aripiprazole|ARIPIPRAZOLE	Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl	82VFR53I78	Launched	serotonin receptor agonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7
armodafinil	armodafinil|MODAFINIL	NC(=O)C[S@@](=O)C(c1ccccc1)c1ccccc1	R3UK8X3U3D	Launched	adrenergic receptor agonist	SLC6A3
ARN-509	ARN-509|APALUTAMIDE	CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C11CCC1)c1cnc(C#N)c(c1)C(F)(F)F	4T36H88UA7	Phase 3	androgen receptor antagonist	AR
arofylline	arofylline|AROFYLLINE	CCCn1c(=O)n(-c2ccc(Cl)cc2)c2[nH]cnc2c1=O	87L38AY71R	Phase 3	phosphodiesterase inhibitor	PDE4A
arotinolol	arotinolol|AROTINOLOL	CC(C)(C)NCC(O)CSc1nc(cs1)-c1ccc(s1)C(N)=O	394E3P3B99	Launched	adrenergic receptor antagonist	ADRB3
ARQ-092	ARQ-092	Nc1ncccc1-c1nc2ccc(nc2n1-c1ccc(cc1)C1(N)CCC1)-c1ccccc1		Phase 1	AKT inhibitor	AKT2
ARQ-621	ARQ-621	NCCCN([C@H](CC#C)c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)C(=O)c1cccc(Cl)c1F	UU55190C8S	Phase 1	kinesin-like spindle protein inhibitor	KIF11
ARRY-334543	ARRY-334543|VARLITINIB	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1	846Y8197W1	Phase 2	EGFR inhibitor	ERBB2
arsanilic-acid	arsanilic-acid|ARSANILIC ACID	Nc1ccc(cc1)[As](O)(O)=O	UDX9AKS7GM	Phase 1		LYZ
arsenic-trioxide	arsenic-trioxide|ARSENIC TRIOXIDE	O[AsH]O[AsH]O	S7V92P67HO	Launched	apoptosis stimulant	AKT1|CCND1|IKBKB|JUN|MAPK1|MAPK3|TXNRD1
artemether	artemether|.ALPHA.-ARTEMETHER|ARTEMETHER	COC1O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3	111W6L37CC|C7D6T3H22J	Launched	antimalarial agent	ATP1A1
artemisinin	artemisinin|ARTEMISININ	C[C@H]1CC[C@H]2[C@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	9RMU91N5K2	Launched	DNA synthesis inhibitor	CYP2B6
artemotil	artemotil|.ALPHA.-ARTEETHER|ARTEMOTIL	CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3	R6TF0B136Q|XGL7GFB9YI	Launched		
artesunate	artesunate|ARTESUNATE	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4	60W3249T9M	Launched	DNA synthesis inhibitor	
articaine	articaine|ARTICAINE	CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC	D3SQ406G9X	Launched	local anesthetic	
arundic-acid	arundic-acid|ARUNDIC ACID	CCCCCC[C@@H](CCC)C(O)=O	F2628ZD0FO	Phase 2/Phase 3	astrocyte modulating agent	PTGS2|S100B
ARV-825	ARV-825	Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)Nc1ccc(OCCOCCOCCOCCNc3cccc4C(=O)N(C5CCC(=O)NC5=O)C(=O)c34)cc1)c1nnc(C)n-21)c1ccc(Cl)cc1		Preclinical	bromodomain inhibitor	BRD4
AS-1949490	AS-1949490	C[C@H](NC(=O)c1sccc1OCc1ccc(Cl)cc1)c1ccccc1		Preclinical	SHIP2 phosphatase inhibitor	INPP5D
AS-252424	AS-252424	Oc1cc(F)ccc1-c1ccc(\C=C2/SC(=O)NC2=O)o1	63D4RUV1GN	Preclinical	PI3K inhibitor	PIK3CG
AS-604850	AS-604850	FC1(F)Oc2ccc(cc2O1)\C=C1/SC(=O)NC1=O		Preclinical	PI3K inhibitor	PIK3CA|PIK3CG
AS-703026	AS-703026|PIMASERTIB	OC[C@@H](O)CNC(=O)c1ccncc1Nc1ccc(I)cc1F	6ON9RK82AL	Phase 2	MEK inhibitor	MAP2K1|MAP2K2
AS-77	AS-77|PAP-1	O=c1ccc2c(OCCCCOc3ccccc3)c3ccoc3cc2o1	A62C114Q0Q	Preclinical	potassium channel blocker	KCNA3|KCNA5|KCNN4
ASA-404	ASA-404|VADIMEZAN	Cc1ccc2c(oc3c(CC(O)=O)cccc3c2=O)c1C	0829J8133H	Phase 3	angiogenesis inhibitor	
asaraldehyde	asaraldehyde|2,4,5-TRIMETHOXYLBENZALDEHYDE	COc1cc(OC)c(C=O)cc1OC	NDU8J2Q00D	Preclinical	cyclooxygenase inhibitor	PTGS2
ASC-J9	ASC-J9|DIMETHYLCURCUMIN	COc1ccc(cc1OC)\C=C\C(=O)CC(=O)\C=C\c1ccc(OC)c(OC)c1	D60XLY608D	Phase 2	androgen receptor enhancer	AR
ascomycin	ascomycin|ASCOMYCIN 19-EPIMER|IMMUNOMYCIN	CCC1\C=C(C)\CC(C)CC(OC)C2OC(O)(C(C)CC2OC)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)C(O)CC1=O)C(\C)=C\C1CCC(O)C(C1)OC	94K77BR6AT|AUF4U5NSJK	Preclinical	calcineurin inhibitor	FKBP1A
ascorbic-acid	ascorbic-acid|ASCORBIC ACID	OCC(O)[C@H]1OC(=O)C(=O)C1O	PQ6CK8PD0R	Launched	antioxidant	ALKBH2|ALKBH3|BBOX1|DBH|EGLN1|EGLN2|EGLN3|KDM5D|LCT|OGFOD1|OGFOD2|P3H1|P3H2|P3H3|P4HA1|P4HTM|PAM|PHYH|PLOD1|PLOD2|PLOD3|SLC23A1|SLC23A2|TMLHE
asenapine	asenapine|ASENAPINE	CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21	JKZ19V908O	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|HRH1|HRH2|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
asiatic-acid	asiatic-acid|ASIATIC ACID	C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O	9PA5A687X5	Preclinical	apoptosis stimulant	PYGM
ASP-2535	ASP-2535	CC(C)c1nnc(-c2ccc(nc2)-c2ccccc2)n1-c1cccc2nonc12		Phase 1	glycine transporter inhibitor	SLC6A9
ASP3026	ASP3026|ASP-3026	COc1cc(ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1)N1CCC(CC1)N1CCN(C)CC1	HP4L6MXF10	Phase 1	ALK tyrosine kinase receptor inhibitor	ALK
aspartame	aspartame|ASPARTAME	COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O	Z0H242BBR1	Launched		TAS1R2|TRPV1
aspirin	aspirin|ASPIRIN	CC(=O)Oc1ccccc1C(O)=O	R16CO5Y76E	Launched	cyclooxygenase inhibitor	AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53
AST-1306	AST-1306	Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=O)C=C)cc34)cc2Cl)c1		Phase 1	EGFR inhibitor	EGFR|ERBB2
astaxanthin	astaxanthin|ASTAXANTHIN	CC(\C=C\C=C(C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)[C@@H](O)CC1(C)C	8XPW32PR7I	Launched	antioxidant	
astemizole	astemizole|ASTEMIZOLE	COc1ccc(CCN2CCC(CC2)Nc2nc3ccccc3n2Cc2ccc(F)cc2)cc1	7HU6337315	Withdrawn	histamine receptor antagonist	HRH1|KCNH1|KCNH2
astragaloside-a	astragaloside-a|ASTRAGALOSIDE A	CC(C)(O)[C@H]1CC[C@](C)(O1)[C@@H]1[C@@H](O)C[C@@]2(C)[C@@H]3C[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)[C@@H]4[C@]5(C[C@]35CC[C@]12C)CC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)C4(C)C	3A592W8XKE	Preclinical	antiinflammatory agent	
asunaprevir	asunaprevir|ASUNAPREVIR	COc1cnc(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C2CC2)c2cc(Cl)ccc12	S9X0KRJ00S	Phase 3	HCV inhibitor	
asymmetrical-dimethylarginine	asymmetrical-dimethylarginine|N,N-DIMETHYLARGININE	CN(C)C(=N)NCCC[C@H](N)C(O)=O	63CV1GEK3Y	Phase 1	nitric oxide synthase inhibitor	NOS2|NOS3
AT-7519	AT-7519	Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1	X1BF92PW9T	Phase 2	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CDK6|CDK9
AT-9283	AT-9283	O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1	XAV9KYN9WL	Phase 2	Aurora kinase inhibitor|JAK inhibitor	AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A
AT13148	AT13148|AT-13148	NCC(O)(c1ccc(Cl)cc1)c1ccc(cc1)-c1cn[nH]c1	A49037RP1E	Phase 1	protein kinase inhibitor	AKT1|AKT2|AKT3|ROCK1|ROCK2|SGK3
AT13387	AT13387|ONALESPIB	CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O	Q7Y33N57ZZ	Phase 2	HSP antagonist	HSP90AA1
AT7867	AT7867	Clc1ccc(cc1)C1(CCNCC1)c1ccc(cc1)-c1cn[nH]c1		Preclinical	AKT inhibitor	AKT2|GSK3B|PKIA|PRKACA
ataluren	ataluren|ATALUREN	OC(=O)c1cccc(c1)-c1noc(n1)-c1ccccc1F	K16AME9I3V	Launched	CFTR channel agonist|dystrophin stimulant	DMD
atazanavir	atazanavir|ATAZANAVIR	COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(cc1)-c1ccccn1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C	QZU4H47A3S	Launched	HIV protease inhibitor	
ATB-346	ATB-346	COc1ccc2cc(ccc2c1)C(C)C(=O)Oc1ccc(cc1)C(N)=S	3096O7WP53	Phase 2	cyclooxygenase inhibitor	PTGER2
atenolol-(-)	atenolol-(-)|ESATENOLOL	CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1	DPF757BOSR	Preclinical	adrenergic receptor antagonist	
atenolol-(+/-)	atenolol-(+/-)|ATENOLOL	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1	50VV3VW0TI	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
atglistatin	atglistatin	CN(C)C(=O)Nc1cccc(c1)-c1ccc(cc1)N(C)C		Preclinical	adipose triglyceride lipase inhibitor	
atipamezole	atipamezole|ATIPAMEZOLE	CCC1(Cc2ccccc2C1)c1cnc[nH]1	03N9U5JAF6	Launched	adrenergic receptor antagonist	
atiprimod	atiprimod|ATIPRIMOD	CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1	MG7D3QD743	Phase 2	JAK inhibitor|STAT inhibitor	JAK2|STAT3
atizoram	atizoram|CP-76593|ATIZORAM	COc1ccc(cc1O[C@H]1C[C@@H]2CC[C@H]1C2)C1CNC(=O)NC1	8SI21E44GN|O84FJB49WI	Phase 2	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D
ATN-161	ATN-161	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O		Phase 2	integrin antagonist	ITGA5|ITGAV|ITGB1|ITGB3
atomoxetine	atomoxetine|ATOMOXETINE	CNCC[C@@H](Oc1ccccc1C)c1ccccc1	ASW034S0B8	Launched	norepinephrine transporter inhibitor	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4
atorvastatin	atorvastatin|ATORVASTATIN	CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(O)=O)-c1ccccc1	A0JWA85V8F	Launched	HMGCR inhibitor	AHR|DPP4|HMGCR
atosiban	atosiban|ATOSIBAN	CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)C(NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)cc1	081D12SI0Z	Launched	oxytocin receptor antagonist	AVPR1A|AVPR1B|AVPR2|OXTR
atovaquone	atovaquone|ATOVAQUONE	Clc1ccc(cc1)[C@H]1CC[C@@H](CC1)C1C(=O)C(=O)c2ccccc2C1=O	Y883P1Z2LT	Launched	mitochondrial electron transport inhibitor	DHODH
ATPA	ATPA	CC(C)(C)c1onc(O)c1CC(N)C(O)=O		Preclinical	glutamate receptor agonist	GRIA2|GRIK1
atracurium	atracurium|ATRACURIUM, (1S,2R,1'S,2'R)-(+/-)-|ATRACURIUM, (1R,2R,1'R,2'S)-(+/-)-|ATRACURIUM, (1R,2R,1'S,2'R)-(+/-)-|ATRACURIUM, (1R,2S,1'S,2'R)-|CISATRACURIUM|ATRACURIUM, (1R,1'R,2R,2'R)-(+/-)-|ATRACURIUM, (1R,2R,1'S,2'S)-	COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC	685T1EWG9C|6I6ZV2IVUX|GH417099YP|I61915ADYP|QX62KLI41N|SKE79AOA7L|UU07RTA53X	Launched	acetylcholine receptor antagonist	CHRNA2
atrasentan	atrasentan|ATRASENTAN	CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1c1ccc(OC)cc1)C(O)=O)c1ccc2OCOc2c1	V6D7VK2215	Phase 3	endothelin receptor antagonist	EDNRA
atropine	atropine|ATROPINE|HYOSCYAMINE|HYOSCYAMINE, (+)-	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1	7C0697DR9I|PX44XO846X|V3203SI72M	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
atropine-oxide	atropine-oxide|ATROPINE OXIDE	C[N+]1([O-])C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1	3Y03IC177D	Preclinical	acetylcholine receptor antagonist	
auranofin	auranofin|AURANOFIN	CCP(CC)(CC)=[Au]S[C@H]1OC(COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)C1OC(C)=O	3H04W2810V	Launched	NFkB pathway inhibitor	IKBKB|PRDX5|TRPA1
aurora-a-inhibitor-i	aurora-a-inhibitor-i	CCN1CCN(CC1)C(=O)Cc1ccc(Nc2ncc(F)c(Nc3ccc(cc3)C(=O)Nc3ccccc3Cl)n2)cc1		Preclinical	Aurora kinase inhibitor	AURKA
aurothioglucose	aurothioglucose|AUROTHIOGLUCOSE	OC[C@H]1OC(S[Au])[C@H](O)[C@@H](O)[C@@H]1O	2P2V9Q0E78	Launched	PKC inhibitor	PRKCI
autotaxin-modulator-1	autotaxin-modulator-1	C[C@@H](N1C2CCC1CC(C2)C(O)=O)c1ccc2ccc(O[C@H]3CC[C@H](CC3)C(F)(F)F)c(c2c1)C(F)(F)F		Preclinical	autotaxin inhibitor	ENPP2
AV-412	AV-412	CN1CCN(CC1)C(C)(C)C#Cc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=C	Z541VW0W40	Phase 1	protein tyrosine kinase inhibitor	EGFR|ERBB2
AV-608	AV-608	FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(=O)N1CC[C@@H](C[C@H]1Cc1ccc(Cl)cc1)NC(=O)c1ccnc2ccccc12		Phase 2	tachykinin antagonist	TACR1
avagacestat	avagacestat|AVAGACESTAT	NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)-c1ncon1)S(=O)(=O)c1ccc(Cl)cc1	TQ44WWY45Q	Phase 2	gamma secretase inhibitor	PSEN1
avanafil	avanafil|AVANAFIL	COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl	DR5S136IVO	Launched	phosphodiesterase inhibitor	PDE5A
avasimibe	avasimibe|AVASIMIBE	CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(cccc2C(C)C)C(C)C)c(c1)C(C)C	28LQ20T5RC	Phase 3	ACAT inhibitor	CES1
avatrombopag	avatrombopag|AVATROMBOPAG	OC(=O)C1CCN(CC1)c1ncc(cc1Cl)C(=O)Nc1nc(-c2cc(Cl)cs2)c(s1)N1CCN(CC1)C1CCCCC1	3H8GSZ4SQL	Phase 3	thrombopoietin receptor agonist	MPL
AVE-0991	AVE-0991	CCNC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2c(C=O)c(OC)nc2-c2ccccc2)cc1	68JR6NCI7I	Preclinical	angiotensin receptor agonist	MRGPRX1
avibactam	avibactam|AVE-1330A FREE ACID|AVIBACTAM	NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O	06MFO7817I|7352665165	Launched	beta lactamase inhibitor	
AVL-292	AVL-292|SPEBRUTINIB	COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1	DRU6NG543J	Phase 2	Bruton's tyrosine kinase (BTK) inhibitor	BTK|YES1
AVN-944	AVN-944	CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(NC(=O)Nc2ccc(-c3cnco3)c(OC)c2)c1	I3NPL1V48Q	Phase 2	inosine monophosphate dehydrogenase inhibitor	IMPDH1|IMPDH2
avobenzone	avobenzone|AVOBENZONE	COc1ccc(cc1)C(=O)CC(=O)c1ccc(cc1)C(C)(C)C	G63QQF2NOX	Launched	UV blocker	TYR
avridine	avridine|AVRIDINE	CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)CCCN(CCO)CCO	P9J7O7YNSW	Preclinical	immunostimulant	
axitinib	axitinib|AXITINIB	CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1	C9LVQ0YUXG	Launched	PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	CSF1|FLT1|FLT4|KDR|PLK4
AY-9944	AY-9944	Clc1ccccc1CNC[C@H]1CC[C@H](CNCc2ccccc2Cl)CC1		Preclinical	hedgehog pathway modulator	
AZ-10417808	AZ-10417808	[O-][N+](=O)c1cc(C(=O)NCC=C)c2nc(Nc3ccc(Cl)c(Cl)c3)[nH]c(=O)c2c1		Preclinical	caspase inhibitor	CASP3
AZ-628	AZ-628	Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ccc2ncn(C)c(=O)c2c1	560S6B5D79	Preclinical	RAF inhibitor	BRAF|RAF1
AZ191	AZ191	COc1cc(ccc1Nc1nccc(n1)-c1cn(C)c2cnccc12)N1CCN(C)CC1		Preclinical	DYRK inhibitor	DYRK1B
AZ20	AZ20	C[C@@H]1COCCN1c1cc(nc(n1)-c1cccc2[nH]ccc12)C1(CC1)S(C)(=O)=O		Preclinical	ATR kinase inhibitor	ATR|MTOR
AZ3146	AZ3146	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2n(C)c(=O)n(C3CCCC3)c2n1		Preclinical	monopolar spindle 1 kinase inhibitor	
AZ505	AZ505	Oc1ccc(CCNCCN(C2CCCCC2)C(=O)CCNCCc2ccc(Cl)c(Cl)c2)c2OCC(=O)Nc12		Preclinical	histone lysine methyltransferase inhibitor	SMYD2
AZ5104	AZ5104	COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1c[nH]c2ccccc12		Preclinical	EGFR inhibitor	EGFR
AZ960	AZ960|AZ-960	C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(F)cc1C#N)c1ccc(F)cc1	M63IS9PTJF	Preclinical	JAK inhibitor	JAK2
azacitidine	azacitidine|AZACITIDINE	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	M801H13NRU	Launched	DNA methyltransferase inhibitor	DNMT1|DNMT3A
azacyclonol	azacyclonol|AZACYCLONOL	OC(C1CCNCC1)(c1ccccc1)c1ccccc1	2MMR990PEM	Preclinical	histamine receptor antagonist	HRH1
azaguanine-8	azaguanine-8|8-AZAGUANINE	Nc1nc2[nH]nnc2c(=O)[nH]1	Q150359I72	Preclinical	purine antagonist	PNP
azalomycin-b	azalomycin-b|AZALOMYCIN B	CC[C@@H]1[C@@H](C)O[C@](O)(C[C@H]1O[C@H]1C[C@H](O)[C@H](O)[C@H](C)O1)[C@@H](C)[C@H](O)[C@H](C)[C@@H]1OC(=O)\C=C\C=C\[C@@H](C)[C@H](OC(=O)\C=C\C=C\[C@@H]1C)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O[C@H]2C[C@H](O)[C@H](O)[C@H](C)O2)[C@H](CC)[C@@H](C)O1	1CAF8865TM	Preclinical	bacterial 50S ribosomal subunit inhibitor	
azaperone	azaperone|AZAPERONE	Fc1ccc(cc1)C(=O)CCCN1CCN(CC1)c1ccccn1	19BV78AK7W	Launched	dopamine receptor antagonist	DRD2|DRD3
azapropazone	azapropazone|APAZONE	CCCC1C(=O)N2N(C1=O)c1cc(C)ccc1N=C2N(C)C	K2VOT966ZI	Withdrawn	cyclooxygenase inhibitor	PTGS2
azaserine	azaserine|AZASERINE	NC(COC(=O)C=[N+]=[N-])C(O)=O	87299V3Q9W	Preclinical	purine antagonist	
azasetron	azasetron|AZASETRON	CN1C(=O)COc2c1cc(Cl)cc2C(=O)NC1CN2CCC1CC2	77HC7URR9Z	Launched	serotonin receptor antagonist	HTR3A|HTR3B
azatadine	azatadine|AZATADINE	CN1CCC(CC1)=C1c2ccccc2CCc2cccnc12	94Z39NID6C	Launched	histamine receptor antagonist	HRH1
azathioprine	azathioprine|AZATHIOPRINE	Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O	MRK240IY2L	Launched	dehydrogenase inhibitor	HPRT1|IMPDH1|PPAT
AZD1080	AZD1080	Oc1[nH]c2ccc(cc2c1-c1ccc(CN2CCOCC2)cn1)C#N		Phase 1	glycogen synthase kinase inhibitor	GSK3A|GSK3B
AZD1208	AZD1208|AZD-1208	N[C@@H]1CCCN(C1)c1c(cccc1-c1ccccc1)\C=C1/SC(=O)NC1=O	S98NFM1378	Phase 1	Pim kinase inhibitor	PIM1|PIM2|PIM3
AZD1283	AZD1283	CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1		Preclinical	purinergic receptor antagonist	P2RY12
AZD1446	AZD1446	Clc1ccc(o1)C(=O)N1CC2CNCC2C1		Phase 2	acetylcholine receptor agonist	CHRNA4|CHRNB2
AZD1480	AZD1480|AZD-1480	C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1	KL2Z2TLF01	Phase 1	JAK inhibitor	JAK1|JAK2|JAK3
AZD1981	AZD1981|AZD-1981	CC(=O)Nc1cccc2n(CC(O)=O)c(C)c(Sc3ccc(Cl)cc3)c12	2AD53WQ2CX	Phase 2	CRTH receptor antagonist	PTGDR2
AZD2014	AZD2014|VISTUSERTIB	CNC(=O)c1cccc(c1)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C	0BSC3P4H5X	Phase 2	mTOR inhibitor	MTOR
AZD2461	AZD2461	COC1CCN(CC1)C(=O)c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F		Phase 1	PARP inhibitor	
AZD2858	AZD2858	CN1CCN(CC1)S(=O)(=O)c1ccc(cc1)-c1cnc(N)c(n1)C(=O)Nc1cccnc1		Preclinical	glycogen synthase kinase inhibitor	GSK3B
AZD3264	AZD3264	Cc1noc(C)c1-c1ccc(-c2cc(C(N)=O)c(NC(N)=O)s2)c(O[C@H]2CCNC2)c1		Preclinical	IKK inhibitor	IKBKB
AZD3463	AZD3463	COc1cc(ccc1Nc1ncc(Cl)c(n1)-c1c[nH]c2ccccc12)N1CCC(N)CC1		Preclinical	ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor	ALK|IGF1R
AZD3514	AZD3514	CC(=O)N1CCN(CCOc2ccc(cc2)C2CCN(CC2)C2=Nn3c(CC2)nnc3C(F)(F)F)CC1		Phase 1	androgen receptor modulator	AR
AZD3759	AZD3759	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C		Phase 1	EGFR inhibitor	EGFR
AZD3839	AZD3839|AZD-3839	NC1N[C@](c2cccc(F)c12)(c1ccnc(c1)C(F)F)c1cccc(c1)-c1cncnc1	I8ID590133	Phase 1	beta-secretase inhibitor	BACE1
AZD3965	AZD3965	CC(C)n1c2sc(Cc3c(C)[nH]nc3C(F)(F)F)c(C(=O)N3C[C@](C)(O)CO3)c2c(=O)n(C)c1=O		Phase 1	monocarboxylate transporter inhibitor	SLC16A1
AZD4282	AZD4282|GLYCINE	NCC(O)=O	TE7660XO1C	Phase 1	glutamate receptor antagonist	AGXT|AGXT2|ALAS1|ALAS2|BAAT|GARS|GATM|GCAT|GCSH|GLDC|GLRA1|GLRA2|GLRA3|GLRB|GLYAT|GLYATL1|GLYATL2|GNMT|GPR18|GPRC6A|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3B|GSS|PIPOX|SHMT1|SHMT2|SLC32A1|SLC36A1|SLC6A5|SLC6A9
AZD4547	AZD4547|AZD-4547	COc1cc(CCc2cc(NC(=O)c3ccc(cc3)N3C[C@H](C)N[C@H](C)C3)n[nH]2)cc(OC)c1	2167OG1EKJ	Phase 2/Phase 3	FGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR
AZD5069	AZD5069	C[C@H](Nc1cc(NS(=O)(=O)N2CCC2)nc(SCc2cccc(F)c2F)n1)[C@@H](O)CO		Phase 2	CC chemokine receptor antagonist	CXCR2
AZD5363	AZD5363|AZD-5363	NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1	WFR23M21IE	Phase 2	AKT inhibitor	AKT1|AKT2|AKT3
AZD5438	AZD5438	CC(C)n1c(C)ncc1-c1ccnc(Nc2ccc(cc2)S(C)(=O)=O)n1		Phase 1	CDK inhibitor	KCNH2
AZD5582	AZD5582	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1[C@@H](Cc2ccccc12)OCC#CC#CCO[C@@H]1Cc2ccccc2[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1		Preclinical	XIAP inhibitor	BIRC2|BIRC3|XIAP
AZD6482	AZD6482	C[C@@H](Nc1ccccc1C(O)=O)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1		Phase 1	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
AZD6738	AZD6738	C[C@@H]1COCCN1c1cc(nc(n1)-c1ccnc2[nH]ccc12)C1(CC1)S(C)(=N)=O		Phase 1/Phase 2	ATR kinase inhibitor	ATR
AZD6765	AZD6765|LANICEMINE	NC(Cc1ccccn1)c1ccccc1	9TMU325RK3	Phase 2	glutamate receptor antagonist	GRIN1
AZD7545	AZD7545	CN(C)C(=O)c1ccc(cc1)S(=O)(=O)c1ccc(NC(=O)C(C)(O)C(F)(F)F)c(Cl)c1		Phase 1	pyruvate dehydrogenase kinase inhibitor	PDK1
AZD7687	AZD7687	Cc1nc(C)c(nc1C(N)=O)-c1ccc(cc1)[C@H]1CC[C@H](CC(O)=O)CC1		Phase 1	diacylglycerol O acyltransferase inhibitor	DGAT1
AZD7762	AZD7762|AZD-7762	NC(=O)Nc1cc(sc1C(=O)N[C@H]1CCCNC1)-c1cccc(F)c1	5D822Y3L1H	Phase 1	CHK inhibitor	CHEK1|CHEK2
AZD8055	AZD8055|AZD-8055	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C	970JJ37FPW	Phase 1	mTOR inhibitor	MTOR
AZD8186	AZD8186|AZD-8186	CC(Nc1cc(F)cc(F)c1)c1cc(cc2c1oc(cc2=O)N1CCOCC1)C(=O)N(C)C	AIQ4OWD0RA	Phase 1	PI3K inhibitor	PIK3CB|PIK3CD
AZD8330	AZD8330|AZD-8330	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O	G4990BOZ66	Phase 1	MEK inhibitor	
AZD8835	AZD8835	CCn1nc(nc1-c1cnc(N)c(n1)-c1nnc(o1)C(C)(C)C)C1CCN(CC1)C(=O)CCO		Phase 1	PI3K inhibitor	PIK3CA|PIK3CD
AZD8931	AZD8931|SAPITINIB	CNC(=O)CN1CCC(CC1)Oc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC	3499328002	Phase 2	EGFR inhibitor	EGFR|ERBB2|ERBB3
AZD9496	AZD9496	C[C@@H]1Cc2c([nH]c3ccccc23)[C@H](N1CC(C)(C)F)c1c(F)cc(\C=C\C(O)=O)cc1F		Phase 1	estrogen receptor agonist	ESR1
AZD9668	AZD9668|ALVELESTAT	Cc1c(cc(C(=O)NCc2ccc(cn2)S(C)(=O)=O)c(=O)n1-c1cccc(c1)C(F)(F)F)-c1ccnn1C	6Y5629322X	Phase 2	elastase inhibitor	ELANE
azelaic-acid	azelaic-acid|AZELAIC ACID	OC(=O)CCCCCCCC(O)=O	F2VW3D43YT	Launched	tyrosinase inhibitor	AKR1D1|SRD5A2|TYR
azelastine	azelastine|AZELASTINE	CN1CCCC(CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O	ZQI909440X	Launched	histamine receptor antagonist	HRH1
azeliragon	azeliragon|AZELIRAGON	CCCCc1nc(cn1-c1ccc(Oc2ccc(Cl)cc2)cc1)-c1ccc(OCCCN(CC)CC)cc1	LPU25F15UQ	Phase 3	RAGE receptor antagonist	AGER
azelnidipine	azelnidipine|AZELNIDIPINE	CC(C)OC(=O)C1=C(C)NC(N)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC1CN(C1)C(c1ccccc1)c1ccccc1	PV23P19YUG	Launched	calcium channel blocker	CACNA1C
azilsartan	azilsartan|AZILSARTAN	CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1	F9NUX55P23	Launched	angiotensin receptor antagonist	AGTR1|AGTR2
azilsartan-medoxomil	azilsartan-medoxomil|AZILSARTAN MEDOXOMIL	CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1	LL0G25K7I2	Launched	angiotensin receptor antagonist	AGTR1|AGTR2
azimilide	azimilide|AZIMILIDE	CN1CCN(CCCCN2C(=O)CN(\N=C\c3ccc(o3)-c3ccc(Cl)cc3)C2=O)CC1	74QU6P2934	Phase 3	potassium channel blocker	KCNA5|KCNE1|KCNH2|KCNQ1
azithromycin	azithromycin|AZITHROMYCIN ANHYDROUS	CC[C@@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)C(C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	J2KLZ20U1M	Launched	bacterial 50S ribosomal subunit inhibitor	MLNR
azlocillin	azlocillin|AZLOCILLIN	CC1(C)SC2C(NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2C1C(O)=O	HUM6H389W0	Launched	bacterial cell wall synthesis inhibitor	
azodicarbonamide	azodicarbonamide|AZODICARBONAMIDE	NC(=O)\N=N\C(N)=O	56Z28B9C8O	Phase 2	DNA synthesis inhibitor	
azomycin-(2-nitroimidazole)	azomycin-(2-nitroimidazole)|AZOMYCIN	[O-][N+](=O)c1ncc[nH]1	K8E96XL55D	Preclinical	protein synthesis inhibitor	
azosemide	azosemide|AZOSEMIDE	NS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2cccs2)cc1Cl	MR40VT1L8Z	Launched	electrolyte reabsorption inhibitor	SLC12A1|SLC12A2
aztreonam	aztreonam|AZTREONAM	C[C@H]1[C@H](NC(=O)C(=N\OC(C)(C)C(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O	G2B4VE5GH8	Launched	bacterial cell wall synthesis inhibitor	
bacampicillin	bacampicillin|BACAMPICILLIN	CCOC(=O)OC(C)OC(=O)C1N2C(SC1(C)C)C(NC(=O)[C@H](N)c1ccccc1)C2=O	8GM2J22278	Launched	bacterial cell wall synthesis inhibitor	
bacitracin	bacitracin|BACITRACIN A	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)C1CN=C(S1)[C@H](N)C(C)C)C(=O)N[C@@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@H](C)CC	DDA3RRX0P7	Launched	bacterial cell wall synthesis inhibitor	A2M|IDE
bacitracin-zinc	bacitracin-zinc	CC[C@H](C)[C@H](N)C1=NCC(S1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]1CCC(=O)O[Zn]OC(=O)C[C@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CC(N)=O)NC2=O)NC(=O)[C@@H](NC1=O)[C@H](C)CC)[C@H](C)CC		Launched	bacterial cell wall synthesis inhibitor	
baclofen	baclofen|BACLOFEN	NCC(CC(O)=O)c1ccc(Cl)cc1	H789N3FKE8	Launched	benzodiazepine receptor agonist	GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
baclofen-(R)	baclofen-(R)|ARBACLOFEN	NC[C@H](CC(O)=O)c1ccc(Cl)cc1	NYU6UTW25B	Preclinical	benzodiazepine receptor agonist	GABBR1|GABBR2
BADGE	BADGE|BISPHENOL A DIGLYCIDYL ETHER	CC(C)(c1ccc(OCC2CO2)cc1)c1ccc(OCC2CO2)cc1	F3XRM1NX4H	Preclinical	PPAR receptor antagonist	PPARG
bafetinib	bafetinib|BAFETINIB	CN(C)C1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2ccc(C)c(Nc3ncc(cn3)-c3cncnc3)c2)C1	NVW4Z03I9B	Phase 2	Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor	ABL1|BCR|LYN
baicalein	baicalein|BAICALEIN	Oc1cc2oc(cc(=O)c2c(O)c1O)-c1ccccc1	49QAH60606	Preclinical	lipoxygenase inhibitor	ALOX5|GLO1|PREP|SELL|SELP|TNF|XDH
baicalin	baicalin|BAICALIN	O[C@H]1[C@@H](Oc2cc3oc(cc(=O)c3c(O)c2O)-c2ccccc2)O[C@H]([C@@H](O)[C@@H]1O)C(O)=O	347Q89U4M5	Launched	beta glucuronidase inhibitor	PREP
bakuchiol	bakuchiol|BAKUCHIOL	CC(C)=CCC[C@@](C)(C=C)\C=C\c1ccc(O)cc1	OT12HJU3AR	Phase 2	DNA polymerase inhibitor	HIF1A
balaglitazone	balaglitazone|BALAGLITAZONE	Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O	4M1609828O	Phase 3	insulin sensitizer|PPAR receptor partial agonist	PPARG
balapiravir	balapiravir|BALAPIRAVIR	CC(C)C(=O)OC[C@]1(O[C@H]([C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C)n1ccc(N)nc1=O)N=[N+]=[N-]	VOT0LP7I9K	Phase 2	RNA polymerase inhibitor	
balicatib	balicatib|BALICATIB	CCCN1CCN(CC1)c1ccc(cc1)C(=O)NC1(CCCCC1)C(=O)NCC#N	E00MVC7O57	Phase 2	cathepsin inhibitor	CTSK
balofloxacin	balofloxacin|BALOFLOXACIN	CNC1CCCN(C1)c1c(F)cc2c(c1OC)n(cc(C(O)=O)c2=O)C1CC1	Q022B63JPM	Launched	bacterial DNA gyrase inhibitor	
balsalazide	balsalazide|BALSALAZIDE	OC(=O)CCNC(=O)c1ccc(cc1)N=Nc1ccc(O)c(c1)C(O)=O	P80AL8J7ZP	Launched	cyclooxygenase inhibitor	ALOX5|PPARG|PTGS1|PTGS2
BAM7	BAM7	CCOc1ccccc1N\N=C1C(=O)N(N=C\1C)c1nc(cs1)-c1ccccc1		Preclinical	BAX activator	BAX
bambuterol	bambuterol|BAMBUTEROL	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(c1)C(O)CNC(C)(C)C	Y1850G1OVC	Launched	adrenergic receptor agonist	ADRB2|BCHE
BAN-ORL-24	BAN-ORL-24	O=C(NCCCN1CCC2(CC1)OCc1ccccc21)[C@H]1CCCN1Cc1ccccc1		Preclinical	nociceptin/orphanin FQ receptor antagonist	OPRL1
barasertib	barasertib|BARASERTIB	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(O)(O)=O	16XC2U7W8N	Phase 2/Phase 3	Aurora kinase inhibitor	AURKA|AURKB
barasertib-HQPA	barasertib-HQPA|AZD-1152HQPA	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	29P8LWS24N	Phase 2/Phase 3	Aurora kinase inhibitor	AURKB
barbital	barbital|BARBITAL	CCC1(CC)C(=O)NC(=O)NC1=O	5WZ53ENE2P	Launched	sedative	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2
bardoxolone	bardoxolone|BARDOXOLONE	CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C1[C@@]2(C)C=C(C#N)C(=O)C(C)(C)[C@@H]2CC[C@@]31C)C(O)=O	7HT68L8941	Phase 1	nuclear factor erythroid derived|like (NRF2) activator	NOS2|PPARG
bardoxolone-methyl	bardoxolone-methyl|BARDOXOLONE METHYL	COC(=O)[C@]12CCC(C)(C)C[C@@H]1[C@@H]1C(=O)C=C3[C@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2	CEG1Q6OGU1	Phase 3	nuclear factor erythroid derived|like (NRF2) activator	PPARG|STAT3
baricitinib	baricitinib|BARICITINIB	CCS(=O)(=O)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12	ISP4442I3Y	Phase 3	JAK inhibitor	JAK1|JAK2
barnidipine	barnidipine|BARNIDIPINE	COC(=O)C1=C(C)NC(C)=C([C@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@H]1CCN(Cc2ccccc2)C1	2VBY96ASWJ	Launched	calcium channel blocker	
basic-fuchsin	basic-fuchsin	CC1=CC(C=CC1=N)=C(c1ccc(N)cc1)c1ccc(N)cc1		Preclinical		
basimglurant	basimglurant|BASIMGLURANT	Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1	3110E3AO8S	Phase 2	glutamate receptor antagonist	GRM5
batimastat	batimastat|BATIMASTAT	CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO	BK349F52C9	Phase 3	matrix metalloprotease inhibitor	ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8
bavisant	bavisant|BAVISANT	O=C(N1CCN(CC1)C1CC1)c1ccc(CN2CCOCC2)cc1	9827P7LFVH	Phase 2	histamine receptor antagonist	HRH3
BAX-channel-blocker	BAX-channel-blocker	OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc12		Preclinical	cytochrome C release inhibitor	BAX
BAY-11-7082	BAY-11-7082|3-(P-TOLUENESULFONYL)ACRYLONITRILE, (E)-	Cc1ccc(cc1)S(=O)(=O)\C=C\C#N	4Y5G2A4F6O	Preclinical	NFkB pathway inhibitor	RELA
BAY-11-7085	BAY-11-7085	CC(C)(C)c1ccc(cc1)S(=O)(=O)\C=C\C#N		Preclinical	NFkB pathway inhibitor	NFKBIA
bay-60-7550	bay-60-7550|BAY-60-7550	COc1ccc(Cc2nn3c(nc(C)c3c(=O)[nH]2)[C@@H](CCCc2ccccc2)[C@@H](C)O)cc1OC	ZRN7LZK9TQ	Preclinical	phosphodiesterase inhibitor	PDE2A
BAY-61-3606	BAY-61-3606	COc1ccc(cc1OC)-c1cc2nccn2c(Nc2ncccc2C(N)=O)n1	96PPV9GQ7A	Preclinical	syk inhibitor	SYK
BAY-85-8050	BAY-85-8050	NC(CC(F)C(O)=O)C(O)=O		Phase 1		
BAY-87-2243	BAY-87-2243	Cc1cc(nn1Cc1ccnc(c1)N1CCN(CC1)C1CC1)-c1nc(no1)-c1ccc(OC(F)(F)F)cc1		Phase 1	hypoxia inducible factor inhibitor	HIF1A
BAY-K-8644-(+/-)	BAY-K-8644-(+/-)	COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1C(F)(F)F)[N+]([O-])=O		Preclinical	L-type calcium channel activator	
BAY-K-8644-(s)-(-)	BAY-K-8644-(s)-(-)	COC(=O)C1=C(C)NC(C)=C([C@H]1c1ccccc1C(F)(F)F)[N+]([O-])=O		Preclinical	L-type calcium channel activator	CACNA1C
bay-w-9798	bay-w-9798	COC(=O)C1=C(C)N(C)C(C)=C(C1c1ccc(cc1)C(F)(F)F)C(=O)OC		Phase 2	antioxidant	
bazedoxifene	bazedoxifene|BAZEDOXIFENE	Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12	Q16TT9C5BK	Launched	selective estrogen receptor modulator (SERM)	ESR1|ESR2
BCI-540	BCI-540|COLURACETAM	Cc1oc2nc3CCCCc3c(NC(=O)CN3CCCC3=O)c2c1C	V6FL6O5GR7	Phase 2	glutamate receptor agonist	
BCX-1470	BCX-1470	NC(=N)c1cc2ccc(OC(=O)c3cccs3)cc2s1		Phase 1	serine protease inhibitor|complement inhibitor	CFD
BD-1008	BD-1008	CN(CCN1CCCC1)CCc1ccc(Cl)c(Cl)c1		Preclinical	sigma receptor antagonist	
BD-1047	BD-1047	CN(C)CCN(C)CCc1ccc(Cl)c(Cl)c1	1S3X75QGDO	Preclinical	adrenergic receptor antagonist	SIGMAR1
BD-1063	BD-1063	CN1CCN(CCc2ccc(Cl)c(Cl)c2)CC1		Preclinical	sigma receptor antagonist	SIGMAR1
BE-2254	BE-2254	Oc1ccc(CCNCC2CCc3ccccc3C2=O)cc1		Phase 2	adrenergic receptor antagonist	ADRA1A
beclamide	beclamide|BECLAMIDE	ClCCC(=O)NCc1ccccc1	F5N0ALI65V	Launched	anticonvulsant	
beclomethasone	beclomethasone|BECLOMETHASONE	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CO	KGZ1SLC28Z	Launched	glucocorticoid receptor agonist	NR3C1|SERPINA6
beclomethasone-dipropionate	beclomethasone-dipropionate|BECLOMETHASONE DIPROPIONATE	CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC12C	5B307S63B2	Launched	glucocorticoid receptor agonist	GPR97|NR3C1
bedaquiline	bedaquiline|BEDAQUILINE	COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12	78846I289Y	Launched	ATPase inhibitor	
befuraline	befuraline|BEFURALINE	O=C(N1CCN(Cc2ccccc2)CC1)c1cc2ccccc2o1	787AQ35GHR	Phase 2		
begacestat	begacestat|BEGACESTAT	OC[C@@H](NS(=O)(=O)c1ccc(Cl)s1)C(C(F)(F)F)C(F)(F)F	3666C56BBU	Phase 1	gamma secretase inhibitor	PSEN1
bekanamycin	bekanamycin|BEKANAMYCIN	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	15JT14C3GI	Launched	bacterial 30S ribosomal subunit inhibitor	
belinostat	belinostat|BELINOSTAT	ONC(=O)\C=C\c1cccc(c1)S(=O)(=O)Nc1ccccc1	F4H96P17NZ	Launched	HDAC inhibitor	HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
bemegride	bemegride|BEMEGRIDE	CCC1(C)CC(=O)NC(=O)C1	57DQA39DO2	Launched	chemoreceptor agonist	GABRA1
bemesetron	bemesetron|BEMESETRON	CN1C2CCC1CC(C2)OC(=O)c1cc(Cl)cc(Cl)c1	O98T3677PA	Phase 3	serotonin receptor antagonist	HTR3A|HTR3B
bemotrizinol	bemotrizinol|BEMOTRIZINOL	CCCCC(CC)COc1ccc(c(O)c1)-c1nc(nc(n1)-c1ccc(OCC(CC)CCCC)cc1O)-c1ccc(OC)cc1	PWZ1720CBH	Launched		
benaxibine	benaxibine|BENAXIBINE	OC1COC(Nc2ccc(cc2)C(O)=O)C(O)C1O	6EEL176LGY	Phase 1		
benazepril	benazepril|BENAZEPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O	UDM7Q7QWP8	Launched	angiotensin converting enzyme inhibitor	ACE
bendamustine	bendamustine|BENDAMUSTINE	Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl	9266D9P3PQ	Launched	DNA inhibitor	
bendazac	bendazac|BENDAZAC	OC(=O)COc1nn(Cc2ccccc2)c2ccccc12	G4AG71204O	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
bendroflumethiazide	bendroflumethiazide|BENDROFLUMETHIAZIDE	NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F	5Q52X6ICJI	Launched	sodium/potassium/chloride transporter inhibitor	CA1|CA2|CA4|KCNMA1|SLC12A1|SLC12A3
benethamine	benethamine	C(Cc1ccccc1)NCc1ccccc1		Preclinical		
benfluorex	benfluorex|BENFLUOREX	CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c1ccccc1	403FO0NQG3	Withdrawn	gluconeogenesis inhibitor	HMGCR
benfluralin	benfluralin|BENFLURALIN	CCCCN(CC)c1c(cc(cc1[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O	28224BUY6R	Phase 3		CYP1A1|CYP1A2|CYP2B6|CYP3A4|ESR1|MMP1|SULT2A1|UGT1A1
benfotiamine	benfotiamine|BENFOTIAMINE	C\C(N(Cc1cnc(C)nc1N)C=O)=C(/CCOP(O)(O)=O)SC(=O)c1ccccc1	Y92OUS2H9B	Launched	antioxidant	AGER
benidipine	benidipine|BENIDIPINE	COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(Cc2ccccc2)C1	4G9T91JS7E	Launched	calcium channel blocker	CACNA1C|CACNA1G
benperidol	benperidol|BENPERIDOL	Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O	97O6X78C53	Launched	dopamine receptor antagonist	DRD2
benproperine	benproperine|BENPROPERINE	CC(COc1ccccc1Cc1ccccc1)N1CCCCC1	3AA6IZ48YK	Launched	antitussive	SCN5A
benserazide	benserazide|BENSERAZIDE	NC(CO)C(=O)NNCc1ccc(O)c(O)c1O	762OS3ZEJU	Launched	DOPA decarboxylase inhibitor	DDC
bentazepam	bentazepam|BENTAZEPAM	O=C1CN=C(c2c3CCCCc3sc2N1)c1ccccc1	66JKK43S1Z	Launched	benzodiazepine receptor agonist	
bentiromide	bentiromide|BENTIROMIDE	OC(=O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1	239IF5W61J	Launched		HPN
benurestat	benurestat|BENURESTAT	ONC(=O)CNC(=O)c1ccc(Cl)cc1	9RA9A22Z0W	Phase 1	urease inhibitor	
benzalkonium	benzalkonium	CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1		Launched	Cationic surfactant	
benzamil	benzamil|BENZAMIL	N\C(NCc1ccccc1)=N/C(=O)c1nc(Cl)c(N)nc1N	04659UUJ94	Phase 2	sodium channel blocker	ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1
benzbromarone	benzbromarone|BENZBROMARONE	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1	4POG0RL69O	Launched	chloride channel blocker	ABCC1
benzethonium	benzethonium|BENZETHONIUM	CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1	1VU15B70BP	Launched	sodium channel blocker	SCN10A
benznidazole	benznidazole|BENZNIDAZOLE	[O-][N+](=O)c1nccn1CC(=O)NCc1ccccc1	YC42NRJ1ZD	Launched	DNA synthesis inhibitor	
benzo[d]thiazole-2(3h)-thione	benzo[d]thiazole-2(3h)-thione|2-MERCAPTOBENZOTHIAZOLE	Sc1nc2ccccc2s1	5RLR54Z22K	Phase 1		
benzocaine	benzocaine|BENZOCAINE	CCOC(=O)c1ccc(N)cc1	U3RSY48JW5	Launched	sodium channel blocker	SCN10A
benzoclidine	benzoclidine|BENZOCLIDINE	O=C(OC1CN2CCC1CC2)c1ccccc1	G84189YY06	Preclinical		
benzofenac	benzofenac	OC(=O)Cc1ccc(OCc2ccccc2)c(Cl)c1		Phase 1		
benzoic-acid	benzoic-acid|BENZOIC ACID	OC(=O)c1ccccc1	8SKN0B0MIM	Launched	food preservative	DAO|HRSP12|PRDX5|RAB9A
benzoin	benzoin|BENZOIN, (+/-)-	OC(C(=O)c1ccccc1)c1ccccc1	L7J6A1NE81	Preclinical		CES1
benzonatate	benzonatate	CCCCNc1ccc(cc1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC		Launched	local anesthetic	SCN5A
benzoquinonium-dibromide	benzoquinonium-dibromide|BENZOQUINONIUM	CC[N+](CC)(CCCNC1=CC(=O)C(NCCC[N+](CC)(CC)Cc2ccccc2)=CC1=O)Cc1ccccc1	T91WJ82JOZ	Preclinical	cholinergic receptor antagonist	CHRNA1
benzotript	benzotript|BENZOTRIPT	OC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1	LS5O682BRO	Phase 1	CCK receptor antagonist	CCKAR|CCKBR
benzoxiquine	benzoxiquine|BENZOXIQUINE	O=C(Oc1cccc2cccnc12)c1ccccc1	GRE0P19C3Z	Preclinical	antiinfective drug	
benzoyl-peroxide	benzoyl-peroxide|BENZOYL PEROXIDE	O=C(OOC(=O)c1ccccc1)c1ccccc1	W9WZN9A0GM	Launched	oxidizing agent	
benzoylpas	benzoylpas|BENZOYLPAS	OC(=O)c1ccc(NC(=O)c2ccccc2)cc1O	XEE879L727	Preclinical		
benzthiazide	benzthiazide|BENZTHIAZIDE	NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O	1TD8J48L61	Launched	carbonic anhydrase inhibitor	CA1|CA12|CA2|CA4|CA9|SLC12A3
benztropine-mesylate	benztropine-mesylate|BENZTROPINE MESYLATE	CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1	WMJ8TL7510	Launched	acetylcholine receptor antagonist	CHRM1|HRH1|SLC6A3
benzydamine	benzydamine|BENZYDAMINE	CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12	4O21U048EF	Launched	prostanoid receptor antagonist	
benzyl-alcohol	benzyl-alcohol|BENZYL ALCOHOL	OCc1ccccc1	LKG8494WBH	Launched	local anesthetic	
benzyl-benzoate	benzyl-benzoate|BENZYL BENZOATE	O=C(OCc1ccccc1)c1ccccc1	N863NB338G	Launched	lipase inhibitor	LIPE
benzyl-isothiocyanate	benzyl-isothiocyanate|BENZYL ISOTHIOCYANATE	S=C=NCc1ccccc1	871J6YOR8Q	Preclinical	methylazoxymethanol acetate inhibitor	
benzyldimethylhexadecylammonium	benzyldimethylhexadecylammonium|CETALKONIUM	CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1	FHG725432Z	Preclinical	cationic surfactant	
benzyldimethyloctylammonium	benzyldimethyloctylammonium|BENZYLDIMETHYLOCTYLAMMONIUM	CCCCCCCC[N+](C)(C)Cc1ccccc1	JJ34P08YMQ	Preclinical		
benzylpenicillin	benzylpenicillin|PENICILLIN G	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(O)=O	Q42T66VG0C	Launched	penicillin binding protein inhibitor	
bephenium-hydroxynaphthoate	bephenium-hydroxynaphthoate|BEPHENIUM HYDROXYNAPHTHOATE	C[N+](C)(CCOc1ccccc1)Cc1ccccc1	47RU9546DX	Launched	anthelmintic agent	
bepotastine	bepotastine|BEPOTASTINE	OC(=O)CCCN1CCC(CC1)O[C@@H](c1ccc(Cl)cc1)c1ccccn1	HYD2U48IAS	Launched	histamine receptor antagonist	HRH1
bepridil	bepridil|BEPRIDIL	CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1	755BO701MA	Launched	calcium channel blocker	ATP1A1|CACNA1A|CACNA1H|CACNA2D2|CALM1|KCNQ1|KCNQ4|PDE1A|PDE1B|TNNC1
berberine	berberine|BERBERINE	COc1ccc2cc3-c4cc5OCOc5cc4CC[n+]3cc2c1OC	0I8Y3P32UF	Phase 2/Phase 3	LDL receptor activator	LDLR
bergapten	bergapten|BERGAPTEN	COc1c2ccoc2cc2oc(=O)ccc12	4FVK84C92X	Preclinical		
bergenin	bergenin|BERGENIN	COc1c(O)cc2C(=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]3c2c1O	L84RBE4IDC	Preclinical	interleukin inhibitor	IL1B|TNF
besifloxacin	besifloxacin|BESIFLOXACIN	N[C@@H]1CCCCN(C1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)C1CC1	BFE2NBZ7NX	Launched	bacterial DNA gyrase inhibitor	
BET-BAY-002	BET-BAY-002	Cc1nnc(C[C@@H]2C=C(c3ccc(Cl)cc3)c3ccccc3-n3c(C)nnc23)o1		Preclinical	bromodomain inhibitor	
beta-amyloid-synthesis-inhibitor	beta-amyloid-synthesis-inhibitor	Oc1cccc(Nc2ccc(Nc3cccc(O)c3)nn2)c1		Preclinical	beta amyloid synthesis inhibitor	APP
beta-carotene	beta-carotene|.BETA.-CAROTENE	CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C\C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C	01YAE03M7J	Launched		
beta-CCB	beta-CCB	CCCCOC(=O)c1cc2c(cn1)[nH]c1ccccc21		Launched	benzodiazepine receptor ligand	GABRA1|GABRG2
beta-elemene	beta-elemene|.BETA.-ELEMENE	CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@@H](C1)C(C)=C	2QG8CX6LXD	Launched	apoptosis stimulant	MMP2|MMP9
beta-funaltrexamine	beta-funaltrexamine	COC(=O)\C=C\C(=O)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45		Preclinical	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
beta-glycerophosphoric-acid	beta-glycerophosphoric-acid|GLYCERYL 2-PHOSPHATE	OCC(CO)OP(O)(O)=O	WWH06G87W6	Preclinical		
beta-hydroxy-beta-methylbutyrate	beta-hydroxy-beta-methylbutyrate|.BETA.-HYDROXYISOVALERIC ACID	CC(C)(O)CC(O)=O.CC(C)(O)CC(O)=O	3F752311CD	Phase 2/Phase 3	protein synthesis stimulant	MTOR
beta-Hydroxybutyrate	beta-Hydroxybutyrate|3-HYDROXYBUTYRIC ACID, (+/-)	CC(O)CC(O)=O	TZP1275679	Phase 1		HCAR2
beta-lapachone	beta-lapachone|LAPACHONE	CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O	6N4FA2QQ6A	Phase 2	topoisomerase inhibitor	TOP1
beta-naphthol	beta-naphthol|BETANAPHTHOL	Oc1ccc2ccccc2c1	P2Z71CIK5H	Preclinical		
betahistine	betahistine|BETAHISTINE	CNCCc1ccccn1	X32KK4201D	Launched	histamine receptor agonist|histamine receptor antagonist	HRH1|HRH3
betaine	betaine|BETAINE	C[N+](C)(C)CC(O)=O	3SCV180C9W	Launched	nitric oxide donor	
betamethasone	betamethasone|BETAMETHASONE	C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	9842X06Q6M	Launched	glucocorticoid receptor agonist	NR3C1
betamethasone-acetate	betamethasone-acetate|BETAMETHASONE ACETATE	C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O	TI05AO53L7	Launched	glucocorticoid receptor agonist	NR3C1
betamethasone-dipropionate	betamethasone-dipropionate|BETAMETHASONE DIPROPIONATE	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@]12C	826Y60901U	Launched	anti-inflammatory agent	
betamethasone-valerate	betamethasone-valerate|BETAMETHASONE VALERATE	CCCCC(=O)O[C@@]1([C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(O)C[C@]12C)C(=O)CO	9IFA5XM7R2	Launched	glucocorticoid receptor agonist	NR3C1
betamipron	betamipron|BETAMIPRON	OC(=O)CCNC(=O)c1ccccc1	3W0M245736	Launched	panipenem uptake inhibitor	
betaxolol	betaxolol|BETAXOLOL	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1	O0ZR1R6RZ2	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
betazole	betazole|BETAZOLE	NCCc1cc[nH]n1	1C065P542O	Launched	histamine receptor agonist	HRH2
bethanechol	bethanechol|BETHANECHOL	CC(C[N+](C)(C)C)OC(N)=O	004F72P8F4	Launched	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
betrixaban	betrixaban|BETRIXABAN	COc1ccc(NC(=O)c2ccc(cc2)C(=N)N(C)C)c(c1)C(=O)Nc1ccc(Cl)cn1	74RWP7W0J9	Phase 3	coagulation factor inhibitor	KCNH2
betulinic-acid	betulinic-acid|BETULINIC ACID	CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]12)C(O)=O	4G6A18707N	Phase 1/Phase 2	apoptosis stimulant|NFkB pathway inhibitor	GPBAR1
bevantolol	bevantolol|BEVANTOLOL	COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC	34ZXW6ZV21	Launched	adrenergic receptor antagonist	ADRA1A|ADRB1|ADRB2
bevirimat-dimeglumine	bevirimat-dimeglumine|BEVIRIMAT DIMEGLUMINE	CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	O6DDV91W1M	Phase 2	HIV capsid assembly inhibitor	
bexarotene	bexarotene|BEXAROTENE	Cc1cc2c(cc1C(=C)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C	A61RXM4375	Launched	retinoid receptor agonist	RXRA|RXRB|RXRG
bezafibrate	bezafibrate|BEZAFIBRATE	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O	Y9449Q51XH	Launched	PPAR receptor agonist	PPARA|PPARD|PPARG
BF2.649	BF2.649|PITOLISANT	Clc1ccc(CCCOCCCN2CCCCC2)cc1	4BC83L4PIY	Phase 3	histamine receptor antagonist	HRH3
BGT226	BGT226|BGT-226 MALEATE	COc1ccc(cn1)-c1ccc2ncc3n(C)c(=O)n(-c4ccc(N5CCNCC5)c(c4)C(F)(F)F)c3c2c1	4YG62LG876	Phase 1/Phase 2	PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CG
BHQ	BHQ|DI-TERT-BUTYLHYDROQUINONE	CC(C)(C)c1cc(O)c(cc1O)C(C)(C)C	26XK13B61B	Preclinical	ATPase inhibitor	ATP2A1
BI-224436	BI-224436	Cc1nc2ccccc2c(-c2ccc3OCCc4ccnc2c34)c1[C@H](OC(C)(C)C)C(O)=O	99A996378Y	Phase 1	HIV integrase inhibitor	
BI-2536	BI-2536	CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O	4LJG22T9C6	Phase 2	PLK inhibitor	BRD4|PLK1|PLK2|PLK3
BI-78D3	BI-78D3	Oc1nnc(Sc2ncc(s2)[N+]([O-])=O)n1-c1ccc2OCCOc2c1		Preclinical	JNK inhibitor	MAPK8
BI-847325	BI-847325	CCNC(=O)C#Cc1ccc2c(NC(=O)\C2=C(\Nc2ccc(CN(C)C)cc2)c2ccccc2)c1		Phase 1	MEK inhibitor|Aurora kinase inhibitor	AURKA|AURKB|AURKC|MAP2K1|MAP2K2
BI-D1870	BI-D1870	CC(C)CCN1C(C)C(=O)N(C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc12		Preclinical	ribosomal protein inhibitor	RPS6KA1|RPS6KA2|RPS6KA3|RPS6KA6
biapenem	biapenem|BIAPENEM	C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O	YR5U3L9ZH1	Launched	bacterial cell wall synthesis inhibitor	
BIBN4096	BIBN4096|OLCEGEPANT	NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(CC1)N1Cc2ccccc2NC1=O)C(=O)N1CCN(CC1)c1ccncc1	WOA5J8TX6M	Phase 2	calcitonin antagonist	CALCA|CALCRL|RAMP1
BIBR-1532	BIBR-1532	C\C(=C/C(=O)Nc1ccccc1C(O)=O)c1ccc2ccccc2c1		Preclinical	telomerase inhibitor	TERT
BIBU-1361	BIBU-1361	CCN(CC)CC1CCN(CC1)c1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1		Preclinical	EGFR inhibitor	EGFR
BIBX-1382	BIBX-1382|FALNIDAMOL	CN1CCC(CC1)Nc1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1	0MU316797D	Phase 1	EGFR inhibitor	EGFR|ERBB2
bicalutamide	bicalutamide|BICALUTAMIDE	CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F	A0Z3NAU9DP	Launched	androgen receptor antagonist	AR
bicuculline-(+)	bicuculline-(+)|CAPNOIDINE|ADLUMIDINE|BICUCULLINE	CN1CCc2cc3OCOc3cc2C1[C@@H]1OC(=O)c2c1ccc1OCOc21	LV8QH3HB1R|XM638185BP|Y37615DVKC	Preclinical	GABA receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|KCNN1
bicuculline-methochloride-(-)	bicuculline-methochloride-(-)	C[N+]1(C)CCc2cc3OCOc3cc2C1[C@@H]1OC(=O)c2c1ccc1OCOc21		Preclinical	GABA receptor antagonist	
bicyclol	bicyclol|BICYCLOL	COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1CO	9734122TH2	Launched	NFkB pathway inhibitor	HSPA1A|HSPB1
bifemelane	bifemelane|BIFEMELANE	CNCCCCOc1ccccc1Cc1ccccc1	Z4501GN13G	Launched	acetylcholine release enhancer	MAOA|MAOB
bifendate	bifendate|BIFENDATE	COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1C(=O)OC	0G32E321W1	Launched		
bifonazole	bifonazole|BIFONAZOLE	c1cn(cn1)C(c1ccccc1)c1ccc(cc1)-c1ccccc1	QYJ305Z91O	Launched	sterol demethylase inhibitor	CYP2B6
BIIB021	BIIB021	COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc23)c1C	851B9FQ7Q0	Phase 2	HSP inhibitor	HSP90AA1
bilastine	bilastine|BILASTINE	CCOCCn1c(nc2ccccc12)C1CCN(CCc2ccc(cc2)C(C)(C)C(O)=O)CC1	PA1123N395	Launched	histamine receptor antagonist	HRH1
bilobalide	bilobalide|BILOBALIDE	CC(C)(C)[C@@]1(O)C[C@@H]2OC(=O)C[C@@]22C(=O)O[C@H]3OC(=O)[C@H](O)C123	M81D2O8H7U	Preclinical	GABA receptor modulator	GLRA1|GLRA2|GLRB|HTR3A|HTR3B
bimatoprost	bimatoprost|BIMATOPROST	CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(O)CCc1ccccc1	QXS94885MZ	Launched	prostanoid receptor agonist	AKR1C3|PTGER1|PTGER3|PTGFR
bindarit	bindarit|BINDARIT	CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(O)=O	JQ11LH711M	Phase 2	NFkB pathway inhibitor	CCL2|CCL7|CCL8
BIO-1211	BIO-1211	CC(C)C[C@H](NC(=O)Cc1ccc(NC(=O)Nc2ccccc2C)cc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O	61G4E2353I	Phase 2	integrin antagonist	ITGA4|ITGB1
biotin	biotin|BIOTIN	OC(=O)CCCCC1SCC2NC(=O)NC12	6SO6U10H04	Launched	vitamin B	ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6
bipenamol	bipenamol|BIPENAMOL	NCc1ccccc1Sc1ccccc1CO	49DCB7156W	Phase 2	dipeptidyl peptidase inhibitor	CTSC
biperiden	biperiden|BIPERIDEN	OC(CCN1CCCCC1)(C1CC2CC1C=C2)c1ccccc1	0FRP6G56LD	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2
birinapant	birinapant|BIRINAPANT	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC	6O4Z07B57R	Phase 2	XIAP inhibitor	BIRC2|XIAP
bis(maltolato)oxovanadium(IV)	bis(maltolato)oxovanadium(IV)	Cc1occc(=O)c1O[V](=O)Oc1c(C)occc1=O		Phase 2	tyrosine phosphatase inhibitor	PTPN1
bisacodyl	bisacodyl|BISACODYL	CC(=O)Oc1ccc(cc1)C(c1ccc(OC(C)=O)cc1)c1ccccn1	10X0709Y6I	Launched	laxative	
bisindolylmaleimide-ix	bisindolylmaleimide-ix|RO-31-8220	Cn1cc(C2=C(C(=O)NC2=O)c2cn(CCCSC(N)=N)c3ccccc23)c2ccccc12	W9A0B5E78O	Preclinical	PKC inhibitor	AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1
bismuth-oxalate	bismuth-oxalate|BISMUTH OXALATE	[Bi].[Bi].OC(=O)C(O)=O.OC(=O)C(O)=O.OC(=O)C(O)=O	JIS20CWG3M	Preclinical		
bismuth-subcitrate-potassium	bismuth-subcitrate-potassium|BISMUTH SUBCITRATE POTASSIUM	OC(=O)CC(O)(CC(=O)O[Bi]1OC(=O)CC(O)(CC(O)=O)C(=O)O1)C(O)=O	R3O80H60KX	Launched		
bismuth-subgallate	bismuth-subgallate|BISMUTH SUBGALLATE	O[Bi]1Oc2cc(cc(O)c2O1)C(O)=O	YIW503MI7V	Launched	nitric oxide synthase inhibitor	NOS1
bismuth-subsalicylate	bismuth-subsalicylate|BISMUTH SUBSALICYLATE	O[Bi]1OC(=O)c2ccccc2O1	62TEY51RR1	Launched	antacid	
bismuth(iii)-trifluoromethanesulfonate	bismuth(iii)-trifluoromethanesulfonate|BISMUTH TRIFLATE	[Bi].OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F	51KD8E1741	Preclinical	direct substitution catalyst	
bisoctrizole	bisoctrizole|BISOCTRIZOLE	CC(C)(C)CC(C)(C)c1cc(Cc2cc(cc(c2O)-n2nc3ccccc3n2)C(C)(C)CC(C)(C)C)c(O)c(c1)-n1nc2ccccc2n1	8NT850T0YS	Phase 2		
bisoprolol	bisoprolol|BISOPROLOL	CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1	Y41JS2NL6U	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
bisphenol-a	bisphenol-a|BISPHENOL A	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1	MLT3645I99	Phase 1	synthetic estrogen	AR|ESR1|ESR2|ESRRG|PPARG
bithionol	bithionol|BITHIONOL	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O	AMT77LS62O	Withdrawn	autotaxin inhibitor	ESR1|ESR2|MCL1
bitopertin	bitopertin|BITOPERTIN	C[C@H](Oc1ccc(cc1C(=O)N1CCN(CC1)c1ncc(cc1F)C(F)(F)F)S(C)(=O)=O)C(F)(F)F	Q8L6AN59YY	Phase 3	glycine transporter inhibitor|GlyT-1 inhibitor	SLC6A5|SLC6A9
bitoscanate	bitoscanate|BITOSCANATE	S=C=Nc1ccc(cc1)N=C=S	6D1R3P86GX	Preclinical	anthelmintic agent	
bivalirudin	bivalirudin	[2H]N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NC(CC(N)=O)C(=O)NCC(=O)NC(CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NC(CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O		Launched	thrombin inhibitor	F2
BIX-01294	BIX-01294	COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N1CCCN(C)CC1		Preclinical	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
BIX-02188	BIX-02188	CN(C)Cc1cccc(N\C(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(N)=O)c1	4Y3VYY2X83	Preclinical	MEK inhibitor	MAP2K5
BIX-02189	BIX-02189	CN(C)Cc1cccc(N\C(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(=O)N(C)C)c1		Preclinical	MEK inhibitor	MAP2K5|MAPK7
BL-5583	BL-5583|THIONAPHTHENE-2-CARBOXYLIC ACID	OC(=O)c1cc2ccccc2s1	HLR49221FQ	Preclinical	hypercalcaemic agent	
blebbistatin-(-)	blebbistatin-(-)|BLEBBISTATIN, (-)-	Cc1ccc2N=C3N(CC[C@@]3(O)C(=O)c2c1)c1ccccc1	8WII7624I5	Preclinical	ATPase inhibitor	
blebbistatin-(+/-)	blebbistatin-(+/-)|BLEBBISTATIN	Cc1ccc2N=C3N(CCC3(O)C(=O)c2c1)c1ccccc1	20WC4J7CQ6	Preclinical	ATPase inhibitor	MYH2
bleomycetin	bleomycetin|BLEOMYCIN A5	C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCCNCCCCN	5DY91Y7601	Phase 2	EGFR expression inhibitor	
bleomycin	bleomycin|BLEOMYCIN A2	CC(O)C(NC(=O)C(C)C(O)C(C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)C(CC(N)=O)NCC(N)C(N)=O)C(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C	13M89UEA7W	Launched	DNA synthesis inhibitor	LIG1|LIG3
blonanserin	blonanserin|BLONANSERIN	CCN1CCN(CC1)c1cc(-c2ccc(F)cc2)c2CCCCCCc2n1	AQ316B4F8C	Launched	dopamine receptor antagonist|serotonin receptor antagonist	DRD2|HTR2A
BLU9931	BLU9931	COc1cc(OC)c(Cl)c(-c2ccc3nc(Nc4c(C)cccc4NC(=O)C=C)ncc3c2)c1Cl		Preclinical	FGFR inhibitor	FGFR4
BML-190	BML-190	COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)N3CCOCC3)c2c1		Preclinical	cannabinoid receptor inverse agonist	CNR2
BML-284	BML-284	COc1cccc(c1)-c1cc(NCc2ccc3OCOc3c2)nc(N)n1		Preclinical	WNT agonist	
BMS-182874	BMS-182874	CN(C)c1cccc2c(cccc12)S(=O)(=O)Nc1onc(C)c1C		Phase 2	endothelin receptor antagonist	EDNRA
BMS-191011	BMS-191011	Oc1ccc(Cl)cc1Cn1nc(oc1=O)-c1ccc(cc1)C(F)(F)F	LW7MXS978N	Preclinical	potassium channel activator	KCNMA1
BMS-191095	BMS-191095	CC1(C)Oc2ccc(cc2[C@@H]([C@H]1O)N(Cc1ncc[nH]1)c1ccc(Cl)cc1)C#N		Phase 1	KATP activator|potassium channel agonist	
BMS-265246	BMS-265246	CCCCOc1c(cnc2[nH]ncc12)C(=O)c1c(F)cc(C)cc1F	4GF4A623RF	Preclinical	CDK inhibitor	CDK1|CDK2
BMS-299897	BMS-299897	C[C@@H](N(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1)c1ccc(F)cc1CCCC(O)=O		Phase 1	gamma secretase inhibitor	
BMS-345541	BMS-345541	Cc1cnc2c(NCCN)nc3ccc(C)cc3n12	BXU277OCN5	Preclinical	IKK inhibitor	CHUK|IKBKB
BMS-387032	BMS-387032|SNS-032	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	9979I93686	Phase 1	CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor	CDK2|CDK7|CDK9
BMS-536924	BMS-536924	Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCOCC1	40E3AZG1MX	Preclinical	IGF-1 inhibitor	AKT1|CCNE1|CDK2|CYP3A4|ERBB2|IGF1R|KDR|LCK|MAPK1|MET|PDGFRA|PDGFRB
BMS-587101	BMS-587101	CN1C(=O)N(C(=O)[C@]11CN(Cc2cc(cs2)C(O)=O)C[C@H]1c1ccc(cc1)C#N)c1cc(Cl)cc(Cl)c1		Phase 2	integrin antagonist	ITGAL|ITGB2
BMS-599626	BMS-599626	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12	2252724U5N	Phase 1	EGFR inhibitor|protein tyrosine kinase inhibitor	EGFR|ERBB2|ERBB4
BMS-626529	BMS-626529|TEMSAVIR	COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12	4B6J53W8N3	Phase 3	HIV attachment inhibitor	
BMS-649	BMS-649	CC1(C)CCC(C)(C)c2cc(ccc12)C1(OCCO1)c1ccc(cc1)C(O)=O		Preclinical	retinoid receptor agonist	RXRA
BMS-688521	BMS-688521	CN1C(=O)N(C(=O)[C@]11CN(C[C@H]1c1ccc(cc1)C#N)c1ccc(cn1)C(O)=O)c1cc(Cl)cc(Cl)c1	N4LDS4H73C	Preclinical	leukocyte function-associated antigen receptor antagonist|ICAM1 antagonist	ICAM1
BMS-690514	BMS-690514	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1	VKU5X213Q7	Phase 2	EGFR inhibitor|VEGFR inhibitor	EGFR|ERBB2|FLT3|KDR
BMS-707035	BMS-707035	Cn1c(nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O)N1CCCCS1(=O)=O	7PR4P7YOKT	Phase 2	HIV integrase inhibitor	
BMS-754807	BMS-754807	C[C@]1(CCCN1c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ccc(F)nc1	W9E3353E8J	Phase 2	IGF-1 inhibitor	AKT1|IGF1R
BMS-777607	BMS-777607	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1	A3MMS6HDO1	Phase 1/Phase 2	AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor	AXL|MERTK|MET|MST1R|TYRO3
BMS-806	BMS-806|BMS-378806	COc1cc[nH]c2ncc(C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)c12	IMN5E6PLUK	Phase 1	HIV attachment inhibitor	
BMS-817378	BMS-817378	Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl		Phase 1	c-Met inhibitor|VEGFR inhibitor	KDR|MET
BMS-833923	BMS-833923	CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(-c4ccccc4)c4ccccc4n3)cc2)c1		Phase 2	smoothened receptor antagonist	SMO
BMS-863233	BMS-863233	Clc1ccc2oc3c(nc([nH]c3=O)[C@@H]3CCCN3)c2c1	8QK62S7492	Phase 1/Phase 2	CDC inhibitor	CDC7|PIM1
BMS-927711	BMS-927711|RIMEGEPANT	N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)n2c3cccnc3[nH]c2=O)c2ncccc12)c1cccc(F)c1F	997WVV895X	Phase 2	calcitonin antagonist	CALCA
BMS-983970	BMS-983970	NC(=O)[C@@H](CC1CC1)[C@@H](CCC(F)(F)F)C(=O)N[C@H]1N=C(c2ccccc2)c2cccc(F)c2NC1=O		Phase 1	notch signaling inhibitor	
BMS-986020	BMS-986020	C[C@@H](OC(=O)Nc1c(C)noc1-c1ccc(cc1)-c1ccc(CC(O)=O)cc1)c1ccccc1		Phase 2	lysophosphatidic acid receptor antagonist	LPAR1
BMY-14802	BMY-14802	OC(CCCN1CCN(CC1)c1ncc(F)cn1)c1ccc(F)cc1		Phase 2	sigma receptor antagonist	HTR1A
BMY-45618	BMY-45618|BRYOSTATIN 1	CCC\C=C\C=C\C(=O)O[C@H]1\C(CC2C[C@@H](OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C\C(C[C@@H](O4)\C=C\C(C)(C)[C@]1(O)O2)=C\C(=O)OC)O3)[C@@H](C)O)=C\C(=O)OC	37O2X55Y9E	Phase 2	PKC activator	PRKCE
BMY-45778	BMY-45778	OC(=O)COc1cccc(c1)-c1ocnc1-c1nc(c(o1)-c1ccccc1)-c1ccccc1		Preclinical	IP1 prostacyclin receptor agonist	PTGIR
BMY-7378	BMY-7378	COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1	KC07KV8T5O	Preclinical	adrenergic receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|HTR1A
BNC105	BNC105|BNC-105	COc1ccc2c(C(=O)c3cc(OC)c(OC)c(OC)c3)c(C)oc2c1O	Z3S2Z6H7B0	Phase 2	tubulin polymerization inhibitor	
BNTX	BNTX	Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)\C(C[C@@]35O)=C\c1ccccc1		Preclinical	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
boceprevir	boceprevir|BOCEPREVIR	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	89BT58KELH	Launched	HCV inhibitor	CMA1|CTSA|CTSF|CTSK|CTSL|CTSS
bonaphthone	bonaphthone	Brc1ccc2C(=O)C(=O)C=Cc2c1		Phase 3		
bopindolol	bopindolol|BOPINDOLOL	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1	KT304VZO57	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3|HTR1A|HTR1B
bornyl-acetate	bornyl-acetate|BORNYL ACETATE|BORNYL ACETATE, (-)-	CC(=O)OC1CC2CCC1(C)C2(C)C	213431586X|24QAP1VCUX	Preclinical		
boronophenylalanine	boronophenylalanine|BORONOPHENYLALANINE	N[C@@H](Cc1ccc(cc1)B(O)O)C(O)=O	JSM63LV5MD	Phase 2		
bortezomib	bortezomib|BORTEZOMIB	CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)C1=CNC=CN1)B(O)O	69G8BD63PP	Launched	NFkB pathway inhibitor|proteasome inhibitor	PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA
bosentan	bosentan|BOSENTAN	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(cc2)C(C)(C)C)nc(nc1OCCO)-c1ncccn1	Q326023R30	Launched	endothelin receptor antagonist	EDNRA|EDNRB
bosutinib	bosutinib|BOSUTINIB	COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl	5018V4AEZ0	Launched	Abl kinase inhibitor|Bcr-Abl kinase inhibitor|src inhibitor	ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK
BP-554	BP-554	C(COc1ccc2OCOc2c1)CN1CCN(CC1)c1ccccc1		Preclinical	serotonin receptor agonist	HTR1A
BP-897	BP-897	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1	20PLE5W821	Phase 2	dopamine receptor agonist	ADRA1A|ADRA1D|ADRA2A|DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2B
BQ-123	BQ-123	CC(C)CC1NC(=O)C(NC(=O)C2CCCN2C(=O)C(CC(O)=O)NC(=O)C(Cc2c[nH]c3ccccc23)NC1=O)C(C)C	S2A8YZM151	Phase 2	endothelin receptor antagonist	EDNRA
BQ-788	BQ-788	CCCC[C@@H](NC(=O)[C@@H](Cc1cn(C(=O)OC)c2ccccc12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@@H](C)CCC[C@H]1C)C(O)=O	44OLL8XEJ4	Phase 1	endothelin receptor antagonist	EDNRB
BQU57	BQU57	Cc1nn(C)c2OC(N)=C(C#N)C(c12)c1ccc(cc1)C(F)(F)F		Preclinical	Ras GTPase inhibitor	RALA|RALB
BRD4770	BRD4770	COC(=O)c1ccc2n(CCCc3ccccc3)c(NC(=O)c3ccccc3)nc2c1		Preclinical	histone lysine methyltransferase inhibitor	EHMT2
brefeldin-a	brefeldin-a|BREFELDIN A	C[C@H]1CCC\C=C\C2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1	XG0D35F9K6	Preclinical	protein synthesis inhibitor	ARF1|CYTH2
bremelanotide	bremelanotide|BREMELANOTIDE	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)C(O)=O	6Y24O4F92S	Phase 3	melanocortin receptor agonist	MC1R|MC2R|MC3R|MC4R|MC5R
brequinar	brequinar|BREQUINAR	Cc1c(nc2ccc(F)cc2c1C(O)=O)-c1ccc(cc1)-c1ccccc1F	5XL19F49H6	Phase 2	dihydroorotate dehydrogenase inhibitor	DHODH
bretazenil	bretazenil|BRETAZENIL	CC(C)(C)OC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc-21	OSZ0E9DGOJ	Phase 2	GABA benzodiazepine site receptor partial agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6
bretylium	bretylium|BRETYLIUM	CC[N+](C)(C)Cc1ccccc1Br	RZR75EQ2KJ	Launched	norepinephrine inhibitor	ATP1A1
brexpiprazole	brexpiprazole|BREXPIPRAZOLE	O=c1ccc2ccc(OCCCCN3CCN(CC3)c3cccc4sccc34)cc2[nH]1	2J3YBM1K8C	Launched	dopamine receptor partial agonist	DRD2
briciclib	briciclib|BRICICLIB	COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(OP(O)(O)=O)c2)c(OC)c1	WG93X96336	Phase 1	cyclin D inhibitor	CCND1
brigatinib	brigatinib|BRIGATINIB	COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N1CCN(C)CC1	HYW8DB273J	Phase 3	ALK tyrosine kinase receptor inhibitor|EGFR inhibitor	ALK|EGFR
brilliant-green	brilliant-green|BRILLIANT GREEN	CCN(CC)c1ccc(cc1)C(c1ccccc1)=C1C=CC(C=C1)=[N+](CC)CC	G0L543D370	Launched		
brimonidine	brimonidine|BRIMONIDINE	Brc1c(NC2=NCCN2)ccc2nccnc12	E6GNX3HHTE	Launched	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
brinzolamide	brinzolamide|BRINZOLAMIDE	CCNC1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O	9451Z89515	Launched	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA2|CA4|CA5A|CA7
brivanib	brivanib|BRIVANIB	C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C	DDU33B674I	Phase 3	FGFR inhibitor|VEGFR inhibitor	CYP3A4|FGFR1|FLT1|KCNH2|KDR
brivanib-alaninate	brivanib-alaninate|BRIVANIB ALANINATE	C[C@H](COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C)OC(=O)[C@H](C)N	U2Y5OFN795	Phase 3	FGFR inhibitor|VEGFR inhibitor	FGFR3
brivaracetam	brivaracetam|BRIVARACETAM	CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1	U863JGG2IA	Launched	voltage-gated sodium channel blocker	SV2A
brivudine	brivudine|BRIVUDINE	OC[C@H]1O[C@H](CC1O)n1cc(\C=C\Br)c(=O)[nH]c1=O	2M3055079H	Launched	DNA directed DNA polymerase inhibitor	
BRL-15572	BRL-15572	OC(CN1CCN(CC1)c1cccc(Cl)c1)C(c1ccccc1)c1ccccc1	LY8CZE6XUD	Preclinical	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6
BRL-26314	BRL-26314	OC(=O)C(Cc1ccccc1)NCc1ccc(Cl)cc1		Phase 1	cholesterol inhibitor	LPL
BRL-37344	BRL-37344|SB-206606	C[C@H](Cc1ccc(OCC(O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1	42FZ27IZLV|5DZZ1926YW	Phase 2	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
BRL-44408	BRL-44408	CC1N(CC2=NCCN2)Cc2ccccc12	ZET7B198W2	Preclinical	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C
BRL-50481	BRL-50481	CN(C)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O	03G869PR3P	Preclinical	phosphodiesterase inhibitor	PDE7A|PDE7B
BRL-52537	BRL-52537	Clc1ccc(CC(=O)N2CCCCC2CN2CCCC2)cc1Cl		Preclinical	opioid receptor agonist	OPRK1
BRL-54443	BRL-54443	CN1CCC(CC1)c1c[nH]c2ccc(O)cc12	Q2DH1CHI0Y	Preclinical	serotonin receptor agonist	HTR1E|HTR1F
brolitene	brolitene|IDROCILAMIDE	OCCNC(=O)\C=C\c1ccccc1	6C816LUB1O	Launched	muscle relaxant	RYR1
bromantan	bromantan|BROMANTANE	Brc1ccc(NC2C3CC4CC(C3)CC2C4)cc1	N1ILS53XWK	Launched	dopamine reuptake inhibitor|serotonin reuptake inhibitor	
bromebric-acid	bromebric-acid|BROMEBRIC ACID	COc1ccc(cc1)C(=O)C(\Br)=C\C(O)=O	FGE8818GWA	Preclinical	purine antagonist|DNA synthesis inhibitor	
bromfenac	bromfenac|BROMFENAC	Nc1c(CC(O)=O)cccc1C(=O)c1ccc(Br)cc1	864P0921DW	Withdrawn	cyclooxygenase inhibitor	PTGS1|PTGS2
bromhexine	bromhexine|BROMHEXINE	CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1	Q1J152VB1P	Launched	mucolytic agent	
bromindione	bromindione|BROMINDIONE	Brc1ccc(cc1)C1C(=O)c2ccccc2C1=O	OQZ7BND2QN	Phase 2	anticoagulant	
bromocriptine	bromocriptine|BROMOCRIPTINE	CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C	3A64E3G5ZO	Launched	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7
bromopride	bromopride|BROMOPRIDE	CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC	75473V2YZK	Launched	dopamine receptor antagonist	DRD2
bromosporine	bromosporine	CCOC(=O)Nc1cc(nn2c(C)nnc12)-c1ccc(C)c(NS(C)(=O)=O)c1		Preclinical	bromodomain inhibitor	
bromperidol	bromperidol|BROMPERIDOL	OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Br)cc1	LYH6F7I22E	Launched	dopamine receptor antagonist	DRD2
brompheniramine	brompheniramine|BROMPHENIRAMINE	CN(C)CCC(c1ccc(Br)cc1)c1ccccn1	H57G17P2FN	Launched	histamine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1
bronopol	bronopol|BRONOPOL	OCC(Br)(CO)[N+]([O-])=O	6PU1E16C9W	Launched		
bropirimine	bropirimine|BROPIRIMINE	Nc1nc(-c2ccccc2)c(Br)c(=O)[nH]1	J57CTF25XJ	Phase 3	interferon inducer	
broxaldine	broxaldine|BROXALDINE	Cc1ccc2c(Br)cc(Br)c(OC(=O)c3ccccc3)c2n1	6308U1DL5F	Preclinical		
broxaterol	broxaterol|BROXATEROL	CC(C)(C)NCC(O)c1cc(Br)no1	ZE4IRB4DUC	Phase 3	adrenergic receptor agonist	ADRB2
broxuridine	broxuridine|BROXURIDINE	OC[C@H]1O[C@H](C[C@@H]1O)n1cc(Br)c(=O)[nH]c1=O	G34N38R2N1	Phase 2	antimetabolite	
broxyquinoline	broxyquinoline|BROXYQUINOLINE	Oc1c(Br)cc(Br)c2cccnc12	UK4C618C8T	Phase 1	antiprotozoal agent	
bruceantin	bruceantin|BRUCEANTIN	COC(=O)[C@]12OC[C@@]34[C@H]1[C@@H](OC(=O)\C=C(/C)C(C)C)C(=O)O[C@@H]3C[C@H]1C(C)C(=O)C(=O)C[C@]1(C)[C@H]4[C@@H](O)[C@@H]2O	S3NW88DI4T	Phase 2	protein synthesis inhibitor	
brucine	brucine|BRUCINE	COc1cc2N3C4[C@@H]5C(CC3=O)OCC=C3CN6CC[C@]4([C@@H]6C[C@H]53)c2cc1OC	6NG17YCK6H	Preclinical	glycine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
BS-181	BS-181	CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12	75M620LLBN	Preclinical	CDK inhibitor	CDK7
BTB06584	BTB06584	[O-][N+](=O)c1ccc(cc1OC(=O)c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1		Preclinical	ATPase inhibitor	ATP5F1
BTS	BTS|PYRUVIC ACID	Cc1ccc(cc1)S(=O)(=O)NCc1ccccc1	8558G7RUTR	Preclinical		
BTS-54505	BTS-54505|DIDESMETHYLSIBUTRAMINE	CC(C)CC(N)C1(CCC1)c1ccc(Cl)cc1	987R943R3P	Withdrawn	dopamine reuptake inhibitor	SLC6A2|SLC6A3|SLC6A4
BTS-72664	BTS-72664	CC(Oc1ccc(Cl)cc1)c1ccnc2ncnn12		Phase 1	GABA receptor antagonist	GABBR1
BTZ043-racemate	BTZ043-racemate|BTZ-043	CC1COC2(CCN(CC2)c2nc(=O)c3cc(cc([N+]([O-])=O)c3s2)C(F)(F)F)O1	G55ZH52P57	Preclinical	DPRE1 inhibitor	
BU-224	BU-224	C1CN=C(N1)c1ccc2ccccc2n1		Preclinical	imidazoline receptor ligand	MAOA|MAOB
BU-239	BU-239	C1CN=C(N1)c1cnc2ccccc2n1		Preclinical	imidazoline receptor ligand|imidazoline receptor agonist	
BU226	BU226	C1CN=C(N1)c1cc2ccccc2cn1		Preclinical	imidazoline receptor ligand	
bucetin	bucetin|BUCETIN, (+)-|BUCETIN|BUCETIN, (-)-	CCOc1ccc(NC(=O)CC(C)O)cc1	1Z23WB033I|6M7CVQ8PF8|PLF54F8S2F	Withdrawn	analgesic agent	
bucillamine	bucillamine|BUCILLAMINE	CC(C)(S)C(=O)N[C@@H](CS)C(O)=O	R80LRA5WTF	Launched	immunosuppressant	
bucladesine	bucladesine|BUCLADESINE	CCCC(=O)Nc1ncnc2n(cnc12)C1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC	63X7MBT2LQ	Launched	adenosine receptor agonist|cAMP stimulant	PRKACA
buclizine	buclizine|BUCLIZINE	CC(C)(C)c1ccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)cc1	0C94V6X681	Launched	histamine receptor antagonist	CHRM1|HRH1
budesonide	budesonide|BUDESONIDE (11.BETA.,16.ALPHA.(S))|DEXBUDESONIDE	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	168L5HT37P|2HI1006KPH	Launched	glucocorticoid receptor agonist	NR3C1
budipine	budipine|BUDIPINE	CC(C)(C)N1CCC(CC1)(c1ccccc1)c1ccccc1	L9026OPI2Z	Launched	glutamate receptor antagonist	GRIN1
bufexamac	bufexamac|BUFEXAMAC	CCCCOc1ccc(CC(=O)NO)cc1	4T3C38J78L	Withdrawn	cyclooxygenase inhibitor	HDAC10|HDAC6
buflomedil	buflomedil|BUFLOMEDIL	COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1	V7I71DQ432	Launched	adrenergic receptor antagonist|calcium channel blocker	ADRA1A
bumetanide	bumetanide|BUMETANIDE	CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O	0Y2S3XUQ5H	Launched	solute carrier family member inhibitor	CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5
bunazosin	bunazosin|BUNAZOSIN	CCCC(=O)N1CCCN(CC1)c1nc(N)c2cc(OC)c(OC)cc2n1	9UUW4V7G2H	Launched	adrenergic receptor antagonist	ADRA1A
buparlisib	buparlisib|BUPARLISIB	Nc1cc(c(cn1)-c1cc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F	0ZM2Z182GD	Phase 3	PI3K inhibitor	PIK3CA|PIK3CG
buparvaquone	buparvaquone|BUPARVAQUONE	CC(C)(C)C1CCC(CC2C(=O)C(=O)c3ccccc3C2=O)CC1	0354RT7LG4	Launched	antiprotozoal agent	
buphenine	buphenine|NYLIDRIN	CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1	695DKH33EI	Launched	adrenergic receptor agonist	ADRB2
bupicomide	bupicomide|BUPICOMIDE	CCCCc1ccc(nc1)C(N)=O	0X3H76N0HY	Phase 1	adrenergic receptor antagonist	ADRB1
bupivacaine	bupivacaine|BUPIVACAINE	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C	Y8335394RO	Launched	sodium channel blocker	KCNA5|PTGER1|SCN10A|SCN4A
bupranolol	bupranolol|BUPRANOLOL	Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1	858YGI5PIT	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
bupropion	bupropion|BUPROPION	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	01ZG3TPX31	Launched	dopamine uptake inhibitor	CHRNA3|SLC6A2|SLC6A3
buramate	buramate|BURAMATE	OCCOC(=O)NCc1ccccc1	Q9HDA6U6V4	Preclinical	antiepileptic	
buspirone	buspirone|BUSPIRONE	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1	TK65WKS8HL	Launched	serotonin receptor agonist	DRD2|HTR1A
busulfan	busulfan|BUSULFAN	CS(=O)(=O)OCCCCOS(C)(=O)=O	G1LN9045DK	Launched	DNA inhibitor	
butabindide	butabindide	CCCCNC(=O)[C@@H]1Cc2ccccc2N1C(=O)[C@@H](N)CC		Preclinical	tripeptidyl peptidase inhibitor	TPP2
butacaine	butacaine|BUTACAINE	CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1	Z84S23CGJJ	Launched	local anesthetic	
butaclamol	butaclamol|BUTACLAMOL	CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc([C@H]2C1)c34	A7A2802VNL	Phase 2	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A
butalbital	butalbital|BUTALBITAL	CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O	KHS0AZ4JVK	Launched	GABA receptor antagonist	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2
butamben	butamben|BUTAMBEN	CCCCOC(=O)c1ccc(N)cc1	EFW857872Q	Withdrawn	sodium channel blocker	
butein	butein|BUTEIN	Oc1ccc(C(=O)\C=C\c2ccc(O)c(O)c2)c(O)c1	4WVS5M0LGF	Preclinical	EGFR inhibitor|src inhibitor	ACE
butenafine	butenafine|BUTENAFINE	CN(Cc1ccc(cc1)C(C)(C)C)Cc1cccc2ccccc12	91Y494NL0X	Launched	fungal squalene epoxidase inhibitor	SQLE
buthionine-sulfoximine	buthionine-sulfoximine|BUTHIONINE SULFOXIMINE	CCCCS(=N)(=O)CC[C@H](N)C(O)=O	LW4108Q0BV	Phase 1	glutathione transferase inhibitor	GCLM
butibufen	butibufen|BUTIBUFEN	CCC(C(O)=O)c1ccc(CC(C)C)cc1	JSS1TEM917	Withdrawn	cyclooxygenase inhibitor	
butoconazole	butoconazole|BUTOCONAZOLE	Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1	0Q771797PH	Launched	bacterial cell wall synthesis inhibitor	
butofilolol	butofilolol|BUTOFILOLOL	CCCC(=O)c1cc(F)ccc1OCC(O)CNC(C)(C)C	4AZC6Y5A8G	Phase 2	adrenergic receptor antagonist	
butorphanol-(+)-tartrate	butorphanol-(+)-tartrate|BUTORPHANOL	Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1	QV897JC36D	Launched	opioid receptor agonist|opioid receptor antagonist	OPRD1|OPRK1|OPRM1
butyl-paraben	butyl-paraben|BUTYLPARABEN	CCCCOC(=O)c1ccc(O)cc1	3QPI1U3FV8	Preclinical	DNA synthesis inhibitor	
butylated-hydroxyanisole	butylated-hydroxyanisole|3-TERT-BUTYL-4-HYDROXYANISOLE	COc1ccc(O)c(c1)C(C)(C)C	62RAC24292	Preclinical	antioxidant	
butylated-hydroxytoluene	butylated-hydroxytoluene|BUTYLATED HYDROXYTOLUENE	Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C	1P9D0Z171K	Phase 1	carbonic anhydrase inhibitor	CA2
butylphthalide	butylphthalide|BUTYLPHTHALIDE	CCCCC1OC(=O)c2ccccc12	822Q956KGM	Launched	potassium channel antagonist	KCNK2
butylscopolamine-bromide	butylscopolamine-bromide|BUTYLSCOPOLAMINE BROMIDE	CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@@H](CO)c1ccccc1	0GH9JX37C8	Launched	cholinergic receptor antagonist	
BVD-523	BVD-523|ULIXERTINIB	CC(C)Nc1cc(-c2c[nH]c(c2)C(=O)N[C@H](CO)c2cccc(Cl)c2)c(Cl)cn1	16ZDH50O1U	Phase 1/Phase 2	MAP kinase inhibitor	
BVT-2733	BVT-2733	CN1CCN(CC1)C(=O)Cc1csc(NS(=O)(=O)c2cccc(Cl)c2C)n1	2EGD70329U	Preclinical	11-beta hydroxysteroid dehydrogenase inhibitor	HSD17B1
BVT-948	BVT-948	CC1(C)C(=O)NC2=C1C(=O)C(=O)c1ccccc21		Preclinical	tyrosine phosphatase inhibitor	PTPN1|PTPN11|PTPN2
BW-180C	BW-180C	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O		Phase 2	opioid receptor agonist	OPRD1|OPRM1
BW-373U86	BW-373U86	CCN(CC)C(=O)c1ccc(cc1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)c1cccc(O)c1		Preclinical	opioid receptor agonist	OPRD1
BW-616U	BW-616U	CNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1		Preclinical	monoamine oxidase inhibitor	MAOA
BW-723C86	BW-723C86	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12		Preclinical	serotonin receptor agonist	HTR2A|HTR2B|HTR2C
BW-A4C	BW-A4C	CC(=O)N(O)C\C=C\c1cccc(Oc2ccccc2)c1		Phase 1	lipoxygenase inhibitor	ALOX5
BW-B70C	BW-B70C	CC(\C=C\c1cccc(Oc2ccc(F)cc2)c1)N(O)C(N)=O		Preclinical	lipoxygenase inhibitor	ALOX5
BX-795	BX-795	Ic1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCCNC(=O)c1cccs1		Preclinical	IKK inhibitor	CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1
BX-912	BX-912	Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc1c[nH]cn1		Preclinical	pyruvate dehydrogenase kinase inhibitor	CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1
BYK-204165	BYK-204165	Cn1cccc1\C=C1/C(=O)NC(=O)c2ccccc12		Preclinical	PARP inhibitor	PARP1
C-1	C-1	O=S(=O)(N1CCNCC1)c1cccc2cnccc12		Preclinical	protein kinase inhibitor	PRKCA
C-751	C-751	CCOC(=O)c1c[nH]cn1		Preclinical		
C106	C106	CN1CCCC1c1cccnc1.Cc1ccc(cc1)C(=O)OC(C(OC(=O)c1ccc(C)cc1)C(O)=O)C(O)=O		Phase 3		
C11-Acetate	C11-Acetate|YTTRIUM CATION	[Y+3]	1FYP74LM4P	Phase 3		ABAT|ACE|AKR1C3|CA2|CELA1|ESR2|FFAR2|FFAR3|HPRT1|LTA4H|MMP12|NOS1|NOS3|PLA2G1B|PTPN1|SOD1|TXN
C646	C646	CC1=NN(C(=O)C\1=C/c1ccc(o1)-c1cc(C)c(C)cc1[N+]([O-])=O)c1ccc(cc1)C(O)=O		Preclinical	histone acetyltransferase inhibitor	EP300
cabagin	cabagin|METHYLMETHIONINE CHLORIDE	C[S+](C)CC[C@H](N)C(O)=O	G9CUR2204U	Launched		
cabaletta	cabaletta|TREHALOSE	OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	B8WCK70T7I	Phase 2	pharmacological chaperone	
cabazitaxel	cabazitaxel|CABAZITAXEL	CO[C@@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@@H](OC(=O)c3ccccc3)[C@@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C	51F690397J	Launched	microtubule inhibitor	TUBA4A|TUBB|TUBB1
cabergoline	cabergoline|CABERGOLINE	CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1	LL60K9J05T	Launched	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7
cabotegravir	cabotegravir|CABOTEGRAVIR	CC1COC2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12	HMH0132Z1Q	Phase 2/Phase 3	HIV integrase inhibitor	
cabozantinib	cabozantinib|CABOZANTINIB	COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC	1C39JW444G	Launched	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET
cadralazine	cadralazine|CADRALAZINE	CCOC(=O)NNc1ccc(nn1)N(CC)CC(C)O	8T96I3U713	Launched	adrenergic receptor antagonist	
cafestol	cafestol|CAFESTOL	C[C@@]12CCc3occc3[C@H]1CC[C@@]13C[C@@H](CC[C@@H]21)[C@@](O)(CO)C3	AC465T6Q6W	Launched	pregnane X receptor agonist	
caffeic-acid	caffeic-acid|CAFFEIC ACID	OC(=O)\C=C\c1ccc(O)c(O)c1	U2S3A33KVM	Preclinical	HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor	ALOX5|MIF
caffeic-acid-phenethyl-ester	caffeic-acid-phenethyl-ester|CAFFEIC ACID PHENETHYL ESTER	Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O	G960R9S5SK	Preclinical	HIV integrase inhibitor	RELA
caffeine	caffeine|CAFFEINE	Cn1cnc2n(C)c(=O)n(C)c(=O)c12	3G6A5W338E	Launched	adenosine receptor antagonist|phosphodiesterase inhibitor	ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3
calcifediol	calcifediol|CALCIFEDIOL	C[C@H](CCCC(C)(C)O)[C@@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1\C[C@@H](O)CCC1=C	P6YZ13C99Q	Launched	vitamin D receptor agonist	VDR
calcipotriol	calcipotriol|CALCIPOTRIENE	C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	143NQ3779B	Launched	vitamin D receptor agonist	VDR
calcitriol	calcitriol|CALCITRIOL	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	FXC9231JVH	Launched	vitamin D receptor agonist	VDR
calcium-gluceptate	calcium-gluceptate|GLUCOHEPTONIC ACID	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O	B1F50160Z2	Launched		
calcium-levofolinate	calcium-levofolinate|LEVOLEUCOVORIN CALCIUM	Nc1nc(=O)c2N(C=O)[C@@H](CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1	778XL6VBS8	Launched		
calpeptin	calpeptin|CALPEPTIN	CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	18X9FR245W	Preclinical	calpain inhibitor	
camicinal	camicinal|CAMICINAL	C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(CC3)Nc3cccc(F)c3)cc2)CCN1	3C8348951H	Phase 2	motilin receptor agonist	MLNR
CaMKII-IN-1	CaMKII-IN-1	Cc1c(Cl)cccc1S(=O)(=O)Nc1nc(NCCc2ccccc2)nc2CCN(Cc3ccccc3)Cc12		Preclinical	calcium/calmodulin dependent protein kinase inhibitor	AKT1|CAMK2A|CAMK4|MYLK
camostat-mesilate	camostat-mesilate|CAMOSTAT MESYLATE	CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(N)=N)cc2)cc1	451M50A1EQ	Launched	protease inhibitor	PRSS1
camphor-(+)	camphor-(+)|CAMPHOR (SYNTHETIC)|CAMPHOR (NATURAL)	CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2	5TJD82A1ET|N20HL7Q941	Phase 2		TRPV1
camphor-(1r)	camphor-(1r)|CAMPHOR, (-)-|CAMPHOR (SYNTHETIC)|CAMPHOR (NATURAL)	CC1(C)[C@@H]2CC[C@]1(C)C(=O)C2	213N3S8275|5TJD82A1ET|N20HL7Q941	Phase 1	TRPV activator	
camptothecin	camptothecin|CAMPTOTHECIN	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O	XT3Z54Z28A	Phase 3	topoisomerase inhibitor	TOP1
camylofine-chlorhydrate	camylofine-chlorhydrate|CAMYLOFIN	CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1	340B6Q764V	Launched		
canagliflozin	canagliflozin|CANAGLIFLOZIN	Cc1ccc(cc1Cc1ccc(s1)-c1ccc(F)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O	0SAC974Z85	Launched	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2
candesartan	candesartan|CANDESARTAN	CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	S8Q36MD2XX	Launched	angiotensin receptor antagonist	AGTR1
candesartan-cilextil	candesartan-cilextil|CANDESARTAN CILEXETIL	CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	R85M2X0D68	Launched	angiotensin receptor antagonist	AGTR1|AGTR2
candicidin	candicidin	CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC(=O)CC(O)C(C(O)CC(O[C@@H]2O[C@H](C)[C@H](O)[C@@H](O)[C@@H]2N)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)C(O)=O)C(O)CC(=O)c1ccc(N)cc1		Launched	fungal ergosterol inhibitor	
canertinib	canertinib|CANERTINIB	Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl	C78W1K5ASF	Phase 3	EGFR inhibitor	AKT1|EGFR|ERBB2|ERBB4
canrenone	canrenone|CANRENONE	C[C@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C1CC[C@@]21CCC(=O)O1	78O20X9J0U	Withdrawn	mineralocorticoid receptor antagonist	NR3C2
cantharidin	cantharidin|CANTHARIDIN	C[C@]12[C@@H]3CC[C@@H](O3)[C@@]1(C)C(=O)OC2=O	IGL471WQ8P	Launched	protein phosphatase inhibitor	
capadenoson	capadenoson|CAPADENOSON	Nc1nc(SCc2csc(n2)-c2ccc(Cl)cc2)c(C#N)c(-c2ccc(OCCO)cc2)c1C#N	O519NVW73R	Phase 2	adenosine receptor agonist	ADORA1
capecitabine	capecitabine|CAPECITABINE	CCCCCOC(=O)Nc1nc(=O)n(cc1F)C1O[C@H](C)[C@@H](O)[C@H]1O	6804DJ8Z9U	Launched	DNA synthesis inhibitor|thymidylate synthase inhibitor	TYMS
capobenic-acid	capobenic-acid|CAPOBENIC ACID	COc1cc(cc(OC)c1OC)C(=O)NCCCCCC(O)=O	3R77T835TA	Preclinical		
capreomycin	capreomycin|CAPREOMYCIN IB	CC1NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC(=O)C(CNC(=O)CC(N)CCCN)NC1=O)=C/NC(N)=O)C1CCNC(=N)N1	2YP3RYC823	Launched	protein synthesis inhibitor	
caprylic-acid	caprylic-acid|OCTANOIC ACID	CCCCCCCC(O)=O	OBL58JN025	Launched		
capsaicin	capsaicin|CAPSAICIN	COc1cc(CNC(=O)CCCC\C=C\C(C)C)ccc1O	S07O44R1ZM	Launched	TRPV agonist	CFTR|TRPV1
capsazepine	capsazepine|CAPSAZEPINE	Oc1cc2CCCN(Cc2cc1O)C(=S)NCCc1ccc(Cl)cc1	LFW48MY844	Preclinical	TRPV agonist	TRPV1|TRPV4
captamine	captamine|CAPTAMINE	CN(C)CCS	9FS0ENU0GR	Preclinical		
captan	captan|CAPTAN	ClC(Cl)(Cl)SN1C(=O)C2CC=CCC2C1=O	EOL5G26Q9F	Phase 1		
captopril	captopril|CAPTOPRIL	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O	9G64RSX1XD	Launched	angiotensin converting enzyme inhibitor	ACE|LTA4H|MMP2|MMP9
caracemide	caracemide|CARACEMIDE	CNC(=O)ON(C(C)=O)C(=O)NC	H74F6J185A	Phase 2	ribonucleotide reductase inhibitor	RRM1
caramiphen	caramiphen|CARAMIPHEN	CCN(CC)CCOC(=O)C1(CCCC1)c1ccccc1	97J7NP0XJY	Launched	cholinergic receptor antagonist	CHRM1|CHRM2
carazolol	carazolol|CARAZOLOL	CC(C)NCC(O)COc1cccc2[nH]c3ccccc3c12	29PW75S82A	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
carbachol	carbachol|CARBACHOL	C[N+](C)(C)CCOC(N)=O	8Y164V895Y	Launched	cholinergic receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2
carbadox	carbadox|CARBADOX	COC(=O)\N=N\C=C1/C=[N+]([O-])c2ccccc2N1O	M2X04R2E2Y	Launched	other antibiotic	
carbamazepine	carbamazepine|CARBAMAZEPINE	NC(=O)N1c2ccccc2C=Cc2ccccc12	33CM23913M	Launched	carboxamide antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
carbaril	carbaril|CARBARIL	CNC(=O)Oc1cccc2ccccc12	R890C8J3N1	Launched	acetylcholinesterase inhibitor	
carbarsone	carbarsone|CARBARSONE	NC(=O)Nc1ccc(cc1)[As](O)(O)=O	8PK70TXE1T	Launched	antiprotozoal agent	
carbazochrome	carbazochrome|CARBAZOCHROME	CN1C(CC2=C\C(=N\NC(N)=O)C(=O)C=C12)S(O)(=O)=O	81F061RQS4	Launched		
carbendazim	carbendazim|CARBENDAZIM	COC(=O)Nc1nc2ccccc2[nH]1	H75J14AA89	Launched	microtubule inhibitor|tubulin polymerization inhibitor	TP53|TUBB
carbenicillin	carbenicillin|CARBENICILLIN	CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O	G42ZU72N5G	Launched	bacterial cell wall synthesis inhibitor	
carbenoxolone	carbenoxolone|CARBENOXOLONE	CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3CC(C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O	MM6384NG73	Launched	11-beta hydroxysteroid dehydrogenase inhibitor	GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3
carbetapentane	carbetapentane|PENTOXYVERINE	CCN(CC)CCOCCOC(=O)C1(CCCC1)c1ccccc1	32C726X12W	Launched	acetylcholine receptor antagonist	CHRM2
carbetocin	carbetocin|CARBETOCIN	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O	88TWF8015Y	Launched	oxytocin receptor agonist	OXTR
carbidopa	carbidopa|CARBIDOPA	CC(Cc1ccc(O)c(O)c1)(NN)C(O)=O	MNX7R8C5VO	Launched	aromatic L-amino acid decarboxylase inhibitor	DDC
carbimazole	carbimazole|CARBIMAZOLE	CCOC(=O)n1ccn(C)c1=S	8KQ660G60G	Launched	antithyroid agent	TPO
carbinoxamine	carbinoxamine|CARBINOXAMINE	CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1	982A7M02H5	Launched	histamine receptor antagonist	HRH1
carboplatin	carboplatin|CARBOPLATIN	N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1	BG3F62OND5	Launched	DNA alkylating agent|DNA inhibitor	
carboxyamidotriazole	carboxyamidotriazole|CARBOXYAMIDOTRIAZOLE	NC(=O)c1nnn(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)c1N	6ST3ZF52WB	Phase 3	calcium channel blocker	CXCL8
carboxylosartan	carboxylosartan|EXP-3174	CCCCc1nc(Cl)c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	GD76OCH73X	Phase 1	angiotensin antagonist	AGTR1
carboxypyridine-disulfide	carboxypyridine-disulfide	OC(=O)c1ccc(SSc2ccc(cn2)C(O)=O)nc1		Phase 2		
cardiogenol-c	cardiogenol-c	COc1ccc(Nc2nccc(NCCO)n2)cc1		Preclinical	cardiomyogenesis inducer	
carebastine	carebastine|CAREBASTINE	CC(C)(C(O)=O)c1ccc(cc1)C(=O)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1	75DLN707DO	Phase 1	histamine receptor antagonist	HRH1
carfilzomib	carfilzomib|CARFILZOMIB	CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1	72X6E3J5AR	Launched	proteasome inhibitor	PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9
carglumic-acid	carglumic-acid|CARGLUMIC ACID	NC(=O)N[C@@H](CCC(O)=O)C(O)=O	5L0HB4V1EW	Launched	carbamoyl phosphate synthase activator	CPS1
caricotamide	caricotamide|CARICOTAMIDE	NC(=O)CN1C=CCC(=C1)C(N)=O	MC09H30MFS	Phase 2	NADPH quinone oxidoreductase inhibitor	NQO2
cariporide	cariporide|CARIPORIDE	CC(C)c1ccc(cc1S(C)(=O)=O)C(=O)N=C(N)N	7E3392891K	Phase 3	sodium/hydrogen exchanger inhibitor	SLC9A1
cariprazine	cariprazine|CARIPRAZINE	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1	F6RJL8B278	Launched	dopamine receptor antagonist	DRD2|DRD3
carisoprodol	carisoprodol|CARISOPRODOL	CCCC(C)(COC(N)=O)COC(=O)NC(C)C	21925K482H	Launched	acetylcholine receptor antagonist	CYP2C19
carmofur	carmofur|CARMOFUR	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O	HA82M3RAB2	Launched	thymidylate synthase inhibitor	TYMS
carmoterol	carmoterol|CARMOTEROL	COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3nc(O)ccc23)cc1	9810NUL4D1	Phase 2	adrenergic receptor agonist	ADRB2
carmoxirole	carmoxirole|CARMOXIROLE	OC(=O)c1ccc2[nH]cc(CCCCN3CCC(=CC3)c3ccccc3)c2c1	MRP4P457ZA	Phase 2	dopamine receptor agonist	DRD2
carmustine	carmustine|CARMUSTINE	[O-][N+]N(CCCl)C(=O)NCCCl	U68WG3173Y	Launched	DNA alkylating agent|DNA inhibitor	GSR
carnitine-(D/L)	carnitine-(D/L)|LEVOCARNITINE|CARNITINE|CARNITINE, (+)-	C[N+](C)(C)CC(O)CC(O)=O	0G389FZZ9M|S7UI8SM58A|U9VY0ZOK7A	Phase 3		
carnosine	carnosine|CARNOSINE	NCCC(=O)NC(Cc1cnc[nH]1)C(O)=O	8HO6PVN24W	Phase 2	antiglycating agent	
caroverine	caroverine|CAROVERINE	CCN(CC)CCN1C(=O)C(Nc2ccccc12)=Cc1ccc(OC)cc1	XJ73B0K6KB	Launched	glutamate receptor antagonist|calcium channel blocker	
caroxazone	caroxazone|CAROXAZONE	NC(=O)CN1Cc2ccccc2OC1=O	807N226MNL	Withdrawn	monoamine oxidase inhibitor	MAOA|MAOB
carprofen	carprofen|CARPROFEN	CC(C(O)=O)c1ccc2c(c1)[nH]c1ccc(Cl)cc21	FFL0D546HO	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
carsalam	carsalam|CARSALAM	O=c1[nH]c(=O)c2ccccc2o1	685H843ULU	Preclinical	analgesic agent	
carteolol	carteolol|CARTEOLOL	CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12	8NF31401XG	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
carumonam	carumonam|CARUMONAM	NC(=O)OC[C@@H]1[C@H](NC(=O)C(=N/OCC(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O	486890PI06	Launched	bacterial cell wall synthesis inhibitor	
carvedilol	carvedilol|CARVEDILOL	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12	0K47UL67F2	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|GJA1|HIF1A|KCNH2|NDUFC2|NPPB|SELE|VCAM1|VEGFA
carzenide	carzenide|CARZENIDE	NS(=O)(=O)c1ccc(cc1)C(O)=O	30Z5HQB5A4	Preclinical		CA1|CA12|CA14|CA2|CA6|CA9
casanthranol-variant	casanthranol-variant	OC[C@H]1O[C@@H](O[C@@H]2c3cccc(O)c3C(=O)c3c(O)cc(CO)cc23)[C@H](O)[C@H](O)[C@H]1O		Launched		
caspofungin	caspofungin|CASPOFUNGIN	CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@@H](O)[C@H](O)c1ccc(O)cc1)[C@H](O)CCN	F0XDI6ZL63	Launched	fungal 1,3-beta-D-glucan synthase inhibitor|bacterial cell wall synthesis inhibitor	
caspofungin-acetate	caspofungin-acetate|CASPOFUNGIN ACETATE	CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)cc1)[C@@H](O)CCN	VUW370O5QE	Launched	fungal 1,3-beta-D-glucan synthase inhibitor	
castanospermine	castanospermine|CASTANOSPERMINE	O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12	Q0I3184XM7	Phase 2	glucosidase inhibitor	GAA|GBA
catharanthine	catharanthine|CATHARANTHINE	CCC1=C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@](C2)([C@@H]13)C(=O)OC	WT0YJV846J	Preclinical	tubulin polymerization inhibitor	
cathepsin-inhibitor-1	cathepsin-inhibitor-1	Cn1nc(cc1C(=O)N[C@@H](Cc1cccc(Cl)c1)C(=O)NCC#N)C(C)(C)C		Preclinical	cathepsin inhibitor	CTSB|CTSL|CTSV
CAY10505	CAY10505	Fc1ccc(cc1)-c1ccc(\C=C2\SC(=O)NC2=O)o1		Preclinical	PI3K inhibitor	PIK3CG
CB-03-01	CB-03-01|CORTEXOLONE 17.ALPHA.-PROPIONATE	CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)CO	XN7MM8XG2M	Phase 3	androgen receptor antagonist	AR
CB-10-277	CB-10-277	CN(C)\N=N\c1ccc(cc1)C(O)=O		Phase 1	DNA synthesis inhibitor	
CB-5083	CB-5083	Cc1cc2c(cccc2n1-c1nc2CCOCc2c(NCc2ccccc2)n1)C(N)=O		Phase 1	valosin-containing protein inhibitor	VCP
CB-839	CB-839	FC(F)(F)Oc1cccc(CC(=O)Nc2ccc(CCCCc3nnc(NC(=O)Cc4ccccn4)s3)nn2)c1		Phase 1/Phase 2	glutaminase inhibitor	GLS
CBS-1114	CBS-1114	N=C(NNc1ccccc1)c1ccccc1		Phase 1	lipoxygenase inhibitor	ALOX5
CC-115	CC-115	CCN1C(=O)CN=C2NC=C(N=C12)c1ccc(nc1C)-c1nnc[nH]1	FII75TFH5L	Phase 1	mTOR inhibitor|DNA protein kinase inhibitor	MTOR
CC-223	CC-223	CO[C@H]1CC[C@@H](CC1)N1C(=O)CNc2ncc(nc12)-c1ccc(nc1)C(C)(C)O	I8RA3543SY	Phase 1/Phase 2	mTOR inhibitor	MTOR
CC-401	CC-401	C(CN1CCCCC1)Oc1cccc(c1)-c1n[nH]c2ccc(cc12)-c1ncn[nH]1	NOE38VQA1W	Phase 1	JNK inhibitor	MAPK8
CC-930	CC-930|TANZISERTIB	O[C@H]1CC[C@@H](CC1)Nc1ncc2nc(Nc3c(F)cc(F)cc3F)n([C@H]3CCOC3)c2n1	M5O06306UO	Phase 2	JNK inhibitor	
CCG-50014	CCG-50014	Cc1ccc(cc1)-n1sc(=O)n(Cc2ccc(F)cc2)c1=O	RA72G28VE9	Preclinical	G protein signaling inhibitor	RGS4|RGS8
CCG-63802	CCG-63802	Cc1cccc(Oc2nc3c(C)cccn3c(=O)c2\C=C(/C#N)c2nc3ccccc3s2)c1	339BU4Y35U	Preclinical	G protein signaling inhibitor	RGS4
CCG-63808	CCG-63808	Cc1cccn2c1nc(Oc1ccc(F)cc1)c(\C=C(/C#N)c1nc3ccccc3s1)c2=O	SAU68994A6	Preclinical	G protein signaling inhibitor	RGS4
CCMI	CCMI|AVL-3288	Cc1cc(on1)C(=C/Nc1ccc(Cl)cc1)\C(=O)Nc1ccc(Cl)cc1	VA80VAX4WF	Preclinical	acetylcholine receptor allosteric modulator	CHRNA7
CCMQ	CCMQ	OC(=O)Cc1cc2ccccc2nc1C(O)=O		Preclinical	homoquinolinic acid binding inhibitor	
CCT018159	CCT018159|CCT-018159	CCc1cc(-c2n[nH]c(C)c2-c2ccc3OCCOc3c2)c(O)cc1O	55H1ZOI1NL	Preclinical	HSP inhibitor	HSP90AA1|HSP90AB1
CCT128930	CCT128930	NC1(Cc2ccc(Cl)cc2)CCN(CC1)c1ncnc2[nH]ccc12		Preclinical	AKT inhibitor	PKIA|PRKACA
CCT129202	CCT129202|CCT-129202	CN(C)c1ccc(cc1)-c1nc2c(N3CCN(CC(=O)Nc4nccs4)CC3)c(Cl)cnc2[nH]1	8N349V9Q27	Preclinical	Aurora kinase inhibitor	AURKA|AURKB|AURKC
CCT137690	CCT137690	CN1CCN(CC1)c1ccc(cc1)-c1nc2c(N3CCN(Cc4cc(C)on4)CC3)c(Br)cnc2[nH]1		Preclinical	Aurora kinase inhibitor	AURKA|AURKB|AURKC
CD-1530	CD-1530	OC(=O)c1ccc(cc1)-c1ccc2cc(O)c(cc2c1)C12CC3CC(CC(C3)C1)C2		Preclinical	retinoid receptor agonist	RARG
CD-437	CD-437	OC(=O)c1ccc2cc(ccc2c1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2		Preclinical	retinoid receptor agonist	RARG
CDBA	CDBA|BETADEX	OCC1OC2OC3C(CO)OC(OC4C(CO)OC(OC5C(CO)OC(OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(OC1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O	JV039JZZ3A	Phase 3		
CDK1-5-inhibitor	CDK1-5-inhibitor	Nc1n[nH]c2nc3ccccc3nc12		Preclinical	CDK inhibitor|glycogen synthase kinase inhibitor	CDK1|CDK5|GSK3B
CDK9-IN-6	CDK9-IN-6	COC[C@H](C)N[C@H]1CC[C@@H](CC1)Nc1cc(c(Cl)cn1)-c1cccc(NCC2(CCOCC2)C#N)n1		Preclinical	CDK inhibitor	CDK9
cebranopadol	cebranopadol|CEBRANOPADOL	CN(C)[C@]1(CC[C@@]2(CC1)OCCc1c2[nH]c2ccc(F)cc12)c1ccccc1	7GDW9S3GN3	Phase 3	opioid receptor agonist	OPRL1|OPRM1
cediranib	cediranib|CEDIRANIB	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1	NQU9IPY4K9	Phase 3	KIT inhibitor|VEGFR inhibitor	CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB
cedrol	cedrol|CEDROL	CC1CCC2C(C)(C)C3CC12CCC3(C)O	63ZM9703BO	Phase 2		
cedrol-(+)	cedrol-(+)|CEDROL	C[C@@H]1CC[C@H]2C(C)(C)[C@H]3C[C@@]12CC[C@@]3(C)O	63ZM9703BO	Phase 2	sedative	
cefaclor	cefaclor|CEFACLOR	N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1	69K7K19H4L	Launched	bacterial cell wall synthesis inhibitor	
cefadroxil	cefadroxil|CEFADROXIL	CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c1ccc(O)cc1)C2=O)C(O)=O	280111G160	Launched	bacterial cell wall synthesis inhibitor	SLC15A1|SLC15A2|SLC22A6|SLC22A8
cefalonium	cefalonium|CEFALONIUM	NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)Cc2cccs2)C3=O)C(O)=O)cc1	K2P920217W	Launched	bacterial cell wall synthesis inhibitor	
cefamandole	cefamandole|CEFAMANDOLE	Cn1nnnc1SCC1=C(N2C(SC1)C(NC(=O)C(O)c1ccccc1)C2=O)C(O)=O	5CKP8C2LLI	Launched	bacterial cell wall synthesis inhibitor	
cefamandole-nafate	cefamandole-nafate|CEFAMANDOLE NAFATE	Cn1nnnc1SCC1=C(N2C(SC1)C(NC(=O)C(OC=O)c1ccccc1)C2=O)C(O)=O	8HDO7941DO	Launched	bacterial cell wall synthesis inhibitor	
cefathiamidine	cefathiamidine|CEFATHIAMIDINE	CC(C)N\C(SCC(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)=N/C(C)C	8M7CAS5T8L	Launched	bacterial cell wall synthesis inhibitor	
cefazolin	cefazolin|CEFAZOLIN	Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn2cnnn2)C3=O)C(O)=O)s1	IHS69L0Y4T	Launched	bacterial cell wall synthesis inhibitor	PON1
cefcapene-pivoxil	cefcapene-pivoxil|CEFCAPENE PIVOXIL	CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1	8I8MJ56XFQ	Launched	bacterial cell wall synthesis inhibitor	
cefdinir	cefdinir|CEFDINIR	Nc1nc(cs1)C(=N\O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O	CI0FAO63WC	Launched	bacterial cell wall synthesis inhibitor	MPO
cefditoren-pivoxil	cefditoren-pivoxil|CEFDITOREN PIVOXIL	CO\N=C(/C(=O)NC1C2SCC(\C=C/c3scnc3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1	78THA212DH	Launched	bacterial cell wall synthesis inhibitor	
cefepime	cefepime|CEFEPIME	CO\N=C(\C(=O)NC1C2SCC(C[N+]3(C)CCCC3)=C(N2C1=O)C(O)=O)c1csc(N)n1	807PW4VQE3	Launched	bacterial cell wall synthesis inhibitor	
cefetamet	cefetamet|CEFETAMET	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(O)=O)c1csc(N)n1	4R5TV783X3	Launched	bacterial cell wall synthesis inhibitor	
cefetamet-pivoxil	cefetamet-pivoxil|CEFETAMET PIVOXIL	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1	F6XA85N260	Launched	bacterial cell wall synthesis inhibitor	
cefixime	cefixime|CEFIXIME	Nc1nc(cs1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O	97I1C92E55	Launched	bacterial cell wall synthesis inhibitor	
cefmenoxime	cefmenoxime|CEFMENOXIME	CO\N=C(\C(=O)NC1C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1csc(N)n1	KBZ4844CXN	Launched	bacterial cell wall synthesis inhibitor	
cefmetazole	cefmetazole|CEFMETAZOLE	CO[C@]1(NC(=O)CSCC#N)C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O	3J962UJT8H	Launched	bacterial cell wall synthesis inhibitor	
cefminox	cefminox|CEFMINOX	CO[C@]1(NC(=O)CSC[C@@H](N)C(O)=O)[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O	PW08Y13465	Launched	bacterial cell wall synthesis inhibitor	
cefodizime	cefodizime|CEFODIZIME	CO\N=C(\C(=O)NC1C2SCC(CSc3nc(C)c(CC(O)=O)s3)=C(N2C1=O)C(O)=O)c1csc(N)n1	Z31298J4HQ	Launched	bacterial cell wall synthesis inhibitor	
cefonicid	cefonicid|CEFONICID	O[C@@H](C(=O)NC1[C@H]2SCC(CSc3nnnn3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)c1ccccc1	6532B86WFG	Launched	bacterial cell wall synthesis inhibitor	
cefoperazone	cefoperazone|CEFOPERAZONE	CCN1CCN(C(=O)NC(C(=O)NC2C3SCC(CSc4nnnn4C)=C(N3C2=O)C(O)=O)c2ccc(O)cc2)C(=O)C1=O	7U75I1278D	Launched	bacterial cell wall synthesis inhibitor	
ceforanide	ceforanide|CEFORANIDE	NCc1ccccc1CC(=O)NC1C2SCC(CSc3nnnn3CC(O)=O)=C(N2C1=O)C(O)=O	8M1YF8951V	Launched	penicillin binding protein inhibitor	
cefoselis	cefoselis|CEFOSELIS	CO\N=C(\C(=O)N[C@@H]1[C@H]2SCC(Cn3ccc(=N)n3CCO)=C(N2C1=O)C(O)=O)c1csc(N)n1	0B50MLU3H1	Launched	bacterial cell wall synthesis inhibitor	
cefotaxime	cefotaxime|CEFOTAXIME	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)c1csc(N)n1	N2GI8B1GK7	Launched	bacterial cell wall synthesis inhibitor	
cefotetan	cefotetan|CEFOTETAN	CO[C@]1(NC(=O)C2SC(S2)=C(C(N)=O)C(O)=O)C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O	48SPP0PA9Q	Launched	bacterial cell wall synthesis inhibitor	
cefotiam	cefotiam|CEFOTIAM	CN(C)CCn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1csc(N)n1)C2=O)C(O)=O	91W6Z2N718	Launched	bacterial cell wall synthesis inhibitor	
cefotiam-cilexetil	cefotiam-cilexetil|CEFOTIAM HEXETIL	CC(OC(=O)OC1CCCCC1)OC(=O)C1=C(CSc2nnnn2CCN(C)C)CSC2C(NC(=O)Cc3csc(N)n3)C(=O)N12	J92A81Y99T	Launched	bacterial cell wall synthesis inhibitor	
cefoxitin	cefoxitin|CEFOXITIN	CO[C@]1(NC(=O)Cc2cccs2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O	6OEV9DX57Y	Launched	bacterial cell wall synthesis inhibitor	
cefozopran	cefozopran|CEFOZOPRAN	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccn4ncccc34)=C(N2C1=O)C(O)=O)c1nsc(N)n1	1LG87K28LW	Launched	bacterial cell wall synthesis inhibitor	
cefpiramide	cefpiramide|CEFPIRAMIDE	Cc1cc(O)c(cn1)C(=O)N[C@@H](C(=O)N[C@H]1C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1ccc(O)cc1	P936YA152N	Launched	bacterial cell wall synthesis inhibitor	
cefpirome	cefpirome|CEFPIROME	CO\N=C(\C(=O)N[C@H]1[C@H]2SCC(C[n+]3cccc4CCCc34)=C(N2C1=O)C(O)=O)c1csc(N)n1	S72Q2F09HY	Launched	bacterial cell wall synthesis inhibitor	
cefpodoxime	cefpodoxime|CEFPODOXIME	COCC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC)\c1csc(N)n1)C2=O)C(=O)OC(C)OC(=O)OC(C)C	7R4F94TVGY	Launched	bacterial cell wall synthesis inhibitor	
cefprozil	cefprozil|CEFPROZIL ANHYDROUS, (E)-|CEFPROZIL ANHYDROUS, (Z)-	C\C=C/C1=C(N2C(SC1)C(NC(=O)C(N)c1ccc(O)cc1)C2=O)C(O)=O	S1SDI2FJIY|W5T767OA4G	Launched	bacterial cell wall synthesis inhibitor	
cefradine	cefradine|CEPHRADINE ANHYDROUS	CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O	9YA6SX5S4D	Launched	bacterial cell wall synthesis inhibitor	CYP3A4
cefsulodin	cefsulodin|CEFSULODIN	NC(=O)c1cc[n+](CC2=C(N3C(SC2)C(NC(=O)C(c2ccccc2)S(O)(=O)=O)C3=O)C(O)=O)cc1	OV42LHE42B	Launched	bacterial cell wall synthesis inhibitor	
ceftaroline-fosamil	ceftaroline-fosamil|CEFTAROLINE FOSAMIL	CCO\N=C(\C(=O)N[C@H]1[C@H]2SCC(Sc3nc(cs3)-c3cc[n+](C)cc3)=C(N2C1=O)C(O)=O)c1nsc(NP(O)(O)=O)n1	7P6FQA5D21	Launched	bacterial cell wall synthesis inhibitor	
ceftazidime	ceftazidime|CEFTAZIDIME	CC(C)(O\N=C(/C(=O)N[C@H]1C2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O	9M416Z9QNR	Launched	bacterial cell wall synthesis inhibitor	
ceftibuten	ceftibuten|CEFTIBUTEN	Nc1nc(cs1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O	IW71N46B4Y	Launched	bacterial cell wall synthesis inhibitor	
ceftiofur	ceftiofur|CEFTIOFUR	CO\N=C(\C(=O)N[C@@H]1[C@H]2SCC(CSC(=O)c3ccco3)=C(N2C1=O)C(O)=O)c1csc(N)n1	83JL932I1C	Launched	bacterial cell wall synthesis inhibitor	
ceftizoxim	ceftizoxim|CEFTIZOXIME	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O)c1csc(N)n1	C43C467DPE	Launched	bacterial cell wall synthesis inhibitor	
ceftriaxone	ceftriaxone|CEFTRIAXONE	CO\N=C(\C(=O)N[C@H]1[C@H]2SCC(CSc3nc(=O)c(O)nn3C)=C(N2C1=O)C(O)=O)c1csc(N)n1	75J73V1629	Launched	bacterial cell wall synthesis inhibitor	
cefuroxime	cefuroxime|CEFUROXIME	CO\N=C(\C(=O)NC1C2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)c1ccco1	O1R9FJ93ED	Launched	bacterial cell wall synthesis inhibitor	
cefuroxime-axetil	cefuroxime-axetil|CEFUROXIME AXETIL	CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OC(C)OC(C)=O)c1ccco1	Z49QDT0J8Z	Launched	bacterial cell wall synthesis inhibitor	
celecoxib	celecoxib|CELECOXIB	Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	JCX84Q7J1L	Launched	cyclooxygenase inhibitor	CA12|PDPK1|PTGS2
celiprolol	celiprolol|CELIPROLOL	CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O	DRB57K47QC	Launched	adrenergic receptor antagonist	ADRA2A|ADRB1|ADRB2
centazolone	centazolone	Nn1cnc2cc3ccccc3cc2c1=O		Phase 1	monoamine oxidase inhibitor	
centpropazine	centpropazine	CCC(=O)c1ccc(OCC(O)CN2CCN(CC2)c2ccccc2)cc1		Phase 3	inositol monophosphatase inhibitor	
CEP-32496	CEP-32496	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(on4)C(C)(C)C(F)(F)F)c3)c2cc1OC	78I4VEX88N	Phase 1/Phase 2	RAF inhibitor	BRAF|RAF1
CEP-33779	CEP-33779	CN1CCN(CC1)c1cccc(Nc2nc3c(cccn3n2)-c2ccc(cc2)S(C)(=O)=O)c1		Preclinical	JAK inhibitor	JAK2
CEP-37440	CEP-37440	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3C[C@H](CCCc3c2OC)N2CCN(CCO)CC2)ncc1Cl	O3MNS8782H	Phase 1	ALK tyrosine kinase receptor inhibitor	ALK
cephalexin	cephalexin|CEPHALEXIN	CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c1ccccc1)C2=O)C(O)=O	OBN7UDS42Y	Launched	bacterial cell wall synthesis inhibitor	
cephalomannine	cephalomannine	C\C=C(/C)C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O)c1ccccc1		Preclinical	DNA polymerase inhibitor	
cephalosporin-c-zn	cephalosporin-c-zn	CC(=O)OCC1=C2N3C(SC1)[C@H](NC(=O)CCCC(N)C(=O)O[Zn]OC2=O)C3=O		Preclinical	bacterial cell wall synthesis inhibitor	
cephalothin	cephalothin|CEPHALOTHIN	CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1cccs1)C2=O)C(O)=O	R72LW146E6	Launched	bacterial cell wall synthesis inhibitor	
cephapirin	cephapirin|CEPHAPIRIN	CC(=O)OCC1=C(N2[C@@H](SC1)[C@H](NC(=O)CSc1ccncc1)C2=O)C(O)=O	89B59H32VN	Launched	bacterial cell wall synthesis inhibitor	
cepharanthine	cepharanthine|CEPHARANTHINE	COc1ccc2C[C@@H]3N(C)CCc4cc(OC)c(Oc5c6OCOc6cc6CCN(C)[C@H](Cc7ccc(Oc1c2)cc7)c56)cc34	7592YJ0J6T	Phase 2	NFkB pathway inhibitor	
cephradine	cephradine|CEPHRADINE ANHYDROUS	CC1=C(N2C(SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O	9YA6SX5S4D	Launched	bacterial cell wall synthesis inhibitor	
ceramide	ceramide|ERYTHRO-SPHINGOSINE, (+/-)-|SPHINGOSINE	CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(C)=O	0Y6SVQ612Q|NGZ37HRE42	Launched	phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator	
ceritinib	ceritinib|CERITINIB	CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1	K418KG2GET	Launched	ALK tyrosine kinase receptor inhibitor	ALK|FLT3|IGF1R|INSR|TSSK1B
cerulenin	cerulenin|CERULENIN	C\C=C\C\C=C\CCC(=O)[C@H]1O[C@H]1C(N)=O	MF286Y830Q	Launched	fatty acid synthase inhibitor	FASN
cetaben	cetaben|CETABEN	CCCCCCCCCCCCCCCCNc1ccc(cc1)C(O)=O	DTL5W0113X	Phase 2	cholesterol inhibitor|ACAT inhibitor	PPARA
cetilistat	cetilistat|CETILISTAT	CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1	LC5G1JUA39	Phase 3	triacylglycerol lipase inhibitor	PNLIP
cetirizine	cetirizine|CETIRIZINE	OC(=O)COCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1	YO7261ME24	Launched	histamine receptor antagonist	HRH1
cetrimonium	cetrimonium|CETRIMONIUM	CCCCCCCCCCCCCCCC[N+](C)(C)C	Z7FF1XKL7A	Launched		
cetrorelix	cetrorelix|CETRORELIX	CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O	OON1HFZ4BA	Launched	gonadotropin releasing factor hormone receptor antagonist	GNRHR|LHCGR
cetylpyridinium	cetylpyridinium|CETYLPYRIDINIUM	CCCCCCCCCCCCCCCC[n+]1ccccc1	CUB7JI0JV3	Launched		
cevimeline	cevimeline|CEVIMELINE	C[C@H]1O[C@]2(CS1)CN1CCC2CC1.C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1	K9V0CDQ56E	Launched	acetylcholine receptor agonist	CHRM1|CHRM3
cevipabulin	cevipabulin|CEVIPABULIN	CNCCCOc1cc(F)c(c(F)c1)-c1c(Cl)nc2ncnn2c1NC(C)C(F)(F)F	P14M0DWS2J	Phase 1	microtubule stimulant|tubulin polymerization inhibitor	TUBB
CF102	CF102|CF-102	CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)nc(Cl)nc12	Z07JR07J6C	Phase 2	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
CFM-1571	CFM-1571	COc1ccc(NC(=O)c2cc(OCCCN(C)C)nn2Cc2ccccc2)cc1	EE9FJW53Z2	Preclinical	guanylate cyclase activator	
CFM-2	CFM-2	COc1cc2CC(=O)NN=C(c3ccc(N)cc3)c2cc1OC		Preclinical	glutamate receptor antagonist	
CFTRinh-172	CFTRinh-172	OC(=O)c1ccc(cc1)\C=C1\SC(=S)N(C1=O)c1cccc(c1)C(F)(F)F		Preclinical	chloride channel blocker	CFTR
CG-400549	CG-400549	Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O	4X6T64D64X	Phase 2	FABI inhibitor	
CGH2466	CGH2466	Nc1nc(c(s1)-c1ccncc1)-c1ccc(Cl)c(Cl)c1		Preclinical	adenosine receptor antagonist	ADORA1|ADORA2B|ADORA3
CGK-733	CGK-733|DIPHENYL ACETAMIDOTRICHLOROETHYL FLUORONITROPHENYL THIOUREA	[O-][N+](=O)c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c2ccccc2)C(Cl)(Cl)Cl)ccc1F	L3DGZ99QYM	Preclinical	ATM kinase inhibitor|ATR kinase inhibitor	ATM|ATR
CGM097	CGM097	COc1cc2CC(=O)N([C@@H](c3ccc(Cl)cc3)c2cc1OC(C)C)c1ccc(cc1)N(C)C[C@H]1CC[C@@H](CC1)N1CCN(C)C(=O)C1		Phase 1	MDM inhibitor	MDM2
CGP-12177	CGP-12177	CC(C)(C)NCC(O)COc1cccc2[nH]c(O)nc12	R89UMZ82MJ	Phase 1	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
CGP-13501	CGP-13501	CC(C)(Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)C=O		Preclinical	GABA receptor modulator	GABBR1
CGP-20712A	CGP-20712A	Cn1cc(nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(c2)C(N)=O)cc1)C(F)(F)F	CNU8DA2K9J	Preclinical	adrenergic receptor antagonist	ADRB1|ADRB3
CGP-37157	CGP-37157	Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1		Preclinical	mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor	SLC8A1
CGP-37849	CGP-37849	C\C(CP(O)(O)=O)=C/C(N)C(O)=O	76IND1BS43	Phase 1	glutamate receptor antagonist	GRIN2A|GRIN2B|GRIN2C|GRIN2D
CGP-52411	CGP-52411|4,5-DIANILINOPHTHALIMIDE	O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc12	Z13D008FZ2	Preclinical	EGFR inhibitor	EGFR
CGP-53353	CGP-53353	Fc1ccc(Nc2cc3C(=O)NC(=O)c3cc2Nc2ccc(F)cc2)cc1		Preclinical	EGFR inhibitor|PKC inhibitor	EGFR|PRKCB
CGP-54626	CGP-54626	C[C@H](NC[C@H](O)CP(O)(=O)CC1CCCCC1)c1ccc(Cl)c(Cl)c1		Preclinical	GABA receptor antagonist	GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
CGP-55845	CGP-55845	C[C@H](NC[C@H](O)CP(O)(=O)Cc1ccccc1)c1ccc(Cl)c(Cl)c1		Preclinical	GABA receptor antagonist	GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
CGP-57380	CGP-57380	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		Preclinical	MAP kinase inhibitor	AURKB|LCK|MKNK1|MKNK2|SGK1
CGP-71683	CGP-71683|CGP-71683A FREE BASE	Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12	E4901JA9JD	Preclinical	neuropeptide receptor antagonist	NPY5R
CGP-78608	CGP-78608	C[C@@H](NCc1cc(Br)cc2[nH]c(=O)c(=O)[nH]c12)P(O)(O)=O		Preclinical	glutamate receptor antagonist	
CGP-7930	CGP-7930	CC(C)(CO)Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C		Preclinical	GABA receptor modulator	GABBR1
CGS-15943	CGS-15943	Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1		Preclinical	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
CGS-20625	CGS-20625	COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O	K9Q4R9S81O	Phase 1	benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6
CGS-21680	CGS-21680	CCNC(=O)[C@H]1O[C@H]([C@@H](O)[C@@H]1O)n1cnc2c(N)nc(NCCc3ccc(CCC(O)=O)cc3)nc12	T5HB1E831H	Preclinical	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
CGS-9896	CGS-9896	Clc1ccc(cc1)-n1[nH]c2c(cnc3ccccc23)c1=O	86PWQ4PVN0	Preclinical	GABA receptor antagonist	GABRA1|GABRB2|GABRG2
CH-170	CH-170	Cc1nc(Cn2cnc3n(C)c(=O)n(C)c(=O)c23)no1		Phase 1		
CH-5183284	CH-5183284|DEBIO-1347	Cc1nc2ccc(cc2[nH]1)-n1ncc(C(=O)c2cc3ccccc3[nH]2)c1N	NR9ZYH80Z8	Phase 1	fibroblast growth factor inhibitor	FGFR1|FGFR2|FGFR3
CH223191	CH223191|CH-223191	Cc1cc(ccc1NC(=O)c1ccnn1C)\N=N\c1ccccc1C	HYE7315Z4C	Preclinical	aryl hydrocarbon receptor antagonist	AHR
CH5132799	CH5132799|CH-5132799	CS(=O)(=O)N1CCc2c1nc(nc2-c1cnc(N)nc1)N1CCOCC1	JCL936W835	Phase 1	PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG
CH55	CH55	CC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)\C=C\c1ccc(cc1)C(O)=O		Preclinical	retinoid receptor binder	RARA|RARB
chenodeoxycholic-acid	chenodeoxycholic-acid|CHENODIOL|URSODIOL	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	0GEI24LG0J|724L30Y2QR	Launched	11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist	NR1H4
chenodiol	chenodiol|CHENODIOL|URSODIOL	C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C	0GEI24LG0J|724L30Y2QR	Launched	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1
CHF5074	CHF5074|CHF-5074	OC(=O)C1(CC1)c1ccc(c(F)c1)-c1ccc(Cl)c(Cl)c1	C35RF1MWQZ	Phase 2	gamma secretase modulator	PSEN1
chicago-sky-blue-6b	chicago-sky-blue-6b|DIRECT BLUE 1 ACID	COc1cc(ccc1\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O)-c1ccc(\N=N\c2ccc3c(cc(c(N)c3c2O)S(O)(=O)=O)S(O)(=O)=O)c(OC)c1	R1UJK1UY9R	Preclinical	glutamate inhibitor|macrophage migration inhibiting factor inhibitor	MIF
chidamide	chidamide|CHIDAMIDE	Nc1ccc(F)cc1NC(=O)c1ccc(CNC(=O)\C=C\c2cccnc2)cc1	87CIC980Y0	Launched	HDAC inhibitor	HDAC10|HDAC3
chiniofon	chiniofon|CHINIOFON	Oc1c(I)cc(c2cccnc12)S(O)(=O)=O	98F8Y85B6W	Launched	antiprotozoal agent	
CHIR-124	CHIR-124	Clc1ccc2[nH]c(=O)c(-c3nc4ccccc4[nH]3)c(N[C@@H]3CN4CCC3CC4)c2c1	5K64W8EU3E	Preclinical	CHK inhibitor	CHEK1
CHIR-98014	CHIR-98014	Nc1nc(NCCNc2ncc(c(n2)-c2ccc(Cl)cc2Cl)-n2ccnc2)ccc1[N+]([O-])=O		Preclinical	glycogen synthase kinase inhibitor	GSK3A|GSK3B
CHIR-99021	CHIR-99021	Cc1c[nH]c(n1)-c1cnc(NCCNc2ccc(cn2)C#N)nc1-c1ccc(Cl)cc1Cl	234CMT4GK4	Preclinical	glycogen synthase kinase inhibitor	CDK1|GSK3A|GSK3B|MAPK1
chloralose	chloralose|CHLORALOSE	OCC(O)[C@H]1O[C@@H]2O[C@@H](O[C@@H]2[C@H]1O)C(Cl)(Cl)Cl	238BZ29MUE	Preclinical		
chlorambucil	chlorambucil|CHLORAMBUCIL	OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl	18D0SL7309	Launched	DNA inhibitor	
chloramine-t	chloramine-t|CHLORAMINE-T TRIHYDRATE	Cc1ccc(cc1)S(=O)(=O)NCl	4IU6VSV0EI	Launched		
chloramphenicol	chloramphenicol|CHLORAMPHENICOL	OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O	66974FR9Q1	Launched	bacterial 50S ribosomal subunit inhibitor	CD55
chloramphenicol-palmitate	chloramphenicol-palmitate|CHLORAMPHENICOL PALMITATE	CCCCCCCCCCCCCCCC(=O)OC[C@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O	43VU4207NW	Launched	protein synthesis inhibitor	
chloramphenicol-sodium-succinate	chloramphenicol-sodium-succinate|CHLORAMPHENICOL SUCCINATE	O[C@@H]([C@@H](COC(=O)CCC(O)=O)NC(=O)C(Cl)Cl)c1ccc(cc1)[N+]([O-])=O	ZCX619U9A1	Launched	protein synthesis inhibitor	
chlorazanil	chlorazanil|CHLORAZANIL	Nc1ncnc(Nc2ccc(Cl)cc2)n1	48SN4K3W0E	Preclinical		
chlorcyclizine	chlorcyclizine|CHLORCYCLIZINE	CN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1	M26C4IP44P	Launched	histamine receptor antagonist	HRH1
chlorfenson	chlorfenson|CHLORFENSON	Clc1ccc(OS(=O)(=O)c2ccc(Cl)cc2)cc1	LW65NJ3YWV	Phase 2	other antifungal	
chlorhexidine	chlorhexidine|CHLORHEXIDINE	Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1	R4KO0DY52L	Launched	membrane integrity inhibitor	
chlorindanol	chlorindanol|CHLORINDANOL	Oc1ccc(Cl)c2CCCc12	7902N03BH0	Preclinical		
chlorindione	chlorindione|CLORINDIONE	Clc1ccc(cc1)C1C(=O)c2ccccc2C1=O	541C7WS64R	Preclinical		
chlorisondamine-diiodide	chlorisondamine-diiodide|CHLORISONDAMINE	C[N+](C)(C)CC[N+]1(C)Cc2c(C1)c(Cl)c(Cl)c(Cl)c2Cl	JD3M24F66I	Preclinical	acetylcholine receptor antagonist	CHRNA1
chlormadinone-acetate	chlormadinone-acetate|CHLORMADINONE ACETATE	CC(=O)O[C@@]1(CCC2C3C=C(Cl)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O	0SY050L61N	Launched	5 alpha reductase inhibitor	PGR
chlormezanone	chlormezanone|CHLORMEZANONE	CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O	GP568V9G19	Withdrawn	GABA receptor modulator	GABRA1|TSPO
chlormidazole	chlormidazole|CHLORMIDAZOLE	Cc1nc2ccccc2n1Cc1ccc(Cl)cc1	8IKK64FJVX	Launched	fungal lanosterol demethylase inhibitor	
chlorobutanol	chlorobutanol|CHLOROBUTANOL	CC(C)(O)C(Cl)(Cl)Cl	HM4YQM8WRC	Launched		
chlorocresol	chlorocresol|CHLOROCRESOL	Cc1cc(O)ccc1Cl	36W53O7109	Launched	ryanodine receptor activator	
chlorogenic-acid	chlorogenic-acid|CHLOROGENIC ACID	O[C@@H]1C[C@@](O)(C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@@H]1O)C(O)=O	318ADP12RI	Launched	antioxidant	SLC37A4
chlorophyllide-cu-complex-na-salt	chlorophyllide-cu-complex-na-salt	CCC1=C(C)C2=Cc3c(C=C)c(C)c4C=C5C(C)C(CCC(O)=O)C6=[N+]5[Cu]5(n34)n3c(=CC1=[N+]25)c(C)c(C(O)=O)c3=C6CC(O)=O		Preclinical		
chlorophyllin	chlorophyllin|PHYTOCHLORIN	CCc1c(C)c2cc3[nH]c(cc4nc([C@@H](CCC(O)=O)[C@@H]4C)c(CC(O)=O)c4nc(cc1[nH]2)c(C)c4C(O)=O)c(C)c3C=C	5S2CCF3T1Z	Preclinical		
chlorophyllin-copper	chlorophyllin-copper|COPPER CHLOROPHYLLIN A	CCC1=C(C)\C2=C\c3c(C=C)c(C)c4\C=C5/N=C(C(CCC(O)=O)C5C)/C(CC(O)=O)=c5/c(C(O)=O)c(C)/c(=C/C1=N/2)n5[Cu]n34	P7D7N8KA5A	Phase 1	cytochrome P450 inhibitor	
chloroprocaine	chloroprocaine|CHLOROPROCAINE	CCN(CC)CCOC(=O)c1ccc(N)cc1Cl	5YVB0POT2H	Launched	sodium channel blocker	ATP1A1|CHRNA10|GRIN3A|HTR3A|SCN10A|SLC6A3
chloropyramine	chloropyramine|CHLOROPYRAMINE	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1	2K3L8O9SOV	Launched	histamine receptor antagonist	HRH1
chloroquine	chloroquine|CHLOROQUINE	CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	886U3H6UFF	Launched	antimalarial agent	GSTA2|MRGPRX1|TLR9|TNF
chlorothiazide	chlorothiazide|CHLOROTHIAZIDE	NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O	77W477J15H	Launched	diuretic	CA1|CA2|CA4|SLC12A3
chlorothymol	chlorothymol|CHLOROTHYMOL	CC(C)c1cc(Cl)c(C)cc1O	LJ25TI0CVT	Launched		
chlorotrianisene	chlorotrianisene|CHLOROTRIANISENE	COc1ccc(cc1)C(Cl)=C(c1ccc(OC)cc1)c1ccc(OC)cc1	6V5034L121	Launched	estrogenic hormone	ESR1|ESR2
chloroxine	chloroxine|CHLOROXINE	Oc1c(Cl)cc(Cl)c2cccnc12	2I8BD50I8B	Launched	opioid receptor antagonist	OPRK1
chloroxoquinoline	chloroxoquinoline	Oc1ccnc2cc(Cl)ccc12		Launched		
chloroxylenol	chloroxylenol|CHLOROXYLENOL	Cc1cc(O)cc(C)c1Cl	0F32U78V2Q	Launched	ATP synthase inhibitor	
chlorphenamine	chlorphenamine|CHLORPHENIRAMINE	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1	3U6IO1965U	Launched	histamine receptor antagonist	HRH1|SLC6A2|SLC6A3|SLC6A4
chlorphenesin	chlorphenesin|CHLORPHENESIN	OCC(O)COc1ccc(Cl)cc1	I670DAL4SZ	Launched	muscle relaxant	
chlorphensin-carbamate	chlorphensin-carbamate|CHLORPHENESIN CARBAMATE	NC(=O)OCC(O)COc1ccc(Cl)cc1	57U5YI11WP	Preclinical	muscle relaxant	
chlorproguanil	chlorproguanil|CHLORPROGUANIL	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1	8O3249M729	Launched	dihydrofolate reductase inhibitor	DHFR
chlorpromazine	chlorpromazine|CHLORPROMAZINE	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc12	U42B7VYA4P	Launched	dopamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5
chlorpropamide	chlorpropamide|CHLORPROPAMIDE	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1	WTM2C3IL2X	Launched	ATP channel blocker	ABCC8|KCNJ10|KCNJ11
chlorpropham	chlorpropham|CHLORPROPHAM	CC(C)OC(=O)Nc1cccc(Cl)c1	0HBU04R8B0	Phase 1	antiviral	
chlorprothixene	chlorprothixene|CHLORPROTHIXENE	CN(C)CC\C=C1\c2ccccc2Sc2ccc(Cl)cc12	9S7OD60EWP	Launched	dopamine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C
chlorpyrifos	chlorpyrifos|CHLORPYRIFOS	CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl	JCS58I644W	Launched	acetylcholinesterase inhibitor	ACHE
chlorquinaldol	chlorquinaldol|CHLORQUINALDOL	Cc1ccc2c(Cl)cc(Cl)c(O)c2n1	D6VHC87LLS	Launched	other antibiotic	
chlortetracycline	chlortetracycline|CHLORTETRACYCLINE	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	WCK1KIQ23Q	Launched	protein synthesis inhibitor	
chlorthalidone	chlorthalidone|CHLORTHALIDONE	NS(=O)(=O)c1cc(ccc1Cl)C1(O)NC(=O)c2ccccc12	Q0MQD1073Q	Launched	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA4|CA7|SLC12A1|SLC12A3
chlorzoxazone	chlorzoxazone|CHLORZOXAZONE	Clc1ccc2oc(=O)[nH]c2c1	H0DE420U8G	Launched	bacterial 30S ribosomal subunit inhibitor	KCNMA1|KCNN4
cholecalciferol	cholecalciferol|CHOLECALCIFEROL	CC(C)CCCC(C)C1CCC2\C(CCCC12C)=C\C=C1\C[C@@H](O)CCC1=C	1C6V77QF41	Launched		VDR
cholesterol	cholesterol|CHOLESTEROL	CC(C)CCCC(C)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C	97C5T2UQ7J	Preclinical		RORA
cholic-acid	cholic-acid|CHOLIC ACID|URSOCHOLIC ACID	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	G1JO7801AE|MLP1T05RBX	Launched	bile acid	ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B
choline	choline|CHOLINE	C[N+](C)(C)CCO	N91BDP6H0X	Phase 3	acetylcholine precursor	ACHE|BCHE|CHRNA2|PCYT1A|PCYT1B|PHOSPHO1|PLD1|PLD2
choline-alfoscerate	choline-alfoscerate|CHOLINE ALFOSCERATE	C[N+](C)(C)CCOP(O)(=O)OC[C@H](O)CO	60M22SGW66	Launched	acetylcholine precursor	GM2A
CHPG	CHPG	NC(C(O)=O)c1cc(O)ccc1Cl		Preclinical	glutamate receptor agonist	GRM5
CHR-6494	CHR-6494	COc1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12		Preclinical	serine/threonine kinase inhibitor	GSG2
chromanol-(+/-)	chromanol-(+/-)	CCS(=O)(=O)N(C)[C@@H]1[C@@H](O)C(C)(C)Oc2ccc(cc12)C#N.CCS(=O)(=O)N(C)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N		Preclinical	potassium channel blocker	
chromocarb	chromocarb|CHROMOCARB	OC(=O)c1cc(=O)c2ccccc2o1	FY38S0790W	Launched	antispasmodic	
chrysin	chrysin|CHRYSIN	Oc1cc(O)c2c(c1)oc(cc2=O)-c1ccccc1	3CN01F5ZJ5	Phase 1	breast cancer resistance protein inhibitor	AKR1B1|CDK6|CYP19A1|CYP1B1
chrysophanic-acid	chrysophanic-acid|CHRYSOPHANIC ACID	Cc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1	N1ST8V8RR2	Preclinical	EGFR inhibitor	EGFR|MTOR
chuanxiongzine	chuanxiongzine|LIGUSTRAZINE	Cc1nc(C)c(C)nc1C	V80F4IA5XG	Phase 2		
CI-844	CI-844	O(c1ccccc1)c1cccnc1		Phase 2		
CI-923	CI-923	CCNC(C)CN1CCc2c(C1)c(=O)oc1ccccc21	PZS19MI6TT	Phase 1	acetylcholine receptor antagonist	
CI-966	CI-966	OC(=O)C1=CCCN(CCOC(c2ccc(cc2)C(F)(F)F)c2ccc(cc2)C(F)(F)F)C1	MGZ24EM59L	Phase 1	GAT inhibitor	SLC6A1
CI-976	CI-976|METHYL IODIDE	CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC	DAT010ZJSR	Phase 1	ACAT inhibitor	ACAT1|CES1
ciaftalan-zinc	ciaftalan-zinc	[Zn]1n2c3\N=C4/N=C(c5ccccc45)/N=c4\n1\c(=N/C1=N/C(c5ccccc15)=N\c2c1ccccc31)c1ccccc41		Phase 1	reactive oxygen species stimulant	
cianidanol	cianidanol|CIANIDANOL, (+/-)-|CIANIDANOL	O[C@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1	5J4Y243W61|8R1V1STN48	Withdrawn	fatty acid synthase inhibitor	PTGS1
cibenzoline	cibenzoline|CIFENLINE	C1C(=C2NCCN2)C1(c1ccccc1)c1ccccc1	Z7489237QT	Launched	sodium channel blocker	
ciclesonide	ciclesonide|CICLESONIDE	CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C)C1CCCCC1	S59502J185	Launched	glucocorticoid receptor agonist	NR3C1|SERPINA6
ciclopirox	ciclopirox|CICLOPIROX	Cc1cc(C2CCCCC2)n(O)c(=O)c1	19W019ZDRJ	Launched	membrane integrity inhibitor	ATP1A1
cicloprofen	cicloprofen|CICLOPROFEN	CC(C(O)=O)c1ccc-2c(Cc3ccccc-23)c1	325708J22C	Preclinical	cyclooxygenase inhibitor	PTGS1|PTGS2
CID-5458317	CID-5458317	O=C1c2ccccc2C(NC2CCCCC2)\C1=C/c1ccccc1		Preclinical	MAP kinase phosphatase inhibitor	MAPK3
cidofovir	cidofovir|CIDOFOVIR	Nc1ccn(C[C@@H](CO)OCP(O)(O)=O)c(=O)n1	JIL713Q00N	Launched	DNA polymerase inhibitor	
ciglitazone	ciglitazone|CIGLITAZONE	CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1	U8QXS1WU8G	Phase 2	PPAR receptor agonist	PPARG
cilastatin	cilastatin|CILASTATIN	CC1(C)C[C@@H]1C(=O)N\C(C(O)=O)=C/CCCCSC[C@@H](N)C(O)=O	141A6AMN38	Launched	dehydropeptidase inhibitor	DPEP1
cilazapril	cilazapril|CILAZAPRIL ANHYDROUS	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](N2C1=O)C(O)=O	8Q9454114Q	Launched	angiotensin converting enzyme inhibitor	ACE
cilengitide	cilengitide|CILENGITIDE	CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O	4EDF46E4GI	Phase 3	integrin antagonist	ITGAV|ITGB3
cilnidipine	cilnidipine|CILNIDIPINE	COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1	97T5AZ1JIP	Launched	calcium channel blocker	CACNA1B
cilomilast	cilomilast|CILOMILAST	COc1ccc(cc1OC1CCCC1)C1(CCC(CC1)C(O)=O)C#N	8ATB1C1R6X	Phase 3	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4D
cilostamide	cilostamide|CILOSTAMIDE	CN(C1CCCCC1)C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1	45S5605Q18	Preclinical	phosphodiesterase inhibitor	PDE3A|PDE3B
cilostazol	cilostazol|CILOSTAZOL	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1	N7Z035406B	Launched	phosphodiesterase inhibitor	PDE3A|PDE3B
cimaterol	cimaterol|CIMATEROL	CC(C)NCC(O)c1ccc(N)c(c1)C#N	ZPY8VRF0GB	Preclinical	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
cimetidine	cimetidine|CIMETIDINE	CN\C(NCCSCc1nc[nH]c1C)=N/C#N	80061L1WGD	Launched	histamine receptor antagonist	HRH2|SLC29A4|SLC47A1|SLC47A2
cimetropium	cimetropium|CIMETROPIUM	C[N+]1(CC2CC2)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1	1N3H74AYTK	Launched	acetylcholine receptor antagonist	CHRM1
cinacalcet	cinacalcet|CINACALCET	C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c1cccc2ccccc12	UAZ6V7728S	Launched	calcium channel activator	CASR
cinaciguat	cinaciguat|CINACIGUAT	OC(=O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(cc1)C(O)=O	59K0Y58UAD	Phase 2	guanylate cyclase activator	GUCY1A3|GUCY1B3
cinalukast	cinalukast|CINALUKAST	CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C2CCC2)c1)C(O)=O	5E1O433QAI	Phase 2	leukotriene receptor antagonist	CYSLTR1
cinanserin	cinanserin|CINANSERIN	CN(C)CCCSc1ccccc1NC(=O)\C=C\c1ccccc1	KI6J9OY7A3	Preclinical	serotonin receptor antagonist	HTR2A
cinchocaine	cinchocaine|DIBUCAINE	CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1	L6JW2TJG99	Launched	sodium channel blocker	CALM1|SCN10A|SCN5A
cinchonidine	cinchonidine|CINCHONIDINE	O[C@@H]([C@@H]1CC2CCN1C[C@@H]2C=C)c1ccnc2ccccc12	1U622LRA8Z	Phase 1	P glycoprotein inhibitor	
cinchonine	cinchonine|CINCHONINE	O[C@@H]([C@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)c1ccnc2ccccc12	V43X79NZCD	Preclinical	P glycoprotein inhibitor	CYP2D6
cinchophen	cinchophen|CINCHOPHEN	OC(=O)c1cc(nc2ccccc12)-c1ccccc1	39Y533Z02M	Launched	analgesic agent	
cinepazet	cinepazet|CINEPAZET	CCOC(=O)CN1CCN(CC1)C(=O)\C=C\c1cc(OC)c(OC)c(OC)c1	0LC95WWE9Q	Launched	vasodilator	
cinepazide	cinepazide|CINEPAZIDE	COc1cc(cc(OC)c1OC)\C=C\C(=O)N1CCN(CC(=O)N2CCCC2)CC1	67Y4P5C84X	Withdrawn	calcium channel activator	
cinflumide	cinflumide|CINFLUMIDE	Fc1cccc(c1)\C=C\C(=O)NC1CC1	F0XVL451MO	Phase 2	muscle relaxant	
cinnamaldehyde	cinnamaldehyde|CINNAMALDEHYDE	O=CC=Cc1ccccc1	SR60A3XG0F	Preclinical	aldose reductase inhibitor|TRPV agonist	TRPA1
cinnarazine	cinnarazine|CINNARIZINE	C(\C=C\c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1	3DI2E1X18L	Launched	calcium channel blocker	
cinoctramide	cinoctramide|CINOCTRAMIDE	COc1cc(cc(OC)c1OC)\C=C\C(=O)N1CCCCCCC1	69J8AO72Q3	Preclinical		
cinoxacin	cinoxacin|CINOXACIN	CCn1nc(C(O)=O)c(=O)c2cc3OCOc3cc12	LMK22VUH23	Launched	topoisomerase inhibitor	
cinoxate	cinoxate|CINOXATE	CCOCCOC(=O)\C=C\c1ccc(OC)cc1	5437O7N5BH	Launched		
cinromide	cinromide|CINROMIDE	CCNC(=O)\C=C\c1cccc(Br)c1	M197KE7A5N	Phase 3		
cintriamide	cintriamide|CINTRIAMIDE	COc1cc(cc(OC)c1OC)\C=C\C(N)=O	731Q8KH51G	Preclinical		
cipemastat	cipemastat|CIPEMASTAT	CN1C(=O)N(C[C@@H]([C@@H](CC2CCCC2)C(=O)N2CCCCC2)C(=O)NO)C(=O)C1(C)C	02HQ4TYQ60	Phase 3	metalloproteinase inhibitor	ADAM17|MMP1|MMP13|MMP2|MMP3|MMP8|MMP9
ciprofibrate	ciprofibrate|CIPROFIBRATE	CC(C)(Oc1ccc(cc1)C1CC1(Cl)Cl)C(O)=O	F8252JGO9S	Launched	PPAR receptor agonist	PPARA
ciprofloxacin	ciprofloxacin|CIPROFLOXACIN	OC(=O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O	5E8K9I0O4U	Launched	bacterial DNA gyrase inhibitor	TOP2A
ciproxifan	ciproxifan|CIPROXIFAN	O=C(C1CC1)c1ccc(OCCCc2c[nH]cn2)cc1	5EVQ7IRG99	Preclinical	histamine receptor antagonist	ADRA2A|ADRA2C|HRH3|HRH4|HTR3A
cirazoline	cirazoline|CIRAZOLINE	C(Oc1ccccc1C1CC1)C1=NCCN1	QK318GVY3Y	Preclinical	adrenergic receptor agonist	ADRA1A
cis-aconitic-acid	cis-aconitic-acid|ACONITIC ACID, (Z)-	OC(=O)C\C(=C\C(O)=O)C(O)=O	OF5471ZHRR	Preclinical		ACO2
cis-ACPD	cis-ACPD	N[C@]1(CC[C@@H](C1)C(O)=O)C(O)=O.N[C@@]1(CC[C@H](C1)C(O)=O)C(O)=O		Preclinical	glutamate receptor agonist	GRM2|GRM3|GRM6|GRM7|GRM8
cis-urocanic-acid	cis-urocanic-acid|UROCANIC ACID	OC(=O)\C=C\c1c[nH]cn1	G8D26XJJ3B	Phase 2	serotonin receptor agonist	HTR2A
cis-urocanic acid	cis-urocanic acid|UROCANIC ACID	OC(=O)\C=C\c1c[nH]cn1	G8D26XJJ3B	Phase 2	serotonin receptor agonist	HTR2A
cisapride	cisapride|CISAPRIDE	COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c1cc(Cl)c(N)cc1OC	UVL329170W	Withdrawn	serotonin receptor agonist	HTR2A|HTR3A|HTR4|KCNH2
cisplatin	cisplatin|CISPLATIN	N[Pt](N)(Cl)Cl	Q20Q21Q62J	Launched	DNA alkylating agent|DNA synthesis inhibitor	XIAP
citalopram	citalopram|CITALOPRAM	CN(C)CCCC1(OCc2cc(ccc12)C#N)c1ccc(F)cc1	0DHU5B8D6V	Launched	selective serotonin reuptake inhibitor (SSRI)	SLC6A2|SLC6A4
CITCO	CITCO|6-(4-CHLOROPHENYL)IMIDAZO(2,1-B)(1,3)THIAZOLE-5-CARBALDEHYDE O-(3,4-DICHLOROBENZYL)OXIME	Clc1ccc(cc1)-c1nc2sccn2c1\C=N\OCc1ccc(Cl)c(Cl)c1	D77H8321PB	Preclinical	constitutive androstane receptor (CAR) agonist	NR1I3
citicoline	citicoline|CITICOLINE	C[N+](C)(C)CCOP(O)(=O)OP(O)(=O)OC[C@H]1OC([C@H](O)[C@@H]1O)n1ccc(N)nc1=O	536BQ2JVC7	Launched	membrane permeability enhancer|glutathione transferase stimulant	ACHE|SLC1A2
citiolone	citiolone|CITIOLONE	CC(=O)NC1CCSC1=O	70JKL15MUH	Preclinical	lipotropic|mucolytic agent	
citric-acid	citric-acid|CITRIC ACID MONOHYDRATE	OC(=O)CC(O)(CC(O)=O)C(O)=O	2968PHW8QP	Preclinical	coagulation factor inhibitor	AKR1B1|ANG|APRT|BHMT|C8G|CA4|CPB1|CS|CTDSP1|GNMT|HGS|HS3ST3A1|IL4I1|ITPA|LSM6|MDH2|MIF|PDE5A|PKD2L1|PLEKHA1|RNASE1|RNASE3|SRC|TNFSF13B|UCK2
CK-636	CK-636	Cc1[nH]c2ccccc2c1CCNC(=O)c1cccs1		Preclinical	actin related protein inhibitor	ACTR2|ACTR3|ARPC1B|ARPC2|ARPC3|ARPC4|ARPC5
CKD-712	CKD-712	Oc1cc2CCNC(Cc3cccc4ccccc34)c2cc1O		Phase 1	NFkB pathway inhibitor	JAK2|STAT1
CL-218872	CL-218872	Cc1nnc2ccc(nn12)-c1cccc(c1)C(F)(F)F		Phase 1	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2
CL-225385	CL-225385	O=C(CC#N)c1ccccc1		Phase 2		
CL316243	CL316243|CL-316243 FREE DIACID	C[C@H](Cc1ccc2OC(Oc2c1)(C(O)=O)C(O)=O)NC[C@H](O)c1cccc(Cl)c1	52H8DB0TKX	Phase 2	adrenergic receptor agonist	ADRB3|UCP1|UCP2|UCP3
cladribine	cladribine|CLADRIBINE	Nc1nc(Cl)nc2n(cnc12)[C@H]1C[C@H](O)[C@@H](CO)O1	47M74X9YT5	Launched	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B
clarithromycin	clarithromycin|CLARITHROMYCIN	CC[C@H]1OC(=O)[C@H](C)[C@H](O[C@@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC	H1250JIK0A	Launched	bacterial 50S ribosomal subunit inhibitor	CYP3A4
clavulanate	clavulanate|CLAVULANIC ACID	OC\C=C1/O[C@@H]2CC(=O)N2[C@H]1C(O)=O	23521W1S24	Launched	beta lactamase inhibitor	
clebopride	clebopride|CLEBOPRIDE	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1	I0A84520Y9	Launched	dopamine receptor antagonist	ACHE|DRD2
clemastine	clemastine|CLEMASTINE	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1	95QN29S1ID	Launched	histamine receptor antagonist	HRH1
clemizole	clemizole|CLEMIZOLE	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc23)cc1	T97CB3796L	Launched	HCV inhibitor	
clenbuterol	clenbuterol|CLENBUTEROL	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1	XTZ6AXU7KN	Launched	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3|NGF|TNF
cleviprex	cleviprex|CLEVIDIPINE	CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC	19O2GP3B7Q	Launched	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1S
clevudine	clevudine|CLEVUDINE	Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@@H]2F)c(=O)[nH]c1=O	IN51MVP5F1	Launched	DNA polymerase inhibitor	
clidinium	clidinium|CLIDINIUM	C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c1ccccc1)c1ccccc1	BO76JF850N	Launched	acetylcholine receptor antagonist	CHRM1|CHRM3
climbazole	climbazole|CLIMBAZOLE	CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1	9N42CW7I54	Launched	enzyme inducer	
clinafloxacin	clinafloxacin|CLINAFLOXACIN	NC1CCN(C1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)C1CC1	8N86XTF9QD	Phase 3	bacterial DNA gyrase inhibitor	
clindamycin	clindamycin|CLINDAMYCIN	CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)C1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O	3U02EL437C	Launched	protein synthesis inhibitor	
clindamycin-palmitate	clindamycin-palmitate|CLINDAMYCIN PALMITATE	CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C1CC(CCC)CN1C)C(C)Cl	C501Z28AFG	Launched	bacterial 50S ribosomal subunit inhibitor	
clindamycin-phosphate	clindamycin-phosphate|CLINDAMYCIN PHOSPHATE	CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@@H]([C@H](C)Cl)[C@H]1O[C@@H](SC)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]1O	EH6D7113I8	Launched	protein synthesis inhibitor	
clinofibrate	clinofibrate|CLINOFIBRATE	CCC(C)(Oc1ccc(cc1)C1(CCCCC1)c1ccc(OC(C)(CC)C(O)=O)cc1)C(O)=O	0374EZJ8CU	Launched	lipase clearing factor inhibitor	LPL
clioquinol	clioquinol|CLIOQUINOL	Oc1c(I)cc(Cl)c2cccnc12	7BHQ856EJ5	Withdrawn	chelating agent	OPRK1
clobazam	clobazam|CLOBAZAM	CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)CC1=O	2MRO291B4U	Launched	GABA benzodiazepine site receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
clobenpropit	clobenpropit|CLOBENPROPIT	Clc1ccc(CNC(=N)SCCCc2c[nH]cn2)cc1	RKU631JF4H	Preclinical	histamine receptor antagonist	HRH1|HRH2|HRH3|HRH4
clobetasol-propionate	clobetasol-propionate|CLOBETASOL PROPIONATE	CCC(=O)O[C@@]1([C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl	779619577M	Launched	glucocorticoid receptor agonist	NR3C1|PLA2G1B
clobetasone-butyrate	clobetasone-butyrate|CLOBETASONE BUTYRATE	CCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]12C)C(=O)CCl	8U0H6XI6EO	Launched	corticosteroid agonist	NR3C1
clobutinol	clobutinol|CLOBUTINOL	CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1	1NY2IX043A	Withdrawn	antitussive	
clocortolone-pivalate	clocortolone-pivalate|CLOCORTOLONE PIVALATE	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C	QBL8IZH14X	Launched	steroid	NR3C1|PLA2G1B
clodronic-acid	clodronic-acid|CLODRONIC ACID	OP(O)(=O)C(Cl)(Cl)P(O)(O)=O	0813BZ6866	Launched	bone resorption inhibitor	SLC25A4|SLC25A5|SLC25A6
clofarabine	clofarabine|CLOFARABINE	Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	762RDY0Y2H	Launched	ribonucleotide reductase inhibitor	POLA1|POLD1|POLE|RRM1|RRM2|RRM2B
clofazimine	clofazimine|CLOFAZIMINE	CC(C)\N=c1/cc2n(-c3ccc(Cl)cc3)c3ccccc3nc2cc1Nc1ccc(Cl)cc1	D959AE5USF	Launched	GK0582 inhibitor	
clofedanol	clofedanol|CHLOPHEDIANOL	CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl	42C50P12AP	Launched	histamine receptor antagonist	HRH1
clofibrate	clofibrate|CLOFIBRATE	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1	HPN91K7FU3	Launched	PPAR receptor agonist	LPL|PPARA
clofibric-acid	clofibric-acid|CLOFIBRIC ACID	CC(C)(Oc1ccc(Cl)cc1)C(O)=O	53PF01Q249	Launched	PPAR receptor agonist	PPARA
clofilium	clofilium|CLOFILIUM	CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1	847G178BMC	Phase 2	potassium channel blocker	KCNA5|KCNH1
clofoctol	clofoctol|CLOFOCTOL	CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1	704083NI0R	Launched	protein synthesis inhibitor	
clomesone	clomesone|CLOMESONE	CS(=O)(=O)CS(=O)(=O)OCCCl	2J031W0YZI	Phase 1	DNA inhibitor	
clomethiazole	clomethiazole|CLOMETHIAZOLE	Cc1ncsc1CCCl	0C5DBZ19HV	Launched	GABA receptor antagonist|GABA receptor modulator	GABRA1
clomifene	clomifene|ZUCLOMIPHENE	CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)\c1ccccc1	3JU1DU3652	Launched	estrogen receptor antagonist	ESR1
clomipramine	clomipramine|CLOMIPRAMINE	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12	NUV44L116D	Launched	serotonin transporter (SERT) inhibitor	GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4
clonazepam	clonazepam|CLONAZEPAM	[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1	5PE9FDE8GB	Launched	GABA benzodiazepine site receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO
clonidine	clonidine|CLONIDINE	Clc1cccc(Cl)c1N=C1NCCN1	MN3L5RMN02	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
clonixin-lysinate	clonixin-lysinate|CLONIXIN LYSINE	NCCCC[C@H](N)C(O)=O.Cc1c(Cl)cccc1Nc1ncccc1C(O)=O	06PW4M190R	Launched	cyclooxygenase inhibitor	
clopamide	clopamide|CLOPAMIDE	CC1CCCC(C)N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O	17S83WON0I	Launched	sodium/chloride cotransporter inhibitor	
cloperastine	cloperastine|CLOPERASTINE	Clc1ccc(cc1)C(OCCN1CCCCC1)c1ccccc1	69M5L7BXEK	Launched	antitussive	
clopidogrel	clopidogrel|CLOPIDOGREL	COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl	A74586SNO7	Launched	purinergic receptor antagonist	P2RY12
clopidol	clopidol|CLOPIDOL	Cc1nc(C)c(Cl)c(O)c1Cl	8J763HFF5N	Launched		
cloprostenol-(+/-)	cloprostenol-(+/-)|CLOPROSTENOL|CLOPROSTENOL, (+)-	O[C@@H](COc1cccc(Cl)c1)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O	4208238832|52EJR3Y9IN	Launched	prostaglandin receptor agonist	PTGDR|PTGER1|PTGER3|PTGFR|TBXA2R
cloranolol	cloranolol|CLORANOLOL	CC(C)(C)NCC(O)COc1cc(Cl)ccc1Cl	Q3U058H86V	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
clorgiline	clorgiline|CLORGILINE	CN(CCCOc1ccc(Cl)cc1Cl)CC#C	LYJ16FZU9Q	Phase 2	monoamine oxidase inhibitor	MAOA
clorotepine	clorotepine|CLOROTEPINE	CN1CCN(CC1)C1Cc2ccccc2Sc2ccc(Cl)cc12	E65W20MU7A	Launched	dopamine receptor antagonist|adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR2C|HTR6
clorprenaline	clorprenaline|CLORPRENALINE	CC(C)NCC(O)c1ccccc1Cl	3W4327W76O	Launched	adrenergic receptor agonist	ADRB1|ADRB2
clorsulon	clorsulon|CLORSULON	Nc1cc(C(Cl)=C(Cl)Cl)c(cc1S(N)(=O)=O)S(N)(=O)=O	EG1ZDO6LRD	Launched	glycolysis inhibitor	
closantel	closantel|CLOSANTEL	Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O	EUL532EI54	Launched	chitinase inhibitor|NFkB pathway inhibitor	
clotiapine	clotiapine|CLOTHIAPINE	CN1CCN(CC1)C1=Nc2ccccc2Sc2ccc(Cl)cc12	Z05HCY0X1T	Launched		
clotrimazole	clotrimazole|CLOTRIMAZOLE	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1	G07GZ97H65	Launched	cytochrome P450 inhibitor|imidazoline receptor ligand	CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8
cloxacillin	cloxacillin|CLOXACILLIN	Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1Cl	O6X5QGC2VB	Launched	bacterial cell wall synthesis inhibitor	
cloxyquin	cloxyquin|CLOXYQUIN	Oc1ccc(Cl)c2cccnc12	BPF36H1G6S	Preclinical	potassium channel activator	KCNK18
clozapine	clozapine|CLOZAPINE	CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12	J60AR2IKIC	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7
CMPD-1	CMPD-1	Oc1ccc(NC(=O)CCCc2ccc(cc2)-c2ccccc2F)cc1		Preclinical	p38 MAPK inhibitor	GNRHR|MAPK14
CNQX	CNQX|6-CYANO-7-NITROQUINOXALINE-2,3-DIONE	[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C#N	6OTE87SCCW	Phase 1	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
CNX-2006	CNX-2006	COc1cc(NC2CN(CCF)C2)ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F		Preclinical	EGFR inhibitor	EGFR
CNX-774	CNX-774	CNC(=O)c1cc(Oc2ccc(Nc3ncc(F)c(Nc4cccc(NC(=O)C=C)c4)n3)cc2)ccn1		Preclinical	Bruton's tyrosine kinase (BTK) inhibitor	BTK
CO-101244	CO-101244	Cc1ccc(CC2(O)CCN(CCOc3ccc(O)cc3)CC2)cc1	Q85IYK36S4	Preclinical	glutamate receptor antagonist	GRIN2B
co-102862	co-102862|CO-102862	NC(=O)N\N=C\c1ccc(Oc2ccc(F)cc2)cc1	0KN11H90GF	Phase 1		SCN4A|SCN9A
cobicistat	cobicistat|COBICISTAT	CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1	LW2E03M5PG	Launched	cytochrome P450 inhibitor	CYP3A4|CYP3A43|CYP3A5|CYP3A7
cobimetinib	cobimetinib|COBIMETINIB	OC1(CN(C1)C(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F)[C@@H]1CCCCN1	ER29L26N1X	Launched	MEK inhibitor	
coenzyme-a	coenzyme-a|COENZYME A	CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)n1cnc2c(N)ncnc12)[C@@H](O)C(=O)NCCC(=O)NCCS	SAA04E81UX	Launched		ACAT2|CRAT|CS|DBI|HMGCR|KAT2A|KAT2B|KAT5
coenzyme-i	coenzyme-i|NADIDE	NC(=O)C1=CN(C=CC1)[C@H]1O[C@@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@H](O)[C@@H]1O	0U46U6E8UK	Phase 2		AASS|ACADS|ADH1A|ADH1B|ADH1C|ADH4|ADH5|ADH7|AKR1B1|AKR1C1|AKR1C2|AKR1C3|AKR1C4|ALDH1A1|ALDH1A2|ALDH1A3|ALDH1B1|ALDH2|ALDH3A1|ALDH3A2|ALDH3B1|ALDH3B2|ALDH4A1|ALDH5A1|ALDH6A1|ALDH7A1|ALDH9A1|AMT|BDH1|BLVRA|BLVRB|CDO1|CYB5R3|CYP17A1|CYP4A11|DHCR7|DHFR|DLAT|DLD|EHHADH|GAPDH|GAPDHS|GLUD1|GLUD2|GPD1|GSR|H6PD|HADH|HADHA|HIBADH|HMGCR|HMOX1|HMOX2|HPGD|HSD11B1|HSD11B2|HSD17B1|HSD17B10|HSD17B2|HSD17B3|HSD17B4|HSD17B7|HSD17B8|HSD3B1|HSD3B2|IDH3A|IDH3B|IDH3G|IMPDH1|IMPDH2|LDHA|LDHAL6A|LDHAL6B|LDHB|LDHC|MDH1|MDH2|ME1|ME2|ME3|MSMO1|MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|MTHFD1|MTHFD2|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFB1|NDUFB10|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3|NNT|NQO2|NSDHL|OGDH|PDHA1|PDHA2|PDHB|PHGDH|PYCR1|PYCR2|QDPR|RDH5|SORD|TSTA3|TYR|UGDH
coenzyme-q10	coenzyme-q10|UBIDECARENONE	COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O	EJ27X76M46	Launched		
colchicine	colchicine|COLCHICINE	COc1cc2CCC(NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC	SML2Y3J35T	Launched	microtubule inhibitor	GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
colesevalam	colesevalam	0		Preclinical		
colforsin	colforsin|COLFORSIN	CC(=O)O[C@H]1[C@@H](O)C2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C	1F7A44V6OU	Phase 2	adenylyl cyclase activator	ADCY2|ADCY5
colforsin-daproate	colforsin-daproate|COLFORSIN DAROPATE	CN(C)CCC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C	1196KQZ976	Launched	adenylyl cyclase activator	
colfosceril-palmitate	colfosceril-palmitate|COLFOSCERIL PALMITATE	CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC	319X2NFW0A	Launched	pulmonary surfactant	
colistimethate	colistimethate	CCC(C)C1NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNCS(O)(=O)=O)NC1=O)C(C)O)NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)CCCCC(C)C)C(C)O)C(C)CC		Launched	bacterial permeability inducer	
colistin	colistin	CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O		Launched	bacterial permeability inducer	
colistin-b-sulfate	colistin-b-sulfate|COLISTIN B	CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)C(CCN)NC1=O)C(C)O	B142O7Y03E	Launched	bacterial permeability inducer	
colistin-sulfate	colistin-sulfate	CCC(C)C1NC(=O)C(NC(=O)C(CCN)NC(=O)C(CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC1=O)C(C)O)NC(=O)C(CCN)NC(=O)C(NC(=O)C(CCN)NC(=O)CCCCC(C)C)C(C)O)C(C)CC		Launched	bacterial permeability inducer	
combretastatin-A-4	combretastatin-A-4|COMBRESTATIN A4	COc1ccc(cc1O)\C=C/c1cc(OC)c(OC)c(OC)c1	16U6OP69RQ	Phase 2	tubulin polymerization inhibitor	
compound-401	compound-401	O=c1cc(nc2c3ccccc3ccn12)N1CCOCC1		Preclinical	DNA dependent protein kinase inhibitor	MTOR|PRKDC
compound-58112	compound-58112	COc1cccc(CN2C[Si](C)(C)O[Si](C)(C)C2)c1		Preclinical		
compound-w	compound-w|SALICYLIC ACID	OC(=O)c1cc(Oc2ccc(cc2)[N+]([O-])=O)cc(Oc2ccc(cc2)[N+]([O-])=O)c1	O414PZ4LPZ	Preclinical	beta-secretase inhibitor	BACE1
conivaptan	conivaptan|CONIVAPTAN	Cc1nc2CCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc3-c2[nH]1	0NJ98Y462X	Launched	vasopressin receptor antagonist	AVPR1A|AVPR2
copanlisib	copanlisib|COPANLISIB	COc1c(OCCCN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cnc(N)nc3)=Nc12	WI6V529FZ9	Phase 3	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
copper-histidine	copper-histidine|COPPER HISTIDINE	N[C@H](Cc1c[nH]cn1)C(O)=O	9078K3MO9U	Phase 3		HAL|HARS|HDC|SLC15A3|SLC15A4|SLC38A3|SLC38A5
cordycepin	cordycepin|CORDYCEPIN	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)C[C@H]1O	GZ8VF4M2J8	Phase 1/Phase 2	DNA inhibitor	
corosolic-acid	corosolic-acid|COROSOLIC ACID	C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O	AMX2I57A98	Phase 2	PKC inhibitor|protein tyrosine kinase inhibitor	HSD11B1|PTPN1
corticosterone	corticosterone|CORTICOSTERONE	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO	W980KJ009P	Preclinical	mineralocorticoid receptor agonist	HSD11B1|NCOA1|NR3C2
cortisone	cortisone|CORTISONE	C[C@]12CC(=O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)CO	V27W9254FZ	Launched	glucocorticoid receptor agonist	NR3C1
cortisone-acetate	cortisone-acetate|CORTISONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3C(=O)C[C@]12C	883WKN7W8X	Launched	glucocorticoid receptor agonist	NR3C1
cortodoxone	cortodoxone|CORTODOXONE	CC12CCC3C(CCC4=CC(=O)CCC34C)C1CC[C@]2(O)C(=O)CO	WDT5SLP0HQ	Phase 3	androgen receptor antagonist	AR
costunolide	costunolide|COSTUNOLIDE	C\C1=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]2CC1	4IK578SA7Z	Preclinical	telomerase inhibitor	
cot-inhibitor-1	cot-inhibitor-1	Fc1ccc(Nc2c(cnc3c(Cl)cc(NCc4cn(CCN5CCCCCC5)nn4)cc23)C#N)cc1Cl		Preclinical	MAPK-interacting kinase inhibitor	MAP3K8
cot-inhibitor-2	cot-inhibitor-2	CCN1CCC(CC1)n1cc(CNc2cc(Cl)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)nn1		Preclinical	MAPK-interacting kinase inhibitor	MAP3K8
cotinine	cotinine|COTININE	CN1[C@@H](CCC1=O)c1cccnc1	K5161X06LL	Phase 2	nicotine metabolite	
coumarin	coumarin|COUMARIN	O=c1ccc2ccccc2o1	A4VZ22K1WT	Launched	vitamin K antagonist	CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP2A6
coumophos	coumophos|COUMAPHOS	CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1	L08SZ5Z5JC	Preclinical	cholinesterase inhibitor	
CP-339818	CP-339818	CCCCCN=c1ccn(Cc2ccccc2)c2ccccc12		Preclinical	potassium channel blocker	KCNA3
CP-376395	CP-376395	CCC(CC)Nc1cc(C)nc(Oc2c(C)cc(C)cc2C)c1C	5113G7FP34	Phase 1	corticosteroid releasing factor receptor antagonist	CRHR1
CP-532623	CP-532623	CC[C@@H]1C[C@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(C)=O)c2cc(ccc2N1C(=O)OC(C)C)C(F)(F)F	5KK52HG8DY	Phase 1	cholesteryl ester transfer protein inhibitor	CETP
CP-640186	CP-640186	O=C([C@@H]1CCCN(C1)C1CCN(CC1)C(=O)c1c2ccccc2cc2ccccc12)N1CCOCC1	04L1E4J3ZT	Preclinical	acetyl-CoA carboxylase inhibitor	ACACA|ACACB
CP-673451	CP-673451	COCCOc1ccc2n(cnc2c1)-c1ccc2cccc(N3CCC(N)CC3)c2n1	0AM0WWD90A	Preclinical	PDGFR tyrosine kinase receptor inhibitor	KIT|PDGFRA|PDGFRB
CP-724714	CP-724714	COCC(=O)NC\C=C\c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1	I05QZ0S4V3	Phase 2	EGFR inhibitor|protein tyrosine kinase inhibitor	ERBB2
CP-91149	CP-91149	CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1	O8EV00W45A	Preclinical	glycogen phosphorylase inhibitor	PYGL
CP-93129	CP-93129	O=c1ccc2[nH]cc(C3=CCNCC3)c2[nH]1		Preclinical	serotonin receptor agonist	HTR1A
CP-94253	CP-94253	CCCOc1ccc2[nH]cc(C3=CCNCC3)c2n1		Preclinical	serotonin receptor agonist	HTR1B
CPA-inhibitor	CPA-inhibitor	ON(CC(Cc1ccccc1)C(O)=O)C(=O)Cc1ccccc1		Preclinical	carboxypeptidase inhibitor	CPA1|CPA2
CPCCOEt	CPCCOEt	CCOC(=O)C12CC1\C(=N/O)c1ccccc1O2		Preclinical	glutamate receptor antagonist	GRM1
CPI-0610	CPI-0610	Cc1noc2[C@H](CC(N)=O)N=C(c3ccc(Cl)cc3)c3ccccc3-c12		Phase 1	bromodomain inhibitor	BRD4
CPI-1189	CPI-1189|CP1-1189	CC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C	9JX1L8VH4Z	Phase 2	tumor necrosis factor release inhibitor	TNF
CPI-169	CPI-169	CCS(=O)(=O)N1CCC(CC1)[C@@H](C)n1c(C)c(C(=O)NCc2c(OC)cc(C)[nH]c2=O)c2ccccc12		Preclinical	histone lysine methyltransferase inhibitor	EZH2
CPI-203	CPI-203	Cc1sc-2c(c1C)C(=N[C@@H](CC(N)=O)c1nnc(C)n-21)c1ccc(Cl)cc1		Preclinical	bromodomain inhibitor	BRD4
CPI-360	CPI-360	COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCOCC2)c2ccccc12		Preclinical	histone lysine methyltransferase inhibitor	EZH2
CPI-613	CPI-613	OC(=O)CCCCC(CCSCc1ccccc1)SCc1ccccc1	E76113IR49	Phase 2	pyruvate dehydrogenase inhibitor	PDHA1
CPP	CPP|MK-212	OC(=O)C1CN(CCCP(O)(O)=O)CCN1	62C3N7238U	Phase 2	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
CR8-(R)	CR8-(R)	CC[C@H](CO)Nc1nc(NCc2ccc(cc2)-c2ccccn2)c2ncn(C(C)C)c2n1		Preclinical	CDK inhibitor	CCNA2
creatine	creatine|CREATINE	CN(CC(O)=O)C(N)=N	MU72812GK0	Launched		CKB|CKM|CKMT1A|CKMT2|GAMT|SLC6A8
creatinine	creatinine|CREATININE	CN1CC(=O)NC1=N	AYI8EX34EU	Preclinical		
creatinol-phosphate	creatinol-phosphate|CREATINOLFOSFATE	CN(CCOP(O)(O)=O)C(N)=N	5O564RN1QD	Launched		
crenolanib	crenolanib|CRENOLANIB	CC1(COc2ccc3n(cnc3c2)-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1	LQF7I567TQ	Phase 2	PDGFR tyrosine kinase receptor inhibitor	CSF1R|FLT3|KIT|PDGFRA|PDGFRB
cresol	cresol|PARA-CRESOL	Cc1ccc(O)cc1	1MXY2UM8NV	Launched		
cresopirine	cresopirine|CRESOPIRINE	CC(=O)Oc1c(C)cccc1C(O)=O	2G83E641HZ	Preclinical		
cridanimod	cridanimod|CRIDANIMOD	OC(=O)Cn1c2ccccc2c(=O)c2ccccc12	X91E9EME19	Launched	progesterone receptor agonist	PGR
crisaborole	crisaborole|CRISABOROLE	OB1OCc2cc(Oc3ccc(cc3)C#N)ccc12	Q2R47HGR7P	Phase 3	phosphodiesterase inhibitor	PDE4B
crizotinib	crizotinib|CRIZOTINIB	C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl	53AH36668S	Launched	ALK tyrosine kinase receptor inhibitor	ALK|MET
crizotinib-(S)	crizotinib-(S)|CRIZOTINIB	CC(Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl	53AH36668S	Preclinical	MTH1 inhibitor	NUDT1
croconazole	croconazole|CROCONAZOLE	Clc1cccc(COc2ccccc2C(=C)n2ccnc2)c1	446254H55G	Launched	bacterial cell wall synthesis inhibitor	
cromoglicic-acid	cromoglicic-acid|CROMOLYN	OC(COc1cccc2oc(cc(=O)c12)C(O)=O)COc1cccc2oc(cc(=O)c12)C(O)=O	Y0TK0FS77W	Launched	immunosuppressant	KCNMA1|S100P
crotamiton	crotamiton|CROTAMITON, (E)-	CCN(C(=O)\C=C\C)c1ccccc1C	2EEH27851Y	Launched	antipruritic	
CRT0044876	CRT0044876	OC(=O)c1cc2cccc([N+]([O-])=O)c2[nH]1		Preclinical		
cryptotanshinone	cryptotanshinone|CRYPTOTANSHINONE	C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)C	5E9SXT166N	Preclinical	acetylcholinesterase inhibitor|STAT inhibitor	STAT3
crystal-violet	crystal-violet|GENTIAN VIOLET	CN(C)c1ccc(cc1)C(c1ccc(cc1)N(C)C)=C1C=CC(C=C1)=[N+](C)C	J4Z741D6O5	Launched	other antibiotic	
CS-110266	CS-110266	C1CCN(CC1)C1(CCCCC1)c1cc2ccccc2s1		Preclinical	dopamine receptor agonist	SLC6A3
CS-917	CS-917	CC(C)Cc1sc(N)nc1-c1ccc(o1)P(O)(O)=O		Phase 2	fructose biphosphate inhibitor	FBP1
CT-7758	CT-7758|ZAURATEGRAST	OC(=O)[C@H](Cc1ccc(Nc2nccc3ccncc23)cc1)NC1=C(Br)C(=O)C11CCCCC1	06A0IC74I3	Phase 2	integrin antagonist	ITGA4
CTEP	CTEP	Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(OC(F)(F)F)cc1		Preclinical	glutamate receptor antagonist	GRM5
CTS-1027	CTS-1027	ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1	2QD3F58224	Phase 2	metalloproteinase inhibitor	MMP1|MMP13|MMP2|MMP3|MMP9
CTS21166	CTS21166	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)C(C)C)[C@@H](O)C[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O		Phase 1	beta-secretase inhibitor	BACE1
CUDC-101	CUDC-101	COc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCCCCCC(=O)NO	1A7Y9MP123	Phase 1	EGFR inhibitor	EGFR|ERBB2
CUDC-427	CUDC-427|GDC-0917	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)Nc1sc(nc1-c1ccccc1)-c1ncco1	KWH46ZDG32	Phase 1	apoptosis inhibitor	XIAP
CUDC-907	CUDC-907	COc1ccc(cn1)-c1nc(N2CCOCC2)c2sc(CN(C)c3ncc(cn3)C(=O)NO)cc2n1	3S9RX35S5X	Phase 2	PI3K inhibitor	HDAC2|PIK3R1
CUR-61414	CUR-61414	COc1cccc(CN([C@H]2C[C@H](N(Cc3ccc4OCOc4c3)C2)C(=O)N2CCNCC2)C(=O)CC(C)(C)C)c1		Phase 1	smoothened receptor antagonist	DHH|IHH|SMO
curcumin	curcumin|CURCUMIN	COc1cc(ccc1O)\C=C\C(=O)CC(=O)\C=C\c1ccc(O)c(OC)c1	IT942ZTH98	Launched	cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor	APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH
curcumol	curcumol|CURCUMOL	CC(C)[C@@H]1C[C@@]23O[C@]1(O)CC(=C)[C@@H]2CC[C@H]3C	9190RTN07X	Phase 1	JAK inhibitor	JAK1|JAK2|JAK3
cutamesine	cutamesine|CUTAMESINE	COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC	9J7A4144BX	Phase 2	sigma receptor agonist	SIGMAR1
CV-1808	CV-1808|2-PHENYLAMINOADENOSINE	Nc1nc(Nc2ccccc2)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	K40I59G1EF	Preclinical	adenosine receptor agonist	ADORA2A
CVT-10216	CVT-10216	CS(=O)(=O)Nc1ccc(cc1)-c1coc2cc(OCc3cccc(c3)C(O)=O)ccc2c1=O	F9H432757X	Phase 1	aldehyde dehydrogenase inhibitor	ALDH2
CX-4945	CX-4945|SILMITASERTIB SODIUM	OC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21	N1E607PU86	Phase 1/Phase 2	casein kinase inhibitor	CSNK2A1|CSNK2A2|DAPK3|HIPK3
CX-516	CX-516|CX516	O=C(N1CCCCC1)c1ccc2OCOc2c1	Z5QU38B4V9	Phase 2/Phase 3	glutamate receptor modulator	
CX-5461	CX-5461	CN1CCCN(CC1)c1ccc2c(n1)n1c3ccccc3sc1c(C(=O)NCc1cnc(C)cn1)c2=O	3R4C5YLB9I	Phase 1	RNA polymerase inhibitor	
CY208-243	CY208-243	CN1Cc2ccccc2[C@H]2[C@H]1Cc1c[nH]c3cccc2c13		Phase 2	dopamine receptor agonist	CALY
cyacetacide	cyacetacide|CYACETACIDE	NNC(=O)CC#N	40H59YCS67	Preclinical		
cyamemazine	cyamemazine|CYAMEMAZINE	CC(CN(C)C)CN1c2ccccc2Sc2ccc(cc12)C#N	A2JGV5CNU4	Launched	serotonin receptor antagonist	HTR1A|HTR2A|HTR2C|HTR7
cyanocobalamin	cyanocobalamin	C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(C)=C4/N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]4CCC(N)=O)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12		Launched	methylmalonyl CoA mutase stimulant|vitamin B	MMAA|MMACHC|MTHFR|MTR|MTRR|MUT
cyanopindolol	cyanopindolol|CYANOPINDOLOL	CC(C)(C)NCC(O)COc1cccc2[nH]c(cc12)C#N	4K0SD5SNFS	Phase 2	adrenergic receptor antagonist	ADRB1|HTR1A|HTR1D
CYC116	CYC116	Cc1nc(N)sc1-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1		Phase 1	Aurora kinase inhibitor	AURKA|AURKB|KDR
cyclamic-acid	cyclamic-acid|CYCLAMIC ACID	OS(=O)(=O)NC1CCCCC1	HN3OFO5036	Preclinical		
cyclandelate	cyclandelate|CYCLANDELATE	CC1CC(CC(C)(C)C1)OC(=O)C(O)c1ccccc1	4139O1OAY2	Launched	calcium channel blocker	CACNA2D1|CES1
cyclic-AMP	cyclic-AMP|ADENOSINE CYCLIC PHOSPHATE	Nc1ncnc2n(cnc12)C1OC2COP(O)(=O)OC2C1O	E0399OZS9N	Preclinical		CNGA3|HCN2|PRKAR1A|PRKAR2B|TRPM7
cyclizine	cyclizine|CYCLIZINE	CN1CCN(CC1)C(c1ccccc1)c1ccccc1	QRW9FCR9P2	Launched	histamine receptor modulator	HRH1|SULT1E1
cyclobenzaprine	cyclobenzaprine|CYCLOBENZAPRINE	CN(C)CCC=C1c2ccccc2C=Cc2ccccc12	69O5WQQ5TI	Launched	adrenergic receptor agonist|serotonin receptor agonist	HTR2A
cyclocreatine	cyclocreatine|CYCLOCREATINE	OC(=O)CN1CCNC1=N	6732XGX1RK	Phase 1	creatine kinase substrate	
cyclocytidine	cyclocytidine|ANCITABINE	OC[C@H]1O[C@@H]2[C@H](Oc3nc(=N)ccn23)[C@H]1O	DO2D32W0VC	Preclinical	DNA synthesis inhibitor|RNA synthesis inhibitor	
cycloheximide	cycloheximide|CYCLOHEXIMIDE	C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC1CC(=O)NC(=O)C1	98600C0908	Preclinical	protein synthesis inhibitor	RPL3
cyclopenthiazide	cyclopenthiazide|CYCLOPENTHIAZIDE, (-)-|CYCLOPENTHIAZIDE, (+)-|CYCLOPENTHIAZIDE	NS(=O)(=O)c1cc2c(NC(CC3CCCC3)NS2(=O)=O)cc1Cl	866GEV195O|T7817XC41U|VX4S2N85F5	Launched	thiazide diuretic	
cyclopentolate	cyclopentolate|CYCLOPENTOLATE	CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1	I76F4SHP7J	Launched	acetylcholine receptor antagonist	CHRM1
cyclophosphamide	cyclophosphamide|CYCLOPHOSPHAMIDE	ClCCN(CCCl)P1(=O)NCCCO1	8N3DW7272P	Launched	DNA alkylating agent	CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7
cyclopiazonic-acid	cyclopiazonic-acid|CYCLOPIAZONIC ACID	CC(=O)C1C(=O)[C@@H]2[C@@H]3[C@@H](Cc4cccc5[nH]cc3c45)C(C)(C)N2C1=O	X9TLY4580Z	Preclinical	ATPase inhibitor	ATP2A1
cycloserine-(d)	cycloserine-(d)|CYCLOSERINE	N[C@@H]1CONC1=O	95IK5KI84Z	Launched	bacterial cell wall synthesis inhibitor	GRIN1
cyclosporin-a	cyclosporin-a|CYCLOSPORINE	CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	83HN0GTJ6D	Launched	calcineurin inhibitor	PPP3CA
cyclosporine	cyclosporine|CYCLOSPORINE	CCC1NC(=O)C([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	83HN0GTJ6D	Launched	calcineurin inhibitor	ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3
cyclothiazide	cyclothiazide|CYCLOTHIAZIDE	NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2C[C@@H]3C[C@H]2C=C3)cc1Cl	P71U09G5BW	Launched	glutamate receptor modulator	CA1|CA2|CA4|FXYD2|GRIA1|GRIA2|GRIA3|GRIA4|SLC12A3
cyclovalone	cyclovalone|CYCLOVALONE	COc1cc(ccc1O)\C=C1/CCC\C(C1=O)=C/c1ccc(O)c(OC)c1	6M4YJ3FA16	Launched	breast cancer resistance protein inhibitor	ABCG2
cyclovirobuxin-d	cyclovirobuxin-d|CYCLOVIROBUXINE D	CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@@H]4[C@]5(C[C@@]35CC[C@]12C)CC[C@H](NC)C4(C)C	51GY352868	Preclinical	calcium channel modulator	
cypermethrin	cypermethrin|CYPERMETHRIN	CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1	1TR49121NP	Launched		
cyproheptadine	cyproheptadine|CYPROHEPTADINE	CN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12	2YHB6175DO	Launched	histamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7
cyproterone	cyproterone|CYPROTERONE	CC(=O)[C@@]1(O)CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5CC5[C@]4(C)C3CC[C@]12C	E61Q31EK2F	Launched	androgen receptor antagonist	AR
cyproterone-acetate	cyproterone-acetate|CYPROTERONE ACETATE	CC(=O)O[C@@]1(CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)C3CC[C@]12C)C(C)=O	4KM2BN5JHF	Launched	androgen receptor antagonist	ADORA1|AR
cyromazine	cyromazine|CYROMAZINE	Nc1nc(N)nc(NC2CC2)n1	CA49Y29RA9	Launched		
cysteamine	cysteamine|CYSTEAMINE	NCCS	5UX2SD1KE2	Launched	tissue transglutaminase inhibitor	NPY2R|SST
CYT-997	CYT-997|LEXIBULIN	CCC[C@H](Nc1nc(ncc1C)-c1ccc(NC(=O)NCC)c(OC)c1)c1cccnc1	2GTU230HA1	Phase 2	tubulin polymerization inhibitor	TUBB
cyt387	cyt387|MOMELOTINIB	O=C(NCC#N)c1ccc(cc1)-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1	6O01GMS00P	Phase 3		JAK1|JAK2|JAK3
cytarabine	cytarabine|CYTARABINE	Nc1ccn(C2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1	04079A1RDZ	Launched	ribonucleotide reductase inhibitor	POLA1|POLB|POLD1|POLE
cytisine	cytisine|CYTISINE	O=c1cccc2C3CNC[C@@H](C3)Cn12	53S5U404NU	Launched	acetylcholine receptor agonist	CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4
cytochalasin-b	cytochalasin-b|CYTOCHALASIN B	C[C@H]1[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]22OC(=O)\C=C/[C@H](O)CCC[C@@H](C)C\C=C\[C@H]2[C@H](O)C1=C	3CHI920QS7	Phase 2	microtubule inhibitor	ACTB
cytochlor	cytochlor|CYTOCHLOR	Nc1nc(=O)n(cc1Cl)[C@H]1C[C@@H](O)[C@@H](CO)O1	J14D49ZN55	Phase 1		
CZC24832	CZC24832	CC(C)(C)NS(=O)(=O)c1cncc(c1)-c1cc(F)c2nc(N)nn2c1		Preclinical	PI3K inhibitor	PIK3CG
D-(+)-maltose	D-(+)-maltose|MALTOSE ANHYDROUS	OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	66Y63L379N	Preclinical		AMY2B|MGAM
D-4476	D-4476	NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCCOc2c1		Preclinical	TGF beta receptor inhibitor	CSNK1A1|CSNK1D|TGFB1
D-64131	D-64131	COc1ccc2[nH]c(cc2c1)C(=O)c1ccccc1		Preclinical	microtubule inhibitor	TUBB
D-7193	D-7193	CC(=O)N[C@@H](CSSC[C@H](NC(C)=O)C(O)=O)C(O)=O		Phase 2		
D-alpha-tocopheryl-succinate	D-alpha-tocopheryl-succinate|.ALPHA.-TOCOPHEROL SUCCINATE, D-	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(OC(=O)CCC(O)=O)c(C)c(C)c2O1	LU4B53JYVE	Launched		
D-delta-Tocopherol	D-delta-Tocopherol|.DELTA.-TOCOPHEROL	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1	JU84X1II0N	Launched		
D-limonene	D-limonene|LIMONENE, (+)-	CC(=C)C1CCC(C)=CC1	GFD7C86Q1W	Phase 1		
D-Phenylalanine	D-Phenylalanine|PHENYLALANINE, D-	N[C@H](Cc1ccccc1)C(O)=O	032K16VRCU	Preclinical	enkephalinase inhibitor	CCBL1|CRH|HCAR3
D-Serine	D-Serine|SERINE, D-	N[C@H](CO)C(O)=O	1K77H2Z9B1	Launched	glutamate receptor agonist	GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3
D609	D609	SC(=S)OC1CC2CC1C1CCCC21		Preclinical	phospholipase inhibitor	
DAA-1106	DAA-1106|DAA-1106 C-11	COc1ccc(OC)c(CN(C(C)=O)c2cc(F)ccc2Oc2ccccc2)c1	696AIN172A	Preclinical	benzodiazepine receptor agonist	TSPO
dabigatran	dabigatran|DABIGATRAN	Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1	I0VM4M70GC	Launched	thrombin inhibitor	F2
dabigatran-etexilate	dabigatran-etexilate|DABIGATRAN ETEXILATE	CCCCCCOC(=O)\N=C(\N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1	2E18WX195X	Launched	thrombin inhibitor	F2
dabrafenib	dabrafenib|DABRAFENIB	CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F	QGP4HA4G1B	Launched	RAF inhibitor	BRAF|LIMK1|NEK11|RAF1|SIK1
dacarbazine	dacarbazine|DACARBAZINE	CN(C)\N=N\c1[nH]cnc1C(N)=O	7GR28W0FJI	Launched	DNA alkylating agent	PGD|POLA2
dacinostat	dacinostat|DACINOSTAT	OCCN(CCc1c[nH]c2ccccc12)Cc1ccc(\C=C\C(=O)NO)cc1	V10P524501	Phase 1	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
daclatasvir	daclatasvir|DACLATASVIR	COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc(cc1)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C	LI2427F9CI	Launched	HCV inhibitor	
dacomitinib	dacomitinib|DACOMITINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN1CCCCC1	5092U85G58	Phase 3	EGFR inhibitor	EGFR|ERBB2|ERBB4
dactinomycin	dactinomycin|DACTINOMYCIN	CC(C)[C@H]1NC(=O)[C@@H](NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@H](NC5=O)C(C)C)c4nc23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O	1CC1JFE158	Launched	RNA polymerase inhibitor	POLR2A
daidzein	daidzein|DAIDZEIN	Oc1ccc(cc1)-c1coc2cc(O)ccc2c1=O	6287WC5J2L	Phase 2	estrogen receptor agonist	ESRRA|ESRRB|ESRRG|TRPC5
dalargin	dalargin|DALARGIN	CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)[C@H](C)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O	V13505565P	Phase 2	opioid receptor agonist	OPRM1
dalbavancin	dalbavancin|DALBAVANCIN	CN[C@@H]1c2ccc(O)c(Oc3cc(O)c(Cl)c(c3)[C@@H]3NC(=O)[C@@H](Cc4ccc(Oc5cc6cc(Oc7ccc(cc7Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]6NC3=O)c3ccc(O)c(c3)-c3c(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)cc(O)cc3[C@H](NC7=O)C(=O)NCCCN(C)C)c5O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)C(O)=O)cc4)NC1=O)c2	808UI9MS5K	Launched	bacterial cell wall synthesis inhibitor	PNLIP
dalcetrapib	dalcetrapib|DALCETRAPIB	CCC(CC)CC1(CCCCC1)C(=O)Nc1ccccc1SC(=O)C(C)C	3D050LIQ3H	Phase 3	cholesteryl ester transfer protein inhibitor	CETP
dalfampridine	dalfampridine|DALFAMPRIDINE	Nc1ccncc1	BH3B64OKL9	Launched	potassium channel blocker	KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2
daltroban	daltroban|DALTROBAN	OC(=O)Cc1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1	S25VDY08ZC	Phase 3	thromboxane receptor antagonist	TBXA2R
danazol	danazol|DANAZOL	C[C@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C1CC[C@@]2(O)C#C	N29QWW3BUO	Launched	estrogen receptor antagonist|progesterone receptor agonist	AR|CCL2|ESR1|GNRHR|GNRHR2|PGR
danegaptide	danegaptide|DANEGAPTIDE	NCC(=O)N1C[C@@H](C[C@H]1C(O)=O)NC(=O)c1ccccc1	PA0Y7735AT	Phase 2	gap junction modulator	
danirixin	danirixin|DANIRIXIN	Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(c1O)S(=O)(=O)[C@H]1CCCNC1	R318PGH5VP	Phase 2	CC chemokine receptor antagonist	CXCR2
danofloxacin	danofloxacin|DANOFLOXACIN	CN1C[C@@H]2C[C@H]1CN2c1cc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1	24CU1YS91D	Launched	bacterial DNA gyrase inhibitor	
danoprevir	danoprevir|DANOPREVIR	CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1Cc2cccc(F)c2C1)C(=O)NS(=O)(=O)C1CC1	911Z9PCQ5F	Phase 2	HCV inhibitor	
dantrolene	dantrolene|DANTROLENE	[O-][N+](=O)c1ccc(cc1)-c1ccc(\C=N\N2CC(=O)NC2=O)o1	F64QU97QCR	Launched	calcium channel blocker	RYR1|RYR3
dantron	dantron|DANTHRON	Oc1cccc2C(=O)c3cccc(O)c3C(=O)c12	Z4XE6IBF3V	Withdrawn	laxative	
danusertib	danusertib|DANUSERTIB	CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1	M3X659D0FY	Phase 2	Aurora kinase inhibitor|growth factor receptor inhibitor	AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK
dapagliflozin	dapagliflozin|DAPAGLIFLOZIN	CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc1	1ULL0QJ8UC	Launched	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2
daphnetin	daphnetin|DAPHNETIN	Oc1ccc2ccc(=O)oc2c1O	XC84571RD2	Preclinical	protein kinase inhibitor	
dapiprazole	dapiprazole|DAPIPRAZOLE	Cc1ccccc1N1CCN(CCc2nnc3CCCCn23)CC1	5RNZ8GJO7K	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D
dapivirine	dapivirine|DAPIVIRINE	Cc1cc(C)c(Nc2ccnc(Nc3ccc(cc3)C#N)n2)c(C)c1	TCN4MG2VXS	Phase 3	non-nucleoside reverse transcriptase inhibitor	CYP3A4|CYP3A5
dapoxetine	dapoxetine|DAPOXETINE	CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1	GB2433A4M3	Launched	selective serotonin reuptake inhibitor (SSRI)	HTR1A|HTR1B|HTR2C|SLC6A4
daprodustat	daprodustat|DAPRODUSTAT	OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O	JVR38ZM64B	Phase 3	hypoxia inducible factor inhibitor	EGLN1
dapsone	dapsone|DAPSONE	Nc1ccc(cc1)S(=O)(=O)c1ccc(N)cc1	8W5C518302	Launched	bacterial antifolate	DHFR
DAPT	DAPT|DIAMINOHYDROXYPROPANETETRAACETIC ACID	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H](C(=O)OC(C)(C)C)c1ccccc1	949B9ZMO7M	Preclinical	gamma secretase inhibitor	
daptomycin	daptomycin|DAPTOMYCIN	CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)c2ccccc2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CCCN)NC(=O)CNC1=O)[C@@H](C)CC(O)=O	NWQ5N31VKK	Launched	bacterial cell wall synthesis inhibitor	
darapladib	darapladib|DARAPLADIB	CCN(CC)CCN(Cc1ccc(cc1)-c1ccc(cc1)C(F)(F)F)C(=O)Cn1c2CCCc2c(=O)nc1SCc1ccc(F)cc1	UI1U1MYH09	Phase 3	phospholipase inhibitor	PLA2G7
darglitazone	darglitazone|DARGLITAZONE	Cc1oc(nc1CCC(=O)c1ccc(Cc2sc(O)nc2O)cc1)-c1ccccc1	AVP9C03Z3K	Phase 2	PPAR receptor antagonist	PPARG
darifenacin	darifenacin|DARIFENACIN	NC(=O)C(C1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1	APG9819VLM	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
darunavir	darunavir|DARUNAVIR	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1	YO603Y8113	Launched	HIV protease inhibitor	CYP3A4
darusentan	darusentan|DARUSENTAN	COc1cc(OC)nc(O[C@H](C(O)=O)C(OC)(c2ccccc2)c2ccccc2)n1	33JD57L6RW	Phase 3	endothelin receptor antagonist	EDNRA
dasabuvir	dasabuvir|DASABUVIR	COc1c(cc(cc1C(C)(C)C)-n1ccc(=O)[nH]c1=O)-c1ccc2cc(NS(C)(=O)=O)ccc2c1	DE54EQW8T1	Launched	HCV inhibitor	
dasatinib	dasatinib|DASATINIB	Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1	RBZ1571X5H	Launched	Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor|tyrosine kinase inhibitor	ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1
DAU-5884	DAU-5884	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)N1Cc2ccccc2NC1=O		Preclinical	acetylcholine receptor antagonist	CHRM3
daucosterol	daucosterol|SITOGLUSIDE	CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)C	U45VN859W3	Phase 2	apoptosis stimulant	
daunorubicin	daunorubicin|DAUNORUBICIN	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(C)=O	ZS7284E0ZP	Launched	RNA synthesis inhibitor|topoisomerase inhibitor	TOP2A|TOP2B
dazmegrel	dazmegrel|DAZMEGREL	Cc1c(Cn2ccnc2)c2ccccc2n1CCC(O)=O	31340R8PVU	Phase 2	thromboxane synthase inhibitor	TBXAS1
dazoxiben	dazoxiben|DAZOXIBEN	OC(=O)c1ccc(OCCn2ccnc2)cc1	09ZFC7974Q	Phase 2	thromboxane synthase inhibitor	TBXAS1
DBeQ	DBeQ	C(Nc1nc(NCc2ccccc2)c2ccccc2n1)c1ccccc1		Preclinical	ATPase inhibitor	CASP3
DBPR108	DBPR108|DBPR-108	CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N	E329HG23ZT	Phase 1	dipeptidyl peptidase inhibitor	DPP4
DCC-2618	DCC-2618	Cn1cc(cn1)-c1cc(Oc2cc(F)c(NC(=O)C3(CC3)C(=O)Nc3ccccc3)cc2F)ccn1		Phase 1	PDGFR tyrosine kinase receptor inhibitor|KIT inhibitor	KIT|PDGFRA
DCEBIO	DCEBIO	CCn1c(O)nc2cc(Cl)c(Cl)cc12		Preclinical	potassium channel activator	KCNN2|KCNN3|KCNN4
DCPIB	DCPIB	CCCCC1(Cc2cc(OCCCC(O)=O)c(Cl)c(Cl)c2C1=O)C1CCCC1		Preclinical	chloride channel blocker|gap junction modulator|glutamate inhibitor	SLC1A2
debrisoquin	debrisoquin|DEBRISOQUIN	NC(=N)N1CCc2ccccc2C1	X31CDK040E	Launched	adrenergic neuron blocker	SLC6A2
decamethonium	decamethonium|DECAMETHONIUM	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C	C1CG1S3T2W	Launched	acetylcholine receptor agonist	ACHE|CHRNA2
decamethoxine	decamethoxine|DECAMETHOXIN	CC(C)C1CCC(C)CC1OC(=O)C[N+](C)(C)CCCCCCCCCC[N+](C)(C)CC(=O)OC1CC(C)CCC1C(C)C	81I73K1HKN	Phase 2	antiseptic	
decernotinib	decernotinib|DECERNOTINIB	CCC(C)(Nc1ccnc(n1)-c1c[nH]c2ncccc12)C(=O)NCC(F)(F)F	MZK2GP0RHK	Phase 2/Phase 3	JAK inhibitor	JAK3
decitabine	decitabine|DECITABINE	Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	776B62CQ27	Launched	DNA methyltransferase inhibitor	DNMT1|DNMT3A
decoquinate	decoquinate|DECOQUINATE	CCCCCCCCCCOc1cc2c(O)c(cnc2cc1OCC)C(=O)OCC	534I52PVWH	Launched	antiprotozoal agent	
defactinib	defactinib|DEFACTINIB	CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(C)(=O)=O)n2)C(F)(F)F)cc1	53O87HA2QU	Phase 2	focal adhesion kinase inhibitor	PTK2
deferasirox	deferasirox|DEFERASIROX	OC(=O)c1ccc(cc1)-n1nc(nc1-c1ccccc1O)-c1ccccc1O	V8G4MOF2V9	Launched	chelating agent	CYP3A4
deferiprone	deferiprone|DEFERIPRONE	Cc1c(O)c(=O)ccn1C	2BTY8KH53L	Launched	chelating agent	UGT1A6
deferoxamine-mesylate	deferoxamine-mesylate|DEFEROXAMINE MESYLATE	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN	V9TKO7EO6K	Launched	chelating agent	
deflazacort	deflazacort|DEFLAZACORT	CC(=O)OCC(=O)[C@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@H]3[C@H](O)C[C@]21C	KR5YZ6AE4B	Launched	glucocorticoid receptor agonist	NR3C1
deforolimus	deforolimus|RIDAFOROLIMUS	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1OP(C)(C)=O	48Z35KB15K	Phase 3	mTOR inhibitor	MTOR
degarelix	degarelix|DEGARELIX	CC(C)CC(NC(=O)C(Cc1ccc(NC(N)=O)cc1)NC(=O)C(Cc1ccc(NC(=O)C2CC(=O)NC(=O)N2)cc1)NC(=O)C(CO)NC(=O)C(Cc1cccnc1)NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)C(Cc1ccc2ccccc2c1)NC(C)=O)C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(N)=O	SX0XJI3A11	Launched	gonadotropin releasing factor hormone receptor antagonist	GNRHR
dehydroacetic-acid	dehydroacetic-acid|DEHYDROACETIC ACID	CC(=O)C1C(=O)OC(C)=CC1=O	2KAG279R6R	Preclinical		
dehydrocholate	dehydrocholate|DEHYDROCHOLIC ACID	C[C@H](CCC(O)=O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]1(C)CCC(=O)CC1CC3=O	NH5000009I	Preclinical		
dehydrocholate-acid	dehydrocholate-acid|DEHYDROCHOLIC ACID	CC(CCC(O)=O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]1(C)CCC(=O)C[C@H]1CC3=O	NH5000009I	Preclinical		
dehydrocorydaline	dehydrocorydaline	COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4c(C)c3-c2cc1OC		Phase 3	acetylcholinesterase inhibitor	ACHE
dehydroepiandrosterone	dehydroepiandrosterone|PRASTERONE	C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O	459AG36T1B	Launched	protein synthesis stimulant	ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1
dehydroepiandrosterone-sulfate	dehydroepiandrosterone-sulfate|PRASTERONE SULFATE	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@H](CC[C@]34C)OS(O)(=O)=O)[C@@H]1CCC2=O	57B09Q7FJR	Launched	androgen receptor agonist|estrogen receptor agonist	AR|ESR1|ESR2
delamanid	delamanid|DELAMANID	C[C@]1(COc2ccc(cc2)N2CCC(CC2)Oc2ccc(OC(F)(F)F)cc2)Cn2cc(nc2O1)[N+]([O-])=O	8OOT6M1PC7	Launched	bacterial cell wall synthesis inhibitor	
delanzomib	delanzomib|DELANZOMIB	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(n1)-c1ccccc1)[C@@H](C)O)B(O)O	6IF28942WO	Phase 1/Phase 2	proteasome inhibitor	CMA1|CTSG|CYP3A4|ELANE
delapril	delapril|DELAPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(O)=O)C1Cc2ccccc2C1	W77UAL9THI	Launched	angiotensin converting enzyme inhibitor	ACE
delavirdine	delavirdine|DELAVIRDINE	CC(C)Nc1cccnc1N1CCN(CC1)C(=O)c1cc2cc(NS(C)(=O)=O)ccc2[nH]1	DOL5F9JD3E	Launched	non-nucleoside reverse transcriptase inhibitor	CYP3A4
delivert	delivert|ANGIOTENSIN II	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1ccccc1)C(O)=O	M089EFU921	Launched	angiotensin receptor agonist	AGTR1|AGTR2
delphinidin	delphinidin|DELPHINIDIN CHLORIDE	Oc1cc(O)c2cc(O)c([o+]c2c1)-c1cc(O)c(O)c(O)c1	EM6MD4AEHE	Phase 2	membrane permeability inhibitor	GLO1
delta-Tocotrienol	delta-Tocotrienol|.DELTA.-TOCOTRIENOL	CC(C)=CCC\C(C)=C\CC\C(C)=C\CC[C@]1(C)CCc2cc(O)cc(C)c2O1	1SRB74OWSI	Phase 1	HMGCR inhibitor	HMGCR
demecarium	demecarium|DEMECARIUM	CN(CCCCCCCCCCN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C)C(=O)Oc1cccc(c1)[N+](C)(C)C	ILP8XJ8R5K	Launched	acetylcholinesterase inhibitor	ACHE|BCHE
demeclocycline	demeclocycline|DEMECLOCYCLINE	CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	5R5W9ICI6O	Launched	bacterial 30S ribosomal subunit inhibitor	
denatonium-benzoate	denatonium-benzoate|DENATONIUM BENZOATE	CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc1ccccc1	4YK5Z54AT2	Preclinical		
denotivir	denotivir|DENOTIVIR	Cc1nsc(NC(=O)c2ccccc2)c1C(=O)Nc1ccc(Cl)cc1	W656S9I00W	Launched	antiviral	
deoxyarbutin	deoxyarbutin|TETRAHYDROPYRANYLOXY PHENOL	Oc1ccc(OC2CCCCO2)cc1	RG969BY5EN	Preclinical	tyrosinase inhibitor	
deoxycholic-acid	deoxycholic-acid|DEOXYCHOLIC ACID	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	005990WHZZ	Launched	biliverdin reductase A activator|G protein-coupled receptor agonist	EFTUD1|FPR1|GPBAR1
deoxycorticosterone-acetate	deoxycorticosterone-acetate|DESOXYCORTICOSTERONE ACETATE	CC(=O)OCC(=O)[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C	6E0A168OB8	Preclinical	progestogen hormone	NR3C2
deoxyepinephrine	deoxyepinephrine|DEOXYEPINEPHRINE	CNCCc1ccc(O)c(O)c1	R7339QLN1C	Preclinical	adrenergic receptor agonist|dopamine receptor agonist	ADRA1A|DRD1|DRD2
deptropine	deptropine|DEPTROPINE	CN1[C@H]2CC[C@@H]1CC(C2)OC1c2ccccc2CCc2ccccc12	AY31301GKG	Preclinical	histamine receptor antagonist	HRH1
dequalinium	dequalinium|DEQUALINIUM	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc12	E7QC7V26B8	Launched	PKC inhibitor	KCNN1|KCNN3
deracoxib	deracoxib|DERACOXIB	COc1ccc(cc1F)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)F	VX29JB5XWV	Launched	cyclooxygenase inhibitor	PTGS2
deserpidine	deserpidine|DESERPIDINE	CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1	9016E3VB47	Launched	angiotensin converting enzyme inhibitor	ACE|SLC18A2
desipramine	desipramine|DESIPRAMINE	CNCCCN1c2ccccc2CCc2ccccc12	TG537D343B	Launched	tricyclic antidepressant	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A4|SMPD1
deslanoside	deslanoside|DESLANOSIDE	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1	YGY317RK75	Launched	Na/K-ATPase inhibitor	ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2
desloratadine	desloratadine|DESLORATADINE	Clc1ccc2c(CCc3cccnc3C2=C2CCNCC2)c1	FVF865388R	Launched	histamine receptor antagonist	HRH1
desmethylclozapine	desmethylclozapine|NORCLOZAPINE	Clc1ccc2Nc3ccccc3C(=Nc2c1)N1CCNCC1	1I9001LWY8	Phase 2	acetylcholine receptor agonist	HTR2C
desmopressin-acetate	desmopressin-acetate|DESMOPRESSIN ACETATE	NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O	XB13HYU18U	Launched	vasopressin receptor agonist	AVPR1A|AVPR1B|AVPR2|OXTR
desogestrel	desogestrel|DESOGESTREL	CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	81K9V7M3A3	Launched	progesterone receptor agonist	ESR1|PGR
desonide	desonide|DESONIDE	CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	J280872D1O	Launched	glucocorticoid receptor agonist	NR3C1|PLA2G1B
desoximetasone	desoximetasone|DESOXIMETASONE	C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO	4E07GXB7AU	Launched	glucocorticoid receptor agonist	NR3C1|PLA2G1B
desoxycorticosterone-pivalate	desoxycorticosterone-pivalate|DESOXYCORTICOSTERONE PIVALATE	CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	16665T4A2X	Launched	corticosteroid agonist	NR3C2
desoxycortone	desoxycortone|DESOXYCORTONE	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO	40GP35YQ49	Preclinical	mineralocorticoid receptor agonist	NR3C1|NR3C2
desoxypeganine	desoxypeganine	C1CN2Cc3ccccc3N=C2C1		Phase 1	acetylcholinesterase inhibitor|monoamine oxidase inhibitor	ACHE
desvenlafaxine	desvenlafaxine|DESVENLAFAXINE	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1	NG99554ANW	Launched	serotoninnorepinephrine reuptake inhibitor (SNRI)	SLC6A2|SLC6A3|SLC6A4
detomidine	detomidine|DETOMIDINE	Cc1cccc(Cc2c[nH]cn2)c1C	7N8K34P2XH	Launched	adrenergic receptor agonist	ADRA2A
dexamethasone	dexamethasone|DEXAMETHASONE	C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	7S5I7G3JQL	Launched	glucocorticoid receptor agonist	ANXA1|NOS2|NR0B1|NR3C1|NR3C2
dexamethasone-acetate	dexamethasone-acetate|DEXAMETHASONE ACETATE ANHYDROUS|BETAMETHASONE ACETATE	C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O	K7V8P532WP|TI05AO53L7	Launched	glucocorticoid receptor agonist	
dexamethasone-sodium-phosphate	dexamethasone-sodium-phosphate|DEXAMETHASONE PHOSPHATE|BETAMETHASONE DIHYDROGEN PHOSPHATE	C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O	2BP70L44PR|YJO1F9W10R	Launched	glucocorticoid receptor agonist	NR3C1
dexchlorpheniramine	dexchlorpheniramine|DEXCHLORPHENIRAMINE	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1	3Q9Q0B929N	Launched	histamine receptor antagonist	
dexfenfluramine	dexfenfluramine|DEXFENFLURAMINE	CCN[C@@H](C)Cc1cccc(c1)C(F)(F)F	E35R3G56OV	Withdrawn	serotonin receptor agonist	HTR2C|SLC6A4
dexfosfoserine	dexfosfoserine|DEXFOSFOSERINE	N[C@@H](COP(O)(O)=O)C(O)=O	VI4F0K069V	Preclinical	membrane integrity inhibitor	CFTR|GRM4|GRM6|GRM7|GRM8|KCNC4|PDPK1|PIM1|PRKACA|PRKCQ|PYGL|PYGM|REG1A|RHO|SERPINB3|SMAD2|TAOK2
dexlansoprazole	dexlansoprazole|LANSOPRAZOLE	Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1	0K5C5T2QPG	Launched	ATPase inhibitor	ATP4A|ATP4B
dexloxiglumide	dexloxiglumide|DEXLOXIGLUMIDE	CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)NC(=O)c1ccc(Cl)c(Cl)c1	69DY40RH9B	Phase 3	CCK receptor antagonist	CCKAR
dexniguldipine	dexniguldipine|DEXNIGULDIPINE	COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1	N9DG6ZTC43	Phase 2	calmodulin antagonist	ADORA3
dexpanthenol	dexpanthenol|DEXPANTHENOL	CC(C)(CO)C(O)C(=O)NCCCO	1O6C93RI7Z	Launched		
dexrazoxane	dexrazoxane|DEXRAZOXANE	C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1	048L81261F	Launched	chelating agent|topoisomerase inhibitor	TOP2A|TOP2B
dextran	dextran	OC[C@H]1O[C@H](OC[C@H]2O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		Launched		
dextroamphetamine	dextroamphetamine|DEXTROAMPHETAMINE	C[C@H](N)Cc1ccccc1	TZ47U051FI	Launched	monoamine oxidase inhibitor	ADRA1A|ADRA1B|SLC18A2|SLC6A2|SLC6A3|TAAR1
dextromethorphan	dextromethorphan|DEXTROMETHORPHAN	COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1	7355X3ROTS	Launched	glutamate receptor antagonist|sigma receptor agonist	CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4
dextrose	dextrose|ANHYDROUS DEXTROSE	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O	5SL0G7R0OK	Launched		
DFB	DFB|1-FLUORO-2,4-DINITROBENZENE	Fc1cccc(c1)\C=N\N=C\c1cccc(F)c1	D241E059U6	Preclinical	glutamate receptor agonist	GRM5
DH-97	DH-97	CCCCC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12		Preclinical	melatonin receptor antagonist	MTNR1B
DHBP	DHBP	CCCCCCC[n+]1ccc(cc1)-c1cc[n+](CCCCCCC)cc1		Preclinical	ryanodine receptor blocker	
diacerein	diacerein|DIACEREIN	CC(=O)Oc1cccc2C(=O)c3cc(cc(OC(C)=O)c3C(=O)c12)C(O)=O	4HU6J11EL5	Launched	interleukin inhibitor	IL1B
diacetamate	diacetamate|DIACETAMATE	CC(=O)Nc1ccc(OC(C)=O)cc1	BFG1TY61BG	Preclinical		
diadenosine-tetraphosphate	diadenosine-tetraphosphate	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H](C(O)C2O)n2cnc3c(N)ncnc23)C(O)C1O		Phase 1	adenosine kinase inhibitor	P2RY13|P2RY2
dianhydrogalactitol	dianhydrogalactitol|DIANHYDROGALACTITOL	O[C@@H]([C@@H](O)[C@H]1CO1)[C@@H]1CO1	4S465RYF7M	Phase 1	DNA alkylating agent	
diarylpropionitrile	diarylpropionitrile|DI-P-HYDROXYPHENYLPROPIONITRILE, (R)-	Oc1ccc(CC(C#N)c2ccc(O)cc2)cc1	BG5CYS8SFD	Preclinical	estrogen receptor agonist	ESR2
diatrizoic-acid	diatrizoic-acid|DIATRIZOIC ACID	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I	5UVC90J1LK	Launched		
diaveridine	diaveridine|DIAVERIDINE	COc1ccc(Cc2cnc(N)nc2N)cc1OC	7KVX81XA87	Launched	dihydrofolate reductase inhibitor	
diazepam	diazepam|DIAZEPAM	CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1	Q3JTX2Q7TU	Launched	benzodiazepine receptor agonist	ADRA1A|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO
diazooxonorleucine	diazooxonorleucine	N[C@@H](CCC(=O)C=[N+]=N)C(O)=O		Phase 2	glutamate receptor antagonist	
diazoxide	diazoxide|DIAZOXIDE	CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1	O5CB12L4FN	Launched	potassium channel activator	ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3
dibekacin	dibekacin|DIBEKACIN	NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1	45ZFO9E525	Launched	bacterial 30S ribosomal subunit inhibitor	
dibenzepine	dibenzepine|DIBENZEPIN	CN(C)CCN1c2ccccc2N(C)c2ccccc2C1=O	510SJZ1Y6L	Preclinical	norepinephrine reputake inhibitor	
dibenzothiophene	dibenzothiophene|DIBENZOTHIOPHENE	c1ccc2c(c1)sc1ccccc21	Z3D4AJ1R48	Preclinical		
dibutyl-phthalate	dibutyl-phthalate|DIBUTYL PHTHALATE	CCCCOC(=O)c1ccccc1C(=O)OCCCC	2286E5R2KE	Preclinical		TRPA1
dichlorisone-acetate	dichlorisone-acetate|DICHLORISONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](Cl)C[C@]12C	64FTA4579H	Phase 2		
dichloroacetate	dichloroacetate|DICHLOROACETIC ACID	[Na].OC(=O)C(Cl)Cl	9LSH52S3LQ	Phase 3	pyruvate dehydrogenase kinase inhibitor	PDK1
dichlorophen	dichlorophen|DICHLOROPHEN	Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O	T1J0JOU64O	Launched	anticestodal agent	
dichlorvos	dichlorvos|DICHLORVOS	COP(=O)(OC)OC=C(Cl)Cl	7U370BPS14	Launched	acetylcholinesterase inhibitor	
diclazuril	diclazuril|DICLAZURIL	Clc1ccc(cc1)C(C#N)c1c(Cl)cc(cc1Cl)-n1ncc(=O)[nH]c1=O	K110K1B1VE	Launched	antiprotozoal agent	
diclofenac	diclofenac|DICLOFENAC	OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	144O8QL0L1	Launched	cyclooxygenase inhibitor	AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A
diclofenamide	diclofenamide|DICHLORPHENAMIDE	NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(N)(=O)=O	VVJ6673MHY	Launched	carbonic anhydrase inhibitor	CA1|CA12|CA2|CA4|CA7
diclofensine	diclofensine|DICLOFENSINE	COc1ccc2C(CN(C)Cc2c1)c1ccc(Cl)c(Cl)c1	09HKW863J6	Phase 3	dopamine reuptake inhibitor	DRD1|MAOA|MAOB
dicloralurea	dicloralurea|DICLORALUREA	OC(NC(=O)NC(O)C(Cl)(Cl)Cl)C(Cl)(Cl)Cl	9J3ZB93FIE	Preclinical		
dicloxacillin	dicloxacillin|DICLOXACILLIN	Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(Cl)cccc1Cl	COF19H7WBK	Launched	bacterial cell wall synthesis inhibitor	
dicoumarol	dicoumarol|DICUMAROL	Oc1c(Cc2c(O)c3ccccc3oc2=O)c(=O)oc2ccccc12	7QID3E7BG7	Launched	NADPH inhibitor	CRYZ|NQO1|VKORC1
dicyclohexylamine	dicyclohexylamine|DICYCLOHEXYLAMINE	C1CCC(CC1)NC1CCCCC1	1A93RJW924	Preclinical		
dicycloverine	dicycloverine|DICYCLOMINE	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1	4KV4X8IF6V	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
didanosine	didanosine|DIDANOSINE	OC[C@@H]1CC[C@@H](O1)n1cnc2c(O)ncnc12	K3GDH6OH08	Launched	nucleoside reverse transcriptase inhibitor	PNP
dideoxyadenosine	dideoxyadenosine|DIDEOXYADENOSINE	Nc1ncnc2n(cnc12)[C@H]1CC[C@@H](CO)O1	4Q86AH641A	Phase 1	nucleoside reverse transcriptase inhibitor	
didox	didox|DIDOX	ONC(=O)c1ccc(O)c(O)c1	L106XFV0RQ	Launched	ribonucleotide reductase inhibitor	RRM1
dienestrol	dienestrol|DIENESTROL	C\C=C(c1ccc(O)cc1)\C(c1ccc(O)cc1)=C\C	RRW32X4U1F	Launched	estrogen receptor agonist	ESR1
dienogest	dienogest|DIENOGEST	C[C@@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N	46M3EV8HHE	Launched	progesterone receptor agonist	PGR
diethylcarbamazine	diethylcarbamazine|DIETHYLCARBAMAZINE	CCN(CC)C(=O)N1CCN(C)CC1	V867Q8X3ZD	Launched	lipoxygenase inhibitor	ALOX5|PTGS1
diethylstilbestrol	diethylstilbestrol|DIETHYLSTILBESTROL	CC\C(c1ccc(O)cc1)=C(\CC)c1ccc(O)cc1	731DCA35BT	Withdrawn	estrogen receptor agonist	ESR1|ESR2|ESRRB|ESRRG
diethyltoluamide	diethyltoluamide|DIETHYLTOLUAMIDE	CCN(CC)C(=O)c1cccc(C)c1	FB0C1XZV4Y	Launched	ionotropic receptor IR40a activator	
difenpiramide	difenpiramide|DIFENPIRAMIDE	O=C(Cc1ccc(cc1)-c1ccccc1)Nc1ccccn1	Q6U5F6E1QL	Launched	cyclooxygenase inhibitor|prostaglandin inhibitor	
diflorasone-diacetate	diflorasone-diacetate|DIFLORASONE DIACETATE	C[C@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(C)=O)C(=O)COC(C)=O	7W2J09SCWX	Launched	glucocorticoid receptor agonist	NR3C1
difloxacin	difloxacin|DIFLOXACIN	CN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1	5Z7OO9FNFD	Launched	bacterial DNA gyrase inhibitor	
diflunisal	diflunisal|DIFLUNISAL	OC(=O)c1cc(ccc1O)-c1ccc(F)cc1F	7C546U4DEN	Launched	prostanoid receptor antagonist	PTGS1|PTGS2
difluprednate	difluprednate|DIFLUPREDNATE	CCCC(=O)O[C@]1(CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)COC(C)=O	S8A06QG2QE	Launched	glucocorticoid receptor agonist	NR3C1
diftalone	diftalone|DIFTALONE	O=C1N2Cc3ccccc3C(=O)N2Cc2ccccc12	142FG4G74X	Launched	cyclooxygenase inhibitor	
digitoxigenin	digitoxigenin|DIGITOXIGENIN	C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@@H]2C1=CC(=O)OC1	S63WOD4VOL	Preclinical	ATPase inhibitor	ATP1A1
digitoxin	digitoxin|DIGITOXIN	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	E90NZP2L9U	Launched	ATPase inhibitor	ATP1A1
digoxigenin	digoxigenin|DIGOXIGENIN	C[C@@]12[C@H](CC[C@]1(O)[C@@H]1CC[C@@H]3C[C@@H](O)CC[C@]3(C)[C@H]1C[C@H]2O)C1=CC(=O)OC1	NQ1SX9LNAU	Preclinical	steroid	
digoxin	digoxin|DIGOXIN	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	73K4184T59	Launched	ATPase inhibitor	ATP1A1
dihomo-gamma-linolenic-acid	dihomo-gamma-linolenic-acid|DIHOMO-.GAMMA.-LINOLENIC ACID	CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O	FC398RK06S	Phase 2	prostanoid receptor agonist	PTGS1|PTGS2
dihydrexidine	dihydrexidine|DIHYDREXIDINE	Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O	32D64VH037	Phase 2	dopamine receptor agonist	DRD1|DRD2|DRD3|DRD4|DRD5
dihydroartemisinin	dihydroartemisinin|ARTENIMOL	C[C@@H]1CC[C@H]2[C@@H](C)C(O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4	6A9O50735X	Launched	antimalarial agent	
dihydroergocristine	dihydroergocristine|DIHYDROERGOCRISTINE	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O	05D48LUM4Z	Launched	adrenergic receptor antagonist|prolactin inhibitor	ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7
dihydroergotamine	dihydroergotamine|DIHYDROERGOTAMINE	CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O	436O5HM03C	Launched	serotonin receptor agonist	ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7
dihydromyricetin	dihydromyricetin|DIHYDROMYRICETIN	O[C@@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c1cc(O)c(O)c(O)c1	KD8QND6427	Preclinical		
dihydrostreptomycin	dihydrostreptomycin|DIHYDROSTREPTOMYCIN	CN[C@H]1C(O)C(O)C(CO)OC1OC1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)OC(C)[C@]1(O)CO	P2I6R8W6UA	Withdrawn	bacterial 30S ribosomal subunit inhibitor	
dihydrotachysterol	dihydrotachysterol|DIHYDROTACHYSTEROL	CC(C)C(C)\C=C\C(C)C1CCC2C1(C)CCC\C2=C/C=C1\CC(O)CCC1C	R5LM3H112R	Launched	vitamin analog	VDR
dihydrotestosterone	dihydrotestosterone|STANOLONE	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O	08J2K08A3Y	Launched	androgen receptor agonist	AR|HSD17B1
dihydroxyacetone	dihydroxyacetone|DIHYDROXYACETONE	OCC(=O)CO	O10DDW6JOO	Launched		
dihydroxyphenylglycine	dihydroxyphenylglycine|DIHYDROXYPHENYLGLYCINE	NC(C(O)=O)c1cc(O)cc(O)c1	CF5G2G268A	Preclinical	glutamate receptor agonist	GRM1|GRM5
diiodothyropropionic-acid	diiodothyropropionic-acid|3,5-DIIODOTHYROPROPIONIC ACID	OC(=O)CCc1cc(I)c(Oc2ccc(O)cc2)c(I)c1	1HTO2X0SJ9	Phase 2	thyroid hormone stimulant	
dilazep	dilazep|DILAZEP	COc1cc(cc(OC)c1OC)C(=O)OCCCN1CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC1	F8KLC2BD5Z	Launched	adenosine reuptake inhibitor	SLC29A1
diloxanide	diloxanide|DILOXANIDE	CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1	89134SCM7M	Launched	protein synthesis inhibitor	
diltiazem	diltiazem|DILTIAZEM	COc1ccc(cc1)C1Sc2ccccc2N(CCN(C)C)C(=O)C1OC(C)=O	EE92BBP03H	Launched	calcium channel blocker	CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5
dimaprit	dimaprit|DIMAPRIT	CN(C)CCCSC(N)=N	ZZQ699148P	Preclinical	histamine receptor agonist	HRH2|HRH3|HRH4
dimemorfan	dimemorfan|DIMEMORFAN	CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(C)cc31	623OAC38YU	Launched	sigma receptor agonist	SIGMAR1
dimenhydrinate	dimenhydrinate|DIMENHYDRINATE	Cn1c2nc(Cl)[nH]c2c(=O)n(C)c1=O.CN(C)CCOC(c1ccccc1)c1ccccc1	JB937PER5C	Launched	histamine receptor antagonist	HRH1
dimercaprol	dimercaprol|DIMERCAPROL	OCC(S)CS	0CPP32S55X	Launched	chelating agent	
dimercaptosuccinic-acid	dimercaptosuccinic-acid|SUCCIMER	OC(=O)[C@@H](S)[C@@H](S)C(O)=O	DX1U2629QE	Launched	chelating agent	DNMT1
dimesna	dimesna|DIMESNA	OS(=O)(=O)CCSSCCS(O)(=O)=O	230R951Y4D	Phase 3	tubulin polymerization inhibitor	
dimethadione	dimethadione|DIMETHADIONE	CC1(C)OC(=O)NC1=O	ALU9NPM703	Preclinical	oxazolidine antiepileptic	
dimethicone	dimethicone|DIMETHICONE 500|DIMETHICONE 12500|HEXAMETHYLDISILOXANE|DIMETHICONE 20|DIMETHICONE 1000|DIMETHICONE 200|DIMETHICONE 100|DIMETHICONE 410	C[Si](C)(C)O[Si](C)(C)C	5L1VVC3K8O|D1R3R4B8M8|D7M4659BPU|H8YMB5QY0D|MCU2324216|RGS4T2AS00|RO266O364U|TYU5GP6XGE	Launched		
dimethindene-(S)-(+)	dimethindene-(S)-(+)|DIMETHINDENE	C[C@@H](C1=C(CCN(C)C)Cc2ccccc12)c1ccccn1	661FH77Z3P	Preclinical	acetylcholine receptor antagonist	HRH1
dimethisoquin	dimethisoquin|DIMETHISOQUIN	CCCCc1cc2ccccc2c(OCCN(C)C)n1	772EN3BH6I	Launched	local anesthetic	
dimethyl-fumarate	dimethyl-fumarate|DIMETHYL FUMARATE	COC(=O)\C=C\C(=O)OC	FO2303MNI2	Launched	nuclear factor erythroid derived|like (NRF2) activator	KEAP1
dimethyl-isosorbide	dimethyl-isosorbide|DIMETHYL ISOSORBIDE	COC1COC2C(COC12)OC	SA6A6V432S	Preclinical	cosmetic moisturizer	
dimetindene	dimetindene|DIMETHINDENE	CC(C1=C(CCN(C)C)Cc2ccccc12)c1ccccn1	661FH77Z3P	Launched	histamine receptor antagonist|cholinergic receptor antagonist	CHRM2|HRH1
dimetridazole	dimetridazole|DIMETRIDAZOLE	Cc1ncc(n1C)[N+]([O-])=O	K59P7XNB8X	Launched	bacterial DNA inhibitor	
diminazene-aceturate	diminazene-aceturate|DIMINAZENE ACETURATE	NC(=N)c1ccc(N\N=N\c2ccc(cc2)C(N)=N)cc1	JI8SAD85NO	Phase 3	angiotensin converting enzyme activator	AOC1|PRDX5|PRSS1
dimpylate	dimpylate|DIMPYLATE	CCOP(=S)(OCC)Oc1cc(C)nc(n1)C(C)C	YUS1M1Q929	Launched	acetylcholinesterase inhibitor	ACHE
dinaciclib	dinaciclib|DINACICLIB	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO	4V8ECV0NBQ	Phase 3	CDK inhibitor	CDK1|CDK2|CDK5|CDK9
dinitolmide	dinitolmide|DINITOLMIDE	Cc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(N)=O	AOX68RY4TV	Launched		
dinoprost	dinoprost|DINOPROST	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O	B7IN85G1HY	Launched	prostacyclin analog	PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R
dinoprostone	dinoprostone|DINOPROSTONE	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O	K7Q1JQR04M	Withdrawn	prostanoid receptor agonist	CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R
dioscin	dioscin|DIOSCIN	C[C@@H]1[C@@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](CC[C@]5(C)[C@@H]4CC[C@]23C)O[C@@H]2O[C@@H](CO)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)O[C@]11CC[C@@H](C)CO1	3B95U4OLWV	Preclinical	apoptosis stimulant	CXCR3
diosgenin	diosgenin|DIOSGENIN	C[C@@H]1[C@@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@@H]4CC[C@]23C)O[C@]11CC[C@@H](C)CO1	K49P2K8WLX	Preclinical	steroid	
diosmetin	diosmetin|DIOSMETIN	COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O)cc2o1	TWZ37241OT	Launched	aryl hydrocarbon receptor agonist	CYP1B1
diosmin	diosmin|DIOSMIN	COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2o1	7QM776WJ5N	Launched	aryl hydrocarbon receptor agonist|capillary stabilizing agent	AHR
dioxybenzone	dioxybenzone|DIOXYBENZONE	COc1ccc(C(=O)c2ccccc2O)c(O)c1	B762XZ551X	Preclinical	topical sunscreen agent	
dipeptamin	dipeptamin|ALANYL GLUTAMINE	C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O	U5JDO2770Z	Launched		
diperodon	diperodon|DIPERODON	O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1	2456GO94TR	Preclinical	local anesthetic	
diphemanil	diphemanil|DIPHEMANIL	C[N+]1(C)CCC(CC1)=C(c1ccccc1)c1ccccc1	Q26TX1UD0W	Launched	acetylcholine receptor antagonist	CHRM3
diphencyprone	diphencyprone|DIPHENCYPRONE	O=c1c(c1-c1ccccc1)-c1ccccc1	I7G14NW5EC	Phase 2	immunostimulant	
diphenhydramine	diphenhydramine|DIPHENHYDRAMINE	CN(C)CCOC(c1ccccc1)c1ccccc1	8GTS82S83M	Launched	histamine receptor antagonist	HRH1
diphenidol	diphenidol|DIPHENIDOL	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1	NQO8R319LY	Launched	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
diphenyleneiodonium	diphenyleneiodonium|DIPHENYLENEIODONIUM	[I+]1c2ccccc2-c2ccccc12	6HJ411TU98	Preclinical	nitric oxide synthase inhibitor	NOS2|NOS3
diphenylguanidine	diphenylguanidine|DIPHENYLGUANIDINE	N=C(Nc1ccccc1)Nc1ccccc1	6MRZ85RNHQ	Preclinical		
diphenylpyraline	diphenylpyraline|DIPHENYLPYRALINE	CN1CCC(CC1)OC(c1ccccc1)c1ccccc1	33361OE3AV	Launched	dopamine uptake inhibitor	HRH1|SLC6A3
dipivefrine	dipivefrine|DIPIVEFRIN	CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1	8Q1PVL543G	Launched	adrenergic receptor agonist	ACHE|ADRA1A|ADRA2A|ADRB2|BCHE
dipraglurant	dipraglurant|DIPRAGLURANT	Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1	CV8JZR21A1	Phase 2	glutamate receptor negative allosteric modulator	GRM5
DIPT	DIPT|N,N-DIISOPROPYLTRYPTAMINE	CC(C)N(CCc1c[nH]c2ccccc12)C(C)C	E352B01VMH	Launched	dopamine reuptake inhibitor|serotonin reuptake inhibitor	HTR1A|HTR2A|HTR2C
dipyridamole	dipyridamole|DIPYRIDAMOLE	OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO	64ALC7F90C	Launched	phosphodiesterase inhibitor	ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1
dipyrocetyl	dipyrocetyl|DIPYROCETYL	CC(=O)Oc1cccc(C(O)=O)c1OC(C)=O	EF5UVE254C	Launched	chelating agent	
dirithromycin	dirithromycin|DIRITHROMYCIN	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)OC([C@H]2C)[C@]1(C)O	1801D76STL	Launched	bacterial 50S ribosomal subunit inhibitor	
diroximel-fumarate	diroximel-fumarate	COC(=O)\C=C\C(=O)OCCN1C(=O)CCC1=O		Phase 3	anti-inflammatory agent	
disodium sebacate	disodium sebacate|DISODIUM SEBACATE	OC(=O)CCCCCCCCC(O)=O	J3YU3MBH4Z	Phase 1		HBA1|HBB
disopyramide	disopyramide|DISOPYRAMIDE	CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C	GFO928U8MQ	Launched	sodium channel blocker	CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A
disulfiram	disulfiram|DISULFIRAM	CCN(CC)C(=S)SSC(=S)N(CC)CC	TR3MLJ1UAI	Launched	aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist	ALDH2|DBH
dithranol	dithranol|ANTHRALIN	Oc1cccc2cc3cccc(O)c3c(O)c12	U8CJK0JH5M	Launched	DNA synthesis inhibitor	
ditiocarb-sodium-trihydrate	ditiocarb-sodium-trihydrate|DITIOCARB	CCN(CC)C(S)=S	99Z2744345	Phase 3	immunostimulant	CA1|CA2|CA4
ditolylguanidine	ditolylguanidine|1,3-DI-O-TOLYLGUANIDINE	Cc1ccccc1NC(=N)Nc1ccccc1C	LL2P01I17O	Preclinical	sigma receptor agonist	GRIN1|GRIN2A|GRIN2B|SIGMAR1
divalproex-sodium	divalproex-sodium|DIVALPROEX SODIUM	CCCC(CCC)C(O)=O	644VL95AO6	Launched	benzodiazepine receptor agonist	ALDH5A1
dixanthogen	dixanthogen|DIXANTHOGEN	CCOC(=S)SSC(=S)OCC	RN4CQ46FDM	Preclinical		
dizocilpine-(-)	dizocilpine-(-)|DIZOCILPINE, (-)-	C[C@@]12N[C@@H](Cc3ccccc13)c1ccccc21	2V2JET5YTL	Phase 1	glutamate receptor antagonist	
dizocilpine-(+)	dizocilpine-(+)|DIZOCILPINE	C[C@]12N[C@H](Cc3ccccc13)c1ccccc21	7PY8KH681I	Preclinical	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
DMAB-anabaseine	DMAB-anabaseine	CN(C)c1ccc(cc1)\C=C1CCCN=C/1c1cccnc1		Preclinical	adrenergic receptor agonist	CHRNA7
DMeOB	DMeOB	COc1cccc(c1)\C=N\N=C\c1cccc(OC)c1		Preclinical		GRM5
DMH1	DMH1	CC(C)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12		Preclinical	ALK tyrosine kinase receptor inhibitor	ACVR1
DMNB	DMNB	COc1cc(C=O)c(cc1OC)[N+]([O-])=O		Preclinical	DNA dependent protein kinase inhibitor	
DMP-543	DMP-543	Fc1cc(CC2(Cc3ccnc(F)c3)c3ccccc3C(=O)c3ccccc23)ccn1		Phase 2	acetylcholine release enhancer	
DMP-777	DMP-777	CCC[C@@H](NC(=O)N1[C@@H](Oc2ccc(cc2)C(=O)N2CCN(C)CC2)C(CC)(CC)C1=O)c1ccc2OCOc2c1	3Q0469283P	Phase 2	elastase inhibitor	MPO
DMPS	DMPS|2,3-DIMERCAPTO-1-PROPANESULFONIC ACID	OS(=O)(=O)CC(S)CS	086L82361J	Phase 1	chelating agent	
DMSO	DMSO|DIMETHYL SULFOXIDE	CS(C)=O.CS(C)=O	YOW8V9698H	Preclinical	control vehicle	
DNQX	DNQX|FG-9041	[O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+]([O-])=O	62T278S1MX	Preclinical	glutamate receptor antagonist	GRIA1|GRIA2|GRIK1|GRIN1|GRIN2A|GRIN2B
dobutamine	dobutamine|DOBUTAMINE	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1	3S12J47372	Launched	adrenergic receptor agonist	ADRB1|ADRB2
docebenone	docebenone|DOCEBENONE	CC1=C(C)C(=O)C(CCCCC#CCCCC#CCO)=C(C)C1=O	2XRX3BD53M	Phase 2	lipoxygenase inhibitor	ALOX5
docetaxel	docetaxel|DOCETAXEL	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)C2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C	15H5577CQD	Launched	tubulin polymerization inhibitor	BCL2|MAP2|MAP4|MAPT|NR1I2|TUBB|TUBB1
doconexent	doconexent|DOCONEXENT	CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O	ZAD9OKH9JC	Launched	PPAR receptor agonist	FFAR1|PTGS1|PTGS2
doconexent-ethyl-ester	doconexent-ethyl-ester|ETHYL DOCOSAHEXAENOATE	CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC	7PO7G8PA8M	Launched	omega 3 fatty acid stimulant	
docosanol	docosanol|DOCOSANOL	CCCCCCCCCCCCCCCCCCCCCCO	9G1OE216XY	Launched	lipase clearing factor inhibitor	TLR7
docusate	docusate|DOCUSATE	CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(O)(=O)=O	M7P27195AG	Launched	laxative	
dodecyl-sulfate	dodecyl-sulfate|LAURYL SULFATE	CCCCCCCCCCCCOS(O)(=O)=O	DIQ16UC154	Preclinical		LYZ
dofequidar	dofequidar|DOFEQUIDAR	OC(COc1cccc2ncccc12)CN1CCN(CC1)C(=O)C(c1ccccc1)c1ccccc1	0BJK6B565B	Phase 3	MRP inhibitor|P glycoprotein inhibitor	ABCB1
dofetilide	dofetilide|DOFETILIDE	CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1	R4Z9X1N2ND	Withdrawn	potassium channel blocker	KCNH1|KCNH2|KCNJ12|KCNK2
dolasetron	dolasetron|DOLASETRON	O=C(O[C@H]1C[C@@H]2C[C@@H]3C[C@@H](C1)N2CC3=O)c1c[nH]c2ccccc12	82WI2L7Q6E	Launched	serotonin receptor antagonist	HTR3A
dolastatin-10	dolastatin-10|DOLASTATIN 10	CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C	EI946JT51X	Phase 2	tubulin polymerization inhibitor	TUBB
dolutegravir	dolutegravir|DOLUTEGRAVIR	C[C@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12	DKO1W9H7M1	Launched	HIV integrase inhibitor	CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1
domiphen	domiphen|DOMIPHEN	CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1	4AZL56CU0F	Preclinical		
domperidone	domperidone|DOMPERIDONE	Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1	5587267Z69	Launched	dopamine receptor antagonist	DRD2|DRD3
donepezil	donepezil|DONEPEZIL	COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC	8SSC91326P	Launched	acetylcholinesterase inhibitor	ACHE|HTR2A
donitriptan	donitriptan|DONITRIPTAN	NCCc1c[nH]c2ccc(OCC(=O)N3CCN(CC3)c3ccc(cc3)C#N)cc12	70968BVH2J	Phase 2	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6
dopamine	dopamine|DOPAMINE	NCCc1ccc(O)c(O)c1	VTD58H1Z2X	Launched	dopamine receptor agonist	DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4
doramapimod	doramapimod|DORAMAPIMOD	Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12)C(C)(C)C	HO1A8B3YVV	Phase 2	p38 MAPK inhibitor	MAPK11|MAPK12|MAPK13|MAPK14
doramectin	doramectin|DORAMECTIN	CO[C@H]1C[C@H](OC2[C@H](C)OC(C[C@@H]2OC)O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(C5)O[C@H](C5CCCCC5)[C@@H](C)C=C2)[C@]34O)O[C@@H](C)[C@@H]1O	KGD7A54H5P	Launched		
doripenem	doripenem|DORIPENEM	C[C@H](O)[C@H]1[C@@H]2[C@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N2C1=O)C(O)=O	BHV525JOBH	Launched	bacterial cell wall synthesis inhibitor	DPEP1
dorzolamide	dorzolamide|DORZOLAMIDE	CCN[C@@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(N)(=O)=O	9JDX055TW1	Launched	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA2|CA4|CA7
dosulepin	dosulepin|DOTHIEPIN	CN(C)CC\C=C1/c2ccccc2CSc2ccccc12	W13O82Z7HL	Launched	norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4
dovitinib	dovitinib|DOVITINIB	CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O	I35H55G906	Phase 3	EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB
doxapram	doxapram|DOXAPRAM	CCN1CC(CCN2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1	94F3830Q73	Launched	potassium channel blocker	KCNK3|KCNK9
doxazosin	doxazosin|DOXAZOSIN	COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1	NW1291F1W8	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7
doxepin	doxepin|CIDOXEPIN	CN(C)CC\C=C1\c2ccccc2COc2ccccc12	F96TTB8728	Launched	histamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HRH2|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|KCNH2|SLC6A2|SLC6A4
doxercalciferol	doxercalciferol|DOXERCALCIFEROL	CC(C)[C@H](C)\C=C\[C@@H](C)[C@@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1\C[C@H](O)C[C@H](O)C1=C	3DIZ9LF5Y9	Launched	vitamin D receptor agonist	VDR
doxifluridine	doxifluridine|DOXIFLURIDINE	C[C@H]1OC(C(O)[C@@H]1O)n1cc(F)c(=O)[nH]c1=O	V1JK16Y2JP	Launched	thymidylate synthase inhibitor	TYMS
doxofylline	doxofylline|DOXOFYLLINE	Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O	MPM23GMO7Z	Launched	adenosine receptor antagonist	ADORA1|PDE4A|PDE4B|PDE4C|PDE4D
doxorubicin	doxorubicin|DOXORUBICIN	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO	80168379AG	Launched	topoisomerase inhibitor	TOP2A
doxycycline	doxycycline|DOXYCYCLINE	C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12	N12000U13O	Launched	metalloproteinase inhibitor	MMP8
doxycycline-hyclate	doxycycline-hyclate|DOXYCYCLINE HYCLATE	CC(C)C[C@H](NC(=O)[C@@H]1O[C@H]1C(O)=O)C(=O)NCCCCN=C(N)N	19XTS3T51U	Launched	bacterial 30S ribosomal subunit inhibitor	
doxylamine	doxylamine|DOXYLAMINE	CN(C)CCOC(C)(c1ccccc1)c1ccccn1	95QB77JKPL	Launched	histamine receptor antagonist	CHRM1|HRH1
DPC-681	DPC-681	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNCc1cccc(F)c1)C(C)(C)C)S(=O)(=O)c1cccc(N)c1		Phase 1	HIV protease inhibitor	
DPCPX	DPCPX|8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE	CCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)C1CCCC1	9PTP4FOI9E	Phase 1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
DPI-201106	DPI-201106	OC(COc1cccc2[nH]c(cc12)C#N)CN1CCN(CC1)C(c1ccccc1)c1ccccc1		Phase 2	sodium channel activator	ADRB2
DPO-1	DPO-1	CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1P(=O)(c1ccccc1)c1ccccc1		Preclinical	potassium channel blocker	KCNA5
DPPE	DPPE|TESMILIFENE	CCN(CC)CCOc1ccc(Cc2ccccc2)cc1	I43T3ID6G2	Phase 3	histamine receptor antagonist	ABCB1|HRH1
DR-2313	DR-2313	Cc1nc(=O)c2CSCCc2[nH]1		Preclinical	PARP inhibitor	PARP1|PARP3
DRF053-(R)	DRF053-(R)	CC[C@H](CO)Nc1nc(Nc2cccc(c2)-c2ccccn2)c2ncn(C(C)C)c2n1		Preclinical	CDK inhibitor	CSNK1A1
drofenine	drofenine|DROFENINE	CCN(CC)CCOC(=O)C(C1CCCCC1)c1ccccc1	4QWV355536	Launched		
droloxifene	droloxifene|DROLOXIFENE	CC\C(=C(\c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1	0M67U6Z98F	Phase 3	selective estrogen receptor modulator (SERM)	ESR1
dromostanolone-propionate	dromostanolone-propionate|DROMOSTANOLONE PROPIONATE	CCC(=O)OC1CCC2C3CCC4CC(=O)C(C)CC4(C)C3CCC12C	X20UZ57G4O	Launched	androgen receptor modulator	AR
dronedarone	dronedarone|DRONEDARONE	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c1c(CCCC)oc2ccc(NS(C)(=O)=O)cc12	JQZ1L091Y2	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A
droperidol	droperidol|DROPERIDOL	Fc1ccc(cc1)C(=O)CCCN1CCC(=CC1)n1c2ccccc2[nH]c1=O	O9U0F09D5X	Launched	dopamine receptor antagonist	ADRA1A|DRD2|DRD3|DRD4|HTR2A
dropropizine	dropropizine|DROPROPIZINE	OCC(O)CN1CCN(CC1)c1ccccc1	U0K8WHL37U	Launched	antitussive	
drospirenone	drospirenone|17-EPIDROSPIRENONE|6,7-EPIDROSPIRENONE|DROSPIRENONE	C[C@]12CCC3C([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)C1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1	525L697X6M|D9Q360L95K|N295J34A25	Launched	mineralocorticoid receptor antagonist	AR|NR3C2|PGR
drotaverine	drotaverine|DROTAVERINE	CCOc1ccc(\C=C2\NCCc3cc(OCC)c(OCC)cc23)cc1OCC	98QS4N58TW	Launched	phosphodiesterase inhibitor	CACNA1C|PDE4A
droxicam	droxicam|DROXICAM	CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O	F24ADO1E2D	Launched	cyclooxygenase inhibitor	PTGS1
droxidopa	droxidopa|THREO-DIHYDROXYPHENYLSERINE|DROXIDOPA	N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O	24A0V01WKS|J7A92W69L7	Launched	norepinephrine precursor	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH
droxinostat	droxinostat	Cc1cc(Cl)ccc1OCCCC(=O)NO		Preclinical	HDAC inhibitor	HDAC6|HDAC8
DS2-(806622)	DS2-(806622)	Clc1ccc(cc1)C(=O)Nc1c(nc2ccccn12)-c1cccs1		Preclinical		
DU-728	DU-728|FIBRONECTIN TETRAPEPTIDE	N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O	AC6UDA2MFC	Phase 1	structural glycoprotein antagonist	ITGA2B|ITGB3
duloxetine	duloxetine|DULOXETINE	CNCC[C@H](Oc1cccc2ccccc12)c1cccs1	O5TNM5N07U	Launched	norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI)	HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4
DUP-697	DUP-697	CS(=O)(=O)c1ccc(cc1)-c1cc(Br)sc1-c1ccc(F)cc1		Phase 1	cyclooxygenase inhibitor	PTGS2
dutasteride	dutasteride|DUTASTERIDE	C[C@]12CC[C@@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@H]2C(=O)Nc1cc(ccc1C(F)(F)F)C(F)(F)F	O0J6XJN02I	Launched	5 alpha reductase inhibitor	SRD5A1|SRD5A2
DVD-111	DVD-111|NOOPEPT	CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)Cc1ccccc1	4QBJ98683M	Phase 2		
DY131	DY131|GSK-9089	CCN(CC)c1ccc(cc1)\C=N\NC(=O)c1ccc(O)cc1	5VWV92039E	Preclinical	estrogen-related receptor agonist	ESRRB|ESRRG
dyclonine	dyclonine|DYCLONINE	CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1	078A24Q30O	Launched	sodium channel blocker	SCN10A|SCN5A
dydrogesterone	dydrogesterone|DYDROGESTERONE	CC(=O)[C@H]1CCC2C3C=CC4=CC(=O)CC[C@@]4(C)C3CC[C@]12C	90I02KLE8K	Launched	progesterone receptor agonist	PGR
dynasore	dynasore	Oc1ccc(\C=N\NC(=O)c2cc3ccccc3cc2O)cc1O		Preclinical	dynamin inhibitor	DNM1|DNM1L|DNM2
dyphylline	dyphylline|DYPHYLLINE	Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O	263T0E9RR9	Launched	adenosine receptor antagonist|phosphodiesterase inhibitor	ADORA1|ADORA2A|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B
E-2012	E-2012	COc1cc(ccc1-n1cnc(C)c1)\C=C1/CCCN([C@@H](C)c2ccc(F)cc2)C1=O	3LSD4Y5F0F	Phase 1	gamma secretase modulator	APH1B
E-4031	E-4031	Cc1cccc(CCN2CCC(CC2)C(=O)c2ccc(NS(C)(=O)=O)cc2)n1		Phase 1	potassium channel blocker	KCNH1|KCNH2
E7449	E7449|E-7449	O=c1[nH][nH]c2nc(CN3Cc4ccccc4C3)nc3cccc1c23	9X5A2QIA7C	Phase 1/Phase 2	PARP inhibitor	PARP1|PARP2|TNKS|TNKS2
ebastine	ebastine|EBASTINE	CC(C)(C)c1ccc(cc1)C(=O)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1	TQD7Q784P1	Launched	histamine receptor antagonist	CYP3A4|HRH1
EBPC	EBPC	CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1=O		Preclinical	aldose reductase inhibitor	AKR1B1
ebrotidine	ebrotidine|EBROTIDINE	NC(=N)Nc1nc(CSCCN\C=N\S(=O)(=O)c2ccc(Br)cc2)cs1	TMZ3IBW2OW	Withdrawn	histamine receptor antagonist	HRH2
ebselen	ebselen|EBSELEN	O=c1n([se]c2ccccc12)-c1ccccc1	40X2P7DPGH	Phase 2/Phase 3	cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor	ALB
EC-23	EC-23	CC1(C)CCC(C)(C)c2cc(ccc12)C#Cc1ccc(cc1)C(O)=O		Preclinical	retinoid receptor agonist	RARA|RARB|RARG
ecabapide	ecabapide|ECABAPIDE	CNC(=O)c1cccc(NCC(=O)NCCc2ccc(OC)c(OC)c2)c1	4KA5WHL8T2	Phase 3		
ecabet	ecabet|ECABET	CC(C)c1cc2CC[C@H]3[C@@](C)(CCC[C@]3(C)c2cc1S(O)(=O)=O)C(O)=O	2K02669KWP	Launched	gastrin inhibitor|urease inhibitor	NOXO1
ecamsule-triethanolamine	ecamsule-triethanolamine|ECAMSULE DITRIETHANOLAMINE	CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/c1ccc(cc1)\C=C1\C2CCC(CS(O)(=O)=O)(C1=O)C2(C)C	078Q44I6CD	Launched		
echinomycin	echinomycin|ECHINOMYCIN	CSC1SCC2N(C)C(=O)C(C)NC(=O)C(COC(=O)C(C(C)C)N(C)C(=O)C1N(C)C(=O)C(C)NC(=O)C(COC(=O)C(C(C)C)N(C)C2=O)NC(=O)c1cnc2ccccc2n1)NC(=O)c1cnc2ccccc2n1	TG824J6RQT	Phase 2	DNA intercalating agent	
econazole	econazole|ECONAZOLE	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1	6Z1Y2V4A7M	Launched	lanosterol demethylase inhibitor|sterol demethylase inhibitor	CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5
ectoine-zwitterion	ectoine-zwitterion|ECTOINE	OC(=O)[C@@H]1CCNC(=C)N1	7GXZ3858RY	Preclinical		
edaravone	edaravone|EDARAVONE	CC1=NN(C(=O)C1)c1ccccc1	S798V6YJRP	Launched	nootropic agent	BCL2
edelfosine	edelfosine|EDELFOSINE	CCCCCCCCCCCCCCCCCCOC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC	1Y6SNA8L5S	Phase 2	phospholipase inhibitor	
editol	editol|EDETOL	CC(O)CN(CCN(CC(C)O)CC(C)O)CC(C)O	Q4R969U9FR	Preclinical		
edoxaban	edoxaban|EDOXABAN	CN(C)C(=O)[C@@H]1CC[C@H](NC(=O)C(=O)Nc2ccc(Cl)cn2)[C@H](C1)NC(=O)c1nc2CCN(C)Cc2s1	NDU3J18APO	Launched	coagulation factor inhibitor	F10
edoxudine	edoxudine|EDOXUDINE	CCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O	15ZQM81Y3R	Launched	DNA directed DNA polymerase inhibitor	
edrophonium	edrophonium|EDROPHONIUM	CC[N+](C)(C)c1cccc(O)c1	70FP3JLY7N	Launched	acetylcholinesterase inhibitor	ACHE|BCHE
EDTMP	EDTMP|LEXIDRONAM	OP(O)(=O)CN(CCN(CP(O)(O)=O)CP(O)(O)=O)CP(O)(O)=O	V4CP8RSX7V	Preclinical	chelating agent	
efaproxiral	efaproxiral|EFAPROXIRAL	Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(O)=O)cc2)c1	J81E81G364	Phase 3	haemoglobin oxygen release stimulant	HBA1|HBB
efaroxan	efaroxan|EFAROXAN	CCC1(Cc2ccccc2O1)C1=NCCN1	G00490L21H	Phase 2	adrenergic receptor antagonist	ADORA2A
efatutazone	efatutazone|EFATUTAZONE	Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N	M17ILL71MC	Phase 2	PPAR receptor agonist	PPARG
efavirenz	efavirenz|EFAVIRENZ	FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1	JE6H2O27P8	Launched	HIV protease inhibitor	CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4
efinaconazole	efinaconazole|EFINACONAZOLE	C[C@@H](N1CCC(=C)CC1)C(O)(Cn1cncn1)c1ccc(F)cc1F	J82SB7FXWB	Launched	lanosterol demethylase inhibitor	CYP51A1
eflornithine	eflornithine|EFLORNITHINE	NCCCC(N)(C(F)F)C(O)=O	ZQN1G5V6SR	Launched	ornithine decarboxylase inhibitor	ARG2|ODC1
efloxate	efloxate|EFLOXATE	CCOC(=O)COc1ccc2c(c1)oc(cc2=O)-c1ccccc1	CZU6V3902K	Preclinical	vasodilator	
efonidipine-monoethanolate	efonidipine-monoethanolate|EFONIDIPINE	CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(Cc1ccccc1)c1ccccc1	40ZTP2T37Q	Launched	L-type calcium channel blocker|T-type calcium channel blocker	CACNA1C|CACNA1G
EG00229	EG00229	NC(=N)NCCC[C@H](NC(=O)c1sccc1NS(=O)(=O)c1cccc2nsnc12)C(O)=O		Preclinical	neuropilin receptor antagonist	NRP1
EGF816	EGF816|NAZARTINIB	CN(C)C\C=C\C(=O)N1CCCC[C@H](C1)n1c(NC(=O)c2ccnc(C)c2)nc2cccc(Cl)c12	KE7K32EME8	Phase 2	EGFR inhibitor	EGFR
eglumetad	eglumetad|EGLUMETAD	N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O	ONU5A67T2S	Phase 2	glutamate receptor agonist	GRM2|GRM3|GRM6|GRM8
EHop-016	EHop-016	CCn1c2ccccc2c2cc(Nc3ccnc(NCCCN4CCOCC4)n3)ccc12		Preclinical	Ras GTPase inhibitor	RAC1|RAC3
EI1	EI1	CCC(CC)n1ccc2c(cc(cc12)C#N)C(=O)NCc1c(C)cc(C)[nH]c1=O		Preclinical	histone lysine methyltransferase inhibitor	EZH2
EIT-hydrobromide	EIT-hydrobromide	CCSC(N)=N		Preclinical	nitric oxide synthase inhibitor	NOS2|NOS3
elacridar	elacridar|ELACRIDAR	COc1cc2CCN(CCc3ccc(NC(=O)c4cccc5c4[nH]c4c(OC)cccc4c5=O)cc3)Cc2cc1OC	N488540F94	Phase 1	P glycoprotein inhibitor	ABCB1
elactocin	elactocin|LEPTOMYCIN B	CCC(\C=C\[C@H]1OC(=O)C=C[C@@H]1C)=C\[C@H](C)C\C=C\C(C)=C\[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C\C(C)=C\C(O)=O	Y031I2N1EO	Phase 1	exportin antagonist	XPO1
elafibranor	elafibranor|ELAFIBRANOR	CSc1ccc(cc1)C(=O)\C=C\c1cc(C)c(OC(C)(C)C(O)=O)c(C)c1	2J3H5C81A5	Phase 3	PPAR receptor agonist	PPARA|PPARD
elagolix	elagolix|ELAGOLIX	COc1cccc(c1F)-c1c(C)n(Cc2c(F)cccc2C(F)(F)F)c(=O)n(C[C@H](NCCCC(O)=O)c2ccccc2)c1=O	5B2546MB5Z	Phase 3	gonadotropin releasing factor hormone receptor antagonist	GNRHR
elbasvir	elbasvir|ELBASVIR	COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc2-c3cc4cc(ccc4n3[C@@H](Oc2c1)c1ccccc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C	632L571YDK	Launched	HCV inhibitor	
elemene	elemene|.BETA.-ELEMENE	CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C1)C(C)=C	2QG8CX6LXD	Phase 2	VEGFR inhibitor	
elesclomol	elesclomol|ELESCLOMOL	CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1	6UK191M53P	Phase 3	oxidative stress inducer	HSPA1A
eletriptan	eletriptan|ELETRIPTAN	CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12	22QOO9B8KI	Launched	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7
eliglustat	eliglustat|ELIGLUSTAT	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1	DR40J4WA67	Launched	Glycosyl transferase inhibitor	UGCG
elinogrel	elinogrel|ELINOGREL	CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F	915Y8E749J	Phase 2	purinergic receptor antagonist	P2RY12
eliprodil	eliprodil|ELIPRODIL	OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1	YW62A6TW29	Phase 3	glutamate receptor antagonist	GRIN1|GRIN2B
ellagic-acid	ellagic-acid|ELLAGIC ACID	Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O	19YRN3ZS9P	Phase 2	glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor	CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK
ELN-441958	ELN-441958	Clc1cccc2CN(C(=O)c12)c1cccc(c1)C(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1	G62X909Y89	Preclinical	bradykinin receptor antagonist	BDKRB1
eltanolone	eltanolone|ELTANOLONE	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	BXO86P3XXW	Phase 3	membrane integrity inhibitor	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2
eltoprazine	eltoprazine|ELTOPRAZINE	C1CN(CCN1)c1cccc2OCCOc12	510M006KO6	Phase 2	serotonin receptor agonist	HTR1A|HTR1B
eltrombopag	eltrombopag|ELTROMBOPAG	CC1=NN(C(=O)C\1=N\Nc1cccc(-c2cccc(c2)C(O)=O)c1O)c1ccc(C)c(C)c1	S56D65XJ9G	Launched	thrombopoietin receptor agonist	MPL
eluxadoline	eluxadoline|ELUXADOLINE	COc1ccc(CN([C@@H](C)c2ncc([nH]2)-c2ccccc2)C(=O)[C@@H](N)Cc2c(C)cc(cc2C)C(N)=O)cc1C(O)=O	45TPJ4MBQ1	Launched	opioid receptor modulator	OPRD1|OPRK1|OPRM1
elvitegravir	elvitegravir|ELVITEGRAVIR	COc1cc2n(cc(C(O)=O)c(=O)c2cc1Cc1cccc(Cl)c1F)[C@H](CO)C(C)C	4GDQ854U53	Launched	HIV integrase inhibitor	
embelin	embelin|EMBELIN	CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O	SHC6U8F5ER	Preclinical	HCV inhibitor|XIAP inhibitor	XIAP
EMD-1214063	EMD-1214063|TEPOTINIB	CN1CCC(COc2cnc(nc2)-c2cccc(Cn3nc(ccc3=O)-c3cccc(c3)C#N)c2)CC1	1IJV77EI07	Phase 1	hepatocyte growth factor receptor inhibitor	MET
EMD-386088	EMD-386088	Cc1[nH]c2ccc(Cl)cc2c1C1=CCNCC1		Preclinical	serotonin receptor agonist	HTR6
EMD-53998	EMD-53998	COc1ccc(cc1OC)C(=O)N1CCCc2cc(ccc12)C1=NNC(=O)SC1C		Phase 1	phosphodiesterase inhibitor	TNNC1
EMD-66684	EMD-66684	CCCCc1nc2ccn(CC(=O)N(C)C)c(=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1		Preclinical	angiotensin receptor antagonist	AGTR1
emedastine	emedastine|EMEDASTINE	CCOCCn1c(nc2ccccc12)N1CCCN(C)CC1	9J1H7Y9OJV	Launched	histamine receptor antagonist	HRH1
emetine	emetine|EMETINE	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3C2C[C@@H]1CC1NCCc2cc(OC)c(OC)cc12	X8D5EPO80M	Phase 2	protein synthesis inhibitor	RPS2
emodin	emodin|EMODIN	Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1	KA46RNI6HN	Preclinical	11-beta hydroxysteroid dehydrogenase inhibitor	CSNK2A1
emorfazone	emorfazone|EMORFAZONE	CCOc1c(cnn(C)c1=O)N1CCOCC1	V93U9DH62C	Launched	antiinflammatory agent|cyclooxygenase inhibitor	
emoxipin	emoxipin|EMOXYPINE	CCc1nc(C)ccc1O	V247P5H4E1	Phase 2		
empagliflozin	empagliflozin|EMPAGLIFLOZIN	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(O[C@H]3CCOC3)cc2)c1	HDC1R2M35U	Launched	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2
emtricitabine	emtricitabine|EMTRICITABINE|EMTRICITABINE, (+/-)-	Nc1nc(=O)n(cc1F)[C@@H]1CS[C@H](CO)O1	G70B4ETF4S|ULS8902U4O	Launched	nucleoside reverse transcriptase inhibitor	
EN460	EN460	OC(=O)c1cc(ccc1Cl)N1N=C(\C(=C\c2ccc(o2)-c2ccccc2)C1=O)C(F)(F)F		Preclinical	endoplasmic reticulum oxidation inhibitor	ERO1A
enalapril	enalapril|ENALAPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O	69PN84IO1A	Launched	angiotensin converting enzyme inhibitor	ACE
enalaprilat	enalaprilat|ENALAPRILAT	C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O	GV0O7ES0R3	Launched	angiotensin converting enzyme inhibitor	ACE
enasidenib	enasidenib|ENASIDENIB	CC(C)(O)CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)-c1cccc(n1)C(F)(F)F	3T1SS4E7AG	Phase 3	isocitrate dehydrogenase inhibitor	IDH1
enbucrilate	enbucrilate|ENBUCRILATE	CCCCOC(=O)C(=C)C#N	F8CEP82QNP	Launched		
enciprazine	enciprazine|ENCIPRAZINE	COc1ccccc1N1CCN(CC(O)COc2cc(OC)c(OC)c(OC)c2)CC1	L6X660925G	Phase 3	GABA receptor modulator	GABRA1
endo-IWR-1	endo-IWR-1	O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O		Preclinical	PARP inhibitor	TNKS|TNKS2
endoxifen	endoxifen|ENDOXIFEN	CC\C(c1ccccc1)=C(/c1ccc(O)cc1)c1ccc(OCCNC)cc1	46AF8680RC	Phase 2	estrogen receptor antagonist	ESR1
enflurane	enflurane|ENFLURANE	FC(F)OC(F)(F)C(F)Cl	91I69L5AY5	Launched	membrane permeability inhibitor	ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|KCNN4
enilconazole	enilconazole|ENILCONAZOLE	Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1	6K0NOF3XQ6	Launched	sterol demethylase inhibitor	CYP19A1|CYP1A2|CYP2B6|CYP2C9|CYP2J2|CYP3A4|CYP3A5|NR1I2|PPARA|PTGER2
eniluracil	eniluracil|ENILURACIL	Oc1ncc(C#C)c(O)n1	2E2W0W5XIU	Phase 3	dihydropyrimidine dehydrogenase inhibitor	AOX1|DPYD|XDH
enisamium-iodide	enisamium-iodide|ENISAMIUM IODIDE	C[n+]1ccc(cc1)C(=O)NCc1ccccc1	G22FG6Q00B	Launched		
ENMD-2076	ENMD-2076	CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(\C=C\c2ccccc2)n1	KXQ762CQTH	Phase 2	Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor	AURKA|FLT3|KDR|PDGFRA|PTK2|SRC
enocitabine	enocitabine|ENOCITABINE	CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)C(O)[C@H]2O)c(=O)n1	9YVR68W306	Launched	DNA synthesis inhibitor	CMPK1|RRM1|TYMS
enoxacin	enoxacin|ENOXACIN	CCn1cc(C(O)=O)c(=O)c2cc(F)c(nc12)N1CCNCC1	325OGW249P	Launched	topoisomerase inhibitor	TOP2A
enoximone	enoximone|ENOXIMONE	CSc1ccc(cc1)C(=O)c1[nH]c(O)nc1C	C7Z4ITI7L7	Launched	phosphodiesterase inhibitor	PDE3A
enoxolone	enoxolone|ENOXOLONE	C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)C3[C@@]4(C)CC[C@H](O)C(C)(C)C4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O	P540XA09DR	Launched	gap junction modulator	HSD11B1
enprofylline	enprofylline|ENPROFYLLINE	CCCn1c2nc[nH]c2c(=O)[nH]c1=O	DT7DT5E518	Phase 3	phosphodiesterase inhibitor	ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B
enrofloxacin	enrofloxacin|ENROFLOXACIN	CCN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1	3DX3XEK1BN	Launched	bacterial DNA gyrase inhibitor	
entacapone	entacapone|ENTACAPONE	CCN(CC)C(=O)C(\C#N)=C\c1cc(O)c(O)c(c1)[N+]([O-])=O	4975G9NM6T	Launched	catechol O methyltransferase inhibitor	COMT
entecavir	entecavir|ENTECAVIR	Nc1nc(=O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)C3=C)c2[nH]1	5968Y6H45M	Launched	DNA replication inhibitor|nucleoside reverse transcriptase inhibitor	
entinostat	entinostat|ENTINOSTAT	Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1	1ZNY4FKK9H	Phase 3	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC9
entrectinib	entrectinib|ENTRECTINIB	CN1CCN(CC1)c1ccc(C(=O)Nc2n[nH]c3ccc(Cc4cc(F)cc(F)c4)cc23)c(NC2CCOCC2)c1	L5ORF0AN1I	Phase 2	ALK tyrosine kinase receptor inhibitor|proto-oncogene tyrosine protein kinase inhibitor	ALK|NTRK1|NTRK2|NTRK3|ROS1
enzalutamide	enzalutamide|ENZALUTAMIDE	CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C1(C)C)c1ccc(C#N)c(c1)C(F)(F)F	93T0T9GKNU	Launched	androgen receptor antagonist	AR
enzastaurin	enzastaurin|ENZASTAURIN	Cn1cc(C2=C(C(=O)NC2=O)c2cn(C3CCN(Cc4ccccn4)CC3)c3ccccc23)c2ccccc12	UC96G28EQF	Phase 3	PKC inhibitor	AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG
EO-1428	EO-1428	Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl	MV2RHJ680O	Preclinical	p38 MAPK inhibitor	MAPK11|MAPK14
epacadostat	epacadostat|EPACADOSTAT	NS(=O)(=O)NCCNc1nonc1C(Nc1ccc(F)c(Br)c1)[N+][O-]	71596A9R13	Phase 3	indoleamine 2,3-dioxygenase inhibitor	IDO1
epalrestat	epalrestat|EPALRESTAT	CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/c1ccccc1	424DV0807X	Launched	aldose reductase inhibitor	AKR1B1
eperezolid	eperezolid|EPEREZOLID	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCN(CC2)C(=O)CO)c(F)c1	C460ZSU1OW	Phase 1	bacterial 30S ribosomal subunit inhibitor	
eperisone	eperisone|EPERISONE	CCc1ccc(cc1)C(=O)C(C)CN1CCCCC1	2M2P0551D3	Launched	acetylcholine receptor antagonist	CYP2J2
ephedrine	ephedrine|EPHEDRINE	CN[C@@H](C)[C@H](O)c1ccccc1	GN83C131XS	Launched	adrenergic receptor agonist	ACHE|ADRA1A|ADRB2|SLC18A2|SLC6A2
ephedrine-(racemic)	ephedrine-(racemic)|EPHEDRINE	CNC(C)C(O)c1ccccc1	GN83C131XS	Launched	adrenergic receptor agonist	ADRA1A|ADRA2A
epiandrosterone	epiandrosterone|EPIANDROSTERONE	C[C@]12CC[C@@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O	8TR252Z538	Preclinical	steroid	G6PD
epicatechin-gallate-(-)	epicatechin-gallate-(-)|EPICATECHIN GALLATE	Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c1ccc(O)c(O)c1	92587OVD8Z	Phase 2	bacterial DNA gyrase inhibitor	BACE1|FASN
epigallocatechin-gallate-(-)	epigallocatechin-gallate-(-)|EPIGALLOCATECHIN GALLATE	Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c1cc(O)c(O)c(O)c1	BQM438CTEL	Phase 2/Phase 3	bacterial DNA gyrase inhibitor	ELANE|EP300|FASN|KAT2B|MMP14|MMP2
epinastine	epinastine|EPINASTINE	NC1=NCC2N1c1ccccc1Cc1ccccc21	Q13WX941EF	Launched	histamine receptor antagonist	ADRA1A|ADRA2A|HRH1|HRH2|HTR2A|HTR7
epinephrine	epinephrine|EPINEPHRINE	CNC[C@H](O)c1ccc(O)c(O)c1	YKH834O4BH	Launched	adrenergic receptor agonist|neurotransmitter	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF
epinephrine-(racemic)	epinephrine-(racemic)|RACEPINEPHRINE	CNCC(O)c1ccc(O)c(O)c1	GR0L9S3J0F	Launched	carbonic anhydrase activator	
epirizole	epirizole|EPIRIZOLE	COc1cc(C)nn1-c1nc(C)cc(OC)n1	3B46O2FH8I	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
epirubicin	epirubicin|EPIRUBICIN	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO	3Z8479ZZ5X	Launched	topoisomerase inhibitor	CHD1|TOP2A
epitiostanol	epitiostanol|EPITIOSTANOL	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O	YE7586973L	Launched	androgen receptor agonist	AR
eplerenone	eplerenone|EPLERENONE	COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13	6995V82D0B	Launched	cytochrome P450 inhibitor	NR3C2
epomediol	epomediol|EPOMEDIOL	CC1(C)OC2(C)C(O)CC1CC2O	KFU4XSK3BK	Launched	cholesterol inhibitor	CYP7A1
epoprostenol	epoprostenol|EPOPROSTENOL	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC(O)=O	DCR9Z582X0	Launched	prostacyclin analog	P2RY12|PTGER1|PTGER4|PTGIR|PTGIS
epothilone-a	epothilone-a|EPOTHILONE A	C[C@H]1CCC[C@H]2O[C@H]2C[C@@H](OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1	51E07YBX96	Preclinical	microtubule stabilizing agent	
epothilone-b	epothilone-b|PATUPILONE	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@@H](OC(=O)C[C@@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1	UEC0H0URSE	Phase 3	microtubule stabilizing agent|tubulin polymerization inhibitor	TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B
epothilone-d	epothilone-d|EPOTHILONE D	C[C@H]1CCC\C(C)=C/C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1	T0358E0YUF	Phase 2	microtubule stabilizing agent|tubulin polymerization inhibitor	TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B
eprazinone	eprazinone|EPRAZINONE	CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1	883YNL63WU	Launched	mucolytic agent	
eprinomectin	eprinomectin|EPRINOMECTIN B1A	CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](NC(C)=O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C	00OY54D31C	Launched	benzodiazepine receptor agonist	
eprobemide	eprobemide|EPROBEMIDE	Clc1ccc(cc1)C(=O)NCCCN1CCOCC1	URX5F7RDER	Launched	monoamine oxidase inhibitor	MAOA
eprodisate	eprodisate|EPRODISATE	OS(=O)(=O)CCCS(O)(=O)=O	6QFP76V7S7	Phase 3	antiamyloidogenic agent|amyloid protein inhibitor	SAA1
eprosartan	eprosartan|EPROSARTAN	CCCCc1ncc(\C=C(/Cc2cccs2)C(O)=O)n1Cc1ccc(cc1)C(O)=O	2KH13Z0S0Y	Launched	angiotensin receptor antagonist	AGTR1
eptifibatide	eptifibatide|EPTIFIBATIDE	NC(=N)NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O	NA8320J834	Launched	platelet aggregation inhibitor	ITGA2B|ITGB3
EPZ-5676	EPZ-5676|PINOMETOSTAT	CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12)[C@@H]1C[C@H](CCc2nc3cc(ccc3[nH]2)C(C)(C)C)C1	8V9YR09EF3	Phase 1	histone lysine methyltransferase inhibitor	DOT1L
EPZ004777	EPZ004777	CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc2c(N)ncnc12		Preclinical	histone lysine methyltransferase inhibitor	DOT1L
EPZ005687	EPZ005687	Cc1cc(C)c(CNC(=O)c2cc(cc3n(ncc23)C2CCCC2)-c2ccc(CN3CCOCC3)cc2)c(=O)[nH]1		Preclinical	histone lysine methyltransferase inhibitor	EZH2
EPZ011989	EPZ011989	CCN([C@H]1CC[C@@H](CC1)N(C)CCOC)c1cc(cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C#CCN1CCOCC1		Preclinical	histone lysine methyltransferase inhibitor	EZH2
EPZ015666	EPZ015666	O[C@@H](CNC(=O)c1cc(NC2COC2)ncn1)CN1CCc2ccccc2C1		Preclinical	protein arginine N-methyltransferase inhibitor	PRMT5
EPZ020411	EPZ020411	CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@@H](C2)OCCC2CCOCC2)cc1		Preclinical	protein arginine N-methyltransferase inhibitor	PRMT6
equilin	equilin|EQUILIN	CC12CCC3C(=CCc4cc(O)ccc34)C1CCC2=O	08O86EX0J4	Preclinical	estrogen receptor agonist	HSD17B1
equol	equol|EQUOL, (-)-	Oc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1	2T6D2HPX7Q	Launched	estrogen receptor agonist	ESR1|ESR2
ER-27319	ER-27319	Cc1ccc2c(c1C)n(CCCN)c1ccccc1c2=O	218W96J218	Preclinical	mediator release inhibitor|SYK inhibitor	SYK
erastin	erastin	CCOc1ccccc1-n1c(=O)c2ccccc2nc1C(C)N1CCN(CC1)C(=O)COc1ccc(Cl)cc1		Preclinical	ion channel antagonist	VDAC2
erbstatin-analog	erbstatin-analog	COC(=O)\C=C\c1cc(O)ccc1O		Preclinical	EGFR inhibitor|tyrosine kinase inhibitor	EGFR
ercalcitriol	ercalcitriol|1,25-DIHYDROXYCALCIFEROL	C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	5RWP08OQ36	Phase 1	vitamin D receptor agonist	VDR
erdafitinib	erdafitinib|ERDAFITINIB	COc1cc(OC)cc(c1)N(CCNC(C)C)c1ccc2ncc(nc2c1)-c1cnn(C)c1	890E37NHMV	Phase 2	FGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4
erdosteine	erdosteine|ERDOSTEINE	OC(=O)CSCC(=O)NC1CCSC1=O	76J0853EKA	Launched	mucolytic agent	
ergocalciferol	ergocalciferol|ERGOCALCIFEROL	CC(C)[C@@H](C)\C=C\[C@@H](C)C1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C	VS041H42XC	Launched	vitamin analog	VDR
ergonovine	ergonovine|ERGONOVINE	CC(CO)NC(=O)C1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34	WH41D8433D	Launched	adrenergic receptor agonist|serotonin receptor agonist	ADRA1A|HTR1E
ergosterol	ergosterol|ERGOSTEROL	CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	Z30RAY509F	Preclinical	vitamin D precursor	
ergotamine	ergotamine|ERGOTAMINE	CN1C[C@@H](C=C2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)C3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O	PR834Q503T	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|DRD1|DRD2|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|SLC6A2
ERK5-IN-1	ERK5-IN-1	COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1		Preclinical	MAP kinase inhibitor	MAPK7
erlotinib	erlotinib|ERLOTINIB	COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC	J4T82NDH7E	Launched	EGFR inhibitor	EGFR|NR1I2
ertapenem	ertapenem|ERTAPENEM	C[C@@H](O)C1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)Nc3cccc(c3)C(O)=O)=C(N2C1=O)C(O)=O	G32F6EID2H	Launched	bacterial cell wall synthesis inhibitor	
erteberel	erteberel|ERTEBEREL	Oc1ccc(cc1)[C@@H]1Oc2ccc(O)cc2[C@@H]2CCC[C@H]12	2ZUL6758TZ	Phase 2	estrogen receptor agonist	ESR1|ESR2
ertugliflozin	ertugliflozin|ERTUGLIFLOZIN	CCOc1ccc(Cc2cc(ccc2Cl)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1	6C282481IP	Phase 3	sodium/glucose cotransporter inhibitor	SLC5A2
erythritol	erythritol|ERYTHRITOL	OC[C@H](O)[C@H](O)CO	RA96B954X6	Launched		
erythromycin	erythromycin|ERYTHROMYCIN	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@@](C)(OC)[C@H](O)[C@@H](C)O2)[C@H](C)[C@@H](O[C@H]2OC(C)C[C@H]([C@H]2O)N(C)C)[C@@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	63937KV33D	Launched	NFkB pathway inhibitor	MLNR
erythromycin-estolate	erythromycin-estolate|ERYTHROMYCIN ESTOLATE	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	XRJ2P631HP	Launched	bacterial 50S ribosomal subunit inhibitor	ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1
erythromycin-ethylsuccinate	erythromycin-ethylsuccinate|ERYTHROMYCIN ETHYLSUCCINATE	CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C	1014KSJ86F	Launched	cytochrome P450 inhibitor|protein synthesis inhibitor	ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1
erythrosine	erythrosine|FD&C RED NO. 3	OC(=O)c1ccccc1-c1c2cc(I)c(O)c(I)c2oc2c(I)c(=O)c(I)cc12	PN2ZH5LOQY	Preclinical	coloring agent	
esaprazole	esaprazole|ESAPRAZOLE	O=C(CN1CCNCC1)NC1CCCCC1	38QSU0IB5L	Phase 2		
escin	escin|.ALPHA.-ESCIN|.BETA.-ESCIN	C\C=C(\C)C(=O)O[C@@H]1[C@H](OC(C)=O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(O)=O)[C@](C)(CO)C5CC[C@@]34C)C2CC1(C)C	LB5DJT9FIW|QYK0D6H79O	Launched	nitric oxide synthase stimulant	
escitalopram	escitalopram|ESCITALOPRAM	CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c1ccc(F)cc1	4O4S742ANY	Launched	selective serotonin reuptake inhibitor (SSRI)	ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4
esculin	esculin|ESCULIN	OC[C@H]1O[C@@H](Oc2cc3ccc(=O)oc3cc2O)[C@@H](O)[C@@H](O)[C@@H]1O	1Y1L18LQAF	Phase 1	antioxidant	
eseroline-(-)	eseroline-(-)	CN1CC[C@]2(C)[C@H]1N(C)c1ccc(O)cc21		Preclinical	acetylcholinesterase inhibitor	OPRD1|OPRM1
ESI-09	ESI-09	CC(C)(C)c1cc(no1)C(=O)C(\C#N)=N\Nc1cccc(Cl)c1		Preclinical	EPAC inhibitor	RAPGEF3|RAPGEF4
eslicarbazepine-acetate	eslicarbazepine-acetate|ESLICARBAZEPINE ACETATE	CC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc12	BEA68ZVB2K	Launched	sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
esmolol	esmolol|ESMOLOL	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1	MDY902UXSR	Launched	adrenergic receptor antagonist	ADRB1
esomeprazole	esomeprazole|OMEPRAZOLE	COc1ccc2[nH]c(nc2c1)[S@@](=O)Cc1ncc(C)c(OC)c1C	KG60484QX9	Launched	ATPase inhibitor	ATP4A
estetrol	estetrol|ESTETROL	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O	ENB39R14VF	Phase 3	selective estrogen receptor modulator (SERM)	ESR1
estradiol	estradiol|ESTRADIOL	C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2O	4TI98Z838E	Launched	estrogen receptor agonist	ESR1|ESR2|GPER1|KCNMA1|NR1I2
estradiol-acetate	estradiol-acetate|ESTRADIOL ACETATE	CC(=O)Oc1ccc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2c1	5R97F5H93P	Launched	estrogen receptor agonist	ESR1
estradiol-benzoate	estradiol-benzoate|ESTRADIOL BENZOATE	C[C@]12CCC3C(CCc4cc(OC(=O)c5ccccc5)ccc34)C1CC[C@@H]2O	1S4CJB5ZGN	Preclinical	contraceptive agent	ESR1
estradiol-cypionate	estradiol-cypionate|ESTRADIOL CYPIONATE	C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2OC(=O)CCC1CCCC1	7E1DV054LO	Launched	estrogen receptor agonist	ESR1
estradiol-valerate	estradiol-valerate|ESTRADIOL VALERATE	CCCCC(=O)O[C@H]1CCC2C3CCc4cc(O)ccc4C3CC[C@]12C	OKG364O896	Launched	estrogen receptor agonist	ESR1
estramustine	estramustine|ESTRAMUSTINE	C[C@]12CCC3C(CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)C1CC[C@@H]2O	35LT29625A	Launched	DNA alkylating agent	ESR1|ESR2|MAP1A|MAP2
estramustine-phosphate	estramustine-phosphate|ESTRAMUSTINE PHOSPHATE	C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O	MUZ9585Y7B	Launched	DNA synthesis inhibitor|microtubule inhibitor	ESR1|ESR2|MAP1A|MAP2
estriol	estriol|ESTRIOL	C[C@]12CCC3C(CCc4cc(O)ccc34)C1C[C@@H](O)[C@@H]2O	FB33469R8E	Launched	estrogen receptor agonist	ESR1|ESR2
estrone	estrone|ESTRONE|ESTRONE, (+/-)-	C[C@]12CCC3C(CCc4cc(O)ccc34)C1CCC2=O	2DI9HA706A|X9XKA379T9	Launched	estrogen receptor agonist|estrogenic hormone	ESR1|ESR2
estropipate	estropipate|ESTROPIPATE	C[C@]12CCC3C(CCc4cc(OS(O)(=O)=O)ccc34)C1CCC2=O	SVI38UY019	Launched	estrogen receptor agonist	ESR1|ESR2
eszopiclone	eszopiclone|ESZOPICLONE	CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1	UZX80K71OE	Launched	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO
etacrynic-acid	etacrynic-acid|ETHACRYNIC ACID	CCC(=C)C(=O)c1ccc(OCC(O)=O)c(Cl)c1Cl	M5DP350VZV	Launched	sodium/potassium/chloride transporter inhibitor	ATP1A1|SLC12A1
etafenone	etafenone|ETAFENONE	CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1	0I14K589E7	Launched	calcium channel blocker	
etamsylate	etamsylate|ETHAMSYLATE	Oc1ccc(O)c(c1)S(O)(=O)=O	24YL531VOH	Launched	haemostatic agent	
etanidazole	etanidazole|ETANIDAZOLE	OCCNC(=O)Cn1ccnc1[N+]([O-])=O	30DKA3Q1HL	Phase 3	bacterial cell wall synthesis inhibitor	
etazolate	etazolate|ETAZOLATE	CCOC(=O)c1cnc2n(CC)ncc2c1NN=C(C)C	I89Y79062L	Phase 2	phosphodiesterase inhibitor	GABRB3|PDE4A
ETC-1002	ETC-1002|BEMPEDOIC ACID	CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O	1EJ6Z6Q368	Phase 3	AMPK inhibitor	ACLY
ETC-159	ETC-159	Cn1c2ncn(CC(=O)Nc3ccc(nn3)-c3ccccc3)c2c(=O)n(C)c1=O		Phase 1	porcupine inhibitor|beta catenin inhibitor	PORCN
etebenecid	etebenecid|ETEBENECID	CCN(CC)S(=O)(=O)c1ccc(cc1)C(O)=O	4413I5098G	Preclinical	uricosuric blocker	
eterobarb	eterobarb|ETEROBARB	CCC1(C(=O)N(COC)C(=O)N(COC)C1=O)c1ccccc1	432SI047GA	Phase 2	anticonvulsant	
ethacizin	ethacizin|ETHACIZINE	CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN(CC)CC)c2c1	FE5SPV1Z6G	Launched	anticonvulsant	
ethacridine-lactate-monohydrate	ethacridine-lactate-monohydrate|ETHACRIDINE	CCOc1ccc2nc3cc(N)ccc3c(N)c2c1	WIX85M1A6R	Preclinical	DNA intercalating agent	
ethambutol	ethambutol|ETHAMBUTOL	CC[C@@H](CO)NCCN[C@@H](CC)CO	8G167061QZ	Launched	bacterial cell wall synthesis inhibitor	
ethamivan	ethamivan|ETHAMIVAN	CCN(CC)C(=O)c1ccc(O)c(OC)c1	M44O63YPV9	Preclinical	respiratory stimulant	
ethanolamine-oleate	ethanolamine-oleate|ETHANOLAMINE OLEATE	NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O	U4RY8MRX7C	Launched	immunostimulant	F12|FABP4|FFAR1|FFAR4|PLD2
ethaverine	ethaverine|ETHAVERINE	CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC	2H2HC19DYZ	Launched	calcium channel blocker	
ethenzamide	ethenzamide|ETHENZAMIDE	CCOc1ccccc1C(N)=O	L929ZCK4BF	Launched	analgesic agent	
ethimizol	ethimizol|ETIMIZOL	CCn1cnc(C(=O)NC)c1C(=O)NC	NG2MF3646P	Phase 1		
ethinyl-estradiol	ethinyl-estradiol|ETHINYL ESTRADIOL	C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@]2(O)C#C	423D2T571U	Launched	estrogen receptor agonist|estrogenic hormone	ESR1|ESR2|NR1I2
ethionamide	ethionamide|ETHIONAMIDE	CCc1cc(ccn1)C(S)=N	OAY8ORS3CQ	Launched	mycolic synthesis inhibitor	
ethisterone	ethisterone|ETHISTERONE	CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2(O)C#C	P201BVY1MJ	Launched	progestogen hormone	TYR
ethopabate	ethopabate|ETHOPABATE	CCOc1cc(NC(C)=O)ccc1C(=O)OC	F4X3L6068O	Launched	antiprotozoal agent	
ethosuximide	ethosuximide|ETHOSUXIMIDE	CCC1(C)CC(=O)NC1=O	5SEH9X1D1D	Launched	succinimide antiepileptic	CACNA1G|CACNA1H|CACNA1I
ethotoin	ethotoin|ETHOTOIN	CCN1C(=O)NC(C1=O)c1ccccc1	46QG38NC4U	Launched	hydantoin antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
ethoxyquin	ethoxyquin|ETHOXYQUIN	CCOc1ccc2NC(C)(C)C=C(C)c2c1	9T1410R4OR	Preclinical	antioxidant	
ethoxzolamide	ethoxzolamide|ETHOXZOLAMIDE	CCOc1ccc2nc(sc2c1)S(N)(=O)=O	Z52H4811WX	Launched	carbonic anhydrase inhibitor	CA1|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9
ethyl-2-(carbamoyloxy)benzoate	ethyl-2-(carbamoyloxy)benzoate	CCOC(=O)c1ccccc1OC(N)=O		Phase 1		
ethyl-paraben	ethyl-paraben|ETHYLPARABEN	CCOC(=O)c1ccc(O)cc1	14255EXE39	Preclinical		
ethyl-pyruvate	ethyl-pyruvate|ETHYL PYRUVATE	CCOC(=O)C(C)=O	03O98E01OB	Phase 2	tumor necrosis factor production inhibitor	HMGB1|TNF
ethyl-vanillin	ethyl-vanillin|ETHYL VANILLIN	CCOc1cc(C=O)ccc1O	YC9ST449YJ	Preclinical		
ethylenediaminetetraacetic-acid	ethylenediaminetetraacetic-acid|EDETIC ACID	OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O	9G34HU7RV0	Launched	PKC inhibitor	
ethylnorepinephrine	ethylnorepinephrine|ETHYLNOREPINEPHRINE	CCC(N)C(O)c1ccc(O)c(O)c1	M6AY4VCZ0A	Preclinical	bronchodilator	
ethynodiol-diacetate	ethynodiol-diacetate|ETHYNODIOL DIACETATE	CC(=O)O[C@H]1CC[C@@H]2[C@@H]3CC[C@@]4(C)[C@@H](CC[C@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1	62H10A1236	Launched		ESR1|PGR
eticlopride	eticlopride|ETICLOPRIDE	CCN1CCC[C@H]1CNC(=O)c1c(O)c(CC)cc(Cl)c1OC	J8M468HBH4	Preclinical	dopamine receptor antagonist	DRD2|DRD3|DRD4
etidronic-acid	etidronic-acid|ETIDRONIC ACID	CC(O)(P(O)(O)=O)P(O)(O)=O	M2F465ROXU	Launched	bone resorption inhibitor	ATP6V1A|PTPRS
etifenin	etifenin|ETIFENIN	CCc1cccc(CC)c1NC(=O)CN(CC(O)=O)CC(O)=O	MH922908EB	Preclinical	renal function diagnostic agent	
etifoxine	etifoxine|ETIFOXINE	CCNC1=Nc2ccc(Cl)cc2C(C)(O1)c1ccccc1	X24X82MX4X	Launched	GABA receptor modulator	GABRA1|GABRA2|GABRA3|GABRA5
etilefrine	etilefrine|ETILEFRINE	CCNCC(O)c1cccc(O)c1	ZB6F8MY53V	Launched	adrenergic receptor agonist	ADRA1A|ADRB1
etilevodopa	etilevodopa|ETILEVODOPA	CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1	895X917GYE	Phase 3	dopamine receptor agonist	DRD3
etizolam	etizolam|ETIZOLAM	CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl	A76XI0HL37	Launched	benzodiazepine receptor agonist	GABRA1
etodolac	etodolac|ETODOLAC	CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12	2M36281008	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2|RXRA
etofenamate	etofenamate|ETOFENAMATE	OCCOCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F	KZF0XM66JC	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
etofibrate	etofibrate|ETOFIBRATE	CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1	23TF67G79M	Launched	PPAR receptor agonist	PPARA
etofylline	etofylline|ETOFYLLINE	Cn1c2ncn(CCO)c2c(=O)n(C)c1=O	L164909TBI	Launched	adenosine receptor antagonist	ADORA1
etofylline-clofibrate	etofylline-clofibrate|THEOFIBRATE	Cn1c2ncn(CCOC(=O)C(C)(C)Oc3ccc(Cl)cc3)c2c(=O)n(C)c1=O	14UH1JQP6L	Launched	platelet aggregation inhibitor	PPARA
etomidate	etomidate|ETOMIDATE	CCOC(=O)c1cncn1C(C)c1ccccc1	Z22628B598	Launched	GABA receptor modulator	ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
etomoxir	etomoxir|ETOMOXIR	CCOC(=O)[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1	MSB3DD2XP6	Phase 2	carnitine palmitoyltransferase inhibitor	CPT1A
etonogestrel	etonogestrel|ETONOGESTREL	CCC12CC(=C)C3C(CCC4=CC(=O)CCC34)C1CC[C@@]2(O)C#C	304GTH6RNH	Launched	progesterone receptor agonist	ESR1|PGR
etoposide	etoposide|ETOPOSIDE	COc1cc(cc(OC)c1O)[C@H]1[C@@H]2C(COC2=O)C(OC2O[C@@H]3COC(C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12	6PLQ3CP4P3	Launched	topoisomerase inhibitor	TOP2A|TOP2B
etoposide-phosphate	etoposide-phosphate|ETOPOSIDE PHOSPHATE	COc1cc(cc(OC)c1OP(O)(O)=O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12	528XYJ8L1N	Launched	topoisomerase inhibitor	TOP2A
etoricoxib	etoricoxib|ETORICOXIB	Cc1ccc(cn1)-c1ncc(Cl)cc1-c1ccc(cc1)S(C)(=O)=O	WRX4NFY03R	Launched	cyclooxygenase inhibitor	PTGS2
etosalamide	etosalamide|ETOSALAMIDE	CCOCCOc1ccccc1C(N)=O	1PU994YJUH	Preclinical	anti-inflammatory agent	
etoxybamide	etoxybamide|ETOXYBAMIDE	OCCCC(=O)NCCO	654KS873DM	Phase 2		
ETP-46464	ETP-46464	CC(C)(C#N)c1ccc(cc1)N1C(=O)OCc2cnc3ccc(cc3c12)-c1cnc2ccccc2c1		Preclinical	ATR kinase inhibitor	
etravirine	etravirine|ETRAVIRINE	Cc1cc(cc(C)c1Oc1nc(Nc2ccc(cc2)C#N)nc(N)c1Br)C#N	0C50HW4FO1	Launched	non-nucleoside reverse transcriptase inhibitor	CYP2C19|CYP2C9|CYP3A4
etretinate	etretinate|ETRETINATE	CCOC(=O)\C=C(C)\C=C\C=C(C)\C=C\c1c(C)cc(OC)c(C)c1C	65M2UDR9AG	Withdrawn	protein synthesis inhibitor	RARA|RARB|RARG|RXRA|RXRB|RXRG
eucalyptol	eucalyptol|EUCALYPTOL	C[C@@]12CC[C@@H](CC1)C(C)(C)O2	RV6J6604TK	Launched	acetylcholinesterase inhibitor	ACHE
eucatropine	eucatropine|EUCATROPINE	CC1CC(CC(C)(C)N1C)OC(=O)C(O)c1ccccc1	4SPJ105W8E	Preclinical	acetylcholine receptor antagonist	
eugenol	eugenol|EUGENOL	COc1cc(CC=C)ccc1O	3T8H1794QW	Launched	androgen receptor antagonist	AR
EUK-134	EUK-134|ETHYLBISIMINOMETHYLGUAIACOL MANGANESE CHLORIDE	COc1cccc2C=[N+]3CC[N+]4=Cc5cccc(OC)c5O[Mn]34(Cl)Oc12	SM5YJ88LTU	Preclinical	catalase stimulant	APP|SOD2
eupatilin	eupatilin|EUPATILIN	COc1ccc(cc1OC)-c1cc(=O)c2c(O)c(OC)c(O)cc2o1	4D58O05490	Launched	mucus protecting agent	
evacetrapib	evacetrapib|EVACETRAPIB	Cc1cc(C)c2N(C[C@H]3CC[C@@H](CC3)C(O)=O)CCC[C@H](N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)c3nnn(C)n3)c2c1	51XWV9K850	Phase 3	cholesteryl ester transfer protein inhibitor	CETP
evans-blue	evans-blue|EVANS BLUE	Cc1cc(ccc1\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O)-c1ccc(c(C)c1)\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O	45PG892GO1	Launched	glutamate receptor negative allosteric modulator	GRIA1|PTPN1
evatanepag	evatanepag|EVATANEPAG	CC(C)(C)c1ccc(CN(Cc2cccc(OCC(O)=O)c2)S(=O)(=O)c2cccnc2)cc1	L266R6E31E	Phase 2	prostaglandin inhibitor	PTGER2|PTGER4
everolimus	everolimus|EVEROLIMUS	CO[C@@H]1C[C@H](C[C@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO	9HW64Q8G6G	Launched	mTOR inhibitor	MTOR
evodiamine	evodiamine|EVODIAMINE	CN1C2N(CCc3c2[nH]c2ccccc32)C(=O)c2ccccc12	C01825BVNL	Preclinical	ATPase inhibitor|TRPV agonist	TRPV1
EVP-6124	EVP-6124|ENCENICLINE	Clc1cccc2cc(sc12)C(=O)N[C@H]1CN2CCC1CC2	5FI5376A0X	Phase 3	acetylcholine receptor agonist	CHRNA7
EVP4593	EVP4593	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		Preclinical	NFkB pathway inhibitor	
EW-7197	EW-7197	Cc1cccc(n1)-c1[nH]c(CNc2ccccc2F)nc1-c1ccc2ncnn2c1		Phase 1	TGF beta receptor inhibitor	ACVR1B|TGFBR1
EX-527	EX-527|SELISISTAT	NC(=O)C1CCCc2c1[nH]c1ccc(Cl)cc21	L19ECD5014	Phase 2	SIRT inhibitor	SIRT1
exalamide	exalamide|EXALAMIDE	CCCCCCOc1ccccc1C(N)=O	7JEC65JCG2	Launched	membrane permeability inhibitor	
examorelin	examorelin|EXAMORELIN	C[C@H](NC(=O)[C@@H](Cc1c(C)[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O	09QF37C617	Phase 2	growth hormone releasing factor agonist	GHRHR|GHSR
exatecan-mesylate	exatecan-mesylate|EXATECAN MESYLATE	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45	D2VJ1CC26Q	Phase 3	topoisomerase inhibitor	TOP1
exemestane	exemestane|EXEMESTANE	C[C@]12CCC3C(CC(=C)C4=CC(=O)C=C[C@]34C)C1CCC2=O	NY22HMQ4BX	Launched	aromatase inhibitor	CYP19A1
exenatide	exenatide	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O		Launched	GLP receptor agonist	GLP1R
exherin	exherin|ADH-1	CC(C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(N)=O)NC(C)=O	B058ME29VU	Phase 2	cadherin antagonist	CDH2
exifone	exifone|EXIFONE	Oc1ccc(C(=O)c2cc(O)c(O)c(O)c2)c(O)c1O	38K9TOD4EG	Withdrawn	nootropic agent	TYR
exisulind	exisulind|EXISULIND	CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)(=O)=O	K619IIG2R9	Phase 3	phosphodiesterase inhibitor	PDE5A
EXO-1	EXO-1	COC(=O)c1ccccc1NC(=O)c1ccc(F)cc1		Preclinical	ARF inhibitor	
ezatiostat	ezatiostat|EZATIOSTAT	CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1	057D10I8S8	Phase 2	glutathione transferase inhibitor	GSTP1
ezetimibe	ezetimibe|EZETIMIBE	OC(CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1	EOR26LQQ24	Launched	cholesterol inhibitor|Niemann-Pick C1-like 1 protein antagonist	ANPEP|NPC1L1|SOAT1
ezutromid	ezutromid|EZUTROMID	CCN(CC)c1ccc(cc1)-n1nc2cc(C)c(N)cc2n1	645R07LF0D	Phase 2	utrophin enhancer	UTRN
F-11440	F-11440|EPTAPIRONE	Cn1c(=O)cnn(CCCCN2CCN(CC2)c2ncccn2)c1=O	3M824XRO8N	Phase 2	serotonin receptor agonist	HTR1A
F351	F351|HYDRONIDONE	Cc1ccc(=O)n(c1)-c1ccc(O)cc1	RXQ128313W	Phase 2	TGF beta receptor inhibitor	TGFB1
fadrozole	fadrozole|FADROZOLE	N#Cc1ccc(cc1)C1CCCc2cncn12	H3988M64PU	Launched	aromatase inhibitor	CYP11B1|CYP19A1
fagomine	fagomine|FAGOMINE, (D)-	OC[C@H]1NCC[C@@H](O)[C@@H]1O	1M10C1P4SM	Phase 2	glucosidase inhibitor	GLB1
falecalcitriol	falecalcitriol|FALECALCITRIOL	C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	G70A8514T8	Launched	vitamin D receptor agonist	VDR
famciclovir	famciclovir|FAMCICLOVIR	CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(C)=O	QIC03ANI02	Launched	DNA polymerase inhibitor	
famotidine	famotidine|FAMOTIDINE	NC(N)=Nc1nc(CSCC\C(N)=N/S(N)(=O)=O)cs1	5QZO15J2Z8	Launched	histamine receptor antagonist	HRH2
famprofazone	famprofazone|FAMPROFAZONE	CC(Cc1ccccc1)N(C)Cc1c(C(C)C)c(=O)n(-c2ccccc2)n1C	HN0NCX453C	Preclinical	cyclooxygenase inhibitor	
fananserin	fananserin|FANANSERIN	Fc1ccc(cc1)N1CCN(CCCN2c3cccc4cccc(c34)S2(=O)=O)CC1	38QJ762ET6	Phase 2	dopamine receptor antagonist|serotonin receptor antagonist	HTR2A
fanetizole	fanetizole|FANETIZOLE	C(Cc1ccccc1)Nc1nc(cs1)-c1ccccc1	BH48F620JA	Phase 3	neutrophil superoxide production	
farnesyl-thiosalicylic-acid-amide	farnesyl-thiosalicylic-acid-amide	CC(C)=CCC\C(C)=C\CC\C(C)=C\CSc1ccccc1C(N)=O		Phase 1	Ras GTPase inhibitor	HRAS
faropenem	faropenem|FAROPENEM	CC(O)C1C2SC(C3CCCO3)=C(N2C1=O)C(O)=O	F52Y83BGH3	Launched	lactamase inhibitor	
faropenem-medoxomil	faropenem-medoxomil|FAROPENEM MEDOXOMIL	C[C@@H](O)[C@@H]1[C@H]2SC([C@H]3CCCO3)=C(N2C1=O)C(=O)OCc1oc(=O)oc1C	5OK523O4FU	Launched	lactamase inhibitor	
fasudil	fasudil|FASUDIL	O=S(=O)(N1CCCNCC1)c1cccc2cnccc12	Q0CH43PGXS	Launched	rho associated kinase inhibitor	PKIA|PRKACA|ROCK1|ROCK2
favipiravir	favipiravir|FAVIPIRAVIR	NC(=O)c1nc(F)cnc1O	EW5GL2X7E0	Phase 3	RNA polymerase inhibitor	
FCE-22250	FCE-22250	COC1\C=C\OC2(C)Oc3c(C2=O)c2c(O)c(\C=N\N=C\N4CCCCC4)c(NC(=O)\C(C)=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)c(O)c2c(O)c3C		Phase 1	DNA directed DNA polymerase inhibitor	
fdcyd	fdcyd|5-FLUORO-2'-DEOXYCYTIDINE	Nc1nc(=O)n(cc1F)[C@H]1C[C@H](O)[C@@H](CO)O1	KUA4693H5W	Phase 2	DNA methyltransferase inhibitor	
febuxostat	febuxostat|FEBUXOSTAT	CC(C)COc1ccc(cc1C#N)-c1nc(C)c(s1)C(O)=O	101V0R1N2E	Launched	xanthine oxidase inhibitor	XDH
felbamate	felbamate|FELBAMATE	NC(=O)OCC(COC(N)=O)c1ccccc1	X72RBB02N8	Launched	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B
felbinac	felbinac|FELBINAC	OC(=O)Cc1ccc(cc1)-c1ccccc1	94WNJ5U8L7	Launched	cyclooxygenase inhibitor	CTSL
felbinac-ethyl	felbinac-ethyl|FELBINAC ETHYL ESTER	CCOC(=O)Cc1ccc(cc1)-c1ccccc1	978ZPS989U	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
felodipine	felodipine|FELODIPINE	CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC	OL961R6O2C	Launched	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CALM1|CFTR|NR3C2|PDE1A|PDE1B|TNNC1|TNNC2
fenaclon	fenaclon|FENACLON	ClCCC(=O)NCCc1ccccc1	6M4IR9QY13	Preclinical		
fenbendazole	fenbendazole|FENBENDAZOLE	COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1	621BVT9M36	Launched	tubulin polymerization inhibitor	TUBB
fenbufen	fenbufen|FENBUFEN	OC(=O)CCC(=O)c1ccc(cc1)-c1ccccc1	9815R1WR9B	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
fenclonine-(+/-)	fenclonine-(+/-)|FENCLONINE	NC(Cc1ccc(Cl)cc1)C(O)=O	R5J7E3L9SP	Preclinical	tryptophan hydroxylase inhibitor	PAH|TPH1|TPH2
fendiline	fendiline|FENDILINE	CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1	S253D559A8	Preclinical	calcium channel blocker	HTR2B
fenigam	fenigam|4-AMINO-3-PHENYLBUTYRIC ACID	NCC(CC(O)=O)c1ccccc1	T2M58D6LA8	Launched	benzodiazepine receptor agonist	GABBR1|GABBR2
fenipentol	fenipentol|FENIPENTOL	CCCCC(O)c1ccccc1	X3FZE77O60	Launched	choleretic agent	
fenobam	fenobam|FENOBAM	CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1	07O6708M02	Phase 2	glutamate receptor antagonist	GRM5
fenofibrate	fenofibrate|FENOFIBRATE	CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1	U202363UOS	Launched	PPAR receptor agonist	MMP25|PPARA
fenofibric-acid	fenofibric-acid|FENOFIBRIC ACID	CC(C)(Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1)C(O)=O	BGF9MN2HU1	Launched	cytochrome P450 inhibitor	CLCN1|PPARA
fenoldopam	fenoldopam|FENOLDOPAM	Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12	INU8H2KAWG	Launched	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD4|DRD5
fenoprofen	fenoprofen|FENOPROFEN	CC(C(O)=O)c1cccc(Oc2ccccc2)c1	RA33EAC7KY	Launched	prostaglandin inhibitor	PTGS1|PTGS2|SLC5A8
fenoterol	fenoterol|FENOTEROL|FENOTEROL, R,R'-	CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1	22M9P70OQ9|5Z64M7W0JM	Withdrawn	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
fenoverine	fenoverine|FENOVERINE	O=C(CN1CCN(Cc2ccc3OCOc3c2)CC1)N1c2ccccc2Sc2ccccc12	N274ZQ6PZJ	Launched	acetylcholine receptor antagonist	
fenoxaprop-p-ethyl	fenoxaprop-p-ethyl|FENOXAPROP-P-ETHYL	CCOC(=O)[C@@H](C)Oc1ccc(Oc2nc3ccc(Cl)cc3o2)cc1	54CSW9U08K	Preclinical		NOS2|NOS3
fenretinide	fenretinide|FENRETINIDE	CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(=O)Nc1ccc(O)cc1	187EJ7QEXL	Phase 3	apoptosis stimulant|retinoid receptor agonist	RARA
fenspiride	fenspiride|FENSPIRIDE	O=C1NCC2(CCN(CCc3ccccc3)CC2)O1	S983QC7HKM	Launched	bronchodilator	
fenthion	fenthion|FENTHION	COP(=S)(OC)Oc1ccc(SC)c(C)c1	BL0L45OVKT	Launched	cholinesterase inhibitor	
fentiazac	fentiazac|FENTIAZAC	OC(=O)Cc1sc(nc1-c1ccc(Cl)cc1)-c1ccccc1	0YHF6E6NLS	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
fenticonazole	fenticonazole|FENTICONAZOLE	Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1	QG05NRB077	Launched	bacterial cell wall synthesis inhibitor	
FERb-033	FERb-033	O\N=C\c1ccc(-c2ccc(O)c(F)c2)c(Cl)c1O		Preclinical	EGFR inhibitor	ERBB2
ferrostatin-1	ferrostatin-1	CCOC(=O)c1ccc(NC2CCCCC2)c(N)c1		Preclinical	ferroptosis inhibitor	
ferulic-acid	ferulic-acid|FERULIC ACID	COc1cc(\C=C\C(O)=O)ccc1O	AVM951ZWST	Phase 2	antioxidant	CA1|CA12|CA14|CA2|CA4|CA6|CA9
fesoterodine	fesoterodine|FESOTERODINE	CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1OC(=O)C(C)C)C(C)C	621G617227	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
fexaramine	fexaramine	COC(=O)\C=C\c1cccc(c1)N(Cc1ccc(cc1)-c1ccc(cc1)N(C)C)C(=O)C1CCCCC1		Preclinical	FXR agonist	NR1H4
fexinidazole	fexinidazole|FEXINIDAZOLE	CSc1ccc(OCc2ncc(n2C)[N+]([O-])=O)cc1	306ERL82IR	Phase 2/Phase 3		
fexofenadine	fexofenadine|FEXOFENADINE	CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1	E6582LOH6V	Launched	histamine receptor antagonist	HRH1
FG-2216	FG-2216	OC(=O)CNC(=O)c1nc(Cl)c2ccccc2c1O	RU921DS4Z5	Phase 2	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN1|EGLN2|HIF1A
FG-4592	FG-4592|ROXADUSTAT	Cc1nc(C(=O)NCC(O)=O)c(O)c2ccc(Oc3ccccc3)cc12	X3O30D9YMX	Phase 3	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN2
FG-7142	FG-7142	CNC(=O)c1cc2c(cn1)[nH]c1ccccc21	60PO70N1BP	Preclinical	GABA benzodiazepine site receptor inverse agonist	
FGIN-1-27	FGIN-1-27	CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccccc12)-c1ccc(F)cc1		Preclinical	inositol monophosphatase inhibitor	TSPO
FGIN-1-43	FGIN-1-43	CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccc(Cl)cc12)-c1ccc(Cl)cc1		Preclinical	benzodiazepine receptor agonist	TSPO
FH1	FH1	CC(=O)Nc1ccc(Cc2ccc(NC(C)=O)cc2)cc1		Preclinical	hepatocyte function enhancer	
fiacitabine	fiacitabine|FIACITABINE	Nc1nc(=O)n(cc1I)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	4058H365ZB	Phase 2	DNA synthesis inhibitor	
fidarestat	fidarestat|FIDARESTAT	NC(=O)C1CC2(NC(=O)NC2=O)c2cc(F)ccc2O1	8SH8T1164U	Phase 3	aldose reductase inhibitor	AKR1B1
fidaxomicin	fidaxomicin|FIDAXOMICIN	CC[C@H]1\C=C(C)/[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)c3c(O)c(Cl)c(O)c(Cl)c3CC)[C@H](O)[C@@H]2OC)\C(=O)O[C@H](C\C=C(C)\C=C(C)[C@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@H]1O)[C@@H](C)O	Z5N076G8YQ	Launched	RNA polymerase inhibitor	
filanesib	filanesib|FILANESIB	CON(C)C(=O)N1N=C(S[C@@]1(CCCN)c1ccccc1)c1cc(F)ccc1F	8A49OSO368	Phase 3	kinesin inhibitor|kinesin-like spindle protein inhibitor	KIF11
filgotinib	filgotinib|FILGOTINIB	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1	3XVL385Q0M	Phase 2	JAK inhibitor	JAK1|JAK2|JAK3|TYK2
fimasartan	fimasartan|FIMASARTAN	CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	P58222188P	Launched	angiotensin receptor antagonist	AGTR1
finafloxacin	finafloxacin|FINAFLOXACIN	OC(=O)c1cn(C2CC2)c2c(C#N)c(N3C[C@@H]4NCCO[C@H]4C3)c(F)cc2c1=O	D26OSN9Q4R	Launched	bacterial DNA gyrase inhibitor	
finasteride	finasteride|FINASTERIDE	CC(C)(C)NC(=O)[C@H]1CCC2C3CCC4NC(=O)C=C[C@]4(C)C3CC[C@]12C	57GNO57U7G	Launched	5 alpha reductase inhibitor	AKR1D1|SRD5A1|SRD5A2
fingolimod	fingolimod|FINGOLIMOD	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1	3QN8BYN5QF	Launched	immunosuppressant|sphingosine phosphate receptor agonist	S1PR1|S1PR5
fipexide	fipexide|FIPEXIDE	Clc1ccc(OCC(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)cc1	TG44VME01D	Withdrawn	psychoactive drug	
fipronil	fipronil|FIPRONIL	Nc1c(c(nn1-c1c(Cl)cc(cc1Cl)C(F)(F)F)C#N)S(=O)C(F)(F)F	QGH063955F	Launched	chloride channel blocker|GABA gated chloride channel blocker	
firategrast	firategrast|FIRATEGRAST	CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(O)=O)cc2)c(OC)c1	OJY3SK9H5F	Phase 2	integrin antagonist	ITGA4
firocoxib	firocoxib|FIROCOXIB	CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(cc1)S(C)(=O)=O	Y6V2W4S4WT	Launched	cyclooxygenase inhibitor	PTGS2
fisetin	fisetin|FISETIN	Oc1ccc2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O	OO2ABO9578	Preclinical	Aurora kinase inhibitor	CDK6|FASN
FIT	FIT	CCC(=O)N(C1CCN(CCc2ccc(cc2)N=C=S)CC1)c1ccccc1		Preclinical	opioid receptor agonist	OPRD1
FK-33-824	FK-33-824	C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N[C@H](CO)CCS(C)=O		Phase 2	opioid receptor agonist	OPRM1
FK-3311	FK-3311	CC(=O)c1ccc(NS(C)(=O)=O)c(Oc2ccc(F)cc2F)c1		Phase 2	cyclooxygenase inhibitor	PTGS2
FK-866	FK-866|DAPORINAD	O=C(NCCCCC1CCN(CC1)C(=O)c1ccccc1)\C=C\c1cccnc1	V71TF6V9M7	Phase 2	niacinamide phosphoribosyltransferase inhibitor	NAMPT
FK-888	FK-888	CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)c1cn(C)c2ccccc12		Phase 2	tachykinin antagonist	TACR1|TACR2
FK-962	FK-962	CC(=O)N1CCC(CC1)NC(=O)c1ccc(F)cc1		Phase 2	somatostatin receptor agonist	
flavin-adenine-dinucleotide	flavin-adenine-dinucleotide|FLAVIN ADENINE DINUCLEOTIDE	Cc1cc2nc3c(nc(=O)[nH]c3=O)n(CC(O)C(O)C(O)COP(O)(=O)OP(O)(=O)OCC3OC(C(O)C3O)n3cnc4c(N)ncnc34)c2cc1C	ZC44YTI8KK	Preclinical		ACAD8|ACADM|ACADS|ACOX1|AIFM1|CYB5R1|CYB5R3|DAO|DLD|DPYD|ERO1LB|FDXR|GCDH|GFER|GSR|IL4I1|IVD|MAOA|MAOB|NOS1|NQO1|NQO2|POR|TXNRD1|XDH
flavoxate	flavoxate|FLAVOXATE	Cc1c(oc2c(cccc2c1=O)C(=O)OCCN1CCCCC1)-c1ccccc1	3E74Y80MEY	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2
flecainide	flecainide|FLECAINIDE	FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1	K94FTS1806	Launched	sodium channel blocker	KCNA5|KCNA7|SCN4A|SCN5A
fleroxacin	fleroxacin|FLEROXACIN	CN1CCN(CC1)c1c(F)cc2c(c1F)n(CCF)cc(C(O)=O)c2=O	N804LDH51K	Launched	topoisomerase inhibitor	
FLI-06	FLI-06	CC1=C(C(c2ccc(cc2)[N+]([O-])=O)C2=C(CC(C)(C)CC2=O)N1)C(=O)OC1CCCCC1		Preclinical	notch signaling inhibitor	
flibanserin	flibanserin|FLIBANSERIN	FC(F)(F)c1cccc(c1)N1CCN(CCn2c3ccccc3[nH]c2=O)CC1	37JK4STR6Z	Launched	serotonin receptor agonist	DRD4|HTR1A|HTR2A
flindokalner	flindokalner|FLINDOKALNER	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(ccc12)C(F)(F)F	J57O328W4W	Phase 3	potassium channel agonist	KCNMA1|KCNN4|KCNQ2|KCNQ4|KCNQ5
floctafenine	floctafenine|FLOCTAFENINE	OCC(O)COC(=O)c1ccccc1Nc1ccnc2c(cccc12)C(F)(F)F	O04HVX6A9Q	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
flopropione	flopropione|FLOPROPIONE	CCC(=O)c1c(O)cc(O)cc1O	05V5NVB5Y1	Launched	serotonin receptor antagonist	HTR1A
florfenicol	florfenicol|FLORFENICOL	CS(=O)(=O)c1ccc(cc1)C(O)[C@H](CF)NC(=O)C(Cl)Cl	9J97307Y1H	Launched	protein synthesis inhibitor	
flosequinan	flosequinan|FLOSEQUINAN	Cn1cc(S(C)=O)c(=O)c2ccc(F)cc12	6NB119DLU7	Withdrawn	phosphodiesterase inhibitor	
floxuridine	floxuridine|FLOXURIDINE	OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O	039LU44I5M	Launched	DNA synthesis inhibitor	TYMS
flubendazole	flubendazole|FLUBENDAZOLE	COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1ccc(F)cc1	R8M46911LR	Launched	tubulin polymerization inhibitor	TUBB
flucloxacillin	flucloxacillin|FLUCLOXACILLIN	Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)C(N2C1=O)C(O)=O)-c1c(F)cccc1Cl	43B2M34G2V	Launched	bacterial cell wall synthesis inhibitor	
fluconazole	fluconazole|FLUCONAZOLE	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F	8VZV102JFY	Launched	sterol demethylase inhibitor	CYP51A1
flucytosine	flucytosine|FLUCYTOSINE	Nc1nc(=O)[nH]cc1F	D83282DT06	Launched	other antifungal	DNMT1
fludarabine	fludarabine|FLUDARABINE	Nc1nc(F)nc2n(cnc12)[C@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	P2K93U8740	Launched	ribonucleotide reductase inhibitor	ADA|RRM1|RRM2
fludarabine-phosphate	fludarabine-phosphate|FLUDARABINE PHOSPHATE	Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O	1X9VK9O1SC	Launched	ribonucleotide reductase inhibitor	DCK|POLA1|POLD1|POLE|RRM1|RRM2|RRM2B
fludrocortisone-acetate	fludrocortisone-acetate|FLUDROCORTISONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	V47IF0PVH4	Launched		AR|NR3C1|NR3C2
fludroxycortide	fludroxycortide|FLURANDRENOLIDE	CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)CC[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	8EUL29XUQT	Launched	glucocorticoid receptor agonist	NR3C1|SERPINA6
flufenamic-acid	flufenamic-acid|FLUFENAMIC ACID	OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F	60GCX7Y6BH	Preclinical	chloride channel blocker	AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5
flumatinib	flumatinib|FLUMATINIB	CN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2cnc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1	R4009Y24AI	Phase 3	Bcr-Abl kinase inhibitor	ABL1|PDGFRB
flumazenil	flumazenil|FLUMAZENIL	CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21	40P7XK9392	Launched	benzodiazepine receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
flumecinol	flumecinol|FLUMECINOL	CCC(O)(c1ccccc1)c1cccc(c1)C(F)(F)F	JB0YA8LDOW	Launched		
flumequine	flumequine|FLUMEQUINE	CC1CCc2cc(F)cc3c2n1cc(C(O)=O)c3=O	UVG8VSP2SJ	Launched	topoisomerase inhibitor	
flumetasone	flumetasone|FLUMETHASONE	C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	LR3CD8SX89	Launched	glucocorticoid receptor agonist	NR3C1
flumethasone	flumethasone|FLUMETHASONE	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	LR3CD8SX89	Launched	glucocorticoid receptor agonist	NR3C1|PLA2G1B
flumethazone-pivalate	flumethazone-pivalate|FLUMETHASONE PIVALATE	C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C	0DV09X6F21	Preclinical	glucocorticoid receptor agonist	NR3C1|SERPINA6
flumexadol	flumexadol|FLUMEXADOL	FC(F)(F)c1cccc(c1)C1CNCCO1	V9783UEL0F	Preclinical		
flunarizine	flunarizine|FLUNARIZINE	Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1	R7PLA2DM0J	Launched	calcium channel blocker	CACNA1G|CACNA1H|CACNA1I|CALM1|HRH1
flunisolide	flunisolide|FLUNISOLIDE	CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@@]2(O1)C(=O)CO	QK4DYS664X	Launched	cytochrome P450 inhibitor	NR3C1
flunixin-meglumin	flunixin-meglumin|FLUNIXIN	Cc1c(Nc2ncccc2C(O)=O)cccc1C(F)(F)F	356IB1O400	Launched	prostanoid receptor antagonist	
fluocinolone-acetonide	fluocinolone-acetonide|FLUOCINOLONE ACETONIDE	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C	0CD5FD6S2M	Launched	glucocorticoid receptor agonist	NR3C1|SERPINA6
fluocinonide	fluocinonide|FLUOCINONIDE	CC(=O)OCC(=O)[C@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]21C	2W4A77YPAN	Launched	glucocorticoid receptor agonist	NR3C1|SERPINA6|SMO
fluorescein	fluorescein|FLUORESCEIN	Oc1ccc2c(Oc3cc(O)ccc3C22OC(=O)c3ccccc23)c1	TPY09G7XIR	Launched		SLC22A6
fluorometholone	fluorometholone|FLUOROMETHOLONE	C[C@H]1CC2C3CC[C@](O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)C2(C)C=CC(=O)C=C12	SV0CSG527L	Launched	glucocorticoid receptor agonist	NR3C1
fluorometholone-acetate	fluorometholone-acetate|FLUOROMETHOLONE ACETATE	C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]2(C)C=CC(=O)C=C12	9I50C3I3OK	Launched		NR3C1
fluoromethylcholine	fluoromethylcholine|FLUOROCHOLINE	C[N+](C)(CF)CCO	6029HGL0QP	Launched		
fluoxetine	fluoxetine|FLUOXETINE	CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1	01K63SUP8D	Launched	selective serotonin reuptake inhibitor (SSRI)	ANO1|HTR2B|SLC6A4
fluoxymesterone	fluoxymesterone|FLUOXYMESTERONE	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	9JU12S4YFY	Launched	androgen receptor modulator	AR|ESR1|NR3C1|PRLR
flupentixol	flupentixol|FLUPENTIXOL	OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	FA0UYH6QUO	Launched	dopamine receptor antagonist	ADRA1A|CHRM1|DRD1|DRD2|DRD3|DRD5|HTR2A
fluphenazine	fluphenazine|FLUPHENAZINE	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	S79426A41Z	Launched	dopamine receptor antagonist	CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7
fluphenazine-decanoate	fluphenazine-decanoate|FLUPHENAZINE DECANOATE	CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	FMU62K1L3C	Launched	dopamine receptor antagonist	DRD2|HTR1B|HTR4
flupirtine	flupirtine|FLUPIRTINE	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N	MOH3ET196H	Launched	glutamate receptor antagonist	ADRA2A|KCNQ1|KCNQ2
fluprazine	fluprazine|FLUPRAZINE	NC(=O)NCCN1CCN(CC1)c1cccc(c1)C(F)(F)F	713BBL6840	Phase 1	serotonin receptor agonist	HTR1A|HTR1B
flurbiprofen-(+/-)	flurbiprofen-(+/-)|FLURBIPROFEN	CC(C(O)=O)c1ccc(c(F)c1)-c1ccccc1	5GRO578KLP	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
flurbiprofen-(S)-(+)	flurbiprofen-(S)-(+)|ESFLURBIPROFEN	C[C@H](C(O)=O)c1ccc(c(F)c1)-c1ccccc1	J5ZZK9P7MX	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
flurofamide	flurofamide|FLUROFAMIDE	NP(N)(=O)NC(=O)c1ccc(F)cc1	599XHU06GH	Preclinical	urease inhibitor	
flurothyl	flurothyl|FLUROTHYL	FC(F)(F)COCC(F)(F)F	9Z467FG2YK	Preclinical		
fluroxene	fluroxene|FLUROXENE	FC(F)(F)COC=C	FO7JHA3G03	Preclinical	local anesthetic	
fluspirilene	fluspirilene|FLUSPIRILENE	Fc1ccc(cc1)C(CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc(F)cc1	C5QA4GLR9M	Launched	dopamine receptor antagonist	CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A
flutamide	flutamide|FLUTAMIDE	CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O	76W6J0943E	Launched	androgen receptor antagonist	AHR|AR
fluticasone-propionate	fluticasone-propionate|FLUTICASONE PROPIONATE	CCC(=O)O[C@@]1([C@H](C)CC2C3CC(F)C4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@]12C)C(=O)SCF	O2GMZ0LF5W	Launched	glucocorticoid receptor agonist	NR3C1|NR3C2|PGR|PLA2G4A
flutrimazole	flutrimazole|FLUTRIMAZOLE	Fc1ccc(cc1)C(c1ccccc1)(c1ccccc1F)n1ccnc1	776S0UP252	Launched	sterol demethylase inhibitor	
fluvastatin	fluvastatin|FLUVASTATIN	CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)c(-c2ccc(F)cc2)c2ccccc12	4L066368AS	Launched	HMGCR inhibitor	HMGCR
fluvoxamine	fluvoxamine|FLUVOXAMINE	COCCCC\C(c1ccc(cc1)C(F)(F)F)=N/OCCN	O4L1XPO44W	Launched	selective serotonin reuptake inhibitor (SSRI)	SLC6A4
fmoc-l-leucine	fmoc-l-leucine|N-(FLUORENYL-9-METHOXYCARBONYL)LEUCINE	CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O	KF18F70UF3	Phase 2	PPAR receptor agonist	
folic-acid	folic-acid|FOLIC ACID	Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2[nH]1	935E97BOY8	Launched	folate receptor ligand	FOLR2|FOLR3|SLC19A1|SLC46A1
fomepizole	fomepizole|FOMEPIZOLE	Cc1cn[nH]c1	83LCM6L2BY	Launched	alcohol dehydrogenase inhibitor	ADH1A|ADH1B|ADH1C|AKR1A1|CAT
fomocaine	fomocaine|FOMOCAINE	C(CN1CCOCC1)Cc1ccc(COc2ccccc2)cc1	4XO7A09HQM	Launched	voltage-gated sodium channel modulator	
foretinib	foretinib|FORETINIB	COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1	81FH7VK1C4	Phase 2	VEGFR inhibitor	FLT1|FLT4|KDR|MET
formestane	formestane|FORMESTANE	C[C@]12CC[C@H]3[C@@H](CCC4C(=O)C(=O)CC[C@]34C)[C@@H]1CCC2=O	PUB9T8T355	Launched	aromatase inhibitor	CYP19A1
formononetin	formononetin|FORMONONETIN	COc1ccc(cc1)-c1coc2cc(O)ccc2c1=O	295DQC67BJ	Preclinical	alcohol dehydrogenase inhibitor	ADH1C|SLC5A2
formoterol	formoterol|FORMOTEROL|ARFORMOTEROL	COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1	5ZZ84GCW8B|F91H02EBWT	Launched	adrenergic receptor agonist	ADRB2
forodesine	forodesine|FORODESINE	OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c1c[nH]c2c1[nH]cnc2=O	426X066ELK	Phase 2	purinergic receptor antagonist	PNP
foropafant	foropafant|FOROPAFANT	CC(C)c1cc(C(C)C)c(-c2csc(n2)N(CCN(C)C)Cc2cccnc2)c(c1)C(C)C	VWJ2QVH41J	Phase 3	platelet activating factor receptor antagonist	PTAFR
forskolin	forskolin|COLFORSIN	CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C	1F7A44V6OU	Launched	adenylyl cyclase activator	ADCY2|ADCY5|GNAS
fosamprenavir	fosamprenavir|FOSAMPRENAVIR	CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1	WOU1621EEG	Launched	HIV protease inhibitor	
fosaprepitant-dimeglumine	fosaprepitant-dimeglumine|FOSAPREPITANT DIMEGLUMINE	C[C@@H](O[C@H]1OCCN(Cc2nn(c(=O)[nH]2)P(O)(O)=O)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F	D35FM8T64X	Launched	tachykinin antagonist	TACR1
fosbretabulin	fosbretabulin|FOSBRETABULIN	COc1ccc(cc1OP(O)(O)=O)\C=C/c1cc(OC)c(OC)c(OC)c1	I5590ES2QZ	Phase 3	tubulin polymerization inhibitor|VE-cadherin antagonist	CDH5
foscarnet	foscarnet|FOSCARNET	OC(=O)P(O)(O)=O	364P9RVW4X	Launched	DNA polymerase inhibitor	
fosfestrol	fosfestrol|FOSFESTROL	CC\C(c1ccc(OP(O)(O)=O)cc1)=C(\CC)c1ccc(OP(O)(O)=O)cc1	A0E0NMA80F	Launched	synthetic estrogen	ESR1|ESR2
fosfomycin	fosfomycin|FOSFOMYCIN	CC1OC1P(O)(O)=O	2N81MY12TE	Launched	bacterial cell wall synthesis inhibitor	
fosfosal	fosfosal|FOSFOSAL	OC(=O)c1ccccc1OP(O)(O)=O	124X2V25W4	Launched	phosphodiesterase inhibitor	PTGS1|PTGS2
fosfructose	fosfructose|FOSFRUCTOSE	O[C@@H]1[C@@H](COP(O)(O)=O)OC(O)(COP(O)(O)=O)[C@H]1O	M7522JYX1H	Phase 3	fructose diphosphate stimulant	PKLR
fosinopril	fosinopril|FOSINOPRIL	CCC(=O)O[C@@H](OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C	R43D2573WO	Launched	angiotensin converting enzyme inhibitor	ACE
fosinoprilat	fosinoprilat|FOSINOPRILAT	OC(=O)[C@@H]1C[C@H](CN1C(=O)CP(O)(=O)CCCCc1ccccc1)C1CCCCC1	S312EY6ZT8	Launched	angiotensin converting enzyme inhibitor	ACE
fosphenytoin	fosphenytoin|FOSPHENYTOIN	OP(O)(=O)OCN1C(=O)NC(C1=O)(c1ccccc1)c1ccccc1	B4SF212641	Launched	sodium channel blocker	SCN5A
fostamatinib	fostamatinib|FOSTAMATINIB	COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC	SQ8A3S5101	Phase 3	SYK inhibitor	RET|SYK
fotemustine	fotemustine|FOTEMUSTINE	CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)[N+][O-]	GQ7JL9P5I2	Launched	thioredoxin inhibitor	TXNRD1
foxy-5	foxy-5|FOXY-5	CSCC[C@H](NC=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O	CBZ9UL0ARB	Phase 1	WNT5a peptide mimetic	WNT5A
FPA-124	FPA-124	Cl[Cu]Cl.NC(=S)N\N=C\c1coc2ccccc2c1=O		Preclinical	AKT inhibitor	
FPH1-(BRD-6125)	FPH1-(BRD-6125)	Cc1ccc(Cl)cc1N(CC(=O)Nc1c(F)cccc1F)S(C)(=O)=O		Preclinical	hepatocyte function enhancer	
FPL-12495	FPL-12495	CC(N)(Cc1ccccc1)c1ccccc1		Phase 1	glutamate receptor antagonist	
FPL-55712	FPL-55712	CCCc1c(OCC(O)COc2ccc3c(oc(cc3=O)C(O)=O)c2CCC)ccc(C(C)=O)c1O		Phase 1	leukotriene receptor antagonist	
FPL-62064	FPL-62064	COc1ccc(Nc2ccn(n2)-c2ccccc2)cc1		Phase 2	cyclooxygenase inhibitor|lipoxygenase inhibitor	
FPL-64176	FPL-64176	COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1	UU89L306PO	Preclinical	calcium channel activator	CACNA1C|CACNA1S
FPS-ZM1	FPS-ZM1	Clc1ccc(cc1)C(=O)N(Cc1ccccc1)C1CCCCC1		Preclinical	RAGE receptor antagonist	AGER
FR-122047	FR-122047	COc1ccc(cc1)-c1nc(sc1-c1ccc(OC)cc1)C(=O)N1CCN(C)CC1		Preclinical	cyclooxygenase inhibitor	
FR-139317	FR-139317	CC(C)C[C@H](NC(=O)N1CCCCCC1)C(=O)N[C@H](Cc1cn(C)c2ccccc12)C(=O)N[C@H](Cc1ccccn1)C(O)=O		Phase 1	endothelin receptor antagonist	EDNRA
FR-180204	FR-180204	Nc1[nH]nc2nnc(cc12)-c1c(nn2ccccc12)-c1ccccc1		Preclinical	MAP kinase inhibitor	MAPK1|MAPK3
FRAX486	FRAX486	CCn1c2nc(Nc3ccc(N4CCNCC4)c(F)c3)ncc2cc(-c2ccc(Cl)cc2Cl)c1=O		Preclinical	serine/threonine kinase inhibitor	PAK1|PAK2|PAK3|PAK4
frentizole	frentizole|FRENTIZOLE	COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1	7EY946394I	Phase 1	immunosuppressant	
frovatriptan	frovatriptan|FROVATRIPTAN	CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(N)=O	H82Q2D5WA7	Launched	serotonin receptor agonist	HTR1A|HTR1B|HTR1D
fruquintinib	fruquintinib|FRUQUINTINIB	CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12	49DXG3M5ZW	Phase 3	VEGFR inhibitor	KDR
ftaxilide	ftaxilide|FTAXILIDE	Cc1cccc(C)c1NC(=O)c1ccccc1C(O)=O	7Z71845H3F	Preclinical		
ftorafur	ftorafur|TEGAFUR	Fc1cn([C@H]2CCCO2)c(=O)[nH]c1=O	1548R74NSZ	Launched	thymidylate synthase inhibitor	TYMS
fudosteine	fudosteine|FUDOSTEINE	N[C@@H](CSCCCO)C(O)=O	UR9VPI71PT	Launched	mucolytic agent	
fulvestrant	fulvestrant|FULVESTRANT	C[C@]12CC[C@H]3C([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31	22X328QOC4	Launched	estrogen receptor antagonist	ESR1|ESR2|GPER1
fumagillin	fumagillin|FUMAGILLIN	CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O	7OW73204U1	Launched	methionine aminopeptidase inhibitor	METAP2
furaltadone	furaltadone|FURALTADONE	[O-][N+](=O)c1ccc(\C=N\N2CC(CN3CCOCC3)OC2=O)o1	5X4V82ZN30	Launched	bacterial DNA inhibitor	
furazolidone	furazolidone|FURAZOLIDONE	[O-][N+](=O)c1ccc(\C=N\N2CCOC2=O)o1	5J9CPU3RE0	Launched	bacterial DNA inhibitor	
furegrelate	furegrelate|FUREGRELATE	OC(=O)c1cc2cc(Cc3cccnc3)ccc2o1	KX4D9BZA6X	Phase 1	thromboxane synthase inhibitor	TBXAS1
furosemide	furosemide|FUROSEMIDE	NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl	7LXU5N7ZO5	Launched	diuretic	CA2|GPR35|SLC12A1|SLC12A2
fursultiamine	fursultiamine|FURSULTIAMINE	C\C(N(Cc1cnc(C)nc1N)C=O)=C(\CCO)SSCC1CCCO1	05J61265PX	Launched	vitamin B	
fusidic-acid	fusidic-acid|FUSIDIC ACID	C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]1(C)C2[C@H](O)C[C@@H]2[C@]1(C)C[C@H](OC(C)=O)\C2=C(/CCC=C(C)C)C(O)=O	59XE10C19C	Launched	bacterial 30S ribosomal subunit inhibitor	
G-1	G-1|FURVINA	CC(=O)c1ccc2N[C@H]([C@H]3CC=C[C@H]3c2c1)c1cc2OCOc2cc1Br	7HFX5XQO7N	Preclinical	G protein-coupled receptor agonist	GPER1
G-15	G-15	Brc1cc2OCOc2cc1[C@H]1Nc2ccccc2[C@H]2C=CC[C@@H]12.Brc1cc2OCOc2cc1[C@@H]1Nc2ccccc2[C@@H]2C=CC[C@H]12		Preclinical	estrogen receptor antagonist	GPER1
g-caryophyllene	g-caryophyllene|CARYOPHYLLENE	C\C1=C/CCC(=C)[C@H]2CC(C)(C)[C@@H]2CC1	BHW853AU9H	Preclinical	acetylcholinesterase inhibitor	ACHE
G007-LK	G007-LK	CS(=O)(=O)c1ccc(nc1)-c1nnc(\C=C\c2nnc(o2)-c2ccc(cc2)C#N)n1-c1ccccc1Cl		Preclinical	tankyrase inhibitor	TNKS|TNKS2
GABA-linoleamide	GABA-linoleamide|N-LINOLEOYL-4-AMINOBUTYRIC ACID	CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCCC(O)=O	Z3NMX9471T	Phase 2	benzodiazepine receptor agonist	
gabapentin	gabapentin|GABAPENTIN	NCC1(CC(O)=O)CCCCC1	6CW7F3G59X	Launched	calcium channel blocker	ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B
gabapentin-enacarbil	gabapentin-enacarbil|GABAPENTIN ENACARBIL	CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1	75OCL1SPBQ	Launched	adrenergic receptor agonist	CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8
gabazine	gabazine|GABAZINE	COc1ccc(cc1)-c1ccc(=N)n(CCCC(O)=O)n1	99460MG420	Preclinical	GABA receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRG2
gabexate	gabexate|GABEXATE	CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1	4V7M9137X9	Launched	serine protease inhibitor	PRSS1|TPSAB1
gaboxadol	gaboxadol|GABOXADOL	Oc1noc2CNCCc12	K1M5RVL18S	Phase 3	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3
gadobutrol	gadobutrol|GADOBUTROL	OCC(O)[C@@H](CO)N1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C3)OC(=O)C2	1BJ477IO2L	Launched	radiopaque medium	
gadodiamide	gadodiamide|GADODIAMIDE	CNC(=O)CN1CCN2CCN(CC(=O)NC)CC(=O)O[Gd](OC(=O)C1)OC(=O)C2	84F6U3J2R6	Launched	radiopaque medium	
gadopentetic-acid	gadopentetic-acid|GADOPENTETIC ACID	OC(=O)CN1CCN2CCN(CC(O)=O)CC(=O)O[Gd](OC(=O)C1)OC(=O)C2	K2I13DR72L	Launched	contrast agent	
gadoterate-meglumine	gadoterate-meglumine|GADOTERATE MEGLUMINE	OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1	L0ND3981AG	Launched	radiopaque medium	
gadoteridol	gadoteridol|GADOTERIDOL	CC(O)CN1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C2)OC(=O)C3	0199MV609F	Launched	radiopaque medium	
galantamine	galantamine|GALANTAMINE|GALANTAMINE, (+/-)-	COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24	0D3Q044KCA|1T835Z585R	Launched	acetylcholinesterase inhibitor	ACHE|BCHE|CHRNA1|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB1|CHRNB2|CHRNB3|CHRNB4|CHRND|CHRNE|CHRNG
galeterone	galeterone|GALETERONE	C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)C1CC=C2n1cnc2ccccc12	WA33E149SW	Phase 3	androgen receptor modulator	AR|CYP17A1
gallamine-triethiodide	gallamine-triethiodide|GALLAMINE TRIETHIODIDE	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC	Q3254X40X2	Launched	acetylcholine receptor antagonist	ACHE|CHRM2|CHRNA1|CHRNA2
gallic-acid	gallic-acid|GALLIC ACID	OC(=O)c1cc(O)c(O)c(O)c1	632XD903SP	Preclinical	beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist	CA1|CA12|CA14|CA2|CA4|CA6|CA9|SELP
gallium-triquinolin-8-olate	gallium-triquinolin-8-olate	O([Ga](Oc1cccc2cccnc12)Oc1cccc2cccnc12)c1cccc2cccnc12		Phase 1		
gallopamil	gallopamil|GALLOPAMIL	COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2cc(OC)c(OC)c(OC)c2)cc1OC	39WPC8JHR8	Launched	L-type calcium channel blocker	ATP2A2
gambogic-acid	gambogic-acid|GAMBOGIC ACID	CC(C)=CCC[C@@]1(C)Oc2c(CC=C(C)C)c3O[C@@]45[C@@H]6CC(C=C4C(=O)c3c(O)c2C=C1)C(=O)[C@]5(C\C=C(\C)C(O)=O)OC6(C)C	8N585K83U2	Phase 2	caspase activator	BCL2
gamma-aminobutyric-acid	gamma-aminobutyric-acid|.GAMMA.-AMINOBUTYRIC ACID	NCCCC(O)=O	2ACZ6IPC6I	Preclinical	benzodiazepine receptor agonist	GABBR1|GABBR2|GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2|GATM|KCTD12|KCTD16|KCTD8|SLC6A1
gamma-linolenic-acid	gamma-linolenic-acid|GAMOLENIC ACID	CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O	78YC2MAX4O	Phase 2	cyclooxygenase inhibitor|prostanoid receptor agonist	PTGS1|PTGS2
ganaxolone	ganaxolone|GANAXOLONE	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C	98WI44OHIQ	Phase 3	GABA receptor modulator	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6
ganciclovir	ganciclovir|GANCICLOVIR	Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1	P9G3CKZ4P5	Launched	DNA polymerase inhibitor	
ganetespib	ganetespib|GANETESPIB	CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3n(C)ccc3c2)c(O)cc1O	2E8412Y946	Phase 3	HSP inhibitor	HSP90AA1
ganglioside-gm1	ganglioside-gm1|GANGLIOSIDE GM1	CCCCCCCCCCCCCCCCCC(=O)N[C@@H](COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(OC4OC(CO)C(O)C(O)C4O)C3NC(C)=O)C(OC3(CC(O)C(NC(C)=O)C(O3)C(O)C(O)CO)C(O)=O)C2O)C(O)C1O)[C@H](O)\C=C\CCCCCCCCCCCCC	562413257Z	Phase 2		
garenoxacin	garenoxacin|GARENOXACIN	C[C@H]1NCc2cc(ccc12)-c1ccc2c(c1OC(F)F)n(cc(C(O)=O)c2=O)C1CC1	V72H9867WB	Launched	topoisomerase inhibitor	TOP2A
gastrodin	gastrodin|GASTRODIN	OC[C@@H]1O[C@@H](Oc2ccc(CO)cc2)[C@H](O)[C@@H](O)[C@@H]1O	5YS9U2W3RQ	Phase 2		
gatifloxacin	gatifloxacin|GATIFLOXACIN	COc1c(N2CCNC(C)C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	L4618BD7KJ	Withdrawn	bacterial DNA gyrase inhibitor	
gavestinel	gavestinel|GAVESTINEL	OC(=O)c1[nH]c2cc(Cl)cc(Cl)c2c1\C=C\C(=O)Nc1ccccc1	318X4QY113	Phase 3	glutamate receptor antagonist	GLRB
GBR-12783	GBR-12783	C(CN1CCN(C\C=C\c2ccccc2)CC1)OC(c1ccccc1)c1ccccc1		Preclinical	dopamine uptake inhibitor	
GBR-12935	GBR-12935	C(CN1CCN(CCOC(c2ccccc2)c2ccccc2)CC1)Cc1ccccc1	9J9974WIBA	Preclinical	dopamine uptake inhibitor	AGTR1|SLC6A3
GBR-13069	GBR-13069|GBR-12879 DIMESYLATE	Fc1ccc(cc1)C(OCCN1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1	9B7G9F1T4T	Preclinical	dopamine uptake inhibitor	SLC6A3
GDC-0068	GDC-0068|IPATASERTIB	CC(C)NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2[C@@H](O)C[C@@H](C)c12)c1ccc(Cl)cc1	524Y3IB4HQ	Phase 2	AKT inhibitor	AKT1|AKT2|AKT3|PRKG1
GDC-0152	GDC-0152	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1	4KW1M48SHS	Phase 1	XIAP inhibitor	BIRC2|BIRC3|BIRC7|XIAP
GDC-0349	GDC-0349	CCNC(=O)Nc1ccc(cc1)-c1nc2CN(CCc2c(n1)N1CCOC[C@@H]1C)C1COC1	579255I6O9	Phase 1	Pim kinase inhibitor	PIK3CA
GDC-0623	GDC-0623	OCCONC(=O)c1ccc2cncn2c1Nc1ccc(I)cc1F	HW67545I4Q	Phase 1	MEK inhibitor	
GDC-0810	GDC-0810	CC\C(=C(\c1ccc(\C=C\C(O)=O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl	9MM2R1A06R	Phase 2	selective estrogen receptor destabilizer	ESR1
GDC-0834	GDC-0834	CN1CCN(C)C(=O)C1c1ccc(Nc2nc(cn(C)c2=O)-c2cccc(NC(=O)c3cc4CCCCc4s3)c2C)cc1	FM7JG3L4SR	Phase 1	Bruton's tyrosine kinase (BTK) inhibitor	BTK
GDC-0879	GDC-0879	OCCn1cc(c(n1)-c1ccncc1)-c1ccc2c(CC\C2=N\O)c1		Preclinical	RAF inhibitor	BRAF
GDC-0941	GDC-0941|PICTILISIB	CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1	ICY00EMP8P	Phase 2	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
GDC-0980	GDC-0980|APITOLISIB	C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)-c2cnc(N)nc2)N2CCOCC2)CC1	1C854K1MIJ	Phase 2	mTOR inhibitor|PI3K inhibitor	FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK
GDC-0994	GDC-0994	Cn1nccc1Nc1nccc(n1)-c1ccn(C(CO)c2ccc(Cl)c(F)c2)c(=O)c1		Phase 1	MAP kinase inhibitor	MAPK1|MAPK3
gedunin	gedunin	CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](OC(=O)[C@H]4O[C@@]34[C@]12C)c1ccoc1		Preclinical	HSP inhibitor	HSP90AA1
gefitinib	gefitinib|GEFITINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1	S65743JHBS	Launched	EGFR inhibitor	EGFR
geldanamycin	geldanamycin|GELDANAMYCIN	CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)\C(C)=C\C=C\[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O	Z3K3VJ16KU	Preclinical	HSP inhibitor	HSP90AA1|HSP90AB1
gemcadiol	gemcadiol|GEMCADIOL	CC(C)(CO)CCCCCCC(C)(C)CO	7M9T46208F	Phase 2	antilipemic	
gemcitabine	gemcitabine|GEMCITABINE	Nc1ccn([C@@H]2O[C@@H](CO)[C@@H](O)C2(F)F)c(=O)n1	B76N6SBZ8R	Launched	ribonucleotide reductase inhibitor	CMPK1|RRM1|RRM2|TYMS
gemcitabine-elaidate	gemcitabine-elaidate|GEMCITABINE ELAIDATE	CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O	231C73W7LG	Phase 1	DNA synthesis inhibitor|apoptosis inhibitor	CMPK1|RRM1|TYMS
gemfibrozil	gemfibrozil|GEMFIBROZIL	Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1	Q8X02027X3	Launched	lipoprotein lipase activator	LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1
gemifloxacin	gemifloxacin|GEMIFLOXACIN	CO\N=C1/CN(CC1CN)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1	OKR68Y0E4T	Launched	bacterial DNA gyrase inhibitor	
genipin	genipin|GENIPIN	COC(=O)C1=CO[C@@H](O)[C@H]2[C@@H]1CC=C2CO	A3V2NE52YG	Preclinical	choleretic agent	
geniposide	geniposide|GENIPOSIDE	COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]2O)[C@@H]2[C@@H]1CC=C2CO	145295QLXY	Preclinical	GLP receptor agonist	GLP1R
geniposidic-acid	geniposidic-acid	OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@H]3CC=C(CO)[C@@H]23)C(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O		Preclinical	cyclooxygenase inhibitor	
genistein	genistein|GENISTEIN	Oc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O	DH2M523P0H	Phase 2/Phase 3	tyrosine kinase inhibitor	CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5
gentamycin	gentamycin|GENTAMICIN C1	CNC(C)[C@@H]1CC[C@@H](N)[C@@H](OC2[C@@H](N)C[C@@H](N)[C@H](OC3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1	I904Y9FPPV	Launched	bacterial 50S ribosomal subunit inhibitor	HSPA8|LRP2
gentiopicrin	gentiopicrin|GENTIOPICRIN	OC[C@H]1O[C@@H](O[C@@H]2OC=C3C(=O)OCC=C3[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O	0WE09Z21RC	Phase 3	glutamate receptor downregulator	GRIN2B
genz-123346	genz-123346	CCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1		Preclinical	glucosylceramidase inhibitor	UGCG
genz-644282	genz-644282|GENZ-644282	CNCCn1c2c(cnc3cc4OCOc4cc23)c2cc(OC)c(OC)cc2c1=O	717I541I2R	Phase 1	topoisomerase inhibitor	TOP1
gepefrine	gepefrine|GEPEFRINE	CC(N)Cc1cccc(O)c1	V51RRX51VH	Launched	adrenergic receptor agonist	
gepon	gepon	CC(C)[C@@H](NC(=O)C(NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)C(CCCNC(N)=N)NC(=O)C(CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)C(CCC(O)=O)NC(=O)[C@H](N)C(C)O)C(C)O)C(=O)N[C@H](CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NC(CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O		Phase 1		
geranyl-farnesylacetate	geranyl-farnesylacetate|GEFARNATE	CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC(=O)OC\C=C(/C)CCC=C(C)C	1ISE2Y6ULA	Phase 2	mucin production enhancer	
gestodene	gestodene|GESTODENE	CC[C@]12CC[C@@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@]2(O)C#C	1664P6E6MI	Launched	contraceptive agent	
gestrinone	gestrinone|GESTRINONE	CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C	1421533RCM	Launched	progesterone receptor antagonist	AR|ESR1|PGR
GF109203X	GF109203X|GO-6850	CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc12	L79H6N0V6C	Preclinical	PKC inhibitor	PDPK1|PIM1|PRKCI|PRKCZ
GGTI-298	GGTI-298	COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1cccc2ccccc12		Preclinical	GGTase inhibitor	CDKN1A
gidazepam	gidazepam|GIDAZEPAM	NNC(=O)CN1c2ccc(Br)cc2C(=NCC1=O)c1ccccc1	XMJ87I93Y9	Launched	GABA benzodiazepine site receptor agonist	
gilteritinib	gilteritinib|GILTERITINIB	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(CC3)N3CCN(C)CC3)c(OC)c2)nc1NC1CCOCC1	66D92MGC8M	Phase 3	FLT3 inhibitor	FLT3
gimeracil	gimeracil|GIMERACIL	Oc1cc(=O)[nH]cc1Cl	UA8SE1325T	Launched	dihydropyrimidine dehydrogenase inhibitor	DPYD
ginkgolide-a	ginkgolide-a|GINKGOLIDE A	C[C@@H]1C(=O)O[C@H]2CC34[C@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O	TAZ2DPR77B	Preclinical	GABA receptor antagonist	GLRA1|GLRB
ginkgolide-b	ginkgolide-b|GINKGOLIDE B	C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O	DF149B9460	Phase 3	platelet activating factor receptor antagonist	GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B
ginsenoside-c-k	ginsenoside-c-k	CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]21C		Preclinical	NFkB pathway inhibitor|nitric oxide synthase inhibitor	PTGS2
ginsenoside-rd	ginsenoside-rd|GINSENOSIDE RD	CC(C)=CCCC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C	WB232T95AV	Phase 3	calcium channel blocker	
ginsenoside-rg3	ginsenoside-rg3|GINSENOSIDE RG3	CC(C)=CCCC(C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C	227D367Y57	Launched	angiogenesis inhibitor|apoptosis stimulant	KCNH2
givinostat	givinostat|GIVINOSTAT	CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(cc3)C(=O)NO)ccc2c1	5P60F84FBH	Phase 2	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
GK921	GK921	C(CN1CCCC1)Oc1nc2cccnc2nc1C#Cc1ccccc1		Preclinical	transglutaminase inhibitor	TGM2
GKT137831	GKT137831|GKT-137831	CN(C)c1cccc(c1)-c1n(C)c(=O)cc2[nH]n(-c3ccccc3Cl)c(=O)c12	45II35329V	Phase 2	NADPH oxidase inhibitor	NOX1|NOX4
glafenine	glafenine|GLAFENINE	OCC(O)COC(=O)c1ccccc1Nc1ccnc2cc(Cl)ccc12	46HL4I09AH	Withdrawn	DeltaF508-CFTR Correctors	CFTR
glasdegib	glasdegib|GLASDEGIB	CN1CC[C@H](C[C@@H]1c1nc2ccccc2[nH]1)NC(=O)Nc1ccc(cc1)C#N	K673DMO5H9	Phase 2	hedgehog pathway inhibitor	SMO
gliclazide	gliclazide|GLICLAZIDE	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1	G4PX8C4HKV	Launched	ATP channel blocker|insulin secretagogue	ABCC8|VEGFA
glimepiride	glimepiride|GLIMEPIRIDE	CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O	6KY687524K	Launched	insulin secretagogue	ABCC8|KCNJ1|KCNJ11
glipizide	glipizide|GLIPIZIDE	Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1	X7WDT95N5C	Launched	sulfonylurea	ABCC8|KCNJ10|KCNJ11|PPARG
gliquidone	gliquidone|GLIQUIDONE	COc1ccc2c(c1)C(=O)N(CCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)C(=O)C2(C)C	C7C2QDD75P	Launched	sulfonylurea	ABCC8|KCNJ10|KCNJ8
GLPG0492	GLPG0492|GLPG-0492	CN1C(=O)N(C(=O)[C@@]1(CO)c1ccccc1)c1ccc(C#N)c(c1)C(F)(F)F	8O59X1ACZT	Phase 1	androgen receptor modulator	AR
GLPG0492-R-enantiomer	GLPG0492-R-enantiomer|GLPG-0492	CN1C(=O)N(C(=O)[C@]1(CO)c1ccccc1)c1ccc(C#N)c(c1)C(F)(F)F	8O59X1ACZT	Phase 1	androgen receptor modulator	AR
glucaric-acid	glucaric-acid|GLUCARIC ACID	O[C@@H]([C@H](O)[C@@H](O)C(O)=O)[C@H](O)C(O)=O	QLZ991V4A2	Phase 1		
gluconolactone	gluconolactone|GLUCONOLACTONE	OC[C@@H]1OC(=O)[C@@H](O)[C@H](O)[C@H]1O	WQ29KQ9POT	Launched		LCT
glucosamine	glucosamine|GLUCOSAMINE	N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O	N08U5BOQ1K	Launched	glycosylated protein precursor	IFNG|IL1B|MMP9|NFKB2|TNF
glutamine-(l)	glutamine-(l)|GLUTAMINE	N[C@@H](CCC(N)=O)C(O)=O	0RH81L854J	Launched		CTPS1|GLUL|GPRC6A|PPAT
glutathione	glutathione|GLUTATHIONE	N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O	GAN16C9B8O	Phase 3	antioxidant	ESD|GGT1|GLO1|GLRX|GLRX2|GPX1|GPX2|GPX3|GPX4|GPX5|GPX6|GPX7|GPX8|GSR|GSS|GSTA1|GSTA2|GSTA3|GSTA4|GSTA5|GSTK1|GSTM1|GSTM2|GSTM3|GSTM4|GSTM5|GSTO1|GSTO2|GSTP1|GSTT1|GSTZ1|HAGH|HPGDS|LTC4S|MGST1|MGST2|MGST3|TXNDC12
glutathione-monoisopropyl-ester	glutathione-monoisopropyl-ester	CC(C)OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(O)=O		Phase 2	lipid peroxidase inhibitor	
gly-gln	gly-gln|GLYCYL-GLUTAMINE	NCC(=O)N[C@@H](CCC(N)=O)C(O)=O	H7125Z98HT	Phase 2		
glyburide	glyburide|GLYBURIDE	COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1	SX6K58TVWC	Launched	ATP channel blocker|insulin secretagogue|sulfonylurea	ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1
glycerol-monolaurate	glycerol-monolaurate|GLYCERYL 1-LAURATE	CCCCCCCCCCCC(=O)OCC(O)CO	WR963Y5QYW	Launched	beta lactamase inhibitor	
glycitein	glycitein|GLYCITEIN	COc1cc2c(cc1O)occ(-c1ccc(O)cc1)c2=O	92M5F28TVF	Phase 3	tumor necrosis factor release inhibitor	TNF
glycopyrrolate	glycopyrrolate|GLYCOPYRROLATE, (2R,3'S)-|GLYCOPYRROLATE	C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)c1ccccc1	68EL47CXSP|V92SO9WP2I	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
GMX1778	GMX1778|CHS-828	Clc1ccc(OCCCCCCN\C(NC#N)=N\c2ccncc2)cc1	8LAP87DNSZ	Phase 1/Phase 2	NAMPT inhibitor	NAMPT
GNF-2	GNF-2	NC(=O)c1cccc(c1)-c1cc(Nc2ccc(OC(F)(F)F)cc2)ncn1	6D7Q9Z2W7T	Preclinical	Bcr-Abl kinase inhibitor	ABL1|BCR
GNTI	GNTI	NC(=N)Nc1ccc2[nH]c3c(C[C@@]4(O)[C@H]5Cc6ccc(O)c7O[C@@H]3[C@]4(CCN5CC3CC3)c67)c2c1		Preclinical	opioid receptor antagonist	OPRK1|OPRM1
go-6983	go-6983	COc1ccc2n(CCCN(C)C)cc(C3=C(C(=O)NC3=O)c3c[nH]c4ccccc34)c2c1		Preclinical	protein kinase inhibitor	PRKCA|PRKCB|PRKCD|PRKCG|PRKCZ
golgicide-a	golgicide-a	Fc1cc(F)c2NC([C@H]3CC=C[C@@H]3c2c1)c1cccnc1		Preclinical	ARF inhibitor	GBF1
golvatinib	golvatinib|GOLVATINIB	CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1cc(Oc2ccc(NC(=O)C3(CC3)C(=O)Nc3ccc(F)cc3)c(F)c2)ccn1	516Z3YP58E	Phase 2	VEGFR inhibitor	KDR|MET
gonadorelin	gonadorelin	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O		Launched	gonadotropin releasing factor hormone receptor agonist	GNRHR|GNRHR2
goserelin-acetate	goserelin-acetate|GOSERELIN	CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O	0F65R8P09N	Launched	gonadotropin releasing factor hormone receptor agonist	GNRHR|LHCGR
gossypol	gossypol|GOSSYPOL, (R)-|GOSSYPOL|GOSSYPOL, (S)-	CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O	8DY2X8LXW4|KAV15B369O|XNA7DR63CQ	Phase 2	BCL inhibitor|MCL1 inhibitor	BCL2
GP1a	GP1a	Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NN2CCCCC2)c1		Preclinical	cannabinoid receptor agonist	CNR2
GP2a	GP2a	Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NC2CCCCC2)c1		Preclinical	cannabinoid receptor agonist	CNR2
GPI-1046	GPI-1046	CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc1cccnc1		Preclinical	FKBP inhibitor	FKBP1A
GPR120-modulator-1	GPR120-modulator-1	Cc1cc(OCc2nc(cs2)-c2ccccc2Cl)ccc1OCC(O)=O		Preclinical	G protein-coupled receptor modulator	FFAR4
GR-103691	GR-103691	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(cc2)-c2ccc(cc2)C(C)=O)CC1	0Y0CM1A77L	Preclinical	dopamine receptor antagonist	DRD3
GR-113808	GR-113808	Cn1cc(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc12	ZT350OYT3I	Preclinical	serotonin receptor antagonist	HTR4
GR-127935	GR-127935	COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1	2LLH6CEB40	Preclinical	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6
GR-135531	GR-135531	COC(=O)Nc1ccc2[nH]cc(CCNC(C)=O)c2c1		Preclinical	melatonin receptor agonist	
GR-144053	GR-144053	NC(=N)c1ccc(cc1)N1CCN(CC1)C1CCN(CC(O)=O)CC1		Preclinical	integrin antagonist	ITGA2B|ITGB3
GR-159897	GR-159897	COC1(C[S@@](=O)c2ccccc2)CCN(CCc2c[nH]c3ccc(F)cc23)CC1		Preclinical	tachykinin antagonist	TAC1|TACR2
GR-235	GR-235|GUGGULSTERONE, (Z)-	C\C=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	6CST3U34GN	Launched	estrogen receptor agonist|FXR antagonist|progesterone receptor agonist	NR1H4
GR-79236	GR-79236	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N[C@H]3CCC[C@@H]3O)ncnc12	Q4H682B2VZ	Phase 1	adenosine receptor agonist	ADORA1|ADORA2A
GR125487	GR125487	COc1[nH]c2ccc(F)cc2c1C(=O)OCC1CCN(CCNS(C)(=O)=O)CC1		Preclinical	serotonin receptor antagonist	HTR4
GR46611	GR46611	COc1ccc(CNC(=O)\C=C\c2ccc3[nH]cc(CCN(C)C)c3c2)cc1		Preclinical	serotonin receptor agonist	HTR1D
gramicidin	gramicidin|VALINEGRAMICIDIN A	CC(C)CC(NC(=O)C(C)NC(=O)CNC(=O)C(NC=O)C(C)C)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCCO	93AG3Q5T2V	Launched	bacterial permeability inducer	
gramine	gramine|GRAMINE	CN(C)Cc1c[nH]c2ccccc12	FGQ8A78L14	Preclinical	norepinephrine reputake inhibitor	
granisetron	granisetron|GRANISETRON	CN1C2CCCC1CC(C2)NC(=O)c1nn(C)c2ccccc12	WZG3J2MCOL	Launched	serotonin receptor antagonist	HTR3A
grapiprant	grapiprant|GRAPIPRANT	CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1	J9F5ZPH7NB	Launched	prostaglandin inhibitor	PTGER4
grazoprevir	grazoprevir|GRAZOPREVIR	COc1ccc2nc3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)Oc3nc2c1)C(C)(C)C	4O2AB118LA	Launched	HCV inhibitor	
griseofulvin	griseofulvin|GRISEOFULVIN	COc1cc(OC)c(Cl)c2O[C@]3([C@H](C)CC(=O)C=C3OC)C(=O)c12	32HRV3E3D5	Launched	tubulin polymerization inhibitor	KRT12
GS-39783	GS-39783	CSc1nc(NC2CCCC2)c(c(NC2CCCC2)n1)[N+]([O-])=O		Preclinical	GABA receptor modulator	GABBR1
GS-6201	GS-6201|CVT-6883	CCCn1c(=O)n(CC)c2nc([nH]c2c1=O)-c1cnn(Cc2cccc(c2)C(F)(F)F)c1	67CKV7X08G	Phase 1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
GS-9620	GS-9620|VESATOLIMOD	CCCCOc1nc(N)c2NC(=O)CN(Cc3cccc(CN4CCCC4)c3)c2n1	O8M467C50G	Phase 2	toll-like receptor agonist	TLR7
GS-9973	GS-9973|ENTOSPLETINIB	C1CN(CCO1)c1ccc(Nc2nc(cn3ccnc23)-c2ccc3cn[nH]c3c2)cc1	6I3O3W6O3B	Phase 2	syk inhibitor	SYK
GSK-0660	GSK-0660	COC(=O)c1sccc1S(=O)(=O)Nc1ccc(Nc2ccccc2)cc1OC		Preclinical	PPAR receptor antagonist	PPARD
GSK-3-inhibitor-IX	GSK-3-inhibitor-IX	O\N=C1/C(Nc2ccccc12)=C1/C(=O)Nc2cc(Br)ccc12		Preclinical	glycogen synthase kinase inhibitor|lipoxygenase inhibitor	GSK3A|GSK3B
GSK-J1	GSK-J1	OC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1		Preclinical	histone demethylase inhibitor	KDM6B
GSK-J2	GSK-J2	OC(=O)CCNc1cc(nc(n1)-c1cccnc1)N1CCc2ccccc2CC1		Preclinical	histone demethylase inhibitor	
GSK-J4	GSK-J4	CCOC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1		Preclinical	histone lysine demethylase inhibitor	KDM6A|KDM6B
GSK1059615	GSK1059615|GSK-1059615	O=C1NC(=O)\C(S1)=C\c1ccc2nccc(-c3ccncc3)c2c1	07YMO87363	Phase 1	PI3K inhibitor	PIK3CG
GSK1070916	GSK1070916|GSK-1070916A	CCn1cc(c(n1)-c1ccc(NC(=O)N(C)C)cc1)-c1ccnc2[nH]c(cc12)-c1cccc(CN(C)C)c1	8VLB51V7HO	Phase 1	Aurora kinase inhibitor	AURKA|AURKB|AURKC|CYP2D6|CYP3A4
GSK1292263	GSK1292263|GSK-1292263	CC(C)c1noc(n1)N1CCC(COc2ccc(nc2)-c2ccc(cc2)S(C)(=O)=O)CC1	R1J57STA6O	Phase 2	glucose dependent insulinotropic receptor agonist	GRPR
GSK163090	GSK163090|GSK-163090	Cc1ccc2c(cccc2n1)N1CCN(CCc2cccc(c2)N2CCNC2=O)CC1	7XI927X82B	Phase 2	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D
GSK1838705A	GSK1838705A	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3N(CCc3cc2OC)C(=O)CN(C)C)nc2[nH]ccc12		Preclinical	insulin growth factor receptor inhibitor	ALK|IGF1R|INSR|RPS6KA1
GSK1904529A	GSK1904529A	CCc1cc(Nc2nccc(n2)-c2c(nc3ccccn23)-c2ccc(OC)c(c2)C(=O)Nc2c(F)cccc2F)c(OC)cc1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O		Preclinical	IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand	IGF1R|INSR
GSK2110183	GSK2110183|AFURESERTIB	Cn1ncc(Cl)c1-c1cc(sc1Cl)C(=O)N[C@H](CN)Cc1cccc(F)c1	8739X25QI3	Phase 2	AKT inhibitor	AKT1|AKT2|AKT3
GSK2126458	GSK2126458|OMIPALISIB	COc1ncc(cc1NS(=O)(=O)c1ccc(F)cc1F)-c1ccc2nccc(-c3ccnnc3)c2c1	1X8F5A3NA0	Phase 1	mTOR inhibitor|PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG
GSK2190915	GSK2190915|FIBOFLAPON	CCOc1ccc(cn1)-c1ccc(Cn2c(CC(C)(C)C(O)=O)c(SC(C)(C)C)c3cc(OCc4ccc(C)cn4)ccc23)cc1	Y1NA96IX3T	Phase 2	lipoxygenase inhibitor	ALOX5AP
GSK2256294A	GSK2256294A|GSK-2256294	CNc1nc(C)nc(N[C@H]2CCC[C@H](C2)C(=O)NCc2ccc(cc2C(F)(F)F)C#N)n1	L33EX3XR0T	Phase 1	epoxide hydolase inhibitor	EPHX2
GSK2330672	GSK2330672|GSK-2330672	CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(O)=O)CC(O)=O)c(OC)cc2[C@H](N1)c1ccccc1	386012Z45S	Phase 2	bile acid transporter inhibitor	SLC10A2
GSK256066	GSK256066|GSK-256066	COc1cccc(Nc2c(cnc3c(C)cc(cc23)S(=O)(=O)c2cccc(c2)C(=O)N(C)C)C(N)=O)c1	2D6GK059SR	Phase 2	phosphodiesterase inhibitor	PDE4A
GSK2606414	GSK2606414	Cn1cc(-c2ccc3N(CCc3c2)C(=O)Cc2cccc(c2)C(F)(F)F)c2c(N)ncnc12		Preclinical	protein kinase inhibitor	EIF2AK3|MYLK2
GSK2636771	GSK2636771|GSK-2636771	Cc1nc2c(cc(cc2n1Cc1cccc(c1C)C(F)(F)F)N1CCOCC1)C(O)=O	DW94IAT0LS	Phase 2	PI3K inhibitor	PIK3CB
GSK2656157	GSK2656157	Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1		Preclinical	PERK inhibitor	
GSK2801	GSK2801	CCCOc1ccn2c(cc(-c3ccccc3S(C)(=O)=O)c2c1)C(C)=O		Preclinical	bromodomain inhibitor	BAZ2A|BAZ2B
GSK2816126	GSK2816126	CC[C@H](C)n1cc(C)c2c(cc(cc12)-c1ccc(nc1)N1CCNCC1)C(=O)NCc1c(C)cc(C)[nH]c1=O		Phase 1	histone lysine methyltransferase inhibitor	EZH2
GSK2830371	GSK2830371	Cc1ncc(Cl)cc1NCc1ccc(s1)C(=O)N[C@@H](CC1CCCC1)C(=O)NC1CC1		Preclinical	protein phosphatase inhibitor	PPM1D
GSK2838232	GSK2838232	CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)Cc1ccc(Cl)cc1		Phase 1	HIV gag inhibitor	
GSK2879552	GSK2879552|GSK-2879552	OC(=O)c1ccc(CN2CCC(CN[C@@H]3C[C@H]3c3ccccc3)CC2)cc1	GT77Z6Y09Z	Phase 1	histone lysine demethylase inhibitor	KDM1A
GSK3787	GSK3787	FC(F)(F)c1ccc(nc1)S(=O)(=O)CCNC(=O)c1ccc(Cl)cc1		Preclinical	PPAR receptor antagonist	PPARD
GSK429286A	GSK429286A	CC1=C(C(CC(=O)N1)c1ccc(cc1)C(F)(F)F)C(=O)Nc1cc2cn[nH]c2cc1F		Preclinical	rho associated kinase inhibitor	ROCK1
GSK461364	GSK461364|GSK-461364	C[C@@H](Oc1cc(sc1C(N)=O)-n1cnc2ccc(CN3CCN(C)CC3)cc12)c1ccccc1C(F)(F)F	8QO27TK6Q4	Phase 1	PLK inhibitor	PLK1
GSK503	GSK503	CC(C)n1cc(C)c2c(cc(cc12)-c1ccc(nc1)N1CCN(C)CC1)C(=O)NCc1c(C)cc(C)[nH]c1=O		Preclinical	histone lysine methyltransferase inhibitor	EZH2
GSK650394	GSK650394|GSK-650394	OC(=O)c1ccc(cc1C1CCCC1)-c1c[nH]c2ncc(cc12)-c1ccccc1	56887611DJ	Preclinical	serum/glucocorticoid regulated kinase inhibitor	SGK1|SGK2
GSK690693	GSK690693|GSK-690693	CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N	GWH480321B	Phase 1	AKT inhibitor	AKT1|AKT2|AKT3|PAK4|PAK6|PAK7|PRKCQ|PRKG1|PRKX
GSK923295	GSK923295|SPARFOSATE SODIUM	CC(C)Oc1ccc(cc1Cl)C(=O)N[C@H](CNC(=O)CN(C)C)Cc1ccc(cc1)-c1cn2cccc([C@H](C)O)c2n1	5R33Q73DYD	Phase 1	centromere associated protein inhibitor	CENPE
GTP-14564	GTP-14564	c1ccc(cc1)-c1n[nH]c2c1oc1ccccc21		Preclinical	FLT3 inhibitor|tyrosine kinase inhibitor	CSF1R|FLT3|KIT|PDGFRB
GTS21	GTS21|GTS-21	COc1ccc(\C=C2CCCN=C/2c2cccnc2)c(OC)c1	8S399XDN2K	Phase 1/Phase 2	cholinergic receptor agonist	CHRNA7
guacetisal	guacetisal|GUACETISAL	COc1ccccc1OC(=O)c1ccccc1OC(C)=O	T6EKB9V2O2	Launched	immunosuppressant	
guaiacol	guaiacol|GUAIACOL	COc1ccccc1O	6JKA7MAH9C	Launched	local anesthetic	CA2
guaifenesin	guaifenesin|GUAIFENESIN	COc1ccccc1OCC(O)CO	495W7451VQ	Launched	expectorant	
guanaben-acetate	guanaben-acetate|GUANABENZ	NC(=N)N\N=C/c1c(Cl)cccc1Cl	GGD30112WC	Launched	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
guanadrel	guanadrel|GUANADREL	NC(=N)NCC1COC2(CCCCC2)O1	765C9332T4	Launched	adrenergic inhibitor	SLC6A2
guanethidine	guanethidine|GUANETHIDINE	NC(=N)NCCN1CCCCCCC1	ZTI6C33Q2Q	Launched	adrenergic inhibitor	SLC6A2
guanfacine	guanfacine|GUANFACINE	NC(=N)NC(=O)Cc1c(Cl)cccc1Cl	30OMY4G3MK	Launched	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
guanidine	guanidine|GUANIDINE	NC(N)=N	JU58VJ6Y3B	Launched	HSP inhibitor	ALDH2|DLG4|GAMT|RNASE1
guanidinoethyldisulfide-bicarbonate	guanidinoethyldisulfide-bicarbonate	NC(N)=NCCSSCCN=C(N)N		Phase 2	nitric oxide synthase inhibitor	NOS2
guanidinopropionic-acid	guanidinopropionic-acid|3-GUANIDINOPROPIONIC ACID	NC(N)=NCCC(O)=O	UL1984YRKA	Phase 2	creatine kinase inhibitor	CKM
guanosine	guanosine|GUANOSINE	Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H]1O	12133JR80S	Preclinical		PNP
guvacine	guvacine|GUVACINE	OC(=O)C1=CCCNC1	41538P325K	Preclinical	GABA uptake inhibitor	SLC6A1|SLC6A11|SLC6A12|SLC6A13
GW-0742	GW-0742	Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(c(F)c1)C(F)(F)F		Preclinical	PPAR receptor agonist	PPARD
GW-1100	GW-1100	CCOC(=O)c1ccc(cc1)-n1cc(Cc2cnc(OCC)nc2)c(=O)nc1SCc1ccc(F)cc1		Preclinical	G protein-coupled receptor agonist	FFAR1
GW-1929	GW-1929	CN(CCOc1ccc(CC(Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)c1ccccn1	X8S066WKF4	Preclinical	PPAR receptor agonist	PPARG
GW-2580	GW-2580	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1	SRV0JCF9LI	Preclinical	cFMS kinase inhibitor	CSF1R
GW-311616	GW-311616	CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)\C=C\CN2CCCCC2)N(C1=O)S(C)(=O)=O	L8012V52PN	Phase 1	leukocyte elastase inhibitor|elastase inhibitor	ELANE
GW-3965	GW-3965	OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c2ccccc2)Cc2cccc(c2Cl)C(F)(F)F)c1	6JI5YOG7RC	Preclinical	LXR agonist	NR1H2|NR1H3
GW-405833	GW-405833|L-768242	COc1ccc2n(C(=O)c3cccc(Cl)c3Cl)c(C)c(CCN3CCOCC3)c2c1	85K154W99L	Preclinical	cannabinoid receptor agonist	CNR2
GW-4064	GW-4064	CC(C)c1onc(c1COc1ccc(\C=C\c2cccc(c2)C(O)=O)c(Cl)c1)-c1c(Cl)cccc1Cl	SR225WUZ0H	Preclinical	FXR agonist	NR1H4
GW-441756	GW-441756	Cn1cc(\C=C2/C(=O)Nc3cccnc23)c2ccccc12		Preclinical	growth factor receptor inhibitor	NTRK1
GW-501516	GW-501516	Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F	7I2HA1NU22	Phase 2	PPAR receptor agonist	PPARA|PPARD
GW-5074	GW-5074	Oc1c(Br)cc(cc1Br)\C=C1/C(=O)Nc2ccc(I)cc12		Preclinical	RAF inhibitor|leucine rich repeat kinase inhibitor	NTRK1|RAF1
GW-583340	GW-583340	CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		Preclinical	EGFR inhibitor	EGFR|ERBB2
GW-6471	GW-6471	CCC(=O)NC[C@H](Cc1ccc(OCCc2nc(oc2C)-c2ccccc2)cc1)N\C(C)=C/C(=O)c1ccc(cc1)C(F)(F)F		Preclinical	PPAR receptor antagonist	PPARA
GW-7647	GW-7647	CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(O)=O		Preclinical	PPAR receptor agonist	PPARA
GW-788388	GW-788388	O=C(NC1CCOCC1)c1ccc(cc1)-c1cc(ccn1)-c1c[nH]nc1-c1ccccn1	N14114957J	Preclinical	ALK tyrosine kinase receptor inhibitor	LCK|MAPK14|TGFBR1
GW-803430	GW-803430	COc1cc(ccc1OCCN1CCCC1)-n1cnc2cc(sc2c1=O)-c1ccc(Cl)cc1	4R0136W1PR	Phase 1	melanin inhibitor	KCNH2|MCHR1
GW-842166	GW-842166|GW842166	FC(F)(F)c1nc(Nc2ccc(Cl)cc2Cl)ncc1C(=O)NCC1CCOCC1	VL1I6P2DZ8	Phase 2	cannabinoid receptor agonist	CNR2
GW-843682X	GW-843682X	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(N)=O)c2cc1OC		Preclinical	PLK inhibitor	PLK1|PLK3
GW-9508	GW-9508	OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1	4T77GYP2CS	Preclinical	free fatty acid receptor agonist|G protein-coupled receptor agonist	FFAR1|FFAR4
GW-9662	GW-9662	[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc1ccccc1		Preclinical	PPAR receptor antagonist	NCOA2|PPARG|RXRA
GYKI-52466	GYKI-52466|GYKI-2466	CC1=NN=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1	471V8NZ5X3	Preclinical	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
gynostemma-extract	gynostemma-extract	CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C		Preclinical	calcium channel modulator	
GZD824	GZD824	CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4[nH]ncc4c3)cc2C(F)(F)F)CC1		Preclinical	Bcr-Abl kinase inhibitor	ABL1|BCR
H-89	H-89	Brc1ccc(\C=C\CNCCNS(=O)(=O)c2cccc3cnccc23)cc1	M876330O56	Preclinical	PKA inhibitor	GSG2|PKIA|PRKACA
HA-1004	HA-1004	NC(=N)NCCNS(=O)(=O)c1cccc2cnccc12		Phase 2	calcium channel blocker	
HA-14-1	HA-14-1	CCOC(=O)C(C#N)C1c2cc(Br)ccc2OC(N)=C1C(=O)OCC		Preclinical	BCL inhibitor	BCL2
HA-966-(R)-(+)	HA-966-(R)-(+)|HA-966, (R)-	N[C@@H]1CCN(O)C1=O	2N9Q4C7WMT	Preclinical	glutamate receptor agonist	GRIA1
HA-966-(S)-(-)	HA-966-(S)-(-)|HA-966, (S)-	N[C@H]1CCN(O)C1=O	3C1G86U80C	Preclinical	glutamate receptor antagonist	GRIA1
HA14-1	HA14-1	CCOC(=O)[C@@H](C#N)[C@@H]1c2cc(Br)ccc2OC(N)=C1C(=O)OCC		Preclinical	BCL inhibitor	BCL2
halazone	halazone|HALAZONE	OC(=O)c1ccc(cc1)S(=O)(=O)N(Cl)Cl	G359OL82VB	Launched		
halcinonide	halcinonide|HALCINONIDE	CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@@]2(O1)C(=O)CCl	SI86V6QNEG	Launched	glucocorticoid receptor agonist	NR3C1
halobetasol-propionate	halobetasol-propionate|HALOBETASOL PROPIONATE	CCC(=O)O[C@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)CCl	91A0K1TY3Z	Launched	glucocorticoid receptor agonist	NR3C1|PLA2G1B
halofantrine	halofantrine|HALOFANTRINE|HALOFANTRINE, (-)-	CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(ccc12)C(F)(F)F	Q2OS4303HZ|R7ADS21FSN	Launched	antimalarial agent	KCNH2|KCNN4
halofuginone	halofuginone|HALOFUGINONE	O[C@H]1CCCN[C@@H]1CC(=O)Cn1cnc2cc(Br)c(Cl)cc2c1=O	L31MM1385E	Launched	collagenase inhibitor	COL1A1|MMP2
halopemide	halopemide|HALOPEMIDE	Oc1nc2cc(Cl)ccc2n1C1CCN(CCNC(=O)c2ccc(F)cc2)CC1	65Q28TV0ZY	Phase 2	phospholipase inhibitor	PLD1|PLD2
haloperidol	haloperidol|HALOPERIDOL	OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1	J6292F8L3D	Launched	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1
haloperidol-decanoate	haloperidol-decanoate|HALOPERIDOL DECANOATE	CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1	AC20PJ4101	Launched	psychoactive drug	DRD2|DRD3|DRD4|HTR2A
haloprogin	haloprogin|HALOPROGIN	Clc1cc(Cl)c(OCC#CI)cc1Cl	AIU7053OWL	Launched	other antifungal	
halothane	halothane|HALOTHANE	FC(F)(F)C(Cl)Br	UQT9G45D1P	Launched	glutamate receptor antagonist	ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GNG2|GRIN2A|GRIN3A|GRIN3B|KCNJ3|KCNJ6|KCNK10|KCNK12|KCNK13|KCNK15|KCNK18|KCNK2|KCNK3|KCNK9|KCNMA1|KCNN4|MT-ND1|NPSR1|RHO
harmane	harmane|HARMAN	Cc1nccc2c3ccccc3[nH]c12	82D6J0535P	Preclinical	monoamine oxidase inhibitor	MAOA|MAOB
harringtonine	harringtonine|HARRINGTONIN	COC(=O)C[C@@](O)(CCC(C)(C)O)C(=O)O[C@H]1[C@@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC	088662H40F	Phase 3	protein synthesis inhibitor	
HC-030031	HC-030031	CC(C)c1ccc(NC(=O)Cn2cnc3n(C)c(=O)n(C)c(=O)c23)cc1		Phase 1	TRPA1 channel blocker	TRPA1
HEMADO	HEMADO	CCCCC#Cc1nc(NC)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1		Preclinical		ADORA1|ADORA2A|ADORA2B|ADORA3
hematoporphyrin	hematoporphyrin|HEMATOPORPHYRIN	CC(O)c1c(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(O)=O)c(CCC(O)=O)c4C)c(C)c3C(C)O	HBT6M5H379	Launched		
hematoxylin	hematoxylin|HEMATOXYLIN	Oc1cc2C[C@@]3(O)COc4c(ccc(O)c4O)[C@H]3c2cc1O	YKM8PY2Z55	Preclinical		
hemin	hemin	[Fe+3].Cc1c(CCC(O)=O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C=C)c5C)c(C=C)c4C)c(C)c3CCC(O)=O		Launched	enzyme inducer	
hemoglobin-modulators-1	hemoglobin-modulators-1	CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O		Phase 3	hemoglobin modulator	
hemomex-s	hemomex-s	CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@@]21C		Launched		PPARG
heptaminol	heptaminol|HEPTAMINOL	CC(N)CCCC(C)(C)O	3DQS188SY5	Launched	vasoconstrictor	
HER2-Inhibitor-1	HER2-Inhibitor-1|N-(4-((1,2,4)TRIAZOLO(1,5-A)PYRIDIN-7-YLOXY)-3-METHYLPHENYL)-6-(5-(((2-(METHYLSULFONYL)ETHYL)AMINO)METHYL)FURAN-2-YL)QUINAZOLIN-4-AMINE	Cc1cc(Nc2ncnc3ccc(cc23)-c2ccc(CNCCS(C)(=O)=O)o2)ccc1Oc1ccn2ncnc2c1	H32S1659ED	Preclinical	EGFR inhibitor	
hesperadin	hesperadin|HESPERADIN	CCS(=O)(=O)Nc1ccc2NC(=O)\C(c2c1)=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1	PTR491OS14	Preclinical	Aurora kinase inhibitor	AURKB
hesperetin	hesperetin|HESPERETIN	COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1	Q9Q3D557F1	Launched	ACAT inhibitor	DGAT1|MTTP|SOAT1|SOAT2
hesperidin	hesperidin|HESPERIDIN	COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1	E750O06Y6O	Launched	flavanone glycoside	CACNA1B
hetacillin	hetacillin|HETACILLIN	CC1(C)S[C@@H]2C(N3C(=O)[C@H](NC3(C)C)c3ccccc3)C(=O)N2[C@H]1C(O)=O	TN4JSC48CV	Launched	bacterial cell wall synthesis inhibitor	
hexachlorophene	hexachlorophene|HEXACHLOROPHENE	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl	IWW5FV6NK2	Launched	potassium channel activator	GLUD1|SDHD
hexamethonium	hexamethonium|HEXAMETHONIUM	C[N+](C)(C)CCCCCC[N+](C)(C)C	3C9PSP36Z2	Preclinical	cholinergic receptor antagonist	CHRNA2|CHRNA3|CHRNA4|CHRNA6
hexamethylenebisacetamide	hexamethylenebisacetamide|HEXAMETHYLENE BISACETAMIDE	CC(=O)NCCCCCCNC(C)=O	LA133J59VU	Phase 2	AKT inhibitor|differentiation inducer|NFKB pathway inhibitor	AKT1
hexaminolevulinate	hexaminolevulinate|HEXAMINOLEVULINATE	CCCCCCOC(=O)CCC(=O)CN	G7H20TKI67	Launched		
hexasodium-phytate	hexasodium-phytate|HEXASODIUM PHYTATE	OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O	ZBX50UG81V	Phase 2		
hexestrol	hexestrol|HEXESTROL	CCC(C(CC)c1ccc(O)cc1)c1ccc(O)cc1	10BI795R7D	Launched	synthetic estrogen	AKR1C1|ESR1|ESR2
hexetidine	hexetidine|HEXETIDINE	CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1	852A84Y8LS	Launched	local anesthetic	
hexonic-acid	hexonic-acid|GULONIC ACID, L-|GULONIC ACID, D-|GLUCONIC ACID|GLUCONATE ION	OCC(O)C(O)C(O)C(O)C(O)=O	0IK55ZPI0I|1HB2H1463Q|R4R8J0Q44B|W552L9Y4VZ	Preclinical		
hexoprenaline	hexoprenaline|HEXOPRENALINE	OC(CNCCCCCCNCC(O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1	G9L6B3W684	Launched	adrenergic receptor agonist	ADRB2
hexylcaine	hexylcaine|HEXYLCAINE	CC(CNC1CCCCC1)OC(=O)c1ccccc1	511IU0826Z	Launched	sodium channel blocker	SCN10A|SCN5A
hexylene-glycol	hexylene-glycol|HEXYLENE GLYCOL	CC(O)CC(C)(C)O	KEH0A3F75J	Preclinical		AKR1C3|CTPS1|DLG4|HSP90AA1|NOS3|PGF|PLA2G1B|PTPN1|SELP
hexylresorcinol	hexylresorcinol|HEXYLRESORCINOL	CCCCCCc1ccc(O)cc1O	R9QTB5E82N	Launched	local anesthetic	TYR
higenamine	higenamine|HIGENAMINE	Oc1ccc(CC2NCCc3cc(O)c(O)cc23)cc1	TBV5O16GAP	Phase 1	adrenergic receptor agonist	ADRB2
hippuric-acid	hippuric-acid|HIPPURIC ACID	OC(=O)CNC(=O)c1ccccc1	TE0865N2ET	Preclinical		
histamine	histamine|HISTAMINE	NCCc1c[nH]cn1	820484N8I3	Launched	histamine receptor agonist	HRH1|HRH2|HRH3|HRH4
HKI-357	HKI-357	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C	39R3638KZ6	Phase 1	EGFR inhibitor	EGFR
HLCL-61	HLCL-61	CCn1c2ccccc2c2cc(CNCc3ccccc3OC)ccc12		Preclinical	protein arginine N-methyltransferase inhibitor	PRMT5
HMN-214	HMN-214	COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1\C=C\c1cc[n+]([O-])cc1	94E9UR0RFR	Phase 1	PLK inhibitor	CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET
homatropine	homatropine|HOMATROPINE	CN1C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c1ccccc1	8QS6WCL55Z	Launched	acetylcholine receptor antagonist	CES1|CHRM1
homatropine-bromide	homatropine-bromide|HOMATROPINE	CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(O)c1ccccc1	8QS6WCL55Z	Launched	acetylcholine receptor antagonist	
homatropine-methylbromide	homatropine-methylbromide|HOMATROPINE METHYLBROMIDE	C[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c1ccccc1	68JRS2HC1C	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
homidium	homidium|HOMIDIUM	CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc12	EN464416SI	Preclinical		
homochlorcyclizine	homochlorcyclizine|HOMOCHLORCYCLIZINE	CN1CCCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1	N5MVC31W2N	Launched	antihistamine	HRH1
homoharringtonine	homoharringtonine|OMACETAXINE MEPESUCCINATE	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC	6FG8041S5B	Launched	protein synthesis inhibitor	RPL3
homoquinolinic-acid	homoquinolinic-acid	OC(=O)Cc1cccnc1C(O)=O		Preclinical	glutamate receptor agonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
homosalate	homosalate|HOMOSALATE	CC1CC(CC(C)(C)C1)OC(=O)c1ccccc1O	V06SV4M95S	Preclinical	HSP inducer	
homoveratrylamine	homoveratrylamine|HOMOVERATRYLAMINE	COc1ccc(CCN)cc1OC	IQF9T435OP	Preclinical	dopamine analog	
honokiol	honokiol|HONOKIOL	Oc1ccc(cc1CC=C)-c1cc(CC=C)ccc1O	11513CCO0N	Phase 3	AKT inhibitor	ALOX5|PTGS1|PTGS2
hordenine	hordenine|HORDENINE	CN(C)CCc1ccc(O)cc1	K3489CA082	Preclinical		
HQK-1001	HQK-1001|SODIUM 2,2-DIMETHYLBUTYRATE	CCC(C)(C)C(O)=O	XKM99SPB5I	Phase 2		
HTMT	HTMT	CC(CCCCC(=O)Nc1ccc(cc1)C(F)(F)F)NCCc1c[nH]cn1		Preclinical	histamine receptor agonist	HRH4
huperzine-a	huperzine-a|HUPERZINE A	C\C=C1\[C@@H]2Cc3nc(O)ccc3[C@@]1(N)CC(C)=C2	0111871I23	Phase 2	acetylcholinesterase inhibitor	ACHE
hyaluronic-acid	hyaluronic-acid	CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1C(O)=O		Launched		C1QBP|CD44|HABP2|HAPLN1|HAPLN3|HAPLN4|HMMR|ICAM1|NCAN|VCAN
hycanthone	hycanthone|HYCANTHONE	CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12	2BXX5EVN2A	Launched	RNA synthesis inhibitor	
hydralazine	hydralazine|HYDRALAZINE	NNc1nncc2ccccc12	26NAK24LS8	Launched	vasodilator	AOC3|P4HA1
hydrastinine	hydrastinine|HYDRASTININE	CN1CCc2cc3OCOc3cc2C1O	V1I0L48X6E	Preclinical	haemostatic agent	
hydrochlorothiazide	hydrochlorothiazide|HYDROCHLOROTHIAZIDE	NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl	0J48LPH2TH	Launched	thiazide diuretic	CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A3
hydrocortisone	hydrocortisone|HYDROCORTISONE	C[C@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)CO	WI4X0X7BPJ	Launched	glucocorticoid receptor agonist	
hydrocortisone-acetate	hydrocortisone-acetate|HYDROCORTISONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C	3X7931PO74	Launched	glucocorticoid receptor agonist	NR3C1|NR3C2
hydrocortisone-butyrate	hydrocortisone-butyrate|HYDROCORTISONE BUTYRATE	CCCC(=O)O[C@@]1(CCC2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)CO	05RMF7YPWN	Launched	glucocorticoid receptor agonist	NR3C1
hydrocortisone-hemisuccinate	hydrocortisone-hemisuccinate|HYDROCORTISONE HEMISUCCINATE	C[C@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O	LIU00Z1Z84	Phase 2/Phase 3		
hydrocortisone-phosphate	hydrocortisone-phosphate|HYDROCORTISONE PHOSPHATE	CC12C[C@H](O)C3C(CCC4=CC(=O)CCC34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O	2Y87E22X71	Launched		ANXA1|NOS2|NR3C1
hydrocortisone-valerate	hydrocortisone-valerate|HYDROCORTISONE VALERATE	CCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)CO	68717P8FUZ	Launched	glucocorticoid receptor agonist	
hydroflumethiazide	hydroflumethiazide|HYDROFLUMETHIAZIDE	NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F	501CFL162R	Launched	sodium/potassium/chloride transporter inhibitor	ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3
hydroquinidine	hydroquinidine|HYDROQUINIDINE	CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12	8P68XPY4HG	Launched	antiarrhythmic	
hydroquinone	hydroquinone|HYDROQUINONE	Oc1ccc(O)cc1	XV74C1N1AE	Launched	melanin inhibitor	TYR
hydroxyamphetamine	hydroxyamphetamine|HYDROXYAMPHETAMINE	CC(N)Cc1ccc(O)cc1	FQR280JW2N	Launched	trace amine associated receptor agonist	TAAR1
hydroxychloroquine	hydroxychloroquine|HYDROXYCHLOROQUINE	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	4QWG6N8QKH	Launched	antimalarial agent	TLR7|TLR9
hydroxyfasudil	hydroxyfasudil	Oc1nccc2c(cccc12)S(=O)(=O)N1CCCNCC1		Preclinical	rho associated kinase inhibitor	PKIA|PRKACA|ROCK1
hydroxyprogesterone	hydroxyprogesterone|HYDROXYPROGESTERONE	CC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C	21807M87J2	Launched	progesterone receptor agonist	PGR
hydroxyprogesterone-acetate	hydroxyprogesterone-acetate|HYDROXYPROGESTERONE ACETATE	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	L124O66YSI	Launched	progesterone receptor agonist	PGR
hydroxypropyl-beta-cyclodextrin	hydroxypropyl-beta-cyclodextrin	CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		Phase 2		
hydroxystilbamidine	hydroxystilbamidine|HYDROXYSTILBAMIDINE	NC(=N)c1ccc(cc1)\C=C\c1ccc(cc1O)C(N)=N	39J262E49W	Launched		
hydroxytoluic-acid	hydroxytoluic-acid|HYDROXYTOLUIC ACID	Cc1cccc(C(O)=O)c1O	ZH3HEY032H	Preclinical		
hydroxyurea	hydroxyurea|HYDROXYUREA	NC(=O)NO	X6Q56QN5QC	Launched	ribonucleotide reductase inhibitor	RRM1|RRM2|RRM2B
hydroxyzine	hydroxyzine|HYDROXYZINE	OCCOCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1	30S50YM8OG	Launched	antihistamine	HRH1
hygromycin-b	hygromycin-b|HYGROMYCIN B	CN[C@@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@@H]3OC4(O[C@@H]23)O[C@H]([C@@H](N)CO)[C@H](O)[C@H](O)[C@@H]4O)[C@@H]1O	3XQ2233B0B	Preclinical	polypeptide synthesis inhibitor	
hymecromone	hymecromone|HYMECROMONE	Cc1cc(=O)oc2cc(O)ccc12	3T5NG4Q468	Phase 2	monoamine oxidase inhibitor	MAOA|MAOB
hyodeoxycholic-acid	hyodeoxycholic-acid|HYODEOXYCHOLIC ACID	C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C	7A33Y6EHYK	Phase 1	atherosclerosis formation inhibitor	
hyoscyamine	hyoscyamine|ATROPINE|HYOSCYAMINE|HYOSCYAMINE, (+)-	CN1C2CC[C@@H]1C[C@H](C2)OC(=O)[C@H](CO)c1ccccc1	7C0697DR9I|PX44XO846X|V3203SI72M	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
hypericin	hypericin|HYPERICIN	Cc1cc(O)c2c3c1c1c(C)cc(O)c4c1c1c3c3c(c(O)cc(O)c3c2=O)c2c(O)cc(O)c(c12)c4=O	7V2F1075HD	Phase 2	tyrosine kinase inhibitor	
hyperin	hyperin|HYPEROSIDE	OCC1OC(Oc2c(oc3cc(O)cc(O)c3c2=O)-c2ccc(O)c(O)c2)C(O)C(O)C1O	8O1CR18L82	Preclinical	aldose reductase inhibitor	ACE|AKR1B1
hypoestoxide	hypoestoxide	CC(=O)O[C@H]1CC2(C)OC2CCC2(C)OC2CC2CC(=O)C(=C)C1C2(C)C		Phase 1	IKK inhibitor	IKBKB|IL1B|TNF
hypoxanthine	hypoxanthine|HYPOXANTHINE	O=c1[nH]cnc2nc[nH]c12	2TN51YD919	Preclinical	PARP inhibitor	PNP
I-BET-762	I-BET-762|GSK-525762	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12	5QIO6SRZ2R	Phase 2	bromodomain inhibitor	BRD2|BRD3|BRD4
I-BET151	I-BET151	COc1cc2c3n([C@H](C)c4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C		Preclinical	bromodomain inhibitor	BRD2|BRD3|BRD4
I-BRD9	I-BRD9	CCn1cc(-c2cccc(c2)C(F)(F)F)c2sc(cc2c1=O)C(=N)NC1CCS(=O)(=O)CC1		Preclinical	bromodomain inhibitor	BRD9
I-BZA	I-BZA	CCN(CC)CCNC(=O)c1ccc(I)cc1		Phase 2		
I-BZA2	I-BZA2	CCN(CC)CCNC(=O)c1ccccc1I		Phase 3		
IB-MECA	IB-MECA|PICLIDENOSON	CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)ncnc12	30679UMI0N	Phase 3	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
ibandronate	ibandronate|IBANDRONIC ACID	CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O	UMD7G2653W	Launched	bone resorption inhibitor	FDPS
IBC-293	IBC-293	CC(C)n1nnc2cc(ccc12)C(O)=O		Preclinical	hydroxycarboxylic acid receptor agonist	HCAR3
ibotenic-acid	ibotenic-acid|IBOTENIC ACID	NC(C(O)=O)c1cc(O)no1	44AS82FRSI	Phase 1	glutamate receptor agonist	GRIN1
ibrolipim	ibrolipim|IBROLIPIM	CCOP(=O)(Cc1ccc(cc1)C(=O)Nc1ccc(Br)cc1C#N)OCC	07H1561618	Phase 2	lipoprotein lipase activator	LPL
ibrutinib	ibrutinib|IBRUTINIB	Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C	1X70OSD4VX	Launched	Bruton's tyrosine kinase (BTK) inhibitor	BLK|BMX|BTK
ibudilast	ibudilast|IBUDILAST	CC(C)C(=O)c1c(nn2ccccc12)C(C)C	M0TTH61XC5	Launched	leukotriene receptor antagonist|phosphodiesterase inhibitor	IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A
ibuprofen	ibuprofen|IBUPROFEN	CC(C)Cc1ccc(cc1)C(C)C(O)=O	WK2XYI10QM	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
ibuprofen-(s)	ibuprofen-(s)|DEXIBUPROFEN	CC(C)Cc1ccc(cc1)[C@H](C)C(O)=O	671DKG7P5S	Preclinical	cyclooxygenase inhibitor	ASIC1|BCL2|CFTR|FABP2|PLAT|PPARG|PTGS1|PTGS2|SLC5A8|THBD
ibuprofen-lysine	ibuprofen-lysine|IBUPROFEN LYSINE	NCCCC[C@H](N)C(O)=O.CC(C)Cc1ccc(cc1)C(C)C(O)=O	N01ORX9D6S	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
ibuprofen-piconol	ibuprofen-piconol|IBUPROFEN PICONOL	CC(C)Cc1ccc(cc1)C(C)C(=O)OCc1ccccn1	B0F91K5U4N	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
ibutamoren	ibutamoren|IBUTAMOREN	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CN(c3ccccc23)S(C)(=O)=O)CC1	GJ0EGN38UL	Phase 2	growth hormone secretagogue receptor agonist	GHR|GHSR
ibutilide	ibutilide|IBUTILIDE	CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1	2436VX1U9B	Launched	potassium channel blocker	CACNA1C|CACNA2D1|CACNB1|CACNG1|KCNH2|KCNH6|KCNH7|KCNJ11|KCNK1|KCNK6
IC261	IC261	COc1cc(OC)c(\C=C2\C(=O)Nc3ccccc23)c(OC)c1		Preclinical	casein kinase inhibitor	CSNK1A1|CSNK1D|CSNK1E|CSNK1G2
icariin	icariin|ICARIIN	COc1ccc(cc1)-c1oc2c(CC=C(C)C)c(OC3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c2c(=O)c1OC1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O	VNM47R2QSQ	Phase 3	phosphodiesterase inhibitor	PDE5A
icaritin	icaritin|ICARITIN	COc1ccc(cc1)-c1oc2c(CC=C(C)C)c(O)cc(O)c2c(=O)c1O	UFE666UELY	Phase 2	PPAR receptor antagonist	PDE5A
icatibant-acetate	icatibant-acetate|ICATIBANT ACETATE	N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O	325O8467XK	Launched	bradykinin receptor antagonist	ANPEP|BDKRB2
ICG-001	ICG-001	Oc1ccc(C[C@H]2N3[C@H](CN(Cc4cccc5ccccc45)C2=O)N(CCC3=O)C(=O)NCc2ccccc2)cc1		Preclinical	beta-catenin inhibitor	CTNNB1
ICI-162846	ICI-162846	NC(=O)CCCCn1ccc(n1)\N=C(/N)NCC(F)(F)F	SJ96DC9C66	Phase 1	histamine receptor antagonist	HRH2
ICI-192605	ICI-192605|METHYLENE IODIDE	OC(=O)CC\C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)c1ccccc1Cl	3J731705OX	Phase 2	thromboxane receptor antagonist	TBXA2R
ICI-199441	ICI-199441|METHYLENE IODIDE	CN([C@H](CN1CCCC1)c1ccccc1)C(=O)Cc1ccc(Cl)c(Cl)c1	3J731705OX	Preclinical	opioid receptor agonist	CYP2D6|OPRD1|OPRK1|OPRM1|UTS2R
ICI-63197	ICI-63197	CCCn1c2nc(N)nn2cc(C)c1=O	015G4I43YD	Preclinical	phosphodiesterase inhibitor	
ICI-89406	ICI-89406|METHYLENE IODIDE	OC(CNCCNC(=O)Nc1ccccc1)COc1ccccc1C#N	3J731705OX	Phase 1	adrenergic receptor antagonist	ADRB1|ADRB2
icilin	icilin|ICILIN	Oc1ccccc1N1CC=C(NC1=O)c1cccc(c1)[N+]([O-])=O	CS70PZQ4QJ	Phase 1	TRPV agonist	TRPA1|TRPM8
icomucret	icomucret|ICOMUCRET	CCCCC[C@H](O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O	44JHK6G39Q	Phase 3	mucin production enhancer	LTB4R2
icosapent	icosapent|ICOSAPENT	CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O	AAN7QOV9EA	Launched	platelet aggregation inhibitor	ACSL3|ACSL4|FADS1|FFAR1|PPARD|PPARG|PTGS1|PTGS2|SLC8A1|TRPV1
icotinib	icotinib|ICOTINIB	C#Cc1cccc(Nc2ncnc3cc4OCCOCCOCCOc4cc23)c1	9G6U5L461Q	Launched	EGFR inhibitor	EGFR
ID-1101	ID-1101|HYDROXYISOLEUCINE	C[C@H](O)[C@H](C)[C@H](N)C(O)=O	4SWT01T54O	Phase 1	insulin sensitizer	INS
ID-8	ID-8	COc1ccc(cc1)-n1c(C)c([N+]([O-])=O)c2ccc(O)cc12		Preclinical		
idalopirdine	idalopirdine|IDALOPIRDINE	FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1	59WCJ0YNWM	Phase 3	serotonin receptor antagonist	HTR6
idarubicin	idarubicin|IDARUBICIN	C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O	ZRP63D75JW	Launched	topoisomerase inhibitor	TOP2A
idasanutlin	idasanutlin|IDASANUTLIN	COc1cc(ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]1c1cccc(Cl)c1F)c1ccc(Cl)cc1F)C(O)=O	QSQ883V35U	Phase 3	MDM inhibitor	MDM2|TP53
idazoxan	idazoxan|IDAZOXAN	C1CN=C(N1)C1COc2ccccc2O1	Y310PA316B	Phase 3	adrenergic receptor antagonist	ADRA2A
idebenone	idebenone|IDEBENONE	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O	HB6PN45W4J	Launched	calcium channel modulator	
idelalisib	idelalisib|IDELALISIB	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1	YG57I8T5M0	Launched	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
idoxuridin	idoxuridin|IDOXURIDINE	OCC1O[C@H](C[C@@H]1O)n1cc(I)c(=O)[nH]c1=O	LGP81V5245	Launched	DNA synthesis inhibitor	
idoxuridine	idoxuridine|IDOXURIDINE	OC[C@H]1O[C@H](C[C@@H]1O)n1cc(I)c(=O)[nH]c1=O	LGP81V5245	Launched	DNA directed DNA polymerase inhibitor	
IDRA-21	IDRA-21	CC1Nc2ccc(Cl)cc2S(=O)(=O)N1		Preclinical	glutamate receptor positive allosteric modulator	GRIA1|GRIA2|GRIA3|GRIA4
idramantone	idramantone|IDRAMANTONE	OC12CC3CC(C1)C(=O)C(C3)C2	7J4759Y5J1	Preclinical		
idronoxil	idronoxil|IDRONOXIL	Oc1ccc(cc1)C1=Cc2ccc(O)cc2OC1	995FT1W541	Phase 3	XIAP inhibitor	ENOX2|SPHK1
IEM1460	IEM1460	C[N+](C)(C)CCCCCNCC12CC3CC(CC(C3)C1)C2		Preclinical	glutamate receptor antagonist	GRIA2
IEM1754	IEM1754	NCCCCCNCC12CC3CC(CC(C3)C1)C2		Preclinical	glutamate receptor antagonist	GRIA1
ifenprodil	ifenprodil|IFENPRODIL	CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1	R8OE3P6O5S	Launched	adrenergic receptor antagonist|glutamate receptor antagonist	GRIN1|GRIN2B
ifosfamide	ifosfamide|IFOSFAMIDE	ClCCNP1(=O)OCCCN1CCCl	UM20QQM95Y	Launched	DNA alkylating agent	CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1
igmesine	igmesine|IGMESINE	CCC(C\C=C\c1ccccc1)(N(C)CC1CC1)c1ccccc1	XA3745J38K	Phase 2	sigma receptor agonist	SIGMAR1
iguratimod	iguratimod|IGURATIMOD	CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1	4IHY34Y2NV	Launched	cyclooxygenase inhibitor|NFkB pathway inhibitor	PTGS2
IKK-16	IKK-16	O=C(N1CCC(CC1)N1CCCC1)c1ccc(Nc2nccc(n2)-c2cc3ccccc3s2)cc1		Preclinical	IKK inhibitor	IKBKB
IKK-2-inhibitor	IKK-2-inhibitor	NC(=O)c1sc(cc1N)-c1ccsc1		Preclinical	IKK inhibitor|SYK inhibitor	IKBKB
IKK-2-inhibitor-V	IKK-2-inhibitor-V|IMD-0354	Oc1ccc(Cl)cc1C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F	76145IS906	Phase 1	IKK inhibitor|NFkB pathway inhibitor	IKBKB
ilepcimide	ilepcimide|ILEPCIMIDE	O=C(C=Cc1ccc2OCOc2c1)N1CCCCC1	5ML58O200F	Phase 3	anticonvulsant	
ilomastat	ilomastat|ILOMASTAT	CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)CC(=O)NO	I0403ML141	Phase 3	matrix metalloprotease inhibitor	ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9
iloperidone	iloperidone|ILOPERIDONE	COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O	VPO7KJ050N	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR2A|HTR6|HTR7
iloprost	iloprost|ILOPROST	CC#CCC(C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(C[C@H]12)=C/CCCC(O)=O	JED5K35YGL	Launched	platelet aggregation inhibitor|prostanoid receptor agonist	PDE4A|PDE4B|PDE4C|PDE4D|PLAT|PTGDR|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R
imatinib	imatinib|IMATINIB	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1	BKJ8M8G5HI	Launched	Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor	ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET
imeglimin	imeglimin|IMEGLIMIN	C[C@@H]1N=C(N)NC(=N1)N(C)C	UU226QGU97	Phase 2	gluconeogenesis inhibitor	
imetit	imetit|IMETIT	NC(=N)SCCc1c[nH]cn1	677MJ4VPZC	Preclinical	histamine receptor agonist	HRH3|HRH4
imexon	imexon|IMEXON	N=C1NC(=O)N2CC12	8F63U28T2V	Phase 2	apoptosis stimulant|ribonucleotide reductase inhibitor	RRM1|RRM2
imidacloprid	imidacloprid|IMIDACLOPRID	[O-][N+](=O)NC1=NCCN1Cc1ccc(Cl)nc1	3BN7M937V8	Launched	acetylcholine receptor antagonist	CHRFAM7A
imidafenacin	imidafenacin|IMIDAFENACIN	Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1	XJR8Y07LJO	Launched	acetylcholine receptor antagonist	CHRM1|CHRM3
imidapril	imidapril|IMIDAPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](CN(C)C1=O)C(O)=O	BW7H1TJS22	Launched	angiotensin converting enzyme inhibitor	ACE
imidurea	imidurea|IMIDUREA	OCN1C(NC(=O)NCNC(=O)NC2N(CO)C(=O)NC2=O)C(=O)NC1=O	M629807ATL	Preclinical	other antibiotic	
imiloxan	imiloxan|IMILOXAN	CCn1ccnc1CC1COc2ccccc2O1	ZJ56PS1DWK	Phase 1	adrenergic receptor antagonist	ADRA2A|ADRA2B
imipenem	imipenem|IMIPENEM	C[C@@H](O)[C@@H]1[C@H]2CC(SCCNC=N)=C(N2C1=O)C(O)=O	71OTZ9ZE0A	Launched	bacterial cell wall synthesis inhibitor	
imipramine	imipramine|IMIPRAMINE	CN(C)CCCN1c2ccccc2CCc2ccccc12	OGG85SX4E4	Launched	norepinephrine reputake inhibitor|serotonin reuptake inhibitor	ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4
imiquimod	imiquimod|IMIQUIMOD	CC(C)Cn1cnc2c(N)nc3ccccc3c12	P1QW714R7M	Launched	interferon inducer|toll-like receptor agonist	TLR7|TLR8
immepip	immepip	C(C1CCNCC1)c1c[nH]cn1		Preclinical	histamine receptor agonist	HRH3|HRH4
immethridine	immethridine	C(c1cnc[nH]1)c1ccncc1		Phase 1	histamine receptor agonist	HRH3
impentamine	impentamine	NCCCCCc1cnc[nH]1		Preclinical	histamine receptor antagonist	HRH3
IMREG-1	IMREG-1	N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(O)=O		Phase 3		
INC-280	INC-280|CAPMATINIB	CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1	TY34L4F9OZ	Phase 2	c-Met inhibitor	MET
INCA-6	INCA-6	O=C1C=CC(=O)C2=C1C1c3ccccc3C2c2ccccc12		Preclinical	calcineurin inhibitor	NFATC1
INCB-003284	INCB-003284|INCB-3284	COc1ccc(cn1)C1(O)CCC(CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F	0W6K09GAQB	Phase 2	CC chemokine receptor antagonist	
INCB-024360	INCB-024360|EPACADOSTAT	Nc1nonc1\C(NO)=N/c1ccc(F)c(Cl)c1	71596A9R13	Phase 2	indoleamine 2,3-dioxygenase inhibitor	IDO1
INCB-3284	INCB-3284	COc1ccc(cn1)[C@]1(O)CC[C@@H](CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F	0W6K09GAQB	Phase 2	CC chemokine receptor antagonist	CCR2
indacaterol	indacaterol|INDACATEROL	CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12	8OR09251MQ	Launched	adrenergic receptor agonist	ADRB1|ADRB2
indalpine	indalpine|INDALPINE	C(Cc1c[nH]c2ccccc12)C1CCNCC1	V35562QSVT	Withdrawn	selective serotonin reuptake inhibitor (SSRI)	SLC6A4
indapamide	indapamide|INDAPAMIDE	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O	F089I0511L	Launched	thiazide diuretic	KCNE1|KCNQ1|SLC12A3
indatraline	indatraline|INDATRALINE	CN[C@@H]1C[C@H](c2ccccc12)c1ccc(Cl)c(Cl)c1	4U40Y96J1Z	Preclinical	norepinephrine transporter inhibitor	MAOA|MAOB
indeloxazine	indeloxazine|INDELOXAZINE	C(Oc1cccc2C=CCc12)C1CNCCO1	834M09R1KM	Withdrawn	norepinephrine reuptake inhibitor|serotonin reuptake inhibitor	
indibulin	indibulin|INDIBULIN	Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c3ccccc23)cc1	80K4H2RB8P	Phase 1/Phase 2	tubulin polymerization inhibitor	
indinavir	indinavir|INDINAVIR	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12	5W6YA9PKKH	Launched	HIV protease inhibitor	CYP3A4|CYP3A5|CYP3A7
indiplon	indiplon|INDIPLON	CN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C(=O)c1cccs1	8BT63DA42E	Phase 3	benzodiazepine receptor agonist	GABRA1
indirubin	indirubin|INDIRUBIN	O=C1Nc2ccccc2\C1=C1\Nc2ccccc2C1=O	V86L8P74GI	Phase 2/Phase 3	CDK inhibitor|glycogen synthase kinase inhibitor	CDK1|CDK5|GSK3A
indirubin-3-monoxime	indirubin-3-monoxime	O\N=C1c2ccccc2NC/1=C1\C(=O)Nc2ccccc12		Preclinical	CDK inhibitor|glycogen synthase kinase inhibitor	CDK1|CDK2|CDK5|CDK5R1|GSK3B
indisulam	indisulam|INDISULAM	NS(=O)(=O)c1ccc(cc1)S(=O)(=O)Nc1cccc2c(Cl)c[nH]c12	WJ98J3NM90	Phase 2	CDK inhibitor	CA1|CA12|CA14|CA2|CA6|CA7|CA9
indium(iii)-isopropoxide	indium(iii)-isopropoxide	[In].CC(C)O.CC(C)O.CC(C)O		Preclinical		
indobufen	indobufen|INDOBUFEN	CCC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O	6T9949G4LZ	Launched	cyclooxygenase inhibitor|platelet aggregation inhibitor	PTGS1|PTGS2
indocyanine-green	indocyanine-green|INDOCYANINE GREEN	CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS(O)(=O)=O)c3ccc4ccccc4c3C2(C)C)N(CCCCS(O)(=O)=O)c2ccc3ccccc3c12	IX6J1063HV	Launched	contrast agent	SLCO1B1
indole-3-carbinol	indole-3-carbinol|INDOLE-3-CARBINOL	OCc1c[nH]c2ccccc12	C11E72455F	Phase 2/Phase 3	aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor	AHR
indole-3-pyrubate	indole-3-pyrubate|INDOLE-3-PYRUVIC ACID	OC(=O)C(=O)Cc1c[nH]c2ccccc12	4QM0LT13A8	Phase 2	melatonin receptor agonist	
indomethacin	indomethacin|INDOMETHACIN	COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(O)=O)c2c1	XXE1CET956	Launched	cyclooxygenase inhibitor	GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1
indoprofen	indoprofen|INDOPROFEN	CC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O	CPE46ZU14N	Withdrawn	cyclooxygenase inhibitor|prostanoid receptor antagonist	CXCR1|CXCR2|PTGS1|PTGS2
indoramin	indoramin|INDORAMIN	O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1	0Z802HMY7H	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C
indoximod	indoximod|INDOXIMOD	Cn1cc(C[C@@H](N)C(O)=O)c2ccccc12	TX5CYN1KMZ	Phase 2	indoleamine 2,3-dioxygenase inhibitor	IDO1
ingenol-mebutate	ingenol-mebutate|INGENOL MEBUTATE	C\C=C(\C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C	7686S50JAH	Launched	PKC activator	PRKCA|PRKCB|PRKCD|PRKCE|PRKCG
INH1	INH1	Cc1ccc(c(C)c1)-c1csc(NC(=O)c2ccccc2)n1		Preclinical	Hec1 inhibitor	NDC80
inimur	inimur|NIFURATEL	CSCC1CN(\N=C\c2ccc(o2)[N+]([O-])=O)C(=O)O1	U60U6P08SP	Launched	other antifungal	
iniparib	iniparib|INIPARIB	NC(=O)c1ccc(I)c(c1)[N+]([O-])=O	2ZWI7KHK8F	Phase 3	PARP inhibitor	PARP1
inosine	inosine|INOSINE	OC[C@H]1OC([C@H](O)[C@@H]1O)n1cnc2c1nc[nH]c2=O	5A614L51CT	Launched	neurotrophic agent	PARP1|PNP
inositol	inositol|INOSITOL	O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O	4L6452S749	Launched	insulin sensitizer	CDIPT|GBA
inositol-hexanicotinate	inositol-hexanicotinate|INOSITOL NIACINATE	O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@@H]1OC(=O)c1cccnc1)c1cccnc1	A99MK953KZ	Launched		
INS316	INS316|URIDINE 5'-TRIPHOSPHATE	OC1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H](C1O)n1ccc(=O)[nH]c1=O	UT0S826Z60	Phase 2	purinergic receptor antagonist	
INT-747	INT-747|OBETICHOLIC ACID	CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(O)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12	0462Z4S4OZ	Phase 3	FXR agonist	
INT-767	INT-767	CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCOS(O)(=O)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12		Phase 1	FXR agonist	GPBAR1
integrin-antagonist-1	integrin-antagonist-1	Cc1cc(C)n(n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCC2=CC=C3CCCN=C3N2)C1)CC(O)=O		Phase 1	integrin antagonist	ITGAV|ITGB6
iobenguane	iobenguane|IOBENGUANE	NC(=N)NCc1cccc(I)c1	35MRW7B4AD	Launched	antineoplastic agent	
iocetamic-acid	iocetamic-acid|IOCETAMIC ACID	CC(CN(C(C)=O)c1c(I)cc(I)c(N)c1I)C(O)=O	FA675Q0E3E	Launched	radiopaque medium	
iodipamide	iodipamide|IODIPAMIDE	OC(=O)c1c(I)cc(I)c(NC(=O)CCCCC(=O)Nc2c(I)cc(I)c(C(O)=O)c2I)c1I	TKQ858A3VW	Launched	radiopaque medium	ALB
iodixanol	iodixanol|IODIXANOL	CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	HW8W27HTXX	Launched	radiopaque medium	
iodoantipyrine	iodoantipyrine|IODOANTIPYRINE	Cc1c(I)c(=O)n(-c2ccccc2)n1C	V30V6H1QX4	Preclinical		
iododexetimide	iododexetimide	Ic1ccc(CN2CCC(CC2)C2(CCC(=O)NC2=O)c2ccccc2)cc1		Phase 2	acetylcholine receptor antagonist	
iodophenpropit	iodophenpropit|IODOPHENPROPIT	Ic1ccc(CCNC(=N)SCCCc2c[nH]cn2)cc1	3SH45L9H3Z	Preclinical	histamine receptor antagonist	HRH3|HRH4
iodoquinol	iodoquinol|IODOQUINOL	Oc1c(I)cc(I)c2cccnc12	63W7IE88K8	Launched	antiseptic	
iohexol	iohexol|IOHEXOL	CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	4419T9MX03	Launched	radiopaque medium	
iopamidol	iopamidol|IOPAMIDOL	C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I	JR13W81H44	Launched	radiopaque medium	
iopanic-acid	iopanic-acid|IOPANOIC ACID	CCC(Cc1c(I)cc(I)c(N)c1I)C(O)=O	FE9794P71J	Preclinical	thyroid hormone inhibitor	
iopodic-acid	iopodic-acid|IPODIC ACID	CN(C)\C=N\c1c(I)cc(I)c(CCC(O)=O)c1I	F604ZKI910	Launched		
iopromide	iopromide|IOPROMIDE	COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I	712BAC33MZ	Launched	radiopaque medium	
iothalamic-acid-d3	iothalamic-acid-d3|IOTHALAMIC ACID	CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I	16CHD79MIX	Preclinical	radiopaque medium	
ioversol	ioversol|IOVERSOL	OCCN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	N3RIB7X24K	Launched	radiopaque medium	
IOWH032	IOWH032|IOWH-032	Oc1c(Br)cc(cc1Br)-c1noc(n1)C(=O)NCc1ccc(Oc2ccccc2)cc1	8Y3GDT6YWV	Phase 2	CFTR channel antagonist	CFTR
IOX1	IOX1|8-HYDROXY-5-QUINOLINECARBOXYLIC ACID	OC(=O)c1ccc(O)c2ncccc12	JM015YQC1C	Preclinical	histone demethylase inhibitor	EGLN1|KDM3A|KDM4C|KDM6B
IOX2	IOX2	OC(=O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O		Preclinical	hypoxia inducible factor inhibitor	EGLN1|KDM2A|KDM5C
ioxaglic-acid	ioxaglic-acid|IOXAGLIC ACID	CNC(=O)c1c(I)c(N(C)C(C)=O)c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(O)=O)c(I)c(C(=O)NCCO)c2I)c1I	Z40X7EI2AF	Launched	radiopaque medium	
ioxilan	ioxilan|IOXILAN	CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I	A4YJ7J11TG	Launched	radiopaque medium	
IPA-3	IPA-3	Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12	3XFG6MQ9G2	Preclinical	p21 activated kinase inhibitor	PAK1
IPAG	IPAG	Ic1ccc(NC(=N)NC2C3CC4CC(C3)CC2C4)cc1		Preclinical		
IPI-145	IPI-145|DUVELISIB	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1	610V23S0JI	Phase 3	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
ipidacrine	ipidacrine|IPIDACRINE	Nc1c2CCCc2nc2CCCCc12	CV71VTP0VN	Phase 3	acetylcholinesterase inhibitor	ACHE
ipragliflozin-l-proline	ipragliflozin-l-proline|IPRAGLIFLOZIN	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(F)c(Cc2cc3ccccc3s2)c1	3N2N8OOR7X	Launched	sodium/glucose cotransporter inhibitor	SLC5A2
ipratropium	ipratropium|IPRATROPIUM	CC(C)[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1	GR88G0I6UL	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
ipriflavone	ipriflavone|IPRIFLAVONE	CC(C)Oc1ccc2c(c1)occ(-c1ccccc1)c2=O	80BJ7WN25Z	Launched	bone resorption inhibitor	
iproniazid	iproniazid|IPRONIAZID	CC(C)NNC(=O)c1ccncc1	D892HFI3XA	Withdrawn	monoamine oxidase inhibitor	MAOA|MAOB
ipsapirone	ipsapirone|IPSAPIRONE	O=C1N(CCCCN2CCN(CC2)c2ncccn2)S(=O)(=O)c2ccccc12	6J9B11MN0K	Phase 3	serotonin receptor agonist	HTR1A
irbesartan	irbesartan|IRBESARTAN	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	J0E2756Z7N	Launched	angiotensin receptor antagonist	AGTR1|JUN|SLC10A1
irinotecan	irinotecan|IRINOTECAN	CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12	7673326042	Launched	topoisomerase inhibitor	TOP1|TOP1MT
IRL-2500	IRL-2500	CN([C@H](Cc1ccc(cc1)-c1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O)C(=O)c1cc(C)cc(C)c1		Preclinical	endothelin receptor antagonist	EDNRB
irosustat	irosustat|IROSUSTAT	NS(=O)(=O)Oc1ccc2c3CCCCCc3c(=O)oc2c1	366037O6O7	Phase 2	steroid sulfatase inhibitor	CA2|STS
irsogladine	irsogladine|IRSOGLADINE	Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl	QBX79NZC1D	Launched	phosphodiesterase inhibitor	PDE4A
isamoltane	isamoltane|ISAMOLTAN	CC(C)NCC(O)COc1ccccc1-n1cccc1	2TP37O5J17	Phase 1	adrenergic receptor antagonist	HTR1A|HTR1B
isavuconazole	isavuconazole|ISAVUCONAZOLE	C[C@@H](c1nc(cs1)-c1ccc(cc1)C#N)C(O)(Cn1cncn1)c1cc(F)ccc1F	60UTO373KE	Phase 3	cytochrome P450 inhibitor	CYP3A4
isaxonine	isaxonine|ISAXONINE	CC(C)Nc1ncccn1	883G6DMT63	Withdrawn	nerve growth factor agonist	
isbufylline	isbufylline|ISBUFYLLINE	CC(C)Cn1cnc2n(C)c(=O)n(C)c(=O)c12	9C8Z5F38D0	Phase 2	phosphodiesterase inhibitor	
isepamicin	isepamicin|ISEPAMICIN	CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)NC(=O)[C@@H](O)CN)OC[C@]1(C)O	G7K224460P	Launched	protein synthesis inhibitor	
isobutamben	isobutamben|ISOBUTAMBEN	CC(C)COC(=O)c1ccc(N)cc1	9566855ULN	Preclinical	local anesthetic	
isobutyramide	isobutyramide|ISOBUTYRAMIDE	CC(C)C(N)=O	82UOE7B38Z	Phase 2	gene expression stimulant	HBE1|HBG1
isocarboxazid	isocarboxazid|ISOCARBOXAZID	Cc1cc(no1)C(=O)NNCc1ccccc1	34237V843T	Launched	monoamine oxidase inhibitor	MAOA|MAOB
isoconazole	isoconazole|ISOCONAZOLE	Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1	GRI7WFR424	Launched	fungal lanosterol demethylase inhibitor	CYP17A1
isodibut	isodibut	OC(=O)CCCN1C(=O)c2cccc3cccc(C1=O)c23		Phase 2	aldehyde reductase inhibitor	
isoetharine	isoetharine|ISOETHARINE	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1	YV0SN3276Q	Launched	adrenergic receptor agonist	ADRB1|ADRB2
isofloxythepin	isofloxythepin|ISOFLOXYTHEPIN	CC(C)c1ccc2Sc3cc(F)ccc3CC(N3CCN(CCO)CC3)c2c1	4P96GSF1NJ	Phase 2	dopamine receptor antagonist	
isoflupredone-acetate	isoflupredone-acetate|ISOFLUPREDONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	55P9TUL75S	Preclinical		NR3C1
isoflurane	isoflurane|ISOFLURANE	FC(F)OC(Cl)C(F)(F)F	CYS9AKD70P	Launched	inhaled anaesthetic	ATP2C1|ATP5D|CALM1|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9
isoflurophate	isoflurophate|ISOFLUROPHATE	CC(C)OP(F)(=O)OC(C)C	12UHW9R67N	Launched	cholinesterase inhibitor	ACHE|BCHE
isoguvacine	isoguvacine|ISOGUVACINE	OC(=O)C1=CCNCC1	YTF580771Y	Preclinical	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3
isoleucine	isoleucine|ISOLEUCINE|ISOLEUCINE, DL-	CCC(C)C(N)C(O)=O	04Y7590D77|5HX0BYT4E3	Launched		ACADSB|BCAT1|BCAT2|IARS|IARS2
isoliquiritigenin	isoliquiritigenin|TRIHYDROXYCHALCONE	Oc1ccc(cc1)\C=C\C(=O)c1ccc(O)cc1O	B9CTI9GB8F	Preclinical	guanylate cyclase activator	GABBR1
isometheptene-mucate	isometheptene-mucate|ISOMETHEPTENE MUCATE	CNC(C)CCC=C(C)C	8O120FDS6P	Launched		ADRA1A|SLC18A2
isoniazid	isoniazid|ISONIAZID	NNC(=O)c1ccncc1	V83O1VOZ8L	Launched	FABI inhibitor	CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4
isopentyl-4-methoxycinnamate	isopentyl-4-methoxycinnamate|AMILOXATE	COc1ccc(cc1)\C=C\C(=O)OCCC(C)C	376KTP06K8	Launched		
isoprenaline	isoprenaline|ISOPROTERENOL	CC(C)NCC(O)c1ccc(O)c(O)c1	L628TT009W	Launched	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3|MAPK1|PIK3R1|PIK3R2|PIK3R3
isopropamide-iodide	isopropamide-iodide|ISOPROPAMIDE IODIDE	CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C	E0KNA372SZ	Launched	acetylcholine receptor antagonist	CHRM3|CHRM4
isopropyl-myristate	isopropyl-myristate|ISOPROPYL MYRISTATE	CCCCCCCCCCCCCC(=O)OC(C)C	0RE8K4LNJS	Launched		
isopropyl-palmitate	isopropyl-palmitate|ISOPROPYL PALMITATE	CCCCCCCCCCCCCCCC(=O)OC(C)C	8CRQ2TH63M	Launched	cosmetic moisturizer	
isosorbide	isosorbide|ISOSORBIDE	O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12	WXR179L51S	Launched	nitric oxide stimulant	
isosorbide-dinitrate	isosorbide-dinitrate|ISOSORBIDE DINITRATE	[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O	IA7306519N	Launched	nitric oxide stimulant	GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3|NPR1
isosorbide-mononitrate	isosorbide-mononitrate|ISOSORBIDE MONONITRATE	O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O	LX1OH63030	Launched	nitric oxide stimulant	GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3
isosteviol	isosteviol|ISOSTEVIOL	C[C@]12C[C@@]3(CC1=O)CC[C@H]1[C@@](C)(CCC[C@@]1(C)C(O)=O)C3CC2	091QB7QO95	Phase 2		
isotiquimide	isotiquimide|ISOTIQUIMIDE	Cc1ccnc2C(CCCc12)C(N)=S	EX1ND80X1I	Phase 1		
isotretinoin	isotretinoin|ISOTRETINOIN	CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C/C(O)=O	EH28UP18IF	Launched	retinoid receptor agonist	RARA|RARB|RARG
isovaleramide	isovaleramide|ISOVALERAMIDE	CC(C)CC(N)=O	9CP4KB634M	Phase 2	alcohol dehydrogenase inhibitor	
isoxepac	isoxepac|ISOXEPAC	OC(=O)Cc1ccc2OCc3ccccc3C(=O)c2c1	2KH283Q0Z5	Phase 2	anti-inflammatory agent	
isoxicam	isoxicam|ISOXICAM	CN1C(C(=O)Nc2cc(C)on2)C(=O)c2ccccc2S1(=O)=O	8XU734C4NG	Withdrawn	cyclooxygenase inhibitor	PTGS1|PTGS2
isoxsuprine	isoxsuprine|ISOXSUPRINE	CC(COc1ccccc1)NC(C)[C@H](O)c1ccc(O)cc1	R15UI3245N	Launched	adrenergic receptor agonist	ADRB2
ispinesib	ispinesib|ISPINESIB	CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)c1nc2cc(Cl)ccc2c(=O)n1Cc1ccccc1	BKT5F9C2NI	Phase 2	kinesin inhibitor	KIF11
isradipine	isradipine|ISRADIPINE	COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C	YO1UK1S598	Launched	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2
ISRIB	ISRIB	Clc1ccc(OCC(=O)N[C@H]2CC[C@@H](CC2)NC(=O)COc2ccc(Cl)cc2)cc1		Preclinical	eukaryotic translation initiation factor inhibitor|PERK inhibitor	EIF2A|EIF2AK3
istaroxime	istaroxime|ISTAROXIME	C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4C\C(CC[C@]34C)=N\OCCN)[C@@H]1CCC2=O	W8I9H2TPPL	Phase 2	ATPase inhibitor	ATP1A1
istradefylline	istradefylline|ISTRADEFYLLINE	CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O	2GZ0LIK7T4	Launched	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
itacitinib	itacitinib|ITACITINIB	Fc1c(ccnc1C(F)(F)F)C(=O)N1CCC(CC1)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12	19J3781LPM	Phase 2	JAK inhibitor	JAK1
ITI214	ITI214	CN1C2=N[C@@H]3CCC[C@@H]3N2c2nn(Cc3ccc(cc3)-c3cccc(F)n3)c(Nc3ccccc3)c2C1=O		Phase 1	phosphodiesterase inhibitor	PDE1A
itopride	itopride|ITOPRIDE	COc1ccc(cc1OC)C(=O)NCc1ccc(OCCN(C)C)cc1	81BMQ80QRL	Launched	dopamine receptor antagonist	CHRM3|DRD2
itraconazole	itraconazole|ITRACONAZOLE	CCC(C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O	304NUG5GF4	Launched	cytochrome P450 inhibitor	CYP51A1
ITX3	ITX3	Cc1cc(\C=c2\sc3nc4ccccc4n3c2=O)c(C)n1-c1ccccc1		Preclinical	GEF inhibitor	TRIO
IU1	IU1	Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1		Preclinical	ubiquitin C-terminal hydrolase inhibitor	USP14
ivabradine	ivabradine|IVABRADINE	COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC	3H48L0LPZQ	Launched	HCN channel antagonist|potassium channel blocker|sodium channel blocker	HCN1|HCN3|HCN4
ivacaftor	ivacaftor|IVACAFTOR	CC(C)(C)c1cc(c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)C(C)(C)C	1Y740ILL1Z	Launched	CFTR channel potentiator	CFTR
ivermectin	ivermectin|IVERMECTIN B1A	CCC(C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](OC3C[C@H](OC)C(O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2	91Y2202OUW	Launched	benzodiazepine receptor agonist	CHRNA7|GABRB3|GLRA3|P2RX7
ivosidenib	ivosidenib|IVOSIDENIB	Fc1cncc(c1)N([C@H](C(=O)NC1CC(F)(F)C1)c1ccccc1Cl)C(=O)[C@@H]1CCC(=O)N1c1cc(ccn1)C#N	Q2PCN8MAM6	Phase 1/Phase 2	isocitrate dehydrogenase inhibitor	IDH1
IWP-L6	IWP-L6	O=C(CSc1nc2CCSc2c(=O)n1-c1ccccc1)Nc1ccc(cn1)-c1ccccc1		Preclinical	porcupine inhibitor	PORCN
ixabepilone	ixabepilone|IXABEPILONE	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1	K27005NP0A	Launched	microtubule stabilizing agent	TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
ixazomib	ixazomib|IXAZOMIB	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O	71050168A2	Launched	proteasome inhibitor	
ixazomib-citrate	ixazomib-citrate|IXAZOMIB CITRATE	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)CC(CC(O)=O)(O1)C(O)=O	46CWK97Z3K	Launched	proteasome inhibitor	
JAK3-inhibitor-V	JAK3-inhibitor-V	C=CC(=O)c1ccc2ccccc2c1		Preclinical	JAK inhibitor	JAK3
JDTic	JDTic	CC(C)[C@@H](CN1CC[C@](C)([C@@H](C)C1)c1cccc(O)c1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1		Phase 1	opioid receptor antagonist	OPRK1
JIB04	JIB04	Clc1ccc(N\N=C(/c2ccccc2)c2ccccn2)nc1		Preclinical	histone lysine demethylase inhibitor	KDM4E
JK-184	JK-184	CCOc1ccc(Nc2nc(cs2)-c2c(C)nc3ccccn23)cc1		Preclinical	hedgehog pathway inhibitor	
JLK-6	JLK-6	COc1oc(=O)c2cc(N)ccc2c1Cl		Preclinical	gamma secretase inhibitor	PSEN1
JNJ-10191584	JNJ-10191584	CN1CCN(CC1)C(=O)c1nc2ccc(Cl)cc2[nH]1	7EE5T3WL8P	Preclinical	histamine receptor antagonist	HRH4
JNJ-16259685	JNJ-16259685	CO[C@H]1CC[C@H](CC1)C(=O)c1ccc2nc3OCCCc3cc2c1		Preclinical	glutamate receptor antagonist	GRM1
JNJ-1661010	JNJ-1661010	O=C(Nc1ccccc1)N1CCN(CC1)c1nc(ns1)-c1ccccc1	62521S57AU	Preclinical	FAAH inhibitor	FAAH
JNJ-17203212	JNJ-17203212	FC(F)(F)c1ccc(NC(=O)N2CCN(CC2)c2ncccc2C(F)(F)F)nc1	71JE0C439X	Preclinical	TRPV antagonist	TRPV1
JNJ-26481585	JNJ-26481585|QUISINOSTAT	Cn1cc(CNCC2CCN(CC2)c2ncc(cn2)C(=O)NO)c2ccccc12	9BJ85K1J8S	Phase 2	HDAC inhibitor	HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2
JNJ-26990990	JNJ-26990990	NS(=O)(=O)NCc1csc2ccccc12	QFG58Y96EP	Phase 2	anticonvulsant	
JNJ-37822681	JNJ-37822681	Fc1ccc(CN2CCC(CC2)Nc2ccc(nn2)C(F)(F)F)cc1F	GJB2URS7NJ	Phase 2	dopamine receptor antagonist	DRD2
JNJ-38877605	JNJ-38877605	Cn1cc(cn1)-c1ccc2nnc(n2n1)C(F)(F)c1ccc2ncccc2c1	15UDG410PN	Phase 1	tyrosine kinase inhibitor	MET
JNJ-40411813	JNJ-40411813	CCCCn1ccc(N2CCC(CC2)c2ccccc2)c(Cl)c1=O	612BYT76F3	Phase 2	glutamate receptor positive allosteric modulator	GRM2
JNJ-42041935	JNJ-42041935	OC(=O)c1cnn(c1)-c1nc2cc(Cl)c(OC(F)(F)F)cc2[nH]1	T4PPL01131	Preclinical	hypoxia inducible factor prolyl hydroxylase inhibitor	PDK2
JNJ-42165279	JNJ-42165279	FC1(F)Oc2ccc(CN3CCN(CC3)C(=O)Nc3cnccc3Cl)cc2O1		Phase 2	FAAH inhibitor	FAAH
JNJ-63533054	JNJ-63533054	C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1		Preclinical	G protein-coupled receptor agonist	GPR139
JNJ-7706621	JNJ-7706621	Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F	74GK72DON8	Preclinical	CDK inhibitor	AURKA|AURKB|CDK1|CDK2
JNJ-7777120	JNJ-7777120	CN1CCN(CC1)C(=O)c1cc2cc(Cl)ccc2[nH]1	4H1AU2V37X	Preclinical	histamine receptor antagonist	HRH4
josamycin	josamycin|JOSAMYCIN	CO[C@H]1[C@@H](CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C)OC(C)=O	HV13HFS217	Launched	bacterial 50S ribosomal subunit inhibitor	
JQ1-(+)	JQ1-(+)|JQ1	Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n-21)c1ccc(Cl)cc1	1MRH0IMX0W	Preclinical	bromodomain inhibitor	BRD4|BRDT
JTC-801	JTC-801	CCc1ccc(OCc2ccccc2C(=O)Nc2ccc3nc(C)cc(N)c3c2)cc1	7I21WLZ2FP	Phase 2	opioid receptor antagonist	OPRL1
JTE-013	JTE-013	CC(C)c1cc(NNC(=O)Nc2cc(Cl)nc(Cl)c2)nc2n(C)nc(C)c12		Preclinical	lysophospholipid receptor antagonist	P2RY10|S1PR2
JTE-607	JTE-607	CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(Cl)c(OCCN2CCN(C)CC2)c(Cl)c1O	2B68H6BWCX	Phase 2	cytokine production inhibitor	IL10|IL1B|IL6|TNF
JTE-907	JTE-907	CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4OCOc4c3)c(=O)[nH]c12	DAV3Q7SNOL	Phase 1	cannabinoid receptor inverse agonist	CNR2
JW-74	JW-74	COc1ccc(cc1)-n1c(SCc2nc(no2)-c2ccc(C)cc2)nnc1-c1ccncc1		Preclinical	WNT signaling inhibitor|tankyrase inhibitor	TNKS|TNKS2
JX-401	JX-401	COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1	TBU7UTV30Q	Preclinical	p38 MAPK inhibitor	MAPK14
JZL-184	JZL-184	OC(C1CCN(CC1)C(=O)Oc1ccc(cc1)[N+]([O-])=O)(c1ccc2OCOc2c1)c1ccc2OCOc2c1	7MZ1I2J68A	Preclinical	monoacylglucerol lipase inhibitor	MGLL
K-247	K-247	OCC1OC(Nc2ccc(cc2)C(O)=O)C(O)C1O		Phase 1		
K-858	K-858	CC(=O)NC1=NN(C(C)=O)C(C)(S1)c1ccccc1	ZA4OIM722G	Preclinical	kinesin-like spindle protein inhibitor	KIF11
K-MAP	K-MAP	OCC1OC(Nc2ccc(cc2)C(O)=O)C(O)C(O)C1O		Phase 2		
K-Ras(G12C)-inhibitor-12	K-Ras(G12C)-inhibitor-12	Oc1cc(Cl)c(I)cc1NCC(=O)N1CCN(CC1)C(=O)C=C		Preclinical	K-ras inhibitor	KRAS
K-Ras(G12C)-inhibitor-6	K-Ras(G12C)-inhibitor-6	SCCCC(=O)NC1CCN(CC1)C(=O)COc1ccc(Cl)cc1Cl		Preclinical	K-ras inhibitor	
k-strophanthidin	k-strophanthidin|STROPHANTHIDIN	C[C@]12CCC3C(CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]1(O)CCC2C1=CC(=O)OC1	W5O632DN33	Phase 2	ATPase inhibitor	ATP1A1
K02288	K02288	COc1cc(cc(OC)c1OC)-c1cc(cnc1N)-c1cccc(O)c1		Preclinical	bone morphogenic protein inhibitor	BMP1
K145	K145	CCCCOc1ccc(CC\C=C2/SC(=O)N(CCN)C2=O)cc1		Preclinical	sphingosine kinase inhibitor	SPHK2
kaempferol	kaempferol|KAEMPFEROL	Oc1ccc(cc1)-c1oc2cc(O)cc(O)c2c(=O)c1O	731P2LE49E	Preclinical	bone resorption inhibitor|estrogen-related receptor inverse agonist	AKR1B1|ALOX15B|ALOX5|AR|CYP1B1|GLO1|HSD17B1|UGT3A1
kainic-acid	kainic-acid|KAINIC ACID	CC(=C)[C@H]1CN[C@@H]([C@H]1CC(O)=O)C(O)=O	SIV03811UC	Preclinical	kainate receptor agonist	GRIA1|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5
kakonein	kakonein|PUERARIN	OCC1OC(C(O)C(O)C1O)c1c(O)ccc2c1occ(-c1ccc(O)cc1)c2=O	Z9W8997416	Phase 2	GABA receptor antagonist|serotonin receptor antagonist	
kanamycin	kanamycin|KANAMYCIN A	NC[C@H]1O[C@H](OC2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	EQK9Q303C5	Launched	bacterial 30S ribosomal subunit inhibitor	
KB-R7943	KB-R7943	NC(=N)SCCc1ccc(OCc2ccc(cc2)[N+]([O-])=O)cc1		Preclinical	sodium/calcium exchange inhibitor	SLC8A1|TRPC3|TRPC5|TRPC6
KBG	KBG	OC1O[C@@H]2COC(O[C@H]2[C@H](O)[C@H]1O)c1ccccc1		Phase 2	neprilysin inhibitor	MME
KD-023	KD-023|RMI-14514	CCCCCCCCCCCCCCOc1ccc(o1)C(O)=O	BI12FRY055	Phase 2	ACAT inhibitor	ACACA|ACACB
KD025	KD025|KD-025 FREE BASE	CC(C)NC(=O)COc1cccc(c1)-c1nc(Nc2ccc3[nH]ncc3c2)c2ccccc2n1	834YJF89WO	Phase 2	rho associated kinase inhibitor	ROCK2
kenpaullone	kenpaullone	Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1		Preclinical	CDK inhibitor|glycogen synthase kinase inhibitor	CCNB1|CDK1|CDK5|GSK3B
ketanserin	ketanserin|KETANSERIN	Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1	97F9DE4CT4	Launched	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2
ketoconazole	ketoconazole|LEVOKETOCONAZOLE|KETOCONAZOLE	CC(=O)N1CCN(CC1)c1ccc(OCC2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1	2DJ8R0NT7K|R9400W927I	Launched	sterol demethylase inhibitor	AR|CYP19A1|CYP21A2|KCNA10
ketoprofen	ketoprofen|KETOPROFEN	CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1	90Y4QC304K	Launched	cyclooxygenase inhibitor	CXCR1|PTGS1|PTGS2|SLC5A8
ketorolac	ketorolac|KETOROLAC	OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1	YZI5105V0L	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
ketotifen	ketotifen|KETOTIFEN	CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12	X49220T18G	Launched	histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor	HRH1|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B|PDE8A|PDE8B|PGD
kevetrin	kevetrin|4-ISOTHIOUREIDOBUTYRONITRILE	NC(=N)SCCCC#N	C3059TG1KN	Phase 1	p53 activator	
KF-38789	KF-38789	COc1ccc(C2CC(=NCCS2)c2c(O)cc(C)oc2=O)c(OC)c1	SD6U8X7NAE	Preclinical	P selectin inhibitor	SELP
KH-CB19	KH-CB19	CCOC(=O)c1c(\C(=C/N)C#N)c2ccc(Cl)c(Cl)c2n1C		Preclinical	CDC inhibitor	CLK1|CLK3|DYRK1A
khellin	khellin|KHELLIN	COc1c2ccoc2c(OC)c2oc(C)cc(=O)c12	5G117T0TJZ	Phase 2	vasodilator	
KHK-IN-1	KHK-IN-1	CSc1ccccc1Nc1nc(nc2c(NCC3CC3)ncnc12)N1CCNCC1		Preclinical	hexokinase inhibitor	KHK
KI-16425	KI-16425	CC(OC(=O)Nc1c(C)noc1-c1ccc(CSCCC(O)=O)cc1)c1ccccc1Cl		Preclinical	lysophosphatidic acid receptor antagonist	LPAR1|LPAR3
KI-8751	KI-8751	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC		Preclinical	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	KDR
ki16198	ki16198	COC(=O)CCSCc1ccc(cc1)-c1onc(C)c1NC(=O)OC(C)c1ccccc1Cl		Preclinical	lipoprotein antagonist	LPA
kifunensine	kifunensine|KIFUNENSINE	OC[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H]2NC(=O)C(=O)N12	0NI8960271	Phase 1	mannosidase inhibitor	MAN1B1|MAN2A1
kinetin	kinetin|KINETIN	C(Nc1ncnc2[nH]cnc12)c1ccco1	P39Y9652YJ	Launched	cell division inducer	
KML29	KML29	OC(C1CCN(CC1)C(=O)OC(C(F)(F)F)C(F)(F)F)(c1ccc2OCOc2c1)c1ccc2OCOc2c1		Preclinical	monoacylglucerol lipase inhibitor	MGLL
KN-62	KN-62	CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(CC1)c1ccccc1)S(=O)(=O)c1cccc2cnccc12	63HM46XPOW	Preclinical	calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist	AKT1|CAMK2A|CHEK1|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|P2RX7|PRKCA|ROCK1|RPS6KB1|SGK1
KN-93	KN-93	COc1ccc(cc1)S(=O)(=O)N(CCO)c1ccccc1CN(C)C\C=C\c1ccc(Cl)cc1		Preclinical	calcium/calmodulin dependent protein kinase inhibitor	CAMK2A
Ko143	Ko143	COc1ccc2c3C[C@@H]4N([C@@H](CC(C)C)c3[nH]c2c1)C(=O)[C@H](CCC(=O)OC(C)(C)C)NC4=O		Preclinical	BCRP inhibitor	ABCB1|ABCC1
KP-1212	KP-1212	NC1=NC(=O)N(CN1)[C@H]1C[C@@H](O)[C@@H](CO)O1		Phase 2		
KPT-185	KPT-185	COc1cc(cc(c1)C(F)(F)F)-c1ncn(\C=C/C(=O)OC(C)C)n1		Preclinical	exportin antagonist	XPO1
KPT-276	KPT-276	FC(F)(F)c1cc(cc(c1)C(F)(F)F)-c1ncn(n1)\C=C/C(=O)N1CC(F)(F)C1		Preclinical	exportin antagonist	XPO1
KRN-633	KRN-633	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		Preclinical	VEGFR inhibitor	FLT1|FLT4|KDR
KT-433	KT-433	CCc1oc2ccccc2c1C(=O)c1ccc(OCC(O)=O)cc1		Phase 2	uricosuric agent	
ku-0063794	ku-0063794|KU-0063794	COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1	81HJG228AB	Preclinical	mTOR inhibitor	MTOR
KU-55933	KU-55933	O=c1cc(oc(c1)-c1cccc2Sc3ccccc3Sc12)N1CCOCC1	O549494L5D	Preclinical	ATM kinase inhibitor	ATM|PRKDC
KU-60019	KU-60019	C[C@H]1CN(CC(=O)Nc2ccc3Sc4c(Cc3c2)cccc4-c2cc(=O)cc(o2)N2CCOCC2)C[C@@H](C)O1	IAN358A69K	Preclinical	ATM kinase inhibitor	ATM
KU14R	KU14R	CCC1(Cc2ccccc2O1)c1ncc[nH]1		Preclinical	imidazoline receptor antagonist	
kuromanin	kuromanin|CYANIDIN 3-GLUCOSIDE CATION	OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O	Q6NK5V5B5O	Preclinical	ribosyl cyclase inhibitor	CD38
KW-2449	KW-2449	O=C(N1CCNCC1)c1ccc(cc1)\C=C\c1n[nH]c2ccccc12		Phase 1	Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor	ABL1|AURKA|AURKB|FLT3
KW-2478	KW-2478	CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC	E628ZH6U2C	Phase 1/Phase 2	HSP inhibitor	
KX2-391	KX2-391|KX-01	O=C(Cc1ccc(cn1)-c1ccc(OCCN2CCOCC2)cc1)NCc1ccccc1	4V9848RS5G	Phase 2	src inhibitor|tubulin polymerization inhibitor	SRC
KY02111	KY02111	COc1ccc(CCC(=O)Nc2nc3ccc(Cl)cc3s2)cc1OC		Preclinical	Wnt pathway inhibitor	DKK1
kynurenic-acid	kynurenic-acid|KYNURENIC ACID	OC(=O)c1cc(O)c2ccccc2n1	H030S2S85J	Preclinical	glutamate receptor antagonist	GPR35|GRIN1|GRIN2A|GRIN2B
L-(+)-Rhamnose-Monohydrate	L-(+)-Rhamnose-Monohydrate|.ALPHA.-D-FUCOPYRANOSE|.ALPHA.-L-FUCOPYRANOSE|.BETA.-L-RHAMNOSE|.ALPHA.-L-RHAMNOSE	C[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O	K15K52FOK4|OF086I9H7W|V3MX976UUR|X0E04Y9M7F	Preclinical		
L-152804	L-152804	CC1(C)CC(=O)C(C2c3ccccc3OC3=C2C(=O)CC(C)(C)C3)C(=O)C1	AP9351PWPR	Preclinical	neuropeptide receptor antagonist	NPY5R
L-161982	L-161982	CCCCc1nn(-c2ccccc2C(F)(F)F)c(=O)n1Cc1ccc(cc1)-c1ccccc1S(=O)(=O)NC(=O)c1sccc1C		Preclinical	prostanoid receptor antagonist	PTGER4
L-165041	L-165041	CCCc1c(OCCCOc2ccc(OCC(O)=O)cc2)ccc(C(C)=O)c1O		Preclinical	PPAR receptor agonist	PPARD
L-168049	L-168049	CCCOc1ccc(Br)cc1-c1cc([nH]c1-c1ccncc1)-c1ccc(Cl)cc1		Preclinical	glucagon receptor antagonist	GCGR
L-365260	L-365260	CN1c2ccccc2C(=N[C@@H](NC(=O)Nc2cccc(C)c2)C1=O)c1ccccc1	370JHF4586	Phase 2	CCK receptor antagonist	CCKAR|CCKBR|KCNQ1
L-368899	L-368899	Cc1ccccc1N1CCN(CC1)S(=O)(=O)CC12CCC(C[C@@H]1NC(=O)[C@@H](N)CCS(C)(=O)=O)C2(C)C	ER33G946JT	Phase 1	oxytocin receptor antagonist	AVPR1A|AVPR2|OXTR
L-655240	L-655240	Cc1c(CC(C)(C)C(O)=O)n(Cc2ccc(Cl)cc2)c2ccc(F)cc12		Phase 1	thromboxane receptor antagonist	PTGES
L-670596	L-670596	CS(=O)(=O)c1ccc(Cn2c3C(CC(O)=O)CCCc3c3cc(F)cc(F)c23)cc1		Preclinical	prostanoid receptor antagonist	
L-689560	L-689560	OC(=O)[C@H]1C[C@H](NC(=O)Nc2ccccc2)c2c(Cl)cc(Cl)cc2N1		Preclinical	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
L-690330	L-690330	CC(Oc1ccc(O)cc1)(P(O)(O)=O)P(O)(O)=O		Preclinical	inositol monophosphatase inhibitor	IMPA1
L-693403	L-693403	C(N1CCC2(CCc3ccccc23)CC1)c1ccccc1		Preclinical	sigma receptor agonist|sigma receptor antagonist	DRD2|SIGMAR1
L-694247	L-694247	CS(=O)(=O)Nc1ccc(Cc2noc(n2)-c2ccc3[nH]cc(CCN)c3c2)cc1		Preclinical	serotonin receptor agonist	HTR1A|HTR1B|HTR1D
L-701252	L-701252	Oc1c(C(=O)C2CC2)c(=O)[nH]c2cc(Cl)ccc12		Preclinical	glutamate receptor antagonist	GRIN1
L-701324	L-701324	Oc1c(-c2cccc(Oc3ccccc3)c2)c(=O)[nH]c2cc(Cl)ccc12	I9WY146163	Preclinical	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
L-733060	L-733060	FC(F)(F)c1cc(CO[C@H]2CCCN[C@H]2c2ccccc2)cc(c1)C(F)(F)F		Preclinical	tachykinin antagonist	TACR1
L-741742	L-741742	Cc1c(noc1-c1ccc(Cl)cc1)C1CCN(CCc2ccccc2)CC1		Preclinical	dopamine receptor antagonist	DRD3|DRD4|SCN1A|SCN3A
L-745870	L-745870	Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1		Preclinical	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR6|HTR7
L-755507	L-755507	CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1		Preclinical	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
L-778123	L-778123	Clc1cccc(c1)N1CCN(Cc2cncn2Cc2ccc(cc2)C#N)CC1=O	2A2059P49U	Phase 1	farnesyltransferase inhibitor	FNTA|FNTB|PGGT1B
L-alanine	L-alanine|ALANINE	C[C@H](N)C(O)=O	OF5P57N2ZX	Launched		
L-Arginine	L-Arginine|ARGININE	N[C@H](CCCNC(N)=N)C(O)=O	94ZLA3W45F	Launched	nitric oxide precursor	ARG2|ASL|ASS1|AZIN2|GPRC6A|NOS2|NOS3|SLC7A1|SLC7A3|SLC7A4
L-Ascorbyl-6-palmitate	L-Ascorbyl-6-palmitate|ASCORBYL PALMITATE	CCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC(=O)C(=O)C1O	QN83US2B0N	Preclinical		
L-asparagine	L-asparagine|ASPARAGINE ANHYDROUS	N[C@@H](CC(N)=O)C(O)=O	7NG0A2TUHQ	Phase 3		ASNS|ASRGL1|NARS|NARS2|SLC1A5|SLC38A3
L-asparagine-n-hydroxy	L-asparagine-n-hydroxy	N[C@@H](CC(=O)NO)C(O)=O		Preclinical		
L-Aspartic-Acid	L-Aspartic-Acid|ASPARTIC ACID	N[C@@H](CC(O)=O)C(O)=O	30KYC7MIAI	Launched	metallic radical formation stimulant	ACY1|ACY3|ADSS|ADSSL1|ASNS|ASPA|ASPH|ASRGL1|ASS1|CAD|DARS|DARS2|GOT1|GOT2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|LYZ|PAICS|RNASE1|SLC1A1|SLC25A12|SLC25A13
L-Citrulline	L-Citrulline|CITRULLINE	NC(CCCNC(N)=O)C(O)=O	29VT07BGDA	Launched	nitric oxide stimulant	ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6
L-cysteine	L-cysteine|CYSTEINE	N[C@@H](CS)C(O)=O	K848JZ4886	Launched		CARS|CARS2|CBS|CDO-1|CDO1|CSAD|CTH|GCLC|GCLM|GOT1|GSS|MGMT|NFS1|SLC19A3
L-Cysteinesulfinic-acid	L-Cysteinesulfinic-acid	N[C@@H](CS(O)=O)C(O)=O		Preclinical	glutamate receptor agonist	GRM1|GRM5|GSR|HMGCS2|PAPOLA|PRDX2
L-Cystine	L-Cystine|CYSTINE	NC(CSSCC(N)C(O)=O)C(O)=O	48TCX9A1VT	Launched		CTNS|SLC3A1|SLC7A11|SLC7A9
L-ergothioneine	L-ergothioneine|ERGOTHIONEINE	C[N+](C)(C)[C@@H](Cc1c[nH]c(=S)[nH]1)C(O)=O	BDZ3DQM98W	Phase 2	free radical scavenger	
L-glutamic-acid	L-glutamic-acid|GLUTAMIC ACID	N[C@@H](CCC(O)=O)C(O)=O	3KX376GY7L	Launched	glutamate receptor agonist	AADAT|AASS|ABAT|ALDH18A1|ASNS|BCAT1|BCAT2|CCBL2|DNPEP|EARS2|ENPEP|EPRS|FOLH1|FPGS|FTCD|GAD1|GAD2|GATB|GCLC|GCLM|GGCX|GLS|GLS2|GLUD1|GLUD2|GLUL|GMPS|GOT1|GOT2|GPT|GPT2|GRIA1|GRIA2|GRIA3|GRIA4|GRID1|GRID2|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM1|GRM2|GRM3|GRM4|GRM6|GRM7|GRM8|LGSN|NADSYN1|NAGS|OPLAH|PFAS|PGCP|PSAT1|SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7|SLC25A18|SLC25A22|SLC7A11|TAT
L-Hydroxyproline	L-Hydroxyproline|HYDROXYPROLINE	OC1CNC(C1)C(O)=O	RMB44WO89X	Launched		
L-leucine	L-leucine|LEUCINE	CC(C)C[C@H](N)C(O)=O	GMW67QNF9C	Phase 3		BCAT1|BCAT2|LARS|LARS2|LCMT1|LCMT2
L-lysine	L-lysine|LYSINE	NCCCC[C@H](N)C(O)=O	K3Z4F929H6	Phase 2	serotonin receptor agonist	GPRC6A|KARS|SLC7A1|SLC7A2|SLC7A3|SLC7A4
L-methionine	L-methionine|METHIONINE	CSCC[C@H](N)C(O)=O	AE28F7PNPL	Launched	voltage-gated calcium channel ligand	
L-mimosine	L-mimosine|MIMOSINE	N[C@@H](CN1CC(=O)C(=O)C=C1)C(O)=O	Z46B1LUI5N	Preclinical	dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor	DBH|EIF5A
L-monomethylarginine	L-monomethylarginine	CN[C@@H](CCCNC(N)=N)C(O)=O		Phase 3	nitric oxide synthase inhibitor	NOS1|NOS2
L-NAME	L-NAME|N.OMEGA.-NITRO-L-ARGININE METHYL ESTER	COC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O	V55S2QJN2X	Phase 2/Phase 3	nitric oxide synthase inhibitor	NOS3
L-NIL	L-NIL	CC(=N)NCCCC[C@H](N)C(O)=O		Preclinical	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
L-proline	L-proline|PROLINE	OC(=O)[C@@H]1CCCN1	9DLQ4CIU6V	Launched	glutamate receptor agonist	EPRS|L3HYPDH|P3H1|P3H2|P3H3|P4HA1|P4HA2|PARS2|PPIA|PPIB|PPIC|PPIF|PPIG|PPIH|PRODH|PROSC|PYCR1|PYCR2|PYCRL|SLC6A14|SLC6A7
L-Quisqualic-acid	L-Quisqualic-acid|QUISQUALIC ACID	N[C@@H](Cn1oc(=O)[nH]c1=O)C(O)=O	8OC22C1B99	Preclinical	glutamate receptor agonist	FOLH1|GRIA2|GRIK1|GRIK2|GRM1|GRM2|GRM3|GRM5|GRM7|GRM8
L-Theanine	L-Theanine|THEANINE	CCNC(=O)CCC(N)C(O)=O	8021PR16QO	Launched	glutamate receptor antagonist	
L-threonine	L-threonine|THREONINE|THREONINE, DL-	C[C@@H](O)[C@H](N)C(O)=O	2ZD004190S|TFM6DU5S6A	Phase 2		TARS|TARS2|THNSL1
labetalol	labetalol|LABETALOL	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O	R5H8897N95	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRB1|ADRB2
lacidipine	lacidipine|LACIDIPINE	CCOC(=O)C1=C(C)NC(C)=C(C1c1ccccc1\C=C\C(=O)OC(C)(C)C)C(=O)OCC	260080034N	Launched	calcium channel blocker	CACNA1C
lacitol	lacitol|MALTITOL|LACTITOL	OC[C@H](O)[C@@H](O)C(O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	D65DG142WK|L2B0WJF7ZY	Launched	osmosis stimulant	
lacosamide	lacosamide|LACOSAMIDE	COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1	563KS2PQY5	Launched	collapsin response mediator protein inhibitor|collapsin response mediator protein stimulant|sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
lactulose	lactulose|.ALPHA.-LACTULOSE	OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O	9XH2P2N8EP	Launched	laxative	
lafutidine	lafutidine|LAFUTIDINE	O=C(CS(=O)Cc1ccco1)NC\C=C/COc1cc(CN2CCCCC2)ccn1	49S4O7ADLC	Launched	histamine receptor antagonist	HRH2
lamivudine	lamivudine|LAMIVUDINE	Nc1ccn(C2CSC(CO)O2)c(=O)n1	2T8Q726O95	Launched	nucleoside reverse transcriptase inhibitor	
lamotrigine	lamotrigine|LAMOTRIGINE	Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl	U3H27498KS	Launched	serotonin receptor antagonist|sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
lanatoside-c	lanatoside-c|LANATOSIDE C	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](OC(C)=O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)C(CCC3C2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1	5RR3JFZ771	Preclinical	cardiac glycoside	
landiolol	landiolol|LANDIOLOL	CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1	62NWQ924LH	Launched	adrenergic receptor antagonist	ADRB1
lanoconazole	lanoconazole|LANOCONAZOLE	Clc1ccccc1C1CS\C(S1)=C(\C#N)n1ccnc1	4E7858311F	Launched	sterol demethylase inhibitor	
lansoprazole	lansoprazole|LANSOPRAZOLE	Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1	0K5C5T2QPG	Launched	ATPase inhibitor	ATP4A|ATP4B
lapatinib	lapatinib|LAPATINIB	CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1	0VUA21238F	Launched	EGFR inhibitor	EGFR|ERBB2
lappaconite	lappaconite|LAPPACONITINE	CCN1C[C@@]2(CC[C@@H](OC)[C@@]34[C@H]5C[C@H]6[C@H](OC)[C@]5(O)[C@](O)(C[C@@H]6OC)[C@H](C[C@H]23)C14)OC(=O)c1ccccc1NC(C)=O	Y4M5974F7Z	Phase 2	sodium channel blocker	
laquinimod	laquinimod|LAQUINIMOD	CCN(C(=O)c1c(O)c2c(Cl)cccc2n(C)c1=O)c1ccccc1	908SY76S4G	Phase 3	immunosuppressant	CXCL2
laropiprant	laropiprant|LAROPIPRANT	CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(O)=O)c3n(Cc3ccc(Cl)cc3)c12	G7N11T8O78	Launched	prostanoid receptor antagonist	PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R
lasalocid	lasalocid|LASALOCID	CC[C@H](C1OC(CC)(C[C@@H]1C)C1CC[C@](O)(CC)[C@H](C)O1)C(=O)C(C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(O)=O	W7V2ZZ2FWB	Launched	bacterial permeability inducer	
lasofoxifene	lasofoxifene|LASOFOXIFENE	O[C@@H]([C@H](O)C(O)=O)C(O)=O.Oc1ccc2[C@H]([C@H](CCc2c1)c1ccccc1)c1ccc(OCCN2CCCC2)cc1	337G83N988	Launched	selective estrogen receptor modulator (SERM)	ESR1|ESR2
latamoxef	latamoxef|LATAMOXEF	CO[C@]1(NC(=O)[C@H](C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O	VUF6C936Z3	Launched	bacterial cell wall synthesis inhibitor	
latanoprost	latanoprost|LATANOPROST	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1	6Z5B6HVF6O	Launched	prostanoid receptor agonist	PTGFR
latrepirdine	latrepirdine|LATREPIRDINE	CN1CCc2c(C1)c1cc(C)ccc1n2CCc1ccc(C)nc1	OD9237K1Z6	Phase 3	glutamate receptor antagonist	HRH1|HTR6
latrunculin-b	latrunculin-b|LATRUNCULIN B	C[C@H]1CC[C@@H]2C[C@H](C[C@@](O)(O2)[C@@H]2CSC(=O)N2)OC(=O)\C=C(C)/CC\C=C/1	LW7U308U7U	Phase 1	actin polymerization inhibitor	ACTA1|MKL1|SPIRE2
lauric-acid	lauric-acid|LAURIC ACID	CCCCCCCCCCCC(O)=O	1160N9NU9U	Phase 3	bacterial permeability inducer	GPR84|HNF4A|LTF|LY96|PLA2G2A|TLR4
lauric-diethanolamide	lauric-diethanolamide|LAURIC DIETHANOLAMIDE	CCCCCCCCCCCC(=O)N(CCO)CCO	I29I2VHG38	Preclinical		
laurocapram	laurocapram|LAUROCAPRAM	CCCCCCCCCCCCN1CCCCCC1=O	1F3X9DRV9X	Phase 3		
lazabemide	lazabemide|LAZABEMIDE	NCCNC(=O)c1ccc(Cl)cn1	420HD787N9	Phase 3	monoamine oxidase inhibitor	MAOB
LB-100	LB-100	CN1CCN(CC1)C(=O)C1C2CCC(O2)C1C(O)=O		Phase 1	protein phosphatase inhibitor	
LB42708	LB42708	Brc1ccc(Cn2cncc2Cn2cc(C(=O)N3CCOCC3)c(c2)-c2cccc3ccccc23)cc1		Preclinical	farnesyltransferase inhibitor	
LCL-161	LCL-161	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1c1nc(cs1)C(=O)c1ccc(F)cc1	6TNS415Y3P	Phase 2	XIAP inhibitor	BIRC2|XIAP
LCQ908	LCQ908|PRADIGASTAT	OC(=O)C[C@H]1CC[C@@H](CC1)c1ccc(cc1)-c1ccc(Nc2ccc(nc2)C(F)(F)F)cn1	2U23G6VNUZ	Phase 3	diacylglycerol O acyltransferase inhibitor	DGAT1
LCZ696	LCZ696|SACUBITRIL VALSARTAN SODIUM HYDRATE	CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)[C@@H](C(C)C)C(O)=O	WB8FT61183	Launched	angiotensin receptor antagonist	
LDC1267	LDC1267	CCOc1cn(nc1C(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)c(F)c1)-c1ccc(F)cc1C		Preclinical	protein tyrosine kinase inhibitor	AXL|MERTK|TYRO3
LDN-212854	LDN-212854	C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12		Preclinical	bone morphogenic protein inhibitor	ABL1|ACVR1|RIPK2
LDN-57444	LDN-57444	CC(=O)O\N=C1\C(=O)N(Cc2cc(Cl)ccc2Cl)c2ccc(Cl)cc12		Preclinical	ubiquitin C-terminal hydrolase inhibitor	
LDN193189	LDN193189|LDN-193189	C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12	W69H5YQU9O	Preclinical	bone morphogenic protein inhibitor	ACVR1|BMPR1A
LE-135	LE-135	CN1c2cc3c(cc2N=C(c2ccc(cc2)C(O)=O)c2ccccc12)C(C)(C)CCC3(C)C		Preclinical	retinoid receptor agonist	RARB
ledipasvir	ledipasvir|LEDIPASVIR	COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1c1ncc([nH]1)-c1ccc2-c3ccc(cc3C(F)(F)c2c1)-c1ccc2nc([nH]c2c1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C	013TE6E4WV	Launched	HCV inhibitor	
leflunomide	leflunomide|LEFLUNOMIDE	Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F	G162GK9U4W	Launched	dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor	AHR|DHODH|PTK2B
lemborexant	lemborexant|LEMBOREXANT	Cc1ncc(OC[C@]2(C[C@H]2C(=O)Nc2ccc(F)cn2)c2cccc(F)c2)c(C)n1	0K5743G68X	Phase 3	orexin receptor antagonist	HCRTR1|HCRTR2
lenalidomide	lenalidomide|LENALIDOMIDE	Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O	F0P408N6V4	Launched	anticancer agent	CDH5|CRBN|PTGS2|TNF|TNFSF11
lenvatinib	lenvatinib|LENVATINIB	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O	EE083865G2	Launched	FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	FLT4|KDR
lercanidipine	lercanidipine|LERCANIDIPINE	COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c1ccccc1	V7XTJ4R0BH	Launched	calcium channel blocker	CACNA2D1|CACNG1
lerisetron	lerisetron|LERISETRON	C(c1ccccc1)n1c(nc2ccccc12)N1CCNCC1	Q36R82SXRG	Phase 3	serotonin receptor antagonist	HTR3A
lersivirine	lersivirine|LERSIVIRINE	CCc1nn(CCO)c(CC)c1Oc1cc(cc(c1)C#N)C#N	R3ZGC15A9A	Phase 2	non-nucleoside reverse transcriptase inhibitor	
lesinurad	lesinurad|LESINURAD	OC(=O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12	09ERP08I3W	Launched	uric acid diuretic	SLC22A12
lestaurtinib	lestaurtinib|LESTAURTINIB	C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13	DO989GC5D1	Phase 3	FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor	FLT3|NTRK1
leteprinim	leteprinim|LETEPRINIM	OC(=O)c1ccc(NC(=O)CCn2cnc3c(O)ncnc23)cc1	NBY3IU407M	Phase 2	nerve growth factor agonist	
letermovir	letermovir|LETERMOVIR	COc1cccc(c1)N1CCN(CC1)C1=Nc2c(F)cccc2[C@H](CC(O)=O)N1c1cc(ccc1OC)C(F)(F)F	1H09Y5WO1F	Phase 3	CMV terminase inhibitor	
letosteine	letosteine|LETOSTEINE	CCOC(=O)CSCCC1NC(CS1)C(O)=O	6MVF9U95DW	Launched	mucolytic agent	
letrozole	letrozole|LETROZOLE	N#Cc1ccc(cc1)C(c1ccc(cc1)C#N)n1cncn1	7LKK855W8I	Launched	aromatase inhibitor	CYP19A1
leucomethylene-blue	leucomethylene-blue|LEUCOMETHYLENE BLUE	CN(C)c1ccc2Nc3ccc(cc3Sc2c1)N(C)C	IHU4GYZ2R3	Phase 3	nitric oxide production inhibitor|tau aggregation inhibitor	MAPT
leucovorin	leucovorin|LEUCOVORIN	Nc1nc(=O)c2N(C=O)C(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1	Q573I9DVLP	Launched	folate receptor ligand	TYMS
leucylleucine-methyl-ester	leucylleucine-methyl-ester	COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C		Phase 2		
leuprolide	leuprolide|LEUPROLIDE	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1	EFY6W0M8TG	Launched	gonadotropin releasing factor hormone receptor agonist	GNRHR
levalbuterol	levalbuterol|LEVALBUTEROL	CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1	EDN2NBH5SS	Launched	adrenergic receptor agonist	ADRB2
levallorphan	levallorphan|LEVALLORPHAN	Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC=C)c2c1	353613BU4U	Launched	opioid antagonist	CHRNA2|OPRM1
levamisole	levamisole|LEVAMISOLE	C1CN2C[C@@H](N=C2S1)c1ccccc1	2880D3468G	Withdrawn	acetylcholine receptor agonist	ALPL|ALPPL2|CHRNA3
levcromakalim	levcromakalim|CROMAKALIM|LEVCROMAKALIM	CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N1CCCC1=O)C#N	0G4X367WA3|RW7PN4BLDJ	Phase 3	potassium channel activator	KCNJ5|KCNJ8
levetiracetam	levetiracetam|LEVETIRACETAM	CC[C@H](N1CCCC1=O)C(N)=O	44YRR34555	Launched	calcium channel blocker	CACNA1B|SCN1A|SV2A
levo-phencynonate	levo-phencynonate|LEVOPHENCYNONATE|PHENCYNONATE	CN1CC2CCCC(C1)C2OC(=O)C(O)(C1CCCC1)c1ccccc1	4TNV157KEQ|H84F112WBJ	Launched	acetylcholine receptor antagonist	CHRM1
levobunolol	levobunolol|LEVOBUNOLOL	CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12	G6317AOI7K	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
levobunolol-(+)	levobunolol-(+)|BUNOLOL|LEVOBUNOLOL	CC(C)(C)NC[C@@H](O)COc1cccc2C(=O)CCCc12	71QSY2UT3G|G6317AOI7K	Preclinical	adrenergic receptor antagonist	
levobunolol-(+/-)	levobunolol-(+/-)|BUNOLOL	CC(C)(C)NCC(O)COc1cccc2C(=O)CCCc12	71QSY2UT3G	Preclinical	adrenergic receptor antagonist	
levocabastine	levocabastine|CABASTINE|LEVOCABASTINE	C[C@@H]1CN(CC[C@]1(C(O)=O)c1ccccc1)[C@H]1CC[C@](CC1)(C#N)c1ccc(F)cc1	COU3RRH769|H68BP06S81	Launched	histamine receptor antagonist	HRH1|NTSR2
levocarnitine	levocarnitine|LEVOCARNITINE	C[N+](C)(C)C[C@H](O)CC(O)=O	0G389FZZ9M	Launched		
levocarnitine-propionate	levocarnitine-propionate|LEVOCARNITINE PROPIONATE	CCC(=O)O[C@H](CC(O)=O)C[N+](C)(C)C	0HU2UI27HF	Launched	carnitine palmitoyltransferase inhibitor	CRAT
levocetirizine	levocetirizine|LEVOCETIRIZINE	OC(=O)COCCN1CCN(CC1)[C@H](c1ccccc1)c1ccc(Cl)cc1	6U5EA9RT2O	Launched	histamine receptor antagonist	HRH1
levodopa	levodopa|LEVODOPA	N[C@@H](Cc1ccc(O)c(O)c1)C(O)=O	46627O600J	Launched	dopamine precursor	DRD1|DRD2|DRD3|DRD4|DRD5|GPR143
levodropropizine	levodropropizine|LEVODROPROPIZINE	OC[C@H](O)CN1CCN(CC1)c1ccccc1	3O31P6T4G3	Launched	antitussive	
levofloxacin	levofloxacin|LEVOFLOXACIN	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O	6GNT3Y5LMF	Launched	bacterial DNA gyrase inhibitor	TOP2A
levomenol	levomenol|LEVOMENOL	CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1	24WE03BX2T	Launched		
levomenthol	levomenthol|LEVOMENTHOL|RACEMENTHOL	CC(C)C1CCC(C)CC1O	BZ1R15MTK7|YS08XHA860	Launched		OPRK1|TRPA1|TRPM8|TRPV3
levomepromazine	levomepromazine|LEVOMEPROMAZINE	COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1	9G0LAW7ATQ	Launched	dopamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR2A|HTR2C
levomequitazine	levomequitazine|LEVOMEQUITAZINE	C(C1CN2CCC1CC2)N1c2ccccc2Sc2ccccc12	5G2MWA892Y	Phase 2	histamine receptor antagonist	HRH1
levonordefrin	levonordefrin|NORDEFRIN|LEVONORDEFRIN	C[C@H](N)[C@H](O)c1ccc(O)c(O)c1	R81X549E70|V008L6478D	Launched	vasodilator	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|SLC6A2
levonorgestrel	levonorgestrel|NORGESTREL|LEVONORGESTREL	CC[C@]12CC[C@@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@]2(O)C#C	3J8Q1747Z2|5W7SIA7YZW	Launched	estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist	AR|ESR1|PGR|SRD5A1
levopropoxyphene	levopropoxyphene|LEVOPROPOXYPHENE	CCC(=O)OC(Cc1ccccc1)(C(C)CN(C)C)c1ccccc1	U75VZ9PK1J	Launched	antitussive	OPRD1|OPRK1|OPRM1
levosimendan	levosimendan|LEVOSIMENDAN	C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1	C6T4514L4E	Launched	calcium sensitizer	KCNJ11|KCNJ8|PDE3A|TNNC1
levosulpiride	levosulpiride|LEVOSULPIRIDE	CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	JTG7R315LK	Launched	dopamine receptor antagonist	CA1|CA12|CA7|DRD2|DRD3
levothyroxine	levothyroxine|LEVOTHYROXINE	N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O	Q51BO43MG4	Launched	thyroid hormone stimulant	THRA|THRB
LFM-A13	LFM-A13	CC(=O)C(C#N)C(=O)Nc1cc(Br)ccc1Br		Preclinical	Bruton's tyrosine kinase (BTK) inhibitor	BTK
LGK-974	LGK-974|WNT-974	Cc1cc(ccn1)-c1ncc(CC(=O)Nc2ccc(cn2)-c2cnccn2)cc1C	U27F40013Q	Phase 2	porcupine inhibitor	PORCN
LGX818	LGX818|ENCORAFENIB	COC(=O)NC(C)CNc1nccc(n1)-c1cn(nc1-c1cc(Cl)cc(NS(C)(=O)=O)c1F)C(C)C	8L7891MRB6	Phase 3	RAF inhibitor	BRAF
LH846	LH846	Cc1cc2sc(NC(=O)Cc3ccccc3)nc2cc1Cl		Preclinical	casein kinase inhibitor	CSNK1D
licarbazepine	licarbazepine|LICARBAZEPINE	NC(=O)N1c2ccccc2CC(O)c2ccccc12	XFX1A5KJ3V	Phase 3	voltage-gated sodium channel blocker	SCN5A
licochalcone-a	licochalcone-a|LICOCHALCONE A	COc1cc(O)c(cc1C=CC(=O)c1ccc(O)cc1)C(C)(C)C=C	JTV5467968	Phase 3	topoisomerase inhibitor	PTPN1
licofelone	licofelone|LICOFELONE	CC1(C)Cc2c(c(c(CC(O)=O)n2C1)-c1ccc(Cl)cc1)-c1ccccc1	P5T6BYS22Y	Phase 3	cyclooxygenase inhibitor|lipoxygenase inhibitor	ALOX5|PLA2G2E|PTGS2
lidamidine	lidamidine|LIDAMIDINE	CNC(=N)NC(=O)Nc1c(C)cccc1C	Q8X04W8418	Launched	adrenergic receptor agonist	
lidocaine	lidocaine|LIDOCAINE	CCN(CC)CC(=O)Nc1c(C)cccc1C	98PI200987	Launched	histamine receptor agonist	EGFR|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
lidoflazine	lidoflazine|LIDOFLAZINE	Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	J4ZHN3HBTE	Launched	calcium channel blocker	SCN1A|SCN3A|SLC29A1
ligustilide	ligustilide	CCC\C=C1OC(=O)C2=C/1CCC=C2		Preclinical	tumor necrosis factor production inhibitor	TNF
limaprost-alfadex	limaprost-alfadex|LIMAPROST	CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O	L02U804092	Launched	prostanoid receptor agonist	PTGER1
limonin	limonin|LIMONIN	CC1(C)O[C@H]2CC(=O)OC[C@@]22[C@H]1CC(=O)[C@@]1(C)[C@@H]2CC[C@@]2(C)[C@@H](OC(=O)[C@@H]3O[C@@]123)c1ccoc1	L0F260866S	Preclinical	HIV protease inhibitor	
linaclotide	linaclotide	C[C@@H](O)C1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N2		Launched	guanylate cyclase activator	GUCY2C
linagliptin	linagliptin|LINAGLIPTIN	CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1	3X29ZEJ4R2	Launched	dipeptidyl peptidase inhibitor	DPP4
linalool	linalool|LINALOOL, (+/-)-	CC(C)=CCCC(C)(O)C=C	D81QY6I88E	Phase 1	anticonvulsant	
lincomycin	lincomycin|LINCOMYCIN	CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@@H]([C@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O	BOD072YW0F	Launched	bacterial 30S ribosomal subunit inhibitor	
lindane	lindane|LINDANE	Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl	59NEE7PCAB	Launched		GABRB1|GLRA1|GLRA2|GLRA3|GLRB
linezolid	linezolid|LINEZOLID	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1	ISQ9I6J12J	Launched	bacterial 50S ribosomal subunit inhibitor	MAOA|MAOB
linifanib	linifanib|LINIFANIB	Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1	CO93X137CW	Phase 3	PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK
linoleic-acid	linoleic-acid|LINOLEIC ACID	CCCCC\C=C/C\C=C/CCCCCCCC(O)=O	9KJL21T0QJ	Phase 3	oxidative stress inducer	FABP4|FFAR1|FFAR4|HNF4A|KCNB1|PPARG|TRPM8
linopirdine	linopirdine|LINOPIRDINE	O=C1N(c2ccccc2C1(Cc1ccncc1)Cc1ccncc1)c1ccccc1	I5TB3NZ94T	Phase 3	potassium channel blocker	KCNQ2|KCNQ3|KCNQ4|KCNQ5
linsidomine	linsidomine|LINSIDOMINE	N=c1c[n+]([n-]o1)N1CCOCC1	5O5U71P6VQ	Launched	nitric oxide donor	
linsitinib	linsitinib|LINSITINIB	C[C@@]1(O)C[C@@H](C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12	15A52GPT8T	Phase 3	IGF-1 inhibitor	IGF1R|INSR|INSRR
liothyronine	liothyronine|LIOTHYRONINE	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O	06LU7C9H1V	Launched	thyroid hormone stimulant	THRA|THRB
liothyronine-(isomer)	liothyronine-(isomer)|DETROTHYRONINE	N[C@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O	46XII7C16X	Preclinical		
lipoamide	lipoamide|THIOCTIC ACID AMIDE	NC(=O)CCCCC1CCSS1	Q1GT04827L	Preclinical		
liraglutide	liraglutide	CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(C)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(Cc1ccccc1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O		Launched	GLP receptor agonist	GLP1R
liranaftate	liranaftate|LIRANAFTATE	COc1cccc(n1)N(C)C(=S)Oc1ccc2CCCCc2c1	5253IGO5X3	Launched	fungal squalene epoxidase inhibitor	
lirimilast	lirimilast|LIRIMILAST	CS(=O)(=O)Oc1ccc2c(NC(N)=O)c(oc2c1)C(=O)c1ccc(Cl)cc1Cl	GDK3KY5FCU	Phase 2	phosphodiesterase inhibitor	
lisadimate	lisadimate|LISADIMATE	Nc1ccc(cc1)C(=O)OCC(O)CO	A886B5N5IM	Launched	topical sunscreen agent	
lisinopril	lisinopril|LISINOPRIL	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O	E7199S1YWR	Launched	angiotensin converting enzyme inhibitor	ACE|ACE2
lisofylline	lisofylline|LISOFYLLINE	CC(O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O	L1F2Q2X956	Phase 2	interleukin receptor antagonist|STAT inhibitor	
lisuride	lisuride|LISURIDE	CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34	E0QN3D755O	Launched	dopamine receptor agonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6
lithium-acetoacetate	lithium-acetoacetate|ACETOACETIC ACID	CC(=O)CC(O)=O	4ZI204Y1MC	Preclinical		
lithium-citrate	lithium-citrate|LITHIUM CITRATE	[Li].[Li].[Li].OC(=O)CC(O)(CC(O)=O)C(O)=O	5Z6E9K79YV	Launched		
lithocholic-acid	lithocholic-acid|LITHOCHOLIC ACID	C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	5QU0I8393U	Preclinical	FXR antagonist|vitamin D receptor agonist	GPBAR1|NR1H4|NR1I2|VDR
litronesib	litronesib|LITRONESIB	CCNCCS(=O)(=O)NC[C@]1(SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C)c1ccccc1	6611F8KYCV	Phase 2	kinesin-like spindle protein inhibitor	KIF11
lixivaptan	lixivaptan|LIXIVAPTAN	Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc23)c(Cl)c1	8F5X4B082E	Phase 3	vasopressin receptor antagonist	AVPR2
LM11A-31	LM11A-31	CCC(C)C(N)C(=O)NCCN1CCOCC1		Phase 1	neurotrophic agent	NGFR
LMI070	LMI070	CC1(C)CC(CC(C)(C)N1)Oc1ccc(nn1)-c1ccc(cc1O)-c1cn[nH]c1		Phase 1/Phase 2	survival motor neuron protein modulator	SMN1
lobeline	lobeline|LOBELINE	CN1C(CC(O)c2ccccc2)CCCC1CC(=O)c1ccccc1	D0P25S3P81	Launched	acetylcholine receptor antagonist	CHRNA10|CHRNA9|SLC18A2
lobendazole	lobendazole|LOBENDAZOLE	CCOC(=O)Nc1nc2ccccc2[nH]1	CMF6Z78SWL	Preclinical	anthelmintic agent	
lobenzarit	lobenzarit|LOBENZARIT	OC(=O)c1ccccc1Nc1cc(Cl)ccc1C(O)=O	915EE91P39	Launched	immunosuppressant	
lodoxamide	lodoxamide|LODOXAMIDE	OC(=O)C(=O)Nc1cc(cc(NC(=O)C(O)=O)c1Cl)C#N	SPU695OD73	Launched	histamine receptor antagonist	
lofemizole	lofemizole|LOFEMIZOLE	Cc1nc[nH]c1-c1ccc(Cl)cc1	D8G23FPC3P	Phase 3	cyclooxygenase inhibitor	
lofepramine	lofepramine|LOFEPRAMINE	CN(CCCN1c2ccccc2CCc2ccccc12)CC(=O)c1ccc(Cl)cc1	OCA4JT7PAW	Launched	norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI)	HTR1A|SLC6A2|SLC6A4
lofexidine	lofexidine|LOFEXIDINE	CC(Oc1c(Cl)cccc1Cl)C1=NCCN1	UI82K0T627	Launched	adrenergic receptor agonist	ADRA2A
lomefloxacin	lomefloxacin|LOMEFLOXACIN	CCn1cc(C(O)=O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12	L6BR2WJD8V	Launched	bacterial DNA gyrase inhibitor	TOP2A
lomeguatrib	lomeguatrib|LOMEGUATRIB	Nc1nc(OCc2cc(Br)cs2)c2[nH]cnc2n1	S79265T71M	Phase 2	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT
lomerizine	lomerizine|LOMERIZINE	COc1ccc(CN2CCN(CC2)C(c2ccc(F)cc2)c2ccc(F)cc2)c(OC)c1OC	DEE37CY4VO	Launched	calcium channel blocker	CACNA1B|SCN5A
lometrexol	lometrexol|LOMETREXOL	Nc1nc(O)c2C[C@@H](CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2n1	6P3AVY8A7Q	Phase 2	glycinamide ribonucleotide formyltransferase inhibitor	GART|MTHFD1
lomitapide	lomitapide|LOMITAPIDE	FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)c2ccccc2-c2ccc(cc2)C(F)(F)F)c2ccccc2-c2ccccc12	82KUB0583F	Launched	microsomal trigylceride transfer protein inhibitor	MTTP
lomustine	lomustine|LOMUSTINE	[O-][N+]N(CCCl)C(=O)NC1CCCCC1	7BRF0Z81KG	Launched	DNA synthesis inhibitor	STMN4
lonafarnib	lonafarnib|LONAFARNIB	NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2c3ncc(Br)cc3CCc3cc(Cl)cc(Br)c23)CC1	IOW153004F	Phase 3	farnesyltransferase inhibitor	FNTA|HRAS|KRAS|NRAS
lonidamine	lonidamine|LONIDAMINE	OC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12	U78804BIDR	Launched	glucokinase inhibitor	GCK
loperamide	loperamide|LOPERAMIDE	CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1	6X9OC3H4II	Launched	opioid receptor agonist	CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC
lopinavir	lopinavir|LOPINAVIR	CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)COc1c(C)cccc1C)Cc1ccccc1	2494G1JF75	Launched	HIV protease inhibitor	
loracarbef	loracarbef|LORACARBEF	N[C@@H](C(=O)NC1C2CCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1	3X11EVM5SU	Launched	bacterial cell wall synthesis inhibitor	
loratadine	loratadine|LORATADINE	CCOC(=O)N1CCC(CC1)=C1c2ccc(Cl)cc2CCc2cccnc12	7AJO3BO7QN	Launched	histamine receptor antagonist	HRH1
lorazepam	lorazepam|LORAZEPAM	OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O	O26FZP769L	Launched	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO
lorcaserin	lorcaserin|LORCASERIN	C[C@H]1CNCCc2ccc(Cl)cc12	637E494O0Z	Launched	serotonin receptor agonist	HTR2A|HTR2B|HTR2C
loreclezole	loreclezole|LORECLEZOLE	Cl\C(=C/n1cncn1)c1ccc(Cl)cc1Cl	6DJ32STZ5W	Phase 2	benzodiazepine receptor agonist	GABRB2|GABRB3
lorediplon	lorediplon|LOREDIPLON	CN(C(C)=O)c1cc(ccc1F)-c1ccnc2c(cnn12)C(=O)c1cccs1	VKU6Z23NSY	Phase 2	GABA receptor modulator	GABRA1
lorglumide	lorglumide|LORGLUMIDE	CCCCCN(CCCCC)C(=O)C(CCC(O)=O)NC(=O)c1ccc(Cl)c(Cl)c1	LAD1UQ73BE	Phase 1	CCK receptor antagonist	CCKAR|CCKBR
lorlatinib	lorlatinib|LORLATINIB	C[C@H]1Oc2cc(cnc2N)-c2c(CN(C)C(=O)c3ccc(F)cc13)nn(C)c2C#N	OSP71S83EU	Phase 2	ALK tyrosine kinase receptor inhibitor	ALK
lornoxicam	lornoxicam|LORNOXICAM	CN1C(C(=O)Nc2ccccn2)C(=O)c2sc(Cl)cc2S1(=O)=O	ER09126G7A	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
losartan	losartan|LOSARTAN	CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	JMS50MPO89	Launched	angiotensin receptor antagonist	AGTR1
losmapimod	losmapimod|LOSMAPIMOD	Cc1c(F)cc(cc1-c1ccc(cn1)C(=O)NCC(C)(C)C)C(=O)NC1CC1	F2DQF16BXE	Phase 3	p38 MAPK inhibitor	MAPK14
loteprednol	loteprednol|LOTEPREDNOL	CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl	Z8CBU6KR16	Launched	glucocorticoid receptor agonist|phospholipase inhibitor	NR3C1
lovastatin	lovastatin|LOVASTATIN	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	9LHU78OQFD	Launched	HMGCR inhibitor	HDAC2|HMGCR|ITGAL|NR1I2
loxapine	loxapine|LOXAPINE	CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12	LER583670J	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4
loxistatin-acid	loxistatin-acid	CC(C)CCNC(=O)C(CC(C)C)NC(=O)C1OC1C(O)=O		Preclinical	cysteine peptidase inhibitor	CTSB
LOXO-101	LOXO-101	O[C@H]1CCN(C1)C(=O)Nc1cnn2ccc(nc12)N1CCC[C@@H]1c1cc(F)ccc1F		Phase 2	tropomyosin receptor kinase inhibitor	NTRK1|NTRK2|NTRK3
loxoprofen	loxoprofen|LOXOPROFEN	CC(C(O)=O)c1ccc(CC2CCCC2=O)cc1	3583H0GZAP	Launched	cyclooxygenase inhibitor|prostanoid receptor antagonist	PTGS2
LPA2-antagonist-1	LPA2-antagonist-1	C[C@@H](CN1CCN(CC1)S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ncnc2c(C)csc12		Preclinical	lysophosphatidic acid receptor antagonist	LPAR2
LRRK2-IN-1	LRRK2-IN-1	COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1		Preclinical	leucine rich repeat kinase inhibitor	LRRK2
LTA	LTA	N=C(Nc1ccccc1)c1cccs1		Phase 2		
LTB4	LTB4|LEUKOTRIENE B4	CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O	1HGW4DR56D	Phase 2	leukocyte activator	LTB4R|LTB4R2
lubiprostone	lubiprostone|LUBIPROSTONE	CCCCC(F)(F)C(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	7662KG2R6K	Launched	chloride channel activator	CLCN2
lucitanib	lucitanib|LUCITANIB	CNC(=O)c1cccc2cc(ccc12)Oc1ccnc2cc(OCC3(N)CC3)c(OC)cc12	PP449XA4BH	Phase 2	FGFR inhibitor|VEGFR inhibitor	FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET
lufenuron	lufenuron|LUFENURON	FC(C(F)(F)F)C(F)(F)Oc1cc(Cl)c(NC(=O)NC(=O)c2c(F)cccc2F)cc1Cl	1R754M4918	Launched	chitin inhibitor	
luliconazole	luliconazole|LULICONAZOLE	Clc1ccc([C@@H]2CS\C(S2)=C(\C#N)n2ccnc2)c(Cl)c1	RE91AN4S8G	Launched	sterol demethylase inhibitor	
lumacaftor	lumacaftor|LUMACAFTOR	Cc1ccc(NC(=O)C2(CC2)c2ccc3OC(F)(F)Oc3c2)nc1-c1cccc(c1)C(O)=O	EGP8L81APK	Launched	CFTR channel agonist	CFTR
lumateperone	lumateperone|LUMATEPERONE	CN1CCN2[C@H]3CCN(CCCC(=O)c4ccc(F)cc4)C[C@H]3c3cccc1c23	70BSQ12069	Phase 3	serotonin receptor antagonist|dopamine receptor modulator	DRD2|HTR2A
lumefantrine	lumefantrine|LUMEFANTRINE, (-)-|LUMEFANTRINE|LUMEFANTRINE, (+)-	CCCCN(CCCC)CC(O)c1cc(Cl)cc2\C(=C/c3ccc(Cl)cc3)c3cc(Cl)ccc3-c12	01NP22J3SV|F38R0JR742|ZUV4B00D9P	Launched	antimalarial agent	ATP1A1
lumiracoxib	lumiracoxib|LUMIRACOXIB	Cc1ccc(Nc2c(F)cccc2Cl)c(CC(O)=O)c1	V91T9204HU	Withdrawn	cyclooxygenase inhibitor	PTGS1|PTGS2
lupanine	lupanine|LUPANINE|LUPANINE, (+/-)-	O=C1CCCC2C3CC(CN12)[C@@H]1CCCCN1C3	183KU7535A|9K48888N9P	Phase 1	sodium channel blocker	INS
lurasidone	lurasidone|LURASIDONE	O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12	22IC88528T	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7
lutein	lutein|LUTEIN	CC(\C=C\C=C(C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C	X72A60C9MT	Launched	antioxidant	
luteolin	luteolin|LUTEOLIN	Oc1cc(O)c2c(c1)oc(cc2=O)-c1ccc(O)c(O)c1	KUX1ZNC9J2	Phase 2	glucosidase inhibitor	TOP1
luzindole	luzindole	CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12		Preclinical	melatonin receptor antagonist	MTNR1A|MTNR1B
LX1031	LX1031|LX-1031	COc1cccc(c1)-c1ccc(cc1)[C@@H](Oc1cc(nc(N)n1)-c1ccc(C[C@H](N)C(O)=O)cc1)C(F)(F)F	J08E1J78GK	Phase 2	tryptophan hydroxylase inhibitor	TPH1
LX7101	LX7101	CN(C)C(=O)Oc1cccc(NC(=O)C2(CN)CCN(CC2)c2ncnc3[nH]cc(C)c23)c1		Phase 1/Phase 2	LIM kinase inhibitor|rho associated kinase inhibitor	LIMK2|ROCK1|ROCK2
LXR-623	LXR-623|LX-623	Fc1ccc(cc1)-c1n(Cc2ccc(F)cc2Cl)nc2c(cccc12)C(F)(F)F	4W82FEU838	Phase 1	LXR agonist	AR|NR1H2|NR1H3|NR1I2|NR3C1
LY2090314	LY2090314|LY-2090314	Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c4cnc5ccccn45)c(c1)c23)C(=O)N1CCCCC1	822M3GYM67	Phase 2	glycogen synthase kinase inhibitor	GSK3B
LY2109761	LY2109761	C(CN1CCOCC1)Oc1ccc2c(ccnc2c1)-c1c(nn2CCCc12)-c1ccccn1		Preclinical	TGF beta receptor inhibitor	TGFBR1|TGFBR2
LY2140023	LY2140023|POMAGLUMETAD METHIONIL ANHYDROUS	N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O	3V85EZ3KFQ	Phase 3	glutamate receptor agonist	GRM3
LY215490	LY215490|TEZAMPANEL ANHYDROUS	OC(=O)[C@@H]1C[C@H]2C[C@@H](CCc3nn[nH]n3)CC[C@H]2CN1	GA36S2O9C2	Phase 1	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4|GRIK1
LY2157299	LY2157299|GALUNISERTIB	Cc1cccc(n1)-c1nn2CCCc2c1-c1ccnc2ccc(cc12)C(N)=O	3OKH1W5LZE	Phase 2/Phase 3	TGF beta receptor inhibitor	TGFBR1
LY2183240	LY2183240	CN(C)C(=O)n1nnnc1Cc1ccc(cc1)-c1ccccc1		Preclinical	FAAH inhibitor|FAAH reuptake inhibitor	FAAH
LY2228820	LY2228820|RALIMETINIB	CC(C)(C)Cn1c(N)nc2ccc(nc12)-c1[nH]c(nc1-c1ccc(F)cc1)C(C)(C)C	73I34XW4HD	Phase 2	p38 MAPK inhibitor	MAPK14
LY223982	LY223982	COc1ccc(\C=C\CCCCOc2ccc(cc2CCC(O)=O)C(=O)c2cccc(c2)C(O)=O)cc1		Phase 2	leukotriene receptor antagonist	LTB4R
LY225910	LY225910	CC(C)Oc1cccc(c1)-n1c(CCc2c[nH]c3ccc(Br)cc23)nc2ccccc2c1=O		Preclinical	CCK receptor antagonist	CCKBR
LY231617	LY231617	CCNCc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C		Preclinical	lipid peroxidase inhibitor	
LY2334737	LY2334737|LY-2334737	CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1	YLR364XYSA	Phase 1	antitumor agent|ribonucleotide reductase inhibitor	
LY2365109	LY2365109	CN(CCOc1ccc(cc1C(C)(C)C)-c1ccc2OCOc2c1)CC(O)=O		Preclinical	Glycine transporter 1 inhibitor	SLC6A9
LY2452473	LY2452473|LY-2452473	CC(C)OC(=O)N[C@@H]1Cc2c(C1)c1cc(ccc1n2Cc1ccccn1)C#N	XKW9MYF94Y	Phase 2	androgen receptor modulator	AR
LY255283	LY255283|LY-255283	CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nnn[nH]1	H037W1I5AL	Preclinical	leukotriene receptor antagonist	LTB4R|LTB4R2
LY2584702	LY2584702|LY-2584702	Cn1cc(nc1C1CCN(CC1)c1ncnc2[nH]ncc12)-c1ccc(F)c(c1)C(F)(F)F	I4965C6W4O	Phase 1	ribosomal protein inhibitor	RPS6KB1
LY2603618	LY2603618|RABUSERTIB	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1	3S9L1NU6U7	Phase 2	CHK inhibitor	CHEK1
LY2606368	LY2606368|PREXASERTIB	COc1cccc(OCCCN)c1-c1cc(Nc2cnc(cn2)C#N)n[nH]1	820NH671E6	Phase 2	CHK inhibitor	CHEK1
LY2608204	LY2608204|LY-2608204	O=C(Nc1ncc(SCCN2CCCC2)s1)[C@@]1(C[C@H]1C1CCCCC1)c1ccc(cc1)S(=O)(=O)C1CC1	5A0L003HEY	Phase 2	glucokinase activator	GCK
LY2784544	LY2784544|GANDOTINIB	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)[nH]n1	ANC71R916O	Phase 2	JAK inhibitor	JAK2|JAK3
LY2801653	LY2801653|MERESTINIB	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1	5OGS5K699E	Phase 2	MET inhibitor	MET
LY2811376	LY2811376|LY-2811376	C[C@]1(CCSC(N)=N1)c1cc(c(F)cc1F)-c1cncnc1	UR18YJ97SJ	Phase 1	beta-secretase inhibitor	BACE1
LY2835219	LY2835219|ABEMACICLIB	CCN1CCN(Cc2ccc(Nc3ncc(F)c(n3)-c3cc(F)c4nc(C)n(C(C)C)c4c3)nc2)CC1	60UAB198HK	Phase 3	CDK inhibitor	CDK4|CDK6
LY2857785	LY2857785	CC(C)c1n(C)nc2ccc(cc12)-c1ccnc(N[C@H]2CC[C@@H](CC2)NC2CCOCC2)n1		Preclinical	CDK inhibitor	CDK9
LY2874455	LY2874455|LY-2874455	C[C@@H](Oc1ccc2[nH]nc(\C=C\c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl	E9M363811V	Phase 1	FGFR antagonist	FGFR1|FGFR2|FGFR3|FGFR4|KDR
LY288513	LY288513|LY-288513	Brc1ccc(NC(=O)N2NC(=O)[C@H]([C@@H]2c2ccccc2)c2ccccc2)cc1	470GWP2CA0	Preclinical	CCK receptor antagonist	CCKBR
LY2886721	LY2886721|LY-2886721	NC1=N[C@]2(COC[C@@H]2CS1)c1cc(NC(=O)c2ccc(F)cn2)ccc1F	2CQ62IWB67	Phase 1/Phase 2	beta-secretase inhibitor	BACE1
LY294002	LY294002|LY-294002	O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1	31M2U1DVID	Preclinical	mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor	AKT1|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKCA|PRKDC|ROCK1|RPS6KB1|SGK1
LY2979165	LY2979165	C[C@H](N)C(=O)N[C@]1(C[C@@H](Sc2nnc[nH]2)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O		Phase 1	glutamate receptor agonist	GRM2
LY3000328	LY3000328	CNC(=O)O[C@H]1COc2ccc(cc2[C@@H]1NC(=O)c1ccc(F)cc1)N1CCN(CC1)C1COC1		Phase 1	cathepsin inhibitor	CTSS
LY3009120	LY3009120|LY-3009120	CNc1ncc2cc(c(C)nc2n1)-c1cc(NC(=O)NCCC(C)(C)C)c(F)cc1C	1GDT36RARO	Phase 1	RAF inhibitor	BRAF|RAF1
LY3023414	LY3023414|LY-3023414	CO[C@@H](C)Cn1c2c(cnc3ccc(cc23)-c2cncc(c2)C(C)(C)O)n(C)c1=O	C88817F47Y	Phase 2	PI3K inhibitor|mTOR inhibitor	MTOR
LY303511	LY303511	O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1		Preclinical	casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor	BRD2|BRD3|BRD4
LY310762	LY310762	CC1(C)C(=O)N(CCN2CCC(CC2)C(=O)c2ccc(F)cc2)c2ccccc12		Preclinical	serotonin receptor antagonist	HTR1D
LY320135	LY320135|LY-320135	COc1ccc(cc1)-c1oc2cc(OC)ccc2c1C(=O)c1ccc(cc1)C#N	CJY03984CT	Preclinical	cannabinoid receptor antagonist	CNR1
LY344864	LY344864	CN(C)[C@@H]1CCc2[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc3c2C1		Preclinical	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR7
LY364947	LY364947	c1[nH]nc(c1-c1ccnc2ccccc12)-c1ccccn1		Preclinical	TGF beta receptor inhibitor|p38 MAPK inhibitor	TGFBR1
LY393558	LY393558	CC(C)N1Cc2cc(ccc2N(CCN2CCC(=CC2)c2c[nH]c3cc(F)ccc23)S1(=O)=O)S(C)(=O)=O		Preclinical	serotonin receptor antagonist	HTR1B|HTR1D|HTR2A|HTR2B
LY411575	LY411575	C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O		Preclinical	gamma secretase inhibitor	
LY450108	LY450108	C[C@@H](CNS(=O)(=O)C(C)C)c1ccc(NC(=O)c2cc(F)cc(F)c2)cc1		Phase 1	glutamate receptor modulator	
LY456236	LY456236	COc1ccc(Nc2ncnc3ccc(OC)cc23)cc1		Preclinical	glutamate receptor antagonist	GRM1
lycopene	lycopene|LYCOPENE	CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(/C)CCC=C(C)C	SB0N2N0WV6	Phase 3	free radical scavenger	
lylamine	lylamine|DEHYDROABIETYLAMINE	CC(C)c1ccc2c(CC[C@H]3[C@](C)(CN)CCC[C@]23C)c1	33289O147P	Preclinical	cannabinoid receptor agonist	CNR1
lymecycline	lymecycline|LYMECYCLINE	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)C1=O	7D6EM3S13P	Launched	bacterial 50S ribosomal subunit inhibitor	
lynestrenol	lynestrenol|LYNESTRENOL	C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	N2Z8ALG4U5	Launched	progestogen hormone	
lypressin	lypressin	NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O		Launched	vasopressin receptor agonist	AVPR1A|AVPR1B|AVPR2
M-14157	M-14157	CCCCCC(O)CCCC(O)=O		Phase 2	ATP-sensitive potassium channel antagonist	KCNQ1
M-344	M-344|VORINOSTAT	CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO	58IFB293JI	Preclinical	HDAC inhibitor	
m-3M3FBS	m-3M3FBS	Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F		Preclinical		PLCB2|PLCB3|PLCD1|PLCG1|PLCG2
m-Chlorophenylbiguanide	m-Chlorophenylbiguanide|1-(3-CHLOROPHENYL)BIGUANIDE	NC(=N)NC(=N)Nc1cccc(Cl)c1	910A4X901V	Preclinical		HTR3A|HTR3B
m-THP	m-THP	Oc1cccc(c1)-c1c2ccc(n2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1[nH]2		Phase 1		
mabuprofen	mabuprofen|MABUPROFEN	CC(C)Cc1ccc(cc1)C(C)C(=O)NCCO	02B8S6J90B	Launched	cyclooxygenase inhibitor	
mabuterol	mabuterol|MABUTEROL	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(c1)C(F)(F)F	R4K19W6S7Q	Launched	adrenergic receptor agonist	ADRB2
macelignan	macelignan|MACELIGNAN	COc1cc(C[C@H](C)[C@H](C)Cc2ccc3OCOc3c2)ccc1O	8PP3614Z43	Preclinical	antioxidant|antiinflammatory agent	
macitentan	macitentan|MACITENTAN	CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1	Z9K9Y9WMVL	Launched	endothelin receptor antagonist	EDNRA|EDNRB
madrasin	madrasin	COc1ccc2c(C)nc(Nc3nc(C)c(C)c(O)n3)nc2c1		Preclinical	cell splicing inhibitor	
mafenide	mafenide|MAFENIDE	NCc1ccc(cc1)S(N)(=O)=O	58447S8P4L	Launched	carbonic anhydrase inhibitor	CA12|CA14|CA2|CA4|CA6|CA9
magnolol	magnolol|MAGNOLOL	Oc1ccc(CC=C)cc1-c1cc(CC=C)ccc1O	001E35HGVF	Preclinical	PPAR receptor agonist	GABRA1|PPARG
malathion	malathion|MALATHION	CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC	U5N7SU872W	Launched	cholinesterase inhibitor	ACHE|BCHE
malic-acid	malic-acid|MALIC ACID	OC(CC(O)=O)C(O)=O	817L1N4CKP	Launched		CS|ME2|PKD2L1
malotilate	malotilate|MALOTILATE	CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1	RV59PND975	Launched	protein synthesis stimulant	
maltobionic-acid	maltobionic-acid|MALTOBIONIC ACID	OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(O)=O	47RDD4XT2O	Launched	matrix metalloprotease inhibitor	
mandelic-acid	mandelic-acid|MANDELIC ACID	OC(C(O)=O)c1ccccc1	NH496X0UJX	Launched		
mangafodipir	mangafodipir|MANGAFODIPIR	Cc1ncc(COP(O)(O)=O)c2C[N+]34CC[N+]56CC(=O)O[Mn]35(OC(=O)C4)(Oc12)Oc1c(C)ncc(COP(O)(O)=O)c1C6	N02W67RKJS	Launched	contrast agent	
manidipine	manidipine|MANIDIPINE	COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1	6O4754US88	Launched	calcium channel blocker	CACNA1C|CACNA1D
mannitol-D	mannitol-D|MANNITOL	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	3OWL53L36A	Launched	diuretic	
maprotiline	maprotiline|MAPROTILINE	CNCCCC12CCC(c3ccccc13)c1ccccc21	2U1W68TROF	Launched	norepinephrine reputake inhibitor|tricyclic antidepressant	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A|HTR2C|HTR7|SLC6A2
maraviroc	maraviroc|MARAVIROC	CC(C)c1nnc(C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1	MD6P741W8A	Launched	CC chemokine receptor antagonist	CCR5
marbofloxacin	marbofloxacin|MARBOFLOXACIN	CN1CCN(CC1)c1c(F)cc2c3c1OCN(C)n3cc(C(O)=O)c2=O	8X09WU898T	Launched	bacterial DNA gyrase inhibitor	
maribavir	maribavir|MARIBAVIR	CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O	PTB4X93HE1	Phase 3	cytomegalovirus inhibitor|protein kinase inhibitor	PYGM
marimastat	marimastat|MARIMASTAT	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	D5EQV23TDS	Phase 3	matrix metalloprotease inhibitor	MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9
maropitant	maropitant|MAROPITANT	COc1ccc(cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1)C(C)(C)C	4XE2T9H4DH	Launched	neurokinin receptor antagonist	TACR1
masitinib	masitinib|MASITINIB	CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1	M59NC4E26P	Launched	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor	FGFR3|KIT|PDGFRA|PDGFRB
masoprocol	masoprocol|MASOPROCOL	CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1	7BO8G1BYQU	Launched	lipoxygenase inhibitor	ALOX5
matrine	matrine|MATRINE	O=C1CCC[C@@H]2[C@@H]3CCCN4CCC[C@H](CN12)[C@@H]34	N390W430AC	Phase 2	opioid receptor agonist	OPRK1
mavoglurant	mavoglurant|MAVOGLURANT	COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1	GT0I9SV4F6	Phase 2	glutamate receptor antagonist	GRM5
maxacalcitol	maxacalcitol|MAXACALCITOL	[2H]C([2H])([2H])C(O)(CCO[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C)C([2H])([2H])[2H]	N2UJM5NBF6	Launched	vitamin D receptor agonist	VDR
maytansinol-isobutyrate	maytansinol-isobutyrate|ANSAMITOMICIN P-3	CO[C@@H]1\C=C\C=C(C)\Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]2(C)O[C@H]2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2	7SUK7876BG	Preclinical		
mazindol	mazindol|MAZINDOL	OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1	C56709M5NH	Launched	dopamine reuptake inhibitor|selective serotonin reuptake inhibitor (SSRI)	SLC6A2|SLC6A3|SLC6A4
MBX-2982	MBX-2982	CCc1cnc(nc1)N1CCC(CC1)c1nc(COc2ccc(cc2)-n2cnnn2)cs1	B5TRY67L51	Phase 2	glucose dependent insulinotropic receptor agonist	GPR119
MC-1	MC-1|PYRIDOXAL PHOSPHATE ANHYDROUS	Cc1ncc(COP(O)(O)=O)c(C=O)c1O	F06SGE49M6	Phase 3		AADAT|ABAT|AGXT|AGXT2|ALAS1|AZIN2|BCAT1|BCAT2|CBS|CCBL1|CCBL2|CSAD|CTH|DDC|FTCD|GAD1|GAD2|GADL1|GCAT|GLDC|GOT1|GOT2|GPT|GPT2|HDC|IGSF10|KYNU|MOCOS|NFS1|OAT|ODC1|PDXDC1|PDXP|PHYKPL|PNPO|PROSC|PSAT1|PYGB|PYGL|PYGM|SCLY|SDS|SDSL|SEPSECS|SGPL1|SHMT1|SHMT2|SPTLC1|SPTLC2|SPTLC3|SRR|TAT|THNSL1
MC1568	MC1568	Cn1c(\C=C\C(=O)NO)ccc1\C=C\C(=O)c1cccc(F)c1		Preclinical	HDAC inhibitor	HDAC2
MCC950	MCC950	CC(C)(O)c1coc(c1)S(=O)(=O)NC(=O)Nc1c2CCCc2cc2CCCc12		Preclinical	NOD like receptor inhibitor	NLRP3
McN-5652-(+/-)	McN-5652-(+/-)|MCN-5652, (-)-	CSc1ccc(cc1)[C@H]1CN2CCC[C@H]2c2ccccc12	Y33Z4ABP6N	Preclinical	selective serotonin reuptake inhibitor (SSRI)	
mCPP	mCPP|M-CHLOROPHENYLPIPERAZINE	Clc1cccc(c1)N1CCNCC1	REY0CNO998	Phase 2	serotonin receptor agonist	HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6
MD-920	MD-920|GIBBERELLIC ACID	C[C@@]12[C@H]3[C@H](C(O)=O)[C@@]45CC(=C)[C@@](O)(C4)CC[C@H]5[C@]3(OC1=O)C=C[C@@H]2O	BU0A7MWB6L	Phase 1	NFkB pathway inhibitor	AADACL2
mdivi-1	mdivi-1	COc1cc(c(Cl)cc1Cl)-n1c(=S)[nH]c2ccccc2c1=O		Preclinical	dynamin inhibitor	DNM1
MDL-11939	MDL-11939|GLEMANSERIN	OC(C1CCN(CCc2ccccc2)CC1)c1ccccc1	X96LS7MC5Z	Phase 2	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
MDL-27531	MDL-27531	Cn1c(nnc1S(C)(=O)=O)-c1ccccc1		Preclinical	glycine receptor agonist	
MDL-29951	MDL-29951	OC(=O)CCc1c([nH]c2cc(Cl)cc(Cl)c12)C(O)=O		Preclinical	glutamate receptor antagonist	FBP1
MDL-72832	MDL-72832	O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2O1		Preclinical	serotonin receptor agonist	HTR1A
MDL-73005EF	MDL-73005EF|BINOSPIRONE	O=C1CC2(CCCC2)CC(=O)N1CCNCC1COc2ccccc2O1	T3M5D109V5	Phase 1	serotonin receptor antagonist	HTR1A
MDMS	MDMS	CS(=O)(=O)OCOS(C)(=O)=O		Phase 2	DNA inhibitor	
ME0328	ME0328	CC(NC(=O)CCc1nc(=O)c2ccccc2[nH]1)c1ccccc1		Preclinical	PARP inhibitor	PARP3
mebendazole	mebendazole|MEBENDAZOLE	COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c1ccccc1	81G6I5V05I	Launched	tubulin polymerization inhibitor	TUBA1A|TUBB|TUBB4B
mebeverine	mebeverine|MEBEVERINE	CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1	7F80CC3NNV	Launched	acetylcholine receptor antagonist	CHRM1
mebhydrolin	mebhydrolin|MEBHYDROLIN	CN1CCc2c(C1)c1ccccc1n2Cc1ccccc1	9SUK9B7XVY	Launched	antihistamine	
mebicar	mebicar|TETRAMETHYLGLYCOLURIL	CN1C2C(N(C)C1=O)N(C)C(=O)N2C	55FE6NPG89	Launched	anxiolytic	
mebrofenin	mebrofenin|MEBROFENIN	Cc1cc(C)c(NC(=O)CN(CC(O)=O)CC(O)=O)c(C)c1Br	7PV0B6ED98	Launched		
mecamylamine	mecamylamine|DEXMECAMYLAMINE|MECAMYLAMINE	CNC1(C)C2CCC(C2)C1(C)C	5Y1141YI4U|6EE945D3OK	Launched	acetylcholine receptor antagonist	CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7
mecarbinate	mecarbinate|MECARBINATE	CCOC(=O)c1c(C)n(C)c2ccc(O)cc12	Z927X3UJ2W	Preclinical		
mechlorethamine	mechlorethamine|MECHLORETHAMINE	CN(CCCl)CCCl	50D9XSG0VR	Launched	DNA inhibitor	
meclinertant	meclinertant|MECLINERTANT	COc1cccc(OC)c1-c1cc(nn1-c1ccnc2cc(Cl)ccc12)C(=O)NC1(C2CC3CC(C2)CC1C3)C(O)=O	5JBP4SI96H	Phase 2/Phase 3	neurotensin receptor antagonist	NTSR1|NTSR2
meclizine	meclizine|MECLIZINE	Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1	3L5TQ84570	Launched	constitutive androstane receptor (CAR) agonist	HRH1|NR1I3
meclocycline-sulfosalicylate	meclocycline-sulfosalicylate|MECLOCYCLINE SULFOSALICYLATE	CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)ccc(Cl)c4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	46VZA7RX2B	Launched	bacterial 50S ribosomal subunit inhibitor	
meclofenamic-acid	meclofenamic-acid|MECLOFENAMIC ACID	Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl	48I5LU4ZWD	Launched	cyclooxygenase inhibitor|prostanoid receptor antagonist	ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2
meclofenoxate	meclofenoxate|MECLOFENOXATE	CN(C)CCOC(=O)COc1ccc(Cl)cc1	C76QQ2I0RG	Launched	nootropic agent	
mecysteine	mecysteine|MECYSTEINE	COC(=O)C(N)CS	RQ6L463N3B	Launched	analgesic agent	
medetomidine	medetomidine|MEDETOMIDINE	CC(c1c[nH]cn1)c1cccc(C)c1C	MR15E85MQM	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
medica-16	medica-16	CC(C)(CCCCCCCCCCC(C)(C)CC(O)=O)CC(O)=O		Phase 2	ATP citrase lyase inhibitor	FFAR1
medorinone	medorinone|MEDORINONE	Cc1nccc2[nH]c(=O)ccc12	80X61Y4X0B	Phase 1		
medronic-acid	medronic-acid|MEDRONIC ACID	OP(O)(=O)CP(O)(O)=O	73OS0QIN3O	Launched	bone resorption inhibitor	
medroxyprogesterone	medroxyprogesterone|MEDROXYPROGESTERONE	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12	HSU1C9YRES	Launched	progesterone receptor agonist	ESR1|PGR
medroxyprogesterone-acetate	medroxyprogesterone-acetate|MEDROXYPROGESTERONE ACETATE	C[C@H]1CC2C3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CCC2[C@@]2(C)CCC(=O)C=C12	C2QI4IOI2G	Launched	progesterone receptor agonist	
medrysone	medrysone|MEDRYSONE	C[C@H]1CC2C3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CCC(=O)C=C12	D2UFC189XF	Launched	glucocorticoid receptor agonist	NR3C1
mefenamic-acid	mefenamic-acid|MEFENAMIC ACID	Cc1cccc(Nc2ccccc2C(O)=O)c1C	367589PJ2C	Launched	cyclooxygenase inhibitor	KCNQ1|PTGS1|PTGS2|TRPM3
mefexamide	mefexamide|MEFEXAMIDE	CCN(CC)CCNC(=O)COc1ccc(OC)cc1	84FP054Z2Q	Preclinical	psychoactive drug	
mefloquine	mefloquine|MEFLOQUINE	OC(C1CCCCN1)c1cc(nc2c(cccc12)C(F)(F)F)C(F)(F)F	TML814419R	Launched	adenosine receptor antagonist|hemoglobin antagonist	ADORA2A|HBA1
megestrol-acetate	megestrol-acetate|MEGESTROL ACETATE	CC(=O)O[C@@]1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O	TJ2M0FR8ES	Launched	progesterone receptor agonist	NR3C1|PGR
meglitinide	meglitinide|MEGLITINIDE	COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)C(O)=O	8V6OK1I088	Phase 2	potassium channel blocker	CCR2
meglumine	meglumine|MEGLUMINE	CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	6HG8UB2MUY	Launched	excipient	
meglutol	meglutol|MEGLUTOL	CC(O)(CC(O)=O)CC(O)=O	CLA99KCD53	Launched	HMGCR inhibitor	HMGCR
meisoindigo	meisoindigo|MEISOINDIGO	CN1C(=O)\C(c2ccccc12)=C1\C(=O)Nc2ccccc12	92UIP6405R	Phase 3	STAT inhibitor	STAT3
MEK1-2-inhibitor	MEK1-2-inhibitor	N\C(Sc1ccc(N)cc1)=C(\C#N)c1ccccc1C(F)(F)F		Preclinical	MEK inhibitor	MAP2K2
MEK162	MEK162|BINIMETINIB	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(cc12)C(=O)NOCCO	181R97MR71	Phase 3	MEK inhibitor	MAP2K1|MAP2K2
melatonin	melatonin|MELATONIN	COc1ccc2[nH]cc(CCNC(C)=O)c2c1	JL5DK93RCL	Launched	melatonin receptor agonist|nitric oxide synthase inhibitor	ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB
meldonium	meldonium|MELDONIUM	C[N+](C)(C)NCCC(O)=O	73H7UDN6EC	Launched	gamma butyrobetaine hydroxylase inhibitor	BBOX1
melengestrol-acetate	melengestrol-acetate|MELENGESTROL ACETATE	CC(=O)O[C@]1(C(C)=O)C(=C)CC2C3C=C(C)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C	4W5HDS3936	Preclinical	progesterone receptor agonist	
melevodopa	melevodopa|MELEVODOPA	COC(=O)C(N)Cc1ccc(O)c(O)c1	M30686U4X4	Launched	dopamine precursor|dopamine receptor agonist	DDC
meloxicam	meloxicam|MELOXICAM	CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O	VG2QF83CGL	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
melperone	melperone|MELPERONE	CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1	J8WA3K39B7	Launched	dopamine receptor antagonist|serotonin receptor antagonist	DRD2|HTR2A
melphalan	melphalan|MELPHALAN	N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O	Q41OR9510P	Launched	DNA alkylating agent|DNA inhibitor	
melphalan-n-oxide	melphalan-n-oxide|PX-478 FREE BASE	N[C@@H](Cc1ccc(cc1)[N+]([O-])(CCCl)CCCl)C(O)=O	55OBY93SEP	Phase 1	hypoxia inducible factor inhibitor	HIF1A
meluadrine	meluadrine|MELUADRINE	CC(C)(C)NCC(O)c1ccc(O)cc1Cl	FYC8314117	Preclinical		
memantine	memantine|MEMANTINE	CC12CC3CC(C)(C1)CC(N)(C3)C2	W8O17SJF3T	Launched	glutamate receptor antagonist	CHRFAM7A|DRD2|GRIN1|GRIN2A|GRIN2B|GRIN3A|HTR3A
menadione	menadione|MENADIONE	CC1=CC(=O)c2ccccc2C1=O	723JX6CXY5	Launched	mitochondrial DNA polymerase inhibitor|phosphatase inhibitor	AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1
menadione-bisulfite	menadione-bisulfite|MENADIONE BISULFITE	CC1(CC(=O)c2ccccc2C1=O)S(O)(=O)=O	I2BE1ZEN8I	Phase 2	vitamin K	GGCX|VKORC1|VKORC1L1
menatetrenone	menatetrenone|MENATETRENONE	CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O	27Y876D139	Launched	bone resorption inhibitor	
menbutone	menbutone|MENBUTONE	COc1ccc(C(=O)CCC(O)=O)c2ccccc12	341YM32546	Launched		
mepacrine	mepacrine|QUINACRINE	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12	H0C805XYDE	Launched	cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator	PLA2G1B|PLA2G4A|PLA2G6|PLCL1
meparfylon	meparfylon|MEPARFYNOL	CCC(C)(O)C#C	B017BC5B1N	Preclinical		
mepazine	mepazine|PECAZINE	CN1CCCC(CN2c3ccccc3Sc3ccccc23)C1	PH34873A38	Phase 2	MALT1 inhibitor (JH)	MALT1
mepenzolate	mepenzolate|MEPENZOLATE	C[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1	ONW3LB39P7	Launched	acetylcholine receptor antagonist	CHRM1|CHRM3
mephenesin	mephenesin|MEPHENESIN	Cc1ccccc1OCC(O)CO	7B8PIR2954	Launched	muscle relaxant	
mephentermine	mephentermine|MEPHENTERMINE	CNC(C)(C)Cc1ccccc1	TEZ91L71V4	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3
mephenytoin	mephenytoin|MEPHENYTOIN	CCC1(NC(=O)N(C)C1=O)c1ccccc1	R420KW629U	Launched	hydantoin antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
mepiroxol	mepiroxol|MEPIROXOL	OCc1ccc[n+]([O-])c1	BR2Z22465M	Preclinical		
mepivacaine	mepivacaine|MEPIVACAINE	CN1CCCCC1C(=O)Nc1c(C)cccc1C	B6E06QE59J	Launched	potassium channel blocker|sodium channel blocker	SCN10A
meprednisone	meprednisone|MEPREDNISONE	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO	67U96J8P35	Launched		NR3C1
meprobamate	meprobamate|MEPROBAMATE	CCCC(C)(COC(N)=O)COC(N)=O	9I7LNY769Q	Launched		GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
meprylcaine	meprylcaine|MEPRYLCAINE	CCCNC(C)(C)COC(=O)c1ccccc1	82YT7WU9PW	Preclinical	local anesthetic	
meptazinol	meptazinol|MEPTAZINOL	CCC1(CCCCN(C)C1)c1cccc(O)c1	18Y7S5JKZD	Launched	opioid receptor agonist	BCHE
mepyramine	mepyramine|PYRILAMINE	COc1ccc(cc1)CN(CCN(C)C)c1ccccn1	HPE317O9TL	Launched	histamine receptor antagonist	HRH1
mequinol	mequinol|MEQUINOL	COc1ccc(O)cc1	6HT8U7K3AM	Launched		TYR
merbarone	merbarone	O=C(Nc1ccccc1)C1C(=O)NC(=S)NC1=O		Phase 2	topoisomerase inhibitor	TOP2A
merbromin	merbromin|MERBROMIN	O[Hg]c1c(O)c(Br)cc2c(-c3ccccc3C(O)=O)c3cc(Br)c(=O)cc3oc12	M0T18YH28D	Launched	antiseptic	
mercaptopurine	mercaptopurine|MERCAPTOPURINE	S=c1[nH]cnc2nc[nH]c12	E7WED276I5	Launched	immunosuppressant|protein synthesis inhibitor|purine antagonist	HPRT1|IMPDH1|IMPDH2|PPAT
mercaptosuccinic-acid	mercaptosuccinic-acid|THIOMALIC ACID	OC(=O)CC(S)C(O)=O	94239W5L4H	Launched		
mericitabine	mericitabine|MERICITABINE	CC(C)C(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C	TA63JX8X52	Phase 2	HCV inhibitor	
merimepodib	merimepodib|MERIMEPODIB	COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1	2ZL2BA06FU	Phase 2	inosine monophosphate dehydrogenase inhibitor	IMPDH1
meropenem	meropenem|MEROPENEM	CC(O)C1C2C(C)C(SC3CNC(C3)C(=O)N(C)C)=C(N2C1=O)C(O)=O	FV9J3JU8B1	Launched	bacterial cell wall synthesis inhibitor	
mesalazine	mesalazine|MESALAMINE	Nc1ccc(O)c(c1)C(O)=O	4Q81I59GXC	Launched	cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist	ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2
mesna	mesna|MESNA	OS(=O)(=O)CCS	NR7O1405Q9	Launched	antioxidant	
mesoridazine	mesoridazine|MESORIDAZINE	CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O	5XE4NWM740	Launched	dopamine receptor antagonist	DRD2|HTR2A
mestinon	mestinon|PYRIDOSTIGMINE BROMIDE	CN(C)C(=O)Oc1ccc[n+](C)c1	KVI301NA53	Launched	cholinesterase inhibitor	ACHE|BCHE
mestranol	mestranol|MESTRANOL	COc1ccc2C3CC[C@@]4(C)C(CC[C@@]4(O)C#C)C3CCc2c1	B2V233XGE7	Launched	estrogen receptor agonist	ESR1
mesulergine	mesulergine|MESULERGINE	CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1	SML95FK06I	Phase 2	dopamine receptor agonist	HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7
meta-cresyl-acetate	meta-cresyl-acetate|M-CRESYL ACETATE	CC(=O)Oc1cccc(C)c1	73UDH1DF0R	Preclinical		
metacetamol	metacetamol|METACETAMOL	CC(=O)Nc1cccc(O)c1	V942ZCN81H	Preclinical	analgesic agent	
metacresol	metacresol|METACRESOL	Cc1cccc(O)c1	GGO4Y809LO	Launched		INS
metafolin	metafolin|LEVOMEFOLATE CALCIUM	CN1[C@@H](CNc2ccc(cc2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2nc(N)[nH]c(=O)c12	A9R10K3F2F	Launched		AMT
metamizole	metamizole|METAMIZOLE	CN(CS(O)(=O)=O)c1c(C)n(C)n(-c2ccccc2)c1=O	934T64RMNJ	Withdrawn	cyclooxygenase inhibitor|opioid receptor agonist	PTGS1
metaphit	metaphit	S=C=Nc1cccc(c1)C1(CCCCC1)N1CCCCC1		Preclinical	phencyclidine receptor acylator	
metaproterenol	metaproterenol|METAPROTERENOL	CC(C)NCC(O)c1cc(O)cc(O)c1	53QOG569E0	Launched	adrenergic receptor agonist	ADRB2
metaraminol	metaraminol|METARAMINOL	C[C@H](N)[C@H](O)c1cccc(O)c1	818U2PZ2EH	Launched	adrenergic receptor agonist	ADRA1A
metatinib	metatinib	Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl		Phase 1	Bcr-Abl kinase inhibitor	ABL1|BCR
metaxalone	metaxalone|METAXALONE	Cc1cc(C)cc(OCC2CNC(=O)O2)c1	1NMA9J598Y	Launched	muscle relaxant	
metazosin	metazosin	COC(C)C(=O)N1CCN(CC1)c1nc(N)c2cc(OC)c(OC)cc2n1		Phase 2	adrenergic receptor antagonist	ADRA1A
metenkephalin	metenkephalin|METENKEFALIN|5-MET-ENKEPHALIN, 4-D-PHE	CSCCC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)C(O)=O	9JEZ9OD3AS|VRD9K9O4B4	Phase 2	immunostimulant	OPRD1
metergoline	metergoline|METERGOLINE	CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]2C1Cc1cn(C)c3cccc2c13	1501393LY5	Launched	dopamine receptor agonist|serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
metformin	metformin|METFORMIN	CN(C)C(=N)NC(N)=N	9100L32L2N	Launched	insulin sensitizer	ACACB|PRKAB1
methacholine	methacholine|METHACHOLINE	CC(C[N+](C)(C)C)OC(C)=O	03V657ZD3V	Launched	acetylcholine receptor agonist	CHRM2|CHRM3|CHRM4
methacycline	methacycline|METHACYCLINE	CN(C)[C@@H]1[C@@H]2[C@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	IR235I7C5P	Launched	protein synthesis inhibitor	
methanesulfonyl-fluoride	methanesulfonyl-fluoride|METHANESULFONYL FLUORIDE	CS(F)(=O)=O	9H250YYY0R	Phase 2	acetylcholinesterase inhibitor	ACHE
methantheline	methantheline|METHANTHELINE	CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc12	36EI79TX7I	Launched	acetylcholine receptor antagonist	CHRM1|HRH2
methapyrilene	methapyrilene|METHAPYRILENE	CN(C)CCN(Cc1cccs1)c1ccccn1	A01LX40298	Withdrawn	histamine receptor antagonist	HRH1
metharbital	metharbital|METHARBITAL	CCC1(CC)C(=O)NC(=O)N(C)C1=O	02OS7K758T	Launched	GABA receptor modulator	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2
methazolamide	methazolamide|METHAZOLAMIDE, (Z)-	CC(=O)N=c1sc(nn1C)S(N)(=O)=O	DA43GW06P1	Launched	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA2|CA4|CA7
methenamine	methenamine|METHENAMINE	C1N2CN3CN1CN(C2)C3	J50OIX95QV	Launched	bacterial DNA inhibitor	
methiazole	methiazole	COC(=O)Nc1nc2cc(SC(C)C)ccc2[nH]1		Preclinical	anthelmintic agent	
methicillin	methicillin|METHICILLIN	COc1cccc(OC)c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O	Q91FH1328A	Launched	bacterial cell wall synthesis inhibitor	
methimazole	methimazole|METHIMAZOLE	Cn1cc[nH]c1=S	554Z48XN5E	Launched	antithyroid agent	TPO
methionine	methionine|METHIONINE	CSCCC(N)C(O)=O	AE28F7PNPL	Launched		BHMT|BHMT2|METAP2|MTR|MTRR
methiopril	methiopril	CC1CCCC(N1C(=O)CCSC(C)=O)C(O)=O		Phase 2	angiotensin converting enzyme inhibitor	ACE
methocarbamol	methocarbamol|METHOCARBAMOL	COc1ccccc1OCC(O)COC(N)=O	125OD7737X	Launched	muscle relaxant	CA1
methoprene-(s)	methoprene-(s)|METHOPRENE, (S)-	COC(C)(C)CCC[C@H](C)C\C=C\C(C)=C\C(=O)OC(C)C	4YIQ0A94UR	Preclinical		
methotrexate	methotrexate|METHOTREXATE	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)NC(CCC(O)=O)C(O)=O	YL5FZ2Y5U1	Launched	dihydrofolate reductase inhibitor	DHFR
methoxamine	methoxamine|METHOXAMINE	COc1ccc(OC)c(c1)C(O)C(C)N	HUQ1KC1YLI	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D
methoxsalen	methoxsalen|METHOXSALEN	COc1c2occc2cc2ccc(=O)oc12	U4VJ29L7BQ	Launched	DNA synthesis inhibitor	CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4
methoxyamine	methoxyamine|METHOXYAMINE	CON	9TZH4WY30J	Phase 2	DNA repair enzyme inhibitor	APEX1
methoxyflurane	methoxyflurane|METHOXYFLURANE	COC(F)(F)C(Cl)Cl	30905R8O7B	Launched	membrane permeability inhibitor	ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|MT-ND1
methoxyphenamine	methoxyphenamine|METHOXYPHENAMINE	CNC(C)Cc1ccccc1OC	J3Z5SRI26Z	Launched	adrenergic receptor agonist	
methscopolamine	methscopolamine|METHSCOPOLAMINE	C[N+]1(C)C2CC(CC1C1OC21)OC(=O)[C@@H](CO)c1ccccc1	VDR09VTQ8U	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
methsuximide	methsuximide|METHSUXIMIDE	CN1C(=O)CC(C)(C1=O)c1ccccc1	0G76K8X6C0	Launched	T-type calcium channel binder	CACNA1G|CACNA1H|CACNA1I
methyclothiazide	methyclothiazide|METHYCLOTHIAZIDE	CN1C(CCl)Nc2cc(Cl)c(cc2S1(=O)=O)S(N)(=O)=O	L3H46UAC61	Launched	chloride reabsorption inhibitor	CA1|CA2|CA4|SLC12A1|SLC12A3
methyl-aminolevulinate	methyl-aminolevulinate|METHYL AMINOLEVULINATE	COC(=O)CCC(=O)CN	585NM85KYM	Launched	oxidizing agent	FCGR1A|FECH
methyl-nicotinate	methyl-nicotinate|METHYL NICOTINATE	COC(=O)c1cccnc1	7B1AVU9DJN	Phase 2		
methyl-salicylate	methyl-salicylate|METHYL SALICYLATE	COC(=O)c1ccccc1O	LAV5U5022Y	Launched		
methylatropine-nitrate	methylatropine-nitrate|METHYLATROPINE NITRATE	C[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)c1ccccc1	Q48D9J47K2	Preclinical	acetylcholine receptor antagonist	CHRM1
methylbenzethonium-chloride	methylbenzethonium-chloride|BENZYLDIMETHYL(2-(2-((4-(1,1,3,3-TETRAMETHYLBUTYL)-O-TOLYL)OXY)ETHOXY)ETHYL)AMMONIUM	Cc1cc(ccc1OCCOCC[N+](C)(C)Cc1ccccc1)C(C)(C)CC(C)(C)C	NJX1653L36	Preclinical	other antibiotic	
methyldopa	methyldopa|METHYLDOPA	C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O	56LH93261Y	Launched	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C|DDC
methyldopate	methyldopate|METHYLDOPATE	CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1	2579Z4P04J	Launched		
methylene-blue	methylene-blue|METHYLENE BLUE	CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C	T42P99266K	Launched	guanylyl cyclase inhibitor|nitric oxide production inhibitor	ACHE
methylergometrine	methylergometrine|METHYLERGONOVINE	CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34	W53L6FE61V	Launched	dopamine receptor antagonist|serotonin receptor antagonist	DRD1|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C
methyllycaconitine	methyllycaconitine	CCN1C[C@]2(COC(=O)c3ccccc3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@](O)([C@@H](OC)C23)[C@H]14		Preclinical	acetylcholine receptor antagonist	CHRNA7
methylnaltrexone	methylnaltrexone|METHYLNALTREXONE|METHYLNALTREXONE, (17S)-	C[N@@+]1(CC2CC2)CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@]3(O)CCC4=O)ccc5O	0RK7M7IABE|72Q1QQ555V	Launched	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
methylparaben	methylparaben|METHYLPARABEN	COC(=O)c1ccc(O)cc1	A2I8C7HI9T	Launched	other antifungal	
methylphenidate	methylphenidate|METHYLPHENIDATE	COC(=O)C(C1CCCCN1)c1ccccc1	207ZZ9QZ49	Launched	dopamine-norepinephrine reuptake inhibitor	SLC6A2|SLC6A3|SLC6A4
methylprednisolone	methylprednisolone|METHYLPREDNISOLONE	C[C@H]1CC2C3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)C2[C@@]2(C)C=CC(=O)C=C12	X4W7ZR7023	Launched	glucocorticoid receptor agonist	NR3C1
methylprednisolone-aceponate	methylprednisolone-aceponate|METHYLPREDNISOLONE ACEPONATE	CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	ET54W9J4U2	Launched	anti-inflammatory agent|glucocorticoid receptor agonist	NR3C1
methylprednisolone-sodium-succinate	methylprednisolone-sodium-succinate|METHYLPREDNISOLONE HEMISUCCINATE	C[C@H]1CC2C3CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]3(C)C[C@H](O)C2[C@@]2(C)C=CC(=O)C=C12	5GMR90S4KN	Launched	glucocorticoid receptor agonist	
methylthiouracil	methylthiouracil|METHYLTHIOURACIL	Cc1cc(=O)[nH]c(=S)[nH]1	QW24888U5F	Launched		
methysergide	methysergide|METHYSERGIDE	CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34	XZA9HY6Z98	Launched	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
meticrane	meticrane|METICRANE	Cc1cc2CCCS(=O)(=O)c2cc1S(N)(=O)=O	I7EKN1924Q	Launched	diuretic	
metipranolol	metipranolol|METIPRANOLOL	CC(C)NCC(O)COc1cc(C)c(OC(C)=O)c(C)c1C	X39AL81KEB	Withdrawn	adrenergic receptor antagonist	ADRB1|ADRB2
metirosine	metirosine|METIROSINE	C[C@](N)(Cc1ccc(O)cc1)C(O)=O	DOQ0J0TPF7	Launched	tyrosine hydroxylase inhibitor	TH
metitepine	metitepine|METITEPINE	CSc1ccc2Sc3ccccc3CC(N3CCN(C)CC3)c2c1	55D94103HL	Preclinical	anti-HCVE2	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
metixene	metixene|METHIXENE	CN1CCCC(CC2c3ccccc3Sc3ccccc23)C1	32VY6L26ZW	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
metoclopramide	metoclopramide|METOCLOPRAMIDE	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC	L4YEB44I46	Launched	dopamine receptor antagonist|serotonin receptor antagonist	CHRM1|DRD2|HTR3A|HTR3B|HTR4
metocurine	metocurine|METOCURINE	COc1ccc2C[C@@H]3c4c(CC[N+]3(C)C)cc(OC)c(OC)c4Oc3ccc(C[C@H]4c5cc(Oc1c2)c(OC)cc5CC[N+]4(C)C)cc3	V0M92G2U26	Launched	acetylcholine receptor antagonist	CHRM2|CHRNA2
metolazone	metolazone|METOLAZONE, (+)-|METOLAZONE, (-)-|METOLAZONE	CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(N)(=O)=O	NM7V2Y3G0U|NN9U607695|TZ7V40X7VX	Launched	carbonic anhydrase inhibitor	SLC12A3
metoprolol	metoprolol|METOPROLOL	COCCc1ccc(OCC(O)CNC(C)C)cc1	GEB06NHM23	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
metoxibutropate	metoxibutropate|METOXIBUTROPATE	COc1ccccc1OC(=O)C(C)c1ccc(CC(C)C)cc1	0N623MNK8Z	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
metrifonate	metrifonate|METRIFONATE	COP(=O)(OC)C(O)C(Cl)(Cl)Cl	DBF2DG4G2K	Phase 3	acetylcholinesterase inhibitor	ACHE
metrizamide	metrizamide|METRIZAMIDE	CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c1I	RHH3W8F1CO	Launched	radiopaque medium	
metrizoic-acid	metrizoic-acid|METRIZOIC ACID	CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I	CM1N99QR1M	Launched	radiopaque medium	
metronidazole	metronidazole|METRONIDAZOLE	Cc1ncc(n1CCO)[N+]([O-])=O	140QMO216E	Launched	DNA inhibitor	CYP2C9|CYP3A4
metyrapone	metyrapone|METYRAPONE	CC(C)(C(=O)c1cccnc1)c1cccnc1	ZS9KD92H6V	Launched	cytochrome P450 inhibitor	CYP11B1
mevastatin	mevastatin|MEVASTATIN	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)C(CCC3C[C@@H](O)CC(=O)O3)[C@@H]12	1UQM1K0W9X	Preclinical	HMGCR inhibitor	HMGCR
mexeneone	mexeneone|MEXENONE	COc1ccc(C(=O)c2ccc(C)cc2)c(O)c1	ET1UGF4A0B	Preclinical		
mexiletine	mexiletine|MEXILETINE	CC(N)COc1c(C)cccc1C	1U511HHV4Z	Launched	sodium channel blocker	AHR|SCN4A|SCN5A
mezlocillin	mezlocillin|MEZLOCILLIN	CC1(C)S[C@H]2[C@@H](NC(=O)[C@@H](NC(=O)N3CCN(C3=O)S(C)(=O)=O)c3ccccc3)C(=O)N2[C@@H]1C(O)=O	OH2O403D1G	Launched	bacterial cell wall synthesis inhibitor	
MF-101	MF-101|LIQUIRITIGENIN	Oc1ccc(cc1)[C@@H]1CC(=O)c2ccc(O)cc2O1	T194LKP9W6	Phase 3	estrogen receptor agonist	CYP19A1|XDH
MG-132	MG-132	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	RF1P63GW3K	Preclinical	proteasome inhibitor	PSMB1
MG-624	MG-624|STILONIUM	CC[N+](CC)(CC)CCOc1ccc(\C=C\c2ccccc2)cc1	4L5V8Z34JM	Preclinical	acetylcholine receptor antagonist	CHRNA7
MGCD-265	MGCD-265|N-(3-FLUORO-4-(2-(1-METHYL-1H-IMIDAZOL-4-YL)THIENO(3,2-B)PYRIDIN-7-YLOXY)PHENYLCARBAMOTHIOYL)-2-PHENYLACETAMIDE	Cn1cnc(c1)-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1	93M6577H9D	Preclinical	VEGFR inhibitor	AXL|MET
mianserin	mianserin|MIANSERIN	CN1CCN2C(C1)c1ccccc1Cc1ccccc21	250PJI13LM	Launched	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4
mibampator	mibampator|MIBAMPATOR	CC(C)S(=O)(=O)NC[C@H](C)c1ccc(cc1)-c1ccc(CCNS(C)(=O)=O)cc1	A9V5BW73UU	Phase 2	glutamate receptor modulator	GRIA1
mibefradil	mibefradil|MIBEFRADIL	COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C	27B90X776A	Withdrawn	T-type calcium channel blocker	ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4
micafungin	micafungin|MICAFUNGIN	CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)NC1C[C@@H](O)[C@@H](O)NC(=O)C2[C@@H](O)[C@@H](C)CN2C(=O)C(NC(=O)C(NC(=O)C2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O	R10H71BSWG	Launched	fungal 1,3-beta-D-glucan synthase inhibitor	
miconazole	miconazole|MICONAZOLE	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1	7NNO0D7S5M	Launched	bacterial cell wall synthesis inhibitor	KCNH2|KCNH6|KCNH7|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|NOS2|NOS3|TRPM2|TRPV5
micronomicin	micronomicin|MICRONOMICIN	CNC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1	S9AZ0R40QV	Launched	protein synthesis inhibitor	
midafotel	midafotel|MIDAFOTEL	OC(=O)[C@H]1CN(C\C=C\P(O)(O)=O)CCN1	7LYU6ZF84G	Phase 3	glutamate receptor antagonist	GRIN2A|GRIN2B|GRIN2C|GRIN2D
midecamycin	midecamycin|MIDECAMYCIN	CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C	N34Z0Y5UH7	Launched	protein synthesis inhibitor	
midodrine	midodrine|MIDODRINE	COc1ccc(OC)c(c1)C(O)CNC(=O)CN	6YE7PBM15H	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D
midostaurin	midostaurin|MIDOSTAURIN	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1	ID912S5VON	Phase 3	FLT3 inhibitor|KIT inhibitor|PKC inhibitor	FLT3|PRKCG
mifepristone	mifepristone|MIFEPRISTONE	CC#C[C@]1(O)CCC2C3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C	320T6RNW1F	Launched	glucocorticoid receptor antagonist|progesterone receptor antagonist	AR|NR1I2|NR3C1|PGR
mifobate	mifobate|MIFOBATE	COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC	ZKA4OVV12E	Phase 2	PPAR receptor antagonist	PPARG
miglitol	miglitol|MIGLITOL	OCCN1C[C@@H](O)[C@@H](O)C(O)C1CO	0V5436JAQW	Launched	glucosidase inhibitor	GAA|GANAB|GANC|MGAM
miglustat	miglustat|MIGLUSTAT	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	ADN3S497AZ	Launched	Glycosyl transferase inhibitor	UGCG
milacemide	milacemide|MILACEMIDE	CCCCCNCC(N)=O	0HXT24RECU	Phase 3	monoamine oxidase inhibitor	MAOB
milnacipran	milnacipran|DEXTROMILNACIPRAN|MILNACIPRAN	CCN(CC)C(=O)C1(CC1CN)c1ccccc1	ES1O38J3C4|G56VK1HF36	Launched	serotoninnorepinephrine reuptake inhibitor (SNRI)	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A4
milrinone	milrinone|MILRINONE	Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N	JU9YAX04C7	Launched	phosphodiesterase inhibitor	PDE2A|PDE3A|PDE3B|PDE5A
miltefosine	miltefosine|MILTEFOSINE	CCCCCCCCCCCCCCCCOP(O)(=O)OCC[N+](C)(C)C	53EY29W7EC	Launched	membrane integrity inhibitor	PLA2G1B
mimosine	mimosine|MIMOSINE	N[C@@H](Cn1ccc(=O)c(O)c1)C(O)=O	Z46B1LUI5N	Preclinical	DNA replication inhibitor	CCL2|SHMT1|SHMT2|TYR
minaprine	minaprine|MINAPRINE	Cc1cc(nnc1NCCN1CCOCC1)-c1ccccc1	00U7GX0NLM	Withdrawn	serotonin reuptake inhibitor	ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4
minerval	minerval	CCCCCCCC\C=C/CCCCCCC(O)C(O)=O		Phase 1/Phase 2	FAAH inhibitor	
minocycline	minocycline|MINOCYCLINE	CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C	FYY3R43WGO	Launched	bacterial 30S ribosomal subunit inhibitor	ALOX5|CASP1|CASP3|CYCS|IL1B|MMP9|VEGFA
minodronic-acid	minodronic-acid|MINODRONIC ACID	OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O	40SGR63TGL	Launched	bone resorption inhibitor	FDPS|GGPS1
minoxidil	minoxidil|MINOXIDIL	Nc1cc(nc(N)[n+]1[O-])N1CCCCC1	5965120SH1	Launched	KATP activator|Kir6 channel (KATP) activator|vasodilator	ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1
miocamycin	miocamycin|MIDECAMYCIN ACETATE	CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(C)=O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](OC(C)=O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C	3T48CPS7U2	Launched	other antibiotic	
MIRA-1	MIRA-1	CCC(=O)OCN1C(=O)C=CC1=O		Preclinical	apoptosis stimulant	
mirabegron	mirabegron|MIRABEGRON	Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1	MVR3JL3B2V	Launched	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3
miriplatin	miriplatin|MIRIPLATIN	[Pt++].NC1CCCCC1N.CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O	780F0P8N4I	Launched	DNA synthesis inhibitor	
mirodenafil	mirodenafil|MIRODENAFIL	CCCOc1ccc(cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1)S(=O)(=O)N1CCN(CCO)CC1	504G362H0H	Launched	phosphodiesterase inhibitor	PDE5A
mirtazapine	mirtazapine|MIRTAZAPINE	CN1CCN2C(C1)c1ccccc1Cc1cccnc21	A051Q2099Q	Launched	adrenergic receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD5|HRH1|HRH3|HTR2A|HTR2B|HTR2C|HTR3A|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4
misonidazole	misonidazole|MISONIDAZOLE	COCC(O)Cn1ccnc1[N+]([O-])=O	8FE7LTN8XE	Phase 3		
misoprostol	misoprostol|MISOPROSTOL	CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC	0E43V0BB57	Launched	prostanoid receptor agonist	PTGER2|PTGER3|PTGER4|PTGIR
mitiglinide	mitiglinide|MITIGLINIDE	OC(=O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1	D86I0XLB13	Launched	insulin secretagogue	ABCC8|KCNJ10|PPARG
mitoflaxone	mitoflaxone|MITOFLAXONE	OC(=O)Cc1cccc2c1oc(cc2=O)-c1ccccc1	X230G6E63B	Phase 2	antitumor agent	VWF
mitomycin-c	mitomycin-c|MITOMYCIN	CO[C@@]12[C@@H]3NC3CN1C1=C([C@@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O	50SG953SK6	Launched	DNA alkylating agent|DNA synthesis inhibitor	
mitotane	mitotane|MITOTANE	ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl	78E4J5IB5J	Launched	antineoplastic agent	CYP11A1|CYP11B1|ESR1|FDX1
mitoxantrone	mitoxantrone|MITOXANTRONE	OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12	BZ114NVM5P	Launched	topoisomerase inhibitor	TOP2A
mivacurium	mivacurium|MIVACURIUM	COc1cc2CC[N+](C)(CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]3(C)CCc4cc(OC)c(OC)cc4[C@H]3Cc3cc(OC)c(OC)c(OC)c3)[C@H](Cc3cc(OC)c(OC)c(OC)c3)c2cc1OC	77D66S9Q93	Launched	acetylcholine receptor antagonist	BCHE|CHRM2|CHRM3|CHRNA2
mivobulin	mivobulin|MIVOBULIN	CCOC(=O)Nc1cc2NC(C)=C(Nc2c(N)n1)c1ccccc1	96U5LG549X	Preclinical	microtubule inhibitor	
mizolastine	mizolastine|MIZOLASTINE	CN(C1CCN(CC1)c1nc2ccccc2n1Cc1ccc(F)cc1)c1nccc(=O)[nH]1	244O1F90NA	Launched	histamine receptor antagonist	HRH1
mizoribine	mizoribine|MIZORIBINE	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c1O	4JR41A10VP	Launched	immunosuppressant|inosine monophosphate dehydrogenase inhibitor	IMPDH1
MK-0354	MK-0354	C1Cc2[nH]nc(-c3nnn[nH]3)c2C1	4U62D8JYIQ	Phase 2	niacin receptor agonist	HCAR2|HCAR3
MK-0752	MK-0752	OC(=O)CC[C@H]1CC[C@@](CC1)(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1	9JD9B4S53T	Phase 1/Phase 2	gamma secretase inhibitor	
MK-0773	MK-0773	CN1[C@@H]2CC[C@H]3[C@@H]4CC[C@H](C(=O)NCc5nc6cccnc6[nH]5)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C(F)C1=O	5730VNW22X	Phase 2	androgen receptor modulator	AR
MK-0812	MK-0812	CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCc2ncc(cc2C1)C(F)(F)F	P3LKY4ZL5O	Phase 2	CC chemokine receptor antagonist	CCR2
MK-0893	MK-0893	COc1ccc2cc(ccc2c1)-c1cc(nn1[C@@H](C)c1ccc(cc1)C(=O)NCCC(O)=O)-c1cc(Cl)cc(Cl)c1	CCP2U6LWTP	Phase 2	glucagon receptor antagonist	GCGR
MK-1775	MK-1775	CN1CCN(CC1)c1ccc(Nc2ncc3c(n2)n(-c2cccc(n2)C(C)(C)O)n(CC=C)c3=O)cc1	K2T6HJX3I3	Phase 2	WEE1 kinase inhibitor	WEE1
MK-2048	MK-2048	CCN1C[C@H](C)n2c(c(O)c3c2c(nn(Cc2ccc(F)c(Cl)c2)c3=O)C(=O)NC)C1=O	LJ8U884TM5	Preclinical	HIV integrase inhibitor	
MK-2206	MK-2206	NC1(CCC1)c1ccc(cc1)-c1nc2ccn3c(n[nH]c3=O)c2cc1-c1ccccc1	4HA45S22ZZ	Phase 2	AKT inhibitor	AKT1|AKT2|AKT3
MK-2295	MK-2295|NGD-8243	FC(F)(F)c1ccc(Nc2ncnc3cc(ccc23)-c2ncccc2C(F)(F)F)cc1	K3S4K8ACHE	Phase 2	TRPV antagonist	TRPV1
MK-2461	MK-2461	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1	4200RD53XF	Phase 1/Phase 2	FGFR inhibitor|VEGFR inhibitor	FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB
MK-2894	MK-2894	Cc1sc(C)c(C(=O)NC2(CC2)c2ccc(cc2)C(O)=O)c1Cc1ccc(cc1)C(F)(F)F		Preclinical	prostaglandin inhibitor	PTGER4
MK-3207	MK-3207	Fc1cc(F)cc(c1)[C@@H]1CNC2(CCCC2)C(=O)N1CC(=O)Nc1ccc2C[C@]3(Cc2c1)C(=O)Nc1ncccc31	5C44M1QYCC	Phase 2	calcitonin antagonist	CALCA
MK-3697	MK-3697	COc1ccc(CNC(=O)c2cc(ncc2-c2nccs2)-c2cncc(C)c2)nc1OC		Phase 2	orexin receptor antagonist	HCRTR2
MK-5046	MK-5046	O[C@@](Cc1nc(CC2(CC2)C(F)(F)F)c[nH]1)(c1ccc(cc1)-n1cccn1)C(F)(F)F		Preclinical	bombesin receptor agonist	BRS3|GRPR|NMBR
MK-5108	MK-5108	OC(=O)[C@@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](CC1)Oc1cccc(Cl)c1F	H8J407531S	Phase 1	Aurora kinase inhibitor	AURKA|AURKB|AURKC
MK-571	MK-571	CN(C)C(=O)CCSC(SCCC(O)=O)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1	76LB1G2X6V	Phase 2	leukotriene receptor antagonist	ABCC2|CYSLTR1
MK-6096	MK-6096|FILOREXANT	C[C@@H]1CC[C@@H](COc2ccc(F)cn2)CN1C(=O)c1cc(C)ccc1-c1ncccn1	E6BTT8VA5Z	Phase 2	orexin receptor antagonist	HCRTR1|HCRTR2
MK-8033	MK-8033	Cn1cc(cn1)-c1cnc2ccc3ccc(CS(=O)(=O)NCc4ccccn4)cc3c(=O)c2c1	350H6PBQ5Q	Phase 1	c-Met inhibitor	MET
MK-8245	MK-8245	OC(=O)Cn1nnc(n1)-c1cc(no1)N1CCC(CC1)Oc1cc(F)ccc1Br	537E7QE8LX	Phase 2	stearoyl-CoA desaturase inhibitor	SCD
MK-8745	MK-8745	Fc1c(Cl)cccc1C(=O)N1CCN(Cc2cccc(Nc3nccs3)n2)CC1		Preclinical	Aurora kinase inhibitor	AURKA
MK2-IN-1	MK2-IN-1	Clc1ccc(cc1)-c1ccc(o1)C(=O)N(Cc1ccccn1)c1ccc(cc1)N1CCNCC1		Preclinical	MAP kinase inhibitor	MAPKAPK2
MKT-077	MKT-077	CCn1\c(=C/c2cccc[n+]2CC)s\c(=C2\Sc3ccccc3N2C)c1=O		Phase 1	HSP inhibitor	
ML-323	ML-323	CC(C)c1ccccc1-c1ncc(C)c(NCc2ccc(cc2)-n2ccnn2)n1		Preclinical	ubiquitin specific protease inhibitor	USP1
ML-9	ML-9	Clc1cccc2c(cccc12)S(=O)(=O)N1CCCNCC1	BZ2L6JK93I	Preclinical	myosin light chain kinase inhibitor	TRPC6
ML130	ML130	Cc1ccc(cc1)S(=O)(=O)n1c(N)nc2ccccc12		Preclinical	NOD1 inhibitor	
ML133	ML133	COc1ccc(CNCc2cccc3ccccc23)cc1		Preclinical	potassium channel blocker	
ML161	ML161	CCCC(=O)Nc1cccc(NC(=O)c2ccccc2Br)c1		Preclinical	protease-activated receptor inhibitor	
ML167	ML167	Cc1ccc(CNc2ncnc3ccc(cc23)-c2ccc(CO)o2)o1		Preclinical	CLK inhibitor|DYRK inhibitor	CLK4|DYRK1B
ML204	ML204	Cc1cc(nc2ccccc12)N1CCCCC1		Preclinical	transient receptor potential channel antagonist	TRPC4|TRPC5
ML314	ML314	COc1ccccc1N1CCN(CC1)c1nc(nc2cc(OC)c(OC)cc12)C1CC1		Preclinical	neurotensin agonist	NTSR1
ML324	ML324	CN(C)CCCNC(=O)c1ccc(cc1)-c1cc(O)c2ncccc2c1		Preclinical	histone lysine demethylase inhibitor	KDM4A
ML347	ML347	COc1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12		Preclinical	ALK tyrosine kinase receptor inhibitor	ACVR1|ACVRL1|BMPR1A
MLN-8054	MLN-8054|MLN8054	OC(=O)c1ccc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2F)cc1	BX854EHD63	Phase 1	Aurora kinase inhibitor	AURKA
MLN0128	MLN0128|SAPANISERTIB	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc12	JGH0DF1U03	Phase 2	mTOR inhibitor	MTOR|PIK3CA|PIK3CD|PIK3CG
MLN1117	MLN1117	Nc1nc2cc(ccc2o1)-c1ccc2ncc(C(=O)N3CCOCC3)n2c1		Phase 1/Phase 2	PI3K inhibitor	PIK3CA
MLN2480	MLN2480|BIIB-024	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(s1)C(=O)Nc1cc(c(Cl)cn1)C(F)(F)F	ZN90E4027M	Phase 1	RAF inhibitor	
MLN9708	MLN9708|MLN-9708	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(O)=O)(CC(O)=O)O1	E8R04MBQ04	Phase 3	proteasome inhibitor	
MM-102	MM-102	CCC(CC)(NC(=O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NC1(CCCC1)C(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1		Preclinical	WDR5/MLL interaction inhibitor	
MM77	MM77	COc1ccccc1N1CCN(CCCCN2C(=O)CCC2=O)CC1		Preclinical	serotonin receptor antagonist	HTR1A
MMPX	MMPX	COCc1nc2n(CC(C)C)c(=O)n(C)c(=O)c2[nH]1		Preclinical	phosphodiesterase inhibitor	
MN-64	MN-64	CC(C)c1ccc(cc1)-c1cc(=O)c2ccccc2o1		Preclinical	tankyrase inhibitor	TNKS
MNITMT	MNITMT	Cn1cnnc1Sc1c(ncn1C)[N+]([O-])=O		Preclinical	lymphocyte inhibitor	
mocetinostat	mocetinostat|MOCETINOSTAT	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(n2)-c2cccnc2)cc1	A6GWB8T96J	Phase 2	HDAC inhibitor	HDAC1|HDAC11|HDAC2|HDAC3
moclobemide	moclobemide|MOCLOBEMIDE	Clc1ccc(cc1)C(=O)NCCN1CCOCC1	PJ0Y7AZB63	Launched	monoamine oxidase inhibitor	MAOA|MAOB
modafinil	modafinil|MODAFINIL	NC(=O)CS(=O)C(c1ccccc1)c1ccccc1	R3UK8X3U3D	Launched	adrenergic receptor agonist	ADRA1B|SLC6A3
modaline	modaline|MODALINE	Cc1nccnc1N1CCCCC1	0M6T2W2993	Preclinical		
moexipril	moexipril|MOEXIPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(O)=O	WT87C52TJZ	Launched	angiotensin converting enzyme inhibitor	ACE|ACE2
mofegiline	mofegiline|MOFEGILINE	NC\C(CCc1ccc(F)cc1)=C\F	1FMJ6D8Y1B	Phase 1	monoamine oxidase inhibitor	MAOA|MAOB
mofezolac	mofezolac|MOFEZOLAC	COc1ccc(cc1)-c1noc(CC(O)=O)c1-c1ccc(OC)cc1	RVJ0BV3H3Y	Launched	cyclooxygenase inhibitor	PTGS1
moguisteine	moguisteine|MOGUISTEINE	CCOC(=O)CC(=O)N1CCSC1COc1ccccc1OC	6Y556547YY	Phase 2	ATP-sensitive potassium channel inhibitor	
molidustat	molidustat|MOLIDUSTAT	O=c1c(c[nH]n1-c1cc(ncn1)N1CCOCC1)-n1ccnn1	9JH486CZ13	Phase 2	hypoxia inducible factor inhibitor	EGLN2
molindone	molindone|MOLINDONE	CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12	RT3Y3QMF8N	Launched	dopamine receptor antagonist	CHRM1|DRD2|HRH1|HTR1A|HTR2A
molsidomine	molsidomine|MOLSIDOMINE	CCOC(=O)Nc1c[n+](no1)N1CCOCC1	D46583G77X	Launched	guanylate cyclase stimulant	GUCY1A3
mometasone	mometasone|MOMETASONE	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl	8HR4QJ6DW8	Launched	glucocorticoid receptor agonist	NR3C1
mometasone-furoate	mometasone-furoate|MOMETASONE FUROATE	C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl	04201GDN4R	Launched	glucocorticoid receptor agonist	NR3C1
monastrol	monastrol|MONASTROL	CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(O)c1	6BSM97YZ8G	Preclinical	kinesin inhibitor	KIF11
monensin	monensin|MONENSIN	CC[C@]1(CC[C@@H](O1)[C@]1(C)CCC2(C[C@H](O)[C@@H](C)[C@H](O2)[C@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)C1O[C@H](C[C@@H]1C)C1O[C@@](O)(CO)[C@H](C)C[C@@H]1C	906O0YJ6ZP	Launched	bacterial permeability inducer	
monobenzone	monobenzone|MONOBENZONE	Oc1ccc(OCc2ccccc2)cc1	9L2KA76MG5	Launched	melanin inhibitor	TYR
monoctanoin	monoctanoin|GLYCERYL 1-CAPRYLATE	CCCCCCCC(=O)OCC(O)CO	MCF579Z59B	Launched		
monosodium-alpha-luminol	monosodium-alpha-luminol|LUMINOL	Nc1cccc2c1c(=O)[nH][nH]c2=O	5EXP385Q4F	Launched		
monostearin	monostearin|GLYCERYL 1-STEARATE	CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO	258491E1RZ	Preclinical		
montelukast	montelukast|MONTELUKAST	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(O)=O)CC1)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1	MHM278SD3E	Launched	leukotriene receptor antagonist	ALOX5|CYSLTR1
moprolol	moprolol|MOPROLOL	COc1ccccc1OCC(O)CNC(C)C	A94HCH4225	Launched	adrenergic receptor antagonist	
moracizine	moracizine|MORICIZINE	CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN3CCOCC3)c2c1	2GT1D0TMX1	Launched	sodium channel blocker	SCN5A
morantel	morantel|MORANTEL	CN1CCCN=C1\C=C\c1sccc1C	7NJ031HAX5	Launched	acetylcholine receptor agonist	
morin	morin|MORIN	Oc1ccc(c(O)c1)-c1oc2cc(O)cc(O)c2c(=O)c1O	8NFQ3F76WR	Preclinical	cytochrome P450 inhibitor	ADORA2A|ESR2|FASN|MCL1|SLC22A12
morinidazole	morinidazole	Cc1ncc(n1CC(O)CN1CCOCC1)[N+]([O-])=O		Launched	other antibiotic	CYP51A1
morniflumate	morniflumate|MORNIFLUMATE	FC(F)(F)c1cccc(Nc2ncccc2C(=O)OCCN2CCOCC2)c1	R133MWH7X1	Launched	anti-inflammatory agent	
moroxydine	moroxydine|MOROXYDINE	NC(=N)NC(=N)N1CCOCC1	O611591WAH	Launched	antiviral	
mosapride	mosapride|MOSAPRIDE	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1	I8MFJ1C0BY	Launched	serotonin receptor agonist	HTR4
motesanib	motesanib|MOTESANIB	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12	U1JK633AYI	Phase 3	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	FLT1|FLT4|KDR|KIT
motolimod	motolimod|MOTOLIMOD	CCCN(CCC)C(=O)C1=Cc2ccc(cc2N=C(N)C1)-c1ccc(cc1)C(=O)N1CCCC1	WP6PY72ZH3	Phase 1/Phase 2	toll-like receptor agonist	TLR8
moxalactam	moxalactam|LATAMOXEF	CO[C@]1(NC(=O)C(C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O	VUF6C936Z3	Launched	bacterial cell wall synthesis inhibitor	
moxaverine	moxaverine|MOXAVERINE	CCc1cc2cc(OC)c(OC)cc2c(Cc2ccccc2)n1	P3P08Y1XJ4	Launched	phosphodiesterase inhibitor	
moxidectin	moxidectin|MOXIDECTIN	CO\N=C1\C[C@]2(C[C@@H]3C[C@@H](C\C=C(C)\C[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@@H]([C@H]1C)C(\C)=C\C(C)C	NGU5H31YO9	Launched	chloride channel antagonist	
moxifloxacin	moxifloxacin|MOXIFLOXACIN	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1	U188XYD42P	Launched	bacterial DNA gyrase inhibitor	TOP2A
moxisylyte	moxisylyte|MOXISYLYTE	CC(C)c1cc(OC(C)=O)c(C)cc1OCCN(C)C	PW8QYA7KI0	Withdrawn	adrenergic receptor antagonist	
moxonidine	moxonidine|MOXONIDINE	COc1nc(C)nc(Cl)c1NC1=NCCN1	CC6X0L40GW	Launched	imidazoline receptor agonist	ADRA2A|ADRA2B|ADRA2C
mozavaptan	mozavaptan|MOZAVAPTAN	CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc12	17OJ42922Y	Launched	vasopressin receptor antagonist	AVPR1A|AVPR1B|AVPR2
MPEP	MPEP|6-METHYL-2-(PHENYLETHYNYL)PYRIDINE	Cc1cccc(n1)C#Cc1ccccc1	7VC0YVI27Y	Preclinical	glutamate receptor antagonist	GRM1|GRM4|GRM5
MPI-0479605	MPI-0479605	Cc1cc(ccc1Nc1nc(NC2CCCCC2)c2[nH]cnc2n1)N1CCOCC1		Preclinical	mitotic kinase inhibitor	TTK
Mps1-IN-5	Mps1-IN-5	COc1cc(ccc1Nc1nc2ccc(cn2n1)-c1ccc(NC(=O)[C@H](C)c2ccc(F)cc2)cc1)S(C)(=O)=O		Preclinical	protein kinase inhibitor	
MR-16728	MR-16728	O=C(NCCCN1CCCCCC1)C(C1CCCCC1)c1ccccc1		Preclinical	acetylcholine release enhancer	
MR-948	MR-948	OCCc1ccc(OCCn2ccnc2)cc1		Phase 1	thromboxane synthase inhibitor	TBXAS1
MRK-016	MRK-016	Cc1cc(no1)-c1nncc2c(c(OCc3ncnn3C)nn12)C(C)(C)C		Phase 1	GABA receptor inverse agonist	GABRA1|GABRA2|GABRA3|GABRA5
MRK-409	MRK-409	Cn1ncnc1COc1nn2c(nnc2cc1C1CCC1)-c1c(F)cccc1F	9VSE02330I	Phase 1	benzodiazepine receptor agonist	
MRS-1220	MRS-1220	Clc1ccc2nc(NC(=O)Cc3ccccc3)n3nc(nc3c2c1)-c1ccco1		Preclinical	adenosine receptor antagonist	ADORA2B|ADORA3
MRS1334	MRS1334	CCOC(=O)C1=C(C)NC(c2ccccc2)=C(C1C#Cc1ccccc1)C(=O)OCc1ccc(cc1)[N+]([O-])=O		Preclinical	adenosine receptor antagonist	ADORA3
MRS1845	MRS1845	CCOC(=O)C1=C(C)N(CC#C)C(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC		Preclinical	calcium channel blocker	
MRS2578	MRS2578	S=C=Nc1cccc(NC(=S)NCCCCNC(=S)Nc2cccc(c2)N=C=S)c1		Preclinical	purinergic receptor antagonist	P2RY6
MRS3777	MRS3777	C1CCC(CC1)Nc1nc(Oc2ccccc2)nc2[nH]cnc12		Preclinical	adenosine receptor antagonist	ADORA2A
MSX-122	MSX-122	C(Nc1ncccn1)c1ccc(CNc2ncccn2)cc1	69D634Q702	Phase 1	CC chemokine receptor antagonist	CXCR4
MTPG	MTPG	CC(N)(C(O)=O)c1ccc(cc1)-c1nnn[nH]1		Preclinical	glutamate receptor antagonist	GRM2|GRM3
mubritinib	mubritinib|MUBRITINIB	FC(F)(F)c1ccc(\C=C\c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1	V734AZP9BR	Phase 1	protein tyrosine kinase inhibitor	EGFR|ERBB2
mupirocin	mupirocin|MUPIROCIN	C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O	D0GX863OA5	Launched	isoleucyl-tRNA synthetase inhibitor	
muscimol	muscimol|MUSCIMOL	NCc1cc(O)no1	D5M179TY2E	Phase 1	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3
MUT056399	MUT056399|FAB-001	CCc1cc(O)c(Oc2ccc(cc2F)C(N)=O)cc1F	B52RPV7VRM	Phase 1	FABI inhibitor	
MY-5445	MY-5445	Clc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1	F8CSS73B6A	Preclinical	phosphodiesterase inhibitor|platelet aggregation inhibitor	PDE5A
mycophenolate-mofetil	mycophenolate-mofetil|MYCOPHENOLATE MOFETIL	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(=O)OCCN1CCOCC1	9242ECW6R0	Launched	dehydrogenase inhibitor|inositol monophosphatase inhibitor	IMPDH1|IMPDH2
mycophenolic-acid	mycophenolic-acid|MYCOPHENOLIC ACID	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O	HU9DX48N0T	Launched	dehydrogenase inhibitor|inositol monophosphatase inhibitor	IMPDH1|IMPDH2
myricetin	myricetin|MYRICETIN	Oc1cc(O)c2c(c1)oc(-c1cc(O)c(O)c(O)c1)c(O)c2=O	76XC01FTOJ	Preclinical	androgen receptor agonist|cytochrome P450 inhibitor	PIK3CG
myricitrin	myricitrin|MYRICITRIN	C[C@@H]1O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)-c2cc(O)c(O)c(O)c2)[C@@H](O)[C@H](O)[C@H]1O	5Z0ZO61WPJ	Preclinical	PKC inhibitor	NOS1|PRKCA
myristyl-nicotinate	myristyl-nicotinate|MYRISTYL NICOTINATE	CCCCCCCCCCCCCCOC(=O)c1cccnc1	8QWM6I035C	Phase 1	topical sunscreen agent	
N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide	N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide	Clc1ccccc1NC(=S)NNC(=S)NNC(=C)c1ccccn1		Preclinical		
N-(3-methoxyphenyl)prop-2-enamide	N-(3-methoxyphenyl)prop-2-enamide	COc1cccc(NC(=O)C=C)c1		Preclinical		
N-(4-chlorophenyl)acrylamide	N-(4-chlorophenyl)acrylamide	Clc1ccc(NC(=O)C=C)cc1		Preclinical		
N-(4-Methoxyphenyl)acrylamide	N-(4-Methoxyphenyl)acrylamide	COc1ccc(NC(=O)C=C)cc1		Preclinical		
N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide	N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide	Ic1ccc(cc1)C(=O)NCCN1CCCCC1		Preclinical	sigma receptor ligand	
N-acetyl-D-glucosamine	N-acetyl-D-glucosamine|N-ACETYLGLUCOSAMINE	CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO	V956696549	Phase 2/Phase 3		B4GALT1|B4GALT2|B4GALT3|B4GALT4|NAGK|NAGLU|NAGPA|RENBP
N-acetyl-tyrosine	N-acetyl-tyrosine|N-ACETYLTYROSINE	CC(=O)NC(Cc1ccc(O)cc1)C(O)=O	DA8G610ZO5	Launched		
N-acetylcarnosine	N-acetylcarnosine|N-ACETYLCARNOSINE	CC(=O)NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O	0TPN86OQIF	Phase 2		
N-acetylglycyl-D-glutamic-acid	N-acetylglycyl-D-glutamic-acid	CC(=O)NCC(=O)N[C@H](CCC(O)=O)C(O)=O		Preclinical	glutamate receptor agonist	
N-acetylmannosamine	N-acetylmannosamine|N-ACETYLMANNOSAMINE	CC(=O)NC1[C@@H](O)OC(CO)[C@@H](O)[C@H]1O	X80PR7P73R	Phase 1		CHIT1
N-acetyltryptamine	N-acetyltryptamine	CC(=O)NCCc1c[nH]c2ccccc12		Preclinical	melatonin receptor agonist	
N-alpha-Methylhistamine-dihydrochloride	N-alpha-Methylhistamine-dihydrochloride|N.ALPHA.-METHYLHISTAMINE	CNCCc1cnc[nH]1	Y7QR253130	Phase 3	histamine receptor agonist	HRH4
N-benzylacrylamide	N-benzylacrylamide	C=CC(=O)NCc1ccccc1		Preclinical		
N-benzylnaltrindole	N-benzylnaltrindole	Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1c(C[C@@]35O)c2ccccc2n1Cc1ccccc1		Preclinical	opioid receptor antagonist	
N-cyanopyrrolidine	N-cyanopyrrolidine	N#CN1CCCC1		Preclinical		CTSK
N-demethylantipyrine	N-demethylantipyrine	Cc1cc(=O)n([nH]1)-c1ccccc1		Preclinical		
N-hydroxynicotinamide	N-hydroxynicotinamide|NICOXAMAT	ONC(=O)c1cccnc1	Z3H2D4MF7A	Preclinical		
N-methylformamide	N-methylformamide|N-METHYLFORMAMIDE	CNC=O	XPE4G7Y986	Phase 2		
N-methyllidocaine-iodide	N-methyllidocaine-iodide	CC[N+](C)(CC)CC(=O)Nc1c(C)cccc1C		Preclinical	antiarrhythmic medication	
N-methylpyrrolidone	N-methylpyrrolidone|METHYL PYRROLIDONE	CN1CCCC1=O	JR9CE63FPM	Phase 1		
N-methylquipazine	N-methylquipazine|N-METHYLQUIPAZINE	CN1CCN(CC1)c1ccc2ccccc2n1	0YV1ZIR6S0	Preclinical	serotonin receptor agonist	HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|SLC6A4
N-MPPP	N-MPPP|N-METHYL-N-(1-PHENYL-2-(1-PYRROLIDINYL)ETHYL)BENZENEACETAMIDE, (S)-	CN([C@H](CN1CCCC1)c1ccccc1)C(=O)Cc1ccccc1	0G3RS2P5HF	Preclinical	opioid receptor agonist	
N-oxydiethylenebenzothiazole-2-sulfenamide	N-oxydiethylenebenzothiazole-2-sulfenamide|MORPHOLINYLMERCAPTOBENZOTHIAZOLE	C1CN(CCO1)Sc1nc2ccccc2s1	VCD7623F3K	Preclinical		
N-phenylacrylamide	N-phenylacrylamide	C=CC(=O)Nc1ccccc1		Preclinical		
N-salicoylaminophenol	N-salicoylaminophenol|OSALMID	Oc1ccc(NC(=O)c2ccccc2O)cc1	89741L759Z	Preclinical	ribonucleotide reductase inhibitor	
N20C	N20C	NC(=O)CNCCC(c1ccccc1)c1ccccc1		Preclinical	glutamate receptor antagonist	
N6-cyclopentyladenosine	N6-cyclopentyladenosine	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NC3CCCC3)ncnc12		Preclinical	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3|SLC29A1
N6-methyladenosine	N6-methyladenosine|N-METHYLADENOSINE	CNc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	CLE6G00625	Preclinical		
N6022	N6022|N-6022	Cc1cc(ccc1-n1c(CCC(O)=O)ccc1-c1ccc(cc1)-n1ccnc1)C(N)=O	80LIU5P95D	Phase 1/Phase 2	alcohol dehydrogenase inhibitor	ADH5
nabumetone	nabumetone|NABUMETONE	COc1ccc2cc(CCC(C)=O)ccc2c1	LW0TIW155Z	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
nadide	nadide|NADIDE	NC(=O)c1ccc[n+](c1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O	0U46U6E8UK	Launched	electron acceptor	AHCY|AKR1A1|ALDH2|BLVRA|DHPS|DLD|GALE|HMGCR|HSD17B1|HSD17B4|IMPDH2|MGAM|P2RY11|SORD|TRPM2
nadifloxacin	nadifloxacin|NADIFLOXACIN	CC1CCc2c(N3CCC(O)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O	6CL9Y5YZEQ	Launched	bacterial DNA gyrase inhibitor	
nadolol	nadolol|SQ-12182|SQ-12181	CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12	4HM3L89S6A|FT49SXL904	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
NADPH	NADPH|NICOTINAMIDE-ADENINE DINUCLEOTIDE PHOSPHATE, REDUCED	NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O	381Q4X082D	Preclinical		AASS|DPYD|GHSR|TXNRD1
nafadotride	nafadotride|NAFADOTRIDE	CCCCN1CCCC1CNC(=O)c1cc(C#N)c2ccccc2c1OC	JP25MZ26IQ	Preclinical	dopamine receptor antagonist	DRD2|DRD3|HTR1A
nafamostat	nafamostat|NAFAMOSTAT	NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N	Y25LQ0H97D	Launched	serine protease inhibitor	ASIC1|ASIC2|ASIC3|C1R|PRSS1|TPSAB1|TRPM7
nafcillin	nafcillin|NAFCILLIN	CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O	4CNZ27M7RV	Launched	bacterial cell wall synthesis inhibitor	CYP1A2|CYP3A4|SLC22A6
naftidrofuryl	naftidrofuryl|NAFRONYL	CCN(CC)CCOC(=O)C(CC1CCCO1)Cc1cccc2ccccc12	42H8PQ0NMJ	Launched	adrenergic receptor antagonist	
naftifine	naftifine|NAFTIFINE	CN(C\C=C\c1ccccc1)Cc1cccc2ccccc12	4FB1TON47A	Launched	fungal squalene epoxidase inhibitor	SQLE
naftopidil	naftopidil|NAFTOPIDIL	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1	R9PHW59SFN	Launched	adrenergic receptor antagonist	ADRA1A
nalbuphine	nalbuphine|NALBUPHINE	O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45	L2T84IQI2K	Launched	opioid receptor agonist|opioid receptor antagonist	OPRD1|OPRK1|OPRM1
nalfurafine	nalfurafine|NALFURAFINE	CN([C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45)C(=O)\C=C\c1ccoc1	XC41AVD567	Launched	opioid receptor agonist	OPRK1|OPRM1
nalidixic-acid	nalidixic-acid|NALIDIXIC ACID	CCn1cc(C(O)=O)c(=O)c2ccc(C)nc12	3B91HWA56M	Launched	bacterial DNA gyrase inhibitor	
nalmefene	nalmefene|NALMEFENE	Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)C(=C)CCC35O	TOV02TDP9I	Launched	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
naloxegol	naloxegol|NALOXEGOL	COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC=C)c45	44T7335BKE	Launched	opioid receptor antagonist	OPRM1
naloxone	naloxone|NALOXONE	Oc1ccc2C[C@H]3N(CC=C)CCC45[C@@H](Oc1c24)C(=O)CC[C@@]35O	36B82AMQ7N	Launched	opioid receptor antagonist	CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4
naloxone-benzoylhydrazone	naloxone-benzoylhydrazone	Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)\C(CC[C@@]35O)=N\NC(=O)c1ccccc1		Preclinical	opioid receptor antagonist	OPRK1|OPRM1
naltrexone	naltrexone|NALTREXONE	Oc1ccc2C[C@H]3N(CC4CC4)CCC45[C@@H](Oc1c24)C(=O)CC[C@@]35O	5S6W795CQM	Launched	opioid receptor antagonist	OPRD1|OPRK1|OPRM1|SIGMAR1
naltriben	naltriben	Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1oc2ccccc2c1C[C@@]35O		Preclinical	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
naltrindole	naltrindole|NALTRINDOLE	Oc1ccc2CC3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1[nH]c2ccccc2c1C[C@@]35O	G167Z38QA4	Preclinical	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
Nampt-IN-1	Nampt-IN-1	CC(C)(O)CS(=O)(=O)Nc1ccc2CN(CCc2c1)C(=O)COc1cccnc1		Preclinical		
NAN-190	NAN-190	COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1		Preclinical	serotonin receptor agonist	ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1F
nanchangmycin	nanchangmycin	CO[C@H]1CCC(O[C@H]2CC(O[C@]3(O[C@H](C[C@@H]3C)C3O[C@@](O)(CO)[C@H](C)C[C@H]3C)[C@@H]2C)[C@]2(C)CC[C@]3(C[C@H](O)[C@H](C)[C@H](O3)[C@@H](C)\C=C(/C)C(=O)[C@H](C)C[C@H](C)C(O)=O)O2)O[C@@H]1C		Preclinical	other antibiotic	
nandrolone	nandrolone|NANDROLONE	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O	6PG9VR430D	Launched	imidazoline receptor agonist	AR|CYP19A1|MAOA|MAOB
nandrolone-decanoate	nandrolone-decanoate|NANDROLONE DECANOATE	CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C	H45187T098	Phase 1	androgenic steroid	AR
napabucasin	napabucasin|NAPABUCASIN	CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O	Z1HHM49K7O	Phase 3	STAT inhibitor	STAT3
naphazoline	naphazoline|NAPHAZOLINE	C(C1=NCCN1)c1cccc2ccccc12	H231GF11BV	Launched	adrenergic receptor agonist	ADRA1A|ADRA2A
naphthoquine-phosphate	naphthoquine-phosphate|NAPHTHOQUINE PHOSPHATE	CC(C)(C)NCc1cc(Nc2ccnc3cc(Cl)ccc23)c2CCCCc2c1O	M6M6AP4KAH	Launched	antimalarial agent	
napirimus	napirimus|NAPIRIMUS	Cn1cc(cc1C(O)=O)C(=O)c1cccc2ccccc12	45081SG6XT	Phase 1	immunosuppressant	
naproxen	naproxen|NAPROXEN	COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O	57Y76R9ATQ	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
narasin	narasin|NARASIN	CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)C4CC[C@](O)(CC)[C@H](C)O4)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@H]1C)C(O)=O	DZY9VU539P	Launched	antiprotozoal agent	
naratriptan	naratriptan|NARATRIPTAN	CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1	QX3KXL1ZA2	Launched	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F
naringenin	naringenin|NARINGENIN	Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1	HN5425SBF2	Phase 1	aromatase inhibitor|TRPV antagonist	CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1
naringeninic-acid	naringeninic-acid|P-COUMARIC ACID	OC(=O)\C=C\c1ccc(O)cc1	IBS9D1EU3J	Phase 1		HCAR2|PTGR1
naringin	naringin|NARINGIN	C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc2cc(O)c3C(=O)C[C@H](Oc3c2)c2ccc(O)cc2)[C@@H](O)[C@H](O)[C@H]1O	N7TD9J649B	Preclinical	cytochrome P450 inhibitor	SLCO1A2
naringin-dihydrochalcone	naringin-dihydrochalcone|NARINGIN DIHYDROCHALCONE	C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc2cc(O)c(C(=O)CCc3ccc(O)cc3)c(O)c2)[C@H](O)[C@H](O)[C@H]1O	7233QDO0QW	Preclinical	cytochrome P450 inhibitor	
narlaprevir	narlaprevir|NARLAPREVIR	CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1	2857LA2O07	Phase 2/Phase 3	HCV inhibitor	
nastorazepide	nastorazepide|NASTORAZEPIDE	CC(C)(C)C(=O)CN1c2ccccc2N(C[C@@H](NC(=O)Nc2cccc(c2)C(O)=O)C1=O)C1CCCCC1	R22TMY97SG	Phase 2	CCK receptor antagonist	CCKBR
natamycin	natamycin|NATAMYCIN	C[C@H]1O[C@@H](OC2CC3OC(O)(CC(O)C3C(O)=O)CC(O)CC3OC3\C=C\C(=O)OC(C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O	8O0C852CPO	Launched	fungal ergosterol inhibitor	
nateglinide	nateglinide|NATEGLINIDE	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O	41X3PWK4O2	Launched	insulin secretagogue	ABCC8|KCNJ10|KCNJ11|PPARG
navarixin	navarixin|NAVARIXIN	CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1	7V3BY6G538	Phase 2	CC chemokine receptor antagonist	CXCR1|CXCR2
navitoclax	navitoclax|NAVITOCLAX	CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1	XKJ5VVK2WD	Phase 2	BCL inhibitor	BCL2|BCL2L1|BCL2L2
NBI-27914	NBI-27914	CCCN(CC1CC1)c1nc(C)nc(Nc2c(Cl)cc(Cl)cc2Cl)c1Cl		Preclinical	corticosteroid releasing factor receptor antagonist	CRHR1
NBQX	NBQX	NS(=O)(=O)c1cccc2c1c(cc1[nH]c(=O)c(=O)[nH]c21)[N+]([O-])=O		Preclinical	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIN1|GRIN2A|GRIN2B
NCS-382	NCS-382|NCS-382 SODIUM	OC1c2ccccc2CCC\C1=C/C(O)=O	6QI4I5N23X	Preclinical	GABA receptor antagonist	GABBR1|GABBR2|SLC52A2
NE-100	NE-100	CCCN(CCC)CCc1ccc(OC)c(OCCc2ccccc2)c1		Phase 2	sigma receptor antagonist	SIGMAR1
nebivolol	nebivolol|NEBIVOLOL|DEXNEBIVOLOL	OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1	030Y90569U|I43D0296P8	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
nebracetam	nebracetam|NEBRACETAM	NCC1CN(Cc2ccccc2)C(=O)C1	T30038QI8N	Phase 3	acetylcholine receptor agonist	CHRM1
NECA	NECA	CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12		Launched	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3|HSP90B1
necrostatin-1	necrostatin-1	CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O		Preclinical	RIPK inhibitor	RIPK1
necrostatin-2	necrostatin-2	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O		Preclinical	necroptosis inhibitor|RIPK inhibitor	RIPK2
nedaplatin	nedaplatin|NEDAPLATIN	N[Pt]1(N)OCC(=O)O1	8UQ3W6JXAN	Launched	DNA inhibitor	
nedocromil	nedocromil|NEDOCROMIL	CCCc1c2oc(cc(=O)c2cc2c1n(CC)c(cc2=O)C(O)=O)C(O)=O	0B535E0BN0	Launched	histamine receptor antagonist	CYSLTR1|CYSLTR2|FPR1|HSP90AA1|PTGDR
nefazodone	nefazodone|NEFAZODONE	CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1	59H4FCV1TF	Withdrawn	adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor	ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4
nefiracetam	nefiracetam|NEFIRACETAM	Cc1cccc(C)c1NC(=O)CN1CCCC1=O	1JK12GX30N	Phase 3	acetylcholine receptor agonist|benzodiazepine receptor agonist	CHRM1
nefopam	nefopam|NEFOPAM	CN1CCOC(c2ccccc2)c2ccccc2C1	4UP8060B7J	Launched	cyclooxygenase inhibitor	
nelarabine	nelarabine|NELARABINE	COc1nc(N)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	60158CV180	Launched	DNA synthesis inhibitor|T cell inhibitor	POLA1
nelfinavir	nelfinavir|NELFINAVIR	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C	HO3OGH5D7I	Launched	HIV protease inhibitor	CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7
nemonapride	nemonapride|NEMONAPRIDE	CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]1CCN(Cc2ccccc2)[C@@H]1C.CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C	Q88T5P3444	Launched	dopamine receptor antagonist	DRD2|DRD3|DRD4
nemorubicin	nemorubicin|NEMORUBICIN	CO[C@@H]1CN(CCO1)[C@H]1C[C@H](O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5cccc(OC)c5C(=O)c4c(O)c23)C(=O)CO)O[C@@H](C)[C@H]1O	7618O47BQM	Phase 2	topoisomerase inhibitor	TOP1|TOP2A
neo-gilurytmal	neo-gilurytmal|PRAJMALIUM BITARTRATE	CCC[N+]12[C@H]3C[C@]45C(O)C3[C@@H](CC1[C@@H]4N(C)c1ccccc51)[C@H](CC)[C@H]2O	H671L9190Z	Launched		
neohesperidin	neohesperidin|NEOHESPERIDIN	COc1cc(O)cc(c1)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]3O)cc2O1	OA5C88H3L0	Preclinical		
neohesperidin-dihydrochalcone	neohesperidin-dihydrochalcone|NEOHESPERIDIN DIHYDROCHALONE	COc1ccc(CCC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)cc2O)cc1O	3X476D83QV	Preclinical		
neomycin	neomycin|FRAMYCETIN	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	4BOC774388	Launched	bacterial 30S ribosomal subunit inhibitor	CXCR4
neomycin-sulfate	neomycin-sulfate|FRAMYCETIN|NEOMYCIN C	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)OC(O[C@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@H]2O)[C@@H](N)[C@@H](O)[C@@H]1O	4BOC774388|6B1U1NS16Z	Launched	bacterial 30S ribosomal subunit inhibitor	
neostigmine	neostigmine|NEOSTIGMINE	CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C	3982TWQ96G	Launched	acetylcholinesterase inhibitor	ACHE
nepafenac	nepafenac|NEPAFENAC	NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N	0J9L7J6V8C	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
nepicastat	nepicastat|NEPICASTAT	NCc1c[nH]c(=S)n1[C@H]1CCc2c(F)cc(F)cc2C1	VPG12K4540	Phase 2	dopamine beta hydroxylase inhibitor	DBH
neratinib	neratinib|NERATINIB	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C	JJH94R3PWB	Phase 3	EGFR inhibitor	EGFR|ERBB2|KDR
nerbacadol	nerbacadol|NERBACADOL	Cc1oncc1C(=O)N1CCCCC1	A9W1Q28TT2	Phase 3	cyclooxygenase inhibitor	
neridronic-acid	neridronic-acid|NERIDRONIC ACID	NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O	8U27U3RIN4	Launched	bone resorption inhibitor	FDPS
nesbuvir	nesbuvir|NESBUVIR	CNC(=O)c1c(oc2cc(N(CCO)S(C)(=O)=O)c(cc12)C1CC1)-c1ccc(F)cc1	EYK815W3Z8	Phase 2	RNA polymerase inhibitor	
netilmicin	netilmicin|NETILMICIN	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O	4O5J85GJJB	Launched	protein synthesis inhibitor	
netupitant	netupitant|NETUPITANT	CN(C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c1cnc(cc1-c1ccccc1C)N1CCN(C)CC1	7732P08TIR	Launched	tachykinin antagonist	TACR1
neurodazine	neurodazine	COc1ccc(cc1)-c1nc([nH]c1-c1ccc(OC)cc1)-c1ccc(o1)-c1cccc(Cl)c1		Preclinical	neurogenesis of non-pluripotent C2C12 myoblast inducer	
nevirapine	nevirapine|NEVIRAPINE	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1	99DK7FVK1H	Launched	non-nucleoside reverse transcriptase inhibitor	CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5
nexturastat-a	nexturastat-a	CCCCN(Cc1ccc(cc1)C(=O)NO)C(=O)Nc1ccccc1		Preclinical	HDAC inhibitor	HDAC1|HDAC6
NFKB-activation-inhibitor-II	NFKB-activation-inhibitor-II	Cc1ccc(NCCCc2ccccc2)c(N)c1		Preclinical	NFkB pathway inhibitor	RELA
NG-nitro-arginine	NG-nitro-arginine|NITROARGININE	N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O	7O8V7H6P2J	Phase 1	nitric oxide synthase inhibitor	NOS1|NOS2|NOS3
NGB-2904	NGB-2904	Clc1cccc(N2CCN(CCCCNC(=O)c3ccc-4c(Cc5ccccc-45)c3)CC2)c1Cl		Preclinical	dopamine receptor antagonist	DRD3
NGD-94-1	NGD-94-1	C(N1CCN(CC1)c1ncccn1)c1cnc([nH]1)-c1ccccc1		Phase 1	dopamine receptor antagonist	DRD4
NH125	NH125	CCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1C		Preclinical	eukaryotic translation elongation factor 2 inhibitor	
niacin	niacin|NIACIN	OC(=O)c1cccnc1	2679MF687A	Launched	NAD precursor|vitamin B	DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT
nialamide	nialamide|NIALAMIDE	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	T2Q0RYM725	Withdrawn	monoamine oxidase inhibitor	COMT|MAOA|MAOB
nibentan	nibentan|N-(5-(DIETHYLAMINO)-1-PHENYLPENTYL)-4-NITROBENZAMIDE HYDROCHLORIDE	CCN(CC)CCCCC(NC(=O)c1ccc(cc1)[N+]([O-])=O)c1ccccc1	N4S59ZCS33	Phase 2	potassium channel blocker	
nicaraven	nicaraven|NICARAVEN, (+)-|NICARAVEN, (-)-|NICARAVEN	CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1	457KF8A3QQ|K13EV3J70Q|UD8PEV6JBD	Phase 3	free radical scavenger	
nicardipine	nicardipine|NICARDIPINE	COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1	CZ5312222S	Launched	calcium channel blocker	ADORA3|ADRA1A|ADRA1B|ADRA1D|CACNA1C|CACNA1D|CACNA2D1|CACNB2|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|PDE1A|PDE1B
nicergoline	nicergoline|NICERGOLINE	CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13	JCV8365FWN	Launched	adrenergic receptor antagonist	ADRA1A
niceritrol	niceritrol|NICERITROL	O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1	F54EHJ34MV	Launched	NAD precursor	
niclosamide	niclosamide|NICLOSAMIDE	Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O	8KK8CQ2K8G	Launched	DNA replication inhibitor|STAT inhibitor	STAT3
nicorandil	nicorandil|NICORANDIL	[O-][N+](=O)OCCNC(=O)c1cccnc1	260456HAM0	Launched	nitric oxide donor|potassium channel activator	KCNJ11
nicotinamide	nicotinamide|NIACINAMIDE	NC(=O)c1cccnc1	25X51I8RD4	Launched	protein synthesis stimulant	BST1|LDHA|PARP1|SIRT5
nicotine	nicotine|NICOTINE	CN1CCCC1c1cccnc1	6M3C89ZY6R	Launched	acetylcholine receptor agonist	CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1
nicotinyl-alcohol-tartrate	nicotinyl-alcohol-tartrate|NICOTINYL ALCOHOL	OCc1cccnc1	9TF312056Y	Launched		
nifedipine	nifedipine|NIFEDIPINE	COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC	I9ZF7L6G2L	Launched	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNB2|CALM1|GLRA1|GLRA3|GLRB|KCNA1|KCNA5|NR1I2|TRPM3
nifekalant	nifekalant|NIFEKALANT	Cn1c(NCCN(CCO)CCCc2ccc(cc2)[N+]([O-])=O)cc(=O)n(C)c1=O	5VZ7GZM43E	Launched	potassium channel blocker	
nifenalol	nifenalol|NIFENALOL	CC(C)NCC(O)c1ccc(cc1)[N+]([O-])=O	D1DE63830P	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
nifenazone	nifenazone|NIFENAZONE	Cc1c(NC(=O)c2cccnc2)c(=O)n(-c2ccccc2)n1C	8780F0K71U	Launched	analgesic agent	
niflumic-acid	niflumic-acid|NIFLUMIC ACID	OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F	4U5MP5IUD8	Launched	cyclooxygenase inhibitor	ANO1|CLCN1|CLCNKA|CLCNKB|KCNQ1|PLA2G1B|PLA2G4A|PTGS1|PTGS2|UGT1A9
nifuroxazide	nifuroxazide|NIFUROXAZIDE	Oc1ccc(cc1)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O	PM5LI0P38J	Launched	bacterial DNA inhibitor	
nifursol	nifursol|NIFURSOL	Oc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O	TG99GOU55Z	Launched	bacterial DNA inhibitor	
nifurtimox	nifurtimox|NIFURTIMOX	CC1CS(=O)(=O)CCN1N=Cc1ccc(o1)[N+]([O-])=O	M84I3K7C2O	Launched	DNA inhibitor	
niguldipine-(S)-(+)	niguldipine-(S)-(+)|NIGULDIPINE	COC(=O)C1=C(C)NC(C)=C([C@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1	Z81N45O25Z	Preclinical	adrenergic receptor antagonist	ADRA1A
nikethamide	nikethamide|NIKETHAMIDE	CCN(CC)C(=O)c1cccnc1	368IVD6M32	Withdrawn	immunostimulant	
nilotinib	nilotinib|NILOTINIB	Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F	F41401512X	Launched	Abl kinase inhibitor|Bcr-Abl kinase inhibitor	ABL1|KIT
nilutamide	nilutamide|NILUTAMIDE	CC1(C)NC(=O)N(C1=O)c1ccc(c(c1)C(F)(F)F)[N+]([O-])=O	51G6I8B902	Launched	androgen receptor antagonist	AR
nilvadipine	nilvadipine|NILVADIPINE	COC(=O)C1=C(NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C)C#N	0214FUT37J	Launched	calcium channel blocker	CACNA1C|CACNA1D|CACNA1S|CACNA2D1|CACNA2D3|CACNB2
nimesulide	nimesulide|NIMESULIDE	CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O	V4TKW1454M	Launched	cyclooxygenase inhibitor	LTF|PLA2G2E|PTGS1|PTGS2
nimodipine	nimodipine|NIMODIPINE	COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C	57WA9QZ5WH	Launched	calcium channel blocker	AHR|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CFTR|NR3C2
nimorazole	nimorazole|NIMORAZOLE	[O-][N+](=O)c1cncn1CCN1CCOCC1	469ULX0H4G	Launched	bacterial DNA inhibitor	
nimustine	nimustine|NIMUSTINE	Cc1ncc(CNC(=O)N(CCCl)[N+][O-])c(N)n1	0S726V972K	Launched	DNA alkylating agent	
nintedanib	nintedanib|NINTEDANIB	COC(=O)c1ccc2c(NC(=O)\C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1	G6HRD2P839	Launched	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB
niraparib	niraparib|NIRAPARIB	NC(=O)c1cccc2cn(nc12)-c1ccc(cc1)[C@@H]1CCCNC1	HMC2H89N35	Phase 3	PARP inhibitor	PARP1
niridazole	niridazole|NIRIDAZOLE	[O-][N+](=O)c1cnc(s1)N1CCNC1=O	N116U8Y5QQ	Launched	phosphofructokinase inhibitor	
nisin	nisin	0		Phase 1	bacterial cell wall synthesis inhibitor	
nisoldipine	nisoldipine|NISOLDIPINE	COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C	4I8HAB65SZ	Launched	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNB2
nisoxetine	nisoxetine|NISOXETINE	CNCCC(Oc1ccccc1OC)c1ccccc1	17NV064B2D	Phase 1	norepinephrine reuptake inhibitor	SLC6A2|SLC6A3|SLC6A4
nitarsone	nitarsone|NITARSONE	O[As](O)(=O)c1ccc(cc1)[N+]([O-])=O	JP2EN8WORU	Launched		
nitazoxanide	nitazoxanide|NITAZOXANIDE	CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+]([O-])=O	SOA12P041N	Launched	pyruvate ferredoxin oxidoreductase inhibitor	
nitecapone	nitecapone|NITECAPONE	CC(=O)C(=Cc1cc(O)c(O)c(c1)[N+]([O-])=O)C(C)=O	98BS722498	Phase 2	catechol O methyltransferase inhibitor	COMT
nitenpyram	nitenpyram|NITENPYRAM	CCN(Cc1ccc(Cl)nc1)C(\NC)=C\[N+]([O-])=O	3A837VZ81Y	Launched		
nithiamide	nithiamide|NITHIAMIDE	CC(=O)Nc1ncc(s1)[N+]([O-])=O	9CBM60191Z	Preclinical	bacterial DNA inhibitor	
nitisinone	nitisinone|NITISINONE	[O-][N+](=O)c1cc(ccc1C(=O)C1C(=O)CCCC1=O)C(F)(F)F	K5BN214699	Launched	hydroxyphenylpyruvate dioxygenase inhibitor	HPD
nitrendipine	nitrendipine|NITRENDIPINE	CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC	9B627AW319	Launched	calcium channel blocker	CACNA1C|CACNA1D|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CACNG1|KCNN4
nitrocaramiphen	nitrocaramiphen	CCN(CC)CCOC(=O)C1(CCCC1)c1ccc(cc1)[N+]([O-])=O		Preclinical	cholinergic receptor antagonist	CHRM1
nitrofurantoin	nitrofurantoin|NITROFURANTOIN	[O-][N+](=O)c1ccc(\C=N\N2CC(=O)NC2=O)o1	927AH8112L	Launched	DNA inhibitor	
nitrofurazone	nitrofurazone|NITROFURAZONE	NC(=O)N\N=C\c1ccc(o1)[N+]([O-])=O	X8XI70B5Z6	Launched	bacterial DNA inhibitor	
nitromide	nitromide|NITROMIDE	NC(=O)c1cc(cc(c1)[N+]([O-])=O)[N+]([O-])=O	9DUJ3CMK8S	Launched		
nitrosodimethylurea	nitrosodimethylurea	CNC(=O)N(C)[N+][O-]		Preclinical	DNA synthesis inhibitor	
nitroxoline	nitroxoline|NITROXOLINE	Oc1ccc([N+]([O-])=O)c2cccnc12	A8M33244M6	Launched	cathepsin inhibitor	METAP2
nizatidine	nizatidine|NIZATIDINE	CN\C(NCCSCc1csc(CN(C)C)n1)=C\[N+]([O-])=O	P41PML4GHR	Launched	histamine receptor antagonist	HRH2
nizofenone	nizofenone|NIZOFENONE	CCN(CC)Cc1nccn1-c1ccc(cc1C(=O)c1ccccc1Cl)[N+]([O-])=O	7A2NOC3R88	Launched	ion channel antagonist	
NKP-1339	NKP-1339	Cl[Ru](Cl)(Cl)(Cl)([n+]1cc2ccccc2[nH]1)[n+]1cc2ccccc2[nH]1		Phase 1	HSP inhibitor	
NLG919	NLG919	OC(CC1c2ccccc2-c2cncn12)C1CCCCC1		Phase 1	indoleamine 2,3-dioxygenase inhibitor	IDO1
NM107	NM107|2'-C-METHYLCYTIDINE	CC1(O)C(O)C(CO)OC1n1ccc(N)nc1=O	27FS20C1D8	Phase 2	RNA polymerase inhibitor	
NMDA	NMDA|N-METHYL-D-ASPARTIC ACID	CNC(CC(O)=O)C(O)=O	1903B9Q6PI	Preclinical	glutamate receptor agonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
NMS-1286937	NMS-1286937|NMS-P937	CN1CCN(CC1)c1ccc(OC(F)(F)F)c(Nc2ncc3CCc4c(nn(CCO)c4-c3n2)C(N)=O)c1	67RM91WDHQ	Phase 1	PLK inhibitor	FLT3|PLK1|PLK2|PLK3
NMS-873	NMS-873	Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(cc1)S(C)(=O)=O		Preclinical	ATPase inhibitor	VCP
NMS-E973	NMS-E973	CN1CCC(CC1)NC(=O)c1cc(on1)-c1c(O)cc(O)cc1Oc1ccc(cc1)[N+]([O-])=O		Preclinical	HSP inhibitor	
NMS-P715	NMS-P715	CCc1cccc(CC)c1NC(=O)c1nn(C)c-2c1CCc1cnc(Nc3ccc(cc3OC(F)(F)F)C(=O)NC3CCN(C)CC3)nc-21		Preclinical	protein kinase inhibitor	
NNC-05-2090	NNC-05-2090|METHYLHYDRAZINE	COc1ccccc1C1(O)CCN(CCCn2c3ccccc3c3ccccc23)CC1	UWA30B5Z1J	Preclinical	GABA uptake inhibitor|GAT inhibitor	SLC6A12
NNC-55-0396	NNC-55-0396	CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1	0A7CE46ERM	Preclinical	T-type calcium channel blocker	CATSPER1|CATSPER2|CATSPER3|CATSPER4
NNC-63-0532	NNC-63-0532	COC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cccc4ccccc34)CC2)C1=O	73663SY1DT	Preclinical	opioid receptor agonist	OPRL1
NNC-711	NNC-711	OC(=O)C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1	500M0G931K	Preclinical	GABA uptake inhibitor	SIGMAR1|SLC6A1
NO-ASA	NO-ASA|NCX-4016	CC(=O)Oc1ccccc1C(=O)Oc1cccc(CO[N+]([O-])=O)c1	EH04H13L6B	Phase 2	cyclooxygenase inhibitor	PTGS2
nobiletin	nobiletin|NOBILETIN	COc1ccc(cc1OC)-c1cc(=O)c2c(OC)c(OC)c(OC)c(OC)c2o1	D65ILJ7WLY	Preclinical	MEK inhibitor	MAP2K1
nocodazole	nocodazole|NOCODAZOLE	COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1cccs1	SH1WY3R615	Preclinical	tubulin polymerization inhibitor	HPGDS
nolatrexed	nolatrexed|NOLATREXED	Cc1ccc2nc(N)nc(O)c2c1Sc1ccncc1	K75ZUN743Q	Phase 3	thymidylate synthase inhibitor	TYMS
nomegestrol-acetate	nomegestrol-acetate|NOMEGESTROL ACETATE	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O	83J78V5W05	Launched	progesterone receptor agonist	PGR
nomifensine	nomifensine|NOMIFENSINE	CN1CC(c2ccccc2)c2cccc(N)c2C1	1LGS5JRP31	Withdrawn	dopamine uptake inhibitor|noradrenaline uptake inhibitor	DRD2|MAOA|MAOB|MPO|SLC6A2|SLC6A3
nonivamide	nonivamide|NONIVAMIDE	CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1	S846B891OR	Launched	TRPV agonist	TRPV1
nonoxynol-9	nonoxynol-9|NONOXYNOL-6|NONOXYNOL-3|NONOXYNOL-18|NONOXYNOL-40|NONOXYNOL-15|NONOXYNOL-20|NONOXYNOL-25|NONOXYNOL-12|NONOXYNOL-13|NONOXYNOL-100|NONOXYNOL-50|NONOXYNOL-11|NONOXYNOL-5|NONOXYNOL-7|NONOXYNOL-44|NONOXYNOL-30|NONOXYNOL-10|NONOXYNOL-4|NONOXYNOL-14|NONOXYNOL-8	CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1	1F75BOT2DZ|283U2KY9DD|3X709X44TE|4867M0AEJI|5V4827GL2O|60ZT1XYO5N|6FW840C8W9|6NR43D77O6|8869L92EOT|A906T4D368|BK168521Q8|E9AU396Z19|ED8J5T817W|GV32KR898G|HR8408HWGL|JJX07DG188|K7O76887AP|KND68343W4|M693M091RR|OSD2GAP7HY	Launched	membrane integrity inhibitor	
nor-Binaltorphimine-dihydrochloride	nor-Binaltorphimine-dihydrochloride|NORBINALTORPHIMINE	Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1[nH]c2[C@@H]4Oc6c7c(C[C@H]8N(CC9CC9)CC[C@@]47[C@@]8(O)Cc2c1C[C@@]35O)ccc6O	36OOQ86QM1	Preclinical	opioid receptor antagonist	OPRD1|OPRK1|OPRM1
norcyclobenzaprine	norcyclobenzaprine|NORCYCLOBENZAPRINE	CNCCC=C1c2ccccc2C=Cc2ccccc12	T6X8KQ83F4	Preclinical	adrenergic receptor agonist|serotonin receptor antagonist	
norelgestromin	norelgestromin|NORELGESTROMIN	CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(O)C#C	R0TAY3X631	Launched		PGR
norepinephrine	norepinephrine|NOREPINEPHRINE	NC[C@H](O)c1ccc(O)c(O)c1	X4W3ENH1CV	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|SLC18A1|SLC18A2
norethindrone	norethindrone|NORETHINDRONE	C[C@]12CC[C@@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CCC2(O)C#C	T18F433X4S	Launched	progestogen hormone	PGR
norethindrone-acetate	norethindrone-acetate|NORETHINDRONE ACETATE	CC(=O)O[C@]1(CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@]12C)C#C	9S44LIC7OJ	Launched	progesterone receptor agonist	
norethisterone	norethisterone|NORETHINDRONE	C[C@]12CCC3C(CCC4=CC(=O)CC[C@H]34)C1CC[C@@]2(O)C#C	T18F433X4S	Launched	progesterone receptor agonist	PGR
norethisterone-enanthate	norethisterone-enanthate|NORETHINDRONE ENANTHATE	CCCCCCC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C	HY3S2K0J0F	Launched	contraceptive agent	
noretynodrel	noretynodrel|NORETHYNODREL	C[C@]12CCC3C(CCC4=C3CCC(=O)C4)C1CC[C@@]2(O)C#C	88181ACA0M	Launched	progestogen hormone	PGR
norfloxacin	norfloxacin|NORFLOXACIN	CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCNCC1	N0F8P22L1P	Launched	bacterial DNA gyrase inhibitor	TOP2A
norfluoxetine	norfluoxetine|NORFLUOXETINE	NCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1	K8D70XE2F4	Phase 1	selective serotonin reuptake inhibitor (SSRI)	HTR2B
norgestimate	norgestimate|NORGESTIMATE	CC[C@]12CCC3C(CCC4=C\C(CCC34)=N\O)C1CC[C@@]2(OC(C)=O)C#C	C291HFX4DY	Launched	progesterone receptor agonist	ESR1|PGR
norgestrel	norgestrel|NORGESTREL|LEVONORGESTREL	CC[C@]12CCC3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	3J8Q1747Z2|5W7SIA7YZW	Launched	progesterone receptor agonist	PGR
nornicotine	nornicotine|NORNICOTINE	C1CNC(C1)c1cccnc1	83H6L5QD8Z	Preclinical	acetylcholine receptor agonist	
nortriptyline	nortriptyline|NORTRIPTYLINE	CNCCC=C1c2ccccc2CCc2ccccc12	BL03SY4LXB	Launched	tricyclic antidepressant	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4
norvancomycin	norvancomycin|NORVANCOMYCIN	CC(C)CC(N)C(=O)NC1C(O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)C(O)C5NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1C(NC5=O)C(O)=O)c3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1)c(Cl)c2	BP129IOC93	Preclinical		
noscapine	noscapine|NOSCAPINE|GNOSCOPINE	COc1ccc2[C@H](OC(=O)c2c1OC)C1N(C)CCc2cc3OCOc3c(OC)c12	8V32U4AOQU|A4C6WE7BZN	Launched	bradykinin receptor antagonist|tubulin polymerization inhibitor	SIGMAR1
NOV-002	NOV-002|OXIGLUTATIONE DISODIUM	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O	GY131TX61G	Phase 3		GSR|GSTM2
novobiocin	novobiocin|NOVOBIOCIN	CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C	17EC19951N	Launched	bacterial DNA gyrase inhibitor	
NPC-01	NPC-01|11.BETA.-HYDROXYANDROSTENEDIONE	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O	41G81C896T	Phase 3	steroid	
NPC-15199	NPC-15199|N-(FLUORENYL-9-METHOXYCARBONYL)LEUCINE	CC(C)C[C@@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O	KF18F70UF3	Phase 2	ICAM1 antagonist	PPARG
NPPB	NPPB|5-NITRO-2-(3-PHENYLPROPYLAMINO)BENZOIC ACID	OC(=O)c1cc(ccc1NCCCc1ccccc1)[N+]([O-])=O	3A35O9G3YZ	Preclinical	chloride channel blocker	ANO1|CLCN2|CLCN7|TRPA1
NPS-2143	NPS-2143	CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N	Z25PJ77W7V	Preclinical	calcium receptor antagonist	CASR
NPY-5RA972	NPY-5RA972	CC(C)n1c2ccccc2c2c(C)c(NC(=O)N3CCOCC3)ccc12		Preclinical	neuropeptide receptor antagonist	NPY5R
NQDI-1	NQDI-1	CCOC(=O)c1c(O)nc2cccc3C(=O)c4ccccc4-c1c23		Preclinical	caspase inhibitor	CASP3
NS-018	NS-018	C[C@H](Nc1cc(cc(Nc2cnccn2)n1)-c1cnn(C)c1)c1ccc(F)cc1	56R994WX4L	Phase 1/Phase 2	JAK inhibitor	JAK1|JAK2|JAK3|TYK2
NS-8	NS-8|1.BETA.-CALCITRIOL	Cc1c([nH]c(N)c1C#N)-c1ccccc1F	IR1PLU81NA	Phase 2	potassium channel agonist	KCNMA1
NSC-23766	NSC-23766	CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1		Preclinical	Ras GTPase inhibitor	
NSC-319726	NSC-319726	C\C(c1ccccn1)=N/NC(=S)N1CCC1		Preclinical	p53 activator	
NSC-3852	NSC-3852	Oc1ccc([N+][O-])c2cccnc12		Preclinical	HDAC inhibitor	HDAC1
NSC-405020	NSC-405020	CCCC(C)NC(=O)c1ccc(Cl)c(Cl)c1		Preclinical	matrix metalloprotease inhibitor	MMP1
NSC-4644	NSC-4644|BETULIN	CC(=C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12	6W70HN7X7O	Phase 2	ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor	PYGM
NSC-625987	NSC-625987	COc1ccc(OC)c2c1[nH]c1ccccc1c2=S		Preclinical	CDK inhibitor	CDK2|CDK4
NSC-632839	NSC-632839	Cc1ccc(cc1)\C=C1/CNC\C(C1=O)=C/c1ccc(C)cc1		Preclinical	ubiquitin specific protease inhibitor	SENP2|USP1|USP2|USP7
NSC-663284	NSC-663284	ClC1=C(NCCN2CCOCC2)C(=O)c2ncccc2C1=O		Preclinical	CDC inhibitor	CDC25A|CDC25B|CDC25C
NSC-697923	NSC-697923	Cc1ccc(cc1)S(=O)(=O)c1ccc(o1)[N+]([O-])=O		Preclinical	ubiquitin-conjugating enzyme inhibitor	UBE2N
NSC-95397	NSC-95397	OCCSC1=C(SCCO)C(=O)c2ccccc2C1=O		Preclinical	CDC inhibitor	CDC25A|CDC25B
NSC-9965	NSC-9965|DIHYDRO-.BETA.-ERYTHROIDINE	CO[C@H]1CC=C2CCN3CCC4=C(CC(=O)OC4)[C@]23C1	RBN56W7U63	Preclinical	acetylcholine receptor antagonist	CHRNA4|CHRNB2
NSC5844	NSC5844	C(CNc1ccnc2cc(Cl)ccc12)Nc1ccnc2cc(Cl)ccc12		Preclinical	CC chemokine receptor agonist	CCR1
NSI-189	NSI-189	CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1	YVE9U408ZL	Phase 2	neurotrophic agent	
NT157	NT157	Oc1cc(CNC(=S)\C=C\c2cc(O)c(O)c(Br)c2)cc(O)c1O		Preclinical	IGF-1 inhibitor	IGF1R
NTNCB	NTNCB	[O-][N+](=O)c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1		Preclinical	neuropeptide receptor antagonist	NPY5R
nTZDpa	nTZDpa	OC(=O)c1n(Cc2ccc(Cl)cc2)c2ccc(Cl)cc2c1Sc1ccccc1		Preclinical	PPAR receptor agonist	PPARG
NU-1025	NU-1025	Cc1nc2c(O)cccc2c(=O)[nH]1		Preclinical	PARP inhibitor	PARP1
NU-7026	NU-7026	O=c1cc(oc2c3ccccc3ccc12)N1CCOCC1		Preclinical	DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor	PRKDC
NU-7441	NU-7441	O=c1cc(oc2c(cccc12)-c1cccc2c3ccccc3sc12)N1CCOCC1		Preclinical	DNA dependent protein kinase inhibitor	PRKDC
NU6027	NU6027	Nc1nc(N)c([N+][O-])c(OCC2CCCCC2)n1		Preclinical	CDK inhibitor	CCNA2|CDK2
nuclomedone	nuclomedone|NUCLOMEDONE	Clc1ccc(CC2C(=O)N=C3SCCN3C2=O)cc1	MR28U787Z2	Phase 3	immunosuppressant	
nutlin-3	nutlin-3|NUTLIN-3|NUTLIN-3A	COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1	53IA0V845C|L7C92IOE65	Preclinical	MDM inhibitor	MDM2|TP53
NVP-231	NVP-231	O=C(Nc1nc2ccc(NC(=O)C34CC5CC(CC(C5)C3)C4)cc2s1)c1ccccc1		Preclinical	ceramidase inhibitor	CERK
NVP-ADW742	NVP-ADW742|ADW-742	Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@H]1C[C@H](CN2CCCC2)C1	MXS2N5862L	Preclinical	insulin growth factor receptor inhibitor	IGF1R
NVP-AEW541	NVP-AEW541|AEW-541	Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@@H]1C[C@H](CN2CCC2)C1	97QB5037VR	Preclinical	IGF-1 inhibitor	IGF1R|INSR
NVP-AUY922	NVP-AUY922|LUMINESPIB	CCNC(=O)c1noc(c1-c1ccc(CN2CCOCC2)cc1)-c1cc(C(C)C)c(O)cc1O	C6V1DAR5EB	Phase 2	HSP inhibitor	HSP90AA1|HSP90AB1
NVP-BEZ235	NVP-BEZ235|DACTOLISIB	Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1	RUJ6Z9Y0DT	Phase 2	mTOR inhibitor|PI3K inhibitor	ATR|MTOR|PIK3CA|PIK3CD|PIK3CG
NVP-BGJ398	NVP-BGJ398|INFIGRATINIB	CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1	A4055ME1VK	Phase 2	FGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|KDR
NVP-BHG712	NVP-BHG712	Cc1ccc(cc1Nc1nc(nc2n(C)ncc12)-c1cccnc1)C(=O)Nc1cccc(c1)C(F)(F)F		Preclinical	ephrin inhibitor	EPHB4
NVP-BSK805	NVP-BSK805	Fc1cc(cc(F)c1CN1CCOCC1)-c1cccc2ncc(nc12)-c1cnn(c1)C1CCNCC1		Preclinical	JAK inhibitor	JAK2
NVP-BVU972	NVP-BVU972	Cn1cc(cn1)-c1ccc2ncc(Cc3ccc4ncccc4c3)n2n1		Preclinical	MET inhibitor	MET
NVP-DPP728	NVP-DPP728	O=C(CNCCNc1ccc(cn1)C#N)N1CCC[C@H]1C#N		Phase 2	dipeptidyl peptidase inhibitor	DPP4
NVP-HSP990	NVP-HSP990|HSP-990	COc1cccc(n1)-c1cc(F)ccc1[C@H]1Cc2nc(N)nc(C)c2C(=O)N1	E0WBA7B62L	Phase 1	HSP inhibitor	HSP90AA1|HSP90AB1
NVP-TAE226	NVP-TAE226	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(cc2OC)N2CCOCC2)ncc1Cl		Preclinical	protein tyrosine kinase inhibitor	PTK2
NVP-TAE684	NVP-TAE684|TAE-684	COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)N1CCC(CC1)N1CCN(C)CC1	EH1713MN4K	Preclinical	ALK tyrosine kinase receptor inhibitor	ALK|INSR
NVP-TNKS656	NVP-TNKS656	COc1ccc(cc1)C(=O)C1CCN(CC(=O)N(CC2CC2)Cc2nc3CCOCc3c(=O)[nH]2)CC1		Preclinical	tankyrase inhibitor	TNKS2
NXY-059	NXY-059|DISUFENTON SODIUM	CC(C)(C)[N+](\[O-])=C\c1ccc(cc1S(O)(=O)=O)S(O)(=O)=O	7M1J3HN9VO	Phase 3	free radical scavenger	
nystatin	nystatin|NYSTATIN A1	C[C@H]1OC(OC2CC3O[C@@](O)(CC(O)C3C(O)=O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)C(C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O	W1LX4T91WI	Launched	fungal ergosterol inhibitor	
O-1918	O-1918	COc1cc(C)cc(OC)c1[C@@H]1C=C(C)CC[C@H]1C(C)=C		Preclinical	cannabinoid receptor antagonist	
o-3M3FBS	o-3M3FBS	Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1ccccc1C(F)(F)F		Preclinical	phospholipase activator	
o-acetyl-L-serine	o-acetyl-L-serine|O-ACETYLSERINE	CC(=O)OC[C@H](N)C(O)=O	G05L7T7ZEQ	Preclinical		PTGS1
o-mercapto-benzoic-acid	o-mercapto-benzoic-acid|THIOSALICYLIC ACID	OC(=O)c1ccccc1S	CIP6LXN5XW	Preclinical		
O6-Benzylguanine	O6-Benzylguanine|6-O-BENZYLGUANINE	Nc1nc(OCc2ccccc2)c2[nH]cnc2n1	01KC87F8FE	Phase 3	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT
OAC1	OAC1	O=C(Nc1cc2cc[nH]c2cn1)c1ccccc1		Preclinical	Oct activator	
OAC2	OAC2	O=C(Nc1ccc2[nH]ccc2c1)c1ccccc1		Preclinical	Oct activator	POU5F1
obatoclax	obatoclax|OBATOCLAX	COC1=CC(=N\C\1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1	QN4128B52A	Phase 3	BCL inhibitor	BCL2
obeticholic-acid	obeticholic-acid|OBETICHOLIC ACID	CCC1C(O)C2C3CCC(C(C)CCC(O)=O)C3(C)CCC2C2(C)CCC(O)CC12	0462Z4S4OZ	Phase 3	FXR agonist	NR1H4
obidoxime	obidoxime|OBIDOXIME	O\N=C\c1cc[n+](COC[n+]2ccc(cc2)\C=N\O)cc1	N6KNE1QA9O	Launched	cholinesterase reactivator	ACHE
OC000459	OC000459|OC-459	Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(O)=O	04XB9TB8OL	Phase 2	CRTH receptor antagonist	PTGDR2
ochromycinone	ochromycinone|OCHROMYCINONE	C[C@@H]1CC(=O)c2c(C1)ccc1C(=O)c3c(O)cccc3C(=O)c21	CKZ6P7I25M	Phase 1	STAT inhibitor	STAT3
ocinaplon	ocinaplon|OCINAPLON	O=C(c1cnn2c(ccnc12)-c1ccncc1)c1ccccn1	2H6KVC5E76	Phase 3	GABA receptor modulator	GABRA1|GABRA2|GABRA3|GABRA5
OCO-1112	OCO-1112	CC(C)c1ccc(cc1)C(=O)NCCOc1ccc(cc1)C(O)=O		Phase 2	cholesterol inhibitor	
octadecan-1-ol	octadecan-1-ol|STEARYL ALCOHOL	CCCCCCCCCCCCCCCCCCO	2KR89I4H1Y	Preclinical		
octamethyltrisiloxane	octamethyltrisiloxane|TRISILOXANE	C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C	9G1ZW13R0G	Preclinical		
octenidine	octenidine|OCTENIDINE	CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(cc2)=NCCCCCCCC)cc1	OZE0372S5A	Launched	membrane integrity inhibitor	
octinoxate	octinoxate|OCTINOXATE	CCCC[C@@H](CC)COC(=O)\C=C\c1ccc(OC)cc1	4Y5P7MUD51	Launched		
octisalate	octisalate|OCTISALATE	CCCC[C@@H](CC)COC(=O)c1ccccc1O	4X49Y0596W	Launched		
octocrylene	octocrylene|OCTOCRYLENE	CCCC[C@@H](CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1	5A68WGF6WM	Launched		
octodrine	octodrine|OCTODRINE	CC(C)CCCC(C)N	3GQ9E911BI	Preclinical	antitumor agent	
octopamine	octopamine|OCTOPAMINE	NCC(O)c1ccc(O)cc1	14O50WS8JD	Preclinical	trace amine associated receptor agonist	F10|TAAR1
octreotide	octreotide|OCTREOTIDE	CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1	RWM8CCW8GP	Launched	somatostatin receptor agonist	SSTR1|SSTR2|SSTR3|SSTR5
odanacatib	odanacatib|ODANACATIB	CC(C)(F)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N	N673F6W2VH	Phase 3	cathepsin inhibitor	CTSK
ODM-201	ODM-201	CC(Cn1ccc(n1)-c1ccc(C#N)c(Cl)c1)NC(=O)c1cc([nH]n1)C(C)O	X05U0N2RCO	Phase 3	androgen receptor antagonist	AR
ODQ	ODQ	O=c1onc2cnc3ccccc3n12		Preclinical	guanylyl cyclase inhibitor	GUCY1A2|GUCY1A3|GUCY1B3
ofloxacin	ofloxacin|OFLOXACIN	CC1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O	A4P49JAZ9H	Launched	bacterial DNA gyrase inhibitor	TOP2A
OG-L002	OG-L002	NC1CC1c1ccc(cc1)-c1cccc(O)c1		Preclinical	histone lysine demethylase inhibitor	KDM1A
oglemilast	oglemilast|OGLEMILAST	CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1	67GXQ6WCC6	Phase 2	phosphodiesterase inhibitor	
olanzapine	olanzapine|OLANZAPINE	CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12	N7U69T4SZR	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7
olaparib	olaparib|OLAPARIB	Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1	WOH1JD9AR8	Launched	PARP inhibitor	PARP1|PARP2
OLDA	OLDA|N-OLEOYLDOPAMINE	CCCCCCCC\C=C/CCCCCCCC(=O)NCCc1ccc(O)c(O)c1	T87P7X9XSZ	Preclinical	TRPV agonist	GPR119
oleamide	oleamide|OLEAMIDE	CCCCCCCC\C=C/CCCCCCCC(N)=O	7L25QK8BWO	Preclinical	cannabinoid receptor agonist	HTR7|PLA2G2A
oleandrin	oleandrin|OLEANDRIN	CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O	II95UDU7I4	Phase 1	Na/K-ATPase inhibitor	
oleanolic-acid	oleanolic-acid|OLEANOLIC ACID	CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O	6SMK8R7TGJ	Preclinical	G protein-coupled receptor agonist	GPBAR1
oleoylethanolamide	oleoylethanolamide|OLEIC MONOETHANOLAMIDE	CCCCCCCC\C=C/CCCCCCCC(=O)NCCO	1HI5J9N8E6	Preclinical	cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist	CNR1|GPR119|GPR55|PPARA
olesoxime	olesoxime|OLESOXIME, Z-	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=C\C(CC[C@]4(C)[C@H]3CC[C@]12C)=N\O	I2QN18P645	Phase 2/Phase 3	apoptosis stimulant	
oleuropein	oleuropein|OLEUROPEIN	COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)\C(=C/C)C1CC(=O)OCCc1ccc(O)c(O)c1	2O4553545L	Phase 2	estrogen receptor agonist	GPER1
oligomycin-a	oligomycin-a|OLIGOMYCIN A	CC[C@@H]1CC[C@@H]2O[C@@]3(CC[C@@H](C)[C@H](C[C@@H](C)O)O3)[C@@H](C)[C@H](OC(=O)\C=C\[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@](C)(O)[C@@H](O)[C@H](C)C\C=C/C=C\1)[C@@H]2C	05HQS4AI99	Preclinical	ATP synthase inhibitor|ATPase inhibitor	ATP5A1
olmesartan	olmesartan|OLMESARTAN	CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)C(C)(C)O	8W1IQP3U10	Launched	angiotensin receptor antagonist	AGTR1
olmesartan-medoxomil	olmesartan-medoxomil|OLMESARTAN MEDOXOMIL	CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1	6M97XTV3HD	Launched	angiotensin receptor antagonist	AGTR1
olmutinib	olmutinib|OLMUTINIB	CN1CCN(CC1)c1ccc(Nc2nc(Oc3cccc(NC(=O)C=C)c3)c3sccc3n2)cc1	CHL9B67L95	Launched	EGFR inhibitor|Bruton's tyrosine kinase (BTK) inhibitor	BTK|EGFR
olomoucine	olomoucine|OLOMOUCINE	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12	6A839B2HYS	Preclinical	CDK inhibitor	CDK1|CDK2|CDK5|MAPK1
olopatadine	olopatadine|OLOPATADINE	CN(C)CC\C=C1/c2ccccc2COc2ccc(CC(O)=O)cc12	D27V6190PM	Launched	histamine receptor antagonist	HRH1|S100A1|S100A12|S100A13|S100A2|S100B
olprinone	olprinone|OLPRINONE	Cc1[nH]c(=O)c(cc1-c1ccc2nccn2c1)C#N	4Y8BMI9YGC	Launched	phosphodiesterase inhibitor	PDE3A
olsalazine	olsalazine|OLSALAZINE	OC(=O)c1cc(ccc1O)\N=N\c1ccc(O)c(c1)C(O)=O	ULS5I8J03O	Launched	cyclooxygenase inhibitor	IFNG|TPMT
oltipraz	oltipraz|OLTIPRAZ	Cc1c(ssc1=S)-c1cnccn1	6N510JUL1Y	Phase 3	nuclear factor erythroid derived|like (NRF2) activator	ANG
olvanil	olvanil|OLVANIL	CCCCCCCC\C=C/CCCCCCCC(=O)NCc1ccc(O)c(OC)c1	4P7KIU7003	Preclinical	TRPV agonist	CNR1|GPR119|TRPV1
omadacycline	omadacycline|OMADACYCLINE	CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(CNCC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C	090IP5RV8F	Phase 3	bacterial 30S ribosomal subunit inhibitor	
omarigliptin	omarigliptin|OMARIGLIPTIN	CS(=O)(=O)n1cc2CN(Cc2n1)[C@H]1CO[C@@H]([C@@H](N)C1)c1cc(F)ccc1F	CVP59Q4JE1	Launched	dipeptidyl peptidase inhibitor	DPP4
ombitasvir	ombitasvir|OMBITASVIR	COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(cc1)[C@@H]1CC[C@H](N1c1ccc(cc1)C(C)(C)C)c1ccc(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)cc1	2302768XJ8	Launched	HCV inhibitor	
OMDM-2	OMDM-2	CCCCCCCC\C=C/CCCCCCCC(=O)N[C@@H](CO)Cc1ccc(O)cc1		Preclinical	FAAH inhibitor	GPR119
omecamtiv-mecarbil	omecamtiv-mecarbil|OMECAMTIV MECARBIL	COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1	2M19539ERK	Phase 2	cardiac myosin activator	MYBPC3
omega-(4-Iodophenyl)pentadecanoic acid	omega-(4-Iodophenyl)pentadecanoic acid|IOCANLIDIC ACID I-123	OC(=O)CCCCCCCCCCCCCCc1ccc(I)cc1	5GM08MR13W	Preclinical		
omega-3-acid-esters	omega-3-acid-esters|ICOSAPENT ETHYL	CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC	6GC8A4PAYH	Launched	cholesterol inhibitor	
omeprazole	omeprazole|OMEPRAZOLE	COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C	KG60484QX9	Launched	ATPase inhibitor	ATP4A|CLCN2
omeprazole-magnesium	omeprazole-magnesium|OMEPRAZOLE MAGNESIUM	COc1ccc2n([Mg]n3c(nc4cc(OC)ccc34)S(=O)Cc3ncc(C)c(OC)c3C)c(nc2c1)S(=O)Cc1ncc(C)c(OC)c1C	426QFE7XLK	Launched	proton pump inhibitor	ATP4A|ATP4B
omeprazole-sulfide	omeprazole-sulfide|UFIPRAZOLE	COc1ccc2nc(SCc3ncc(C)c(OC)c3C)[nH]c2c1	6FFV1V867C	Phase 1	ATPase inhibitor	
ON-01500	ON-01500	COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(N)c2)c(OC)c1		Preclinical	apoptosis stimulant	
ON123300	ON123300|ON-123300	CN1CCN(CC1)c1ccc(Nc2ncc3cc(C#N)c(=O)n(C4CCCC4)c3n2)cc1	QJ8RO3296G	Preclinical	CDK inhibitor	CDK4|NUAK1|PDGFRB
ONC201	ONC201	Cc1ccccc1CN1C2=NCCN2C2=C(CN(Cc3ccccc3)CC2)C1=O		Phase 2	AKT inhibitor|MAP kinase inhibitor	TNFSF10
oncrasin-1	oncrasin-1	Clc1ccc(Cn2cc(C=O)c3ccccc23)cc1		Preclinical	apoptosis stimulant	
ondansetron	ondansetron|ONDANSETRON	Cc1nccn1CC1CCc2c(C1=O)c1ccccc1n2C	4AF302ESOS	Launched	serotonin receptor antagonist	HTR1A|HTR1B|HTR3A|HTR3B|HTR4|OPRM1
ONO-4059	ONO-4059	Nc1ncnc2n(C3CCCN(C3)C(=O)C=C)c(=O)n(-c3ccc(Oc4ccccc4)cc3)c12		Phase 1	Bruton's tyrosine kinase (BTK) inhibitor	BTK
ONO-4817	ONO-4817	CCOCOC[C@H](C[C@H](C)C(=O)NO)NC(=O)c1ccc(Oc2ccccc2)cc1		Phase 1	matrix metalloprotease inhibitor	MMP8
ONX-0914	ONX-0914	COc1ccc(C[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@]2(C)CO2)cc1		Preclinical	proteasome inhibitor	
OPC-21268	OPC-21268	CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2ccccc12		Phase 1	vasopressin receptor antagonist	AVPR1A|AVPR2|OXTR
opicapone	opicapone|OPICAPONE	Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(n1)-c1cc(O)c(O)c(c1)[N+]([O-])=O	Y5929UIJ5N	Phase 3	catechol O methyltransferase inhibitor	COMT
opipramol	opipramol|OPIPRAMOL	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc23)CC1	D23ZXO613C	Launched	sigma receptor agonist	
oprozomib	oprozomib|OPROZOMIB	COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc1ccccc1)C(=O)C1(C)CO1	MZ37792Y8J	Phase 1/Phase 2	proteasome inhibitor	
OR-486	OR-486|3,5-DINITROCATECHOL	Oc1cc(cc(c1O)[N+]([O-])=O)[N+]([O-])=O	VK0VA22GY2	Preclinical	catechol O methyltransferase inhibitor	COMT
orantinib	orantinib|ORANTINIB	Cc1[nH]c(\C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O	9RL37ZZ665	Phase 3	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB
orbifloxacin	orbifloxacin|ORBIFLOXACIN	C[C@H]1CN(C[C@@H](C)N1)c1c(F)c(F)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1	660932TPY6	Launched	bacterial DNA gyrase inhibitor	
ORE1001	ORE1001|ORE-1001	CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(O)=O)C(O)=O	4LD0ZHV25K	Phase 1/Phase 2	angiotensin converting enzyme inhibitor	ACE2
Org-12962	Org-12962	FC(F)(F)c1ccc(nc1Cl)N1CCNCC1		Phase 2	serotonin receptor agonist	HTR2A|HTR2B|HTR2C
org-26576	org-26576|ORG-26576	O=C1N2CCC[C@H]2COc2ncccc12	0H1IDR8Z4F	Phase 2	glutamate receptor modulator	
org-27569	org-27569	CCc1c([nH]c2ccc(Cl)cc12)C(=O)NCCc1ccc(cc1)N1CCCCC1		Preclinical	cannabinoid receptor modulator	CNR1
org-9768	org-9768	CC1(CN)Cc2ccccc2C1		Phase 1	adrenergic receptor antagonist	ADRA2A
oridonin	oridonin|ORIDONIN	CC1(C)CC[C@H](O)[C@]23CO[C@](O)([C@@H](O)[C@H]12)[C@@]12[C@H](O)[C@@H](CCC31)C(=C)C2=O	0APJ98UCLQ	Preclinical	BCL inhibitor	BCL2
oritavancin	oritavancin|ORITAVANCIN	CNC(CC(C)C)C(=O)NC1C(O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)C(OC5CC(C)(N)C(O)C(C)O5)C5NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1C(NC5=O)C(O)=O)c3OC1OC(CO)C(O)C(O)C1OC1CC(C)(NCc3ccc(cc3)-c3ccc(Cl)cc3)C(O)C(C)O1)c(Cl)c2	PUG62FRZ2E	Launched	bacterial cell wall synthesis inhibitor	
orlistat	orlistat|ORLISTAT	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	95M8R751W8	Launched	lipase inhibitor	CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP
ornidazole	ornidazole|ORNIDAZOLE	Cc1ncc(n1CC(O)CCl)[N+]([O-])=O	62XCK0G93T	Launched	antiprotozoal agent	
ornithine	ornithine|ORNITHINE	NCCCC(N)C(O)=O	E524N2IXA3	Launched	NFkB pathway modulator	ARG1|ARG2|GATM|GPRC6A|OAT|OAZ1|OAZ2|OAZ3|OTC|SLC25A15|SLC25A2|SLC7A1|SLC7A2|SLC7A3|SLC7A4
orotic-acid	orotic-acid|OROTIC ACID	OC(=O)c1cc(=O)[nH]c(=O)[nH]1	61H4T033E5	Phase 2		DHODH
orphanin-fq	orphanin-fq|NOCICEPTIN	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O	7AYI9N34FF	Phase 1	opioid receptor agonist	OPRL1|OPRM1
orphenadrine	orphenadrine|ORPHENADRINE	CN(C)CCOC(c1ccccc1)c1ccccc1C	AL805O9OG9	Launched	acetylcholine receptor antagonist	GRIN1|GRIN2D|GRIN3A|GRIN3B|HRH1|SCN10A|SLC6A2
orteronel	orteronel|ORTERONEL	CNC(=O)c1ccc2cc(ccc2c1)[C@]1(O)CCn2cncc12	UE5K2FNS92	Phase 3	androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor	CYP17A1
ORY-1001	ORY-1001	NC1CCC(CC1)N[C@@H]1C[C@H]1c1ccccc1		Phase 1/Phase 2	histone lysine demethylase inhibitor	KDM1A
oseltamivir-carboxylate	oseltamivir-carboxylate|OSELTAMIVIR ACID	CCC(CC)O[C@@H]1C=C(C[C@H](N)[C@H]1NC(C)=O)C(O)=O	K6106LV5Q8	Launched	neuraminidase inhibitor	
oseltamivir-phosphate	oseltamivir-phosphate|OSELTAMIVIR PHOSPHATE	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	4A3O49NGEZ	Launched	neuraminidase inhibitor	CES1|NEU1|NEU2
osemozotan	osemozotan|OSEMOZOTAN	C(CNC[C@H]1COc2ccccc2O1)COc1ccc2OCOc2c1	M65825806Q	Phase 2/Phase 3	serotonin receptor agonist	HTR1A
OSI-027	OSI-027	COc1cccc2cc([nH]c12)-c1nc([C@H]2CC[C@@H](CC2)C(O)=O)n2ncnc(N)c12	25MKH1SZ0M	Phase 1	mTOR inhibitor	MTOR
OSI-420	OSI-420	COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCO		Preclinical	EGFR inhibitor	EGFR
OSI-930	OSI-930	FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1	G1PEG5Q9Y2	Phase 1	KIT inhibitor|VEGFR inhibitor	KDR|KIT
osimertinib	osimertinib|OSIMERTINIB	COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1cn(C)c2ccccc12	3C06JJ0Z2O	Launched	EGFR inhibitor	EGFR
ospemifene	ospemifene|OSPEMIFENE	OCCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1	B0P231ILBK	Launched	selective estrogen receptor modulator (SERM)	ESR1|ESR2
ostarine	ostarine|ENOBOSARM	C[C@](O)(COc1ccc(cc1)C#N)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F	O3571H3R8N	Phase 3	androgen receptor modulator	AR
osthol	osthol|OSTHOL	COc1ccc2ccc(=O)oc2c1CC=C(C)C	XH1TI1759C	Preclinical	calcium channel blocker	
OT-R-antagonist-1	OT-R-antagonist-1	CO\N=C1\C[C@H](N(C1)C(=O)c1ccc(cc1)-c1ccccc1C)C(=O)NC[C@@H](O)c1ccccc1		Preclinical	oxytocin receptor antagonist	AVPR1A|OXTR
otamixaban	otamixaban|OTAMIXABAN	COC(=O)[C@H](Cc1cccc(c1)C(N)=N)[C@@H](C)NC(=O)c1ccc(cc1)-c1cc[n+]([O-])cc1	S173RED00L	Phase 3	coagulation factor inhibitor	F10
otenzepad	otenzepad|OTENZEPAD	CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc12	OM7J0XAL0S	Phase 3	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
otilonium	otilonium|OTILONIUM	CCCCCCCCOc1ccccc1C(=O)Nc1ccc(cc1)C(=O)OCC[N+](C)(CC)CC	6330179ARU	Launched	acetylcholine receptor antagonist	CACNA1C
OTS167	OTS167|OTS-167	CN(C)C[C@H]1CC[C@@H](CC1)Nc1c(cnc2ccc(nc12)-c1cc(Cl)c(O)c(Cl)c1)C(C)=O	VY778IXU5T	Phase 1	maternal embryonic leucine zipper kinase inhibitor	MELK
OTS514	OTS514	C[C@@H](CN)c1ccc(cc1)-c1c(O)cc(C)c2[nH]c(=O)c3sccc3c12		Preclinical	TOPK inhibitor	
OTX015	OTX015	Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n-21)c1ccc(Cl)cc1		Phase 1/Phase 2	bromodomain inhibitor	BRD2|BRD3|BRD4
ouabain	ouabain|OUABAIN	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)C4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)C4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O	5ACL011P69	Launched	ATPase inhibitor	ATP1A1
oxacillin	oxacillin|OXACILLIN	Cc1onc(c1C(=O)NC1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1	UH95VD7V76	Launched	bacterial cell wall synthesis inhibitor	
oxacyclohexadecan-2-one	oxacyclohexadecan-2-one|PENTADECALACTONE	O=C1CCCCCCCCCCCCCCO1	OK17S3S98K	Preclinical	protein kinase inhibitor	
oxaliplatin	oxaliplatin|OXALIPLATIN	O=C1O[Pt]2(NC3CCCC[C@H]3N2)OC1=O	04ZR38536J	Launched	DNA inhibitor	
oxaloacetate	oxaloacetate|OXALOACETIC ACID	OC(=O)CC(=O)C(O)=O	2F399MM81J	Phase 2/Phase 3	glutamate release inhibitor	CS|SPR
oxandrolone	oxandrolone|OXANDROLONE	C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C	7H6TM3CT4L	Launched	androgen receptor agonist	AR
oxantel	oxantel|OXANTEL	CN1CCCN=C1\C=C\c1cccc(O)c1	94AJJ30D9E	Phase 3	anthelmintic agent	
oxaprozin	oxaprozin|OXAPROZIN	OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1	MHJ80W9LRB	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
oxatomide	oxatomide|OXATOMIDE	O=c1[nH]c2ccccc2n1CCCN1CCN(CC1)C(c1ccccc1)c1ccccc1	J31IL9Z2EE	Launched	histamine receptor antagonist	HRH1
oxazepam	oxazepam|OXAZEPAM	OC1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O	6GOW6DWN2A	Launched	GABA benzodiazepine site receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3
oxcarbazepine	oxcarbazepine|OXCARBAZEPINE	NC(=O)N1c2ccccc2CC(=O)c2ccccc12	VZI5B1W380	Launched	sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
oxelaidin	oxelaidin|OXELADIN	CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1	SNC1080T5Y	Launched	antitussive	
oxethazaine	oxethazaine|OXETHAZAINE	CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1	IP8QT76V17	Launched	local anesthetic	
oxfendazole	oxfendazole|OXFENDAZOLE	COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)c1ccccc1	OMP2H17F9E	Launched	anthelmintic agent	
oxfenicine	oxfenicine|OXFENICINE	NC(C(O)=O)c1ccc(O)cc1	9YH0WH2Z02	Phase 1	carnitine palmitoyltransferase inhibitor	CPT1A|CPT1B
oxibendazole	oxibendazole|OXIBENDAZOLE	CCCOc1ccc2nc(NC(=O)OC)[nH]c2c1	022N12KJ0X	Launched	tubulin polymerization inhibitor	TUBB|TUBB4B
oxiconazole	oxiconazole|OXICONAZOLE	Clc1ccc(CO\N=C(/Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1	C668Q9I33J	Launched	bacterial cell wall synthesis inhibitor	
oxidopamine	oxidopamine|OXIDOPAMINE	NCCc1cc(O)c(O)cc1O	8HW4YBZ748	Preclinical	neurotoxin	
oxiniacic-acid	oxiniacic-acid|OXINIACIC ACID	OC(=O)c1ccc[n+]([O-])c1	YY03Q39E6L	Preclinical		
oxiperomide	oxiperomide|OXIPEROMIDE	Oc1nc2ccccc2n1C1CCN(CCOc2ccccc2)CC1	WRO75M6RW2	Phase 2	dopamine receptor antagonist	
oxiracetam	oxiracetam|OXIRACETAM	NC(=O)CN1C[C@H](O)CC1=O	P7U817352G	Launched	acetylcholine receptor agonist	
oxolamine	oxolamine|OXOLAMINE	CCN(CC)CCc1nc(no1)-c1ccccc1	90BEA145GY	Launched	antitussive	
oxolinic-acid	oxolinic-acid|OXOLINIC ACID	CCn1cc(C(O)=O)c(=O)c2cc3OCOc3cc12	L0A22B22FT	Preclinical	bacterial DNA gyrase inhibitor	
oxonic-acid	oxonic-acid|OTERACIL	OC(=O)c1nc(=O)[nH]c(=O)[nH]1	5VT6420TIG	Preclinical	uricase inhibitor	
oxotremorine-m	oxotremorine-m	C[N+](C)(C)CC#CCN1CCCC1=O		Preclinical	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
oxotremorine-sesquifumarate	oxotremorine-sesquifumarate|OXOTREMORINE	O=C1CCCN1CC#CCN1CCCC1	5RY0UWH1JL	Preclinical	cholinergic receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4
oxprenolol	oxprenolol|OXPRENOLOL	CC(C)NCC(O)COc1ccccc1OCC=C	519MXN9YZR	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
oxtriphylline	oxtriphylline|OXTRIPHYLLINE	Cn1c2nc[nH]c2c(=O)n(C)c1=O	3K045XR58X	Launched	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE4A|PDE4B|PDE5A
oxybenzone	oxybenzone|OXYBENZONE	COc1ccc(C(=O)c2ccccc2)c(O)c1	95OOS7VE0Y	Launched	lipase inhibitor	LIPE
oxybuprocaine	oxybuprocaine|BENOXINATE	CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC	AXQ0JYM303	Launched	local anesthetic	SCN10A
oxybutynin	oxybutynin|OXYBUTYNIN	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1	K9P6MC7092	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
oxyclozanide	oxyclozanide|OXYCLOZANIDE	Oc1c(Cl)cc(Cl)cc1NC(=O)c1c(O)c(Cl)cc(Cl)c1Cl	1QS9G4876X	Launched		
oxyfedrine	oxyfedrine|OXYFEDRINE|OXYFEDRINE HYDROCHLORIDE, DL-	COc1cccc(c1)C(=O)CCN[C@@H](C)[C@H](O)c1ccccc1	DWL616XF1K|H1CAC99B4D	Launched	adrenergic receptor agonist	
oxymatrine	oxymatrine|OXYMATRINE	[O-][N+]12CCC[C@@H]3CN4[C@H](CCCC4=O)[C@H](CCC1)[C@@H]23	85U4C366QS	Launched		
oxymetazoline	oxymetazoline|OXYMETAZOLINE	Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C	8VLN5B44ZY	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C
oxymetholone	oxymetholone|OXYMETHOLONE	C[C@@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C(C[C@]4(C)[C@@H]3CC[C@]12C)C=O	L76T0ZCA8K	Launched	androgen receptor agonist	AR
oxyphenbutazone	oxyphenbutazone|OXYPHENBUTAZONE	CCCCC1C(=O)N(N(C1=O)c1ccc(O)cc1)c1ccccc1	H806S4B3NS	Withdrawn	cyclooxygenase inhibitor	PLA2G2E|PTGS1|PTGS2
oxyphencyclimine	oxyphencyclimine|OXYPHENCYCLIMINE	CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)c1ccccc1	4V44H1O8XI	Launched	cholinergic receptor antagonist	CHRM1|CHRM2|CHRM3
oxyphenonium	oxyphenonium|OXYPHENONIUM	CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c1ccccc1	D2G5508Y7I	Launched	cholinergic receptor antagonist	CHRM1
oxypurinol	oxypurinol|OXYPURINOL	O=c1[nH]c2n[nH]cc2c(=O)[nH]1	G97OZE5068	Phase 2/Phase 3	xanthine oxidase inhibitor	XDH
oxyquinoline	oxyquinoline|OXYQUINOLINE	Oc1cccc2cccnc12	5UTX5635HP	Launched	chelating agent	METAP2
oxytetracycline	oxytetracycline|OXYTETRACYCLINE	CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	X20I9EN955	Launched	bacterial 30S ribosomal subunit inhibitor	
oxytocin	oxytocin	CC[C@H](C)C1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O		Launched	oxytocin receptor agonist	AVPR1A|AVPR1B|AVPR2|OXTR
ozagrel	ozagrel|OZAGREL	OC(=O)\C=C\c1ccc(Cn2ccnc2)cc1	L256JB984D	Launched	thromboxane synthase inhibitor	TBXAS1
ozanimod	ozanimod|OZANIMOD	CC(C)Oc1ccc(cc1C#N)-c1nc(no1)-c1cccc2[C@H](CCc12)NCCO	Z80293URPV	Phase 3	sphingosine 1 phosphate receptor agonist	S1PR1
ozolinone	ozolinone|OZOLINONE	CN1C(=O)C(S\C1=C/C(O)=O)N1CCCCC1	55TIT7J81D	Phase 3	diuretic	
p-dimethylinamyl-benzoate	p-dimethylinamyl-benzoate|PENTYL P-DIMETHYLAMINOBENZOATE	CCCCCOC(=O)c1ccc(cc1)N(C)C	3I0HW37A8Q	Preclinical		
P22077	P22077	CC(=O)c1cc(c(Sc2ccc(F)cc2F)s1)[N+]([O-])=O		Preclinical	ubiquitin specific protease inhibitor	USP7
P276-00	P276-00|RIVICICLIB HYDROCHLORIDE	CN1CC[C@H]([C@@H]1CO)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl	DRP53ZDY6H	Phase 2	CDK inhibitor	CDK1|CDK4|CDK9
P5091	P5091	CC(=O)c1cc(c(Sc2cccc(Cl)c2Cl)s1)[N+]([O-])=O		Preclinical	ubiquitin specific protease inhibitor	USP7
PA-824	PA-824|PRETOMANID	[O-][N+](=O)c1cn2C[C@@H](COc2n1)OCc1ccc(OC(F)(F)F)cc1	2XOI31YC4N	Phase 3	nitric oxide donor	FASN
PAC-1	PAC-1	Oc1c(CC=C)cccc1\C=N\NC(=O)CN1CCN(Cc2ccccc2)CC1	9LIS8N0B2C	Phase 1	caspase activator	CASP3
paclitaxel	paclitaxel|PACLITAXEL	CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)C3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1	P88XT4IS4D	Launched	tubulin polymerization inhibitor	BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBB|TUBB1
PACOCF3	PACOCF3	CCCCCCCCCCCCCCCC(=O)C(F)(F)F		Preclinical	phospholipase inhibitor	PLA2G4A
pacritinib	pacritinib|PACRITINIB	C(CN1CCCC1)Oc1ccc2Nc3nccc(n3)-c3cccc(COC\C=C\COCc1c2)c3	G22N65IL3O	Phase 3	FLT3 inhibitor|JAK inhibitor	FLT3|JAK1|JAK2|JAK3
paeoniflorin	paeoniflorin|PEONIFLORIN	C[C@]12C[C@@]3(O)O[C@@H](O1)[C@]1(COC(=O)c4ccccc4)[C@H]3C[C@]21O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O	21AIQ4EV64	Preclinical	anticonvulsant	
paeonol	paeonol|PAEONOL	COc1ccc(C(C)=O)c(O)c1	3R834EPI82	Preclinical	anti-inflammatory agent	
pafuramidine	pafuramidine|PAFURAMIDINE	CONC(=N)c1ccc(cc1)-c1ccc(o1)-c1ccc(cc1)C(=N)NOC	H1VG379J2X	Phase 3	DNA synthesis inhibitor	
palbociclib	palbociclib|PALBOCICLIB	CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O	G9ZF61LE7G	Launched	CDK inhibitor	CDK4|CDK6
palifosfamide	palifosfamide|PALIFOSFAMIDE	OP(=O)(NCCCl)NCCCl	6A4U6NN813	Phase 3	DNA alkylating agent	
paliperidone	paliperidone|PALIPERIDONE	Cc1nc2C(O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12	838F01T721	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CYP2D6|CYP3A4|CYP3A5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1D|HTR2A|HTR2C
palmatine-chloride	palmatine-chloride|PALMATINE CHLORIDE	COc1cc2CC[n+]3cc4c(OC)c(OC)ccc4cc3-c2cc1OC	ZJ6W8881Z8	Preclinical	dopamine synthesis inhibitor	CYP3A4
palmitoleic-acid	palmitoleic-acid|PALMITOLEIC ACID	CCCCCC\C=C/CCCCCCCC(O)=O	209B6YPZ4I	Preclinical		
palmitoylcarnitine	palmitoylcarnitine|PALMITOYL CARNITINE, (-)-|PALMITOYL CARNITINE, (+/-)-	CCCCCCCCCCCCCCCC(=O)OC(CC(O)=O)C[N+](C)(C)C	1G38O5K038|U8K6DKA8V2	Preclinical	protein kinase inhibitor	
palmitoylethanolamide	palmitoylethanolamide|PALMIDROL	CCCCCCCCCCCCCCCC(=O)NCCO	6R8T1UDM3V	Launched	cannabinoid receptor agonist	CNR2|GPR119|GPR55
palomid-529	palomid-529|PALOMID 529	COc1ccc(COc2cc3oc(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1	XV9409EWG4	Phase 1	AKT inhibitor|mTOR inhibitor	MTOR
palonosetron	palonosetron|PALONOSETRON	O=C1N(C[C@H]2CCCc3cccc1c23)[C@@H]1CN2CCC1CC2	5D06587D6R	Launched	serotonin receptor antagonist	HTR3A
palosuran	palosuran|PALOSURAN	Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1	ULD9ZKE457	Phase 2	urotensin receptor antagonist	UTS2R
palovarotene	palovarotene|PALOVAROTENE	CC1(C)CCC(C)(C)c2cc(\C=C\c3ccc(cc3)C(O)=O)c(Cn3cccn3)cc12	28K6I5M16G	Phase 2	retinoid receptor agonist	RARG
pamabrom	pamabrom|PAMABROM	CC(C)(N)CO.Cn1c2nc(Br)[nH]c2c(=O)n(C)c1=O	UA8U0KJM72	Launched	diuretic	
pamidronate	pamidronate|PAMIDRONIC ACID	NCCC(O)(P(O)(O)=O)P(O)(O)=O	OYY3447OMC	Launched	bone resorption inhibitor	FDPS
pancuronium	pancuronium|PANCURONIUM	CC(=O)O[C@@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@@H]3CC[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1	J76UF062FS	Launched	acetylcholine receptor antagonist	CHRM2|CHRM3|CHRNA1|CHRNA2
panobinostat	panobinostat|PANOBINOSTAT	Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1	9647FM7Y3Z	Launched	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9
pantethine	pantethine|PANTETHINE	CC(C)(CO)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO	7K81IL792L	Launched	coenzyme A precursor	
pantoprazole	pantoprazole|PANTOPRAZOLE	COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC	D8TST4O562	Launched	ATPase inhibitor	ATP4A
pantothenic-acid	pantothenic-acid|PANTOTHENIC ACID	CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O	19F5HK2737	Launched	coenzyme A precursor	
papaverine	papaverine|PAPAVERINE	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC	DAA13NKG2Q	Launched	phosphodiesterase inhibitor	PDE10A|PDE4B|PDE5A
para-toluenesulfonamide	para-toluenesulfonamide|P-TOLUENESULFONAMIDE	Cc1ccc(cc1)S(N)(=O)=O	I8266RI90M	Phase 3		CA12|CA2|CA6|CA9
paracetamol	paracetamol|ACETAMINOPHEN	CC(=O)Nc1ccc(O)cc1	362O9ITL9D	Launched	cyclooxygenase inhibitor	FAAH|PTGS1|PTGS2|TRPV1
parachlorophenol	parachlorophenol|PARACHLOROPHENOL	Oc1ccc(Cl)cc1	3DLC36A01X	Launched	antiinfective drug	
paramethadione	paramethadione|PARAMETHADIONE	CCC1(C)OC(=O)N(C)C1=O	Z615FRW64N	Launched	anticonvulsant	CACNA1G|CACNA1H|CACNA1I
paraxanthine	paraxanthine|PARAXANTHINE	Cn1cnc2[nH]c(=O)n(C)c(=O)c12	Q3565Y41V7	Phase 1	adenosine receptor antagonist	
parbendazole	parbendazole|PARBENDAZOLE	CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1	N4X8WVX2UG	Preclinical	tubulin polymerization inhibitor	TUBB
pardoprunox	pardoprunox|PARDOPRUNOX	CN1CCN(CC1)c1cccc2[nH]c(=O)oc12	5R72CHP32S	Phase 3	serotonin receptor agonist|dopamine receptor agonist	DRD2|DRD3|DRD4|HTR1A|HTR7
parecoxib	parecoxib|PARECOXIB	CCC(=O)NS(=O)(=O)c1ccc(cc1)-c1c(C)onc1-c1ccccc1	9TUW81Y3CE	Launched	cyclooxygenase inhibitor	LTF
parethoxycaine	parethoxycaine|PARETHOXYCAINE	CCOc1ccc(cc1)C(=O)OCCN(CC)CC	68E52E5J67	Preclinical	local anesthetic	
pargyline	pargyline|PARGYLINE	CN(CC#C)Cc1ccccc1	9MV14S8G3E	Launched	monoamine oxidase inhibitor	MAOA|MAOB
paricalcitol	paricalcitol|PARICALCITOL	C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1C[C@@H](O)C[C@H](O)C1	6702D36OG5	Launched	vitamin D receptor agonist	VDR
paritaprevir	paritaprevir|PARITAPREVIR	Cc1cnc(cn1)C(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)Oc1nc2ccccc2c2ccccc12)C(=O)NS(=O)(=O)C1CC1	OU2YM37K86	Launched	HCV inhibitor	
paromomycin	paromomycin|PAROMOMYCIN	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)OC(O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	61JJC8N5ZK	Launched	bacterial 30S ribosomal subunit inhibitor	
paroxetine	paroxetine|PAROXETINE	Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1	41VRH5220H	Launched	selective serotonin reuptake inhibitor (SSRI)	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4
paroxypropione	paroxypropione|PAROXYPROPIONE	CCC(=O)c1ccc(O)cc1	X9952001TG	Launched	gonadotropin inhibitor	
parthenolide	parthenolide|PARTHENOLIDE	C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1	2RDB26I5ZB	Phase 1	NFkB pathway inhibitor	
parthenolide-(-)	parthenolide-(-)|PARTHENOLIDE	C\C1=C\CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1	2RDB26I5ZB	Preclinical	NFkB pathway inhibitor	HDAC1
parthenolide-(alternate-stereo)	parthenolide-(alternate-stereo)|PARTHENOLIDE	C\C1=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1	2RDB26I5ZB	Preclinical	NFkB pathway inhibitor	IKBKB|RELA
pasiniazid	pasiniazid|PASINIAZID	NNC(=O)c1ccncc1	83J17CN0MN	Launched	cyclooxygenase inhibitor	
pasireotide	pasireotide|PASIREOTIDE	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1	98H1T17066	Launched	somatostatin receptor agonist	SSTR1|SSTR2|SSTR3|SSTR5
pazopanib	pazopanib|PAZOPANIB	CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1	7RN5DR86CK	Launched	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3
pazufloxacin	pazufloxacin|PAZUFLOXACIN	C[C@H]1COc2c(c(F)cc3c2n1cc(C(O)=O)c3=O)C1(N)CC1	4CZ1R38NDI	Launched	topoisomerase inhibitor	
PCA-4248	PCA-4248	COC(=O)C1=C(C)NC(C)=C(C1C)C(=O)OCCSc1ccccc1		Phase 1	platelet activating factor receptor antagonist	PTAFR
PCI-24781	PCI-24781|ABEXINOSTAT	CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO	IYO470654U	Phase 1/Phase 2	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC6
PCI-34051	PCI-34051	COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1	PUI52VXV61	Preclinical	HDAC inhibitor	HDAC1|HDAC10|HDAC6|HDAC8
PCO-400	PCO-400	CC1(C)Oc2ccc(cc2[C@@H](OC2=CC(=O)CC2)[C@@H]1O)C#N		Phase 1	potassium channel activator	KCNJ8
PD-0325901	PD-0325901	OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	86K0J5AK6M	Phase 2	MEK inhibitor	MAP2K1
PD-102807	PD-102807	CCOC(=O)c1c(C)[nH]c2ccc3OC4N(CCc5cc(OC)ccc45)Cc3c12		Preclinical	acetylcholine receptor antagonist	CHRM4
PD-118057	PD-118057	OC(=O)c1ccccc1Nc1ccc(CCc2ccc(Cl)c(Cl)c2)cc1		Preclinical	potassium channel activator	KCNH2
PD-123319	PD-123319	CN(C)c1ccc(Cn2cnc3CN([C@@H](Cc23)C(O)=O)C(=O)C(c2ccccc2)c2ccccc2)cc1C		Phase 1	angiotensin antagonist	AGTR2
PD-128907	PD-128907	CCCN1CCO[C@H]2[C@@H]1COc1ccc(O)cc21		Preclinical	dopamine receptor agonist	DRD2|DRD3
PD-153035	PD-153035	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC	TC62B68RSL	Phase 1	EGFR inhibitor	EGFR|KDR
PD-156707	PD-156707	COc1ccc(cc1)C(=O)C(\Cc1cc(OC)c(OC)c(OC)c1)=C(/C(O)=O)c1ccc2OCOc2c1		Preclinical	endothelin receptor antagonist	EDNRA|EDNRB
PD-158780	PD-158780	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		Preclinical	EGFR inhibitor	EGFR
PD-160170	PD-160170	CC(C)c1ccccc1S(=O)(=O)c1cc(N)c2ncccc2c1[N+]([O-])=O		Preclinical	neuropeptide receptor antagonist	NPY1R
PD-161570	PD-161570	CCN(CC)CCCCNc1ncc2cc(c(NC(=O)NC(C)(C)C)nc2n1)-c1c(Cl)cccc1Cl		Preclinical	FGFR inhibitor	FGFR1
PD-166793	PD-166793	CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O	U855L3SOXD	Preclinical	collagenase inhibitor|metalloproteinase inhibitor	MMP13|MMP2|MMP3
PD-168077	PD-168077	Cc1cccc(c1)C(=O)NCN1CCN(CC1)c1ccccc1C#N		Preclinical	dopamine receptor agonist	DRD2
PD-168393	PD-168393	Brc1cccc(Nc2ncnc3ccc(NC(=O)C=C)cc23)c1	3R996Y9T0I	Preclinical	EGFR inhibitor	EGFR|ERBB2|SRC
PD-173074	PD-173074	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1	A4TLL8634Y	Preclinical	FGFR inhibitor|VEGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB
PD-184352	PD-184352|CI-1040	Fc1ccc(C(=O)NOCC2CC2)c(Nc2ccc(I)cc2Cl)c1F	R3K9Y00J04	Phase 2	MEK inhibitor	MAP2K1|MAP3K1|MAP3K2
PD-198306	PD-198306	Cc1cc(I)ccc1Nc1c(F)c(F)c(F)cc1C(=O)NOCC1CC1	WQ5121ZGT3	Preclinical	MAP kinase inhibitor|MEK inhibitor	MAP2K1|MAP2K2
PD-318088	PD-318088	OCC(O)CONC(=O)c1cc(Br)c(F)c(F)c1Nc1ccc(I)cc1F		Preclinical	MEK inhibitor	MAP2K1
PD-407824	PD-407824	Oc1ccc2[nH]c3cc(c4C(=O)NC(=O)c4c3c2c1)-c1ccccc1		Preclinical	PKC inhibitor	WEE1
PD-81723	PD-81723	Cc1sc(N)c(C(=O)c2cccc(c2)C(F)(F)F)c1C		Preclinical	adenosine receptor agonist	ADORA1
PD-98059	PD-98059	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		Preclinical	MEK inhibitor	AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1
PD1-PDL-inhibitor-1	PD1-PDL-inhibitor-1	COc1cc(OCc2cccc(-c3ccccc3)c2C)cc(OC)c1CN1CCCC[C@H]1C(O)=O		Preclinical	programmed death ligand inhibitor	CD274
PDE10-IN-1	PDE10-IN-1	Cc1c(nc2c3cccnc3ccn12)[C@@H]1C[C@H]1c1nc2c(C)ncc(C)n2n1		Preclinical	phosphodiesterase inhibitor	PDE10A
peficitinib	peficitinib|PEFICITINIB	NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2	HPH1166CKX	Phase 3	JAK inhibitor	JAK1|JAK2|JAK3
pefloxacin	pefloxacin|PEFLOXACIN	CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCN(C)CC1	2H52Z9F2Q5	Launched	bacterial DNA gyrase inhibitor	TOP2A
pelanserin	pelanserin|PELANSERIN	O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(CC1)c1ccccc1	6SNR96E409	Phase 2	serotonin receptor antagonist	HTR2A
pelitinib	pelitinib|PELITINIB	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C	X5DWL380Z6	Phase 2	EGFR inhibitor	EGFR
pemetrexed	pemetrexed|PEMETREXED	Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1	04Q9AIZ7NO	Launched	dihydrofolate reductase inhibitor|thymidylate synthase inhibitor	ATIC|DHFR|GART|TYMS
pemirolast	pemirolast|PEMIROLAST	Cc1cccn2c1ncc(-c1nnn[nH]1)c2=O	2C09NV773M	Launched	mediator release inhibitor	HRH1
pempidine	pempidine|PEMPIDINE	CN1C(C)(C)CCCC1(C)C	N5I18JI9D6	Launched	ganglionic blocker	
penbutolol	penbutolol|PENBUTOLOL	CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1	78W62V43DY	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|HTR1A|HTR1B
penciclovir	penciclovir|PENCICLOVIR	Nc1nc(O)c2ncn(CCC(CO)CO)c2n1	359HUE8FJC	Launched	DNA directed DNA polymerase inhibitor	
penfluridol	penfluridol|PENFLURIDOL	OC1(CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1ccc(Cl)c(c1)C(F)(F)F	25TLU22Q8H	Launched	T-type calcium channel blocker	CACNA1G
penicillamine-(D)	penicillamine-(D)|PENICILLAMINE	CC(C)(S)[C@@H](N)C(O)=O	GNN1DV99GX	Launched	chelating agent	
penicillamine-(racemic)	penicillamine-(racemic)|PENICILLAMINE, (+/-)-	CC(C)(S)C(N)C(O)=O	2XOP7Y1H98	Preclinical		
penicillin-v-potassium	penicillin-v-potassium|PENICILLIN V	CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(O)=O	Z61I075U2W	Launched	bacterial cell wall synthesis inhibitor	
pentacosanoic-acid	pentacosanoic-acid|PENTACOSANOIC ACID	CCCCCCCCCCCCCCCCCCCCCCCCC(O)=O	4S768OX95G	Preclinical		
pentagastrin	pentagastrin|PENTAGASTRIN	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	EF0NX91490	Launched	CCK receptor agonist	CCKBR
pentamidine	pentamidine|PENTAMIDINE	NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(N)=N)cc1	673LC5J4LQ	Launched	anti-pneumocystis agent	TRDMT1
pentetic-acid	pentetic-acid|PENTETIC ACID	OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O	7A314HQM0I	Phase 2	chelating agent	PGD
pentobarbital	pentobarbital|PENTOBARBITAL	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O	I4744080IR	Withdrawn	barbiturate antiepileptic|GABA receptor modulator	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B
pentolinium	pentolinium|PENTOLINIUM	C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1	ULL76WPU5X	Launched	cholinergic receptor antagonist	CHRNA10|CHRNA3|CHRNA4|CHRNB4
pentostatin	pentostatin|PENTOSTATIN	OC[C@H]1O[C@H](CC1O)n1cnc2[C@H](O)CNC=Nc12	395575MZO7	Launched	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	ADA
pentoxifylline	pentoxifylline|PENTOXIFYLLINE	CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O	SD6QCT3TSU	Launched	phosphodiesterase inhibitor	ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF
pentylenetetrazol	pentylenetetrazol|PENTETRAZOL	C1CCc2nnnn2CC1	WM5Z385K7T	Withdrawn	GABA receptor antagonist	
pepstatin	pepstatin|PEPSTATIN	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O	V6Y2T27Q1U	Preclinical	aspartic protease inhibitor	CTSB|CTSD|CTSL|REN
peramivir	peramivir|PERAMIVIR	CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O	QW7Y7ZR15U	Launched	neuraminidase inhibitor	
perampanel	perampanel|PERAMPANEL	O=c1c(cc(cn1-c1ccccc1)-c1ccccn1)-c1ccccc1C#N	H821664NPK	Launched	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
perchlozone	perchlozone	NC(=S)NN=Cc1ccncc1		Launched		
peretinoin	peretinoin|PERETINOIN	CC(C)=CCC\C(C)=C\CC\C(C)=C\C=C\C(C)=C\C(O)=O	11ALM7A4RV	Phase 3	retinoid receptor agonist	RXRA
perfluamine	perfluamine|PERFLUAMINE	FC(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F	3T396UK091	Launched		
perflubron	perflubron|PERFLUBRON	FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br	Q1D0Q7R4D9	Launched	contrast agent	
perfluorodecalin	perfluorodecalin|PERFLUNAFENE	FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C1(F)F	54A06VV62N	Launched		
pergolide	pergolide|PERGOLIDE	CCCN1C[C@@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13	24MJ822NZ9	Withdrawn	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
perhexiline	perhexiline|PERHEXILINE	C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1	KU65374X44	Launched	carnitine palmitoyltransferase inhibitor	CPT1A|CPT2
perifosine	perifosine|PERIFOSINE	CCCCCCCCCCCCCCCCCCOP(O)(=O)OC1CC[N+](C)(C)CC1	2GWV496552	Phase 3	AKT inhibitor	AKT1
perillyl-alcohol	perillyl-alcohol|PERILLYL ALCOHOL	CC(=C)C1CCC(CO)=CC1	319R5C7293	Phase 2	apoptosis stimulant|farnesyltransferase inhibitor	FNTA
perindopril	perindopril|PERINDOPRIL	CCCC(N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@@H]1C(O)=O)C(=O)OCC	Y5GMK36KGY	Launched	angiotensin converting enzyme inhibitor	ACE
perindoprilat	perindoprilat|PERINDOPRILAT	CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(O)=O	2UV6ZNQ92K	Phase 2	angiotensin converting enzyme inhibitor	ACE
permethrin	permethrin|PERMETHRIN	CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1	509F88P9SZ	Launched		SCN1A
perospirone	perospirone|PEROSPIRONE	O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12	N303OK87DT	Launched	dopamine receptor antagonist|serotonin receptor antagonist	DRD2|DRD3|DRD4
perphenazine	perphenazine|PERPHENAZINE	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1	FTA7XXY4EZ	Launched	dopamine receptor antagonist	CALM1|DRD1|DRD2|HRH1|HTR2A|HTR2C|HTR6|HTR7
peruvoside	peruvoside|PERUVOSIDE	CO[C@H]1[C@@H](O)C(C)O[C@@H](O[C@H]2CC[C@@]3(C=O)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C3=CC(=O)OC3)C2)C1O	CT36KGC6A6	Phase 1	cardiac glycoside	
perzinfotel	perzinfotel|PERZINFOTEL	OP(O)(=O)CCN1CCCNc2c1c(=O)c2=O	FX5AUU7Z8T	Phase 2	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B
PETCM	PETCM	OC(Cc1ccncc1)C(Cl)(Cl)Cl		Preclinical	caspase activator	CASP3
pevonedistat	pevonedistat|PEVONEDISTAT	NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n1ccc2c(N[C@H]3CCc4ccccc34)ncnc12	S3AZD8D215	Phase 2	nedd activating enzyme inhibitor	NAE1|UBA3
pexidartinib	pexidartinib|PEXIDARTINIB	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	6783M2LV5X	Phase 3	tyrosine kinase inhibitor	CSF1R|FLT3|KIT
pexmetinib	pexmetinib|PEXMETINIB	Cc1ccc(cc1)-n1nc(cc1NC(=O)NCc1cc(F)ccc1Oc1ccc2n(CCO)ncc2c1)C(C)(C)C	3750D0U8B5	Phase 1	TIE tyrosine kinase inhibitor|MAP kinase inhibitor	MAPK14|TEK
PF-02545920	PF-02545920|PF-2545920	Cn1cc(c(n1)-c1ccc(OCc2ccc3ccccc3n2)cc1)-c1ccncc1	R9Y8EY0G42	Phase 2	phosphodiesterase inhibitor	PDE10A
PF-03049423	PF-03049423	CCCOCCn1c2cc(ncc2nc(N2CCN(CCO)CC2)c1=O)-c1ccc(OC)nc1		Phase 2	phosphodiesterase inhibitor	PDE5A
PF-03084014	PF-03084014|NIROGACESTAT	CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(cn1)C(C)(C)CNCC(C)(C)C	QZ62892OFJ	Phase 2	gamma secretase inhibitor	
PF-03758309	PF-03758309	CN(C)C[C@@H](NC(=O)N1Cc2c(Nc3nc(C)nc4ccsc34)n[nH]c2C1(C)C)c1ccccc1	PK459EA5I2	Phase 1	p21 activated kinase inhibitor	PAK4
PF-03814735	PF-03814735	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(c(NC4CCC4)n3)C(F)(F)F)ccc21	6V5T4O5758	Phase 1	Aurora kinase inhibitor	AURKA|AURKB
PF-03882845	PF-03882845	OC(=O)c1ccc2C3=C(CCc2c1)[C@H](C1CCCC1)N(N3)c1ccc(C#N)c(Cl)c1	34ZKU73FU3	Phase 1		
PF-04136309	PF-04136309	O[C@]1(CC[C@@H](CC1)N[C@H]1CCN(C1)C(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc(cn1)-c1ncccn1		Phase 2	CC chemokine receptor antagonist	
PF-04217903	PF-04217903	OCCn1cc(cn1)-c1cnc2nnn(Cc3ccc4ncccc4c3)c2n1	CYJ9ATV1IJ	Phase 1	c-Met inhibitor	MET
PF-04418948	PF-04418948	COc1ccc2cc(OCC3(CN(C3)C(=O)c3ccc(F)cc3)C(O)=O)ccc2c1	I7Z38E70VF	Phase 1	prostaglandin inhibitor	PTGER2
PF-04447943	PF-04447943	C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2n(ncc2c(=O)[nH]1)C1CCOCC1	7N969W8Y4O	Phase 2	phosphodiesterase inhibitor	PDE9A
PF-04457845	PF-04457845	FC(F)(F)c1ccc(Oc2cccc(C=C3CCN(CC3)C(=O)Nc3cccnn3)c2)nc1	H4C81M8YYW	Phase 2	FAAH inhibitor	FAAH
PF-04620110	PF-04620110	Nc1ncnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC(O)=O)CC3)C(=O)c12		Phase 1	diacylglycerol O acyltransferase inhibitor	DGAT1
PF-04691502	PF-04691502	COc1ccc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCCO)c1=O	4W39NS61KI	Phase 2	mTOR inhibitor|PI3K inhibitor	MTOR|PIK3CA
PF-04937319	PF-04937319	CN(C)C(=O)c1ncc(Oc2cc(cc3oc(C)cc23)C(=O)Nc2cnc(C)cn2)cn1		Phase 2	glucokinase activator	GCK
PF-05190457	PF-05190457	Cc1cn2cc(CC(=O)N3CCC4(CN(C4)[C@@H]4CCc5cc(ccc45)-c4cc(C)ncn4)CC3)nc2s1		Phase 2	growth hormone secretagogue receptor inverse agonist	GHSR
PF-05212384	PF-05212384|GEDATOLISIB	CN(C)C1CCN(CC1)C(=O)c1ccc(NC(=O)Nc2ccc(cc2)-c2nc(nc(n2)N2CCOCC2)N2CCOCC2)cc1	96265TNH2R	Phase 2	mTOR inhibitor|PI3K inhibitor	MTOR|PIK3CA
PF-06447475	PF-06447475	N#Cc1cccc(c1)-c1c[nH]c2ncnc(N3CCOCC3)c12		Preclinical	serine/threonine kinase inhibitor	LRRK2
PF-06463922	PF-06463922|LORLATINIB	CC1Oc2cc(cnc2N)-c2c(CN(C)C(=O)c3ccc(F)cc13)nn(C)c2C#N	OSP71S83EU	Phase 2	ALK tyrosine kinase receptor inhibitor	ALK|FES|ROS1
PF-3274167	PF-3274167	COCc1nnc(N2CC(C2)Oc2ccc(F)cc2Cl)n1-c1ccc(OC)nc1		Phase 2	oxytocin receptor antagonist	AVPR1A|OXTR
PF-3845	PF-3845	FC(F)(F)c1ccc(Oc2cccc(CC3CCN(CC3)C(=O)Nc3cccnc3)c2)nc1	Q3PW846TYN	Preclinical	FAAH inhibitor	FAAH
PF-4708671	PF-4708671	CCc1cncnc1N1CCN(CC1)Cc1nc2cc(ccc2[nH]1)C(F)(F)F		Preclinical	ribosomal protein inhibitor	RPS6KB1
PF-477736	PF-477736	Cn1cc(cn1)-c1[nH]c2cc(NC(=O)[C@H](N)C3CCCCC3)cc3c2c1cn[nH]c3=O	XO23PGZ0SM	Phase 1	CHK inhibitor	CHEK1|CHEK2
PF-4981517	PF-4981517	Cc1ccc(cc1)-c1c(cnn1C)-c1nn(C)c2ncnc(N3CC[C@@H](C3)N3CCCCC3)c12		Preclinical	cytochrome P450 inhibitor	CYP3A4
PF-5274857	PF-5274857	Cc1cnc(c(C)c1)-c1cc(ncc1Cl)N1CCN(CC1)C(=O)CCS(C)(=O)=O		Preclinical	smoothened receptor antagonist	SMO
PF-562271	PF-562271	CN(c1ncccc1CNc1nc(Nc2ccc3NC(=O)Cc3c2)ncc1C(F)(F)F)S(C)(=O)=O		Phase 1	focal adhesion kinase inhibitor	PTK2|PTK2B
PF-573228	PF-573228	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4NC(=O)CCc4c3)ncc2C(F)(F)F)c1		Preclinical	focal adhesion kinase inhibitor	CDK1|CDK2|CDK7|GSK3B|IKBKB
PF-670462	PF-670462	Nc1nccc(n1)-c1c(ncn1C1CCCCC1)-c1ccc(F)cc1	D68ANS5I8B	Preclinical	casein kinase inhibitor	CSNK1D|CSNK1E
PF-8380	PF-8380	Clc1cc(Cl)cc(COC(=O)N2CCN(CCC(=O)c3ccc4[nH]c(=O)oc4c3)CC2)c1		Preclinical	autotaxin inhibitor	ENPP2
PF-915275	PF-915275	Nc1cccc(NS(=O)(=O)c2ccc(cc2)-c2ccc(cc2)C#N)n1	388927163B	Phase 1	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1
PFI-1	PFI-1	COc1ccccc1S(=O)(=O)Nc1ccc2NC(=O)N(C)Cc2c1		Preclinical	bromodomain inhibitor	BRD4
PFK-015	PFK-015	O=C(\C=C\c1ccc2ccccc2n1)c1ccncc1		Phase 1	phosphofructokinase inhibitor	PFKFB3
PFK-158	PFK-158	FC(F)(F)c1ccc2ccc(\C=C\C(=O)c3ccncc3)nc2c1		Phase 1	phosphofructokinase inhibitor	PFKFB3
PG-9	PG-9	CC(C(=O)OC1CC2CCC(C1)N2C)c1ccc(Br)cc1		Preclinical	acetylcholine receptor agonist	
PGL5001	PGL5001|BENTAMAPIMOD	N#CC(c1nc2ccccc2s1)c1ccnc(OCc2ccc(CN3CCOCC3)cc2)n1	TT3L4B4U0N	Phase 2	JNK inhibitor	MAPK10|MAPK8|MAPK9
PH-797804	PH-797804	CNC(=O)c1ccc(C)c(c1)-n1c(C)cc(OCc2ccc(F)cc2F)c(Br)c1=O	SI09I1V827	Phase 2	p38 MAPK inhibitor	MAPK11|MAPK14
PHA-665752	PHA-665752	Cc1[nH]c(\C=C2\C(=O)Nc3ccc(cc23)S(=O)(=O)Cc2c(Cl)cccc2Cl)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1	0VXU5T5R3J	Preclinical	c-Met inhibitor	MET
PHA-680632	PHA-680632	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1		Preclinical	Aurora kinase inhibitor	AURKA|AURKB|AURKC
PHA-767491	PHA-767491	O=C1NCCc2[nH]c(cc12)-c1ccncc1		Preclinical	CDC inhibitor	CDK1|RPS6KB1
PHA-793887	PHA-793887	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C	MKS45S912B	Phase 1	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CDK7|CDK9
PHA-848125	PHA-848125|MILCICLIB	CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21	688000M8S8	Phase 2	CDK inhibitor|growth factor receptor inhibitor	CDK2|CDK4|CDK7|NTRK1
PHCCC	PHCCC	O\N=C1/C2CC2(Oc2ccccc12)C(=O)Nc1ccccc1		Preclinical	glutamate receptor agonist	GRM1|GRM4
phenacaine	phenacaine|PHENACAINE	CCOc1ccc(NC(C)=Nc2ccc(OCC)cc2)cc1	V3M4D317W8	Launched	local anesthetic	
phenacemide	phenacemide|PHENACEMIDE	NC(=O)NC(=O)Cc1ccccc1	PAI7J52V09	Launched	sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
phenacetin	phenacetin|PHENACETIN	CCOc1ccc(NC(C)=O)cc1	ER0CTH01H9	Withdrawn	cyclooxygenase inhibitor	PTGS1
phenazone	phenazone|ANTIPYRINE	Cc1cc(=O)n(-c2ccccc2)n1C	T3CHA1B51H	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
phenazopyridine	phenazopyridine|PHENAZOPYRIDINE	Nc1ccc(\N=N\c2ccccc2)c(N)n1	K2J09EMJ52	Launched	local anesthetic	SCN1A
phenelzine	phenelzine|PHENELZINE	NNCCc1ccccc1	O408N561GF	Launched	monoamine oxidase inhibitor	ABAT|AOC3|GAD2|GPT|GPT2|MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4
phenethicillin	phenethicillin|PHENETICILLIN	CC(Oc1ccccc1)C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O	EFA30X554H	Launched	bacterial cell wall synthesis inhibitor	
phenethyl-isothiocyanate	phenethyl-isothiocyanate|PHENETHYL ISOTHIOCYANATE	S=C=NCCc1ccccc1	6U7TFK75KV	Phase 2	anticancer agent	CYP2E1
phenformin	phenformin|PHENFORMIN	NC(=N)NC(=N)NCCc1ccccc1	DD5K7529CE	Withdrawn	AMPK activator	KCNJ8|PRKAA1
phenindamine	phenindamine|PHENINDAMINE	CN1CCC2=C(C1)C(c1ccccc21)c1ccccc1	772BQ8KSST	Launched	histamine receptor antagonist	HRH1
phenindione	phenindione|PHENINDIONE	O=C1C(C(=O)c2ccccc12)c1ccccc1	5M7Y6274ZE	Launched	vitamin K antagonist	VKORC1
pheniramine	pheniramine|PHENIRAMINE	CN(C)CCC(c1ccccc1)c1ccccn1	134FM9ZZ6M	Launched	histamine receptor antagonist	HRH1
phenol	phenol|PHENOL	Oc1ccccc1	339NCG44TV	Preclinical		CA1|CA12|CA14|CA2|CA4|CA9
phenolphthalein	phenolphthalein|PHENOLPHTHALEIN	Oc1ccc(cc1)C1(OC(=O)c2ccccc12)c1ccc(O)cc1	6QK969R2IF	Withdrawn	indicator dye	UGT1A9
phenolsulfonphthalein	phenolsulfonphthalein|PHENOLSULFONPHTHALEIN	Oc1ccc(cc1)C1(OS(=O)(=O)c2ccccc12)c1ccc(O)cc1	I6G9Y0J1OJ	Launched		
phenothiazine	phenothiazine|PHENOTHIAZINE	N1c2ccccc2Sc2ccccc12	GS9EX7QNU6	Preclinical	dopamine receptor antagonist	
phenothrin	phenothrin|PHENOTHRIN	CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C	707484X33X	Launched		
phenoxybenzamine	phenoxybenzamine|PHENOXYBENZAMINE	CC(COc1ccccc1)N(CCCl)Cc1ccccc1	0TTZ664R7Z	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB2|CALM1
phenprobamate	phenprobamate|PHENPROBAMATE	NC(=O)OCCCc1ccccc1	UJZ473TPS0	Launched	muscle relaxant	
phenprocoumon	phenprocoumon|PHENPROCOUMON	CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O	Q08SIO485D	Launched	vitamin K antagonist	VKORC1
phenserine	phenserine|PHENSERINE, (+/-)-|PHENSERINE	CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21	N8142NV8UM|SUE285UG3S	Phase 3	acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor	ACHE|BCHE
phensuximide	phensuximide|PHENSUXIMIDE	CN1C(=O)CC(C1=O)c1ccccc1	6WVL9C355G	Launched	succinimide antiepileptic	CACNA1G|CACNA1H|CACNA1I
phentermine	phentermine|PHENTERMINE	CC(C)(N)Cc1ccccc1	C045TQL4WP	Launched	dopamine uptake inhibitor|serotonin reuptake inhibitor	MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4
phentolamine	phentolamine|PHENTOLAMINE	Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1	Z468598HBV	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
phenyl-aminosalicylate	phenyl-aminosalicylate|PHENYL AMINOSALICYLATE	Nc1ccc(C(=O)Oc2ccccc2)c(O)c1	52936SIP7V	Launched		
phenyl-salicylate	phenyl-salicylate|PHENYL SALICYLATE	Oc1ccccc1C(=O)Oc1ccccc1	28A37T47QO	Launched	antiseptic	
phenylacetylglutamine	phenylacetylglutamine	NC(=O)CC[C@H](NC(=O)Cc1ccccc1)C(O)=O		Phase 2	DNA methylase inhibitor|protein synthesis inhibitor	
phenylbenzimidazole-sulfonic-acid	phenylbenzimidazole-sulfonic-acid|ENSULIZOLE	OS(=O)(=O)c1ccc2[nH]c(nc2c1)-c1ccccc1	9YQ9DI1W42	Launched		
phenylbutazone	phenylbutazone|PHENYLBUTAZONE	CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1	GN5P7K3T8S	Withdrawn	cyclooxygenase inhibitor|prostanoid receptor antagonist	PTGIS|PTGS1|PTGS2
phenylbutyrate	phenylbutyrate|PHENYLBUTYRIC ACID	OC(=O)CCCc1ccccc1	7WY7YBI87E	Launched	HDAC inhibitor	HDAC1
phenylephrine	phenylephrine|PHENYLEPHRINE	CNC[C@H](O)c1cccc(O)c1	1WS297W6MV	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D
phenylethyl-alcohol	phenylethyl-alcohol|PHENYLETHYL ALCOHOL	OCCc1ccccc1	ML9LGA7468	Preclinical		
phenylmercuric-acetate	phenylmercuric-acetate|PHENYLMERCURIC ACETATE	CC(=O)O[Hg]c1ccccc1	OSX88361UX	Preclinical	other antifungal	
phenylmethylsulfonyl-fluoride	phenylmethylsulfonyl-fluoride|PHENYLMETHANESULFONYL FLUORIDE	FS(=O)(=O)Cc1ccccc1	57KD15003I	Preclinical	serine protease inhibitor	
phenylpiracetam	phenylpiracetam|FONTURACETAM	NC(=O)CN1CC(CC1=O)c1ccccc1	99QW5JU66Y	Launched	noradrenaline uptake inhibitor	
phenytoin	phenytoin|PHENYTOIN	O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1	6158TKW0C5	Launched	hydantoin antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
phloretin	phloretin|PHLORETIN	Oc1ccc(CCC(=O)c2c(O)cc(O)cc2O)cc1	S5J5OE47MK	Launched	sodium/glucose cotransporter inhibitor	AQP9|CLCN3|SLC23A1
phlorizin	phlorizin|PHLORIZIN	OC[C@H]1O[C@@H](Oc2cc(O)cc(O)c2C(=O)CCc2ccc(O)cc2)[C@@H](O)[C@@H](O)[C@@H]1O	CU9S17279X	Preclinical	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A11|SLC5A2|SLC5A3
phloroglucin	phloroglucin|PHLOROGLUCINOL	Oc1cc(O)cc(O)c1	DHD7FFG6YS	Launched		
phortress	phortress	Cc1cc(ccc1NC(=O)[C@@H](N)CCCCN)-c1nc2cc(F)ccc2s1		Phase 1	aryl hydrocarbon receptor ligand	AHR
phosphatidylcholine	phosphatidylcholine	CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC		Launched		PCTP
PHT-427	PHT-427	CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc1nncs1		Preclinical	AKT inhibitor|pyruvate dehydrogenase inhibitor	AKT2|PDPK1
phthalylsulfacetamide	phthalylsulfacetamide|PHTHALYLSULFACETAMIDE	CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2C(O)=O)cc1	24PUW23GRX	Preclinical		
phthalylsulfathiazole	phthalylsulfathiazole|PHTHALYLSULFATHIAZOLE	OC(=O)c1ccccc1C(=O)Nc1ccc(cc1)S(=O)(=O)Nc1nccs1	6875L5852V	Launched	dihydropteroate synthetase inhibitor	
PHTPP	PHTPP	Oc1ccc(cc1)-c1c(nn2c(cc(nc12)C(F)(F)F)C(F)(F)F)-c1ccccc1		Preclinical	estrogen receptor antagonist	ESR2
physostigmine	physostigmine|PHYSOSTIGMINE	CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1	9U1VM840SP	Launched	cholinesterase inhibitor	ACHE|BCHE
physostigmine-salicylate	physostigmine-salicylate|PHYSOSTIGMINE SALICYLATE	CNC(=O)Oc1ccc2N(C)C3N(C)CC[C@@]3(C)c2c1	2046ZRO9VU	Phase 3	acetylcholinesterase inhibitor	
phytonadione	phytonadione|PHYTONADIONE, (E)-	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O	S5Z3U87QHF	Launched		BGLAP|GGCX
phytosphingosine	phytosphingosine|PHYTOSPHINGOSINE	CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO	GIN46U9Q2Q	Phase 1		
PI-103	PI-103	Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1	YQX02F616F	Preclinical	mTOR inhibitor|PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC
PI-828	PI-828	Nc1ccc(cc1)-c1cccc2c1oc(cc2=O)N1CCOCC1		Preclinical	PI3K inhibitor	
PI3K-IN-2	PI3K-IN-2	Nc1cc(c(cn1)-c1nc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F		Phase 2	PI3K inhibitor	
PI4KIII-beta-inhibitor-1	PI4KIII-beta-inhibitor-1	COc1ccc(cc1S(=O)(=O)Nc1ccc(O)cc1)-c1sc(NC(=O)C(C)(C)C)nc1C		Preclinical	PI4K inhibitor	PI4K2B
pibenzimol	pibenzimol|PIBENZIMOL	CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1ccc2nc([nH]c2c1)-c1ccc(O)cc1	LHQ7J5KV9B	Phase 2	DNA inhibitor	
piboserod	piboserod|PIBOSEROD	CCCCN1CCC(CNC(=O)c2c3OCCCn3c3ccccc23)CC1	4UQ3S81B25	Phase 2	serotonin receptor antagonist	HTR2B|HTR4
picartamide	picartamide|PICARTAMIDE	CNC(=S)C1(CCCS1)c1ccccn1	7JZ930H2M6	Phase 2	H+/K+-ATPase inhibitor	ATP4A
piceatannol	piceatannol|PICEATANNOL	Oc1cc(O)cc(c1)\C=C\c1ccc(O)c(O)c1	6KS3LS0D4F	Preclinical	SYK inhibitor	ATP5A1|ATP5B|ATP5C1|IRF3
piclamilast	piclamilast|PICLAMILAST	COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl	WM58D7C3ZT	Phase 2	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D
picolamine	picolamine|PICOLAMINE	NCc1cccnc1	31LA41942J	Preclinical		
picolinic-acid	picolinic-acid|PICOLINIC ACID	O=C(O[Cr](OC(=O)c1ccccn1)OC(=O)c1ccccn1)c1ccccn1	QZV2W997JQ	Phase 2	chelating agent	
piconol	piconol|PICONOL	OCc1ccccn1	7HQ8UT1TPS	Preclinical		
picotamide	picotamide|PICOTAMIDE	COc1ccc(cc1C(=O)NCc1cccnc1)C(=O)NCc1cccnc1	654G2VCI4Q	Launched	thromboxane receptor antagonist|thromboxane synthase inhibitor	TBXA2R
picrotin	picrotin|PICROTIN	CC(C)(O)C1C2OC(=O)C1C1(O)CC3OC33C(=O)OC2C13C	U06Z6QD7N2	Phase 2	GABA receptor antagonist	GABRA1|GABRR1|GLRA1|GLRA2|GLRA3|GLRB
picrotoxinin	picrotoxinin|PICROTOXININ	CC(=C)[C@@H]1[C@H]2OC(=O)[C@H]1[C@]1(O)C[C@H]3O[C@]33C(=O)O[C@H]2[C@]13C	9K011NUF0R	Preclinical	GABA receptor antagonist	GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B
pidolic-acid	pidolic-acid|PIDOLIC ACID	OC(=O)[C@@H]1CCC(=O)N1	SZB83O1W42	Launched		ADAM28|AMY1A|AMY2A|AMY2B|ANG|CCL8|HCRT|IGLC1|KRTAP5-2|TFF2|VEGFA
pidotimod	pidotimod|PIDOTIMOD	OC(=O)[C@@H]1CSCN1C(=O)[C@@H]1CCC(=O)N1	785363R681	Launched	interferon receptor agonist|interleukin receptor agonist	
pifithrin-alpha	pifithrin-alpha	Cc1ccc(cc1)C(=O)Cn1c2CCCCc2sc1=N		Preclinical	TP53 inhibitor	TP53
pifithrin-mu	pifithrin-mu|PIFITHRIN-.ALPHA.	NS(=O)(=O)C#Cc1ccccc1	D213B92S1Y	Preclinical	HSP inhibitor	HSPA1A|TP53
PIK-293	PIK-293	Cc1ccccc1-n1c(Cn2ncc3c(N)ncnc23)nc2cccc(C)c2c1=O		Preclinical	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
PIK-294	PIK-294	Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc23)nc2cccc(C)c2c1=O		Preclinical	PI3K inhibitor	PIK3CB|PIK3CD|PIK3CG
PIK-75	PIK-75	CN(\N=C\c1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O	9058I8S63D	Preclinical	DNA protein kinase inhibitor|PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC
PIK-93	PIK-93	CC(=O)Nc1nc(C)c(s1)-c1ccc(Cl)c(c1)S(=O)(=O)NCCO		Preclinical	PI3K inhibitor	PI4KB|PIK3C3|PIK3CG
pikamilone	pikamilone|PICAMILON	OC(=O)CCCNC(=O)c1cccnc1	0S5N9SEK4N	Phase 1		
piketoprofen	piketoprofen|PIKETOPROFEN	CC(C(=O)Nc1cc(C)ccn1)c1cccc(c1)C(=O)c1ccccc1	362QBC4NL0	Launched	cyclooxygenase inhibitor	
pilaralisib	pilaralisib|PILARALISIB	COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1	60ES45KTMK	Phase 2	PI3K inhibitor	
pilocarpine	pilocarpine|PILOCARPINE	CC[C@H]1[C@@H](Cc2cncn2C)COC1=O	01MI4Q9DI3	Launched	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
pilsicainide	pilsicainide|PILSICAINIDE	Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2	AV0X7V6CSE	Launched	sodium channel blocker	SCN5A
PIM-1-Inhibitor-2	PIM-1-Inhibitor-2	Nc1nccc(n1)-c1ccc2noc(-c3ccc(Cl)cc3)c2c1		Preclinical	Pim kinase inhibitor	PIM1
pimavanserin	pimavanserin|PIMAVANSERIN	CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1	JZ963P0DIK	Launched	serotonin receptor inverse agonist	DRD2|HTR2A
pimecrolimus	pimecrolimus|PIMECROLIMUS	CC[C@@H]1\C=C(C)\C[C@H](C)C[C@H](OC)[C@@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(\C)=C\[C@@H]1CC[C@@H](Cl)[C@@H](C1)OC	7KYV510875	Launched	calcineurin inhibitor	FKBP1A|MTOR
pimethixene	pimethixene|PIMETHIXENE	CN1CCC(CC1)=C1c2ccccc2Sc2ccccc12	T46J20J26F	Launched	antihistamine	
pimobendan	pimobendan|PIMOBENDAN|PIMOBENDAN, (+)-|PIMOBENDAN, (-)-	COc1ccc(cc1)-c1nc2cc(ccc2[nH]1)C1=NNC(=O)CC1C	34AP3BBP9T|613JXV89SU|9HTU209Z0N	Launched	calcium sensitizer|phosphodiesterase inhibitor	PDE3A
pimonidazole	pimonidazole|PIMONIDAZOLE	OC(CN1CCCCC1)Cn1ccnc1[N+]([O-])=O	46JO4D76R2	Phase 3		
pimozide	pimozide|PIMOZIDE	Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1	1HIZ4DL86F	Launched	dopamine receptor antagonist	CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2
pinacidil	pinacidil|PINACIDIL	CC(N\C(Nc1ccncc1)=N\C#N)C(C)(C)C	7B0ZZH8P2W	Launched	ATP channel activator|potassium channel activator	ABCC8|ABCC9
pinanediol	pinanediol|PINANEDIOL	CC1(C)[C@@H]2C[C@H]1[C@@](C)(O)[C@@H](O)C2	R58L0W3A75	Preclinical		
pinaverium	pinaverium|PINAVERIUM	COc1cc(Br)c(C[N+]2(CCOCCC3CC[C@H]4C[C@@H]3C4(C)C)CCOCC2)cc1OC	U2368VVE7O	Launched	T-type calcium channel blocker	CACNA1C
pincainide	pincainide|PINCAINIDE	Cc1cccc(C)c1NC(=O)CN1CCCCCC1	66803GMO3G	Phase 1	antiarrhythmic	
pindolol	pindolol|PINDOLOL	CC(C)NCC(O)COc1cccc2[nH]ccc12	BJ4HF6IU1D	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|HTR1A|HTR1B|HTR2A|HTR2B
pindolol-(-)	pindolol-(-)|PINDOLOL	CC(C)NC[C@H](O)COc1cccc2[nH]ccc12	BJ4HF6IU1D	Preclinical	adrenergic receptor antagonist|serotonin receptor antagonist	HTR1A
pinitol	pinitol|METHYLINOSITOL, (+/-)-|METHYLINOSITOL	COC1C(O)[C@@H](O)C(O)C(O)[C@H]1O	N55OCE7X7M|TF9HZN9T0M	Phase 2	gamma secretase inhibitor	
pinocembrin	pinocembrin|PINOCEMBRIN	Oc1cc(O)c2C(=O)C[C@H](Oc2c1)c1ccccc1	8T7C8CH791	Phase 2	cytochrome P450 inhibitor	CYP1B1
pioglitazone	pioglitazone|PIOGLITAZONE	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1	X4OV71U42S	Launched	insulin sensitizer|PPAR receptor agonist	PPARG|TRPM3
pipamperone	pipamperone|PIPAMPERONE	NC(=O)C1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)N1CCCCC1	5402501F0W	Launched	dopamine receptor antagonist	DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR2A
pipecuronium	pipecuronium|PIPECURONIUM	CC(=O)OC1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1	1N3O74HM92	Launched	neuromuscular blocker	CHRM2|CHRM3|CHRNA2
pipemidic-acid	pipemidic-acid|PIPEMIDIC ACID	CCn1cc(C(O)=O)c(=O)c2cnc(nc12)N1CCNCC1	LT12J5HVR8	Launched	topoisomerase inhibitor	
pipenzolate	pipenzolate|PIPENZOLATE	CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1	RS3K5YXV34	Launched	cholinergic receptor antagonist	CHRM1
piperacetazine	piperacetazine|PIPERACETAZINE	CC(=O)c1ccc2Sc3ccccc3N(CCCN3CCC(CCO)CC3)c2c1	KL6248WNW4	Launched	dopamine receptor antagonist	
piperacillin	piperacillin|PIPERACILLIN	CCN1CCN(C(=O)NC(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O	X00B0D5O0E	Launched	bacterial cell wall synthesis inhibitor	
piperaquine-phosphate	piperaquine-phosphate|PIPERAQUINE PHOSPHATE	Clc1ccc2c(ccnc2c1)N1CCN(CCCN2CCN(CC2)c2ccnc3cc(Cl)ccc23)CC1	854D7K8LXB	Launched	antimalarial agent	
piperazine	piperazine|PIPERAZINE	C1CNCCN1	1RTM4PAL0V	Launched	benzodiazepine receptor agonist	GABRB3
piperazinedione	piperazinedione|2,5-PIPERAZINEDIONE	O=C1CNC(=O)CN1	240L69DTV7	Phase 2	DNA synthesis inhibitor	
piperidolate	piperidolate|PIPERIDOLATE	CCN1CCCC(C1)OC(=O)C(c1ccccc1)c1ccccc1	RJO31255V9	Launched	acetylcholine receptor antagonist	CHRM1
piperine	piperine|PIPERINE	O=C(\C=C\C=C\c1ccc2OCOc2c1)N1CCCCC1	U71XL721QK	Phase 1	monoamine oxidase inhibitor	MAOA|MAOB|TRPV1
piperonyl-butoxide	piperonyl-butoxide|PIPERONYL BUTOXIDE	CCCCOCCOCCOCc1cc2OCOc2cc1CCC	LWK91TU9AH	Launched	cytochrome P450 inhibitor	
pipobroman	pipobroman|PIPOBROMAN	BrCCC(=O)N1CCN(CC1)C(=O)CCBr	6Q99RDT97R	Launched	DNA alkylating agent	
pipotiazine-palmitate	pipotiazine-palmitate|PIPOTIAZINE PALMITATE	CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(cc23)S(=O)(=O)N(C)C)CC1	4Q3H01QRMI	Launched	dopamine receptor antagonist|serotonin receptor antagonist	DRD1|DRD2|HTR1A|HTR2A
piracetam	piracetam|PIRACETAM	NC(=O)CN1CCCC1=O	ZH516LNZ10	Launched	acetylcholine receptor agonist	GRIA1|GRIA2|GRIA3|GRIA4
pirarubicin	pirarubicin|PIRARUBICIN	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO	D58G680W0G	Launched	topoisomerase inhibitor	TOP2A
pirenoxine	pirenoxine|PIRENOXINE	OC(=O)c1cc(O)c2c3nc4ccccc4oc3cc(=O)c2n1	27L0EP6IZK	Launched	AGE inhibitor	
pirenperone	pirenperone|PIRENPERONE	Cc1nc2ccccn2c(=O)c1CCN1CCC(CC1)C(=O)c1ccc(F)cc1	Y9FMC4513X	Preclinical	serotonin receptor antagonist	HTR2A|HTR7
pirenzepine	pirenzepine|PIRENZEPINE	CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1	3G0285N20N	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
piretanide	piretanide|PIRETANIDE	NS(=O)(=O)c1cc(cc(N2CCCC2)c1Oc1ccccc1)C(O)=O	DQ6KK6GV93	Launched	glucocorticoid receptor agonist	SLC12A1|SLC12A2
pirfenidone	pirfenidone|PIRFENIDONE	Cc1ccc(=O)n(c1)-c1ccccc1	D7NLD2JX7U	Launched	TGF beta receptor inhibitor	FURIN|TNF
piribedil	piribedil|PIRIBEDIL	C(N1CCN(CC1)c1ncccn1)c1ccc2OCOc2c1	DO22K1PRDJ	Launched	dopamine receptor agonist	ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B
piricapiron	piricapiron	CC1(C)C2CCC1(C)C(=O)N(CCCCN1CCN(CC1)c1ccccn1)C2=O		Phase 2	dopamine receptor antagonist|serotonin receptor antagonist	HTR2A
pirinixic-acid	pirinixic-acid|PIRINIXIC ACID	Cc1cccc(Nc2cc(Cl)nc(SCC(O)=O)n2)c1C	86C4MRT55A	Preclinical	PPAR receptor agonist	PPARA
pirlindole	pirlindole|PIRLINDOLE	Cc1ccc2n3CCNC4CCCc(c34)c2c1	V39YPH45FZ	Launched	monoamine oxidase inhibitor	MAOA
piroctone-olamine	piroctone-olamine|PIROCTONE OLAMINE	CC(Cc1cc(C)cc(=O)n1O)CC(C)(C)C	A4V5C6R9FB	Launched		
pirodavir	pirodavir|PIRODAVIR	CCOC(=O)c1ccc(OCCC2CCN(CC2)c2ccc(C)nn2)cc1	BML697718K	Phase 2		
piromidic-acid	piromidic-acid|PIROMIDIC ACID	CCn1cc(C(O)=O)c(=O)c2cnc(nc12)N1CCCC1	3I12WH4EWF	Phase 2	bacterial DNA gyrase inhibitor	
piroxicam	piroxicam|PIROXICAM	CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O	13T4O6VMAM	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
piroximone	piroximone|PIROXIMONE	CCc1[nH]c(O)nc1C(=O)c1ccncc1	2VSD0380YB	Phase 2	phosphodiesterase inhibitor	PDE3A
pirquinozol	pirquinozol|PIRQUINOZOL	OCc1cc2c3ccccc3[nH]c(=O)n2n1	D16HG4V2UC	Phase 1	histamine release inhibitor	
PIT	PIT	[O-][N+]1=C(C(=O)c2ccccc12)c1ccccn1		Preclinical	purinergic receptor antagonist	P2RY1
pitavastatin	pitavastatin|PITAVASTATIN	O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1-c1ccc(F)cc1)C1CC1)CC(O)=O	M5681Q5F9P	Launched	HMGCR inhibitor	HMGCR
pivagabine	pivagabine|PIVAGABINE	CC(C)(C)C(=O)NCCCC(O)=O	C53SV0WO4V	Launched	corticosteroid releasing factor receptor antagonist	CRHR1|CRHR2
pivampicillin	pivampicillin|PIVAMPICILLIN	CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O	0HLM346LL7	Launched	bacterial cell wall synthesis inhibitor	
pivanex	pivanex|AN-9	CCCC(=O)OCOC(=O)C(C)(C)C	55VNK5440P	Phase 2	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC8
pivmecillinam	pivmecillinam|AMDINOCILLIN PIVOXIL	CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N1CCCCCC1)C2=O	1WAM1OQ30B	Launched	bacterial cell wall synthesis inhibitor	
pixantrone	pixantrone|PIXANTRONE	NCCNc1ccc(NCCN)c2C(=O)c3cnccc3C(=O)c12	F5SXN2KNMR	Launched	topoisomerase inhibitor	TOP2A
pizotifen	pizotifen|PIZOTYLINE	CN1CCC(CC1)=C1c2ccsc2CCc2ccccc12	0BY8440V3N	Launched	serotonin receptor antagonist	HTR1A|HTR2A|HTR2C
PJ-34	PJ-34	CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1		Preclinical	PARP inhibitor	EEF2|PARP1|PARP15|PARP3
PK-11195	PK-11195	CCC(C)N(C)C(=O)c1cc2ccccc2c(n1)-c1ccccc1Cl	YNF83VN1RL	Phase 1	benzodiazepine receptor antagonist	TSPO
PKI-166	PKI-166	C[C@@H](Nc1ncnc2[nH]c(cc12)-c1ccc(O)cc1)c1ccccc1		Phase 1	EGFR inhibitor	EGFR
PKI-179	PKI-179	O=C(Nc1ccncc1)Nc1ccc(cc1)-c1nc(nc(n1)N1CCOCC1)N1C2CCC1COC2	CNN7Y60164	Phase 1	mTOR inhibitor|PI3K inhibitor	MTOR
pleconaril	pleconaril|PLECONARIL	Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1	9H4570Q89D	Phase 3		
plerixafor	plerixafor|PLERIXAFOR	C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1	S915P5499N	Launched	CC chemokine receptor antagonist	ACKR3|CCR4|CXCR4
plicamycin	plicamycin|PLICAMYCIN	CO[C@@H]([C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1)C(=O)[C@@H](O)[C@@H](C)O	NIJ123W41V	Launched	alcohol dehydrogenase inhibitor	
plinabulin	plinabulin|PLINABULIN	CC(C)(C)c1[nH]cnc1\C=c1/[nH]c(=O)\c(=C\c2ccccc2)[nH]c1=O	986FY7F8XR	Phase 3	tubulin polymerization inhibitor	
plovamer-acetate	plovamer-acetate|TYROSINE, DL-	NC(Cc1ccc(O)cc1)C(O)=O	A9BAT9B32M	Phase 2		TAT|TH|YARS|YARS2
plurisin-#1	plurisin-#1	O=C(NNc1ccccc1)c1ccncc1		Preclinical	stearoyl-CoA desaturase inhibitor	SCD
PLX-4720	PLX-4720	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F	EQY31RO8HA	Preclinical	RAF inhibitor	BRAF|KDR
PLX8394	PLX8394	F[C@@H]1CCN(C1)S(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2cnc(nc2)C2CC2)c1F		Phase 1/Phase 2	serine/threonine kinase inhibitor	BRAF
PMPA	PMPA|TENOFOVIR	OC(=O)CCC(CP(O)(O)=O)C(O)=O	99YXE507IL	Preclinical	glutamate receptor antagonist	FOLH1
PNU-120596	PNU-120596	COc1cc(OC)c(NC(=O)Nc2cc(C)on2)cc1Cl		Preclinical	acetylcholine receptor agonist	CHRNA7
PNU-142633	PNU-142633	CNC(=O)c1ccc2[C@H](CCN3CCN(CC3)c3ccc(cc3)C(N)=O)OCCc2c1	B54P1BQ73L	Phase 2	serotonin receptor agonist	HTR1D
PNU-22394	PNU-22394	Cn1c2CCNCCc2c2ccccc12		Phase 2	serotonin receptor agonist	HTR2A|HTR2B|HTR2C|MAOA|MAOB
PNU-282987	PNU-282987	Clc1ccc(cc1)C(=O)N[C@H]1CN2CCC1CC2	810P1694K2	Preclinical	cholinergic receptor agonist	CHRNA7
PNU-37883	PNU-37883	C1CCC(CC1)N\C(N1CCOCC1)=N\C12CC3CC(CC(C3)C1)C2		Preclinical	ATP-sensitive potassium channel antagonist	
PNU-74654	PNU-74654	Cc1ccc(\C=N\NC(=O)c2ccccc2Oc2ccccc2)o1		Preclinical	beta-catenin inhibitor	CTNNB1|TCF4
PNU-89843	PNU-89843	Cc1cc2c(nc(nc2n1C)N1CCCC1)N1CCCC1		Preclinical	benzodiazepine receptor agonist	GABBR1
podophyllotoxin	podophyllotoxin|PODOFILOX	COc1cc(cc(OC)c1OC)[C@H]1[C@@H]2[C@H](COC2=O)[C@@H](O)c2cc3OCOc3cc12	L36H50F353	Launched	microtubule inhibitor|tubulin polymerization inhibitor	IGF1R|TOP2A|TUBA4A|TUBB
polidocanol	polidocanol|LAURETH-15|POLIDOCANOL|LAURETH-21|LAURETH-20|LAURETH-11|LAURETH-10|LAURETH-40|LAURETH-6|DODECYL ETHYLENEGLYCOL MONOETHER|LAURETH-16|LAURETH-50|LAURETH-12|LAURETH-5|LAURETH-8|LAURETH-25|LAURETH-30|LAURETH-38|LAURETH-7	CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO	002FR4N8OV|0AWH8BFG9A|5Q366RLH25|6SU0SC83AH|APG12V4K45|BD7AST04GA|ELB3Y6474W|J2N33740SH|J89TKQ5R54|KZF7XN8153|MGU0HEW21Q|OAH19558U1|Q9F4A7XYE8|QU7U88D04I|RPD53041LR|W9D845551A|WG3R46N0SV|Z95S6G8201	Launched	local anesthetic	
polydatin	polydatin|POLYDATIN	OC[C@H]1O[C@@H](Oc2cc(O)cc(\C=C\c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	XM261C37CQ	Phase 2	ICAM1 expression inhibitor	ICAM1
polyinosine	polyinosine|9-.BETA.-D-ARABINOFURANOSYLHYPOXANTHINE 5'-MONOPHOSPHATE|INOSINIC ACID	OC1C(COP(O)(O)=O)OC(C1O)n1cnc2c(O)ncnc12	73N4B5C687|TAO7US05G5	Preclinical	immunostimulant	ADSSL1|HPRT1|IMPDH2|PYGM
polymyxin-b-sulfate	polymyxin-b-sulfate|POLYMYXIN B1	CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CCN)NC1=O)C(C)O	B35S89JSRU	Launched	bacterial permeability inducer	
polythiazide	polythiazide|POLYTHIAZIDE	CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(cc2S1(=O)=O)S(N)(=O)=O	36780APV5N	Launched	sodium/chloride cotransporter inhibitor	SLC12A3
pomalidomide	pomalidomide|POMALIDOMIDE	Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12	D2UX06XLB5	Launched	angiogenesis inhibitor|tumor necrosis factor production inhibitor	CRBN|PTGS2|TNF
ponatinib	ponatinib|PONATINIB	CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1	4340891KFS	Launched	Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor	ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK
ponesimod	ponesimod|PONESIMOD	CCC\N=C1/S\C(=C/c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C	5G7AKV2MKP	Phase 3	sphingosine 1 phosphate receptor agonist	S1PR1
posaconazole	posaconazole|POSACONAZOLE	CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@@H]3CO[C@](Cn4cncn4)(C3)c3ccc(F)cc3F)cc2)c1=O	6TK1G07BHZ	Launched	sterol demethylase inhibitor	CYP3A4
potassium-canrenoate	potassium-canrenoate|CANRENOATE POTASSIUM	C[C@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C1CC[C@@]2(O)CCC(O)=O	M671F9NLEA	Launched	mineralocorticoid receptor antagonist	NR3C2
potassium-iodide	potassium-iodide|POTASSIUM IODIDE	[K].I	1C4QK22F9J	Launched		
potassium-p-aminobenzoate	potassium-p-aminobenzoate|AMINOBENZOIC ACID	Nc1ccc(cc1)C(O)=O	TL2TJE8QTX	Launched		
pozanicline	pozanicline|POZANICLINE	Cc1ncccc1OC[C@@H]1CCCN1	CL2002R563	Phase 2	acetylcholine receptor antagonist	CHRNA4|CHRNB2
poziotinib	poziotinib|POZIOTINIB	COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3F)c2cc1OC1CCN(CC1)C(=O)C=C	OEI6OOU6IK	Phase 2	EGFR inhibitor	EGFR|ERBB2|ERBB4
PP-1	PP-1	Cc1ccc(cc1)-c1nn(c2ncnc(N)c12)C(C)(C)C		Preclinical	src inhibitor	HCK|RET
PP-121	PP-121	C1CCC(C1)n1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc12		Preclinical	protein tyrosine kinase inhibitor	ABL1|EGFR|HCK|KDR|MTOR|PDGFRA|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SRC
PP-2	PP-2	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc12		Preclinical	src inhibitor	ABL1|LCK|LYN|RIPK2|SRC
PP242	PP242|PP-242	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc12	H5669VNZ7V	Preclinical	mTOR inhibitor	MTOR|PASK
PPT	PPT|4,4',4''-(4-PROPYL-(1H)-PYRAZOLE-1,3,5-TRIYL)TRISPHENOL	CCCc1c(nn(c1-c1ccc(O)cc1)-c1ccc(O)cc1)-c1ccc(O)cc1	0T83Y6JZPF	Preclinical	estrogen receptor agonist	ESR1
PQ-401	PQ-401	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12	2N3LV83S8J	Preclinical	IGF-1 inhibitor	IGF1R
PR-619	PR-619	Nc1nc(N)c(SC#N)cc1SC#N		Preclinical	DUB inhibitor	
practolol	practolol|PRACTOLOL	CC(C)NCC(O)COc1ccc(NC(C)=O)cc1	SUG9176GRW	Withdrawn	adrenergic receptor antagonist	ADRB1
pralatrexate	pralatrexate|PRALATREXATE	Nc1nc(N)c2nc(CC(CC#C)c3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2n1	A8Q8I19Q20	Launched	dihydrofolate reductase inhibitor	DHFR|TYMS
pralidoxime	pralidoxime|PRALIDOXIME	C[n+]1ccccc1C=NO	P7MU9UTP52	Launched	acetylcholinesterase inhibitor	ACHE|BCHE
pralidoxime-chloride	pralidoxime-chloride|PRALIDOXIME CHLORIDE	C[n+]1ccccc1C[N+][O-]	38X7XS076H	Launched	acetylcholinesterase inhibitor	ACHE|BCHE
pramipexole	pramipexole|PRAMIPEXOLE	CCCN[C@H]1CCc2nc(N)sc2C1	83619PEU5T	Launched	dopamine receptor agonist	ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
pramiracetam	pramiracetam|PRAMIRACETAM	CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C	4449F8I3LE	Launched	acetylcholine receptor agonist	
pramoxine	pramoxine|PRAMOXINE	CCCCOc1ccc(OCCCN2CCOCC2)cc1	068X84E056	Launched	topical anesthetic	
pranidipine	pranidipine|PRANIDIPINE	COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1	9DES9QVH58	Phase 2	calcium channel blocker	CACNA1C
pranlukast	pranlukast|PRANLUKAST	O=C(Nc1ccc2c(c1)oc(cc2=O)-c1nnn[nH]1)c1ccc(OCCCCc2ccccc2)cc1	TB8Z891092	Launched	leukotriene receptor antagonist	CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF
pranoprofen	pranoprofen|PRANOPROFEN	CC(C(O)=O)c1ccc2Oc3ncccc3Cc2c1	2R7O1ET613	Launched	cyclooxygenase inhibitor	
prasterone-acetate	prasterone-acetate|PRASTERONE ACETATE	CC(=O)O[C@H]1CC[C@]2(C)C3CC[C@@]4(C)C(CCC4=O)C3CC=C2C1	45751H45MY	Preclinical		
prasugrel	prasugrel|PRASUGREL	CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C1CC1)c1ccccc1F	34K66TBT99	Launched	purinergic receptor antagonist	P2RY12
pravadoline	pravadoline|PRAVADOLINE	COc1ccc(cc1)C(=O)c1c(C)n(CCN2CCOCC2)c2ccccc12	P3JW662TWA	Preclinical	cyclooxygenase inhibitor	CNR1|CNR2
pravastatin	pravastatin|PRAVASTATIN	CCC(C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)C12	KXO2KT9N0G	Launched	HMGCR inhibitor	HMGCR|SLCO1B1
praziquantel	praziquantel|PRAZIQUANTEL	O=C(C1CCCCC1)N1CC2N(CCc3ccccc23)C(=O)C1	6490C9U457	Launched	anthelmintic agent	
prazosin	prazosin|PRAZOSIN	COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1	XM03YJ541D	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7
PRE-084	PRE-084	O=C(OCCN1CCOCC1)C1(CCCCC1)c1ccccc1		Preclinical	sigma receptor agonist	SIGMAR1
preclamol	preclamol|PRECLAMOL	CCCN1CCC[C@@H](C1)c1cccc(O)c1	9V2O6CRQ6Z	Phase 2	dopamine receptor agonist	DRD2
prednicarbate	prednicarbate|PREDNICARBATE	CCOC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC	V901LV1K7D	Launched	phospholipase activator	NR3C1|PLA2G1B
prednisolone	prednisolone|PREDNISOLONE	C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO	9PHQ9Y1OLM	Launched	glucocorticoid receptor agonist	NR3C1|NR3C2|SERPINA6
prednisolone-acetate	prednisolone-acetate|PREDNISOLONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3[C@@H](O)C[C@]12C	8B2807733D	Launched	glucocorticoid receptor agonist	NR3C1
prednisolone-hemisuccinate	prednisolone-hemisuccinate|PREDNISOLONE HEMISUCCINATE	C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O	G7080T74ON	Preclinical	glucocorticoid receptor agonist	NR3C1
prednisolone-sodium-phosphate	prednisolone-sodium-phosphate|PREDNISOLONE 21-PHOSPHATE	C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O	752SY38R6C	Launched	glucocorticoid receptor agonist	NR3C1
prednisolone-tebutate	prednisolone-tebutate|PREDNISOLONE TEBUTATE	CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@]12C	1V7A1U282K	Launched	anti-inflammatory agent	
prednisone	prednisone|PREDNISONE	C[C@]12CC(=O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO	VB0R961HZT	Launched	glucocorticoid receptor agonist	HSD11B1|NR3C1
pregabalin	pregabalin|PREGABALIN	CC(C)C[C@H](CN)CC(O)=O	55JG375S6M	Launched	voltage-gated calcium channel ligand	CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8
pregnenolone	pregnenolone|PREGNENOLONE	CC(=O)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C	73R90F7MQ8	Launched	glutamate receptor modulator	CYP17A1|SULT2B1
pregnenolone-succinate	pregnenolone-succinate|PREGNENOLONE SUCCINATE	CC(=O)[C@H]1CCC2C3CC=C4C[C@H](CC[C@]4(C)C3CC[C@]12C)OC(=O)CCC(O)=O	6LN4W6JJK6	Preclinical	GABA receptor negative allosteric modulator	
preladenant	preladenant|PRELADENANT	COCCOc1ccc(cc1)N1CCN(CCn2ncc3c2nc(N)n2nc(nc32)-c2ccco2)CC1	950O97NUPO	Phase 3	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
prenylamine	prenylamine|PRENYLAMINE	CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1	K2OH82Z000	Withdrawn	calcium channel blocker	CALM1|MYLK2
presatovir	presatovir|PRESATOVIR	Cc1cn2nc(cc2nc1N1CC[C@H](N)C1)[C@@H]1CCCCN1C(=O)c1cc(Cl)ccc1NS(C)(=O)=O	9628AJ27JA	Phase 2	RSV fusion inhibitor	
pridinol	pridinol|PRIDINOL	OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1	9E75Q6SUUB	Launched	muscle relaxant	
prilocaine	prilocaine|PRILOCAINE	CCCNC(C)C(=O)Nc1ccccc1C	046O35D44R	Launched	local anesthetic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
PRIMA1	PRIMA1	OCC1(CO)N2CCC(CC2)C1=O		Preclinical	TP53 inhibitor	ACHE
primaquine	primaquine|PRIMAQUINE	COc1cc(NC(C)CCCN)c2ncccc2c1	MVR3634GX1	Launched	antimalarial agent|DNA inhibitor	KRT7|NQO2
primidone	primidone|PRIMIDONE	CCC1(C(=O)NCNC1=O)c1ccccc1	13AFD7670Q	Launched	GABA receptor antagonist	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
prinaberel	prinaberel|PRINABEREL	Oc1cc(C=C)c2oc(nc2c1)-c1ccc(O)c(F)c1	A9C8MNF7CA	Phase 2	estrogen receptor agonist	ESR2|NCOA1
priralfinamide	priralfinamide|PRIRALFINAMIDE	C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O	3LPF0S0GVV	Phase 3	sodium channel blocker	CACNA1B
pritelivir	pritelivir|PRITELIVIR	CN(C(=O)Cc1ccc(cc1)-c1ccccn1)c1nc(C)c(s1)S(N)(=O)=O	07HQ1TJ4JE	Phase 2	helicase primase inhibitor	
proacipimox	proacipimox	COCc1c[n+]([O-])c(C)cn1		Phase 1	cholesterol inhibitor	
proadifen	proadifen|PROADIFEN	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1	A510CA4CBT	Preclinical	nitric oxide synthase inhibitor	NOS1
probenecid	probenecid|PROBENECID	CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O	PO572Z7917	Launched	uricosuric blocker	PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1
probucol	probucol|PROBUCOL	CC(C)(Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C	P3CTH044XJ	Launched	atherogenesis inhibitor	ABCA1|ABCB11|CES1
procainamide	procainamide|PROCAINAMIDE	CCN(CC)CCNC(=O)c1ccc(N)cc1	L39WTC366D	Launched	sodium channel blocker	DNMT1|SCN5A
procaine	procaine|PROCAINE	CCN(CC)CCOC(=O)c1ccc(N)cc1	4Z8Y51M438	Launched	HMGCR inhibitor	CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3
procarbazine	procarbazine|PROCARBAZINE	CNNCc1ccc(cc1)C(=O)NC(C)C	35S93Y190K	Launched	monoamine oxidase inhibitor	
procaterol	procaterol|PROCATEROL	CC[C@H](NC(C)C)[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12	X7I3EMM5K0	Launched	adrenergic receptor agonist	ADRB2
prochlorperazine	prochlorperazine|PROCHLORPERAZINE	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1	YHP6YLT61T	Launched	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4
procodazole	procodazole|PROCODAZOLE	OC(=O)CCc1nc2ccccc2[nH]1	SG5IU7FD3R	Preclinical	immunostimulant	
procyanidin-b-2	procyanidin-b-2|PROCYANIDIN B1	O[C@H]1Cc2c(O)cc(O)c([C@@H]3[C@@H](O)[C@H](Oc4cc(O)cc(O)c34)c3ccc(O)c(O)c3)c2O[C@@H]1c1ccc(O)c(O)c1	0566J48E7X	Phase 2		
procyclidine	procyclidine|PROCYCLIDINE	OC(CCN1CCCC1)(C1CCCCC1)c1ccccc1	C6QE1Q1TKR	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
procysteine	procysteine|OXOTHIAZOLIDINECARBOXYLIC ACID	OC(=O)[C@@H]1CSC(=O)N1	X7063P804E	Phase 3	glutathione synthase stimulant	
profenamine	profenamine|PROFENAMINE	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc12	7WI4P02YN1	Launched	butyrylcholinesterase inhibitor|cholinergic receptor antagonist	CHRM1|CHRM2|GRIN3A
proflavine-hemisulfate	proflavine-hemisulfate|PROFLAVINE HEMISULFATE	Nc1ccc2cc3ccc(N)cc3nc2c1	27V8M747VB	Phase 2	topical anesthetic	F2
progesterone	progesterone|PROGESTERONE	CC(=O)[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C	4G7DS2Q64Y	Launched	progesterone receptor agonist	CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5
proglumetacin	proglumetacin|PROGLUMETACIN	CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)Cc2c(C)n(C(=O)c3ccc(Cl)cc3)c3ccc(OC)cc23)CC1)NC(=O)c1ccccc1	FV919079LU	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
proglumide	proglumide|PROGLUMIDE	CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)c1ccccc1	EPL8W5565D	Withdrawn	CCK receptor antagonist	CCKAR|CCKBR
proguanil	proguanil|PROGUANIL	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1	S61K3P7B2V	Launched	dihydrofolate reductase inhibitor	DHFR
prolylleucylglycinamide	prolylleucylglycinamide|MELANOCYTE-STIMULATING HORMONE RELEASE-INHIBITING FACTOR-1	CC(C)CC(NC(=O)C1CCCN1)C(=O)NCC(N)=O	3KY24B4Q62	Phase 2	melanocyte-stimulating hormone release inhibitor	
promazine	promazine|PROMAZINE	CN(C)CCCN1c2ccccc2Sc2ccccc12	O9M39HTM5W	Launched	dopamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR2A|HTR2C
promestriene	promestriene|PROMESTRIENE	CCCOc1ccc2[C@H]3CC[C@]4(C)[C@H](CC[C@H]4[C@@H]3CCc2c1)OC	GXM4PER6WZ	Launched	estrogen receptor agonist	ESR1
promethazine	promethazine|PROMETHAZINE	CC(CN1c2ccccc2Sc2ccccc12)N(C)C	FF28EJQ494	Launched	histamine receptor antagonist	ADRA1A|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A
pronethalol	pronethalol|PRONETALOL	CC(C)NCC(O)c1ccc2ccccc2c1	XBP4RT1IMQ	Withdrawn	adrenergic receptor antagonist	
propacetamol	propacetamol|PROPACETAMOL	CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1	5CHW4JMR82	Launched	cyclooxygenase inhibitor	PTGS2
propafenone	propafenone|PROPAFENONE	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1	68IQX3T69U	Launched	antiarrhythmic	ADRB1|ADRB2|KCNA5|KCNH2|SCN5A
propagermanium	propagermanium|PROPAGERMANIUM	OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O	1Q2P9TO9Q7	Launched	interferon receptor agonist|CCR agonist	CCR2
propantheline	propantheline|PROPANTHELINE	CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc12)C(C)C	1306V2B0Q8	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
propatylnitrate	propatylnitrate|PROPATYL NITRATE	CCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O	AJT2YN495R	Launched		
propentofylline	propentofylline|PROPENTOFYLLINE	CCCn1cnc2n(C)c(=O)n(CCCCC(C)=O)c(=O)c12	5RTA398U4H	Launched	adenosine reuptake inhibitor|phosphodiesterase inhibitor	PDE1A
propidium-iodide	propidium-iodide|PROPIDIUM IODIDE	CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc12	TP416O228T	Preclinical		ACHE
propiolactone	propiolactone|PROPIOLACTONE	O=C1CCO1	6RC3ZT4HB0	Launched		
propiverine	propiverine|PROPIVERINE	CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1	468GE2241L	Launched	acetylcholine receptor antagonist	CHRM1
propofol	propofol|PROPOFOL	CC(C)c1cccc(C(C)C)c1O	YI7VU623SF	Launched	benzodiazepine receptor agonist	FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|SCN2A|SCN4A
propoxur	propoxur|PROPOXUR	CNC(=O)Oc1ccccc1OC(C)C	BFH029TL73	Launched		
propoxycaine	propoxycaine|PROPOXYCAINE	CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC	EPD1EH7F53	Launched	local anesthetic	
propranolol	propranolol|PROPRANOLOL	CC(C)NCC(O)COc1cccc2ccccc12	9Y8NXQ24VQ	Launched	adrenergic receptor antagonist	
propranolol-(R)	propranolol-(R)|DEXPROPRANOLOL	CC(C)NC[C@@H](O)COc1cccc2ccccc12	PG6KY07UD7	Preclinical	adrenergic receptor antagonist	ADRB2|ADRB3
propranolol-(S)	propranolol-(S)|LEVOPROPRANOLOL	CC(C)NC[C@H](O)COc1cccc2ccccc12	74MLR03FLC	Preclinical	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3|HTR1A|HTR1B|HTR5A|SLC10A1
propyl-benzoate	propyl-benzoate|PROPYL BENZOATE	CCCOC(=O)c1ccccc1	VWK210B7WS	Launched		
propylene-glycol	propylene-glycol|PROPYLENE GLYCOL|PPG-16|PPG-17	CC(O)CO	6DC9Q167V3|GK69D49CJ0|OV0Q322E0U	Launched		F13A1
propylhexedrine	propylhexedrine|PROPYLHEXEDRINE	CNC(C)CC1CCCCC1	LQU92IU8LL	Launched	adrenergic receptor agonist	SLC18A2|TAAR1
propylparaben	propylparaben|PROPYLPARABEN	CCCOC(=O)c1ccc(O)cc1	Z8IX2SC1OH	Launched		
propylthiouracil	propylthiouracil|PROPYLTHIOURACIL	CCCc1cc(=O)[nH]c(=S)[nH]1	721M9407IY	Launched	thyroid peroxidase inhibitor	DIO1|TPO
proquazone	proquazone|PROQUAZONE	CC(C)n1c2cc(C)ccc2c(nc1=O)-c1ccccc1	42VPJ2980S	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
proscillaridin-a	proscillaridin-a|PROSCILLARIDIN	C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CCC3=C2)c2ccc(=O)oc2)C(O)C(O)[C@H]1O	KC6BL281EN	Launched		
protionamide	protionamide|PROTIONAMIDE	CCCc1cc(ccn1)C(S)=N	76YOO33643	Launched		
protirelin	protirelin|PROTIRELIN	NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1	5Y5F15120W	Launched	thyrotropin releasing hormone receptor agonist	TRHR
protoporphyrin-ix	protoporphyrin-ix|PROTOPORPHYRIN	Cc1c(CCC(O)=O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5C=C)c(C)c4C=C)c(C)c3CCC(O)=O	C2K325S808	Preclinical	heme oxygenase inhibitor	HMOX1
protriptyline	protriptyline|PROTRIPTYLINE	CNCCCC1c2ccccc2C=Cc2ccccc12	4NDU154T12	Launched	tricyclic antidepressant	SLC6A2|SLC6A4
proxodolol	proxodolol|ZOLEPRODOLOL HYDROCHLORIDE	Cc1noc(COc2ccccc2OCC(O)CNC(C)(C)C)n1	87016Q25GZ	Launched	adrenergic receptor antagonist	
proxyfan	proxyfan	C(COCc1ccccc1)Cc1cnc[nH]1		Preclinical	histamine receptor modulator	HRH3
proxymetacaine	proxymetacaine|PROPARACAINE	CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC	B4OB0JHI1X	Launched	sodium channel blocker	SCN10A|SCN5A
proxyphylline	proxyphylline|PROXYPHYLLINE	CC(O)Cn1cnc2n(C)c(=O)n(C)c(=O)c12	13G1DMN4P0	Launched		
PRT062070	PRT062070|CERDULATINIB	CCS(=O)(=O)N1CCN(CC1)c1ccc(Nc2ncc(C(N)=O)c(NC3CC3)n2)cc1	D1LXQ45S1O	Phase 1	JAK inhibitor|syk inhibitor	SYK
PRT062607	PRT062607	N[C@H]1CCCC[C@H]1Nc1ncc(C(N)=O)c(Nc2cccc(c2)-n2nccn2)n1		Phase 2	syk inhibitor	FGR|MAP3K9|SYK
PRT4165	PRT4165|PRT-4165	O=C1C(=Cc2cccnc2)C(=O)c2ccccc12	J625FJL5DX	Preclinical	polycomb repressive complex inhibitor	PRC1
prucalopride	prucalopride|PRUCALOPRIDE	COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(N)c2CCOc12	0A09IUW5TP	Launched	serotonin receptor agonist	HTR4
prulifloxacin	prulifloxacin|PRULIFLOXACIN	CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCN(Cc2oc(=O)oc2C)CC1	J42298IESW	Launched	bacterial DNA gyrase inhibitor	
pruvanserin	pruvanserin|PRUVANSERIN	Fc1ccc(CCN2CCN(CC2)C(=O)c2cccc3c(c[nH]c23)C#N)cc1	UL09X1D9EM	Phase 2	serotonin receptor antagonist	HTR2A|HTR2C
PRX-08066	PRX-08066	Fc1ccc(CN2CCC(CC2)Nc2ncnc3sc(Cl)cc23)cc1C#N	92E9B7675Y	Phase 2	serotonin receptor antagonist	HTR2B
PS178990	PS178990|BMS-564929	Cc1c(ccc(C#N)c1Cl)N1C(=O)[C@@H]2[C@H](O)CCN2C1=O	9BLW27W4X7	Phase 1	androgen receptor modulator	AR
PSB-06126	PSB-06126	Nc1c2C(=O)c3ccccc3C(=O)c2c(Nc2cccc3ccccc23)cc1S(O)(=O)=O		Preclinical	NTPDase inhibitor	ENTPD3
PSB-11	PSB-11	CC[C@@H]1CN2C(=N1)c1[nH]c(nc1N(C)C2=O)-c1ccccc1		Preclinical	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA3
PSB-1115	PSB-1115	CCCn1c(=O)[nH]c2nc([nH]c2c1=O)-c1ccc(cc1)S(O)(=O)=O		Preclinical	adenosine receptor antagonist	ADORA1|ADORA2B|ADORA3
PSB-36	PSB-36	CCCCn1c(=O)n(CCCO)c2nc([nH]c2c1=O)C12CC3CC1CC(C2)C3		Preclinical	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
PSI-6130	PSI-6130|2'-DEOXY-2'-FLUORO-2'-C-METHYLCYTIDINE	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O	05J68784G1	Phase 1	RNA polymerase inhibitor	
PSI-7976	PSI-7976|PSI-7851|SOFOSBUVIR	CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1	3S5S1851OV|WJ6CA3ZU8B	Preclinical	HCV inhibitor	
PSN-375963	PSN-375963	CCCCC1CCC(CC1)c1nc(no1)-c1ccncc1		Preclinical	glucose dependent insulinotropic receptor agonist	GPR119
psoralen	psoralen|PSORALEN	O=c1ccc2cc3ccoc3cc2o1	KTZ7ZCN2EX	Launched		MAOA|MAOB
PT-2385	PT-2385	CS(=O)(=O)c1ccc(Oc2cc(F)cc(c2)C#N)c2CC(F)(F)[C@@H](O)c12		Phase 1	hypoxia inducible factor inhibitor	EPAS1
PTC-209	PTC-209	COc1cc(Br)c(Nc2nc(cs2)-c2c(C)nc3ncccn23)c(Br)c1		Preclinical	BMI-1 inhibitor	
pterostilbene	pterostilbene|PTEROSTILBENE	COc1cc(OC)cc(C=Cc2ccc(O)cc2)c1	26R60S6A5I	Phase 2/Phase 3	cyclooxygenase inhibitor|PPAR receptor agonist	PTGS2
PU-H71	PU-H71	CC(C)NCCCn1c(Sc2cc3OCOc3cc2I)nc2c(N)ncnc12	06IVK87M04	Phase 1	HSP inhibitor	HSP90AA1
puerarin	puerarin|PUERARIN	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1c(O)ccc2c1occ(-c1ccc(O)cc1)c2=O	Z9W8997416	Phase 2	serotonin receptor antagonist	
pumosetrag	pumosetrag|PUMOSETRAG	Oc1c(cnc2ccsc12)C(=O)N[C@H]1CN2CCC1CC2	1G26B32139	Phase 2	serotonin receptor agonist	HTR3A|HTR4
purmorphamine	purmorphamine|PURMORPHAMINE	C1CCC(CC1)n1cnc2c(Nc3ccc(cc3)N3CCOCC3)nc(Oc3cccc4ccccc34)nc12	PB12M2F8KY	Preclinical	smoothened receptor agonist	SMO
puromycin	puromycin|PUROMYCIN	COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)OC([C@@H]2O)n2cnc3c(ncnc23)N(C)C)cc1	4A6ZS6Q2CL	Preclinical	protein synthesis inhibitor	NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1
purvalanol-a	purvalanol-a	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		Preclinical	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CSNK1G3|RPS6KA1|SRC
purvalanol-b	purvalanol-b	CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(O)=O)c(Cl)c2)c2ncn(C(C)C)c2n1		Preclinical	tyrosine kinase inhibitor	CDK2|CDK4|CDK5|MAPK1|MAPK3|SRPK2
putrescine	putrescine|PUTRESCINE	NCCCCN	V10TVZ52E4	Phase 2	tissue transglutaminase inhibitor	AMD1|KCNJ4|ODC1
PX-12	PX-12	CCC(C)SSc1ncc[nH]1	8PQ9CZ8BTJ	Phase 2	thioredoxin inhibitor	TXN|TXNRD1
PX-478	PX-478	NC(Cc1ccc(cc1)[N+]([O-])(CCCl)CCCl)C(O)=O	T23U22X160	Phase 1	hypoxia inducible factor inhibitor	
PYM50028	PYM50028|TIGOGENIN|SARSAGENIN|SMILAGENIN	C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@]11CC[C@H](C)CO1	4SMU15RR44|CFS802C28F|GQE3Q7YMVZ	Phase 2	neurotrophic agent	
PYR-41	PYR-41	CCOC(=O)c1ccc(cc1)N1NC(=O)\C(=C\c2ccc(o2)[N+]([O-])=O)C1=O		Preclinical	ubiquitin activating enzyme inhibitor	
pyrantel	pyrantel|PYRANTEL	OC(=O)c1cc2ccccc2c(Cc2c(O)c(cc3ccccc23)C(O)=O)c1O	4QIH0N49E7	Launched	nicotinic receptor agonist	
pyrantel-pamoate	pyrantel-pamoate|PYRANTEL PAMOATE	CN1CCCN=C1\C=C\c1cccs1	81BK194Z5M	Launched	neuromuscular blocker	
pyrantel-tartrate	pyrantel-tartrate|PYRANTEL TARTRATE	CN1CCCN=C1\C=C\c1cccs1	SC82VF0480	Preclinical	acetylcholine receptor agonist	CHRNA1
pyrazinamide	pyrazinamide|PYRAZINAMIDE	NC(=O)c1cnccn1	2KNI5N06TI	Launched	fatty acid synthase inhibitor	FASN
pyrazinoylguanidine	pyrazinoylguanidine	NC(=N)NC(=O)c1cnccn1		Phase 1	diuretic	
pyrazolanthrone	pyrazolanthrone|PYRAZOLANTHRONE	O=C1c2ccccc2-c2n[nH]c3cccc1c23	1TW30Y2766	Preclinical	JNK inhibitor	MAPK10|MAPK8|MAPK8IP1|MAPK9|TTK
pyrazoloacridine	pyrazoloacridine|PYRAZOLOACRIDINE	COc1ccc2[nH]c3c(ccc4n(CCCN(C)C)nc(c34)c2c1)[N+]([O-])=O	L24XJN68OW	Phase 2	topoisomerase inhibitor	TOP1|TOP2A
pyrethrins	pyrethrins	CC(C)=C[C@@H]1[C@@H](C(=O)O[C@H]2CC(=O)C(C\C=C/C=C)=C2)C1(C)C		Launched		
pyridoxal	pyridoxal|PYRIDOXAL	Cc1ncc(CO)c(C=O)c1O	3THM379K8A	Launched		PDXK
pyridoxal-isonicotinoyl-hydrazone	pyridoxal-isonicotinoyl-hydrazone	Cc1ncc(CO)c(\C=N\NC(=O)c2ccncc2)c1O		Phase 2	apoptosis stimulant	
pyridoxamine	pyridoxamine|PYRIDOXAMINE	Cc1ncc(CO)c(CN)c1O	6466NM3W93	Phase 3	AGE inhibitor	
pyridoxine	pyridoxine|PYRIDOXINE	Cc1ncc(CO)c(CO)c1O	KV2JZ1BI6Z	Launched	vitamin B	DDC|PDXK
pyrimethamine	pyrimethamine|PYRIMETHAMINE	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1	Z3614QOX8W	Launched	dihydrofolate reductase inhibitor	DHFR|SLC47A1
pyrithione-zinc	pyrithione-zinc|PYRITHIONE ZINC	O1[n+]2ccccc2S[Zn]11O[n+]2ccccc2S1	R953O2RHZ5	Launched	ATP synthase inhibitor	KCNQ1|KCNQ2|KCNQ4|KCNQ5
pyrithyldione	pyrithyldione|PYRITHYLDIONE	CCC1(CC)C(=O)NC=CC1=O	8AB20823CK	Withdrawn	psychoactive drug	
pyritinol	pyritinol|PYRITINOL	Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O	AK5Q5FZH2R	Launched		
pyronaridine	pyronaridine|PYRONARIDINE	COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1	TD3P7Q3SG6	Phase 3	antimalarial agent	
pyroxamide	pyroxamide|PYROXAMIDE	ONC(=O)CCCCCCC(=O)Nc1cccnc1	12N86DSS23	Phase 1	HDAC inhibitor	HDAC1
pyrrolidine-dithiocarbamate	pyrrolidine-dithiocarbamate	SC(=S)N1CCCC1		Preclinical	NFkB pathway inhibitor	HSD11B1|RELA
pyrvinium	pyrvinium|PYRVINIUM	CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1.CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1	6B9991FLU3	Launched	androgen receptor antagonist	
pyrvinium-pamoate	pyrvinium-pamoate|PYRVINIUM PAMOATE	CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1	310X6S84LW	Launched	androgen receptor antagonist	AR
Q-203	Q-203	CCc1nc2ccc(Cl)cn2c1C(=O)NCc1ccc(cc1)N1CCC(CC1)c1ccc(OC(F)(F)F)cc1	55G92WGH3X	Phase 1	ATP synthase inhibitor	
quazinone	quazinone|QUAZINONE	Cc1c(O)nc2Nc3cccc(Cl)c3Cn12	D1Q7F6C2FP	Phase 2	phosphodiesterase inhibitor	PDE3A|PDE3B
quercetin	quercetin|QUERCETIN	Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O	9IKM0I5T1E	Launched	polar auxin transport inhibitor	ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1
quetiapine	quetiapine|QUETIAPINE	OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12	BGL0JSY5SI	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2
quiflapon	quiflapon|QUIFLAPON	CC(C)(C)Sc1c(CC(C)(C)C(O)=O)n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12	9295C885I4	Phase 2	leukotriene synthesis inhibitor	ALOX5|ALOX5AP
quinagolide	quinagolide|QUINAGOLIDE	CCCN1C[C@H](C[C@@H]2Cc3c(O)cccc3C[C@@H]12)NS(=O)(=O)N(CC)CC	80Q9QWN15M	Launched	dopamine receptor agonist	DRD2
quinapril	quinapril|QUINAPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O	RJ84Y44811	Launched	angiotensin converting enzyme inhibitor	ACE
quinaprilat	quinaprilat|QUINAPRILAT	C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O	34SSX5LDE5	Launched	angiotensin converting enzyme inhibitor	ACE
quinelorane	quinelorane|QUINELORANE	CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12	Z0X4VT3Y1Q	Phase 3	dopamine receptor agonist	DRD2|DRD3
quinestrol	quinestrol|QUINESTROL	C[C@]12CCC3C(CCc4cc(OC5CCCC5)ccc34)C1CC[C@@]2(O)C#C	JR0N7XD5GZ	Launched	estrogen receptor agonist	ESR1
quinethazone	quinethazone|QUINETHAZONE	CCC1NC(=O)c2cc(c(Cl)cc2N1)S(N)(=O)=O	455E0S048W	Launched	thiazide diuretic	CA1|CA2|SLC12A1|SLC12A2|SLC12A3
quinidine	quinidine|QUINIDINE	COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1	ITX08688JL	Launched	sodium channel blocker	KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4
quinine	quinine|QUININE	COc1ccc2nccc([C@@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1	A7V27PHC7A	Launched	hemozoin biocrystallization inhibitor	GP9|KCNB2|KCNN4|SLC29A4
quinine-ethyl-carbonate	quinine-ethyl-carbonate|QUININE ETHYLCARBONATE	CCOC(=O)O[C@H]([C@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)c1ccnc2ccc(OC)cc12	L2V8911157	Launched		
quinolinic-acid	quinolinic-acid|QUINOLINIC ACID	OC(=O)c1cccnc1C(O)=O	F6F0HK1URN	Preclinical	glutamate receptor agonist	
quinpirol-(-)	quinpirol-(-)|QUINPIROLE	CCCN1CCC[C@@H]2Cc3n[nH]cc3C[C@@H]12	20OP60125T	Phase 2	dopamine receptor agonist	DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR2B|HTR2C
quipazine	quipazine|QUIPAZINE	C1CN(CCN1)c1ccc2ccccc2n1	4WCY05C0SJ	Preclinical	serotonin receptor agonist	
quizartinib	quizartinib|QUIZARTINIB	CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1	7LA4O6Q0D3	Phase 3	FLT3 inhibitor	CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET
QX-222	QX-222	Cc1cccc(C)c1NC(=O)C[N+](C)(C)C		Preclinical	sodium channel blocker	
QX-314	QX-314	CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C		Preclinical	sodium channel blocker	MAPK14|TGFBR1
R-1479	R-1479	Nc1ccn([C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@H]2O)c(=O)n1	M71RA9DMGJ	Phase 1	HCV inhibitor	
R-428	R-428	Nc1nc(Nc2ccc3CC[C@@H](CCc3c2)N2CCCC2)nn1-c1cc2CCCc3ccccc3-c2nn1	0ICW2LX8AS	Phase 1	AXL kinase inhibitor	AXL
R-59022	R-59022|R-59-022	Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccccc1)c1ccc(F)cc1	PF550QIT3I	Preclinical	diacylglycerol kinase inhibitor|protein kinase inhibitor	DGKA
R-96544	R-96544	COc1cccc(CCc2ccccc2OCC[C@@H]2C[C@@H](O)CN2C)c1		Preclinical	serotonin receptor antagonist	HTR2A
r(-)-apomorphine	r(-)-apomorphine|APOMORPHINE	CN1CCc2cccc-3c2C1Cc1ccc(O)c(O)c-31	N21FAR7B4S	Launched	dopamine receptor agonist	DRD2|HTR5A
R112	R112	Oc1cccc(Nc2ncc(F)c(Nc3cccc(O)c3)n2)c1		Preclinical	syk inhibitor	SYK
R306465	R306465|R-306465	ONC(=O)c1cnc(nc1)N1CCN(CC1)S(=O)(=O)c1ccc2ccccc2c1	5WD7KK1IIQ	Phase 1	HDAC inhibitor	
R547	R547|R-547	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(CC2)S(C)(=O)=O)nc1N	T61871RKRI	Phase 1	CDK inhibitor	CDK1|CDK2|CDK4|CDK7
rabeprazole	rabeprazole|RABEPRAZOLE	COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C	32828355LL	Launched	ATPase inhibitor|gastrin inhibitor	ATP4A
racecadotril	racecadotril|RACECADOTRIL	CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1	76K53XP4TO	Launched	enkephalinase inhibitor	MME
raclopride	raclopride|RACLOPRIDE	CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC	430K3SOZ7G	Launched	dopamine receptor antagonist	DRD2|DRD3|HTR1A
ractopamine	ractopamine|RACTOPAMINE	CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1	57370OZ3P1	Launched	adrenergic receptor agonist	
radafaxine	radafaxine|RADAFAXINE	C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1	Q47741214K	Phase 2	dopamine-norepinephrine reuptake inhibitor	SLC6A3
radezolid	radezolid|RADEZOLID	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(c(F)c1)-c1ccc(CNCc2cnn[nH]2)cc1	53PC6LO35W	Phase 2	bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor	
RAF265	RAF265	Cn1c(Nc2ccc(cc2)C(F)(F)F)nc2cc(Oc3ccnc(c3)-c3ncc([nH]3)C(F)(F)F)ccc12		Phase 2	RAF inhibitor|VEGFR inhibitor	BRAF
raloxifene	raloxifene|RALOXIFENE	Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1	YX9162EO3I	Launched	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	ESR1|ESR2
raltegravir	raltegravir|RALTEGRAVIR	Cc1nnc(o1)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C	22VKV8053U	Launched	HIV integrase inhibitor	
raltitrexed	raltitrexed|RALTITREXED	CN(Cc1ccc2[nH]c(C)nc(=O)c2c1)c1ccc(s1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	FCB9EGG971	Launched	thymidylate synthase inhibitor	FPGS|TYMS
ramatroban	ramatroban|RAMATROBAN	OC(=O)CCn1c2CC[C@H](Cc2c2ccccc12)NS(=O)(=O)c1ccc(F)cc1	P1ALI72U6C	Launched	prostanoid receptor antagonist	PTGDR2|TBXA2R
ramelteon	ramelteon|RAMELTEON	CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12	901AS54I69	Launched	melatonin receptor agonist	MTNR1A|MTNR1B
ramifenazone	ramifenazone|RAMIFENAZONE	CC(C)Nc1c(C)n(C)n(-c2ccccc2)c1=O	GKH2KOV2RF	Launched	cyclooxygenase inhibitor	
ramipril	ramipril|RAMIPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@@H]1C(O)=O	L35JN3I7SJ	Launched	angiotensin converting enzyme inhibitor	ACE
ramosetron	ramosetron|RAMOSETRON	Cn1cc(C(=O)[C@@H]2CCc3nc[nH]c3C2)c2ccccc12	7ZRO0SC54Y	Launched	serotonin receptor antagonist	HTR3A
ranirestat	ranirestat|RANIRESTAT	Fc1cc(Br)ccc1CN1C(=O)c2cccn2[C@@]2(CC(=O)NC2=O)C1=O	Z26P56GFTV	Phase 3	aldose reductase inhibitor	AKR1B1
ranitidine	ranitidine|RANITIDINE	CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O	884KT10YB7	Launched	histamine receptor antagonist	HRH2
ranolazine	ranolazine|RANOLAZINE	COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1	A6IEZ5M406	Launched	sodium channel blocker	SCN10A|SCN4A|SCN5A|SCN9A
rapastinel	rapastinel|RAPASTINEL	C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(N)=O	6A1X56B95E	Phase 2	glutamate receptor agonist	
rasagiline	rasagiline|RASAGILINE	C#CCN[C@@H]1CCc2ccccc12	003N66TS6T	Launched	monoamine oxidase inhibitor	BCL2|MAOB
ravoxertinib	ravoxertinib	Cn1nccc1Nc1nccc(n1)-c1ccn([C@H](CO)c2ccc(Cl)c(F)c2)c(=O)c1		Phase 1	ERK1 and ERK2 phosphorylation inhibitor	MAPK1|MAPK3
ravuconazole	ravuconazole|RAVUCONAZOLE	C[C@@H](c1nc(cs1)-c1ccc(cc1)C#N)[C@](O)(Cn1cncn1)c1ccc(F)cc1F	95YH599JWV	Phase 2	sterol demethylase inhibitor	
RBC8	RBC8	COc1ccc(OC)c(c1)C1c2c(OC(N)=C1C#N)[nH]nc2-c1ccc2ccccc2c1		Preclinical	Ral GTPase inhibitor	RALA|RALB
rebamipide	rebamipide|REBAMIPIDE	OC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1	LR583V32ZR	Launched	free radical scavenger	FPR1
rebastinib	rebastinib|REBASTINIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1	75017Q6I97	Phase 1	Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor	ABL1|BCR|FGR|FLT3|HCK|LYN|SRC
reboxetine	reboxetine|REBOXETINE	CCOc1ccccc1OC(C1CNCCO1)c1ccccc1	947S0YZ36I	Launched	adrenergic receptor antagonist	SLC6A2
refametinib	refametinib|REFAMETINIB	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1	JPX07AFM0N	Phase 2	MEK inhibitor	MAP2K1|MAP2K2
regadenoson	regadenoson|REGADENOSON	CNC(=O)c1cnn(c1)-c1nc(N)c2ncn([C@@H]3O[C@H](CO)C(O)C3O)c2n1	2XLN4Y044H	Launched	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3
regorafenib	regorafenib|REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1	24T2A1DOYB	Launched	FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK
relcovaptan	relcovaptan|RELCOVAPTAN	COc1ccc(cc1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(c2cc(Cl)ccc12)c1ccccc1Cl	C1GL8G6G0O	Phase 2	vasopressin receptor antagonist	AVPR1A|AVPR1B|AVPR2|OXTR
relebactam	relebactam|RELEBACTAM MONOHYDRATE	OS(=O)(=O)ON1[C@H]2CN([C@@H](CC2)C(=O)NC2CCNCC2)C1=O	Y1MYA2UHFL	Phase 3	beta lactamase inhibitor	
remacemide	remacemide|REMACEMIDE	CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1	EH6763C1IC	Phase 3	glutamate receptor antagonist	GRIN1
remimazolam	remimazolam|REMIMAZOLAM	COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc12	7V4A8U16MB	Phase 3	benzodiazepine receptor agonist	GABBR1
remoxipride	remoxipride|REMOXIPRIDE	CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC	0223RD59PE	Withdrawn	dopamine receptor antagonist	DRD2|DRD3|DRD4|HTR2A|SIGMAR1
repaglinide	repaglinide|REPAGLINIDE	CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O	668Z8C33LU	Launched	insulin secretagogue	ABCC8|KCNJ11|PPARG
reparixin	reparixin|REPARIXIN	CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)NS(C)(=O)=O	U604E1NB3K	Phase 3	CC chemokine receptor antagonist	CXCR1|CXCR2
repsox	repsox	Cc1cccc(n1)-c1n[nH]cc1-c1ccc2ncccc2n1		Preclinical	TGF beta receptor inhibitor	TGFBR1
resatorvid	resatorvid|RESATORVID	CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(F)cc1Cl	H2MZ648C31	Phase 3	toll-like receptor antagonist	TLR4
reserpine	reserpine|RESERPINE	CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1	8B1QWR724A	Launched	vesicular monoamine transporter inhibitor	SLC18A1|SLC18A2
resibufogenin	resibufogenin|BUFOGENIN	C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@]11O[C@@H]1C[C@@H]2c1ccc(=O)oc1	3K654P2M4J	Phase 2	Na/K-ATPase inhibitor	
resiquimod	resiquimod|RESIQUIMOD	CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O	V3DMU7PVXF	Phase 3	toll-like receptor agonist	TLR7|TLR8
resminostat	resminostat|RESMINOSTAT	CN(C)Cc1ccc(cc1)S(=O)(=O)n1ccc(c1)\C=C\C(=O)NO	1578EUB98L	Phase 2	HDAC inhibitor	HDAC1|HDAC3|HDAC6|HDAC8
resorcinol	resorcinol|RESORCINOL	Oc1cccc(O)c1	YUL4LO94HK	Launched	phosphodiesterase inhibitor	CA12|CA14|CA2|PTGS1
resveratrol	resveratrol|RESVERATROL	Oc1ccc(cc1)\C=C\c1cc(O)cc(O)c1	Q369O8926L	Launched	cytochrome P450 inhibitor|SIRT activator	CSNK2A1|NQO2|PTGS1|PTGS2
retapamulin	retapamulin|RETAPAMULIN	C[C@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C	4MG6O8991R	Launched	protein synthesis inhibitor	
retaspimycin	retaspimycin|RETASPIMYCIN	CO[C@H]1C[C@H](C)Cc2c(O)c(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)cc(O)c2NCC=C	BZF2ZM0I5Z	Phase 3	HSP inhibitor	HSP90AA1
retigabine	retigabine|EZOGABINE	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N	12G01I6BBU	Launched	potassium channel activator	KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5
retinaldehyde	retinaldehyde|RETINAL, ALL-TRANS	CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=O	RR725D715M	Launched		
retinol	retinol|RETINOL	CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/CO	G2SH0XKK91	Launched	retinoid receptor ligand	ALDH1A1|ALDH1A2|ALDH1A3|DHRS3|DHRS4|LRAT|NR2C2|RBP1|RBP3|RDH11|RDH12|RDH13|RDH14|RDH5|RDH8|RETSAT|RHO|RLBP1|RXRA|RXRB|RXRG
retinyl-acetate	retinyl-acetate|VITAMIN A ACETATE	CC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C	3LE3D9D6OY	Launched		
retinyl-palmitate	retinyl-palmitate|VITAMIN A PALMITATE	CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C	1D1K0N0VVC	Launched		
REV-5901	REV-5901	CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1		Phase 2	leukotriene receptor antagonist|lipoxygenase inhibitor	ALOX5
revaprazan	revaprazan|REVAPRAZAN	CC1N(CCc2ccccc12)c1nc(Nc2ccc(F)cc2)nc(C)c1C	5P184180P5	Launched	potassium-competitive acid antagonist	ATP4A
reversine	reversine|REVERSINE	C1CCC(CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2[nH]cnc12	Z499CLJ023	Preclinical	Aurora kinase inhibitor	AURKB|INCENP|MAP2K1
RG108	RG108	OC(=O)[C@H](Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O		Preclinical	DNA methyltransferase inhibitor	DNMT1|DNMT3B
RG1530	RG1530|R-1530	COc1cc2N=C3NNC(C)=C3N=C(c3ccccc3Cl)c2cc1F	XQJ55R5PPQ	Phase 1	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	FGFR1|FGFR2
RG2833	RG2833|RG-2833	Cc1ccc(cc1)C(=O)NCCCCCC(=O)Nc1ccccc1N	17V14R89EU	Phase 1	HDAC inhibitor	HDAC1|HDAC3
RG4733	RG4733|RG-4733	CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1c2ccccc2-c2ccccc2NC1=O	KK8645V7LE	Phase 2	gamma secretase inhibitor	PSEN1
RG7112	RG7112|RO-5045337	CCOc1cc(ccc1C1=NC(C)(c2ccc(Cl)cc2)C(C)(N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1)c1ccc(Cl)cc1)C(C)(C)C	Q8MI0X869M	Phase 1	MDM inhibitor	MDM2
RGB-286638	RGB-286638	COCCN1CCN(Cc2ccc(cc2)-c2n[nH]c3-c4cccc(NC(=O)NN5CCOCC5)c4C(=O)c23)CC1	478ZV54680	Phase 1	CDK inhibitor	CDK1|CDK2|CDK3|CDK4|CDK5|CDK6|CDK7|CDK9|FLT3|GSK3B|JAK2|MAP3K7|MAPK9
RGFP966	RGFP966	Nc1cc(F)ccc1NC(=O)\C=C\c1cnn(C\C=C\c2ccccc2)c1		Preclinical	HDAC inhibitor	HDAC3
RHC-80267	RHC-80267	O=C(NCCCCCCNC(=O)ON=C1CCCCC1)ON=C1CCCCC1		Preclinical	triacylglycerol lipase inhibitor	DAGLA|DAGLB
rhein	rhein|RHEIN	OC(=O)c1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1	YM64C2P6UX	Phase 1		HSP90AA1
rheochrysidin	rheochrysidin|PHYSCIONE	COc1cc(O)c2C(=O)c3c(O)cc(C)cc3C(=O)c2c1	H6PT94IV61	Preclinical	protein tyrosine kinase inhibitor	PTPN1
rhodamine-123	rhodamine-123|RHODAMINE 123	COC(=O)c1ccccc1-c1c2ccc(N)cc2[o+]c2cc(N)ccc12	1N3CZ14C5O	Phase 1		
RI-1	RI-1	ClC1=C(N2CCOCC2)C(=O)N(C1=O)c1ccc(Cl)c(Cl)c1		Preclinical		RAD51
ribavirin	ribavirin|RIBAVIRIN	NC(=O)c1ncn(n1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	49717AWG6K	Launched	antiviral	ADK|ENPP1|IMPDH1|IMPDH2|NT5C2
ribitol	ribitol|ADONITOL	OC[C@H](O)[C@H](O)[C@H](O)CO	353ZQ9TVDA	Preclinical		
ribociclib	ribociclib|RIBOCICLIB	CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n1C1CCCC1	TK8ERE8P56	Phase 3	CDK inhibitor	CDK4|CDK6
riboflavin	riboflavin|RIBOFLAVIN	Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2cc1C	TLM2976OFR	Launched	vitamin B2	BLVRB|RFK
riboflavin-5-phosphate-sodium	riboflavin-5-phosphate-sodium|FLAVIN MONONUCLEOTIDE	Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)c2cc1C	7N464URE7E	Launched		BLVRB|DHODH|DPYD|HAO1|HAO2|MT-ND1|NOS1|PNPO|POR|PPCDC|RFK|RPS6KA4|SGK1
ribostamycin	ribostamycin|RIBOSTAMYCIN	NCC1OC(OC2C(N)CC(N)C(O)C2OC2OC(CO)C(O)C2O)C(N)C(O)C1O	2Q5JOU7T53	Launched	bacterial 30S ribosomal subunit inhibitor	
ribostamycin-sulfate	ribostamycin-sulfate|RIBOSTAMYCIN SULFATE	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)C2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	QFN1QU7PEN	Launched	bacterial 30S ribosomal subunit inhibitor	P4HB
ricinoleic-acid	ricinoleic-acid|RICINOLEIC ACID	CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O	I2D0F69854	Launched	prostanoid receptor agonist	PTGER3
rifabutin	rifabutin|RIFABUTIN	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(c(O)c3C)c(O)c(NC(=O)\C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c1=NC3(CCN(CC(C)C)CC3)N=c21	1W306TDA6S	Launched	protein synthesis inhibitor	HSP90AA1|HSP90B1
rifampin	rifampin|RIFAMPIN	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(C)CC4)c(NC(=O)\C(C)=C/C=C/C(C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C	VJT6J7R4TR	Launched	RNA polymerase inhibitor	NR1I2|SLCO1A2|SLCO1B1|SLCO1B3
rifamycin	rifamycin|RIFAMYCIN	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C	DU69T8ZZPA	Launched	DNA directed RNA polymerase inhibitor	SLCO1A2|SLCO1B1|SLCO1B3|SLCO2B1
rifamycin-sv	rifamycin-sv|RIFAMYCIN	CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\C(C)=C/C=C\[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]([C@H]1C)C(=O)OC)c(O)c2c(O)c3C	DU69T8ZZPA	Phase 3	RNA synthesis inhibitor	
rifapentine	rifapentine|RIFAPENTINE	CO[C@H]1\C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(CC4)C4CCCC4)c(NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C	XJM390A33U	Launched	RNA polymerase inhibitor	CYP2C8|CYP2C9|CYP3A4
rifaximin	rifaximin|RIFAXIMIN	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c4nc5cc(C)ccn5c4c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)C(O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C	L36O5T016N	Launched	RNA synthesis inhibitor	NR1I2
rigosertib	rigosertib|RIGOSERTIB	COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(NCC(O)=O)c2)c(OC)c1	67DOW7F9GL	Phase 3	cell cycle inhibitor|PLK inhibitor	PLK1
rilmenidine	rilmenidine|RILMENIDINE	C1CC1C(NC1=NCCO1)C1CC1	P67IM25ID8	Launched	adrenergic receptor agonist|imidazoline receptor agonist	ADRA2A
rilpivirine	rilpivirine|RILPIVIRINE	Cc1cc(\C=C\C#N)cc(C)c1Nc1ccnc(Nc2ccc(cc2)C#N)n1	FI96A8X663	Launched	non-nucleoside reverse transcriptase inhibitor	NR1I2|SCN10A
riluzole	riluzole|RILUZOLE	Nc1nc2ccc(OC(F)(F)F)cc2s1	7LJ087RS6F	Launched	glutamate inhibitor	KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11
rimantadine	rimantadine|RIMANTADINE	CC(N)C12CC3CC(CC(C3)C1)C2	0T2EF4JQTU	Launched	antiviral|RNA synthesis inhibitor	
rimcazole	rimcazole|RIMCAZOLE	C[C@H]1CN(CCCn2c3ccccc3c3ccccc23)C[C@@H](C)N1	C3N1PS8CX1	Phase 1	sigma receptor antagonist	SIGMAR1
rimexolone	rimexolone|RIMEXOLONE	CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	O7M2E4264D	Launched	glucocorticoid receptor agonist	NR3C1|SERPINA6
rimonabant	rimonabant|RIMONABANT	Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1	RML78EN3XE	Withdrawn	cannabinoid receptor antagonist	CNR1|GPR55
riociguat	riociguat|RIOCIGUAT	COC(=O)N(C)c1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncccc12	RU3FE2Y4XI	Launched	guanylate cyclase stimulant	GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3
riodipine	riodipine|RIODIPINE	COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1OC(F)F)C(=O)OC	W12VDB26LB	Phase 2	calcium channel blocker	
riodoxol	riodoxol|2,4,6-TRIIODORESORCINOL	Oc1c(I)cc(I)c(O)c1I	RA62C2YQOZ	Launched	other antibiotic	
ripasudil	ripasudil|RIPASUDIL	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12	11978226XX	Launched	rho associated kinase inhibitor	ROCK1|ROCK2
ripazepam	ripazepam|RIPAZEPAM	CCn1nc(C)c2NC(=O)CN=C(c12)c1ccccc1	92000WH9C9	Phase 2	benzodiazepine receptor agonist	GABRA1
risedronate	risedronate|RISEDRONIC ACID	OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O	KM2Z91756Z	Launched	osteoclast inhibitor	FDPS
risperidone	risperidone|RISPERIDONE	Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12	L6UH7ZF8HC	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7
RITA	RITA	OCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1		Preclinical	MDM inhibitor	MDM2
ritanserin	ritanserin|RITANSERIN	Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccc(F)cc1)c1ccc(F)cc1	145TFV465S	Phase 3	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
ritodrine	ritodrine|RITODRINE	CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1	I0Q6O6740J	Launched	adrenergic receptor agonist	ADRB2
ritonavir	ritonavir|RITONAVIR	CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1	O3J8G9O825	Launched	HIV protease inhibitor	CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7
rivanicline	rivanicline|RIVANICLINE	CNCC\C=C\c1cccnc1	6H35LF645A	Phase 2	acetylcholine receptor agonist	CHRNA4|CHRNB2|CXCL8
rivaroxaban	rivaroxaban|RIVAROXABAN	Clc1ccc(s1)C(=O)NCC1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O	9NDF7JZ4M3	Launched	coagulation factor inhibitor	F10
rivastigmine	rivastigmine|RIVASTIGMINE	CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C	PKI06M3IW0	Launched	acetylcholinesterase inhibitor	ACHE|BCHE
rizatriptan	rizatriptan|RIZATRIPTAN	CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12	51086HBW8G	Launched	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F
RKI-1447	RKI-1447	Oc1cccc(CNC(=O)Nc2nc(cs2)-c2ccncc2)c1		Preclinical	rho associated kinase inhibitor	CDC42BPA|DMPK|LIMK1|MYLK|PAK1|PKN1|ROCK1|ROCK2
RLX	RLX	O=c1n2CCCCCc2nc2ccccc12		Preclinical		
RN-1734	RN-1734	CC(C)NCCN(C(C)C)S(=O)(=O)c1ccc(Cl)cc1Cl		Preclinical	TRPV antagonist	TRPV4
RN-1747	RN-1747	[O-][N+](=O)c1cc(Cl)ccc1S(=O)(=O)N1CCN(Cc2ccccc2)CC1		Preclinical	TRPV agonist	TRPV4
Ro-04-5595	Ro-04-5595	COc1cc2CCN(C)C(CCc3ccc(Cl)cc3)c2cc1O		Preclinical		GRIN2B
Ro-08-2750	Ro-08-2750	Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C)c2cc1C=O		Preclinical		NGF
Ro-10-5824	Ro-10-5824	Cc1ncc(CN2CCC(=CC2)c2ccccc2)c(N)n1		Preclinical	dopamine receptor agonist	DRD4
Ro-106-9920	Ro-106-9920	O=S(c1ccccc1)c1ccc2nnnn2n1		Preclinical	NFkB pathway inhibitor	
Ro-15-4513	Ro-15-4513|RO-15-4513	CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(ccc-21)N=[N+]=[N-]	S5XGL82O5Y	Preclinical		GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2
Ro-19-4605	Ro-19-4605	CN1Cc2c(ncn2-c2ccsc2C1=O)C(=O)OC(C)(C)C		Preclinical		GABRA1|GABRA2|GABRA3|GABRA5
Ro-20-1724	Ro-20-1724|RO-20-1724	CCCCOc1cc(CC2CNC(=O)N2)ccc1OC	DIW6F13QW2	Preclinical	phosphodiesterase inhibitor	PDE3A|PDE4A|PDE4B|PDE4C|PDE4D
Ro-25-6981	Ro-25-6981	C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1		Preclinical		GRIN2B
Ro-28-1675	Ro-28-1675	CS(=O)(=O)c1ccc(cc1)[C@@H](CC1CCCC1)C(=O)Nc1nccs1		Preclinical	glucokinase activator	GCK
Ro-48-8071	Ro-48-8071	CN(CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1)CC=C		Preclinical	oxidosqualene cyclase inhibitor	LSS
Ro-4987655	Ro-4987655|RO-4987655	OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F	I3733P75ML	Phase 1	MEK inhibitor	MAP2K1
Ro-5126766	Ro-5126766	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		Phase 1	RAF inhibitor|MEK inhibitor	BRAF|MAP2K1|MAP2K2|RAF1
Ro-60-0175	Ro-60-0175	C[C@H](N)Cn1ccc2cc(F)c(Cl)cc12		Preclinical		HTR2A|HTR2B|HTR2C
Ro-61-8048	Ro-61-8048	COc1ccc(cc1OC)S(=O)(=O)Nc1nc(cs1)-c1cccc(c1)[N+]([O-])=O		Preclinical	kynurenine 3-monooxygenase inhibitor	KMO
Ro-90-7501	Ro-90-7501	Nc1ccc(cc1)-c1nc2ccc(cc2[nH]1)-c1nc2ccc(N)cc2[nH]1		Preclinical		APP
Ro-9187	Ro-9187|R-1479	Nc1ccn([C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@@H]2O)c(=O)n1	M71RA9DMGJ	Preclinical	HCV inhibitor	
rociletinib	rociletinib|ROCILETINIB	COc1cc(ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F)N1CCN(CC1)C(C)=O	72AH61702G	Phase 3	EGFR inhibitor	EGFR
rocuronium	rocuronium|ROCURONIUM	CC(=O)O[C@H]1[C@H](CC2C3CCC4C[C@H](O)[C@H](C[C@]4(C)C3CC[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1	WRE554RFEZ	Launched	acetylcholine receptor antagonist	CHRM2|CHRNA2|HTR3A
rofecoxib	rofecoxib|ROFECOXIB	CS(=O)(=O)c1ccc(cc1)C1=C(C(=O)OC1)c1ccccc1	0QTW8Z7MCR	Withdrawn	cyclooxygenase inhibitor	ELN|PTGS2
roflumilast	roflumilast|ROFLUMILAST	FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl	0P6C6ZOP5U	Launched	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D
rolipram	rolipram|ROLIPRAM	COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1	K676NL63N7	Phase 3	phosphodiesterase inhibitor	
rolipram-R(-)	rolipram-R(-)|ROLIPRAM, (R)-	COc1ccc(cc1OC1CCCC1)[C@@H]1CNC(=O)C1	DPX51KUP08	Preclinical	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D|PDE5A
rolipram-S(+)	rolipram-S(+)|ROLIPRAM, (S)-	COc1ccc(cc1OC1CCCC1)[C@H]1CNC(=O)C1	H6G4VMQ24K	Preclinical	phosphodiesterase inhibitor	
rolitetracycline	rolitetracycline|ROLITETRACYCLINE	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCN2CCCC2)C1=O	GH9IW85221	Launched	bacterial 30S ribosomal subunit inhibitor	
rolziracetam	rolziracetam|ROLZIRACETAM	O=C1CCC2CCC(=O)N12	RES9I0LGG5	Phase 2		
romidepsin	romidepsin|ROMIDEPSIN	C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C	CX3T89XQBK	Launched	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
ronidazole	ronidazole|RONIDAZOLE	Cn1c(COC(N)=O)ncc1[N+]([O-])=O	E01R4M1063	Launched	antiprotozoal agent	
ropinirole	ropinirole|ROPINIROLE	CCCN(CCC)CCc1cccc2NC(=O)Cc12	030PYR8953	Launched	dopamine receptor agonist	ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
ropivacaine	ropivacaine|ROPIVACAINE	CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C	7IO5LYA57N	Launched	sodium channel blocker	SCN10A
roquinimex	roquinimex|ROQUINIMEX	CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1	372T2944C0	Phase 3	angiogenesis inhibitor|tumor necrosis factor production inhibitor	
rosamicin	rosamicin|ROSARAMICIN	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)CC(C2O)N(C)C)C(CC=O)CC(C)C(=O)\C=C\C2(C)OC2C1C	E907BNQ7SH	Phase 2	protein synthesis inhibitor	
roscovitine	roscovitine|SELICICLIB	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	0ES1C2KQ94	Phase 2	CDK inhibitor	CDK2|CDK9
rose-bengal	rose-bengal|ROSE BENGAL POTASSIUM	OC(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(I)c(O)c(I)c2oc2c(I)c(=O)c(I)cc12	1ZPG1ELY14	Launched	contrast agent	
rose-bengal-disodium	rose-bengal-disodium	OC(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(I)c(O)c(I)c2oc2c(I)c(=O)c(I)cc12		Phase 2	immunostimulant	
rose-bengal-lactone	rose-bengal-lactone|ROSE BENGAL LACTONE	Oc1c(I)cc2c(Oc3c(I)c(O)c(I)cc3C22OC(=O)c3c2c(Cl)c(Cl)c(Cl)c3Cl)c1I	BIU7Q7W2SH	Launched	coloring agent	
rosiglitazone	rosiglitazone|ROSIGLITAZONE	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1	05V02F2KDG	Withdrawn	insulin sensitizer|PPAR receptor agonist	ACSL4|FFAR1|PPARG|TRPC5|TRPM3
rosmarinic-acid	rosmarinic-acid|ROSMARINIC ACID	OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)\C=C\c1ccc(O)c(O)c1	MQE6XG29YI	Launched	GABA transaminase inhibitor	MCL1|TYR
rosoxacin	rosoxacin|ROSOXACIN	CCn1cc(C(O)=O)c(=O)c2ccc(cc12)-c1ccncc1	3Y1OT3J4NW	Launched	topoisomerase inhibitor	
rostafuroxine	rostafuroxine|ROSTAFUROXIN	C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)c1ccoc1	P848LCX62B	Phase 2	ATPase inhibitor	ATP1A1
rosuvastatin	rosuvastatin|ROSUVASTATIN	CC(C)c1nc(nc(-c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O	413KH5ZJ73	Launched	HMGCR inhibitor	HMGCR
rotigotine	rotigotine|ROTIGOTINE	CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1	87T4T8BO2E	Launched	dopamine receptor agonist	ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A
rotundine	rotundine|TETRAHYDROPALMATINE	COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC	3X69CO5I79	Launched	serotonin receptor agonist	DRD1|DRD2|DRD3|HTR1A
roxarsone	roxarsone|ROXARSONE	Oc1ccc(cc1[N+]([O-])=O)[As](O)(O)=O	H5GU9YQL7L	Launched	antiprotozoal agent	
roxatidine-acetate	roxatidine-acetate|ROXATIDINE ACETATE	CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1	ZUP3LSD0DO	Launched	histamine receptor antagonist	HRH2
roxithromycin	roxithromycin|ROXITHROMYCIN	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O	21KOF230FA	Launched	bacterial 50S ribosomal subunit inhibitor	ABCB1|MLNR
RP67580	RP67580|RP-67580	COc1ccccc1C=C(N)N1C[C@H]2[C@@H](C1)C(CCC2=O)(c1ccccc1)c1ccccc1	49U9M41BGY	Preclinical		
RRx-001	RRx-001|RRX-001	[O-][N+](=O)C1(CN(C1)C(=O)CBr)[N+]([O-])=O	7RPW6SU9SC	Phase 2	glucose 6-phosphate dehydrogenase inhibitor	G6PD
RS-0481	RS-0481	CC(NC(=O)C1CSCN1C(=O)c1ccccc1)c1ccccc1		Phase 2	immunostimulant	
RS-100329	RS-100329	Cc1c[nH]c(=O)n(CCCN2CCN(CC2)c2ccccc2OCC(F)(F)F)c1=O		Preclinical	adrenergic receptor antagonist	ADRA1A|ADRA1D
RS-102221	RS-102221	COc1cc(OC)c(cc1NS(=O)(=O)c1ccc(cc1)C(F)(F)F)C(=O)CCCCN1CCC2(CC1)NC(=O)NC2=O		Preclinical	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
RS-102895	RS-102895	FC(F)(F)c1ccc(CCN2CCC3(CC2)OC(=O)Nc2ccccc32)cc1		Preclinical	CCR antagonist	CCR2
RS-127445	RS-127445	CC(C)c1cc(nc(N)n1)-c1ccc(F)c2ccccc12	0JAU3P8OBM	Phase 1	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
RS-16566	RS-16566	CC(C)n1cnc2c(cc(Cl)cc12)C(=O)N[C@H]1CN2CCC1CC2		Preclinical	serotonin receptor antagonist	
RS-17053	RS-17053	CC(C)(Cc1c[nH]c2ccc(Cl)cc12)NCCOc1ccccc1OCC1CC1		Preclinical	adrenergic receptor antagonist	ADRA1A|ADRA1D
RS-23597-190	RS-23597-190	COc1cc(N)c(Cl)cc1C(=O)OCCCN1CCCCC1		Preclinical	serotonin receptor antagonist	HTR4
RS-39604	RS-39604	COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC2CCN(CCNS(C)(=O)=O)CC2)cc(OC)c1		Preclinical	serotonin receptor antagonist	HTR4
RS-45041-190	RS-45041-190	Clc1cccc2CN(Cc12)C1=NCCN1		Preclinical	imidazoline receptor agonist	
RS-504393	RS-504393	Cc1oc(nc1CCN1CCC2(CC1)OC(=O)Nc1ccc(C)cc21)-c1ccccc1		Preclinical	CC chemokine receptor antagonist	CCL2|CCR2
RS-56812	RS-56812	Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc12		Preclinical	serotonin receptor partial agonist	HTR3A
RS-67333	RS-67333	CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1		Preclinical	serotonin receptor partial agonist	HTR4
RS-67506	RS-67506	COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CCNS(C)(=O)=O)CC1		Preclinical	serotonin receptor partial agonist	HTR4
RS-79948	RS-79948	CCS(=O)(=O)N1CCC[C@@H]2CN3CCc4cc(OC)ccc4[C@@H]3C[C@H]12		Preclinical	adrenergic receptor antagonist	ADRA2A
RSV604	RSV604	Fc1ccccc1NC(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O		Phase 2	RSV replication inhibitor	
RTA-408	RTA-408|OMAVELOXOLONE	CC(F)(F)C(=O)NC12CCC(C)(C)CC1C1C(=O)C=C3C4(C)C=C(C#N)C(=O)C(C)(C)C4CCC3(C)C1(C)CC2	G69Z98951Q	Phase 2	nitric oxide production inhibitor	NFE2L2
RU-24969	RU-24969	COc1ccc2[nH]cc(C3=CCNCC3)c2c1		Phase 1	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6
RU-28318	RU-28318|OXPRENOATE	CCC[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]3(O)CCC(O)=O)[C@H]12	2JGY63UVRO	Phase 2	cytochrome P450 inhibitor	NR3C2
RU-42173	RU-42173|ZILPATEROL	CC(C)N[C@@H]1CCn2c3c(cccc3[nH]c2=O)[C@H]1O	S384A1Y12J	Phase 2	adrenergic receptor agonist	ADRB2
RU-58841	RU-58841	CC1(C)N(CCCCO)C(=O)N(C1=O)c1ccc(C#N)c(c1)C(F)(F)F		Phase 2	androgen receptor antagonist	AR
rubitecan	rubitecan|RUBITECAN	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cccc([N+]([O-])=O)c4cc3Cn1c2=O	H19C446XXB	Phase 3	topoisomerase inhibitor	TOP1
rucaparib	rucaparib|RUCAPARIB	CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23	8237F3U7EH	Phase 3	PARP inhibitor	PARP1|PARP2
rucinol	rucinol|4-BUTYLRESORCINOL	CCCCc1ccc(O)cc1O	2IK4UQ3ZGA	Phase 1	tyrosinase inhibitor	TYR
rufinamide	rufinamide|RUFINAMIDE	NC(=O)c1cn(Cc2c(F)cccc2F)nn1	WFW942PR79	Launched	voltage-gated sodium channel blocker	GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
rufloxacin	rufloxacin|RUFLOXACIN	CN1CCN(CC1)c1c(F)cc2c3c1SCCn3cc(C(O)=O)c2=O	Y521XM2900	Launched	bacterial DNA gyrase inhibitor	
rupatadine	rupatadine|RUPATADINE	Cc1cncc(CN2CCC(CC2)=C2c3ccc(Cl)cc3CCc3cccnc23)c1	2AE8M83G3E	Launched	histamine receptor antagonist|platelet activating factor receptor antagonist	HRH1|PTAFR
rutaecarpine	rutaecarpine|RUTECARPINE	O=c1n2CCc3c([nH]c4ccccc34)-c2nc2ccccc12	8XZV289PRY	Preclinical	cyclooxygenase inhibitor	PTGS2
rutin	rutin|RUTIN	C[C@@H]1O[C@@H](OC[C@H]2OC(Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O	5G06TVY3R7	Launched	antioxidant|capillary stabilizing agent|nitric oxide scavenger	AKR1C3
ruxolitinib	ruxolitinib|RUXOLITINIB	N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12	82S8X8XX8H	Launched	JAK inhibitor	JAK1|JAK2|JAK3|TYK2
ruxolitinib-(S)	ruxolitinib-(S)|RUXOLITINIB	N#CC[C@@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12	82S8X8XX8H	Preclinical	JAK inhibitor	JAK1|JAK2
RWJ-21757	RWJ-21757|LOXORIBINE	Nc1nc2n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c(=O)n(CC=C)c2c(=O)[nH]1	9CAS0V66OI	Phase 1	toll-like receptor agonist	TLR7
RWJ-67657	RWJ-67657	OCCC#Cc1nc(c(-c2ccncc2)n1CCCc1ccccc1)-c1ccc(F)cc1		Phase 1	MAP kinase inhibitor	MAPK14|PTGS2
RX-3117	RX-3117	Nc1ccn([C@H]2[C@H](O)[C@H](O)C(CO)=C2F)c(=O)n1		Phase 1/Phase 2	DNA synthesis inhibitor|CDK inhibitor	CDK2|DNMT1
RX-821002	RX-821002	COC1(COc2ccccc2O1)C1=NCCN1		Preclinical	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
ryuvidine	ryuvidine	Cc1nc2c(s1)C(=O)C=C(Nc1ccc(C)cc1)C2=O		Preclinical	histone lysine methyltransferase inhibitor	CDK2|CDK4
S-111	S-111|PROTOPANAXADIOL	CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]21C	P6717R7BP8	Phase 2	PARP inhibitor	PARP1
S-14506	S-14506	COc1ccc2cccc(N3CCN(CCNC(=O)c4ccc(F)cc4)CC3)c2c1	YVO8LE53MI	Preclinical	serotonin receptor agonist	HTR1A
S-Isopropylisothiourea	S-Isopropylisothiourea	CC(C)SC(N)=N		Preclinical	nitric oxide synthase inhibitor	NOS3
S-methylcysteine	S-methylcysteine|S-METHYLCYSTEINE	CSC[C@H](N)C(O)=O	A34I1H07YM	Phase 1		CTSD|MGMT
S-Nitrosoglutathione	S-Nitrosoglutathione	N[C@@H](CCC(=O)N[C@@H](CS[N+][O-])C(=O)NCC(O)=O)C(O)=O		Phase 1	nitric oxide stimulant	PTPN1
S-Sulfo-L-cysteine-sodium-salt	S-Sulfo-L-cysteine-sodium-salt|S-SULFOCYSTEINE	N[C@@H](CSS(O)(=O)=O)C(O)=O	885F2S42LL	Preclinical	glutamate receptor agonist	
S-Trityl-L-cysteine	S-Trityl-L-cysteine	N[C@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(O)=O		Preclinical	mitotic kinesin inhibitor	
S18986	S18986|S-18986	O=S1(=O)N[C@H]2CCCN2c2ccccc12	IA262432Y9	Phase 2	glutamate receptor modulator	GRIA1|GRIA2|GRIA3|GRIA4
S1P1-agonist-III	S1P1-agonist-III	COc1ccncc1C(=O)NC(=O)Nc1ccc(-c2ccccc2)c(c1)C(F)(F)F		Preclinical	sphingosine kinase inhibitor	S1PR1
S26948	S26948	COC(=O)C(Cc1ccc(OCCn2c3ccc(cc3sc2=O)C(=O)c2ccccc2)cc1)C(=O)OC		Preclinical	PPAR receptor agonist	PPARG
saccharin	saccharin|SACCHARIN	O=C1NS(=O)(=O)c2ccccc12	FST467XS7D	Launched	DNA polymerase inhibitor	CA1|CA12|CA2|CA9
saclofen	saclofen|SACLOFEN	NCC(CS(O)(=O)=O)c1ccc(Cl)cc1	LRZ36BCQ1Y	Preclinical	GABA receptor antagonist	GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
sacubitril	sacubitril|SACUBITRIL	CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O	17ERJ0MKGI	Launched	neprilysin inhibitor	MME
safflower-yellow	safflower-yellow	OC[C@H]1OC([C@H](O)[C@@H](O)[C@@H]1O)[C@]1(O)C(=O)C(\C=C2/C(=O)C(C(=O)\C=C\c3ccc(O)cc3)C(=O)[C@@](O)(C3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C2=O)C(=O)C(C(=O)\C=C\c2ccc(O)cc2)C1=O		Preclinical	anti-inflammatory agent	
safinamide	safinamide|SAFINAMIDE	C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O	90ENL74SIG	Launched	dopamine uptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor	MAOB
safingol	safingol|SAFINGOL	CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO	OWA98U788S	Phase 1	PKC inhibitor	TRPM3
safranal	safranal|SAFRANAL	CC1=C(C=O)C(C)(C)CC=C1	4393FR07EA	Phase 2	benzodiazepine receptor agonist	GABBR1
sal003	sal003	Clc1ccc(cc1)NC(=S)NC(C(Cl)(Cl)Cl)NC(=O)\C=C\c1ccccc1		Preclinical	eukaryotic translation initiation factor inhibitor	EIF2A
salazodine	salazodine|SALAZODINE	COc1ccc(NS(=O)(=O)c2ccc(cc2)N=Nc2ccc(O)c(c2)C(O)=O)nn1	4L219Q1D16	Phase 2		
salicin	salicin|SALICIN	OC[C@H]1O[C@@H](Oc2ccccc2CO)[C@H](O)[C@@H](O)[C@@H]1O	4649620TBZ	Phase 1	anti-inflammatory agent	
salicyl-alcohol	salicyl-alcohol|SALICYL ALCOHOL	OCc1ccccc1O	FA1N0842KB	Preclinical		
salicylamide	salicylamide|SALICYLAMIDE	NC(=O)c1ccccc1O	EM8BM710ZC	Launched	analgesic agent	
salicylanilide	salicylanilide|SALICYLANILIDE	Oc1ccccc1C(=O)Nc1ccccc1	LHP8NEY345	Preclinical	other antibiotic	
salicylic-acid	salicylic-acid|SALICYLIC ACID	OC(=O)c1ccccc1O	O414PZ4LPZ	Launched	cyclooxygenase inhibitor	AKR1C1|PTGS1|PTGS2
salidroside	salidroside|SALIDROSIDE	OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O	M983H6N1S9	Preclinical	beta amyloid protein neurotoxicity inhibitor	APP
salinomycin	salinomycin|SALINOMYCIN	CC[C@H]([C@H]1CC[C@H](C)[C@@H](O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]1OC2(O[C@@]3(CC[C@](C)(O3)C3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O	62UXS86T64	Launched		
salirasib	salirasib|SALIRASIB	CC(C)=CCC\C(C)=C\CC\C(C)=C\CSc1ccccc1C(O)=O	MZH0OM550M	Phase 2	mTOR inhibitor	TRPA1
salmeterol	salmeterol|SALMETEROL	OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1	2I4BC502BT	Launched	adrenergic receptor agonist	ADRB2
salsolinol-1-carboxylic-acid	salsolinol-1-carboxylic-acid	CC1(NCCc2cc(O)c(O)cc12)C(O)=O		Preclinical		
salubrinal	salubrinal	ClC(Cl)(Cl)C(NC(=O)\C=C\c1ccccc1)NC(=S)Nc1cccc2cccnc12		Preclinical	eukaryotic translation initiation factor inhibitor	EIF2S1
salvianolic-acid-B	salvianolic-acid-B|SALVIANOLIC ACID B	OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)\C=C\c1ccc(O)c2O[C@H]([C@H](C(=O)O[C@H](Cc3ccc(O)c(O)c3)C(O)=O)c12)c1ccc(O)c(O)c1	C1GQ844199	Phase 2	metalloproteinase inhibitor|EGFR inhibitor	MMP9
salvinorin-a	salvinorin-a|SALVINORIN A	COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)c1ccoc1	T56W91NG6J	Phase 1	opioid receptor agonist	OPRD1|OPRK1|OPRM1
sanazole	sanazole|SANAZOLE	COCCNC(=O)Cn1cnc(n1)[N+]([O-])=O	1EIF6HTA24	Phase 1		
sangivamycin	sangivamycin	NC(=O)c1cn(C2OC(CO)[C@H](O)[C@@H]2O)c2ncnc(N)c12		Phase 1	DNA inhibitor	
sanguinarium-chloride	sanguinarium-chloride|SANGUINARIUM CHLORIDE	C[n+]1cc2c3OCOc3ccc2c2ccc3cc4OCOc4cc3c12	B8Z8J4400H	Phase 1	apoptosis stimulant	CASP3
SANT-1	SANT-1	Cc1nn(c(C)c1\C=N\N1CCN(Cc2ccccc2)CC1)-c1ccccc1		Preclinical	smoothened receptor antagonist	SHH|SMO
SANT-2	SANT-2	CCOc1cc(cc(OCC)c1OCC)C(=O)Nc1ccc(Cl)c(c1)-c1nc2ccccc2[nH]1		Preclinical	smoothened receptor antagonist	SHH|SMO
sapropterin	sapropterin|SAPROPTERIN	C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1	EGX657432I	Launched	phenylalanine 4-hydroxylase stimulant	NOS3|PAH|TH|TPH1
saquinavir	saquinavir|SAQUINAVIR	CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1	L3JE09KZ2F	Launched	HIV protease inhibitor	CYP3A4
SAR-245409	SAR-245409|VOXTALISIB	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)c(OC)c3)cc2)cc(OC)c1	CVL1685GPH	Phase 1/Phase 2	PI3K inhibitor	MTOR|PIK3CG
SAR131675	SAR131675	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(nc12)C#C[C@@](C)(O)COC		Preclinical	VEGFR inhibitor	FLT4
SAR405838	SAR405838|SAR-405838	CC(C)(C)CC1NC(C(c2cccc(Cl)c2F)C11C(=O)Nc2cc(Cl)ccc12)C(=O)NC1CCC(O)CC1	8570LZ3RCA	Phase 1	MDM inhibitor	MDM2
SAR407899	SAR407899	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		Phase 2	rho associated kinase inhibitor	ROCK1
saracatinib	saracatinib|SARACATINIB	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c5OCOc5ccc4Cl)ncnc3c2)CC1	9KD24QGH76	Phase 2/Phase 3	src inhibitor	ABL1|LCK|SRC|YES1
sarafloxacin	sarafloxacin|SARAFLOXACIN	OC(=O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O	RC3WJ907XY	Launched	bacterial DNA gyrase inhibitor	
sarcosine	sarcosine|SARCOSINE	CNCC(O)=O	Z711V88R5F	Phase 2	Glycine transporter 1 inhibitor	SLC6A9
sari-59-801	sari-59-801	CCc1noc(C)c1-c1[nH]c2ccccc2c1C(O)CN(C)C		Phase 1		
saroglitazar	saroglitazar|SAROGLITAZAR	CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(O)=O	E0YMX3S4JD	Phase 3	PPAR receptor agonist	PPARA|PPARG
sarpogrelate	sarpogrelate|SARPOGRELATE	COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(O)=O)c1	19P708E787	Launched	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
sasapyrine	sasapyrine|SALSALATE	OC(=O)c1ccccc1OC(=O)c1ccccc1O	V9MO595C9I	Launched	NFkB pathway inhibitor	PTGS1|PTGS2
satraplatin	satraplatin|SATRAPLATIN	CC(=O)O[Pt](N)(Cl)(Cl)(NC1CCCCC1)OC(C)=O	8D7B37T28G	Phase 3	DNA alkylating agent	
savolitinib	savolitinib|SAVOLITINIB	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(nc12)-c1cnn(C)c1	2A2DA6857R	Phase 2	c-Met inhibitor	MET
saxagliptin	saxagliptin|SAXAGLIPTIN MONOHYDRATE	N[C@H](C(=O)N1[C@@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2	9GB927LAJW	Launched	dipeptidyl peptidase inhibitor	DPP4
SB-200646	SB-200646	Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc12		Preclinical	serotonin receptor antagonist	HTR2B|HTR2C
SB-202190	SB-202190	Oc1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1	PVX798P8GI	Preclinical	p38 MAPK inhibitor	AKT1|ALOX5|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1
SB-203186	SB-203186	O=C(OCCN1CCCCC1)c1c[nH]c2ccccc12		Preclinical	serotonin receptor antagonist	HTR4
SB-203580	SB-203580	CS(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1	OU13V1EYWQ	Preclinical	p38 MAPK inhibitor	AKT1|ALOX5|CHEK1|CYP2D6|CYP3A4|GAK|GSK3B|LCK|MAPK1|MAPK10|MAPK11|MAPK12|MAPK14|MAPK8|MAPK9|PRKCA|RAF1|RIPK2|ROCK1|RPS6KB1|SGK1|SRC|TNF
SB-205384	SB-205384	CC#CCOC(=O)c1c(C)nc2sc3CC(O)CCc3c2c1N		Preclinical	GABA receptor modulator	GABRA3|GABRA5|GABRA6
SB-206553	SB-206553	Cn1ccc2cc3N(CCc3cc12)C(=O)Nc1cccnc1		Preclinical	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
SB-216641	SB-216641	COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1OCCN(C)C		Preclinical	serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
SB-216763	SB-216763	Cn1cc(C2=C(C(=O)NC2=O)c2ccc(Cl)cc2Cl)c2ccccc12		Preclinical	glycogen synthase kinase inhibitor	CCNA2|CDK2|GSK3A|GSK3B
SB-218078	SB-218078	O=C1NC(=O)c2c1c1c3ccccc3n3C4CCC(O4)n4c5ccccc5c2c4c13		Preclinical	CHK inhibitor	CHEK1
SB-218795	SB-218795	COC(=O)[C@H](NC(=O)c1cc(nc2ccccc12)-c1ccccc1)c1ccccc1		Preclinical	tachykinin antagonist	TACR3
SB-221284	SB-221284	CSc1cc2CCN(C(=O)Nc3cccnc3)c2cc1C(F)(F)F		Preclinical	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
SB-222200	SB-222200	CC[C@H](NC(=O)c1c(C)c(nc2ccccc12)-c1ccccc1)c1ccccc1		Preclinical	tachykinin antagonist	TACR3
SB-225002	SB-225002	Oc1cc(ccc1NC(=O)Nc1ccccc1Br)[N+]([O-])=O		Preclinical	CC chemokine receptor antagonist	CXCR2
SB-228357	SB-228357	COc1cc2CCN(C(=O)Nc3cc(F)cc(c3)-c3cccnc3)c2cc1C(F)(F)F	5RDN2E8E97	Preclinical	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
SB-2343	SB-2343|VS-5584	CC(C)n1c(C)nc2c(nc(nc12)N1CCOCC1)-c1cnc(N)nc1	W71J4X250V	Phase 1	mTOR inhibitor|PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG
SB-239063	SB-239063	COc1nccc(n1)-c1c(ncn1[C@H]1CC[C@H](O)CC1)-c1ccc(F)cc1	HII3DC8CPI	Preclinical	p38 MAPK inhibitor	MAPK11|MAPK14|PTGS2
SB-242235	SB-242235	COc1nccc(n1)-c1c(ncn1C1CCNCC1)-c1ccc(F)cc1		Phase 1	p38 MAPK inhibitor	HSPB1|MAPK14
SB-258585	SB-258585	COc1ccc(NS(=O)(=O)c2ccc(I)cc2)cc1N1CCN(C)CC1		Preclinical	serotonin receptor antagonist	HTR6
SB-269970	SB-269970	CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1		Preclinical	serotonin receptor antagonist	HTR7
SB-271046	SB-271046	COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1		Phase 1	serotonin receptor antagonist	HTR6
SB-328437	SB-328437	COC(=O)[C@H](Cc1ccc(cc1)[N+]([O-])=O)NC(=O)c1cccc2ccccc12		Preclinical	CCR antagonist	
SB-334867	SB-334867	Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1		Preclinical	orexin receptor antagonist	HCRTR1|HCRTR2
SB-366791	SB-366791	COc1cccc(NC(=O)\C=C\c2ccc(Cl)cc2)c1		Preclinical	TRPV antagonist	TRPV1
SB-408124	SB-408124	CN(C)c1ccc(NC(=O)Nc2cc(C)nc3c(F)cc(F)cc23)cc1		Preclinical	orexin receptor antagonist	HCRTR1|HCRTR2
SB-415286	SB-415286	Oc1ccc(NC2=C(C(=O)NC2=O)c2ccccc2[N+]([O-])=O)cc1Cl		Preclinical	glycogen synthase kinase inhibitor	GSK3A|GSK3B|RPS6KB1
SB-431542	SB-431542	NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCOc2c1	E1557V1V0N	Preclinical	TGF beta receptor inhibitor	ACVR1C|TGFBR1
SB-505124	SB-505124	Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2OCOc2c1)C(C)(C)C		Preclinical	ALK tyrosine kinase receptor inhibitor	TGFBR1
SB-525334	SB-525334	Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2nccnc2c1)C(C)(C)C		Preclinical	TGF beta receptor inhibitor	TGFBR1
SB-590885	SB-590885	CN(C)CCOc1ccc(cc1)-c1nc(c([nH]1)-c1ccc2c(CC\C2=N\O)c1)-c1ccncc1	ISE5ATW631	Preclinical	RAF inhibitor	BRAF
SB-657510	SB-657510	COc1cc(Br)c(cc1OC)S(=O)(=O)Nc1ccc(Cl)c(O[C@@H]2CCN(C)C2)c1		Preclinical	urotensin receptor antagonist	UTS2R
SB-683698	SB-683698	COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)c2c(Cl)cccc2Cl)C(O)=O)cc1		Phase 1	integrin antagonist	ITGA4|ITGAV|ITGB1|ITGB7
SB-705498	SB-705498	FC(F)(F)c1ccc(nc1)N1CC[C@H](C1)NC(=O)Nc1ccccc1Br	T74V9O0Y2W	Phase 2	TRPV antagonist	TRPV1
SB-742457	SB-742457|INTEPIRDINE	O=S(=O)(c1ccccc1)c1cnc2c(cccc2c1)N1CCNCC1	2IOB2M82HY	Phase 3	serotonin receptor antagonist	HTR6
SB-743921	SB-743921	CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)c1oc2cc(Cl)ccc2c(=O)c1Cc1ccccc1		Phase 1/Phase 2	kinesin-like spindle protein inhibitor	KIF11
SB-756050	SB-756050	COc1ccc(cc1OC)S(=O)(=O)N1CCCN(CC1)S(=O)(=O)c1ccc(OC)c(OC)c1		Phase 1	G protein-coupled receptor agonist	GPBAR1
SB-939	SB-939|PRACINOSTAT	CCCCc1nc2cc(ccc2n1CCN(CC)CC)\C=C\C(=O)NO	GPO2JN4UON	Phase 2	HDAC inhibitor	HDAC1|HDAC10|HDAC3|HDAC4|HDAC5|HDAC9
SC-10	SC-10	CCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12		Preclinical	protein kinase activator	PRKCA
SC-12267	SC-12267|VIDOFLUDIMUS	COc1cccc(c1)-c1ccc(NC(=O)C2=C(CCC2)C(O)=O)c(F)c1	8Y1PJ3VG81	Phase 2	dihydroorotate dehydrogenase inhibitor	IL17A
SC-144	SC-144	Fc1ccc2c(c1)nc(NNC(=O)c1cnccn1)c1cccn21		Preclinical	P glycoprotein inhibitor	
SC-19220	SC-19220|METHYL MERCAPTAN	CC(=O)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc12	2X8406WW9I	Preclinical	prostanoid receptor antagonist	PTGER1
SC-560	SC-560|METHYL MERCAPTAN	COc1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F	2X8406WW9I	Preclinical	cyclooxygenase inhibitor	PTGS1
SC-9	SC-9	Clc1cccc2c(cccc12)S(=O)(=O)NCCCCCCc1ccccc1		Preclinical	protein tyrosine kinase activator	PRKCA
SCH-202676	SCH-202676	CN=c1nc(-c2ccccc2)n(s1)-c1ccccc1		Preclinical	G protein-coupled receptor modulator	CHRM1|CHRM2|DRD1|DRD2
SCH-23390	SCH-23390	CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c1ccccc1	UGT5535REQ	Preclinical	dopamine receptor antagonist	DRD1|DRD5|HTR2C|KCNJ4|KCNJ6
SCH-28080	SCH-28080	Cc1nc2c(OCc3ccccc3)cccn2c1CC#N	00427X161I	Phase 1	ATPase inhibitor	ATP4A
SCH-58261	SCH-58261	Nc1nc2n(CCc3ccccc3)ncc2c2nc(nn12)-c1ccco1	4309023MAH	Preclinical	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
SCH-900776	SCH-900776|MK-8776	Cn1cc(cn1)-c1cnn2c(N)c(Br)c(nc12)[C@@H]1CCCNC1	K2ZSF0992C	Phase 2	CHK inhibitor	CDK2|CHEK1
schisandrin-b	schisandrin-b|SCHISANDRIN B|GOMISIN N	COc1cc2C[C@H](C)[C@@H](C)Cc3cc4OCOc4c(OC)c3-c2c(OC)c1OC	02XA4X3KZW|DKO6O75Z5V	Preclinical	antioxidant	ATR
schisandrol-b	schisandrol-b|BESIGOMSIN	COc1cc2C[C@](C)(O)[C@@H](C)Cc3cc4OCOc4c(OC)c3-c2c(OC)c1OC	L5U70J87J8	Phase 3	lipid peroxidase inhibitor	
sclareol	sclareol|SCLAREOL	CC(O)(CC[C@H]1[C@](C)(O)CCC2C(C)(C)CCC[C@]12C)C=C	B607NP0Q8Y	Preclinical		
sclareolide	sclareolide|SCLAREOLIDE	C[C@@]12CC[C@H]3C(C)(C)CCC[C@@]3(C)[C@H]1CC(=O)O2	37W4O0O6E6	Launched	other antifungal	
SCMC-Lys	SCMC-Lys|CARBOCYSTEINE LYSINE MONOHYDRATE	N[C@@H](CSCC(O)=O)C(O)=O	QA5ZP9OL3E	Launched	mucolytic agent	GSTP1
scopine	scopine	CN1[C@H]2C[C@H](O)C[C@@H]1[C@H]1O[C@@H]21		Launched		
scopolamine	scopolamine|SCOPOLAMINE	CN1C2C[C@@H](C[C@H]1[C@H]1OC21)OC(=O)[C@H](CO)c1ccccc1	DL48G20X8X	Launched	acetylcholine receptor antagonist	
scopolamine-n-oxide	scopolamine-n-oxide|SCOPOLAMINE N-OXIDE	C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1	0I3054Z711	Preclinical	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI
SCP-1	SCP-1	Oc1ccc(NC(=O)CN2C(=O)c3ccccc3S2(=O)=O)cc1		Phase 1	analgesic agent	
scriptaid	scriptaid	ONC(=O)CCCCCN1C(=O)c2cccc3cccc(C1=O)c23		Preclinical	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
SCS	SCS|METHANEDITHIOL	Oc1ccccc1\C=N\NC(=O)c1ccccc1O	LSC543N4PH	Preclinical		
SD-169	SD-169	NC(=O)c1ccc2[nH]ccc2c1		Preclinical	p38 MAPK inhibitor	MAPK14
SD-208	SD-208	Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1		Preclinical	TGF beta receptor inhibitor	TGFBR1
SDM25N	SDM25N	CC(=C)CN1CC[C@@]23[C@H]4Oc5c2c(CC1[C@]3(O)Cc1c4[nH]c2ccccc12)ccc5O		Preclinical	opioid receptor antagonist	OPRD1
SDZ-205-557	SDZ-205-557	CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC		Preclinical	serotonin receptor antagonist	HTR3A|HTR3B
SDZ-21009	SDZ-21009|CARPINDOLOL	CC(C)OC(=O)c1cc2c(OCC(O)CNC(C)(C)C)cccc2[nH]1	W8F97XP38W	Preclinical	adrenergic receptor antagonist|serotonin receptor antagonist	HTR1A|HTR1B
SDZ-220-040	SDZ-220-040	N[C@@H](Cc1cc(cc(CP(O)(O)=O)c1O)-c1ccc(Cl)cc1Cl)C(O)=O		Preclinical	glutamate receptor antagonist	GRIN1
SDZ-220-581	SDZ-220-581	N[C@@H](Cc1cc(CP(O)(O)=O)cc(c1)-c1ccccc1Cl)C(O)=O		Preclinical	glutamate receptor antagonist	GRIN1
SDZ-NKT-343	SDZ-NKT-343	CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1CCCN1C(=O)Nc1ccccc1[N+]([O-])=O		Phase 1	tachykinin antagonist	TACR1
SDZ-SER-082	SDZ-SER-082	CN1CC[C@@H]2CN3CCc4cccc([C@@H]2C1)c34		Preclinical	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C
SDZ-WAG-994	SDZ-WAG-994	CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC3CCCCC3)ncnc12	567EWI9U1E	Phase 2	adenosine receptor agonist	ADORA1
se-methylselenocysteine	se-methylselenocysteine|METHYLSELENOCYSTEINE	C[Se]C[C@H](N)C(O)=O	TWK220499Z	Phase 2		
secalciferol	secalciferol|SECALCIFEROL	C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C	460029IUDA	Launched	vitamin D receptor agonist	VDR
seclazone	seclazone|SECLAZONE	Clc1ccc2OC3CCON3C(=O)c2c1	JW3UZ4I1A8	Phase 1	anti-inflammatory agent	
secnidazole	secnidazole|SECNIDAZOLE	CC(O)Cn1c(C)ncc1[N+]([O-])=O	R3459K699K	Launched	acetylcholinesterase inhibitor|microtubule inhibitor	
secoisolariciresinol-(-)	secoisolariciresinol-(-)|SECOISOLARICIRESINOL	COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O	M8QRJ7JEJH	Preclinical		
secoisolariciresinol-diglucoside	secoisolariciresinol-diglucoside|SECOISOLARICIRESINOL DIGLUCOSIDE	COc1cc(C[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)Cc2ccc(O)c(OC)c2)ccc1O	T9281L29MV	Phase 2	antioxidant	
securinine	securinine|SECURININE	O=C1O[C@@]23C[C@@H](C=CC2=C1)N1CCCC[C@H]31	G4VS580P5E	Preclinical	GABA receptor antagonist|TP53 activator	GABRA1
selamectin	selamectin|SELAMECTIN	CO[C@H]1CC(O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4C(=N/O)\C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(CC[C@H](C)[C@H](O2)C2CCCCC2)C5)[C@]34O)O[C@@H](C)C1O	A2669OWX9N	Launched	nematocide	
selegiline	selegiline|SELEGILINE	CC(Cc1ccccc1)N(C)CC#C	2K1V7GP655	Launched	monoamine oxidase inhibitor	MAOA|MAOB
selenomethionine	selenomethionine|SELENOMETHIONINE	C[Se]CCC(N)C(O)=O	964MRK2PEL	Launched		
selexipag	selexipag|SELEXIPAG	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1	5EXC0E384L	Phase 3	platelet aggregation inhibitor|IP1 prostacyclin receptor agonist	PTGIR
selfotel	selfotel|SELFOTEL|SELFOTEL, (+)-	OC(=O)[C@H]1C[C@@H](CP(O)(O)=O)CCN1	4VGJ4A41L2|N0905W44Y3	Phase 3	glutamate receptor antagonist	GRIN2A|GRIN2B|GRIN2C|GRIN2D
selinexor	selinexor|SELINEXOR	FC(F)(F)c1cc(cc(c1)C(F)(F)F)-c1ncn(\C=C/C(=O)NNc2cnccn2)n1	31TZ62FO8F	Phase 2/Phase 3	exportin antagonist	XPO1
selumetinib	selumetinib|SELUMETINIB	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO	6UH91I579U	Phase 3	MEK inhibitor	MAP2K1
semagacestat	semagacestat|SEMAGACESTAT	CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1c2ccccc2CCN(C)C1=O	3YN0602W4W	Phase 3	gamma secretase inhibitor	PSEN1
semapimod	semapimod|SEMAPIMOD	NC(=N)NNC(=C)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(cc(c2)C(=C)NNC(N)=N)C(=C)NNC(N)=N)cc(c1)C(=C)NNC(N)=N	9SGW2H1K8P	Phase 2	cytokine production inhibitor|p38 MAPK inhibitor	MAPK14
semaxanib	semaxanib|SEMAXANIB	Cc1cc(C)c(\C=C2/C(=O)Nc3ccccc23)[nH]1	71IA9S35AJ	Phase 3	VEGFR inhibitor	FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET
semustine	semustine|UREA, N-(2-CHLOROETHYL)-N'-(4-METHYLCYCLOHEXYL)-N-NITROSO-, CIS-|UREA, N-(2-CHLOROETHYL)-N'-(4-METHYLCYCLOHEXYL)-N-NITROSO-, TRANS-	CC1CCC(CC1)NC(=O)N(CCCl)[N+][O-]	2281H4FBL9|EGU4CMI14D	Phase 3	DNA alkylating agent	
senicapoc	senicapoc|SENICAPOC	NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1	TS6G201A6Q	Phase 3	intermediate conductance potassium channel blocker	KCNN4
sennoside-a	sennoside-a|SENNOSIDE A	OC[C@H]1O[C@H](Oc2cccc3C([C@H]4c5cccc(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c5c(O)cc(cc45)C(O)=O)c4cc(cc(O)c4C(=O)c23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O	2F1O30GVXH	Launched	glycoside agonist	
sennoside-protonated	sennoside-protonated	OCC1OC(Oc2cccc3c(-c4c5cccc(OC6OC(CO)C(O)C(O)C6O)c5c(O)c5c(O)cc(cc45)C(O)=O)c4cc(cc(O)c4c(O)c23)C(O)=O)C(O)C(O)C1O		Preclinical		
seocalcitol	seocalcitol|SEOCALCITOL	CCC(O)(CC)\C=C\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	Q0OZ0D9223	Phase 3	vitamin D receptor agonist	VDR
SEP-227900	SEP-227900	OC(=O)c1cc2occc2[nH]1		Phase 1	D-Amino Acid Oxidase Inhibitor	DAO
seratrodast	seratrodast|SERATRODAST	CC1=C(C)C(=O)C(C(CCCCCC(O)=O)c2ccccc2)=C(C)C1=O	4U58JM421N	Launched	prostanoid receptor antagonist	TBXA2R
serdemetan	serdemetan|SERDEMETAN	C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1	ID6YB4W3V8	Phase 1	MDM inhibitor	MDM2
serotonin	serotonin|SEROTONIN	NCCc1c[nH]c2ccc(O)cc12	333DO1RDJY	Launched	growth factor receptor activator	DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR4|HTR5A|HTR6|HTR7|SLC36A1
sertaconazole	sertaconazole|SERTACONAZOLE	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1	72W71I16EG	Launched	sterol demethylase inhibitor	
sertindole	sertindole|SERTINDOLE	Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12	GVV4Z879SP	Withdrawn	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2
sertraline	sertraline|SERTRALINE	CN[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc12	QUC7NX6WMB	Launched	selective serotonin reuptake inhibitor (SSRI)	SLC6A3|SLC6A4
sesamin	sesamin|SESAMIN, (+/-)-|SESAMIN	C1Oc2ccc(cc2O1)[C@H]1OC[C@@H]2[C@@H]1CO[C@@H]2c1ccc2OCOc2c1	FY3S29JVC9|S7946O4P76	Preclinical	NFkB pathway inhibitor	
setipiprant	setipiprant|SETIPIPRANT	OC(=O)Cn1c2CCN(Cc2c2cc(F)ccc12)C(=O)c1cccc2ccccc12	BHF20LA2GM	Phase 3	prostaglandin inhibitor	PTGDR2
setiptiline	setiptiline|SETIPTILINE	CN1CCC2=C(C1)c1ccccc1Cc1ccccc21	7L38105Z6E	Launched	adrenergic receptor antagonist	HRH1|HTR2A|HTR2C
sevelamer	sevelamer	NCC=C.ClCC1CO1		Launched	phosphate antagonist	
sevoflurane	sevoflurane|SEVOFLURANE	FCOC(C(F)(F)F)C(F)(F)F	38LVP0K73A	Launched	membrane integrity inhibitor	ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|MT-ND1
SEW-2871	SEW-2871	FC(F)(F)c1sc(cc1-c1ccccc1)-c1nc(no1)-c1cccc(c1)C(F)(F)F		Preclinical	lysophospholipid receptor agonist	S1PR1
SGC-0946	SGC-0946	CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(Br)c2c(N)ncnc12		Preclinical	histone lysine methyltransferase inhibitor	
SGC-CBP30	SGC-CBP30	COc1ccc(CCc2nc3cc(ccc3n2C[C@H](C)N2CCOCC2)-c2c(C)noc2C)cc1Cl		Preclinical	bromodomain inhibitor	CREBBP|EP300
SGI-1027	SGI-1027	Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1		Preclinical	DNA methyltransferase inhibitor	DNMT1|DNMT3A|DNMT3B
SGI-1776	SGI-1776	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1	72AUA0603W	Phase 1	Pim kinase inhibitor	FLT3|PIM1|PIM2|PIM3
SGX523	SGX523|SGX-523	Cn1cc(cn1)-c1ccc2nnc(Sc3ccc4ncccc4c3)n2n1	WH8SQN09KJ	Phase 1	hepatocyte growth factor receptor inhibitor	MET
shikimic-acid	shikimic-acid|SHIKIMIC ACID	O[C@@H]1CC(=CC(O)C1O)C(O)=O	29MS2WI2NU	Preclinical		
SIB-1553A	SIB-1553A	CN1CCCC1CCSc1ccc(O)cc1		Phase 2	acetylcholine receptor agonist	CHRNB4
SIB-1757	SIB-1757	Cc1ccc(O)c(N=Nc2ccccc2)n1		Preclinical	glutamate receptor antagonist	GRM5
SIB-1893	SIB-1893	Cc1cccc(\C=C\c2ccccc2)n1		Preclinical	glutamate receptor antagonist	GRM4|GRM5
sibutramine	sibutramine|SIBUTRAMINE	CC(C)CC(N(C)C)C1(CCC1)c1ccc(Cl)cc1	WV5EC51866	Withdrawn	serotoninnorepinephrine reuptake inhibitor (SNRI)	SLC6A2|SLC6A3|SLC6A4
SID-7969543	SID-7969543	CCOC(=O)C(C)Oc1cccc2c1ccn(CC(=O)Nc1ccc3OCCOc3c1)c2=O		Preclinical	steroidogenic factor antagonist	NR5A1
siguazodan	siguazodan|SIGUAZODAN	CN\C(NC#N)=N/c1ccc(cc1)C1=NNC(=O)CC1C	5E4UI00UQJ	Phase 1	phosphodiesterase inhibitor	PDE3A
sildenafil	sildenafil|SILDENAFIL	CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1	3M7OB98Y7H	Launched	phosphodiesterase inhibitor	PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3
silibinin	silibinin|SILIBININ A|SILIBININ B	COc1cc(ccc1O)[C@H]1Oc2cc(ccc2O[C@@H]1CO)[C@@H]1Oc2cc(O)cc(O)c2C(=O)[C@@H]1O	33X338MNE4|853OHH1429	Launched	cytochrome P450 inhibitor	ALOX5
silodosin	silodosin|SILODOSIN	C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(N)=O)NCCOc1ccccc1OCC(F)(F)F	CUZ39LUY82	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D
silver-sulfadiazine	silver-sulfadiazine|SILVER SULFADIAZINE	Nc1ccc(cc1)S(=O)(=O)N([Ag])c1ncccn1	W46JY43EJR	Launched	PABA antagonist	
silymarin	silymarin|ISOSILYBIN B|ISOSILYBIN A	COc1cc(ccc1O)C1Oc2ccc(cc2OC1CO)C1Oc2cc(O)cc(O)c2C(=O)C1O	15EH97604R|HHN3Q9H3DK	Launched		
simeprevir	simeprevir|SIMEPREVIR	COc1ccc2c(O[C@@H]3C[C@@H]4C(C3)C(=O)N(C)CCCC\C=C/[C@@H]3C[C@]3(NC4=O)C(=O)NS(=O)(=O)C3CC3)cc(nc2c1C)-c1nc(cs1)C(C)C	9WS5RD66HZ	Launched	HCV inhibitor	CYP1A2|CYP3A4
simvastatin	simvastatin|SIMVASTATIN	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	AGG2FN16EV	Launched	HMGCR inhibitor	HMGCR|ITGB2
sinefungin	sinefungin|SINEFUNGIN	N[C@@H](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12	W2U467CIIL	Preclinical	DNA methyltransferase inhibitor|RNA synthesis inhibitor	CARM1
sinomenine	sinomenine|SINOMENINE	COC1=C[C@@H]2[C@@H]3Cc4ccc(OC)c(O)c4[C@]2(CCN3C)CC1=O	63LT81K70N	Preclinical	angiogenesis inhibitor	
sipatrigine	sipatrigine|SIPATRIGINE	CN1CCN(CC1)c1ncc(c(N)n1)-c1cc(Cl)cc(Cl)c1Cl	OON9AVW1T3	Phase 2	voltage-gated sodium channel blocker	CACNA1D|SCN10A|SCN1A|SCN3A|SCN4A|SCN5A|SCN9A
siponimod	siponimod|SIPONIMOD	CCc1cc(ccc1CN1CC(C1)C(O)=O)C(\C)=N\OCc1ccc(C2CCCCC2)c(c1)C(F)(F)F	RR6P8L282I	Phase 3	sphingosine phosphate receptor modulator	S1PR1
siramesine	siramesine|SIRAMESINE	Fc1ccc(cc1)-n1cc(CCCCN2CCC3(CC2)OCc2ccccc32)c2ccccc12	3IX8CWR24V	Phase 2	sigma receptor antagonist	ADRA1A|ADRA1B|ADRA1D
sirolimus	sirolimus|SIROLIMUS	COC1CC(CC(C)C2CC(=O)C(C)\C=C(C)\C(O)C(OC)C(=O)C(C)CC(C)\C=C\C=C\C=C(C)\C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1O	W36ZG6FT64	Launched	mTOR inhibitor	FGF2|FKBP1A|MTOR
sirtinol	sirtinol	CC(NC(=O)c1ccccc1\N=C\c1c(O)ccc2ccccc12)c1ccccc1		Preclinical	SIRT inhibitor	SIRT1|SIRT2
sisomicin	sisomicin|SISOMICIN	CNC1C(O)C(OC2C(N)CC(N)C(OC3OC(CN)=CCC3N)C2O)OCC1(C)O	X55XSL74YQ	Launched	protein synthesis inhibitor	
sisomicin-sulfate	sisomicin-sulfate|SISOMICIN SULFATE	CN[C@@H]1C(O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O	K14444371C	Launched	bacterial 30S ribosomal subunit inhibitor	
sitafloxacin	sitafloxacin|SITAFLOXACIN	N[C@@H]1CN(CC11CC1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)[C@@H]1C[C@@H]1F	9TD681796G	Launched	bacterial DNA gyrase inhibitor	
sitagliptin	sitagliptin|SITAGLIPTIN	N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F	QFP0P1DV7Z	Launched	dipeptidyl peptidase inhibitor	DPP4
sitaxentan	sitaxentan|SITAXENTAN	Cc1noc(NS(=O)(=O)c2ccsc2C(=O)Cc2cc3OCOc3cc2C)c1Cl	J9QH779MEM	Withdrawn	endothelin receptor antagonist	EDNRA
sitosterol	sitosterol|.GAMMA.-SITOSTEROL|.BETA.-SITOSTEROL	CC[C@H](CC[C@@H](C)[C@@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C	5LI01C78DD|S347WMO6M4	Preclinical		
sivelestat	sivelestat|SIVELESTAT	CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc1ccccc1C(=O)NCC(O)=O	DWI62G0P59	Launched	elastase inhibitor	CELA1|ELANE
SJ-172550	SJ-172550	CCOc1cc(\C=C2C(=O)N(N=C\2C)c2ccccc2)cc(Cl)c1OCC(=O)OC		Preclinical	MDM inhibitor	MDM4
SK&F-10047-(+)	SK&F-10047-(+)	C[C@H]1C2Cc3ccc(O)cc3[C@@]1(C)CCN2CC=C		Phase 1	sigma receptor agonist	SIGMAR1
SKA-31	SKA-31	Nc1nc2c(ccc3ccccc23)s1		Preclinical	potassium channel activator	KCNN4
skepinone-l	skepinone-l	OC[C@@H](O)COc1ccc2CCc3cc(Nc4ccc(F)cc4F)ccc3C(=O)c2c1		Preclinical	p38 MAPK inhibitor	MAPK14
SKF-38393	SKF-38393	Oc1cc2CCNCC(c3ccccc3)c2cc1O		Preclinical	dopamine receptor agonist	CALY|DRD1|DRD5
SKF-77434	SKF-77434	Oc1cc2CCN(CC=C)CC(c3ccccc3)c2cc1O	XA99M7XZR5	Preclinical	dopamine receptor agonist	DRD1
SKF-81297	SKF-81297	Oc1cc2C(CNCCc2c(Cl)c1O)c1ccccc1		Preclinical	dopamine receptor agonist	DRD1|DRD5
SKF-83566	SKF-83566	CN1CCc2cc(Br)c(O)cc2C(C1)c1ccccc1	D203LR7XUS	Preclinical	dopamine receptor antagonist	DRD1|DRD5
SKF-86002	SKF-86002	Fc1ccc(cc1)-c1nc2SCCn2c1-c1ccncc1		Preclinical	p38 MAPK inhibitor	ALOX5|MAPK14
SKF-89976A	SKF-89976A	OC(=O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1		Preclinical	GABA uptake inhibitor	SLC6A1
SKF-91488	SKF-91488	CN(C)CCCCSC(N)=N	1I4LVX494H	Preclinical	histamine N-methyltransferase inhibitor	HNMT
SKF-96365	SKF-96365	COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1		Preclinical	calcium channel blocker	CYP3A4|PKD2|TRPC1|TRPC3|TRPC4|TRPC5|TRPV2
SKI-II	SKI-II	Oc1ccc(Nc2nc(cs2)-c2ccc(Cl)cc2)cc1		Preclinical	sphingosine kinase inhibitor	SPHK1
SKLB1002	SKLB1002	COc1cc2ncnc(Sc3nnc(C)s3)c2cc1OC		Preclinical	VEGFR inhibitor	KDR
SLV-320	SLV-320|DERENOFYLLINE	O[C@H]1CC[C@@H](CC1)Nc1nc(nc2[nH]ccc12)-c1ccccc1	O1Q96UZ63W	Phase 2	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
SM-108	SM-108|5-HYDROXYIMIDAZOLE 4-CARBOXAMIDE	NC(=O)c1[nH]cnc1O	U6IZ97918F	Phase 2		
SM-164	SM-164	CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@H](c1cn(CCCCc2ccc(CCCCn3cc(nn3)[C@@H](NC(=O)[C@@H]3CC[C@@H]4CCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N34)c3ccccc3)cc2)nn1)c1ccccc1		Preclinical	XIAP inhibitor	BIRC2|BIRC3|XIAP
SM-21	SM-21	CCC(Oc1ccc(Cl)cc1)C(=O)OC1CC2CCC(C1)N2C		Preclinical	sigma receptor antagonist	PGRMC1
SMI-4a	SMI-4a	FC(F)(F)c1cccc(c1)\C=C1\SC(=O)NC1=O		Preclinical	Pim kinase inhibitor	PIM1
SN-38	SN-38|7-ETHYL-10-HYDROXYCAMPTOTHECIN	CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(O)cc12	0H43101T0J	Launched	topoisomerase inhibitor	TOP1
SN-6	SN-6	CCOC(=O)C1CSC(N1)Cc1ccc(OCc2ccc([N+]([O-])=O)cc2)cc1		Preclinical	sodium/calcium exchange inhibitor	
SNAP	SNAP	CC(=O)NC(C(O)=O)C(C)(C)S[N+][O-]		Phase 2	nitric oxide donor	PTPN1
SNAP-5089	SNAP-5089	COC(=O)C1=C(C)NC(C)=C(C1c1ccc(cc1)[N+]([O-])=O)C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1		Preclinical	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CACNA1C|CACNA1D
SNAP-94847	SNAP-94847	CC(C)C(=O)Nc1ccc(C)c(c1)C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1		Preclinical		ADRA1A|DRD2
SNC-80	SNC-80	CCN(CC)C(=O)c1ccc(cc1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)c1cccc(OC)c1		Preclinical		OPRD1
SNG-1153	SNG-1153	CC(C)=CCc1c(O)cc(O)c2c1oc(-c1ccc(cc1)C(F)(F)F)c(O)c2=O		Preclinical	selective estrogen receptor modulator (SERM)	ESR1
SNS-314	SNS-314	Clc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1	802IFJ0Z8X	Phase 1	Aurora kinase inhibitor	AURKA|AURKB|AURKC
SNX-2112	SNX-2112	CC1(C)Cc2c(c(nn2-c2ccc(C(N)=O)c(N[C@H]3CC[C@H](O)CC3)c2)C(F)(F)F)C(=O)C1	10C9P3FFOW	Phase 1	HSP inhibitor	
SNX-5422	SNX-5422	CC1(C)Cc2c(c(nn2-c2ccc(C(N)=O)c(N[C@H]3CC[C@@H](CC3)OC(=O)CN)c2)C(F)(F)F)C(=O)C1	BF52J69Q8T	Phase 1/Phase 2	HSP inhibitor	HSP90AA1
sobetirome	sobetirome|SOBETIROME	CC(C)c1cc(Cc2c(C)cc(OCC(O)=O)cc2C)ccc1O	XQ31741E9Q	Phase 1	thyroid hormone receptor agonist	THRA|THRB
sobrepin	sobrepin|SOBREROL, (-)-TRANS-|SOBREROL	CC1=CC[C@H](C[C@@H]1O)C(C)(C)O	7WJQ6A6U4W|AI0NX02O35	Launched	mucolytic agent	
sodium-ascorbate	sodium-ascorbate|SODIUM ASCORBATE	OC[C@H](O)[C@H]1OC(=O)C(O)C1O	S033EH8359	Launched		
sodium-butyrate	sodium-butyrate|SODIUM BUTYRATE	CCCC(O)=O	8RAS91C36W	Phase 2	HDAC inhibitor	BCHE|FFAR2|FFAR3|HDAC1|HDAC2|HDAC3|HDAC8
sodium-danshensu	sodium-danshensu|2-HYDROXY-3-(3,4-DIHYDROXYPHENYL)PROPANOIC ACID	OC(Cc1ccc(O)c(O)c1)C(O)=O	NA8H56YM3K	Preclinical		
sodium-dodecyl-sulfate	sodium-dodecyl-sulfate	[Na].CCCCCCCCCCCCOS(O)(=O)=O		Preclinical		ALB|LYZ
sodium-glucoheptonate	sodium-glucoheptonate|GLUCOHEPTONIC ACID	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O	B1F50160Z2	Launched		
sodium-gluconate	sodium-gluconate|SODIUM GLUCONATE	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O	R6Q3791S76	Launched		
sodium-gualenate	sodium-gualenate|SODIUM GUALENATE	CC(C)c1ccc(C)c2c(cc(C)c2c1)S(O)(=O)=O	19WSH095WP	Launched	antacid	
sodium-monofluorophosphate	sodium-monofluorophosphate|SODIUM MONOFLUOROPHOSPHATE	OP(O)(F)=O	C810JCZ56Q	Launched		PYGM
sodium-nitrite	sodium-nitrite|SODIUM NITRITE	[O-][N+][O-]	M0KG633D4F	Launched	nitric oxide donor	
sodium-nitroprusside	sodium-nitroprusside|SODIUM NITROPRUSSIDE	[O-][N+][Fe--](C#N)(C#N)(C#N)(C#N)C#N	EAO03PE1TC	Launched	nitric oxide donor	
sodium-orthovanadate	sodium-orthovanadate|SODIUM ORTHOVANADATE	O[V](O)(O)=O	7845MV6C8V	Preclinical		
sodium-oxybate	sodium-oxybate|SODIUM OXYBATE	OCCCC(O)=O	7G33012534	Launched	benzodiazepine receptor agonist	GABRB1|HCAR1|SLC52A2
sodium-picosulfate	sodium-picosulfate|SODIUM PICOSULFATE	OS(=O)(=O)Oc1ccc(cc1)C(c1ccc(OS(O)(=O)=O)cc1)c1ccccn1	LR57574HN8	Launched		
sodium-salicylate	sodium-salicylate|SODIUM SALICYLATE	OC(=O)c1ccccc1O	WIQ1H85SYP	Launched	prostanoid receptor antagonist	ASIC3|PTGS1|PTGS2
sodium-stibogluconate	sodium-stibogluconate|SODIUM STIBOGLUCONATE ANHYDROUS	OCC(O)C1O[Sb]2(O)(O[Sb]34(O)OC(C(O)CO)C(O3)C(O4)C(O)=O)OC1C(O2)C(O)=O	V083S0159D	Launched	tyrosine phosphatase inhibitor	PTPN6|TOP1
sodium-tanshinone-ii-a-sulfonate	sodium-tanshinone-ii-a-sulfonate	Cc1c2c(oc1S(O)(=O)=O)-c1ccc3c(CCCC3(C)C)c1C(=O)C2=O		Phase 2	potassium channel activator	
sodium-tetradecyl-sulfate	sodium-tetradecyl-sulfate|TETRADECYL HYDROGEN SULFATE (ESTER)	CCCCC(CC)CCC(CC(C)C)OS(O)(=O)=O	6326W0DRHY	Launched		PROC|PROS1
sofalcone	sofalcone|SOFALCONE	CC(C)=CCOc1ccc(\C=C\C(=O)c2ccc(OCC=C(C)C)cc2OCC(O)=O)cc1	2B668TJX8E	Launched	mucus protecting agent	CBR1
sofosbuvir	sofosbuvir|SOFOSBUVIR	CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1	WJ6CA3ZU8B	Launched	RNA polymerase inhibitor	
solamargine	solamargine|SOLAMARGINE	CC1C2C(CC3C4CC=C5CC(CCC5(C)C4CCC23C)OC2OC(CO)C(OC3OC(C)C(O)C(O)C3O)C(O)C2OC2OC(C)C(O)C(O)C2O)OC11CCC(C)CN1	8KG991E7BN	Phase 3	apoptosis inhibitor	
solcitinib	solcitinib|SOLCITINIB	CC1(C)CN(C1)C(=O)c1ccc(cc1)-c1cccc2nc(NC(=O)C3CC3)nn12	3V7GQ1260K	Phase 1	JAK inhibitor	JAK1
solifenacin-succinate	solifenacin-succinate|SOLIFENACIN SUCCINATE	O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1	KKA5DLD701	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
solithromycin	solithromycin|SOLITHROMYCIN	CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cc(nn3)-c3cccc(N)c3)C(=O)O[C@]12C)OC	9U1ETH79CK	Phase 3	protein synthesis inhibitor	
somantadine	somantadine|SOMANTADINE	CC(C)(N)CC12CC3CC(CC(C3)C1)C2	02WMX1FS9Y	Phase 1	antiviral	
somatostatin	somatostatin|8-D-TRYPTOPHAN-SOMATOSTATIN	C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N	O1208M5SQ8	Launched	somatostatin receptor agonist	OPRD1|OPRM1|SSTR1|SSTR2|SSTR3|SSTR4|SSTR5
sonidegib	sonidegib|SONIDEGIB	C[C@H]1CN(C[C@@H](C)O1)c1ccc(NC(=O)c2cccc(-c3ccc(OC(F)(F)F)cc3)c2C)cn1	0RLU3VTK5M	Launched	smoothened receptor antagonist	SMO
sophocarpine	sophocarpine	O=C1C=CC[C@@H]2[C@@H]3CCCN4CCC[C@@H](CN12)[C@@H]34		Phase 3		
sorafenib	sorafenib|SORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1	9ZOQ3TZI87	Launched	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET
sorbic-acid	sorbic-acid|SORBIC ACID	CC=CC=CC(O)=O	X045WJ989B	Preclinical		
sorbinil	sorbinil|SORBINIL	Fc1ccc2OCCC3(NC(=O)NC3=O)c2c1	G4186B906P	Phase 3	aldose reductase inhibitor	AKR1B1
sorbitan-monostearate	sorbitan-monostearate|SORBITAN MONOSTEARATE	CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O	NVZ4I0H58X	Preclinical		
sorbitol	sorbitol|SORBITOL	OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO	506T60A25R	Launched	mucolytic agent	
sotagliflozin	sotagliflozin|SOTAGLIFLOZIN	CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)cc1	6B4ZBS263Y	Phase 3	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2
sotalol	sotalol|SOTALOL	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1	A6D97U294I	Launched	adrenergic receptor antagonist	ADRB1|ADRB2|KCNH2
sotrastaurin	sotrastaurin|SOTRASTAURIN	CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1	7I279E1NZ8	Phase 2	PKC inhibitor	PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ
SP-420	SP-420	COCCOCCOc1ccc(C2=N[C@](C)(CS2)C(O)=O)c(O)c1		Phase 1		
spaglumic-acid	spaglumic-acid|SPAGLUMIC ACID	CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O	X81L78B3RB	Launched	glutamate receptor antagonist	GRM3
sparfloxacin	sparfloxacin|SPARFLOXACIN	CC1CN(C[C@H](C)N1)c1c(F)c(N)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1	Q90AGA787L	Withdrawn	bacterial DNA gyrase inhibitor	TOP2A
sparfosate	sparfosate|SPARFOSIC ACID	OC(=O)CC(NC(=O)CP(O)(O)=O)C(O)=O	78QVZ7RG8L	Phase 3	aspartate carbamoyltransferase inhibitor	CA2|CA4|CAD
sparteine-sulfate	sparteine-sulfate|SPARTEINE SULFATE	C1CCN2C[C@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1	GQ3J2TLZ7E	Launched		
spectinomycin	spectinomycin|SPECTINOMYCIN	CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O	93AKI1U6QF	Launched	bacterial 30S ribosomal subunit inhibitor	
spermidine	spermidine|SPERMIDINE	NCCCCNCCCN	U87FK77H25	Preclinical	glutamate receptor modulator	KCNJ4|TXNRD1
spermine	spermine|SPERMINE	NCCCNCCCCNCCCN	2FZ7Y3VOQX	Preclinical		CA14|CA4|CA6|CA9|CASR|GRIN1|GRIN2A|KCNJ4|ODC1|SMOX|SMS|TRPM4|TRPM5
sphingosylphosphorylcholine	sphingosylphosphorylcholine	CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(=O)OCC[N+](C)(C)C		Preclinical	gene expression stimulant	GPR12
spiperone	spiperone|SPIPERONE	Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1	4X6E73CJ0Q	Launched	dopamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7
spiradoline	spiradoline|SPIRADOLINE	CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1)C(=O)Cc1ccc(Cl)c(Cl)c1	N18ZH0M4NP	Phase 2	opioid receptor agonist	OPRK1
spiramycin	spiramycin|SPIRAMYCIN I	CO[C@H]1[C@H](O)CC(=O)O[C@@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C	033ECH6IFG	Launched	bacterial 50S ribosomal subunit inhibitor	
spirobromin	spirobromin|DIBROSPIDIUM	BrCCC(=O)N1CC[N+]2(CC1)CC[N+]1(CCN(CC1)C(=O)CCBr)CC2	34R8M96SDC	Phase 1		
spironolactone	spironolactone|SPIRONOLACTONE	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)C12	27O7W4T232	Launched	mineralocorticoid receptor antagonist	AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG
spiroxatrine	spiroxatrine|SPIROXATRINE	O=C1NCN(c2ccccc2)C11CCN(CC2COc3ccccc3O2)CC1	DR0QR50ALL	Preclinical	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A|HTR2B
spizofurone	spizofurone|SPIZOFURONE	CC(=O)c1ccc2OC3(CC3)C(=O)c2c1	94F21T5G3C	Withdrawn		
splitomycin	splitomycin	O=C1CCc2c(O1)ccc1ccccc21		Preclinical	SIRT inhibitor	SIRT1
SPP301	SPP301|AVOSENTAN	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(nc1OC)-c1ccncc1	L94KSX715K	Phase 3	endothelin receptor antagonist	EDNRA
SQ-109	SQ-109	CC(C)=CCC\C(C)=C\CNCCNC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2	9AU7XUV31A	Phase 3	bacterial cell wall synthesis inhibitor	FDFT1
SQ-22536	SQ-22536	Nc1ncnc2n(cnc12)C1CCCO1		Preclinical	adenylyl cyclase inhibitor	ADCY1
SR-11302	SR-11302	CC(\C=C\C=C(\C=C\C1=C(C)CCCC1(C)C)c1ccc(C)cc1)=C/C(O)=O		Preclinical		
SR-2640	SR-2640	OC(=O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1		Phase 2	leukotriene receptor antagonist	CYSLTR1
SR-27897	SR-27897|LINTITRIPT	OC(=O)Cn1c(cc2ccccc12)C(=O)Nc1nc(cs1)-c1ccccc1Cl	3YFV00531K	Phase 2	CCK receptor antagonist	CCKAR
SR-3306	SR-3306	Cc1ccc(cn1)-c1ncn(n1)-c1ccc(Nc2nccc(n2)-c2cccc(c2)N2CCOCC2)cc1		Preclinical	JNK inhibitor	MAPK10|MAPK8|MAPK9
SR-33805	SR-33805	COc1ccc(CCN(C)CCCOc2ccc(cc2)S(=O)(=O)c2c(C(C)C)c3ccccc3n2C)cc1OC		Phase 1	calcium channel blocker	
SR-57227A	SR-57227A	NC1CCN(CC1)c1cccc(Cl)n1	OW45B79UZD	Phase 2	serotonin receptor agonist	HTR3A
SR-59230A	SR-59230A	CCc1ccccc1OC[C@@H](O)CN[C@H]1CCCc2ccccc12		Preclinical	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
SR-95639A	SR-95639A	C(CN1CCOCC1)Nc1cc2CCCc3ccccc3-c2nn1		Preclinical	acetylcholine receptor agonist	CHRM1
SRC-kinase-inhibitor-I	SRC-kinase-inhibitor-I	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		Preclinical	src inhibitor	CSK|LCK|RIPK2
SRPIN340	SRPIN340	Oc1cccc(CNC(=O)Nc2nc(cs2)-c2ccncc2)c1		Preclinical	serine arginine protein kinase inhibitor	SRPK1|SRPK2
SRT1720	SRT1720	O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1		Preclinical	SIRT activator	SIRT1
SRT2104	SRT2104|SRT-2104	Cc1nc(sc1C(=O)Nc1ccccc1-c1cn2c(CN3CCOCC3)csc2n1)-c1cccnc1	4521NR0J09	Phase 2	SIRT activator	SIRT1
SSR128129E	SSR128129E	COc1c(C)c(C(=O)c2ccc(N)c(c2)C(O)=O)n2ccccc12		Preclinical		
ST-1859	ST-1859|SQUOXIN	Oc1ccc2ccccc2c1Cc1c(O)ccc2ccccc12	WSE97K4L90	Phase 1	antiamyloidogenic agent	
ST-2825	ST-2825	NC(=O)[C@H]1CCS[C@@H]2C[C@]3(CCCN3C(=O)Cc3ccc(NC(=O)COc4ccc(Cl)cc4Cl)cc3)C(=O)N12		Preclinical	myeloid differentiation primary response inhibitor	MYD88
ST-91	ST-91	CCc1cccc(CC)c1N=C1NCCN1	U94VU1Q8HC	Preclinical	adrenergic receptor agonist	
STA-5326	STA-5326|APILIMOD	Cc1cccc(\C=N\Nc2cc(nc(OCCc3ccccn3)n2)N2CCOCC2)c1	GFW2K84S4L	Phase 2	interleukin synthesis inhibitor	IL12A
stanozolol	stanozolol|STANOZOLOL	C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4Cc5[nH]ncc5C[C@]4(C)[C@H]3CC[C@]12C	4R1VB9P8V3	Launched	androgen receptor agonist	AR
STAT3-inhibitor-VI	STAT3-inhibitor-VI|S31-201	Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc1ccc(C(O)=O)c(O)c1	JG1E8503OI	Preclinical	STAT inhibitor	STAT3
stattic	stattic	[O-][N+](=O)c1ccc2C=CS(=O)(=O)c2c1		Preclinical		
stavudine	stavudine|STAVUDINE	Cc1cn(C2OC(CO)C=C2)c(=O)[nH]c1=O	BO9LE4QFZF	Launched	DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor	
stemregenin-1	stemregenin-1	CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(nc12)-c1csc2ccccc12		Preclinical	aryl hydrocarbon receptor antagonist	AHR
stepronin	stepronin|STEPRONIN	CC(SC(=O)c1cccs1)C(=O)NCC(O)=O	0NOY894QRB	Launched	mucolytic agent	
stetaderm	stetaderm	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@]12C		Launched		
STF-083010	STF-083010	Oc1ccc2ccccc2c1\C=N\S(=O)(=O)c1cccs1		Preclinical	serine/threonine kinase inhibitor	ERN1
STF-118804	STF-118804	Cc1oc(nc1CS(=O)(=O)c1ccc(C)cc1)-c1ccc(cc1)C(=O)NCc1cccnc1		Preclinical	NAMPT inhibitor	NAMPT
STF-62247	STF-62247	Cc1cccc(Nc2nc(cs2)-c2ccncc2)c1		Preclinical	autophagy inducer	
stigmasterol	stigmasterol|STIGMASTEROL	CC[C@H](\C=C\[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C	99WUK5D0Y8	Preclinical		
stiripentol	stiripentol|STIRIPENTOL	CC(C)(C)C(O)\C=C\c1ccc2OCOc2c1	R02XOT8V8I	Launched	GABA uptake inhibitor	GABRA3
stobadine	stobadine|DICARBINE	CN1CCC2Nc3ccc(C)cc3C2C1	Y0EA50IJ3V	Phase 2	adrenergic receptor antagonist	ADRA1A
streptomycin	streptomycin|STREPTOMYCIN	CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1OC1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O	Y45QSO73OB	Launched	bacterial 30S ribosomal subunit inhibitor	
streptozotocin	streptozotocin|STREPTOZOCIN	CN([N+][O-])C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O	5W494URQ81	Launched	DNA alkylating agent	SLC2A2
strontium-ranelate	strontium-ranelate|STRONTIUM RANELATE	O=C1CN(CC(=O)O[Sr]O1)c1sc2c(CC(=O)O[Sr]OC2=O)c1C#N	04NQ160FRU	Launched	bone formation stimulant|bone resorption inhibitor	CASR
strychnine	strychnine|STRYCHNINE	O=C1CC2OCC=C3CN4CC[C@@]56C4C[C@@H]3[C@@H]2C5N1c1ccccc61	H9Y79VD43J	Preclinical	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA10|CHRNA9|GLRA1|GLRA2|GLRA3|GLRB
SU-11274	SU-11274	CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)\C(=C\c3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1		Preclinical	hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor	MET
SU-4312	SU-4312	CN(C)c1ccc(cc1)\C=C1/C(=O)Nc2ccccc12		Preclinical	PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor	KDR|PDGFRB
SU014813	SU014813|SU-14813	Cc1[nH]c(\C=C2\C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1	ZZ6VH5MZ17	Phase 2	PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	KDR
SU3327	SU3327	Nc1nnc(Sc2ncc(s2)[N+]([O-])=O)s1		Preclinical	JNK inhibitor	MAPK8
SU9516	SU9516	COc1ccc2NC(=O)\C(=C/c3c[nH]cn3)c2c1		Preclinical	CDK inhibitor	CDK1|CDK2|CDK4|CDK5
substance-p	substance-p	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O		Phase 1	neurokinin receptor antagonist	TACR1|TACR2|TACR3
succinic-acid	succinic-acid|SUCCINIC ACID	OC(=O)CCC(O)=O	AB6MNQ6J6L	Launched		ALDH5A1|ASPH|BBOX1|HSD17B6|OXCT1|OXCT2|P3H1|P3H2|P3H3|P4HA1|P4HA2|PLOD1|PLOD3|SDHA|SDHB|SDHC|SDHD|SLC13A1|SLC13A2|SLC13A3|SLC25A10|SUCLA2|SUCLG1|SUCLG2|SUCNR1|TMLHE
succinylcholine-chloride	succinylcholine-chloride|SUCCINYLCHOLINE CHLORIDE	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	I9L0DDD30I	Launched		CHRFAM7A|CHRM1|CHRM2|CHRM3|CHRNA1|CHRNA10
succinylsulfathiazole	succinylsulfathiazole|SUCCINYLSULFATHIAZOLE	OC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1nccs1	RSS8647O4S	Phase 2	dihydrofolate reductase inhibitor	DHFR
sucralfate	sucralfate	O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O		Launched	antacid	EGF|FGA|FGB|FGF2|FGG
sucralose	sucralose|SUCRALOSE	OC[C@@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl	96K6UQ3ZD4	Launched		
sucrose	sucrose|SUCROSE	OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O	C151H8M554	Launched		ACTA1|ATOX1|C22orf28|LYZ
sucrose-octaacetate	sucrose-octaacetate|SUCROSE OCTAACETATE	CC(=O)OC[C@H]1O[C@@](COC(C)=O)(O[C@H]2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O	07V591057T	Preclinical		
sudan-iv	sudan-iv|SCARLET RED	Cc1ccccc1N=Nc1ccc(N=Nc2c(O)ccc3ccccc23)c(C)c1	I35E9QU96C	Preclinical		
sufentanil	sufentanil|SUFENTANIL	CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1	AFE2YW0IIZ	Launched	opioid receptor modulator	OPRD1|OPRK1|OPRM1
sulbactam	sulbactam|SULBACTAM	CC1(C)C(N2[C@@H](CC2=O)S1(=O)=O)C(O)=O	S4TF6I2330	Launched	beta lactamase inhibitor	
sulbactam-pivoxil	sulbactam-pivoxil|SULBACTAM PIVOXIL	CC(C)(C)C(=O)OCOC(=O)C1N2C(CC2=O)S(=O)(=O)C1(C)C	2X0WTA96KX	Launched	beta lactamase inhibitor	
sulbentine	sulbentine|SULBENTINE	S=C1SCN(Cc2ccccc2)CN1Cc1ccccc1	D0NR12WK9J	Preclinical	other antifungal	
sulbutiamine	sulbutiamine|SULBUTIAMINE	CC(C)C(=O)OCC\C(SS\C(CCOC(=O)C(C)C)=C(/C)N(Cc1cnc(C)nc1N)C=O)=C(\C)N(Cc1cnc(C)nc1N)C=O	42NCM1BW43	Launched	acetylcholine receptor antagonist	
sulconazole	sulconazole|SULCONAZOLE	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1	5D9HAA5Q5S	Launched	sterol demethylase inhibitor	
sulfabenzamide	sulfabenzamide|SULFABENZAMIDE	Nc1ccc(cc1)S(=O)(=O)NC(=O)c1ccccc1	G58F8OPL4I	Launched	bacterial antifolate	
sulfacarbamide	sulfacarbamide|SULFACARBAMIDE	NC(=O)NS(=O)(=O)c1ccc(N)cc1	W6CD25Z4QR	Withdrawn		
sulfacetamide	sulfacetamide|SULFACETAMIDE	CC(=O)NS(=O)(=O)c1ccc(N)cc1	4965G3J0F5	Launched	PABA antagonist	
sulfachlorpyridazine	sulfachlorpyridazine|SULFACHLORPYRIDAZINE	Nc1ccc(cc1)S(=O)(=O)Nc1ccc(Cl)nn1	P78D9P90C0	Launched	bacterial antifolate	
sulfadiazine	sulfadiazine|SULFADIAZINE	Nc1ccc(cc1)S(=O)(=O)Nc1ncccn1	0N7609K889	Launched	bacterial antifolate	
sulfadoxine	sulfadoxine|SULFADOXINE	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC	88463U4SM5	Launched	dihydropteroate synthase inhibitor	
sulfafurazole	sulfafurazole|SULFISOXAZOLE	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C	740T4C525W	Launched	bacterial antifolate	
sulfaguanidine	sulfaguanidine|SULFAGUANIDINE	NC(=N)NS(=O)(=O)c1ccc(N)cc1	15XQ8043FN	Launched	bacterial antifolate	
sulfamerazine	sulfamerazine|SULFAMERAZINE	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1	UR1SAB295F	Launched	bacterial antifolate	
sulfameter	sulfameter|SULFAMETER	COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1	3L179F09D6	Launched	dihydrofolate reductase inhibitor	DHFR
sulfamethazine	sulfamethazine|SULFAMETHAZINE	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1	48U51W007F	Launched	PABA antagonist	
sulfamethizole	sulfamethizole|SULFAMETHIZOLE	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1	25W8454H16	Launched	bacterial antifolate	
sulfamethoxazole	sulfamethoxazole|SULFAMETHOXAZOLE	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1	JE42381TNV	Launched	PABA antagonist	
sulfamethoxypyridazine	sulfamethoxypyridazine|SULFAMETHOXYPYRIDAZINE	COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1	T034E4NS2Z	Withdrawn	bacterial antifolate	
sulfametopyrazine	sulfametopyrazine|SULFALENE	COc1nccnc1NS(=O)(=O)c1ccc(N)cc1	T6BL4ZC15G	Launched	PABA antagonist	
sulfamonomethoxine	sulfamonomethoxine|SULFAMONOMETHOXINE	COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1	U700P169W2	Launched	bacterial antifolate	
sulfamoxole	sulfamoxole|SULFAMOXOLE	Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C	HGG82XE020	Launched	PABA antagonist	
sulfanilamide	sulfanilamide|SULFANILAMIDE	Nc1ccc(cc1)S(N)(=O)=O	21240MF57M	Launched	carbonic anhydrase inhibitor	CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4
sulfanilate-zinc	sulfanilate-zinc|SULFANILATE ZINC	Nc1ccc(cc1)S(=O)(=O)O[Zn]OS(=O)(=O)c1ccc(N)cc1	N2PK74J33Y	Preclinical		
sulfanitran	sulfanitran|SULFANITRAN	CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)[N+]([O-])=O	QT35T5T35Q	Launched		
sulfaphenazole	sulfaphenazole|SULFAPHENAZOLE	Nc1ccc(cc1)S(=O)(=O)Nc1ccnn1-c1ccccc1	0J8L4V3F81	Launched	dihydropteroate synthetase inhibitor	DHPS
sulfapyridine	sulfapyridine|SULFAPYRIDINE	Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1	Y5V2N1KE8U	Launched	PABA antagonist	
sulfaquinoxaline	sulfaquinoxaline|SULFAQUINOXALINE	Nc1ccc(cc1)S(=O)(=O)Nc1cnc2ccccc2n1	WNW8115TM9	Launched	vitamin K antagonist	
sulfasalazine	sulfasalazine|SULFASALAZINE	OC(=O)c1cc(ccc1O)\N=N\c1ccc(cc1)S(=O)(=O)Nc1ccccn1	3XC8GUZ6CB	Launched	cyclooxygenase inhibitor	ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1
sulfathiazole	sulfathiazole|SULFATHIAZOLE	Nc1ccc(cc1)S(=O)(=O)Nc1nccs1	Y7FKS2XWQH	Launched	dihydropteroate synthase inhibitor	
sulfinpyrazone	sulfinpyrazone|SULFINPYRAZONE	O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c1ccccc1)c1ccccc1	V6OFU47K3W	Launched	uricosuric blocker	ABCC1|ABCC2|FPR1|SLC22A12
sulfisoxazole-acetyl	sulfisoxazole-acetyl|SULFISOXAZOLE ACETYL	CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1	WBT5QH3KED	Launched	folic acid antagonist	
sulforaphane	sulforaphane|SULFORAPHANE, (+/-)-	CS(=O)CCCCN=C=S	41684WL1GL	Phase 2	anticancer agent|aryl hydrocarbon receptor antagonist	NFE2L2
sulindac	sulindac|SULINDAC	CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)=O	184SNS8VUH	Launched	cyclooxygenase inhibitor	AKR1B1|MAPK3|PPARD|PTGDR2|PTGS1|PTGS2
sulisobenzone	sulisobenzone|SULISOBENZONE	COc1cc(O)c(cc1S(O)(=O)=O)C(=O)c1ccccc1	1W6L629B4K	Launched		
sulmazole	sulmazole|SULMAZOLE	COc1cc(ccc1-c1nc2ncccc2[nH]1)S(C)=O	HK56EH9K44	Phase 1	adenosine receptor antagonist	
sulmetozine	sulmetozine|TRITIOZINE	COc1cc(cc(OC)c1OC)C(=S)N1CCOCC1	93VJ1QVD6V	Launched	gastrin inhibitor	GAST
suloctidil	suloctidil|SULOCTIDIL	CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1	XV1N1XY17K	Withdrawn	adrenergic receptor antagonist	
sulphadimethoxine	sulphadimethoxine|SULFADIMETHOXINE	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1	30CPC5LDEX	Launched	dihydropteroate synthetase inhibitor	
sulpiride	sulpiride|SULPIRIDE	CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	7MNE9M8287	Launched	dopamine receptor antagonist	
sumanirole	sumanirole|SUMANIROLE	CN[C@@H]1Cc2cccc3nc(O)n(C1)c23	3E93IV1U45	Phase 3	dopamine receptor agonist	DRD2
sumatriptan	sumatriptan|SUMATRIPTAN	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1	8R78F6L9VO	Launched	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7
SUN-B-8155	SUN-B-8155	C\C(=N/c1ccccc1N)c1c(C)cc(=O)n(O)c1O		Preclinical	calcitonin agonist	CALCR
sunitinib	sunitinib|SUNITINIB	CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C	V99T50803M	Launched	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	
suplatast	suplatast|SUPLATAST	CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1	4T0HO29O56	Launched	histamine release inhibitor|immunoglobulin inhibitor	
suprofen	suprofen|SUPROFEN	CC(C(O)=O)c1ccc(cc1)C(=O)c1cccs1	988GU2F9PE	Withdrawn	cyclooxygenase inhibitor	PTGS1|PTGS2
suramin	suramin|SURAMIN	Cc1ccc(cc1NC(=O)c1cccc(NC(=O)Nc2cccc(c2)C(=O)Nc2cc(ccc2C)C(=O)Nc2ccc(c3cc(cc(c23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)c1)C(=O)Nc1ccc(c2cc(cc(c12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O	6032D45BEM	Launched	DNA synthesis inhibitor	F2|FSHR|P2RY1|P2RY11|P2RY13|P2RY2|PLA2G2A|RYR1|RYR2|SIRT5
suritozole	suritozole|SURITOZOLE	Cn1nc(-c2cccc(F)c2)n(C)c1=S	3H7H68317X	Phase 2	GABA receptor inverse agonist	GABBR1
sutezolid	sutezolid|SUTEZOLID	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCSCC2)c(F)c1	3A71182L8P	Phase 2	protein synthesis inhibitor	
suvorexant	suvorexant|SUVOREXANT	C[C@@H]1CCN(CCN1C(=O)c1cc(C)ccc1-n1nccn1)c1nc2cc(Cl)ccc2o1	081L192FO9	Launched	orexin receptor antagonist	HCRTR1|HCRTR2
suxibuzone	suxibuzone|SUXIBUZONE	CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)c1ccccc1)c1ccccc1	86TDZ5WP2B	Launched	cyclooxygenase inhibitor	
swainsonine	swainsonine|TRIDOLGOSIR	O[C@@H]1CN2CCC[C@@H](O)[C@@H]2[C@@H]1O	RSY4RK37KQ	Phase 2	alpha mannosidase inhibitor	MAN2A1
SX-011	SX-011	CN(C)C(=O)C(=O)c1cn(C)c2cc(Cl)c(cc12)C(=O)N1CCC(Cc2ccc(F)cc2)CC1		Preclinical	MAP kinase inhibitor	MAPK14
SYM-2081	SYM-2081	C[C@H](C[C@H](N)C(O)=O)C(O)=O		Preclinical	kainate receptor antagonist	GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SLC1A2
SYM-2206	SYM-2206	CCCNC(=O)N1N=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1C		Preclinical	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
symclosene	symclosene|SYMCLOSENE	Cln1c(=O)n(Cl)c(=O)n(Cl)c1=O	RL3HK1I66B	Preclinical		
synephrine	synephrine|OXEDRINE	CNCC(O)c1ccc(O)cc1	PEG5DP7434	Launched	adrenergic receptor agonist	ADRA1A
T-0070907	T-0070907	[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc1ccncc1		Preclinical	PPAR receptor antagonist	PPARG
T-0156	T-0156	COC(=O)c1c(-c2cc(OC)c(OC)c(OC)c2)c2ccnc(OCc3ncccn3)c2c(=O)n1Cc1ccnc(C)c1		Preclinical	phosphodiesterase inhibitor	PDE5A
T-0901317	T-0901317|T0901317	OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F	A07663A39I	Preclinical	LXR agonist	NCOA1|NCOA2|NR1H2|NR1H3|NR1I2|RXRB
T-5224	T-5224	OC(=O)CCc1cc(ccc1OCc1ccc2c(O)noc2c1)C(=O)c1ccc(OC2CCCC2)cc1O		Phase 2	AP inhibitor	JUN
T-62	T-62	Nc1sc2CCCCc2c1C(=O)c1ccc(Cl)cc1	9Q765ZIF8L	Phase 2	adenosine receptor modulator	ADORA2A
TA-01	TA-01	Fc1ccc(cc1)-c1nc([nH]c1-c1ccncc1)-c1c(F)cccc1F		Preclinical	casein kinase inhibitor|MAP kinase inhibitor	CSNK1D|CSNK1E|MAPK14
tabimorelin	tabimorelin|TABIMORELIN	CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)\C=C\CC(C)(C)N	L51CBE03KF	Phase 2	growth hormone secretagogue receptor agonist	GHSR
tacalcitol	tacalcitol|TACALCITOL	CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	C2W72OJ5ZU	Launched	vitamin D receptor agonist	VDR
tacedinaline	tacedinaline|TACEDINALINE	CC(=O)Nc1ccc(cc1)C(=O)Nc1ccccc1N	UMF554N5FG	Phase 3	HDAC inhibitor	HDAC1
tacrine	tacrine|TACRINE	Nc1c2CCCCc2nc2ccccc12	4VX7YNB537	Launched	acetylcholinesterase inhibitor	ACHE|BCHE
tacrolimus	tacrolimus|TACROLIMUS	CO[C@@H]1CC(CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC	WM0HAQ4WNM	Launched	calcineurin inhibitor	FKBP1A
tadalafil	tadalafil|TADALAFIL	CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O	742SXX0ICT	Launched	phosphodiesterase inhibitor	PDE11A|PDE5A
tafamidis-meglumine	tafamidis-meglumine|TAFAMIDIS MEGLUMINE	OC(=O)c1ccc2nc(oc2c1)-c1cc(Cl)cc(Cl)c1	ZU7CF08A1A	Launched	transthyretin amyloid inhibitor	TTR
tafenoquine	tafenoquine|TAFENOQUINE	COc1cc(C)c2c(Oc3cccc(c3)C(F)(F)F)c(OC)cc(NC(C)CCCN)c2n1	262P8GS9L9	Phase 3	antimalarial agent	
tagatose	tagatose|TAGATOSE	OCC(O)C(O)C(O)C(=O)CO	T7A20Y888Y	Phase 3	phosphorylase inhibitor	PYGL
TAK-063	TAK-063	COc1cn(nc(-c2ccnn2-c2ccccc2)c1=O)-c1ccc(cc1F)-n1cccn1		Phase 2	phosphodiesterase inhibitor	PDE10A
TAK-220	TAK-220	CC(=O)N1CCC(CC1)C(=O)N(CCCN1CCC(Cc2ccc(cc2)C(N)=O)CC1)c1ccc(C)c(Cl)c1	928QIN0R16	Phase 1	CC chemokine receptor antagonist	CCR5
TAK-285	TAK-285	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(c4)C(F)(F)F)c(Cl)c3)c12	70CCB438L6	Phase 1	EGFR inhibitor	ERBB2
TAK-593	TAK-593	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1	H3I42X8XX7	Phase 1	VEGFR inhibitor	PDGFRA
TAK-632	TAK-632	Fc1ccc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2C#N)cc1NC(=O)Cc1cccc(c1)C(F)(F)F		Preclinical	RAF inhibitor	BRAF
TAK-715	TAK-715	CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1	WE92U03C5Z	Phase 2	p38 MAPK inhibitor	MAPK14
TAK-733	TAK-733	Cn1c2ncn(C[C@@H](O)CO)c(=O)c2c(Nc2ccc(I)cc2F)c(F)c1=O	5J61HSP0QJ	Phase 1	MEK inhibitor	MAP2K1
TAK-875	TAK-875|FASIGLIFAM HEMIHYDRATE	Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3[C@H](CC(O)=O)COc3c2)c1	8LDT91CH8A	Phase 3	insulin secretagogue	FFAR1
TAK-901	TAK-901	CCS(=O)(=O)c1cccc(c1)-c1cc(C(=O)NC2CCN(C)CC2)c(C)c2[nH]c3ncc(C)cc3c12	DM9UIR23R7	Phase 1	Aurora kinase inhibitor	AURKB
TAK-960	TAK-960	COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2N(C)C(=O)C(F)(F)CN(C3CCCC3)c2n1		Phase 1	PLK inhibitor	PLK1
talabostat	talabostat|TALABOSTAT	CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O	KZ1O2SH88Z	Phase 3	dipeptidyl peptidase inhibitor|fibroblast activation protein inhibitor	DPP4
taladegib	taladegib|TALADEGIB	CN(C1CCN(CC1)c1nnc(-c2ccnn2C)c2ccccc12)C(=O)c1ccc(F)cc1C(F)(F)F	QY8BWX1LJ5	Phase 2	smoothened receptor antagonist	DHH|IHH|SMO
talampanel	talampanel|TALAMPANEL	C[C@@H]1Cc2cc3OCOc3cc2C(=NN1C(C)=O)c1ccc(N)cc1	CVS43XG1L5	Phase 2	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4
talarozole	talarozole|TALAROZOLE	CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1	XKD9N5CJ6W	Phase 2	cytochrome P450 inhibitor	CYP26A1
talazoparib	talazoparib|TALAZOPARIB	Cn1ncnc1[C@@H]1[C@H](Nc2cc(F)cc3c2c1n[nH]c3=O)c1ccc(F)cc1	9QHX048FRV	Phase 3	PARP inhibitor	PARP2
talc	talc	O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O		Launched		
talinolol	talinolol|TALINOLOL	CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1	3S82268BKG	Launched	adrenergic receptor antagonist	ADRB1
talipexole	talipexole|TALIPEXOLE	Nc1nc2CCN(CC=C)CCc2s1	7AM2J46Z1Y	Launched	adrenergic receptor agonist|dopamine receptor agonist	ADRA2A|DRD2|HTR3A
talmapimod	talmapimod|TALMAPIMOD	C[C@H]1CN([C@H](C)CN1Cc1ccc(F)cc1)C(=O)c1cc2c(cn(C)c2cc1Cl)C(=O)C(=O)N(C)C	B1E00KQ6NT	Phase 2	p38 MAPK inhibitor	MAPK11|MAPK14
talnetant	talnetant|TALNETANT	CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)-c1ccccc1)c1ccccc1	CZ3T9T146K	Phase 2	tachykinin antagonist	TACR2|TACR3
talniflumate	talniflumate|TALNIFLUMATE	FC(F)(F)c1cccc(Nc2ncccc2C(=O)OC2OC(=O)c3ccccc23)c1	JFK78S0U9S	Launched	cyclooxygenase inhibitor	CLCA1
taltirelin	taltirelin|TALTIRELIN	CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(N)=O	DOZ62MV6A5	Launched	thyrotropin releasing hormone receptor agonist	TRHR
taltobulin	taltobulin|TALTOBULIN	CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](C(C)C)\C=C(/C)C(O)=O)C(C)(C)C)C(C)(C)c1ccccc1	J6D6912BXS	Phase 1	tubulin polymerization inhibitor	
TAME	TAME|TERT-AMYL METHYL ETHER	COC(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)c1ccc(C)cc1	94525J1AP8	Preclinical		
tamibarotene	tamibarotene|TAMIBAROTENE	CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12	08V52GZ3H9	Launched	retinoid receptor agonist	RARA|RARB
tamoxifen	tamoxifen|TAMOXIFEN	CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1	094ZI81Y45	Launched	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ
tamsulosin	tamsulosin|TAMSULOSIN	CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O	G3P28OML5I	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D
tanaproget	tanaproget|TANAPROGET	Cn1c(ccc1-c1ccc2NC(=S)OC(C)(C)c2c1)C#N	W9F9H8GXWR	Phase 2	progesterone receptor agonist	PGR
tandospirone	tandospirone|TANDOSPIRONE	O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(CC1)c1ncccn1	190230I669	Launched	serotonin receptor agonist	HTR1A
tandutinib	tandutinib|TANDUTINIB	COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1	E1IO3ICJ9A	Phase 2	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor	CSF1R|FLT3|KIT|PDGFD|PDGFRB
tanespimycin	tanespimycin|TANESPIMYCIN	CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(C)=C/C=C\[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O	4GY0AVT3L4	Phase 3	HSP inhibitor	HSP90AA1
tangeritin	tangeritin|TANGERETIN	COc1ccc(cc1)-c1cc(=O)c2c(OC)c(OC)c(OC)c(OC)c2o1	I4TLA1DLX6	Preclinical	cell cycle inhibitor	
tannic-acid	tannic-acid|TANNIC ACID (RHUS SPP. LEAF)	Oc1cc(cc(O)c1O)C(=O)Oc1cc(cc(O)c1O)C(=O)OC[C@H]1O[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1	54OM1T1DZQ	Launched	PARG inhibitor	ANO1
tanshinone-i	tanshinone-i|TANSHINONE I	Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c(C)cccc12	03UUH3J385	Phase 2	AP inhibitor	IFNG
tanshinone-iia	tanshinone-iia|TANSHINONE IIA	Cc1coc-2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C	4GPC9FQG6L	Phase 2/Phase 3	anti-inflammatory agent|interleukin inhibitor	IL1B|NR1I2|TNF
tapentadol	tapentadol|TAPENTADOL	CC[C@H]([C@@H](C)CN(C)C)c1cccc(O)c1	H8A007M585	Launched	opioid receptor agonist	HTR3A|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4
taprenepag	taprenepag|TAPRENEPAG	OC(=O)COc1cccc(CN(Cc2ccc(cc2)-n2cccn2)S(=O)(=O)c2cccnc2)c1	9CD894KUMJ	Phase 2	prostaglandin receptor agonist	PTGER2
tarafenacin	tarafenacin|TARAFENACIN	Fc1cccc(c1)N(Cc1cc(F)c(F)c(F)c1)C(=O)O[C@H]1CN2CCC1CC2	LDV98UN52Y	Phase 2	acetylcholine receptor antagonist	CHRM3
taranabant	taranabant|TARANABANT	C[C@H](NC(=O)C(C)(C)Oc1ccc(cn1)C(F)(F)F)[C@@H](Cc1ccc(Cl)cc1)c1cccc(c1)C#N	X9U622S114	Phase 3	cannabinoid receptor inverse agonist	CNR1
targinine	targinine|TILARGININE	CNC(=N)NCCC[C@H](N)C(O)=O	27JT06E6GR	Phase 3	nitric oxide synthase inhibitor	NOS3
tariquidar	tariquidar|TARIQUIDAR	COc1cc2CCN(CCc3ccc(NC(=O)c4cc(OC)c(OC)cc4NC(=O)c4cnc5ccccc5c4)cc3)Cc2cc1OC	J58862DTVD	Phase 3	P glycoprotein inhibitor	ABCB1
tartaric-acid	tartaric-acid|TARTARIC ACID, DL-|TARTARIC ACID	O[C@H]([C@@H](O)C(O)=O)C(O)=O	4J4Z8788N8|W4888I119H	Launched	antioxidant	ATP6V1C1|B3GAT1|DDX6|HIF1AN|TREM1
TAS-103	TAS-103|TAS-103 FREE BASE	CN(C)CCNc1nc2cc(O)ccc2c2-c3ccccc3C(=O)c12	YVC96489QV	Phase 1	topoisomerase inhibitor	TOP1
taselisib	taselisib|TASELISIB	CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O	L08J2O299M	Phase 3	PI3K inhibitor	PIK3CA
tasimelteon	tasimelteon|TASIMELTEON	CCC(=O)NC[C@@H]1C[C@H]1c1cccc2OCCc12	SHS4PU80D9	Launched	melatonin receptor agonist	MTNR1A|MTNR1B
tasisulam	tasisulam|TASISULAM	Clc1ccc(C(=O)NS(=O)(=O)c2ccc(Br)s2)c(Cl)c1	1YC4W9MSLJ	Phase 3	apoptosis stimulant	
tasquinimod	tasquinimod|TASQUINIMOD	COc1cccc2n(C)c(=O)c(C(=O)N(C)c3ccc(cc3)C(F)(F)F)c(O)c12	756U07KN1R	Phase 3	angiogenesis inhibitor|S100A9 inhibitor	HDAC4
tasuldine	tasuldine|TASULDINE	C(Sc1ncccn1)c1cccnc1	S4ZCE64Q3O	Phase 3	mucolytic agent	
taurine	taurine|TAURINE	NCCS(O)(=O)=O	1EQV5MLY3D	Launched	antioxidant	
taurocholate	taurocholate|TAUROCHOLIC ACID	C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	5E090O0G3Z	Phase 1	G protein-coupled receptor agonist	CEL|FABP6|SLCO1C1
taurolidine	taurolidine|TAUROLIDINE	O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1	8OBZ1M4V3V	Launched	apoptosis stimulant	
tavaborole	tavaborole|TAVABOROLE	OB1OCc2cc(F)ccc12	K124A4EUQ3	Launched	leucyl-tRNA synthetase inhibitor	
taxifolin	taxifolin|DIHYDROQUERCETIN, (+)-(2R,3R)-	O[C@@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c1ccc(O)c(O)c1	9SOB9E3987	Phase 2	opioid receptor antagonist	ADIPOR2
tazarotene	tazarotene|TAZAROTENE	CCOC(=O)c1ccc(nc1)C#Cc1ccc2SCCC(C)(C)c2c1	81BDR9Y8PS	Launched	retinoid receptor agonist	RARA|RARB|RARG|RXRB
tazemetostat	tazemetostat|TAZEMETOSTAT	CCN(C1CCOCC1)c1cc(cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)-c1ccc(CN2CCOCC2)cc1	Q40W93WPE1	Phase 2	histone lysine methyltransferase inhibitor	EZH2
tazobactam	tazobactam|TAZOBACTAM	C[C@]1(Cn2ccnn2)C(N2C(CC2=O)S1(=O)=O)C(O)=O	SE10G96M8W	Launched	beta lactamase inhibitor	
TBA-354	TBA-354	[O-][N+](=O)c1cn2C[C@@H](COc2n1)OCc1ccc(nc1)-c1ccc(OC(F)(F)F)cc1		Phase 1		
TBOA-(DL)	TBOA-(DL)	N[C@@H]([C@H](OCc1ccccc1)C(O)=O)C(O)=O.N[C@H]([C@@H](OCc1ccccc1)C(O)=O)C(O)=O		Preclinical	excitatory amino acid transporter inhibitor	SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7
TC1	TC1	OC12C3C4C5C3C(C3C5CC4C13)N2CCc1cccc(F)c1		Preclinical	beta-secretase inhibitor	BACE1
TC2559	TC2559	CCOc1cncc(\C=C\CCNC)c1		Preclinical	acetylcholine receptor agonist	CHRNA4
TCID	TCID	Clc1c2C(=O)CC(=O)c2c(Cl)c(Cl)c1Cl		Preclinical		
TCN201	TCN201	Fc1ccc(cc1Cl)S(=O)(=O)NCc1ccc(cc1)C(=O)NNC(=O)c1ccccc1		Preclinical	glutamate receptor antagonist	GRIN2A
TCS-359	TCS-359	COc1ccc(cc1OC)C(=O)Nc1sc2CCCCc2c1C(N)=O		Preclinical	FLT3 inhibitor	FLT3
TCS2002	TCS2002	Cc1nnc(o1)-c1ccc2occ(-c3ccc(cc3)S(C)=O)c2c1		Preclinical	glycogen synthase kinase inhibitor	GSK3B
tebipenem	tebipenem|TEBIPENEM	C[C@@H](O)[C@@H]1[C@@H]2[C@H](C)C(SC3CN(C3)C3=NCCS3)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C	Q2TWQ1I31U	Launched	bacterial cell wall synthesis inhibitor	CNR1
tecalcet	tecalcet|TECALCET	COc1cccc(c1)[C@@H](C)NCCCc1ccccc1Cl	8I16YLE4US	Phase 2	calcium-sensing receptor agonist	CASR
tecastemizole	tecastemizole|TECASTEMIZOLE	Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc23)cc1	W5DCO14M05	Phase 3	histamine receptor antagonist	KCNH2
tecovirimat	tecovirimat|TECOVIRIMAT	FC(F)(F)c1ccc(cc1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O	F925RR824R	Phase 3	orthopoxvirus egress inhibitor	
tedizolid	tedizolid|TEDIZOLID	Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](CO)OC1=O	97HLQ82NGL	Launched	bacterial 50S ribosomal subunit inhibitor	
tedizolid-phosphate	tedizolid-phosphate|TEDIZOLID PHOSPHATE	Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](COP(O)(O)=O)OC1=O	O7DRJ6R4DW	Launched	protein synthesis inhibitor	
tegaserod	tegaserod|TEGASEROD	CCCCCNC(=N)N\N=C\c1c[nH]c2ccc(OC)cc12	458VC51857	Withdrawn	serotonin receptor partial agonist	HTR2A|HTR2B|HTR2C|HTR4
tegobuvir	tegobuvir|TEGOBUVIR	Fc1ccccc1-c1nc2ccn(Cc3ccc(nn3)-c3ccc(cc3C(F)(F)F)C(F)(F)F)cc2n1	5NOK5X389M	Phase 3	HCV inhibitor|protease inhibitor	
teicoplanin	teicoplanin|TEICOPLANIN A2-3	CCCCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H]1NC(=O)[C@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@@H](NC1=O)C(O)=O)c5)cc3Cl	6LN24Z7AMM	Launched	bacterial cell wall synthesis inhibitor	
teicoplanin-A2-1	teicoplanin-A2-1|TEICOPLANIN A2-1	CCCCC\C=C\CCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(CC4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H]1NC(=O)[C@H](NC4=O)c2ccc(O)c(c2)-c2c(OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@H](NC1=O)C(O)=O)c5)cc3Cl	36DYU0VKRK	Launched	bacterial cell wall synthesis inhibitor	
teicoplanin-a2-3	teicoplanin-a2-3|TEICOPLANIN A2-5	CC(C)CCCCCCCC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1NC(C)=O)[C@@H]1NC(=O)[C@@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@@H](NC1=O)C(O)=O)c5)cc3Cl	55234TX04D	Launched	bacterial cell wall synthesis inhibitor	
telaprevir	telaprevir|TELAPREVIR	CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1	655M5O3W0U	Launched	HCV inhibitor	CTSA|PGR
telatinib	telatinib|TELATINIB	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1	18P7197Q7J	Phase 2	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	KDR
telbivudine	telbivudine|TELBIVUDINE	Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O	2OC4HKD3SF	Launched	DNA polymerase inhibitor	TK2
telcagepant	telcagepant|TELCAGEPANT	Fc1cccc([C@@H]2CC[C@@H](NC(=O)N3CCC(CC3)n3c4cccnc4[nH]c3=O)C(=O)N(CC(F)(F)F)C2)c1F	D42O649ALL	Phase 3	calcitonin antagonist	CALCRL|RAMP1
telenzepine	telenzepine|TELENZEPINE	CN1CCN(CC(=O)N2c3c(C)scc3C(=O)Nc3ccccc23)CC1	0990EG3K10	Phase 3	acetylcholine receptor antagonist	CHRM1
telithromycin	telithromycin|TELITHROMYCIN	CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H](C)[C@@H]2N(CCCCn3cnc(c3)-c3cccnc3)C(=O)O[C@]12C)OC	KI8H7H19WL	Launched	bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor	CYP1A2|CYP2D6|CYP3A4|CYP3A5|CYP3A7
telmesteine	telmesteine|TELMESTEINE	CCOC(=O)N1CSCC1C(O)=O	124I3FE35T	Launched	mucolytic agent	
telmisartan	telmisartan|TELMISARTAN	CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C	U5SYW473RQ	Launched	angiotensin receptor antagonist	AGTR1|PPARG
telotristat	telotristat|TELOTRISTAT	Cc1ccn(n1)-c1cc(Cl)ccc1[C@@H](Oc1cc(nc(N)n1)-c1ccc(C[C@H](N)C(O)=O)cc1)C(F)(F)F	381V4FCV2Z	Phase 3	serotonin receptor antagonist|serotonin release inhibitor	TPH1
temazepam	temazepam|TEMAZEPAM	CN1c2ccc(Cl)cc2C(=NC(O)C1=O)c1ccccc1	CHB1QD2QSS	Withdrawn	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO
temefos	temefos|TEMEFOS	COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1	ONP3ME32DL	Launched	cholinesterase inhibitor	
temocapril	temocapril|TEMOCAPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)c1cccs1	18IZ008EU6	Launched	angiotensin converting enzyme inhibitor	ACE
temoporfin	temoporfin|TEMOPORFIN	Oc1cccc(c1)-c1c2CCc(n2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1[nH]2	FU21S769PF	Launched	radical formation stimulant	
temozolomide	temozolomide|TEMOZOLOMIDE	Cn1nnc2c(ncn2c1=O)C(N)=O	YF1K15M17Y	Launched	DNA alkylating agent	MGMT
tempol	tempol|TEMPOL-H	CC1(C)CC(O)CC(C)(C)N1O	V55XB6IT82	Phase 2	free radical scavenger	
temsirolimus	temsirolimus|TEMSIROLIMUS	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1OC(=O)C(C)(CO)CO	624KN6GM2T	Launched	mTOR inhibitor	MTOR
tenatoprazole	tenatoprazole|TENATOPRAZOLE	COc1ccc2[nH]c(nc2n1)S(=O)Cc1ncc(C)c(OC)c1C	RE0689TX2K	Phase 2	ATPase inhibitor	IDO1
teneligliptin	teneligliptin|TENELIGLIPTIN	Cc1cc(N2CCN(CC2)[C@@H]2CN[C@@H](C2)C(=O)N2CCSC2)n(n1)-c1ccccc1	28ZHI4CF9C	Launched	dipeptidyl peptidase inhibitor	DPP4
tenidap	tenidap|TENIDAP	NC(=O)N1C(=O)C(C(=O)c2cccs2)c2cc(Cl)ccc12	9K7CJ74ONH	Phase 3	cyclooxygenase inhibitor	KCNJ4|PTGS1
tenilsetam	tenilsetam|TENILSETAM	O=C1NCCNC1c1cccs1	O4Q7XM74N6	Phase 3	AGE inhibitor	
teniposide	teniposide|TENIPOSIDE	COc1cc(cc(OC)c1O)[C@H]1[C@@H]2C(COC2=O)C(O[C@@H]2O[C@@H]3CO[C@H](OC3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12	957E6438QA	Launched	topoisomerase inhibitor	TOP2A|TOP2B
tenofovir	tenofovir|TENOFOVIR	C[C@H](Cn1cnc2c(N)ncnc12)OCP(O)(O)=O	99YXE507IL	Launched	HIV integrase inhibitor|nucleoside reverse transcriptase inhibitor	
tenofovir-alafenamide	tenofovir-alafenamide|TENOFOVIR ALAFENAMIDE	CC(C)OC(=O)C(C)NP(=O)(COC(C)Cn1cnc2c(N)ncnc12)Oc1ccccc1	EL9943AG5J	Preclinical	nucleoside reverse transcriptase inhibitor	
tenofovir-disoproxil	tenofovir-disoproxil|TENOFOVIR DISOPROXIL	CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)OCOC(=O)OC(C)C	F4YU4LON7I	Launched	nucleoside reverse transcriptase inhibitor	CYP1A2
tenovin-1	tenovin-1	CC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1		Preclinical	SIRT inhibitor|TP53 activator	SIRT1
tenovin-6	tenovin-6	CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1		Preclinical	SIRT inhibitor	SIRT1|SIRT2|SIRT3
tenoxicam	tenoxicam|TENOXICAM	CN1C(C(=O)Nc2ccccn2)C(=O)c2sccc2S1(=O)=O	Z1R9N0A399	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
tenylidone	tenylidone|TENYLIDONE	O=C1\C(CCC\C1=C/c1cccs1)=C\c1cccs1	75C83N4YJ7	Preclinical		
tepoxalin	tepoxalin|TEPOXALIN	COc1ccc(cc1)-n1nc(CCC(=O)N(C)O)cc1-c1ccc(Cl)cc1	TZ4OX61974	Launched	cyclooxygenase inhibitor|lipoxygenase inhibitor	ALOX5
TEPP-46	TEPP-46	Cn1c2cc(sc2c2cnn(Cc3cccc(N)c3)c(=O)c12)S(C)=O		Preclinical	pyruvate kinase isozyme activator	PKM
teprenone	teprenone|TETRAPRENYLACETONE	CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C	57B67OXM8F	Launched	mucus protecting agent	
terameprocol	terameprocol|TERAMEPROCOL	COc1ccc(C[C@H](C)[C@H](C)Cc2ccc(OC)c(OC)c2)cc1OC	53YET703F2	Phase 1/Phase 2	lipoxygenase inhibitor	BIRC5|CDK1
terazosin	terazosin|TERAZOSIN	COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1	8L5014XET7	Launched	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7
terbinafine	terbinafine|TERBINAFINE	CN(C\C=C\C#CC(C)(C)C)Cc1cccc2ccccc12	G7RIW8S0XP	Launched	fungal squalene epoxidase inhibitor	SQLE
terbutaline	terbutaline|TERBUTALINE	CC(C)(C)NCC(O)c1cc(O)cc(O)c1	N8ONU3L3PG	Launched	adrenergic receptor agonist	ADRB2
terciprazine	terciprazine|TERCIPRAZINE	OC(COC1(CCCCC1)C#C)CN1CCN(CC1)c1cccc(c1)C(F)(F)F	TCE6830H8P	Phase 1		
terconazole	terconazole|TERCONAZOLE	CC(C)N1CCN(CC1)c1ccc(OC[C@@H]2CO[C@](Cn3cncn3)(O2)c2ccc(Cl)cc2Cl)cc1	0KJ2VE664U	Launched	sterol demethylase inhibitor	
terfenadine	terfenadine|TERFENADINE	CC(C)(C)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1	7BA5G9Y06Q	Withdrawn	histamine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|KCNH1|KCNH2
terguride	terguride|TERGURIDE	CCN(CC)C(=O)N[C@H]1CC2C(Cc3c[nH]c4cccc2c34)N(C)C1	21OJT43Q88	Launched	dopamine receptor agonist|serotonin receptor antagonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
teriflunomide	teriflunomide|TERIFLUNOMIDE	CC(=O)C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F	1C058IKG3B	Launched	dihydroorotate dehydrogenase inhibitor	DHODH
terlipressin	terlipressin	NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O		Launched	vasopressin receptor agonist	AVPR1A|AVPR1B|AVPR2
terodiline	terodiline|TERODILINE	CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C	70KG06964W	Phase 3	cholinergic receptor antagonist	
teroxirone	teroxirone|TRIGLYCIDYL ISOCYANURATE, (R,R,S)-|TEROXIRONE	O=c1n(CC2CO2)c(=O)n(CC2CO2)c(=O)n1CC1CO1	24N3OU2YDR|456V4159SL	Phase 1	DNA inhibitor	
terpene	terpene|TERPIN, TRANS-|TERPIN	CC(C)(O)C1CCC(C)(O)CC1	4HW1S44T5G|MPF495B08R	Preclinical		
terreic-acid-(-)	terreic-acid-(-)|TERREIC ACID	CC1C(=O)[C@H]2O[C@H]2C(=O)C1=O	XM2Y0DRJ7D	Preclinical	Bruton's tyrosine kinase (BTK) inhibitor	BTK
terutroban	terutroban|TERUTROBAN	Cc1ccc2C[C@@H](CCc2c1CCC(O)=O)NS(=O)(=O)c1ccc(Cl)cc1	A6WX9391D8	Phase 3	prostanoid receptor antagonist	TBXA2R
tesaglitazar	tesaglitazar|TESAGLITAZAR	CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(O)=O	6734037O3L	Phase 3	insulin sensitizer|PPAR receptor agonist	PPARA|PPARG
testolactone	testolactone|TESTOLACTONE	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CCC(=O)O2	6J9BLA949Q	Launched	aromatase inhibitor	CYP19A1
testosterone	testosterone|TESTOSTERONE	C[C@]12CCC3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@@H]2O	3XMK78S47O	Launched	androgen receptor agonist	AR
testosterone-enanthate	testosterone-enanthate|TESTOSTERONE ENANTHATE	CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	7Z6522T8N9	Launched	androgen receptor agonist	AR
testosterone-propionate	testosterone-propionate|TESTOSTERONE PROPIONATE	CCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C	WI93Z9138A	Launched	androgen receptor agonist	AR
testosterone-undecanoate	testosterone-undecanoate|TESTOSTERONE UNDECANOATE	CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	H16A5VCT9C	Launched	androgen receptor agonist	AR
tetrabenazine	tetrabenazine|TETRABENAZINE, (-)-|TETRABENAZINE	COc1cc2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3c2cc1OC	8A3NP33E5M|Z9O08YRN8O	Launched	vesicular monoamine transporter inhibitor	DRD2|SLC18A1|SLC18A2
tetracaine	tetracaine|TETRACAINE	CCCCNc1ccc(cc1)C(=O)OCCN(C)C	0619F35CGV	Launched	membrane integrity inhibitor	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
tetracycline	tetracycline|TETRACYCLINE	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	F8VB5M810T	Launched	bacterial 30S ribosomal subunit inhibitor	PRNP
tetradecylthioacetic-acid	tetradecylthioacetic-acid|TETRADECYLTHIOACETIC ACID	CCCCCCCCCCCCCCSCC(O)=O	7ZU5I25S2O	Phase 2	lipid peroxidase inhibitor	
tetraethylenepentamine	tetraethylenepentamine|TETRAETHYLENEPENTAMINE	NCCNCCNCCNCCN	YZD1C9KQ28	Phase 2/Phase 3	superoxide dismutase inhibitor	SOD1|SOD2
tetrahydrofolic-acid	tetrahydrofolic-acid|TETRAHYDROFOLIC ACID	Nc1nc(O)c2NC(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2n1	43ZWB253H4	Launched		ALDH1L1|AMT|ATIC|FOLR2|FTCD|MTFMT|MTHFD1|MTHFD2|MTHFR|MTR|SHMT1|SHMT2
tetrahydropapaverine	tetrahydropapaverine	COc1ccc(CC2NCCc3cc(OC)c(OC)cc23)cc1OC		Preclinical		
tetrahydrouridine	tetrahydrouridine|TETRAHYDROURIDINE	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(O)NC1=O	0NIZ8H6OL8	Phase 2	cytidine deaminase inhibitor	CDA
tetrahydrozoline	tetrahydrozoline|TETRAHYDROZOLINE	C1CN=C(N1)C1CCCc2ccccc12	S9U025Y077	Launched	adrenergic receptor agonist	
tetramethylthiuram-monosulfide	tetramethylthiuram-monosulfide|TETRAMETHYLTHIURAM MONOSULFIDE	CN(C)C(=S)SC(=S)N(C)C	01W430XXSQ	Preclinical		
tetramisole	tetramisole|TETRAMISOLE	C1CN2CC(N=C2S1)c1ccccc1	C8M7RFE4NO	Launched	immunostimulant	
tetrandrine	tetrandrine|TETRANDRINE	COc1ccc2C[C@@H]3N(C)CCc4cc(OC)c(OC)c(Oc5cc6[C@H](Cc7ccc(Oc1c2)cc7)N(C)CCc6cc5OC)c34	29EX23D5AJ	Preclinical	calcium channel blocker	SLC6A3
tetrazol-5-yl-glycine-(RS)	tetrazol-5-yl-glycine-(RS)	NC(C(O)=O)c1nnn[nH]1		Preclinical	glutamate receptor agonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
tetrindole	tetrindole	C1CCC(CC1)c1ccc2n3CCNC4CCCc(c34)c2c1		Phase 3	monoamine oxidase inhibitor	MAOA
tetroquinone	tetroquinone|TETROQUINONE	OC1C(=O)C(=O)C(O)C(=O)C1=O	U7L4P6H0SU	Preclinical		
TG-003	TG-003	CCN1\C(Sc2ccc(OC)cc12)=C\C(C)=O		Preclinical	CLK inhibitor	CLK1|CLK4|DYRK1A|DYRK1B
TG-02	TG-02	CN1C\C=C\CCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2		Phase 1	CDK inhibitor|FLT3 inhibitor|JAK inhibitor	CDK1|CDK2|CDK7|CDK9|FLT3|JAK2
TG-100572	TG-100572	Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(O)ccc1Cl		Preclinical	src inhibitor|VEGFR inhibitor	KDR|SRC
TG-100713	TG-100713	Nc1nc(N)c2nc(cnc2n1)-c1cccc(O)c1		Preclinical	PI3K inhibitor	
TG-100801	TG-100801	Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl	1VZO7A0J9S	Phase 2	src inhibitor|VEGFR inhibitor	FGFR1|FLT1|KDR|SRC
TG-101209	TG-101209	CN1CCN(CC1)c1ccc(Nc2ncc(C)c(Nc3cccc(c3)S(=O)(=O)NC(C)(C)C)n2)cc1		Preclinical	JAK inhibitor	JAK2|JAK3
TG-101348	TG-101348|FEDRATINIB	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C	6L1XP550I6	Phase 3	FLT3 inhibitor|JAK inhibitor	BRD4|JAK1|JAK2|JAK3|TYK2
TG100-115	TG100-115|TG-100115	Nc1nc(N)c2nc(-c3cccc(O)c3)c(nc2n1)-c1cccc(O)c1	7ACH1U1E2M	Phase 1/Phase 2	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG
TGR-1202	TGR-1202	CC(C)Oc1ccc(cc1F)-c1nn([C@@H](C)c2oc3ccc(F)cc3c(=O)c2-c2cccc(F)c2)c2ncnc(N)c12		Phase 3	PI3K inhibitor	
TGX-221	TGX-221	CC(Nc1ccccc1)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1	6L28AW98TH	Preclinical	PI3K inhibitor	PIK3CB|PIK3CD
TH-302	TH-302|EVOFOSFAMIDE	Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+]([O-])=O	8A9RZ3HN8W	Phase 3	DNA alkylating agent	
TH588	TH588	Nc1nc(NC2CC2)cc(n1)-c1cccc(Cl)c1Cl		Preclinical	MTH1 inhibitor	NUDT1
thaliblastine	thaliblastine|THALICARPINE	COc1cc(C[C@@H]2N(C)CCc3cc(OC)c(OC)cc23)c(Oc2cc3C[C@@H]4N(C)CCc5cc(OC)c(OC)c(-c3cc2OC)c45)cc1OC	8X1D791RF6	Phase 2	DNA inhibitor	
thalidomide	thalidomide|THALIDOMIDE	O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12	4Z8R6ORS6L	Launched	tumor necrosis factor production inhibitor	CRBN|FGFR2|NFKB1|ORM1|ORM2|PTGS2|TNF
theobromine	theobromine|THEOBROMINE	Cn1cnc2n(C)c(=O)[nH]c(=O)c12	OBD445WZ5P	Launched	phosphodiesterase inhibitor	ADORA1|ADORA2A|PDE4B
theophylline	theophylline|THEOPHYLLINE	Cn1c2nc[nH]c2c(=O)n(C)c1=O	C137DTR5RG	Launched	adenosine receptor antagonist	
thiamet-g	thiamet-g	CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1		Preclinical	GLCNAC phosphotransferase inhibitor	MGEA5
thiamine	thiamine|THIAMINE	Cc1c(CCO)sc[n+]1Cc1cnc(C)nc1N	X66NSO3N35	Launched	vitamin B	SLC19A2|SLC19A3|TPK1
thiamine-pyrophosphate	thiamine-pyrophosphate|COCARBOXYLASE	Cc1c(CCOP(O)(=O)OP(O)(O)=O)sc[n+]1Cc1cnc(C)nc1N	Q57971654Y	Launched		
thiamphenicol	thiamphenicol|RACEPHENICOL|THIAMPHENICOL	CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl	283383NO13|FLQ7571NPM	Launched	bacterial 50S ribosomal subunit inhibitor	
thiamylal	thiamylal|THIAMYLAL	CCCC(C)C1(CC=C)C(=O)NC(S)=NC1=O	01T23W89FR	Launched	glutamate receptor antagonist	GABRA1|KCNJ11|KCNJ8
thiazovivin	thiazovivin	O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1		Preclinical	rho associated kinase inhibitor	
thiethylperazine	thiethylperazine|THIETHYLPERAZINE	CCSc1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1	8ETK1WAF6R	Launched	dopamine receptor antagonist	DRD1|DRD2|DRD4
thiocolchicoside	thiocolchicoside|THIOCOLCHICOSIDE	COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2CC[C@H](NC(C)=O)c3cc(=O)c(SC)ccc3-c2c1OC	T1X8S697GT	Launched	GABA receptor antagonist	GABRA1|GABRB2|GABRG2|GLRA1|GLRB
thioctic-acid	thioctic-acid|THIOCTIC ACID	OC(=O)CCCCC1CCSS1	73Y7P0K73Y	Launched	reducing agent	ACHE|LIAS|LIPT1|PTGS2|SLC5A6
thiodiglycol	thiodiglycol|THIODIGLYCOL	OCCSCCO	9BW5T43J04	Preclinical		
thioguanine	thioguanine|THIOGUANINE	Nc1nc2nc[nH]c2c(=S)[nH]1	FTK8U1GZNX	Launched	purine antagonist	IMPDH1|IMPDH2
thiomersal	thiomersal|THIMEROSAL	CC[Hg]Sc1ccccc1C(O)=O	2225PI3MOV	Launched	other antibiotic	OXCT1
thiopental	thiopental|THIOPENTAL	CCCC(C)C1(CC)C(=O)NC(S)=NC1=O	JI8Z5M7NA3	Launched	GABA receptor antagonist	CHRNA4|CHRNA7|FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2
thioperamide	thioperamide|THIOPERAMIDE	S=C(NC1CCCCC1)N1CCC(CC1)c1c[nH]cn1	II4319BWUI	Preclinical	histamine receptor antagonist	HRH3|HRH4
thiophanate	thiophanate|THIOPHANATE	COC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OC	5Q0Y96D5I8	Preclinical		
thioproperazine	thioproperazine|THIOPROPERAZINE	CN(C)S(=O)(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1	YJ050AQ56X	Launched	dopamine receptor antagonist	ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A
thioridazine	thioridazine|THIORIDAZINE	CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1	N3D6TG58NI	Withdrawn	dopamine receptor antagonist	ADRA1A|ADRA1B|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCNH2
thiorphan	thiorphan|THIORPHAN	OC(=O)CNC(=O)C(CS)Cc1ccccc1	B79L7B5X3Z	Phase 1	membrane metalloendopeptidase inhibitor	MME
thiostrepton	thiostrepton|THIOSTREPTON	CCC(C)C1NC2C=Cc3c(cc(nc3C2O)C(=O)OC(C)C2NC(=O)c3csc(n3)C(NC(=O)C3CSC(=N3)\C(NC(=O)C(NC(=O)c3csc(n3)C3(CCC(=NC3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C/C)C(C)(O)C(C)O)C(C)O	HR4S203Y18	Launched	FOXM1 inhibitor|protein synthesis inhibitor	FOXM1
thiotepa	thiotepa|THIOTEPA	S=P(N1CC1)(N1CC1)N1CC1	905Z5W3GKH	Launched	cytochrome P450 inhibitor	CYP2B6|CYP3A4
thiothixene	thiothixene|THIOTHIXENE	CN(C)S(=O)(=O)c1ccc2Sc3ccccc3\C(=C/CCN3CCN(C)CC3)c2c1	7318FJ13YJ	Launched	dopamine receptor antagonist	DRD1|DRD2|HRH1|HTR2A
thiram	thiram|THIRAM	CN(C)C(=S)SSC(=S)N(C)C	0D771IS0FH	Launched		JAK2
thonzonium	thonzonium|THONZONIUM	CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1	Z05ZE98FV8	Launched	ATPase inhibitor	
thonzylamine	thonzylamine|THONZYLAMINE	COc1ccc(CN(CCN(C)C)c2ncccn2)cc1	R79646H5Z8	Launched	antihistamine	
threo-2-methylisocitrate-(DL)	threo-2-methylisocitrate-(DL)	CC(O)([C@@H](CC(O)=O)C(O)=O)C(O)=O.CC(O)([C@H](CC(O)=O)C(O)=O)C(O)=O		Preclinical	isocitrate lyase substrate	
thymol	thymol|THYMOL	CC(C)c1ccc(C)cc1O	3J50XA376E	Launched	GABA receptor positive allosteric modulator	TRPA1
thymol-iodide	thymol-iodide|THYMOL IODIDE	CC(C)c1cc(c(C)cc1OI)-c1cc(C(C)C)c(OI)cc1C	A51HJM3XSU	Preclinical		
THZ1	THZ1	CN(C)C\C=C\C(=O)Nc1ccc(cc1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1		Preclinical	CDK inhibitor	CDK7
THZ1-R	THZ1-R	CN(C)CCCC(=O)Nc1ccc(cc1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1		Preclinical	CDK inhibitor	CDK7
THZ2	THZ2	CN(C)C\C=C\C(=O)Nc1cccc(c1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1		Preclinical	CDK inhibitor	CDK7
tiabendazole	tiabendazole|THIABENDAZOLE	c1nc(cs1)-c1nc2ccccc2[nH]1	N1Q45E87DT	Launched	angiogenesis inhibitor	
tiagabine	tiagabine|TIAGABINE	Cc1ccsc1C(=CCCN1CCC[C@H](C1)C(O)=O)c1sccc1C	Z80I64HMNP	Launched	GABA uptake inhibitor	SLC6A1
tianeptine	tianeptine|TIANEPTINE|TIANEPTINE, (+)-|TIANEPTINE, (-)-	CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O	0T493YFU8O|AKU7QFL9ZT|XV6773012I	Launched	selective serotonin reuptake enhancer (SSRE)	OPRD1|OPRK1|OPRM1
tiapride	tiapride|TIAPRIDE	CCN(CC)CCNC(=O)c1cc(ccc1OC)S(C)(=O)=O	LAH70H9JPH	Launched	dopamine receptor antagonist	DRD2|DRD3
tiaprofenic-acid	tiaprofenic-acid|TIAPROFENIC ACID	CC(C(O)=O)c1ccc(s1)C(=O)c1ccccc1	1LS1T6R34C	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
tiaramide	tiaramide|TIARAMIDE	OCCN1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O	BB17WGM686	Launched	anti-inflammatory agent	
tibolone	tibolone|TIBOLONE	C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12	FF9X0205V2	Launched	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	ESR1
TIC10	TIC10	Cc1ccccc1CN1CC2=C(CCN(Cc3ccccc3)C2=O)N2CCN=C12		Phase 2	AKT inhibitor|TRAIL modulator	AKT1|MAPK1
ticagrelor	ticagrelor|TICAGRELOR	CCCSc1nc(N[C@@H]2C[C@@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@H](O)[C@H]3O)c2n1	GLH0314RVC	Launched	purinergic receptor antagonist	P2RY12
ticarcillin	ticarcillin|TICARCILLIN	CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O	F93UJX4SWT	Launched	lactamase inhibitor	
ticlopidine	ticlopidine|TICLOPIDINE	Clc1ccccc1CN1CCc2sccc2C1	OM90ZUW7M1	Launched	purinergic receptor antagonist	P2RY12
tideglusib	tideglusib|TIDEGLUSIB	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1	Q747Y6TT42	Phase 2	glycogen synthase kinase inhibitor	GSK3B
tie2-kinase-inhibitor	tie2-kinase-inhibitor	COc1ccc2cc(ccc2c1)-c1nc([nH]c1-c1ccncc1)-c1ccc(cc1)S(C)=O		Preclinical	TIE tyrosine kinase inhibitor	KDR|MAPK14
tienilic-acid	tienilic-acid|TICRYNAFEN	OC(=O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl	HC95205SY4	Withdrawn	sodium/potassium/chloride transporter inhibitor|cytochrome P450 inhibitor	CYP2C9|SLC12A1
tifenazoxide	tifenazoxide|TIFENAZOXIDE	CC1(CC1)NC1=NS(=O)(=O)c2sc(Cl)cc2N1	Y79681GLMG	Phase 1	ATP-sensitive potassium channel agonist	ABCC8|KCNJ11
tigecycline	tigecycline|TIGECYCLINE	CN(C)[C@@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C	70JE2N95KR	Launched	bacterial 30S ribosomal subunit inhibitor	
tiletamine	tiletamine|TILETAMINE	CCNC1(CCCCC1=O)c1cccs1	2YFC543249	Launched	glutamate receptor antagonist	
tilmicosin	tilmicosin|TILMICOSIN	CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN2C[C@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@H]1CO[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC	XL4103X2E3	Launched	bacterial 50S ribosomal subunit inhibitor	
tilorone	tilorone|TILORONE	CCN(CC)CCOc1ccc2-c3ccc(OCCN(CC)CC)cc3C(=O)c2c1	O6W7VEW6KS	Launched	interferon inducer	
tiludronate	tiludronate|TILUDRONIC ACID	OP(O)(=O)C(Sc1ccc(Cl)cc1)P(O)(O)=O	6PNS59HP4Y	Launched	bone resorption inhibitor|osteoclast inhibitor	ATP6V1A|MMP2|PTPN1
timofibrate	timofibrate|TIMOFIBRATE	CC(C)(Oc1ccc(Cl)cc1)C(=O)N1CSCC1C(O)=O	85P20FW39R	Phase 2	cholesterol inhibitor|lipase clearing factor inhibitor	LPL
timolol	timolol|TIMOLOL	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1	817W3C6175	Launched	adrenergic receptor antagonist	ADRB1|ADRB2
timonacic	timonacic|TIMONACIC	OC(=O)C1CSCN1	E5913T3IBL	Launched	antioxidant	ANXA5
tinidazole	tinidazole|TINIDAZOLE	CCS(=O)(=O)CCn1c(C)ncc1[N+]([O-])=O	033KF7V46H	Launched	antiprotozoal agent	
tioconazole	tioconazole|TIOCONAZOLE	Clc1sccc1COC(Cn1ccnc1)c1ccc(Cl)cc1Cl	S57Y5X1117	Launched	sterol demethylase inhibitor	CYP51A1
tioguanine	tioguanine|THIOGUANINE ANHYDROUS	Nc1nc(S)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1	WIX31ZPX66	Phase 2	purine antagonist	
tiopronin	tiopronin|TIOPRONIN	CC(S)C(=O)NCC(O)=O	C5W04GO61S	Launched	chelating agent|reducing agent	
tiotidine	tiotidine|TIOTIDINE	CN\C(NCCSCc1csc(N=C(N)N)n1)=N/C#N	EZU9AIZ69M	Phase 2	histamine receptor antagonist	HRH2
tiotropium	tiotropium|TIOTROPIUM	C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1	0EB439235F	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
tioxolone	tioxolone|TIOXOLONE	Oc1ccc2sc(=O)oc2c1	S0FAJ1R9CD	Preclinical	carbonic anhydrase inhibitor	CA2
tipifarnib	tipifarnib|TIPIFARNIB	Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2n(C)c(=O)cc(-c3cccc(Cl)c3)c2c1	MAT637500A	Phase 3	farnesyltransferase inhibitor	FNTA|FNTB
tipiracil	tipiracil|TIPIRACIL	Clc1c(CN2CCCC2=N)[nH]c(=O)[nH]c1=O	NGO10K751P	Launched	thymidine phosphorylase inhibitor	TYMP
tiplaxtinin	tiplaxtinin|TIPLASININ	OC(=O)C(=O)c1cn(Cc2ccccc2)c2ccc(cc12)-c1ccc(OC(F)(F)F)cc1	L396QIB983	Phase 1	plasminogen activator inhibitor	SERPINE1
tipranavir	tipranavir|TIPRANAVIR	CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1	ZZT404XD09	Launched	HIV protease inhibitor	
tiprenolol	tiprenolol|TIPRENOLOL	CSc1ccccc1OCC(O)CNC(C)C	R86K1U4O7J	Phase 2	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
tiquizium	tiquizium|TIQUIZIUM	C[N@+]12CCCC[C@@H]1CCC(C2)=C(c1cccs1)c1cccs1	340Q44041A	Launched	acetylcholine receptor antagonist	
tiracizine	tiracizine|TIRACIZINE	CCOC(=O)Nc1ccc2CCc3ccccc3N(C(=O)CN(C)C)c2c1	9UUO2T61K7	Withdrawn	sodium channel blocker	SCN5A
tirapazamine	tirapazamine|TIRAPAZAMINE	On1c2ccccc2[n+]([O-])nc1=N	1UD32YR59G	Phase 3	DNA inhibitor	
tirasemtiv	tirasemtiv|TIRASEMTIV	CCC(CC)n1c2nc(cnc2[nH]c1=O)C#C	G8WSM7R635	Phase 2	troponin activator	
tiratricol	tiratricol|TIRATRICOL	OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1	29OQ9EU4R1	Launched	thyroid hormone stimulant	THRA|THRB
tirofiban	tirofiban|TIROFIBAN	CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O	GGX234SI5H	Launched	platelet aggregation inhibitor|structural glycoprotein antagonist	ITGA2B|ITGB3
titanocene-dichloride	titanocene-dichloride|TITANOCENE DICHLORIDE	Cl[Ti](Cl)(C1C=CC=C1)C1C=CC=C1	MJE0547U1U	Phase 2	apoptosis stimulant	
tivantinib	tivantinib|TIVANTINIB	O=C1NC(=O)[C@H]([C@@H]1c1c[nH]c2ccccc12)c1cn2CCCc3cccc1c23	PJ4H73IL17	Phase 3	tyrosine kinase inhibitor	MET
tivozanib	tivozanib|TIVOZANIB	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC	172030934T	Phase 3	VEGFR inhibitor	FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB
tizanidine	tizanidine|TIZANIDINE	Clc1ccc2nsnc2c1NC1=NCCN1	6AI06C00GW	Launched	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C|NISCH
TMC-353121	TMC-353121	Cc1ccc(CCCO)c(NCc2ccc3nc(NCCCN4CCOCC4)n(Cc4nc(C)ccc4O)c3c2)c1	538EBT31Z1	Phase 2	RSV fusion inhibitor	
TMC647055	TMC647055|TMC-647055	COc1ccc2-c3c(C4CCCCC4)c4ccc5cc4n3CC(=Cc2c1)C(=O)N(C)CCOCCN(C)S(=O)(=O)NC5=O	11BD024G7J	Phase 2	RNA polymerase inhibitor	
TMPH	TMPH	CCCCCCC(=O)OC1CC(C)(C)NC(C)(C)C1		Preclinical		
TMS	TMS	COc1ccc(\C=C\c2cc(OC)cc(OC)c2)c(OC)c1		Preclinical		
TNP-470	TNP-470	CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)NC(=O)CCl	X47GR46481	Phase 2	methionine aminopeptidase inhibitor	
tobramycin	tobramycin|TOBRAMYCIN	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O	VZ8RRZ51VK	Launched	bacterial 30S ribosomal subunit inhibitor	
tocainide	tocainide|TOCAINIDE	CC(N)C(=O)Nc1c(C)cccc1C	27DXO59SAN	Launched	sodium channel blocker	SCN5A
toceranib	toceranib|TOCERANIB	Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN1CCCC1	59L7Y0530C	Launched	protein tyrosine kinase inhibitor	FLT1|FLT3|KDR|PDGFRA|PDGFRB
tocofersolan	tocofersolan	CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(=O)CCC(=O)OCCO)c(C)c(C)c2O1		Launched	antioxidant	
todralazine	todralazine|TODRALAZINE	CCOC(=O)NNc1nncc2ccccc12	WEN3K83YKD	Launched	antihypertensive agent	
tofacitinib	tofacitinib|TOFACITINIB	C[C@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N	87LA6FU830	Launched	JAK inhibitor	JAK1|JAK2|JAK3|TYK2
tofisopam	tofisopam|TOFISOPAM	CCC1=C(C)NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc12	UZC80HAU42	Launched	phosphodiesterase inhibitor|cytochrome P450 inhibitor	CYP3A4|PDE10A|PDE2A|PDE3A|PDE4A
tofogliflozin	tofogliflozin|TOFOGLIFLOZIN	CCc1ccc(Cc2ccc3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c2)cc1	P8DD8KX4O4	Launched	sodium/glucose cotransporter inhibitor	GCK
tolamolol	tolamolol|TOLAMOLOL	Cc1ccccc1OCC(O)CNCCOc1ccc(cc1)C(N)=O	F03W3WUW58	Phase 3	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3
tolazamide	tolazamide|TOLAZAMIDE	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1	9LT1BRO48Q	Launched	ATP channel blocker	ABCC8|KCNJ1|KCNJ10|KCNJ11
tolazoline	tolazoline|TOLAZOLINE	C(C1=NCCN1)c1ccccc1	CHH9H12AQ3	Launched	adrenergic receptor antagonist	ADRA1A|ADRA2A|ADRA2B|ADRA2C|HRH1|HRH2
tolbutamide	tolbutamide|TOLBUTAMIDE	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1	982XCM1FOI	Launched	ATP channel blocker	ABCC8|KCNJ1|KCNJ11|KCNJ8
tolcapone	tolcapone|TOLCAPONE	Cc1ccc(cc1)C(=O)c1cc(O)c(O)c(c1)[N+]([O-])=O	CIF6334OLY	Withdrawn	catechol O methyltransferase inhibitor	COMT
tolfenamic-acid	tolfenamic-acid|TOLFENAMIC ACID	Cc1c(Cl)cccc1Nc1ccccc1C(O)=O	3G943U18KM	Launched	cyclooxygenase inhibitor|prostanoid receptor antagonist	
tolimidone	tolimidone|TOLIMIDONE	Cc1cccc(Oc2cnc(=O)[nH]c2)c1	MU3JD8E9IS	Phase 2	src activator	LYN|SRC
tolmetin	tolmetin|TOLMETIN	Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C	D8K2JPN18B	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
tolnaftate	tolnaftate|TOLNAFTATE	CN(C(=S)Oc1ccc2ccccc2c1)c1cccc(C)c1	06KB629TKV	Launched	fungal squalene epoxidase inhibitor	
tolonidine	tolonidine|TOLONIDINE	Cc1ccc(NC2=NCCN2)c(Cl)c1	I4O795Q03O	Launched	adrenergic receptor antagonist	ADRA2A
tolonium	tolonium|TOLONIUM	CN(C)c1ccc2nc3cc(C)c(N)cc3[s+]c2c1	P3Y6XJA2D1	Launched		
toloxatone	toloxatone|TOLOXATONE	Cc1cccc(c1)N1CC(CO)OC1=O	5T206015T5	Launched	monoamine oxidase inhibitor	MAOA|MAOB
tolperisone	tolperisone|TOLPERISONE	CC(CN1CCCCC1)C(=O)c1ccc(C)cc1	F5EOM0LD8E	Launched	voltage-gated sodium channel blocker	CYP2C19|CYP2D6
tolrestat	tolrestat|TOLRESTAT	COc1ccc2c(cccc2c1C(F)(F)F)C(=S)N(C)CC(O)=O	0T93LG5NMK	Withdrawn	aldose reductase inhibitor	AKR1A1|AKR1B1|AKR1B10
tolterodine	tolterodine|TOLTERODINE	CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C	WHE7A56U7K	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
toltrazuril	toltrazuril|TOLTRAZURIL	Cc1cc(ccc1Oc1ccc(SC(F)(F)F)cc1)-n1c(=O)[nH]c(=O)n(C)c1=O	QVZ3IAR3JS	Launched	antiprotozoal agent	
tolvaptan	tolvaptan|TOLVAPTAN	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc23)c(C)c1	21G72T1950	Launched	vasopressin receptor antagonist	AVPR1A|AVPR2
tomelukast	tomelukast|TOMELUKAST	CCCc1c(OCCCCc2nnn[nH]2)ccc(C(C)=O)c1O	59762X5CLS	Phase 3	leukotriene receptor antagonist	CYSLTR1
tonabersat	tonabersat|TONABERSAT	CC(=O)c1ccc2OC(C)(C)[C@@H](O)[C@@H](NC(=O)c3ccc(F)c(Cl)c3)c2c1	2XD9773ZMN	Phase 2	gap junction modulator|nitric oxide production inhibitor	
topiramate	topiramate|TOPIRAMATE	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	0H73WJJ391	Launched	carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist	CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
topiroxostat	topiroxostat|TOPIROXOSTAT	N#Cc1cc(ccn1)-c1n[nH]c(n1)-c1ccncc1	0J877412JV	Launched	xanthine oxidase inhibitor	XDH
topotecan	topotecan|TOPOTECAN	CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O	7M7YKX2N15	Launched	topoisomerase inhibitor	TOP1|TOP1MT
torasemide	torasemide|TORSEMIDE	CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc1cccc(C)c1	W31X2H97FB	Launched	electrolyte reabsorption inhibitor|thromboxane receptor antagonist	SLC12A1
torcetrapib	torcetrapib|TORCETRAPIB	CCOC(=O)N1[C@H](CC)C[C@@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)OC)c2cc(ccc12)C(F)(F)F	4N4457MV2U	Phase 3	cholesteryl ester transfer protein inhibitor	CETP
torcitabine	torcitabine|TORCITABINE	Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	6BZN07BMW3	Phase 2	DNA polymerase inhibitor	DCK|TK2
toremifene	toremifene|TOREMIFENE	CN(C)CCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1	7NFE54O27T	Launched	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	ESR1
torin-1	torin-1	CCC(=O)N1CCN(CC1)c1ccc(cc1C(F)(F)F)-n1c2c(ccc1=O)cnc1ccc(cc21)-c1cnc2ccccc2c1		Preclinical	mTOR inhibitor	MTOR
torin-2	torin-2	Nc1ccc(cn1)-c1ccc2ncc3ccc(=O)n(-c4cccc(c4)C(F)(F)F)c3c2c1		Preclinical	mTOR inhibitor	MTOR
tosedostat	tosedostat|TOSEDOSTAT	CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1	KZK563J2UW	Phase 2	peptidase inhibitor	ANPEP|LAP3|NPEPPS
tosufloxacin	tosufloxacin|TOSUFLOXACIN	NC1CCN(C1)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F	GHJ553KQPS	Launched	bacterial DNA gyrase inhibitor	
toyocamycin	toyocamycin|TOYOCAMYCIN	Nc1ncnc2n(cc(C#N)c12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	L7995C4D7F	Phase 1	serine/threonine kinase inhibitor	ERN1
tozadenant	tozadenant|TOZADENANT	COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12	D9K857J81I	Phase 3	adenosine receptor antagonist	ADORA2A
tozasertib	tozasertib|TOZASERTIB	CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1	234335M86K	Phase 2	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	AURKA|AURKB|AURKC|LCK
TP-0903	TP-0903	CN(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(CN3CCN(C)CC3)cc2)ncc1Cl		Preclinical	AXL kinase inhibitor	AXL
TPCA-1	TPCA-1	NC(=O)Nc1sc(cc1C(N)=O)-c1ccc(F)cc1		Preclinical	IKK inhibitor	IKBKB
TPPS4	TPPS4	OS(=O)(=O)c1ccc(cc1)-c1c2ccc(n2)c(-c2ccc(cc2)S(O)(=O)=O)c2ccc([nH]2)c(-c2ccc(cc2)S(O)(=O)=O)c2ccc(n2)c(-c2ccc(cc2)S(O)(=O)=O)c2ccc1[nH]2		Phase 1		
tracazolate	tracazolate|TRACAZOLATE	CCCCNc1c(C(=O)OCC)c(C)nc2n(CC)ncc12	NH0HPL3U1T	Phase 2	GABA receptor modulator	GABRA1
TRAM-34	TRAM-34	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1cccn1		Preclinical	potassium channel antagonist	KCNN4
tramadol	tramadol|TRAMADOL	COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C	39J1LGJ30J	Launched	norepinephrine reputake inhibitor|opioid receptor agonist|serotonin reuptake inhibitor	CHRFAM7A|CHRM3|GRIN3A|HTR2C|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4
trametinib	trametinib|TRAMETINIB	CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O	33E86K87QN	Launched	MEK inhibitor	MAP2K1|MAP2K2
tramiprosate	tramiprosate|TRAMIPROSATE	NCCCS(O)(=O)=O	5K8EAX0G53	Phase 3	beta amyloid protein neurotoxicity inhibitor	APP
trandolapril	trandolapril|TRANDOLAPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@H](C)C(=O)N1C2CCCCC2C[C@H]1C(O)=O	1T0N3G9CRC	Launched	angiotensin converting enzyme inhibitor	ACE
tranexamic-acid	tranexamic-acid|TRANEXAMIC ACID	NC[C@H]1CC[C@@H](CC1)C(O)=O	6T84R30KC1	Launched	antifibrinolytic|plasminogen activator inhibitor	PLG
tranilast	tranilast|TRANILAST	COc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC	HVF50SMY6E	Launched	angiogenesis inhibitor	HPGDS|HRH1
trans-2-Undecenoic-acid	trans-2-Undecenoic-acid	CCCCCCCC\C=C\C(O)=O		Preclinical		
trans-4-Hydroxycrotonic-acid	trans-4-Hydroxycrotonic-acid	OC\C=C\C(O)=O		Preclinical	gamma hydroxybutyric acid ligand	
trans-4-Methoxycinnamic-acid	trans-4-Methoxycinnamic-acid|4-METHOXYCINNAMIC ACID	COc1ccc(cc1)\C=C\C(O)=O	6G4ML8401A	Preclinical		
tranylcypromine	tranylcypromine|TRANYLCYPROMINE	NC1C[C@H]1c1ccccc1	3E3V44J4Z9	Launched	monoamine oxidase inhibitor	KDM1A|MAOA|MAOB
trap-101	trap-101	CCn1c2ccccc2n(C2=C(CO)CN(CC3CCCCCCC3)CC2)c1=O		Preclinical	nociceptin/orphanin FQ receptor antagonist|opioid receptor antagonist	OPRL1
trapidil	trapidil|TRAPIDIL	CCN(CC)c1cc(C)nc2ncnn12	EYG5Y6355E	Launched	PDGFR tyrosine kinase receptor inhibitor	PDGFRA
travoprost	travoprost|TRAVOPROST	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COc1cccc(c1)C(F)(F)F	WJ68R08KX9	Launched	prostanoid receptor agonist	PTGFR
traxoprodil	traxoprodil|TRAXOPRODIL	C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(CC1)c1ccccc1	UTC046R5HM	Phase 2	glutamate receptor antagonist	GRIN2B
trazodone	trazodone|TRAZODONE	Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1	YBK48BXK30	Launched	adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor	ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4
trebenzomine	trebenzomine|TREBENZOMINE	CC1Oc2ccccc2CC1N(C)C	E26GV7524F	Phase 2		
trelagliptin	trelagliptin|TRELAGLIPTIN	Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O	Q836OWG55H	Launched	dipeptidyl peptidase inhibitor	DPP4
tremorine	tremorine|TREMORINE	C(C#CCN1CCCC1)N1CCCC1	U817VZ1URQ	Preclinical	acetylcholine receptor agonist	
treosulfan	treosulfan|TREOSULFAN	CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O	CO61ER3EPI	Launched	DNA synthesis inhibitor	
trepibutone	trepibutone|TREPIBUTONE	CCOc1cc(OCC)c(cc1OCC)C(=O)CCC(O)=O	H1187LU49Q	Launched	cholinergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
trequinsin	trequinsin|TREQUINSIN	COc1cc2CCn3c(c\c(=N/c4c(C)cc(C)cc4C)n(C)c3=O)-c2cc1OC	739I2958C1	Phase 1	phosphodiesterase inhibitor	PDE5A
tretazicar	tretazicar|TRETAZICAR	NC(=O)c1cc(N2CC2)c(cc1[N+]([O-])=O)[N+]([O-])=O	7865D5D01M	Phase 2	DNA replication inhibitor	NQO2
tretinoin	tretinoin|TRETINOIN	CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O	5688UTC01R	Launched	retinoid receptor agonist|retinoid receptor ligand	ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG
triacetin	triacetin|TRIACETIN	CC(=O)OCC(COC(C)=O)OC(C)=O	XHX3C3X673	Launched		
triamcinolone	triamcinolone|TRIAMCINOLONE	C[C@]12C[C@H](O)[C@@]3(F)C(CCC4=CC(=O)C=C[C@]34C)C1C[C@@H](O)[C@]2(O)C(=O)CO	1ZK20VI6TY	Launched	glucocorticoid receptor agonist	NR3C1|SERPINA6
triamcinolone-acetonide	triamcinolone-acetonide|TRIAMCINOLONE ACETONIDE	CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	F446C597KA	Launched	glucocorticoid receptor agonist|immunosuppressant	NR3C1
triamterene	triamterene|TRIAMTERENE	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1	WS821Z52LQ	Launched	sodium channel blocker	SCNN1A|SCNN1B|SCNN1D|SCNN1G
triapine	triapine|TRIAPINE	NC(=S)N\N=C\c1ncccc1N	U4XIL4091C	Phase 2	ribonucleotide reductase inhibitor	RRM1|RRM2
triazolam	triazolam|TRIAZOLAM	Cc1nnc2CN=C(c3ccccc3Cl)c3cc(Cl)ccc3-n12	1HM943223R	Withdrawn	GABA benzodiazepine site receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO
tribenoside	tribenoside|TRIBENOSIDE	CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O	Z7N0Y673NU	Launched	anti-inflammatory agent|capillary stabilizing agent	
tribomsalan	tribomsalan|TRIBROMSALAN	Oc1c(Br)cc(Br)cc1C(=O)Nc1ccc(Br)cc1	6MCE3VTF0O	Preclinical		
tribromoethanol	tribromoethanol|TRIBROMOETHANOL	OCC(Br)(Br)Br	149JI83A44	Preclinical	analgesic agent	
tributyrin	tributyrin|TRIBUTYRIN	CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC	S05LZ624MF	Phase 1	HDAC inhibitor	
tricaprylin	tricaprylin|TRICAPRYLIN	CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC	6P92858988	Launched		
trichlormethiazide	trichlormethiazide|TRICHLORMETHIAZIDE	NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl	Q58C92TUN0	Launched	chloride channel blocker	ATP1A1|CA1|CA2|CA4|SLC12A1|SLC12A3
trichlormethine	trichlormethine|TRICHLORMETHINE	ClCCN(CCCl)CCCl	66WBM7N0NM	Preclinical	DNA alkylating agent	
trichloroacetic-acid	trichloroacetic-acid|TRICHLOROACETIC ACID	OC(=O)C(Cl)(Cl)Cl	5V2JDO056X	Launched		
trichloroethylene	trichloroethylene|TRICHLOROETHYLENE	ClC=C(Cl)Cl	290YE8AR51	Preclinical		
trichostatin-a	trichostatin-a|TRICHOSTATIN A	C[C@H](\C=C(C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C	3X2S926L3Z	Preclinical	HDAC inhibitor	HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
triciribine	triciribine|TRICIRIBINE	Cn1nc(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23	2421HMY9N6	Phase 1/Phase 2	AKT inhibitor	AKT1|AKT2|AKT3
triclabendazole	triclabendazole|TRICLABENDAZOLE	CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1	4784C8E03O	Launched	microtubule inhibitor	DNMT1
triclocarban	triclocarban|TRICLOCARBAN	Clc1ccc(NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1	BGG1Y1ED0Y	Launched	other antibiotic	
triclosan	triclosan|TRICLOSAN	Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl	4NM5039Y5X	Launched	antibacterial agent	DNMT1
tridihexethyl	tridihexethyl|TRIDIHEXETHYL	CC[N+](CC)(CC)CCC(O)(C1CCCCC1)c1ccccc1	7HE50A367X	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
trientine	trientine|TRIENTINE	NCCNCCNCCN	SJ76Y07H5F	Launched	chelating agent	CA14
trifluoperazine	trifluoperazine|TRIFLUOPERAZINE	CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1	214IZI85K3	Launched	dopamine receptor antagonist	ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1
triflupromazine	triflupromazine|TRIFLUPROMAZINE	CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F	RO16TQF95Y	Launched	dopamine receptor antagonist	CHRM1|CHRM2|DRD1|DRD2|HTR2B
trifluridine	trifluridine|TRIFLURIDINE	OC[C@H]1OC(C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F	RMW9V5RW38	Launched	DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor	TYMS
triflusal	triflusal|TRIFLUSAL	CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F	1Z0YFI05OO	Launched	cyclooxygenase inhibitor|platelet aggregation inhibitor|thromboxane synthase inhibitor	NFKB1|NOS2|PDE10A|PTGS1
trigonelline	trigonelline|TRIGONELLINE	C[n+]1cccc(c1)C(O)=O	3NQ9N60I00	Phase 1		
trihexyphenidyl	trihexyphenidyl|TRIHEXYPHENIDYL	OC(CCN1CCCCC1)(C1CCCCC1)c1ccccc1	6RC5V8B7PO	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
trilostane	trilostane|TRILOSTANE	C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O	L0FPV48Q5R	Launched	3beta-hydroxy-delta5-steroid dehydrogenase inhibitor	ESR1|ESR2|HSD3B1|HSD3B2
TRIM	TRIM	FC(F)(F)c1ccccc1-n1ccnc1		Preclinical		
trimebutine	trimebutine|TRIMEBUTINE	CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c1ccccc1	QZ1OJ92E5R	Launched	opioid receptor agonist	OPRD1|OPRK1|OPRM1
trimeprazine	trimeprazine|TRIMEPRAZINE	CC(CN(C)C)CN1c2ccccc2Sc2ccccc12.CC(CN(C)C)CN1c2ccccc2Sc2ccccc12	76H78MJJ52	Launched	histamine receptor ligand|histamine receptor antagonist	HRH1
trimetazidine	trimetazidine|TRIMETAZIDINE	COc1ccc(CN2CCNCC2)c(OC)c1OC	N9A0A0R9S8	Launched	3-ketoacyl CoA thiolase inhibitor	ACAA2
trimethadione	trimethadione|TRIMETHADIONE	CN1C(=O)OC(C)(C)C1=O	R7GV3H6FQ4	Launched	oxazolidine antiepileptic	CACNA1G|CACNA1H|CACNA1I
trimethobenzamide	trimethobenzamide|TRIMETHOBENZAMIDE	COc1cc(cc(OC)c1OC)C(=O)NCc1ccc(OCCN(C)C)cc1	W2X096QY97	Launched	histamine receptor antagonist	DRD2
trimethoprim	trimethoprim|TRIMETHOPRIM	COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC	AN164J8Y0X	Launched	dihydrofolate reductase inhibitor	DHFR|TYMS
trimethoquinol	trimethoquinol|TRETOQUINOL	COc1cc(CC2NCCc3cc(O)c(O)cc23)cc(OC)c1OC	JIO3275WGI	Launched	adrenergic receptor antagonist	ADRB2|ADRB3
trimethylolpropane-triacrylate	trimethylolpropane-triacrylate|TRIMETHYLOLPROPANE TRIACRYLATE	CCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C	4B67KGL96S	Preclinical		
trimetozine	trimetozine|TRIMETOZINE	COc1cc(cc(OC)c1OC)C(=O)N1CCOCC1	31EPT7G9PL	Launched	sedative	
trimipramine	trimipramine|TRIMIPRAMINE|TRIMIPRAMINE, (-)-|TRIMIPRAMINE, (+)-	CC(CN(C)C)CN1c2ccccc2CCc2ccccc12	6S082C9NDT|9K5931C1H5|QJ9MUH57H8	Launched	norepinephrine reputake inhibitor|tricyclic antidepressant	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR1D|HTR2A|HTR2C|HTR3A|SLC6A2|SLC6A3|SLC6A4
trioxsalen	trioxsalen|TRIOXSALEN	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1	Y6UY8OV51T	Launched	DNA synthesis inhibitor	
tripelennamine	tripelennamine|TRIPELENNAMINE	CN(C)CCN(Cc1ccccc1)c1ccccn1	3C5ORO99TY	Launched	histamine receptor antagonist	HRH1
triprolidine	triprolidine|TRIPROLIDINE	Cc1ccc(cc1)C(=C/CN1CCCC1)\c1ccccn1	2L8T9S52QM	Launched	histamine receptor antagonist	HRH1
triptan	triptan|2,2,3-TRIMETHYLBUTANE	CC(C)C(C)(C)C	40V943JDGR	Phase 1	serotonin receptor agonist	HTR1B|HTR1D
triptolide	triptolide|TRIPTOLIDE	CC(C)[C@@]12O[C@@H]1[C@@H]1O[C@]11[C@]3(O[C@@H]3C[C@@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O	19ALD1S53J	Phase 3	RNA polymerase inhibitor	RELA
triptorelin	triptorelin|TRIPTORELIN ACETATE	CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O	43OFW291R9	Launched	gonadotropin releasing factor hormone receptor agonist	GNRHR
TRO19622	TRO19622|OLESOXIME, Z-	CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(CC[C@]4(C)[C@H]3CC[C@]12C)=NO	I2QN18P645	Phase 2/Phase 3	apoptosis inhibitor	
troclosene	troclosene|TROCLOSENE	Cln1c(=O)[nH]c(=O)n(Cl)c1=O	PHR838Y52L	Launched		
trofinetide	trofinetide|TROFINETIDE	NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O	Z2ME8F52QL	Phase 2	cytokine production inhibitor	IFNG|IL6|TNF
troglitazone	troglitazone|TROGLITAZONE, (2R,5R)-(+/-)-|TROGLITAZONE, (2S,5R)-(+/-)-	Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O	1A70L3TM4P|BFQ06OHW4R	Withdrawn	insulin sensitizer|PPAR receptor agonist	ACSL4|ESRRA|ESRRG|PPARG|SERPINE1|SLC29A1|TRPM3
troleandomycin	troleandomycin|TROLEANDOMYCIN	CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](OC3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O	C4DZ64560D	Launched	protein synthesis inhibitor	
trolox	trolox|6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID	Cc1c(C)c2OC(C)(CCc2c(C)c1O)C(O)=O	S18UL9710X	Launched	antioxidant	
tromaril	tromaril|ENFENAMIC ACID	OC(=O)c1ccccc1NCCc1ccccc1	05KO5G76R2	Launched	prostanoid receptor antagonist	
trometamol	trometamol|TROMETHAMINE	NC(CO)(CO)CO	023C2WHX2V	Launched		AMD1|CANT1|DCN|NEIL1|VEGFA
tropesin	tropesin|2-CARBOXY-2-PHENYLETHYL 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOLE-3-ACETATE	COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(C(O)=O)c3ccccc3)c2c1	P8NV2308A2	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
tropicamide	tropicamide|TROPICAMIDE	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1	N0A3Z5XTC6	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
tropisetron	tropisetron|TROPISETRON	CN1[C@H]2CC[C@@H]1CC(C2)OC(=O)C1C=Nc2ccccc12	6I819NIK1W	Launched	serotonin receptor antagonist	GLRA1|GLRA2|GLRB|HTR3A|HTR4
trospium	trospium|TROSPIUM	OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)(c1ccccc1)c1ccccc1	T4Y8ORK057	Launched	acetylcholine receptor antagonist	CHRM1
trovafloxacin	trovafloxacin|TROVAFLOXACIN	N[C@H]1[C@@H]2CN(C[C@H]12)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F	9F388J00UK	Withdrawn	bacterial DNA gyrase inhibitor	TOP2A
troventol	troventol	CCC(CO)(C(=O)OC1CC2CCC(C1)[N+]2(C)C)c1ccccc1		Phase 1		
trovirdine	trovirdine|TROVIRDINE	Brc1ccc(NC(=S)NCCc2ccccn2)nc1	ZE3K6J8614	Phase 1	non-nucleoside reverse transcriptase inhibitor	
troxerutin	troxerutin|TROXERUTIN	C[C@@H]1O[C@@H](OC[C@H]2OC(Oc3c(oc4cc(OCCO)cc(O)c4c3=O)-c3ccc(OCCO)c(OCCO)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O	7Y4N11PXO8	Launched	antioxidant	
troxipide	troxipide|TROXIPIDE	COc1cc(cc(OC)c1OC)C(=O)NC1CCCNC1	W6QJX1Q00Z	Launched	glucosamine synthetase stimulant	
TRV130	TRV130	COc1ccsc1CNCC[C@]1(CCOC2(CCCC2)C1)c1ccccn1		Phase 3	opioid receptor agonist	OPRM1
tryptanthrin	tryptanthrin	O=C1c2ccccc2-n2c1nc1ccccc1c2=O		Preclinical	cyclooxygenase inhibitor	IDO1
tryptophan	tryptophan|TRYPTOPHAN	N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O	8DUH1N11BX	Launched	serotonin receptor partial agonist	CASR|IDO1|SLC36A1|WARS|WARS2
TTNPB	TTNPB|AROTINOID ACID	C\C(=C/c1ccc(cc1)C(O)=O)c1ccc2c(c1)C(C)(C)CCC2(C)C	673M8C29UR	Phase 1	retinoid receptor agonist	RARA|RARB|RARG
TU-2100	TU-2100|AZELOYL DIETHYL SALICYLATE	CCOC(=O)c1ccccc1OC(=O)CCCCCCCC(=O)Oc1ccccc1C(=O)OCC	6P1YVC1J3O	Phase 2		
tuaminoheptane	tuaminoheptane|TUAMINOHEPTANE	CCCCCC(C)N	Z0420GYD84	Launched		
tubastatin-a	tubastatin-a	CN1CCc2c(C1)c1ccccc1n2Cc1ccc(cc1)C(=O)NO		Preclinical	HDAC inhibitor	HDAC6
tubocurarine	tubocurarine|TUBOCURARINE	COc1cc2CCN(C)[C@H]3Cc4ccc(Oc5c(O)c(OC)cc6CC[N+](C)(C)[C@H](Cc7ccc(O)c(Oc1cc23)c7)c56)cc4	W9YXS298BM	Launched	acetylcholine receptor antagonist	ACHE|CHRNA2|HTR3A|HTR3B|KCNN1|KCNN2|KCNN3|ZACN
tucatinib	tucatinib|TUCATINIB	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1	234248D0HH	Phase 2	EGFR inhibitor	ERBB2
TUG-770	TUG-770	OC(=O)CCc1ccc(cc1F)C#Cc1ccccc1CC#N		Preclinical	free fatty acid receptor agonist	FFAR1
tulobuterol	tulobuterol|TULOBUTEROL	CC(C)(C)NCC(O)c1ccccc1Cl	591I9SU0F7	Launched	adrenergic receptor agonist	ADRB2
TW-37	TW-37	CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O		Preclinical	BCL inhibitor	BCL2|BCL2L1|MCL1
TWS-119	TWS-119	Nc1cccc(c1)-c1cc2c(Oc3cccc(O)c3)ncnc2[nH]1		Preclinical	glycogen synthase kinase inhibitor	GSK3B|JUN|MYC
TXA127	TXA127|ANGIOTENSIN 1-7	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O	IJ3FUK8MOF	Phase 2	angiotensin receptor agonist	
TY-52156	TY-52156	CC(C)(C)C(=O)C(\NNc1ccc(Cl)cc1)=N\c1ccc(Cl)cc1		Preclinical	sphingosine 1-phosphate receptor antagonist	S1PR3
tylosin	tylosin|TYLOSIN	CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC	YEF4JXN031	Launched	protein synthesis inhibitor	
tyloxapol	tyloxapol	C=O.C1CO1.CC(C)(C)CC(C)(C)c1ccc(O)cc1		Launched	NFkB pathway inhibitor	LPL|NFKB2
tymazoline	tymazoline|TYMAZOLINE	CC(C)c1ccc(C)cc1OC=C1NCCN1	U993RH5585	Launched		
tyrphostin-A9	tyrphostin-A9|MALONOBEN	CC(C)(C)c1cc(C=C(C#N)C#N)cc(c1O)C(C)(C)C	87TE8MRS65	Preclinical	protein tyrosine kinase inhibitor|tyrosine kinase inhibitor	
tyrphostin-AG-1296	tyrphostin-AG-1296	COc1cc2ncc(nc2cc1OC)-c1ccccc1		Preclinical	FLT3 inhibitor	FLT3
tyrphostin-AG-1478	tyrphostin-AG-1478	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		Preclinical	EGFR inhibitor	EGFR|MAPK14
tyrphostin-AG-18	tyrphostin-AG-18|TYRPHOSTIN A23	Oc1ccc(C=C(C#N)C#N)cc1O	RV0GCD31OJ	Preclinical	EGFR inhibitor|tyrosine kinase inhibitor	EGFR
tyrphostin-AG-494	tyrphostin-AG-494	Oc1ccc(cc1O)\C=C(/C#N)C(=O)Nc1ccccc1		Preclinical	EGFR inhibitor	EGFR
tyrphostin-AG-825	tyrphostin-AG-825	COc1cc(\C=C(/C#N)C(N)=O)cc(CSc2nc3ccccc3s2)c1O		Preclinical	protein tyrosine kinase inhibitor	ERBB2
tyrphostin-AG-835	tyrphostin-AG-835	C[C@H](NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N)c1ccccc1		Preclinical	protein tyrosine kinase inhibitor	EGFR
tyrphostin-AG-879	tyrphostin-AG-879	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)\C=C(/C#N)C(N)=S		Preclinical	tyrosine kinase inhibitor	ERBB2|KDR|NTRK1
tyrphostin-AG-99	tyrphostin-AG-99	NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N		Preclinical	tyrosine kinase inhibitor	EGFR
U-0124	U-0124	CS\C(N)=C(C#N)\C(C#N)=C(/N)SC		Preclinical	MEK inhibitor	
U-0126	U-0126	N\C(Sc1ccccc1N)=C(C#N)/C(C#N)=C(\N)Sc1ccccc1N	8027P94HLL	Preclinical	MEK inhibitor	AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAP2K2|MAP2K7|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1
U-0521	U-0521	CC(C)C(=O)c1ccc(O)c(O)c1		Preclinical	catechol O methyltransferase inhibitor	COMT
U-104	U-104|BRIMONIDINE	NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1	E6GNX3HHTE	Preclinical	carbonic anhydrase inhibitor	CA1|CA12|CA2|CA9
U-18666A	U-18666A|3.BETA.-(2-(DIETHYLAMINO)ETHOXY)ANDROST-5-EN-17-ONE	CCN(CC)CCO[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3CC=C2C1	539DN9NA2P	Preclinical	oxidosqualene cyclase inhibitor	
U-50488-(-)	U-50488-(-)	CN([C@H]1CCCC[C@@H]1N1CCCC1)C(=O)Cc1ccc(Cl)c(Cl)c1		Preclinical	opioid receptor agonist	OPRK1
U-50488-(+/-)	U-50488-(+/-)	CN([C@H]1CCCC[C@@H]1N1CCCC1)C(=O)Cc1ccc(Cl)c(Cl)c1.CN([C@@H]1CCCC[C@H]1N1CCCC1)C(=O)Cc1ccc(Cl)c(Cl)c1		Preclinical	opioid receptor agonist	OPRK1
U-54494A	U-54494A	CN([C@@H]1CCCC[C@@H]1N1CCCC1)C(=O)c1ccc(Cl)c(Cl)c1	I3NE36R0XJ	Preclinical	opioid receptor agonist	OPRK1
U-75799E	U-75799E|GROWTH HORMONE RELEASING HEXAPEPTIDE	C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O	4H7N4I6X6A	Phase 1	growth hormone releasing factor agonist	GHSR
U-99194	U-99194|JPC-211	CCCN(CCC)C1Cc2cc(OC)c(OC)cc2C1	929J96FO8T	Preclinical	dopamine receptor antagonist	DRD3
UB-165	UB-165	Clc1ccc(cn1)C1=CCCC2CCC1N2		Preclinical	acetylcholine receptor agonist	CHRNA3|CHRNA4|CHRNB2
ubenimex	ubenimex|UBENIMEX	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O	I0J33N5627	Launched	leukotriene synthesis inhibitor	LTA4H|RNPEP
UBP-302	UBP-302	NC(Cn1ccc(=O)n(Cc2ccccc2C(O)=O)c1=O)C(O)=O		Preclinical	glutamate receptor antagonist	GRIK1
UCL-2077	UCL-2077	C(NC(c1ccccc1)(c1ccccc1)c1ccccc1)c1cccnc1		Preclinical	slow afterhyperpolarization channel blocker	
ufenamate	ufenamate|UFENAMATE	CCCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F	8Z7O7C1SLZ	Launched	cyclooxygenase inhibitor	PTGS1|PTGS2
UH-232-(+)	UH-232-(+)	CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C		Preclinical	dopamine receptor antagonist	DRD2|DRD3|DRD4|HTR1A
UK-383367	UK-383367	NC(=O)c1noc(n1)[C@H](CCCC1CCCCC1)CC(=O)NO		Phase 1	Procollagen C-Endopeptidase Inhibitors	BMP1
ulifloxacin	ulifloxacin|ULIFLOXACIN	CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCNCC1	C38638H76Y	Launched		
ulipristal	ulipristal|ULIPRISTAL	CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12	6J5J15Q2X8	Launched	progesterone receptor antagonist	PGR
umeclidinium	umeclidinium|UMECLIDINIUM	OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2	GE2T1418SV	Launched	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3
UNBS-5162	UNBS-5162	CN(C)CCN1C(=O)c2cccc3cc(NC(N)=O)cc(C1=O)c23	JY9JF7D78N	Phase 1	CC chemokine receptor antagonist	
UNC0224	UNC0224	COc1cc2c(NC3CCN(C)CC3)nc(nc2cc1OCCCN(C)C)N1CCCN(C)CC1		Preclinical	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
UNC0321	UNC0321	COc1cc2c(NC3CCN(C)CC3)nc(nc2cc1OCCOCCN(C)C)N1CCCN(C)CC1		Preclinical	histone lysine methyltransferase inhibitor	EHMT2
UNC0631	UNC0631	COc1cc2c(NC3CCN(CC4CCCCC4)CC3)nc(nc2cc1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C		Preclinical	histone lysine methyltransferase inhibitor	EHMT2
UNC0638	UNC0638|UNC-0638	COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)C1CCCCC1	26A103L2FO	Preclinical	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
UNC0642	UNC0642	COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)N1CCC(F)(F)CC1		Preclinical	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
UNC0646	UNC0646	COc1cc2c(NC3CCN(CC3)C3CCCCC3)nc(nc2cc1OCCCN1CCCCC1)N1CCCN(CC1)C(C)C		Preclinical	histone lysine methyltransferase inhibitor	EHMT2
UNC0737	UNC0737	COc1cc2c(nc(nc2cc1OCCCN1CCCC1)C1CCCCC1)N(C)C1CCN(CC1)C(C)C		Preclinical	histone lysine methyltransferase inhibitor	EHMT1|EHMT2
UNC1215	UNC1215	O=C(N1CCC(CC1)N1CCCC1)c1ccc(C(=O)N2CCC(CC2)N2CCCC2)c(Nc2ccccc2)c1		Preclinical	L3MBTL antagonist	L3MBTL3
UNC1999	UNC1999	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(cc2n(ncc12)C(C)C)-c1ccc(nc1)N1CCN(CC1)C(C)C		Preclinical	histone lysine methyltransferase inhibitor	EZH2
UNC2025	UNC2025	CCCCNc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(CN2CCN(C)CC2)cc1		Preclinical	MER tyrosine kinase inhibitor|FLT3 inhibitor	FLT3|MERTK
UNC2250	UNC2250	CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		Preclinical	MER tyrosine kinase inhibitor	MERTK
UNC669	UNC669	Brc1cncc(c1)C(=O)N1CCC(CC1)N1CCCC1		Preclinical	L3MBTL antagonist	L3MBTL1
undecylenic-acid	undecylenic-acid|UNDECYLENIC ACID	OC(=O)CCCCCCCCC=C	K3D86KJ24N	Launched	other antifungal	
UPF-1069	UPF-1069	O=C(COc1cccc2c1cc[nH]c2=O)c1ccccc1		Preclinical	PARP inhibitor	PARP2
uprosertib	uprosertib|UPROSERTIB	Cn1ncc(Cl)c1-c1cc(oc1Cl)C(=O)N[C@H](CN)Cc1ccc(F)c(F)c1	ZXM835LQ5E	Phase 2	AKT inhibitor	AKT1|AKT2|AKT3
uracil	uracil|URACIL	Oc1ccnc(O)n1	56HH86ZVCT	Launched		DPYD|UCKL1
uracil-mustard	uracil-mustard|URACIL MUSTARD	Oc1ncc(N(CCCl)CCCl)c(O)n1	W7KQ46GJ8U	Launched	DNA synthesis inhibitor	
urapidil	urapidil|URAPIDIL	COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1	A78GF17HJS	Launched	adrenergic receptor antagonist	HTR1A
URB597	URB597|URB-597	NC(=O)c1cccc(c1)-c1cccc(OC(=O)NC2CCCCC2)c1	PX47LB88FO	Phase 1	FAAH inhibitor	FAAH|FAAH2|TRPA1
urea	urea|UREA	NC(N)=O	8W8T17847W	Launched	hydroxy radical formation stimulant	ARG1|CA2|CTNNB1
urethane	urethane|URETHANE	CCOC(N)=O	3IN71E75Z5	Preclinical	local anesthetic	
uric-acid	uric-acid|URIC ACID	O=c1[nH]c2[nH]c(=O)[nH]c(=O)c2[nH]1	268B43MJ25	Phase 3		PYGL
uridine	uridine|URIDINE	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O	WHI7HQ7H85	Phase 2	dopamine receptor agonist	LSM6|TYMP
uridine-5'-triphosphate	uridine-5'-triphosphate|URIDINE 5'-TRIPHOSPHATE	O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O	UT0S826Z60	Launched	purinergic receptor activator	P2RY11|P2RY2|P2RY4|P2RY6|UCK2
uridine-triacetate	uridine-triacetate|URIDINE TRIACETATE	CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)n1ccc(=O)[nH]c1=O	2WP61F175M	Launched		
URMC-099	URMC-099	CN1CCN(Cc2ccc(cc2)-c2cnc3[nH]cc(-c4ccc5[nH]ccc5c4)c3c2)CC1		Preclinical	mixed lineage kinase inhibitor	CDKL2|DAPK3|FLT3|LRRK2|MAP3K10|MAP3K11|MAP3K2|MAP3K9|SRPK2
ursodeoxycholyltaurine	ursodeoxycholyltaurine|TAUROURSODEOXYCHOLIC ACID	C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	60EUX8MN5X	Phase 2	cholesterol inhibitor	
ursodiol	ursodiol|CHENODIOL|URSODIOL	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	0GEI24LG0J|724L30Y2QR	Launched	nuclear factor erythroid derived|like (NRF2) activator	NR1H4
ursolic-acid	ursolic-acid|URSOLIC ACID	C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O	P3M2575F3F	Phase 1	ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor	HSD11B1|PLA2G1B|PTPN1|PYGM
usniacin-(+)	usniacin-(+)	CC(=O)C1C(=O)C=C2Oc3c(c(O)c(C)c(O)c3C(C)=O)[C@@]2(C)C1=O		Preclinical	MAP kinase activator	PTPN1
V-51	V-51	COc1cc(CN2CCN(CC2)c2ccc(F)cc2)cc(OC)c1OC		Phase 1	adrenergic receptor antagonist	
val	val|VALINE	CC(C)[C@@H](N)C(O)=O	HG18B9YRS7	Phase 2		BCAT1|PCCB|VARS
valaciclovir	valaciclovir|VALACYCLOVIR	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O	MZ1IW7Q79D	Launched	DNA polymerase inhibitor	
valdecoxib	valdecoxib|VALDECOXIB	Cc1onc(c1-c1ccc(cc1)S(N)(=O)=O)-c1ccccc1	2919279Q3W	Withdrawn	cyclooxygenase inhibitor	CA12|PTGS2
valethamate	valethamate|VALETHAMATE	CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1	D64S64QVX7	Launched	acetylcholine receptor antagonist	CHRM1|CHRM4|CHRM5
valganciclovir	valganciclovir|VALGANCICLOVIR, (R)-|VALGANCICLOVIR, (S)-	CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c1nc(N)[nH]c2=O	H61CHR8D70|L74941S4HN	Launched	DNA synthesis inhibitor	
valnemulin	valnemulin|VALNEMULIN	CC(C)[C@@H](N)C(=O)NCC(C)(C)SCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@]23CCC(=O)[C@H]2[C@]1(C)[C@H](C)CC3	2AHC415BQG	Launched	bacterial 50S ribosomal subunit inhibitor	
valnoctamide	valnoctamide|VALNOCTAMIDE	CCC(C)C(CC)C(N)=O	3O25NRX9YG	Phase 3	arachidonic acid acylation inhibitor|benzodiazepine receptor agonist	
valproic-acid	valproic-acid|VALPROIC ACID	CCCC(CCC)C(O)=O	614OI1Z5WI	Launched	HDAC inhibitor	ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A
valpromide	valpromide|VALPROMIDE	CCCC(CCC)C(N)=O	RUA6CWU76G	Launched	epoxide hydolase inhibitor	
valrocemide	valrocemide|VALROCEMIDE	CCCC(CCC)C(=O)NCC(N)=O	1C7GO6OW7L	Phase 2		
valrubicin	valrubicin|VALRUBICIN	CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1	2C6NUM6878	Launched	DNA inhibitor|topoisomerase inhibitor	TOP2A
valsartan	valsartan|VALSARTAN	CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O	80M03YXJ7I	Launched	angiotensin receptor antagonist	AGTR1
valsartan-sacubitril-combination	valsartan-sacubitril-combination|SACUBITRIL VALSARTAN SODIUM HYDRATE	CCOC(=O)C(C)CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)C(C(C)C)C(O)=O	WB8FT61183	Launched	angiotensin receptor antagonist|neprilysin inhibitor	AGTR1
valspodar	valspodar|VALSPODAR	C\C=C\C[C@@H](C)C(=O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](NC1=O)C(C)C)C(C)C	Q7ZP55KF3X	Phase 3	P glycoprotein inhibitor	ABCB1
vancomycin	vancomycin|VANCOMYCIN	CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2	6Q205EH1VU	Launched	bacterial cell wall synthesis inhibitor	
vandetanib	vandetanib|VANDETANIB	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	YO460OQ37K	Launched	EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA
vanillin	vanillin|VANILLIN	COc1cc(C=O)ccc1O	CHI530446X	Preclinical		ABAT|ALDH5A1
vanillylacetone	vanillylacetone|ZINGERONE	COc1cc(CCC(C)=O)ccc1O	4MMW850892	Preclinical		
vanitiolide	vanitiolide|VANITIOLIDE	COc1cc(ccc1O)C(=S)N1CCOCC1	26Y8H6WPAW	Preclinical		
vanoxerine	vanoxerine|VANOXERINE	Fc1ccc(cc1)C(OCCN1CCN(CCCc2ccccc2)CC1)c1ccc(F)cc1	90X28IKH43	Phase 3	dopamine uptake inhibitor	SLC6A3
vardenafil	vardenafil|VARDENAFIL	CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1	UCE6F4125H	Launched	phosphodiesterase inhibitor	PDE5A|PDE6G|PDE6H
varenicline	varenicline|VARENICLINE	C1C2CNCC1c1cc3nccnc3cc21	W6HS99O8ZO	Launched	acetylcholine receptor agonist	CHRNA3|CHRNA4|CHRNA6|CHRNA7
varespladib	varespladib|VARESPLADIB	CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1	2Q3P98DATH	Phase 3	secretory phospholipase inhibitor	PLA2G2A
vasopressin	vasopressin	N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O		Launched	vasopressin receptor agonist	AVPR1A|AVPR1B|AVPR2|OXTR
vatalanib	vatalanib|VATALANIB	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	5DX9U76296	Phase 3	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	EGFR|FLT1|FLT4|KDR|PDGFRB
VBY-825	VBY-825	CC[C@H](NC(=O)[C@H](CS(=O)(=O)CC1CC1)N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)C(=O)NC1CC1		Preclinical	cathepsin inhibitor	CTSB|CTSL|CTSS
VCH-916	VCH-916	CO[C@H]1CC[C@@H](CC1)N(C(=O)[C@H]1CC[C@H](C)CC1)c1cc(sc1C(O)=O)C1=CCCCC1		Phase 1	HCV inhibitor	
VE-821	VE-821	CS(=O)(=O)c1ccc(cc1)-c1cnc(N)c(n1)C(=O)Nc1ccccc1		Preclinical	ATR kinase inhibitor	ATR
VE-822	VE-822|VX-970	CNCc1ccc(cc1)-c1cc(on1)-c1nc(cnc1N)-c1ccc(cc1)S(=O)(=O)C(C)C	L423PRV3V3	Phase 2	ATR kinase inhibitor	ATM|ATR|MTOR|PIK3CG
vecuronium	vecuronium|VECURONIUM	CC(=O)O[C@H]1[C@H](CC2C3CCC4C[C@H](OC(C)=O)[C@H](C[C@]4(C)C3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1	5438723848	Launched	acetylcholine receptor antagonist	CHRNA2
veliflapon	veliflapon|VELIFLAPON	OC(=O)[C@H](C1CCCC1)c1ccc(OCc2ccc3ccccc3n2)cc1	JXH6X663L0	Phase 3	leukotriene synthesis inhibitor	ALOX5AP
veliparib	veliparib|VELIPARIB	C[C@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O	01O4K0631N	Phase 3	PARP inhibitor	PARP1|PARP2
velneperit	velneperit|VELNEPERIT	CC(C)(C)S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)Nc1ccc(cn1)C(F)(F)F	09BQ2KJ22J	Phase 2	neuropeptide receptor antagonist	NPY5R
vemurafenib	vemurafenib|VEMURAFENIB	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F	207SMY3FQT	Launched	RAF inhibitor	BRAF|RAF1
venetoclax	venetoclax|VENETOCLAX	CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1	N54AIC43PW	Launched	BCL inhibitor	BCL2
venlafaxine	venlafaxine|VENLAFAXINE	COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1	GRZ5RCB1QG	Launched	adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI)	SLC6A2|SLC6A3|SLC6A4
VER-49009	VER-49009	CCNC(=O)c1[nH]nc(c1-c1ccc(OC)cc1)-c1cc(Cl)c(O)cc1O		Preclinical	HSP inhibitor	HSP90AA1
verapamil	verapamil|VERAPAMIL	COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC	CJ0O37KU29	Launched	calcium channel blocker	CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4
verbascoside	verbascoside|ACTEOSIDE	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)\C=C\c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O	3TGX09BD5B	Phase 2/Phase 3	PKC inhibitor|NFkB pathway inhibitor	
vercirnon	vercirnon|VERCIRNON	CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc1ccc(Cl)cc1C(=O)c1cc[n+]([O-])cc1	MWI54OUA12	Phase 3	CC chemokine receptor antagonist	CCR9
verinurad	verinurad|VERINURAD	CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(O)=O	12WJ62D047	Phase 2	urate transporter inhibitor	SLC22A12
vernakalant	vernakalant|VERNAKALANT	COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC	9G468C8B13	Launched	potassium channel blocker	KCNA5
verteporfin	verteporfin|VERTEPORFIN C ISOMER	COC(=O)CCc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)c(CCC(O)=O)c5C)c(C=C)c4C)C1=CC=C([C@@H](C(=O)OC)[C@@]31C)C(=O)OC	WU713D62N9	Launched	photosensitizing agent	
verubulin	verubulin|VERUBULIN	COc1ccc(cc1)N(C)c1nc(C)nc2ccccc12	X97O9FTB92	Phase 2	tubulin polymerization inhibitor	TUBB
vesamicol	vesamicol|VESAMICOL, (+/-)-|VESAMICOL, (-)-	O[C@@H]1CCCC[C@H]1N1CCC(CC1)c1ccccc1	3D416V0FLM|I1A877466V	Preclinical	acetylcholinesterase inhibitor	SLC18A3
vesnarinone	vesnarinone|VESNARINONE	COc1ccc(cc1OC)C(=O)N1CCN(CC1)c1ccc2NC(=O)CCc2c1	5COW40EV8M	Launched	phosphodiesterase inhibitor	KCNH2|PDE3A
VGX-1027	VGX-1027	OC(=O)CC1CC(=NO1)c1ccccc1		Phase 1	tumor necrosis factor receptor antagonist	TLR4
vicriviroc	vicriviroc|VICRIVIROC	COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F	TL515DW4QS	Phase 3	CC chemokine receptor antagonist	CCR5
vidarabine	vidarabine|VIDARABINE	Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	FA2DM6879K	Launched	antiviral	ADA
vigabatrin	vigabatrin|VIGABATRIN	NC(CCC(O)=O)C=C	GR120KRT6K	Launched	GABA aminotransferase inhibitor	ABAT|GABBR1|SLC32A1
vilanterol	vilanterol|VILANTEROL	OC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc(ccc1O)[C@@H](O)CNCCCCCCOCCOCc1c(Cl)cccc1Cl	028LZY775B	Launched	adrenergic receptor agonist	ADRB2
vilazodone	vilazodone|VILAZODONE	NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1	S239O2OOV3	Launched	serotonin reuptake inhibitor	DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4
vildagliptin	vildagliptin|VILDAGLIPTIN	OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N	I6B4B2U96P	Launched	dipeptidyl peptidase inhibitor	DPP4
viloxazine	viloxazine|VILOXAZINE	CCOc1ccccc1OCC1CNCCO1	5I5Y2789ZF	Launched	norepinephrine reuptake inhibitor	SLC6A2
vinblastine	vinblastine|VINBLASTINE	CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1C22CCN3CC=C[C@](CC)([C@@H]23)[C@H](OC(C)=O)[C@]1(O)C(=O)OC	5V9KLZ54CY	Launched	microtubule inhibitor|tubulin polymerization inhibitor	JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1
vinburnine	vinburnine|VINBURNINE, (+/-)-|VINBURNINE	CC[C@@]12CCCN3CCc4c([C@H]13)n(C(=O)C2)c1ccccc41	64UB2942IE|G54D0HMY25	Launched	adrenergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
vincamine	vincamine|VINCAMINE	CC[C@@]12CCCN3CCc4c([C@H]13)n(c1ccccc41)[C@@](O)(C2)C(=O)OC	996XVD0JHT	Withdrawn	adrenergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4
vincristine	vincristine|VINCRISTINE	CC[C@]1(O)CC2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC	5J49Q6B70F	Launched	tubulin polymerization inhibitor	TUBA4A|TUBB
vindesine	vindesine|VINDESINE	CC[C@]1(O)C[C@H]2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](O)[C@]1(O)C(N)=O	RSA8KO39WH	Launched	tubulin polymerization inhibitor	TUBB|TUBB1
vinflunine	vinflunine|VINFLUNINE	CCC12C=CCN3CCC4(C13)C(N(C)c1cc(OC)c(cc41)C1(CC3CC(CN(C3)Cc3c1[nH]c1ccccc31)C(C)(F)F)C(=O)OC)C(O)(C2OC(C)=O)C(=O)OC	5BF646324K	Launched	microtubule inhibitor	
vinorelbine	vinorelbine|VINORELBINE	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC	Q6C979R91Y	Launched	tubulin polymerization inhibitor	TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
vinpocetine	vinpocetine|VINPOCETINE	CCOC(=O)C1=C[C@@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41	543512OBTC	Launched	phosphodiesterase inhibitor|sodium channel blocker	PDE1A|PDE1C
viomycin	viomycin|VIOMYCIN	NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)=C\NC(N)=O)C1C[C@H](O)N=C(N)N1	YVU35998K5	Launched	protein synthesis inhibitor	
vipadenant	vipadenant|VIPADENANT	Cc1cc(Cn2nnc3c(nc(N)nc23)-c2ccco2)ccc1N	LDR3USH1NJ	Phase 1	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
vismodegib	vismodegib|VISMODEGIB	Clc1cc(ccc1C(=O)Nc1ccc(Cl)c(c1)-c1ccccn1)S(C)(=O)=O	25X868M3DS	Launched	hedgehog pathway inhibitor|smoothened receptor antagonist	SMO
vitamin-b12	vitamin-b12	C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2[N+]3=C1C(C)=C1[C@@H](CCC(N)=O)C(C)(C)C4=[N+]1[Co]31(C#N)N3C([C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@]23C)=C(C)C2=[N+]1C(=C4)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12		Launched		
vitamin-E	vitamin-E|.ALPHA.-TOCOPHEROL, D-	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1	N9PR3490H9	Phase 2/Phase 3	PKC inhibitor|LDL oxidation inhibitor	ALOX5|DGKA|NR1I2|PPP2CA|PPP2CB|PRKCA|PRKCB|SEC14L2|SEC14L3|SEC14L4
VLX600	VLX600|VLX-600	C\C(=N\Nc1nnc2c(n1)[nH]c1c(C)cccc21)c1ccccn1	YZO6DG19MG	Phase 1	ubiquitin C-terminal hydrolase inhibitor	USP14
voglibose	voglibose|VOGLIBOSE	OCC(CO)N[C@H]1C[C@@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O	S77P977AG8	Launched	glucosidase inhibitor	MGAM
volasertib	volasertib|VOLASERTIB	CC[C@H]1N(C(C)C)c2nc(Nc3ccc(cc3OC)C(=O)N[C@H]3CC[C@@H](CC3)N3CCN(CC4CC4)CC3)ncc2N(C)C1=O	6EM57086EA	Phase 3	PLK inhibitor	PLK1
volinanserin	volinanserin|VOLINANSERIN	COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC	EW71EE171J	Phase 3	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C|KCNH2
vonoprazan	vonoprazan|VONOPRAZAN	CNCc1cc(-c2ccccc2F)n(c1)S(=O)(=O)c1cccnc1	1R5L3J156G	Launched	potassium-competitive acid antagonist	ATP4A
vorapaxar	vorapaxar|VORAPAXAR	CCOC(=O)N[C@@H]1CC[C@@H]2[C@H](C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\c2ccc(cn2)-c2cccc(F)c2)C1	ZCE93644N2	Launched	thrombin receptor antagonist	F2R
voreloxin	voreloxin|VOSAROXIN	CN[C@H]1CN(C[C@@H]1OC)c1ccc2c(n1)n(cc(C(O)=O)c2=O)-c1nccs1	K6A90IIZ19	Phase 3	topoisomerase inhibitor	TOP2A
voriconazole	voriconazole|VORICONAZOLE|VORICONAZOLE, (+/-)-	C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F	JFU09I87TR|USG4B1CD29	Launched	cytochrome P450 inhibitor	CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1
vorinostat	vorinostat|VORINOSTAT	ONC(=O)CCCCCCC(=O)Nc1ccccc1	58IFB293JI	Launched	HDAC inhibitor	HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9
vortioxetine	vortioxetine|VORTIOXETINE	Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1	3O2K1S3WQV	Launched	serotonin receptor agonist|serotonin receptor antagonist	HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4
voxtalisib	voxtalisib|VOXTALISIB	CCn1c2nc(N)nc(C)c2cc(-c2cc[nH]n2)c1=O	CVL1685GPH	Phase 2	mTOR inhibitor|PI3K inhibitor	MTOR|PIK3CA
VP-20629	VP-20629|3-INDOLEPROPIONIC ACID	OC(=O)CCc1c[nH]c2ccccc12	JF49U1Q7KN	Phase 1	beta amyloid antagonist	PLA2G2E|SLC36A1
VS-4718	VS-4718	CNC(=O)c1ccccc1Nc1cc(Nc2ccc(cc2OC)N2CCOCC2)ncc1C(F)(F)F		Phase 1	focal adhesion kinase inhibitor	
VT-464	VT-464|SEVITERONEL	CC(C)[C@@](O)(c1c[nH]nn1)c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1	8S5OIN36X4	Phase 2	cytochrome P450 inhibitor	CYP17A1
VTP-27999	VTP-27999	CN[C@H](CNC(=O)N1CCC[C@H](C1)[C@@H](OCCNC(=O)OC)c1cccc(Cl)c1)C[C@H]1CCCOC1	254XY8NV84	Phase 1	renin inhibitor	REN
VU-0240551	VU-0240551	Cc1csc(NC(=O)CSc2ccc(nn2)-c2ccccc2)n1		Preclinical	potassium/chloride cotransporter inhibitor	SLC12A5
VU0155069	VU0155069	C[C@@H](CN1CCC(CC1)n1c2ccc(Cl)cc2[nH]c1=O)NC(=O)c1ccc2ccccc2c1		Preclinical	phospholipase inhibitor	PLD1
VU0238429	VU0238429	COc1ccc(CN2C(=O)C(=O)c3cc(OC(F)(F)F)ccc23)cc1		Preclinical	acetylcholine receptor allosteric modulator	CHRM5
VU0357121	VU0357121	CCCCOc1ccc(cc1)C(=O)Nc1ccc(F)cc1F		Preclinical	glutamate receptor positive allosteric modulator	GRM5
VU0361737	VU0361737	COc1cc(NC(=O)c2ccccn2)ccc1Cl		Preclinical	glutamate receptor positive allosteric modulator	GRM4
VU0364439	VU0364439	Clc1ccccc1NS(=O)(=O)c1ccc(NC(=O)c2ccccn2)cc1Cl		Preclinical	glutamate receptor positive allosteric modulator	GRM4
VU0364770	VU0364770	Clc1cccc(NC(=O)c2ccccn2)c1		Preclinical	glutamate receptor positive allosteric modulator	GRM4
VUF10166	VUF10166	CN1CCN(CC1)c1nc2ccccc2nc1Cl		Preclinical	serotonin receptor antagonist	HTR3A|HTR3B
VX-11e	VX-11e	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(c1)C(=O)N[C@H](CO)c1cccc(Cl)c1		Preclinical	MAP kinase inhibitor	MAPK1
VX-222	VX-222|LOMIBUVIR	C[C@H]1CC[C@@H](CC1)C(=O)N([C@@H]1CC[C@H](O)CC1)c1cc(sc1C(O)=O)C#CC(C)(C)C	37L2LF4A2D	Phase 2	HCV inhibitor	
VX-661	VX-661|TEZACAFTOR	CC(C)(CO)c1cc2cc(NC(=O)C3(CC3)c3ccc4OC(F)(F)Oc4c3)c(F)cc2n1C[C@@H](O)CO	8RW88Y506K	Phase 3	CFTR channel agonist	CFTR
VX-702	VX-702	NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F	527E7SK68P	Phase 2	p38 MAPK inhibitor	MAPK11|MAPK12|MAPK14
VX-745	VX-745	Fc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c(F)c1	TYL52QM320	Phase 2	p38 MAPK inhibitor	MAPK11|MAPK12|MAPK14
VX-765	VX-765|BELNACASAN	CCO[C@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C	00OLE78529	Phase 2	caspase inhibitor	CASP1
W-54011	W-54011	COc1ccc2CCCC(C(=O)N(Cc3ccc(cc3)N(C)C)c3ccc(cc3)C(C)C)c2c1		Preclinical	anaphylatoxin chemotactic receptor antagonist	C5AR1
walrycin-b	walrycin-b	Cn1nc(nc2c1nc(=O)n(C)c2=O)-c1ccc(cc1)C(F)(F)F		Preclinical	transcriptional regulatory protein WalR	
warfarin	warfarin|WARFARIN	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O	5Q7ZVV76EI	Launched	vitamin K antagonist	VKORC1
WAY-100635	WAY-100635	COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1	71IH826FEG	Phase 1	serotonin receptor antagonist	HTR1A
WAY-161503	WAY-161503	Clc1cc2NC(=O)C3CNCCN3c2cc1Cl		Preclinical	serotonin receptor agonist	HTR2C
WAY-170523	WAY-170523	Cc1cc(C)c(N(Cc2ccccc2)S(=O)(=O)c2ccc(OCCNC(=O)c3cc4ccccc4o3)cc2)c(c1)C(=O)NO		Preclinical	metalloproteinase inhibitor	MMP13
WAY-200070	WAY-200070	Oc1ccc(cc1)-c1nc2cc(O)cc(Br)c2o1		Preclinical	estrogen receptor agonist	ERBB2|ERBB3|ERBB4|ESR2
WAY-213613	WAY-213613	N[C@@H](CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(O)=O		Preclinical	glutamate inhibitor	SLC1A2
WAY-316606	WAY-316606	FC(F)(F)c1ccc(cc1S(=O)(=O)NC1CCNCC1)S(=O)(=O)c1ccccc1		Preclinical	secreted frizzled related protein inhibitor	SFRP1
WAY-362450	WAY-362450|TUROFEXORATE ISOPROPYL	CC(C)OC(=O)C1=CN(CC(C)(C)c2c1[nH]c1ccccc21)C(=O)c1ccc(F)c(F)c1	S6KDM312I5	Phase 1	FXR agonist	NR1H4
WAY-600	WAY-600	C(N1CCC(CC1)n1ncc2c(nc(nc12)-c1ccc2[nH]ccc2c1)N1CCOCC1)c1cccnc1		Preclinical	mTOR inhibitor	MTOR
WAY-629	WAY-629	C1CCc2c(C1)n1CCNCc3cccc2c13		Preclinical	serotonin receptor agonist	HTR2C
WB-4101	WB-4101	COc1cccc(OC)c1OCCNCC1COc2ccccc2O1		Preclinical	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A
WEHI-345-analog	WEHI-345-analog	Cc1ccc(cc1)-c1nn(c2ncnc(N)c12)C(C)(C)CNC(=O)c1ncccc1C		Preclinical	src inhibitor	
WHI-P154	WHI-P154	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		Preclinical	JAK inhibitor	EGFR|JAK1|JAK2|JAK3
WIKI4	WIKI4	COc1ccc(cc1)-n1c(SCCCN2C(=O)c3cccc4cccc(C2=O)c34)nnc1-c1ccncc1		Preclinical	Wnt pathway inhibitor|tankyrase inhibitor	TNKS2
WIN-18446	WIN-18446|FERTILYSIN	ClC(Cl)C(=O)NCCCCCCCCNC(=O)C(Cl)Cl	3F56RA64JN	Preclinical	aldehyde dehydrogenase inhibitor	ALDH1A2
WIN-64338	WIN-64338	CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)N\C(NC2CCCCC2)=N\C2CCCCC2)cc1		Preclinical	bradykinin receptor antagonist	BDKRB2
wnt-c59	wnt-c59	Cc1cc(ccn1)-c1ccc(CC(=O)Nc2ccc(cc2)-c2cccnc2)cc1		Preclinical	porcupine inhibitor	PORCN
wortmannin	wortmannin|WORTMANNIN	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C([C@@H]2CCC(=O)[C@@]2(C)C[C@@H]1OC(C)=O)C3=O	XVA4O219QW	Preclinical	PI3K inhibitor	PI4KA|PI4KB|PIK3CA|PIK3CD|PIK3CG|PIK3R1|PLK1|PRKDC
WP1066	WP1066|WP 1066	C[C@H](NC(=O)C(=C\c1cccc(Br)n1)\C#N)c1ccccc1	63V8AIE65T	Phase 1	STAT inhibitor	STAT3
WP1130	WP1130	CCC[C@H](NC(=O)C(=C\c1cccc(Br)n1)\C#N)c1ccccc1		Preclinical	deubiquitinase inhibitor	JAK2|UCHL5|USP14|USP9X
WR99210	WR99210	CC1(C)N=C(N)N=C(N)N1OCCCOc1cc(Cl)c(Cl)cc1Cl		Preclinical	dihydrofolate reductase inhibitor	TYMS
Wy-16922	Wy-16922	CCOC(=O)C(=O)Nc1cccc(OC)c1C(N)=O		Phase 1	histamine release inhibitor	
WYE-125132	WYE-125132	CNC(=O)Nc1ccc(cc1)-c1nc(N2CC3CCC(C2)O3)c2cnn(C3CCC4(CC3)OCCO4)c2n1		Preclinical	mTOR inhibitor	MTOR
WYE-354	WYE-354	COC(=O)Nc1ccc(cc1)-c1nc(N2CCOCC2)c2cnn(C3CCN(CC3)C(=O)OC)c2n1		Preclinical	mTOR inhibitor	MTOR
WZ-3146	WZ-3146	CN1CCN(CC1)c1ccc(Nc2ncc(Cl)c(Oc3cccc(NC(=O)C=C)c3)n2)cc1		Preclinical	EGFR inhibitor	EGFR
WZ-4002	WZ-4002	COc1cc(ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)C=C)c2)n1)N1CCN(C)CC1	6BQ432Z61M	Preclinical	EGFR inhibitor	EGFR|ERBB2
WZ4003	WZ4003	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(cc3OC)N3CCN(C)CC3)ncc2Cl)c1		Preclinical	AMPK inhibitor	NUAK1|NUAK2
WZ8040	WZ8040	CN1CCN(CC1)c1ccc(Nc2ncc(Cl)c(Sc3cccc(NC(=O)C=C)c3)n2)cc1		Preclinical	EGFR inhibitor	EGFR
WZ811	WZ811	C(Nc1ccccn1)c1ccc(CNc2ccccn2)cc1		Preclinical	CC chemokine receptor antagonist	CXCR4
xaliproden	xaliproden|XALIPRODEN	FC(F)(F)c1cccc(c1)C1=CCN(CCc2ccc3ccccc3c2)CC1	V8QL94KNQO	Phase 3	serotonin receptor agonist	HTR1A
xamoterol	xamoterol|XAMOTEROL	OC(CNCCNC(=O)N1CCOCC1)COc1ccc(O)cc1	7HE0JQL703	Phase 3	adrenergic receptor agonist	ADRB1
xanomeline	xanomeline|XANOMELINE	CCCCCCOc1nsnc1C1=CCCN(C)C1	9ORI6L73CJ	Phase 3	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7
xanthone	xanthone|XANTHONE	O=c1c2ccccc2oc2ccccc12	9749WEV0CA	Preclinical	antimalarial agent	
XAV-939	XAV-939	Oc1nc(nc2CCSCc12)-c1ccc(cc1)C(F)(F)F		Preclinical	tankyrase inhibitor	TNKS|TNKS2
XBD173	XBD173|EMAPUNIL	CCN(Cc1ccccc1)C(=O)Cn1c2nc(ncc2n(C)c1=O)-c1ccccc1	OG837L732J	Phase 2	benzodiazepine receptor ligand	TSPO
XE-991	XE-991	O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc12		Preclinical	potassium channel blocker	KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5
xenalipin	xenalipin|XENALIPIN	OC(=O)c1ccccc1-c1ccc(cc1)C(F)(F)F	28W00I603X	Phase 2		
xibenolol	xibenolol|XIBENOLOL	Cc1cccc(OCC(O)CNC(C)(C)C)c1C	0871JY946G	Phase 3	adrenergic receptor antagonist	
xilobam	xilobam|XILOBAM	CN1CCC\C1=N\C(=O)Nc1c(C)cccc1C	Q53S20XGPU	Phase 1		
xipamide	xipamide|XIPAMIDE	Cc1cccc(C)c1NC(=O)c1cc(c(Cl)cc1O)S(N)(=O)=O	4S9EY0NUEC	Launched	carbonic anhydrase inhibitor	SLC12A3
XL-147	XL-147|PILARALISIB	Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2nsnc2c1	60ES45KTMK	Phase 2	PI3K inhibitor	PIK3CA|PIK3CD|PIK3CG
XL-647	XL-647|TESEVATINIB	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@H]1C[C@H]2CN(C)C[C@H]2C1	F6XM2TN5A1	Phase 3	EGFR inhibitor|VEGFR inhibitor	EGFR|EPHB4|ERBB2|FLT4|KDR
XL019	XL019|XL-019	O=C(Nc1ccc(cc1)-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1)[C@@H]1CCCN1	4L1AM42NVA	Phase 1	JAK inhibitor	JAK1|JAK2|JAK3
XL228	XL228|XL-228	CC(C)c1cc(CNc2nc(Nc3cc([nH]n3)C3CC3)cc(n2)N2CCN(C)CC2)on1	33M2XSK003	Phase 1	Abl kinase inhibitor|insulin growth factor receptor inhibitor|src inhibitor	IGF1R|SRC
XL388	XL388	Cc1c(F)c(ccc1C(=O)N1CCOc2ccc(cc2C1)-c1ccc(N)nc1)S(C)(=O)=O		Preclinical	mTOR inhibitor	MTOR
XL888	XL888|XL-888	CC[C@@H](C)Nc1cc(C(=O)NC2CC3CCC(C2)N3c2ccc(cn2)C(=O)C2CC2)c(C)cc1C(N)=O	7M346920EV	Phase 1	HSP inhibitor	
XMD17-109	XMD17-109	CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C3CCCC3)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1		Preclinical	MAP kinase inhibitor	MAPK7
XMD8-92	XMD8-92	CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCC(O)CC1		Preclinical	MAP kinase inhibitor	DCLK2|MAPK7|PLK4|TNK1
xylazine	xylazine|XYLAZINE	Cc1cccc(C)c1NC1=NCCCS1	2KFG9TP5V8	Launched	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C
xylometazoline	xylometazoline|XYLOMETAZOLINE	Cc1cc(cc(C)c1CC1=NCCN1)C(C)(C)C	WPY40FTH8K	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
xylose	xylose|XYLOSE	OC[C@@H](O)[C@H](O)[C@@H](O)C=O	A1TA934AKO	Launched		
Y-134	Y-134	CC(C)N1CCN(CC1)c1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1		Preclinical	estrogen receptor antagonist	ESR1|ESR2
Y-26763	Y-26763	CC(=O)N(O)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N	Q9F3XV8A6X	Phase 1	potassium channel activator	KCNJ8
Y-27152	Y-27152	CC(=O)N(OCc1ccccc1)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N		Phase 1	potassium channel activator	KCNJ8
Y-27632	Y-27632	C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)Nc1ccncc1	0X370ROP6H	Preclinical	rho associated kinase inhibitor	PKIA|PKN2|PRKACA|PRKCE|ROCK1|ROCK2
Y-29794	Y-29794	CC(C)c1ccc(C(=O)c2cccs2)c(SCCCCCCCCN(C)C)n1		Preclinical	prolyl endopeptidase inhibitor	PREP
Y-320	Y-320	Cc1c(cnn1-c1ccc(Cl)cc1)C(=O)Nc1ccc(N2CCC(CC2)N2CCOCC2)c(c1)C#N		Preclinical	interleukin inhibitor	IL17A
Y-39983	Y-39983	C[C@@H](N)c1ccc(cc1)C(=O)Nc1ccnc2[nH]ccc12	3304VH0J6B	Phase 2	rho associated kinase inhibitor	ROCK1|ROCK2
Y16	Y16	Cc1cccc(COc2cccc(\C=C3/C(=O)NN(C3=O)c3ccccc3)c2)c1		Preclinical	rho associated kinase inhibitor	RHOA
YK-4-279	YK-4-279	COc1ccc(cc1)C(=O)CC1(O)C(=O)Nc2c1c(Cl)ccc2Cl		Preclinical	apoptosis inhibitor	EWSR1|FLI1
YM-155	YM-155|SEPANTRONIUM BROMIDE	COCCn1c2c(C(=O)c3ccccc3C2=O)[n+](Cc2cnccn2)c1C	7H5Q4J1CM5	Phase 2	survivin inhibitor	BIRC5
YM-201636	YM-201636	Nc1ccc(cn1)C(=O)Nc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1		Preclinical	PI3K inhibitor	
YM-298198	YM-298198	Cc1c(sc2nc3ccc(N)cc3n12)C(=O)NC1CCCCC1		Preclinical	glutamate receptor antagonist	GRM1
YM-511	YM-511	Brc1ccc(CN(c2ccc(cc2)C#N)n2cnnc2)cc1		Phase 2	aromatase inhibitor	CYP19A1
YM-58483	YM-58483	Cc1nnsc1C(=O)Nc1ccc(cc1)-n1nc(cc1C(F)(F)F)C(F)(F)F		Preclinical	calcium channel blocker	TRPC3|TRPC5|TRPM4
YM-750	YM-750	Cc1cc(C)c(NC(=O)N(Cc2ccc-3c(Cc4ccccc-34)c2)C2CCCCCC2)c(C)c1		Phase 1	ACAT inhibitor	SOAT1
YM-90709	YM-90709	COc1cc2CC(C)(C)n3c(cc4nc5ccccc5nc34)-c2cc1OC		Preclinical	IL5 inhibitor	CSF2RB|IL5RA
YM-976	YM-976	CCc1ccc2c(nc(=O)n(CC)c2n1)-c1cccc(Cl)c1		Phase 1	phosphodiesterase inhibitor	PDE4A
YM022	YM022|YM-022	Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(CC(=O)c3ccccc3C)C2=O)c1	772CP7W12N	Phase 2	CCK receptor antagonist	CCKBR
YO-01027	YO-01027	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O		Preclinical	gamma secretase inhibitor	
yohimbine	yohimbine|YOHIMBINE	COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12	2Y49VWD90Q	Launched	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
YS-035	YS-035	COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC		Preclinical	calcium channel blocker	
Z160	Z160|Z-160	O=C(CC(c1ccccc1)c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1	TX3R141LEP	Phase 2	N-type calcium channel blocker	CACNA2D1
zacopride	zacopride|ZACOPRIDE	COc1cc(N)c(Cl)cc1C(=O)NC1CN2CCC1CC2	9GN3OT4156	Phase 2	serotonin receptor antagonist	HTR3A|HTR3B|HTR4|HTR5A
zafirlukast	zafirlukast|ZAFIRLUKAST	COc1cc(ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12)C(=O)NS(=O)(=O)c1ccccc1C	XZ629S5L50	Launched	leukotriene receptor antagonist	CYSLTR1|CYSLTR2
zalcitabine	zalcitabine|ZALCITABINE	Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1	6L3XT8CB3I	Launched	nucleoside reverse transcriptase inhibitor	
zaldaride	zaldaride|ZALDARIDE	CC1(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)OCc2ccccc2-n2cccc12	GH66PET6S3	Phase 3	calmodulin antagonist	CALM1
zaleplon	zaleplon|ZALEPLON	CCN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C#N	S62U433RMH	Launched	benzodiazepine receptor agonist	GABRA1|GABRB1|GABRG2|TSPO
zaltidine	zaltidine|ZALTIDINE	Cc1ncc([nH]1)-c1csc(NC(N)=N)n1	54HY424479	Phase 3	histamine receptor antagonist	HRH2
zaltoprofen	zaltoprofen|ZALTOPROFEN	CC(C(O)=O)c1ccc2Sc3ccccc3C(=O)Cc2c1	H8635NG3PY	Launched	cyclooxygenase inhibitor	
ZAMI-633	ZAMI-633|PROPIONOHYDROXAMIC ACID	CCC(=O)NO	9K8TD4EMP0	Phase 3	urease inhibitor	
zamifenacin	zamifenacin|ZAMIFENACIN	C(Cc1ccc2OCOc2c1)N1CCC[C@H](C1)OC(c1ccccc1)c1ccccc1	Y88Q418Y7M	Phase 3	acetylcholine receptor antagonist	CHRM3
zanamivir	zanamivir|ZANAMIVIR	CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O	L6O3XI777I	Launched	neuraminidase inhibitor	NEU2
ZAPA	ZAPA	NC(=N)S\C=C/C(O)=O		Preclinical		
zaprinast	zaprinast|ZAPRINAST	CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1	GXT25D5DS0	Phase 2	phosphodiesterase inhibitor	GPR35|PDE1A|PDE4D|PDE5A|PDE9A
zardaverine	zardaverine|ZARDAVERINE	COc1cc(ccc1OC(F)F)-c1ccc(=O)[nH]n1	TQ358GWH6Y	Phase 2	phosphodiesterase inhibitor	PDE4D
zatebradine	zatebradine|ZATEBRADINE	COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC	TV27RY5876	Phase 3	HCN channel blocker	HCN1|HCN2|HCN3|HCN4
ZCL-278	ZCL-278	Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)COc3ccc(Br)cc3Cl)cc2)n1		Preclinical	CDC inhibitor	CDC42
ZD-2079	ZD-2079|TALIBEGRON	O[C@@H](CNCCOc1ccc(CC(O)=O)cc1)c1ccccc1	M7O3VK2O7W	Phase 2	adrenergic receptor agonist	ADRB3
ZD-7114	ZD-7114	COCCNC(=O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1		Phase 1	adrenergic receptor agonist	ADRB3
ZD-7155	ZD-7155	CCc1cc2N(Cc3ccc(cc3)-c3ccccc3-c3nnn[nH]3)C(=O)CCc2c(CC)n1		Preclinical	angiotensin receptor antagonist	AGTR1
ZD-7288	ZD-7288	CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1		Phase 2	HCN channel blocker	HCN1|HCN2|HCN3|HCN4
zeatin	zeatin|ZEATIN	C\C(CO)=C/CNc1[nH]cnc2ncnc12	7I6OOJ9GR6	Phase 1		
zebularine	zebularine|4-DEOXYURIDINE	OC[C@H]1O[C@H](C(O)[C@H]1O)n1cccnc1=O	7A9Y5SX0GY	Preclinical	DNA methyltransferase inhibitor	CDA|DNMT1
zibotentan	zibotentan|ZIBOTENTAN	COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(cc1)-c1nnco1	8054MM4902	Phase 3	endothelin receptor antagonist	EDNRA
zidovudine	zidovudine|ZIDOVUDINE	Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O	4B9XT59T7S	Launched	nucleoside reverse transcriptase inhibitor	TERT
zileuton	zileuton|ZILEUTON	CC(N(O)C(N)=O)c1cc2ccccc2s1	V1L22WVE2S	Launched	leukotriene synthesis inhibitor|lipoxygenase inhibitor	ALOX5
zilpaterol	zilpaterol|ZILPATEROL	CC(C)N[C@H]1CCn2c(O)nc3cccc([C@@H]1O)c23	S384A1Y12J	Launched	adrenergic receptor agonist	ADRB2
zimelidine	zimelidine|ZIMELDINE	CN(C)C\C=C(\c1ccc(Br)cc1)c1cccnc1	3J928617DW	Withdrawn	selective serotonin reuptake inhibitor (SSRI)	MAOA|MAOB|SLC6A4
zinc-undecylenate	zinc-undecylenate|ZINC UNDECYLENATE	C=CCCCCCCCCC(=O)O[Zn]OC(=O)CCCCCCCCC=C	388VZ25DUR	Launched	other antifungal	
zindotrine	zindotrine|ZINDOTRINE	Cc1cc(nn2cnnc12)N1CCCCC1	VQM3328PO0	Phase 2	phosphodiesterase inhibitor	
ziprasidone	ziprasidone|ZIPRASIDONE	Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12	6UKA5VEJ6X	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4
ZK-164015	ZK-164015	CCCCCS(=O)(=O)CCCCCCCCCCn1c(c(C)c2cc(O)ccc12)-c1ccc(O)cc1		Preclinical	estrogen receptor antagonist	ESR1|ESR2
ZK-200775	ZK-200775|FANAPANEL	OP(O)(=O)Cn1c2cc(N3CCOCC3)c(cc2[nH]c(=O)c1=O)C(F)(F)F	E3AP71EM0O	Phase 2	kainate receptor antagonist	
ZK-93423	ZK-93423	CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC		Phase 3	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2
ZK-93426	ZK-93426	CCOC(=O)c1ncc2[nH]c3cccc(OC(C)C)c3c2c1C		Phase 1	benzodiazepine receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA5
ZK811752	ZK811752|BX-471	C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1ccc(Cl)cc1NC(N)=O	L350B5LO1J	Phase 2	CC chemokine receptor antagonist	CCR1
ZLN005	ZLN005	CC(C)(C)c1ccc(cc1)-c1nc2ccccc2[nH]1		Preclinical		
ZM-226600	ZM-226600	CC(O)(C(=O)Nc1ccc(cc1)S(=O)(=O)c1ccccc1)C(F)(F)F		Preclinical	Kir6 channel (KATP) activator	
ZM-241385	ZM-241385	Nc1nc(NCCc2ccc(O)cc2)nc2nc(nn12)-c1ccco1		Preclinical	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3
ZM-306416	ZM-306416	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		Preclinical	Abl kinase inhibitor|src inhibitor|VEGFR inhibitor	EGFR|FLT1|FLT4|KDR
ZM-323881	ZM-323881	Cc1cc(F)c(Nc2ncnc3cc(OCc4ccccc4)ccc23)cc1O		Preclinical	VEGFR inhibitor	KDR
ZM-336372	ZM-336372	CN(C)c1cccc(c1)C(=O)Nc1ccc(C)c(NC(=O)c2ccc(O)cc2)c1		Preclinical	RAF inhibitor	BRAF|LCK|MAPK14|RAF1
ZM-39923	ZM-39923	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		Preclinical	JAK inhibitor	JAK1|JAK3
ZM-447439	ZM-447439	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1	RSN3P9776R	Preclinical	Aurora kinase inhibitor	AURKA|AURKB
zofenopril-calcium	zofenopril-calcium|ZOFENOPRIL CALCIUM	C[C@H](CSC(=O)c1ccccc1)C(=O)N1C[C@H](C[C@H]1C(O)=O)Sc1ccccc1	88ZQ329PU2	Launched	angiotensin converting enzyme inhibitor	ACE
zolantidine	zolantidine|ZOLANTIDINE	C(CNc1nc2ccccc2s1)COc1cccc(CN2CCCCC2)c1	M1108XAY01	Preclinical	histamine receptor antagonist	
zoledronic-acid	zoledronic-acid|ZOLEDRONIC ACID	OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O	6XC1PAD3KF	Launched	bone resorption inhibitor	FDPS|GGPS1
zolimidine	zolimidine|ZOLIMIDINE	CS(=O)(=O)c1ccc(cc1)-c1cn2ccccc2n1	YCF001N8QB	Launched	mucus protecting agent	
zolmitriptan	zolmitriptan|ZOLMITRIPTAN	CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12	2FS66TH3YW	Launched	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F
zolpidem	zolpidem|ZOLPIDEM	CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1	7K383OQI23	Launched	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3
zomepirac	zomepirac|ZOMEPIRAC	Cc1cc(CC(O)=O)n(C)c1C(=O)c1ccc(Cl)cc1	822G987U9J	Withdrawn	prostaglandin synthesis inhibitor	PTGDR2
zometapine	zometapine|ZOMETAPINE	Cc1nn(C)c2NCCN=C(c12)c1cccc(Cl)c1	9171J97IQP	Phase 2		
zonisamide	zonisamide|ZONISAMIDE	NS(=O)(=O)Cc1noc2ccccc12	459384H98V	Launched	sodium channel blocker|T-type calcium channel blocker	CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A
zopolrestat	zopolrestat|ZOPOLRESTAT	OC(=O)C=C1NN(Cc2nc3cc(ccc3s2)C(F)(F)F)C(=O)c2ccccc12	1PV3S9WP3D	Phase 2		
zosuquidar	zosuquidar|ZOSUQUIDAR	O[C@@H](COc1cccc2ncccc12)CN1CCN(CC1)[C@@H]1c2ccccc2[C@@H]2[C@H](c3ccccc13)C2(F)F	AB5K82X98Y	Phase 3	P glycoprotein inhibitor	ABCB1|ABCB4
zotarolimus	zotarolimus|ZOTAROLIMUS	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1n1cnnn1	H4GXR80IZE	Launched	mTOR inhibitor	FKBP1A
zotepine	zotepine|ZOTEPINE	CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc12	U29O83JAZW	Launched	dopamine receptor antagonist|serotonin receptor antagonist	ADRA2B|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR6|HTR7|SLC6A2|SLC6A4
zoxazolamine	zoxazolamine|ZOXAZOLAMINE	Nc1nc2cc(Cl)ccc2o1	9DOW362Q29	Phase 2	myorelaxant	
ZSTK-474	ZSTK-474	FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1	K0068GK39A	Phase 1/Phase 2	PI3K inhibitor	PIK3CB|PIK3CD|PIK3CG
zuclopenthixol	zuclopenthixol|ZUCLOPENTHIXOL	OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(Cl)cc23)CC1	47ISU063SG	Launched	dopamine receptor antagonist	ADRA1A|ADRA2A|DRD1|DRD2|DRD5|HRH1|HTR2A
